data_2hna_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hna _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 tpp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.23 161.9 41.89 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.887 0.875 . . . . 10.0 110.287 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.11 -18.62 21.6 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.751 1.22 . . . . 10.0 110.984 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mt -137.22 129.15 42.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 C-N-CA 124.399 1.08 . . . . 10.0 108.429 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 t -91.41 137.62 32.22 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.645 -1.242 . . . . 10.0 107.645 168.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -112.4 91.75 3.77 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 104.614 -2.365 . . . . 10.0 104.614 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.4 104.08 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.4 1.48 . . . . 10.0 107.195 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -128.69 46.09 2.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.469 0.708 . . . . 10.0 111.868 -154.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.39 56.33 0.44 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-O 117.968 -1.462 . . . . 10.0 114.103 -161.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 m -33.39 -52.86 0.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.124 1.77 . . . . 10.0 113.646 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.35 42.33 2.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.514 1.125 . . . . 10.0 108.491 -170.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.9 tp 56.9 28.8 15.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.658 1.583 . . . . 10.0 111.075 -164.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.33 155.22 17.34 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.965 2.698 . . . . 10.0 106.485 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.05 -164.78 35.55 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 117.932 0.866 . . . . 10.0 111.669 -166.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.47 52.23 0.62 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.578 1.951 . . . . 10.0 112.882 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -55.8 -31.63 62.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.241 1.016 . . . . 10.0 112.212 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -60.92 -50.07 74.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.981 0.81 . . . . 10.0 110.768 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.45 -39.97 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.29 84.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.897 -0.573 . . . . 10.0 111.813 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.37 -39.48 85.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.974 0.807 . . . . 10.0 110.331 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -63.65 -46.82 83.88 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.93 -0.482 . . . . 10.0 110.279 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.4 mt -57.96 -47.28 83.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.811 0.844 . . . . 10.0 110.15 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.18 83.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.209 1.004 . . . . 10.0 110.028 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.54 -47.06 87.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.371 0.532 . . . . 10.0 110.687 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -61.58 -34.7 76.07 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.673 -0.642 . . . . 10.0 111.33 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.17 -32.89 67.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.516 0.598 . . . . 10.0 111.185 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -70.79 -38.94 73.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.708 1.14 . . . . 10.0 109.865 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.68 -32.45 71.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.244 0.618 . . . . 10.0 111.087 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.19 -17.07 64.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.733 0.813 . . . . 10.0 112.799 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.38 18.96 4.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.836 -0.98 . . . . 10.0 113.555 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -120.82 -170.88 2.08 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.808 1.304 . . . . 10.0 109.797 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 p -131.66 145.26 51.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.146 -1.427 . . . . 10.0 107.146 172.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -136.65 158.86 43.45 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.125 -0.359 . . . . 10.0 110.912 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.01 92.59 3.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -65.17 119.84 11.59 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.307 1.043 . . . . 10.0 108.42 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -148.39 149.01 31.0 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 123.584 0.754 . . . . 10.0 108.988 -171.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -90.49 35.43 0.88 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.292 -0.88 . . . . 10.0 110.184 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.22 51.02 21.48 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.983 1.754 . . . . 10.0 114.572 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.04 -15.68 49.56 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.858 2.372 . . . . 10.0 113.435 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.11 13.6 11.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.404 1.482 . . . . 10.0 110.704 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 tp 62.42 -43.89 0.18 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.557 2.743 . . . . 10.0 113.316 -166.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -148.8 78.11 1.39 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.873 1.669 . . . . 10.0 108.121 -167.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.473 -0.767 . . . . 10.0 111.357 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.2 mt -84.48 147.42 49.62 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.947 -1.131 . . . . 10.0 107.947 164.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 47' ' ' SER . 72.1 Cg_endo -69.64 -175.4 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.08 2.52 . . . . 10.0 111.873 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.61 21.94 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.896 1.678 . . . . 10.0 113.694 173.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' PRO . 17.9 m -142.39 136.08 29.21 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.321 1.848 . . . . 10.0 106.797 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.01 -136.88 10.11 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.92 -1.272 . . . . 10.0 109.92 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -130.35 136.34 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.159 -1.793 . . . . 10.0 106.159 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -117.87 157.5 26.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -141.72 145.87 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.021 -1.844 . . . . 10.0 106.021 168.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.3 t -130.88 124.34 56.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.37 97.36 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.669 -1.604 . . . . 10.0 106.669 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -148.7 174.12 12.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 10.0 108.372 -170.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 m -137.52 70.47 1.4 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.597 1.09 . . . . 10.0 110.312 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -169.169 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 110.298 -0.26 . . . . 10.0 110.298 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.19 58.48 1.31 Allowed 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.486 0.714 . . . . 10.0 110.038 -170.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -45.95 -56.17 11.09 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.228 -1.368 . . . . 10.0 114.566 -167.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.57 -44.34 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 122.034 1.762 . . . . 10.0 111.633 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -65.41 -43.35 90.82 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 10.0 111.264 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.36 -45.49 83.9 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.921 0.782 . . . . 10.0 110.158 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.18 -42.79 99.42 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.12 96.03 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.03 0.377 . . . . 10.0 111.461 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -59.69 -51.56 69.26 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.703 0.683 . . . . 10.0 109.47 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.19 -31.27 72.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.667 0.667 . . . . 10.0 111.81 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.87 -30.95 71.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.724 0.81 . . . . 10.0 112.251 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -124.21 -27.3 3.84 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.491 1.293 . . . . 10.0 114.491 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 32.45 61.78 1.38 Allowed Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.286 1.834 . . . . 10.0 112.572 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.47 160.26 40.33 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.12 2.546 . . . . 10.0 110.955 -172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -73.23 76.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.071 0.949 . . . . 10.0 111.187 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 9.22 1.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.93 1.292 . . . . 10.0 112.269 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.0 m -60.84 -17.5 50.34 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.219 -1.551 . . . . 10.0 113.344 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.44 10.83 39.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.78 1.232 . . . . 10.0 112.594 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.95 160.79 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.229 1.012 . . . . 10.0 108.997 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -123.81 150.81 44.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.296 -1.742 . . . . 10.0 106.296 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.63 163.53 25.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.606 0.717 . . . . 10.0 110.476 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.04 116.66 1.69 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.394 -2.682 . . . . 10.0 106.394 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.04 144.32 56.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.38 131.23 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.521 -1.659 . . . . 10.0 106.521 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.09 -27.54 1.71 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.757 1.17 . . . . 10.0 113.012 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.24 139.29 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 127.15 2.18 . . . . 10.0 107.606 171.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.58 0.72 8.67 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.269 -0.739 . . . . 10.0 112.387 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 C-N-CA 124.518 1.127 . . . . 10.0 109.834 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 mttt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 113.491 0.923 . . . . 10.0 113.491 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.84 -52.8 62.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.23 0.923 . . . . 10.0 110.813 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.52 -43.77 98.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.1 93.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.046 0.938 . . . . 10.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -67.97 -36.79 80.65 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.416 1.007 . . . . 10.0 111.222 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.05 -45.14 94.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.278 0.944 . . . . 10.0 110.06 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -65.87 -39.21 90.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.22 0.608 . . . . 10.0 110.524 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.58 97.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.066 . . . . 10.0 110.975 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 m -72.45 -29.08 63.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.727 0.411 . . . . 10.0 110.651 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.89 -13.15 1.49 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.426 -1.208 . . . . 10.0 114.327 160.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.08 116.55 9.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.241 1.521 . . . . 10.0 108.131 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -61.73 139.02 58.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 167.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -80.84 128.78 34.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.154 -2.165 . . . . 10.0 105.154 158.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 m -105.06 148.45 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.8 -133.93 46.84 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.09 -1.604 . . . . 10.0 109.09 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.93 163.65 33.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.535 -1.654 . . . . 10.0 106.535 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -48.59 123.32 6.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.293 1.037 . . . . 10.0 112.082 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.33 147.36 48.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.793 1.237 . . . . 10.0 107.92 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -118.6 136.75 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.838 -1.171 . . . . 10.0 107.838 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 -174.263 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 118.588 -0.72 . . . . 10.0 111.223 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.81 -44.92 93.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.483 1.038 . . . . 10.0 108.934 171.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.47 -46.03 91.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.42 97.3 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.409 0.528 . . . . 10.0 112.672 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.6 m -61.57 -56.79 16.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.341 1.071 . . . . 10.0 110.75 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -59.51 -40.69 87.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.942 1.297 . . . . 10.0 110.699 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.27 -56.18 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.849 -0.596 . . . . 10.0 110.042 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -69.68 -21.86 63.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 10.0 112.136 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.45 -45.25 76.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.708 0.685 . . . . 10.0 110.631 168.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -22.43 57.69 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.973 0.806 . . . . 10.0 112.61 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.9 mttt . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.252 1.021 . . . . 10.0 108.406 169.521 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.55 167.21 31.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.126 1.371 . . . . 0.0 108.921 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.36 -25.07 25.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.697 0.799 . . . . 0.0 110.893 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.6 mt -138.27 127.63 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.749 1.22 . . . . 0.0 107.943 -171.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.18 135.21 33.39 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.4 104.64 13.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.7 mt -96.46 100.57 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -102.64 20.12 17.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.241 1.016 . . . . 0.0 110.735 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 36.51 2.17 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.072 1.32 . . . . 0.0 115.163 -169.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -47.65 -50.84 23.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.215 1.406 . . . . 0.0 112.268 -172.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -127.33 50.77 1.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.7 tp 63.29 20.05 12.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.813 2.045 . . . . 0.0 111.283 -169.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.14 178.1 36.64 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.248 3.308 . . . . 0.0 106.661 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -3.19 1.51 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.009 -1.439 . . . . 0.0 115.026 169.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.14 2.14 0.76 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.877 1.839 . . . . 0.0 113.966 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -53.29 -36.39 61.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.297 1.039 . . . . 0.0 112.07 -172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -54.97 -30.75 59.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.779 1.232 . . . . 0.0 112.825 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.99 -26.33 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.776 0.83 . . . . 0.0 109.522 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.36 72.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.228 0.922 . . . . 0.0 111.346 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.88 -39.3 93.32 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.238 0.926 . . . . 0.0 111.243 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -67.97 -45.4 74.27 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.804 -0.56 . . . . 0.0 109.617 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -54.13 -50.82 66.04 Favored 'General case' 0 C--N 1.337 0.035 0 C-N-CA 124.359 1.064 . . . . 0.0 110.323 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -48.69 72.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.895 0.878 . . . . 0.0 110.88 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.81 -53.56 56.81 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.69 0.677 . . . . 0.0 110.675 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -54.91 -42.51 72.26 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 123.838 0.855 . . . . 0.0 111.816 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -32.2 67.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.88 -46.67 74.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.472 1.033 . . . . 0.0 109.842 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -67.38 -14.13 62.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.658 0.663 . . . . 0.0 112.312 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.12 63.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.128 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.56 17.64 0.74 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.274 -1.292 . . . . 0.0 115.887 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -139.18 -171.44 3.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.602 1.701 . . . . 0.0 111.236 -169.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 p -124.71 147.61 48.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.6 p -140.66 157.86 44.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.12 98.98 4.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.76 123.43 19.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.3 mt -142.26 153.99 44.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.558 0.743 . . . . 0.0 109.298 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -89.76 31.68 0.94 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.675 0.79 . . . . 0.0 110.968 172.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.13 48.77 38.78 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.587 1.565 . . . . 0.0 114.533 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.49 -21.45 66.07 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.683 2.255 . . . . 0.0 113.503 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 42' ' ' GLU . 78.7 mt -124.31 10.15 8.61 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.967 1.707 . . . . 0.0 109.89 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 tp 60.86 -19.15 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.85 2.46 . . . . 0.0 114.31 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.1 pt-20 -166.47 87.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.68 -44.81 76.9 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.723 -0.611 . . . . 0.0 109.989 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.8 mt -80.23 151.58 72.7 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.38 -175.31 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.056 3.171 . . . . 0.0 112.621 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.74 34.42 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.147 1.379 . . . . 0.0 112.377 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.1 m -158.62 132.12 7.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.01 2.124 . . . . 0.0 106.311 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.79 -142.97 14.44 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -174.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.1 mm -126.53 140.32 49.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -121.76 152.52 39.37 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.7 mt -138.76 142.8 38.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.6 t -128.5 125.52 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.2 103.21 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -148.85 -177.3 5.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.876 1.271 . . . . 0.0 108.795 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.2 m -150.65 65.56 0.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.749 -1.219 . . . . 0.0 108.366 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 126.99 2.116 . . . . 0.0 112.916 -178.688 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.5 t30 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.807 0.337 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.41 120.73 24.24 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.63 -58.52 0.43 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.55 -169.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 -42.34 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.873 1.715 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -64.0 1.09 Allowed 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.218 1.007 . . . . 0.0 111.624 -168.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.56 -41.8 95.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.128 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -71.17 -45.98 62.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.958 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.58 79.06 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.714 0.688 . . . . 0.0 111.271 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.1 mt -55.12 -57.29 12.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.411 0.551 . . . . 0.0 110.002 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -74.11 -15.7 61.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.42 -38.21 65.65 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.692 0.678 . . . . 0.0 111.231 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -114.42 -26.49 7.94 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 32.88 60.43 1.51 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.683 1.993 . . . . 0.0 113.133 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -65.16 165.41 22.0 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.587 2.191 . . . . 0.0 112.538 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.53 63.38 2.66 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.405 1.482 . . . . 0.0 111.561 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.41 9.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.15 1.38 . . . . 0.0 112.391 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.4 m -61.1 -7.09 2.33 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.299 2.64 . . . . 0.0 112.871 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.24 10.02 17.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.795 1.638 . . . . 0.0 111.217 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.81 163.68 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 122.192 0.996 . . . . 0.0 110.283 174.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -122.09 149.83 43.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 171.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -123.61 166.84 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.721 0.638 . . . . 0.0 110.036 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.08 115.43 1.02 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 106.831 -2.507 . . . . 0.0 106.831 169.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.81 143.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.2 mt -139.42 131.34 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.98 -23.57 1.35 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.293 0.949 . . . . 0.0 114.082 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -50.19 128.46 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 126.137 1.775 . . . . 0.0 108.415 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.06 -27.69 6.48 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 124.441 1.096 . . . . 0.0 108.77 176.466 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -63.32 -56.04 19.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.514 1.052 . . . . 0.0 109.394 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -60.59 -39.49 88.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.294 0.638 . . . . 0.0 109.568 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.3 -46.6 89.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.967 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -62.43 -37.75 87.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.158 0.89 . . . . 0.0 111.029 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.07 -48.25 76.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.05 0.841 . . . . 0.0 111.057 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.331 6.9 ptmt -71.8 -28.35 63.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -37.72 86.33 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.961 0.904 . . . . 0.0 110.852 169.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -66.99 -40.96 87.5 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.92 -22.97 0.53 Allowed Glycine 0 C--N 1.34 0.75 0 CA-C-O 118.243 -1.31 . . . . 0.0 114.987 169.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.9 137.92 56.92 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.216 1.508 . . . . 0.0 108.869 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.95 134.04 35.63 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.6 99.47 8.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 97.4 m -73.54 145.59 45.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.32 -123.58 29.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.433 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.4 pt-20 -153.11 176.11 12.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.598 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 m -49.8 121.73 5.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.085 1.354 . . . . 0.0 109.922 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.1 153.33 26.14 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -127.65 144.23 51.09 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.965 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.433 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.7 m-90 -65.6 -50.65 64.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.195 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.1 mt -55.08 -51.29 66.84 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.13 -51.96 54.25 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -64.16 -46.24 84.92 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.495 1.148 . . . . 0.0 110.774 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -61.56 -39.04 89.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.398 1.079 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.9 t -64.85 -47.58 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.835 1.254 . . . . 0.0 110.381 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -60.38 -24.4 65.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.551 1.069 . . . . 0.0 111.288 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.06 -28.63 43.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.409 0.684 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -36.49 19.28 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.04 0.936 . . . . 0.0 111.531 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 125.448 1.499 . . . . 0.0 109.824 172.036 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.07 161.01 43.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -95.52 -24.12 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.674 1.59 . . . . 0.0 110.492 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.7 mt -136.22 128.94 46.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.33 1.052 . . . . 0.0 108.223 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -85.92 126.98 34.49 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.91 97.53 7.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -96.38 89.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 108.694 -169.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -75.9 141.07 42.43 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 168.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.99 1.1 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 117.913 -1.493 . . . . 0.0 116.774 -175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 115.28 2.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.984 1.892 . . . . 0.0 109.714 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m 46.06 40.86 7.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.217 1.807 . . . . 0.0 111.811 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp 47.84 69.64 0.51 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 126.003 1.721 . . . . 0.0 111.16 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 163.14 25.59 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.534 1.54 . . . . 0.0 109.423 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.38 -29.92 2.82 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.415 -1.214 . . . . 0.0 114.244 -169.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 41.47 43.96 2.36 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.955 1.302 . . . . 0.0 111.412 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -50.7 -33.29 22.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.966 1.306 . . . . 0.0 113.592 -169.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -59.37 -52.22 66.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.735 1.152 . . . . 0.0 111.431 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.09 -29.05 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.646 -0.659 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.46 91.12 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.575 0.625 . . . . 0.0 110.87 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.47 -38.19 71.26 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.686 -0.633 . . . . 0.0 110.242 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -58.73 -44.18 90.37 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.57 0.623 . . . . 0.0 110.368 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.02 -55.82 30.2 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.393 0.677 . . . . 0.0 109.989 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.4 -40.42 65.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -53.77 -54.03 43.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.358 0.663 . . . . 0.0 110.083 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -62.44 -41.76 98.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -58.22 -45.3 87.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.446 0.566 . . . . 0.0 109.799 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.21 -35.97 71.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.833 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.16 -29.65 70.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.665 0.786 . . . . 0.0 111.586 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.45 -18.1 63.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.861 0.755 . . . . 0.0 111.795 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.1 -4.8 4.98 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.499 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -100.41 -170.31 1.85 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.568 1.684 . . . . 0.0 109.82 -169.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.8 p -128.88 148.58 50.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -139.89 149.95 44.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 111.826 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.26 92.13 3.92 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 m -69.29 118.02 11.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.9 mt -149.35 153.76 37.92 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.281 0.562 . . . . 0.0 112.186 -169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -93.7 39.22 1.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.386 1.074 . . . . 0.0 108.432 168.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 39.14 54.66 2.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.724 2.107 . . . . 0.0 115.42 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.48 -20.69 54.09 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.792 2.328 . . . . 0.0 113.731 -173.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 42' ' ' GLU . 83.0 mt -112.94 8.3 18.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.661 1.584 . . . . 0.0 109.772 177.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tt 60.29 -17.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.557 2.743 . . . . 0.0 114.563 -169.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' A' ' 40' ' ' LEU . 6.5 pt-20 -169.46 76.82 0.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.94 -45.38 93.94 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.744 -0.598 . . . . 0.0 109.566 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.63 149.43 44.09 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.28 -175.46 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.793 2.995 . . . . 0.0 112.798 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.88 36.63 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.61 1.564 . . . . 0.0 111.334 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.7 m -158.3 128.69 6.13 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.31 2.244 . . . . 0.0 106.321 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.55 -145.98 17.54 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.2 mm -124.55 142.0 42.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -122.12 151.21 41.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.8 mt -137.44 138.9 40.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.07 134.25 66.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.12 111.91 30.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -156.53 -176.4 5.95 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 108.638 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -153.07 62.82 0.77 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.4 1.095 . . . . 0.0 110.344 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 CA--C 1.542 0.669 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.301 175.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 . . . . . 0 N--CA 1.466 0.368 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mp -75.48 131.16 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.44 -58.87 0.33 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.045 0.839 . . . . 0.0 110.228 -170.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -81.18 -38.56 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.325 2.016 . . . . 0.0 111.989 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -59.29 -49.9 76.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.432 0.693 . . . . 0.0 111.511 -169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -60.26 -44.28 95.44 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.348 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.37 -47.56 75.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.31 0.504 . . . . 0.0 110.467 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.21 89.28 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.01 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 mt -53.72 -55.62 24.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.914 0.779 . . . . 0.0 109.463 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.14 -17.27 61.97 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.87 -32.25 65.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.732 0.413 . . . . 0.0 111.337 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.9 -29.97 5.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 mttt 27.45 66.28 0.57 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.804 2.042 . . . . 0.0 113.273 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.94 176.81 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.824 2.349 . . . . 0.0 112.715 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -82.13 68.67 8.63 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.383 1.073 . . . . 0.0 111.125 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.22 3.11 1.8 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.875 0.87 . . . . 0.0 112.886 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -64.67 -6.25 7.41 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.365 2.666 . . . . 0.0 113.336 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.78 9.04 24.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.85 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 p -134.62 157.22 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.573 0.749 . . . . 0.0 110.529 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -121.01 152.02 39.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 168.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -118.1 173.87 6.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.03 160.11 28.08 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 106.68 -2.568 . . . . 0.0 106.68 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.81 145.87 50.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.45 121.1 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.09 -14.4 6.32 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.818 1.199 . . . . 0.0 114.593 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.9 141.34 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.981 1.313 . . . . 0.0 108.799 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.47 -15.01 60.84 Favored Glycine 0 N--CA 1.468 0.768 0 O-C-N 121.083 -1.01 . . . . 0.0 112.919 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.4 m . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 127.553 2.341 . . . . 0.0 115.195 -174.241 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.8 mttt . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.41 -57.25 13.79 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.581 0.628 . . . . 0.0 109.433 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.38 -31.17 65.34 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.093 0.557 . . . . 0.0 109.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.89 94.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.002 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.53 -37.98 83.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.503 1.047 . . . . 0.0 110.449 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.43 -40.48 96.72 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.536 0.734 . . . . 0.0 111.626 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.297 7.6 ptmm? -79.92 -29.54 39.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.544 -0.722 . . . . 0.0 112.509 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.42 86.46 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.162 0.985 . . . . 0.0 110.995 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 p -77.49 -20.48 54.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.07 -37.48 0.46 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.715 0.689 . . . . 0.0 113.597 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.91 -177.99 2.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.97 0.891 . . . . 0.0 111.435 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -135.14 150.14 50.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -77.11 126.98 31.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 m -77.58 140.93 39.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.45 -121.31 19.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -153.81 162.33 41.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.877 1.271 . . . . 0.0 108.927 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.9 m -53.41 124.18 14.07 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.811 -169.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.51 164.66 26.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.864 1.666 . . . . 0.0 108.283 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -135.99 144.4 45.32 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.014 -1.053 . . . . 0.0 109.318 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.328 -0.349 0 C-N-CA 127.003 2.121 . . . . 0.0 108.697 178.336 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 119.47 -0.3 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -44.85 83.01 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.599 0.759 . . . . 0.0 109.579 175.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -61.59 -52.05 66.0 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.9 -49.74 40.76 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 124.518 1.136 . . . . 0.0 111.475 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.1 m -61.47 -54.55 41.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 125.111 1.364 . . . . 0.0 111.54 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -55.7 -41.18 73.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.151 0.98 . . . . 0.0 111.365 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t -60.56 -49.54 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.358 1.063 . . . . 0.0 109.83 173.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.81 -27.65 68.2 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.474 1.033 . . . . 0.0 111.651 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.79 -45.01 19.59 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.513 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 pp -71.15 -36.01 71.88 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.607 0.64 . . . . 0.0 111.592 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.6 mttm . . . . . 0 C--O 1.248 0.991 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 175.799 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 119.244 -0.408 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.92 164.05 36.47 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.777 1.231 . . . . 0.0 109.147 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.46 -23.34 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.354 1.462 . . . . 0.0 110.64 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mt -133.11 126.19 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.813 1.245 . . . . 0.0 108.078 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -88.09 126.81 35.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.37 91.19 4.16 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.4 mt -86.09 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 t -111.54 -162.2 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.311 1.044 . . . . 0.0 108.319 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.32 57.29 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 123.646 0.641 . . . . 0.0 111.858 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -44.37 121.77 2.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.108 1.363 . . . . 0.0 111.095 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.272 39.1 m 67.31 53.15 0.78 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.884 1.273 . . . . 0.0 110.478 -171.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 52.92 37.85 25.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.954 2.101 . . . . 0.0 114.494 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.83 156.52 10.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.246 0.926 . . . . 0.0 111.478 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.16 -171.06 41.11 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.39 68.38 2.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.217 1.407 . . . . 0.0 110.893 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.85 -24.46 6.2 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.763 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -51.95 -34.78 43.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.148 0.979 . . . . 0.0 112.906 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 p -71.69 -34.2 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.641 1.109 . . . . 0.0 109.853 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.47 61.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.378 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.73 -40.45 84.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.031 0.832 . . . . 0.0 110.361 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -57.88 -51.16 70.75 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.509 0.724 . . . . 0.0 109.347 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.32 -49.89 73.03 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.096 0.558 . . . . 0.0 110.487 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.25 -40.8 64.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.671 1.188 . . . . 0.0 111.796 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.98 -58.5 7.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.336 0.971 . . . . 0.0 109.998 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -53.89 -43.4 69.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.657 1.183 . . . . 0.0 112.188 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.1 -36.83 82.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.733 0.813 . . . . 0.0 111.967 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.67 -36.99 73.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.703 1.138 . . . . 0.0 109.732 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.83 -23.2 67.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.287 0.635 . . . . 0.0 111.801 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.97 -10.92 60.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.853 0.861 . . . . 0.0 112.108 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 21.61 5.98 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.319 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -125.87 -171.81 2.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.465 1.132 . . . . 0.0 109.584 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 p -125.16 151.02 46.34 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -142.29 159.8 41.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.861 -0.524 . . . . 0.0 110.336 -170.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 110.96 11.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m -76.01 124.6 27.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.9 mt -141.88 159.45 42.21 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.268 0.627 . . . . 0.0 110.718 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -110.74 39.39 2.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.165 1.386 . . . . 0.0 109.022 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.78 46.67 39.48 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.906 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.62 -21.16 70.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 121.398 2.599 . . . . 0.0 113.736 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 42' ' ' GLU . 73.1 mt -126.32 14.2 7.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.43 1.892 . . . . 0.0 109.309 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 66.12 -31.72 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.366 2.667 . . . . 0.0 112.436 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 40' ' ' LEU . 8.9 pt-20 -158.12 89.8 1.02 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.132 1.773 . . . . 0.0 107.075 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.54 -42.49 91.86 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.667 -0.645 . . . . 0.0 110.409 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.59 154.5 59.1 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.35 -175.27 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.055 3.17 . . . . 0.0 113.173 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.57 28.84 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.63 1.572 . . . . 0.0 113.067 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -153.56 137.33 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.817 2.447 . . . . 0.0 106.342 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.23 -140.58 12.42 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mm -121.55 137.3 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -122.34 137.23 54.92 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 mt -129.83 134.18 47.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.09 128.09 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.23 59.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.335 1.854 . . . . 0.0 106.689 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -67.92 -32.36 72.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.661 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 m 28.54 55.31 0.09 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 127.905 2.482 . . . . 0.0 113.505 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.226 -0.18 0 C-N-CA 127.63 2.372 . . . . 0.0 114.715 -169.114 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.5 t30 . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.36 84.45 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 169.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.5 m -70.51 -56.49 6.43 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.644 -167.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.12 -37.91 39.48 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.428 1.189 . . . . 0.0 110.006 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -68.19 -50.43 54.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.58 -46.36 83.04 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.883 0.765 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.46 -40.44 94.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.841 1.2 . . . . 0.0 110.922 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.29 90.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.314 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.2 mt -54.65 -52.72 61.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.512 1.051 . . . . 0.0 109.78 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -67.03 -22.59 65.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -75.42 -43.64 48.8 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.486 0.585 . . . . 0.0 111.083 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -98.88 -29.16 13.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.54 62.68 0.98 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 127.014 2.126 . . . . 0.0 112.609 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.75 164.63 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.259 2.639 . . . . 0.0 113.278 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.13 64.41 2.57 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.372 1.469 . . . . 0.0 111.613 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.19 9.53 0.97 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 112.737 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m -60.55 -6.87 1.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 127.858 2.463 . . . . 0.0 112.717 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.62 8.75 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.758 1.623 . . . . 0.0 111.183 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.69 152.84 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.93 0.871 . . . . 0.0 111.808 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -105.0 152.69 22.4 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -122.8 147.89 46.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.911 1.285 . . . . 0.0 107.561 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.05 116.98 1.65 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.116 -2.793 . . . . 0.0 106.116 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.23 145.19 35.65 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 mt -139.37 124.11 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.61 -2.82 20.75 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.714 1.626 . . . . 0.0 113.996 173.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -60.3 117.51 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.532 . . . . 0.0 107.955 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.13 -29.96 63.77 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 129.719 3.208 . . . . 0.0 111.768 169.873 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.6 -57.31 7.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.586 1.084 . . . . 0.0 108.461 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -58.46 -37.78 76.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.083 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.56 67.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 126.157 1.783 . . . . 0.0 109.873 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.93 -34.17 77.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.132 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.1 -40.65 74.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.903 1.229 . . . . 0.0 110.402 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -63.97 -41.54 97.52 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.966 1.306 . . . . 0.0 109.586 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -34.11 73.38 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.057 1.743 . . . . 0.0 111.742 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -67.56 -42.16 83.06 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.81 -17.32 0.56 Allowed Glycine 0 CA--C 1.528 0.898 0 CA-C-O 117.956 -1.469 . . . . 0.0 115.391 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 140.16 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.809 1.804 . . . . 0.0 109.43 -170.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -89.12 112.91 24.0 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.16 128.67 36.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.7 m -106.39 149.97 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.86 -122.4 29.86 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.83 168.67 26.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.19 1.396 . . . . 0.0 108.315 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.1 m -43.91 116.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.09 169.51 15.87 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.879 1.672 . . . . 0.0 108.095 172.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 138.96 42.79 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 120.948 -1.095 . . . . 0.0 111.123 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.325 -0.486 0 C-N-CA 127.247 2.219 . . . . 0.0 105.372 169.406 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.65 -44.63 93.27 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.12 -52.64 64.85 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.265 1.026 . . . . 0.0 108.807 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.53 -44.91 85.72 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.252 0.93 . . . . 0.0 111.844 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -61.71 -55.01 34.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.567 0.683 . . . . 0.0 109.548 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -57.69 -40.52 79.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.525 0.73 . . . . 0.0 111.666 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.41 -55.28 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 124.924 1.29 . . . . 0.0 109.699 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -15.05 63.34 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.442 1.019 . . . . 0.0 112.197 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.69 -45.85 20.4 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.796 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.7 -36.87 76.32 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.57 0.623 . . . . 0.0 111.639 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.032 0 C-N-CA 125.435 1.494 . . . . 0.0 109.658 175.264 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.41 165.61 33.6 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.05 0.94 . . . . 0.0 110.37 -173.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.15 -23.07 15.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.721 1.608 . . . . 0.0 110.808 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.69 126.69 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.411 1.084 . . . . 0.0 108.328 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -85.73 128.91 34.92 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -108.7 88.33 2.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.8 mt -77.74 91.41 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -93.02 17.1 11.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.812 2.045 . . . . 0.0 112.98 -168.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.89 77.78 0.11 Allowed Glycine 0 N--CA 1.446 -0.657 0 O-C-N 121.707 -0.621 . . . . 0.0 112.086 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -56.44 -14.4 3.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.247 1.019 . . . . 0.0 113.344 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -122.08 33.42 5.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.722 2.009 . . . . 0.0 109.92 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.8 mt 58.11 23.97 10.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.699 1.999 . . . . 0.0 112.854 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.0 161.96 16.25 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 128.585 2.993 . . . . 0.0 106.223 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.35 -36.33 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.917 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.82 16.42 0.98 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.034 1.417 . . . . 0.0 113.826 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.26 -36.49 63.66 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.535 1.061 . . . . 0.0 113.288 -170.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -60.65 -50.56 73.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.559 0.618 . . . . 0.0 111.313 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.8 -32.24 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 122.029 -0.419 . . . . 0.0 110.094 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.61 87.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.919 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -62.17 -40.06 94.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.323 0.965 . . . . 0.0 111.147 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -64.98 -47.6 76.96 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.639 -0.663 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.41 -49.54 72.12 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.984 0.914 . . . . 0.0 110.606 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.58 -48.23 72.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.999 1.319 . . . . 0.0 110.774 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.59 -50.75 72.27 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.962 0.905 . . . . 0.0 110.524 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.1 -22.64 62.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.567 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -72.79 -41.5 64.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 121.156 1.798 . . . . 0.0 109.024 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -62.9 -25.08 68.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.779 0.832 . . . . 0.0 111.462 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -11.99 60.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.149 0.98 . . . . 0.0 112.546 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 19.85 7.03 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.241 172.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -124.21 -166.78 1.55 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.354 1.061 . . . . 0.0 108.642 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -132.1 150.73 52.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.9 p -141.71 153.88 44.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 110.806 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -123.13 90.48 3.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.231 1.012 . . . . 0.0 108.524 -172.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -66.61 118.9 10.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.2 mt -145.59 138.07 25.76 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.815 0.846 . . . . 0.0 109.167 -170.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -83.66 40.88 0.76 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.035 -1.041 . . . . 0.0 110.601 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.16 44.98 34.2 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 117.892 -1.504 . . . . 0.0 115.863 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.69 -20.99 39.64 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.175 2.487 . . . . 0.0 114.005 -170.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 42' ' ' GLU . 79.6 mt -119.37 13.41 12.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.53 1.532 . . . . 0.0 109.391 -175.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.0 tp 64.52 -27.2 0.09 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.886 2.474 . . . . 0.0 113.568 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 40' ' ' LEU . 6.7 pt-20 -174.1 87.77 0.05 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.507 1.523 . . . . 0.0 107.378 -169.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.37 -43.29 91.23 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.816 -0.553 . . . . 0.0 110.298 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.81 151.1 49.42 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.69 -174.33 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.139 3.226 . . . . 0.0 112.962 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.44 29.02 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.527 1.531 . . . . 0.0 113.115 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -152.23 131.93 13.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.949 2.5 . . . . 0.0 106.287 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.39 -139.73 11.19 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mm -126.89 137.07 58.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -121.76 133.95 54.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -127.62 138.12 52.76 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.22 133.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.93 107.58 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -171.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -163.53 -160.52 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.08 2.152 . . . . 0.0 105.598 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 m -148.02 155.12 41.15 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.199 -1.563 . . . . 0.0 109.045 170.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 123.207 0.603 . . . . 0.0 111.872 -175.103 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.25 120.94 8.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -54.89 0.56 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.3 -172.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -99.3 -34.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.18 2.587 . . . . 0.0 113.554 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.93 -54.68 44.44 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.722 0.809 . . . . 0.0 112.063 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -65.42 -40.3 93.17 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.659 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.47 -49.62 76.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.246 0.475 . . . . 0.0 110.038 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.13 93.22 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.01 -53.75 54.58 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.773 0.715 . . . . 0.0 110.305 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -72.92 -19.0 61.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.6 -49.82 56.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.368 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -100.8 -26.53 13.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 29.36 64.66 0.78 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 127.19 2.196 . . . . 0.0 113.011 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -63.65 164.81 19.91 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.605 2.203 . . . . 0.0 112.443 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -82.39 66.19 7.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.661 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.43 7.52 0.6 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.306 1.042 . . . . 0.0 113.041 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -62.82 -6.12 3.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.517 2.727 . . . . 0.0 113.041 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.21 8.77 19.95 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.271 1.428 . . . . 0.0 110.983 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.46 147.22 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.709 0.686 . . . . 0.0 110.911 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -97.75 154.05 17.85 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -119.52 152.11 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.6 146.78 17.55 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.8 135.71 53.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.55 127.88 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.48 -19.99 3.62 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.352 0.977 . . . . 0.0 113.662 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.67 144.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.3 1.84 . . . . 0.0 108.677 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.09 -19.61 1.1 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.783 1.182 . . . . 0.0 113.308 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.466 0.371 0 C-N-CA 126.396 1.878 . . . . 0.0 113.34 171.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 118.137 -0.935 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.45 -59.12 5.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 120.013 1.279 . . . . 0.0 109.185 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.88 -39.52 81.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.109 0.413 . . . . 0.0 110.597 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.21 81.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.269 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.56 -38.18 90.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.048 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.97 -46.91 88.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.29 0.95 . . . . 0.0 110.592 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -65.69 -38.34 88.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.798 0.839 . . . . 0.0 110.074 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -34.24 77.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.688 1.195 . . . . 0.0 111.324 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.1 m -71.67 -31.25 66.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.388 -0.339 . . . . 0.0 111.336 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.97 -33.15 0.56 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 118.994 -0.892 . . . . 0.0 114.781 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.6 171.97 6.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.433 1.116 . . . . 0.0 110.465 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -132.72 141.93 48.8 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -75.78 111.13 10.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.0 m -74.58 152.69 39.24 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.08 -104.13 1.68 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.79 -177.34 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.812 2.445 . . . . 0.0 106.541 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 124.99 31.51 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.431 ' HG ' ' CG ' ' A' ' 138' ' ' TRP . 2.3 tt -79.65 151.02 30.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -129.85 146.67 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.814 1.188 . . . . 0.0 108.798 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 110.9 178.043 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.431 ' CG ' ' HG ' ' A' ' 121' ' ' LEU . 9.2 t90 -51.85 -50.34 61.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 110.653 173.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.82 -55.96 24.53 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.483 1.114 . . . . 0.0 109.359 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.28 -42.38 99.76 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 123.319 0.387 . . . . 0.0 112.179 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -60.28 -63.35 1.33 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 125.194 1.397 . . . . 0.0 110.171 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -53.95 -46.72 71.66 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.846 1.658 . . . . 0.0 111.849 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.5 t -59.77 -55.89 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -18.17 63.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.461 1.028 . . . . 0.0 112.201 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.24 -47.1 21.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.545 0.611 . . . . 0.0 111.0 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.17 -30.69 62.36 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 112.261 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.9 mttm . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.804 1.242 . . . . 0.0 109.781 171.491 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.2 167.63 29.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.842 1.257 . . . . 0.0 109.309 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.07 -27.59 18.49 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.882 0.873 . . . . 0.0 110.025 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -132.71 132.09 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.941 0.896 . . . . 0.0 109.319 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -89.46 129.86 35.89 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.57 95.11 5.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.2 mt -88.27 77.51 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -74.27 153.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.31 -0.869 . . . . 0.0 109.54 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.93 -175.64 32.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-O 122.576 1.098 . . . . 0.0 114.973 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 p -150.51 -50.07 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.05 -1.575 . . . . 0.0 109.508 -169.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 48.0 m -121.48 58.64 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.0 tp 48.89 48.08 20.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.067 2.147 . . . . 0.0 112.549 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.72 153.34 10.98 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.21 -174.51 41.09 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 118.31 1.055 . . . . 0.0 113.745 -169.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.06 59.5 1.32 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.296 1.838 . . . . 0.0 110.52 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -56.67 -27.38 58.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.148 -0.97 . . . . 0.0 112.05 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -58.91 -44.81 91.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.932 0.787 . . . . 0.0 111.324 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.71 -43.14 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.33 91.38 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.549 -0.262 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.66 -41.45 75.51 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.363 0.665 . . . . 0.0 110.886 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -61.27 -45.55 94.04 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.736 -0.602 . . . . 0.0 110.147 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.13 -52.57 65.0 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.093 0.957 . . . . 0.0 110.469 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.55 -46.25 57.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.224 1.009 . . . . 0.0 110.886 177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -56.69 -54.23 48.53 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.549 0.613 . . . . 0.0 110.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -61.65 -39.45 91.38 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.87 -37.59 84.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.396 0.678 . . . . 0.0 110.779 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.36 -39.41 89.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.592 0.633 . . . . 0.0 110.369 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -63.14 -30.01 71.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.867 0.758 . . . . 0.0 111.388 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -20.62 60.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.623 0.769 . . . . 0.0 111.676 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 16.92 6.73 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 118.514 -1.159 . . . . 0.0 114.228 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.03 142.58 51.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.066 1.433 . . . . 0.0 108.49 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -83.15 151.84 25.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -138.32 158.62 43.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.03 104.46 7.8 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 m -68.82 123.21 20.33 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.271 1.028 . . . . 0.0 108.344 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -145.43 166.35 25.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.163 0.985 . . . . 0.0 110.042 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -110.36 39.33 2.21 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.622 1.169 . . . . 0.0 109.141 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.85 50.9 14.1 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.718 1.627 . . . . 0.0 114.867 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 -21.75 62.61 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.846 2.364 . . . . 0.0 113.775 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 42' ' ' GLU . 74.0 mt -124.1 13.93 9.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.18 1.792 . . . . 0.0 108.93 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.7 tp 61.59 -25.57 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.654 2.782 . . . . 0.0 114.464 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 40' ' ' LEU . 8.5 pt-20 -161.3 86.44 0.68 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -168.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.57 -45.25 87.82 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.685 -0.634 . . . . 0.0 110.081 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.13 151.34 59.93 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.48 -178.9 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.584 2.856 . . . . 0.0 112.996 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.54 35.92 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.882 1.673 . . . . 0.0 111.807 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -158.49 123.99 4.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.293 2.237 . . . . 0.0 105.773 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.48 -147.9 19.38 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.6 mm -123.5 128.91 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -119.79 152.25 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 mt -140.43 138.16 34.51 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.76 132.29 44.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -125.11 68.44 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.931 1.292 . . . . 0.0 108.292 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -103.09 16.24 27.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.524 1.13 . . . . 0.0 112.241 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m 2.22 83.49 0.0 OUTLIER 'General case' 0 C--N 1.344 0.357 0 C-N-CA 129.999 3.319 . . . . 0.0 114.516 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.6 p . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 124.148 0.979 . . . . 0.0 109.609 -169.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 C--O 1.228 -0.065 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -150.09 108.07 3.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 m -82.65 -63.04 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.948 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.86 -40.57 16.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.695 1.596 . . . . 0.0 110.625 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -63.46 -49.87 71.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.976 0.51 . . . . 0.0 110.718 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.53 -45.83 88.81 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.801 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -61.07 -46.43 90.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.746 0.703 . . . . 0.0 110.231 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -24.02 67.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.6 mt -67.71 -61.24 1.98 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.469 1.031 . . . . 0.0 108.657 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -73.62 -13.14 60.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.19 -36.11 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.202 1.001 . . . . 0.0 110.356 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -120.72 -30.11 4.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.798 -172.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.3 mttt 25.62 68.69 0.43 Allowed Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.043 1.737 . . . . 0.0 112.872 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.45 173.95 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.309 2.006 . . . . 0.0 111.883 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -81.15 95.6 6.94 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.37 -0.832 . . . . 0.0 108.992 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -88.45 6.25 38.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.992 0.517 . . . . 0.0 111.561 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.6 p -68.06 -5.26 16.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 119.694 -1.879 . . . . 0.0 112.583 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.56 43.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.461 1.504 . . . . 0.0 110.939 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.61 155.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.246 1.022 . . . . 0.0 111.095 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -114.91 147.48 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -125.61 156.92 38.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 109.791 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.45 116.42 2.15 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.6 146.36 44.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.1 mt -139.99 129.45 28.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.92 -9.36 2.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.442 1.02 . . . . 0.0 113.775 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.85 136.17 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.35 14.22 7.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.799 1.19 . . . . 0.0 112.052 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 125.308 1.443 . . . . 0.0 113.392 -178.469 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.2 mttt . . . . . 0 N--CA 1.463 0.211 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.5 -57.81 11.36 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.13 -40.31 95.49 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.8 68.12 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 117.329 -1.32 . . . . 0.0 111.603 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.98 -45.0 94.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.736 1.607 . . . . 0.0 110.805 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.84 -39.47 90.83 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -30.71 70.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.161 1.384 . . . . 0.0 111.948 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.9 m -80.58 -18.65 47.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.953 0.501 . . . . 0.0 111.098 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.5 -19.58 4.5 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.694 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.49 136.89 55.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.674 1.737 . . . . 0.0 108.829 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -86.23 132.77 33.92 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -85.63 103.23 14.26 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -77.09 150.26 35.68 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.322 -0.236 . . . . 0.0 110.487 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.65 -95.45 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.413 1.006 . . . . 0.0 111.195 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.34 176.99 6.31 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 128.439 2.696 . . . . 0.0 106.511 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.3 m -63.72 131.03 46.62 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 tt -73.78 139.93 45.54 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.51 139.77 51.45 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 124.924 1.29 . . . . 0.0 108.702 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -44.14 -56.66 3.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 125.359 1.464 . . . . 0.0 110.943 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -59.17 4.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.809 1.644 . . . . 0.0 109.002 -174.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.07 60.32 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 123.874 0.734 . . . . 0.0 111.349 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 t -65.27 -47.86 75.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.671 0.735 . . . . 0.0 110.566 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -60.67 -41.66 95.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.655 1.182 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t -59.4 -49.94 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.557 0.743 . . . . 0.0 109.675 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -61.26 -30.33 70.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.241 0.928 . . . . 0.0 111.247 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.23 -46.83 26.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.442 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -74.16 -32.01 62.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.188 0.449 . . . . 0.0 112.129 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.443 1.097 . . . . 0.0 109.825 173.376 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.43 164.62 37.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.184 0.994 . . . . 0.0 109.96 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.92 -24.0 15.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.672 1.589 . . . . 0.0 110.577 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.15 126.6 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.291 1.036 . . . . 0.0 108.413 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.48 127.2 35.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.44 95.55 6.15 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.1 mt -91.26 117.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.29 168.65 17.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.315 0.646 . . . . 0.0 110.525 -169.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.64 38.77 93.49 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.918 -0.379 . . . . 0.0 112.34 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 m -61.64 0.31 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.521 2.329 . . . . 0.0 116.343 -169.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -123.31 31.53 5.94 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.118 1.767 . . . . 0.0 108.183 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.2 tp 53.66 63.92 2.03 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 126.223 1.809 . . . . 0.0 109.952 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.56 -144.7 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.07 1.795 . . . . 0.0 109.189 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.97 163.37 34.77 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 37.22 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.128 1.771 . . . . 0.0 108.125 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.56 -36.4 61.82 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 0.0 113.244 -169.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -58.62 -47.02 85.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.099 0.863 . . . . 0.0 110.819 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -72.82 -47.09 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.85 99.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.99 -38.59 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.904 0.482 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -61.81 -48.0 82.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.764 0.711 . . . . 0.0 110.031 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.91 -54.06 49.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.856 0.863 . . . . 0.0 109.878 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.06 63.9 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.408 1.083 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.61 -54.92 40.85 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.567 0.747 . . . . 0.0 110.476 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -59.52 -37.12 77.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.2 mt -66.08 -34.31 77.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.213 0.605 . . . . 0.0 111.42 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -70.66 -38.3 73.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.046 1.294 . . . . 0.0 110.263 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.05 -29.76 70.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.37 0.668 . . . . 0.0 111.134 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.46 -14.77 62.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.819 0.848 . . . . 0.0 112.112 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.04 7.32 6.61 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.197 -1.335 . . . . 0.0 114.522 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -112.1 -167.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.668 1.734 . . . . 0.0 110.131 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -128.7 150.22 50.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.1 p -142.0 154.46 45.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.264 0.554 . . . . 0.0 112.061 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -121.26 98.03 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.579 1.552 . . . . 0.0 108.013 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -72.42 121.0 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.1 mt -146.16 149.0 33.15 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.996 0.518 . . . . 0.0 111.456 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -90.87 34.9 0.9 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.112 0.965 . . . . 0.0 110.319 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 49.94 27.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.735 1.636 . . . . 0.0 114.791 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.64 -21.89 65.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.82 2.347 . . . . 0.0 114.007 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -132.16 10.54 4.54 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.78 2.032 . . . . 0.0 107.099 -175.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 62.99 -26.66 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.628 2.771 . . . . 0.0 114.03 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 40' ' ' LEU . 8.7 pt-20 -157.59 80.43 0.88 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.857 0.863 . . . . 0.0 109.271 -168.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.97 -44.73 96.14 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.586 -0.696 . . . . 0.0 110.523 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.11 151.25 69.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 47' ' ' SER . 43.4 Cg_endo -67.92 -173.93 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.261 3.307 . . . . 0.0 113.021 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.45 27.56 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.422 1.489 . . . . 0.0 113.262 170.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 45' ' ' PRO . 15.5 m -150.76 133.28 15.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.768 2.427 . . . . 0.0 106.403 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.88 -142.07 13.28 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 mm -124.29 142.77 39.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 17.2 m0 -121.41 150.45 41.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.9 mt -141.07 141.2 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -133.71 121.19 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.72 103.09 14.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.324 1.85 . . . . 0.0 107.138 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -146.09 -161.0 1.22 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.334 1.054 . . . . 0.0 108.685 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.0 m -150.43 150.61 31.58 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.663 -1.273 . . . . 0.0 108.414 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.658 177.069 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 t30 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.68 77.8 1.76 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -66.64 -55.12 19.29 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 127.706 2.402 . . . . 0.0 112.411 -168.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.39 -34.53 54.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.117 1.211 . . . . 0.0 110.071 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.77 -59.42 5.45 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 123.783 0.677 . . . . 0.0 109.689 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.55 -46.81 87.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.957 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.12 -46.13 90.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.274 0.943 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.27 -23.53 65.69 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.1 mt -67.06 -62.35 1.47 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.61 -20.11 65.92 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.98 -34.49 77.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.545 0.738 . . . . 0.0 111.11 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -128.86 -24.41 2.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 mttt 28.58 65.1 0.69 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 127.108 2.163 . . . . 0.0 112.763 -170.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.28 163.29 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.679 2.253 . . . . 0.0 113.195 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -80.79 66.76 6.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.734 1.214 . . . . 0.0 110.731 -174.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.91 17.42 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.578 1.551 . . . . 0.0 112.886 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 p -65.99 -4.29 6.85 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 119.955 -1.715 . . . . 0.0 112.6 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 11.14 13.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.877 1.671 . . . . 0.0 111.081 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.99 157.16 40.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.815 0.817 . . . . 0.0 110.926 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -120.02 148.56 43.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -115.46 169.25 9.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.06 120.19 1.58 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.31 139.93 41.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 90' ' ' ILE . 17.5 mt -138.59 130.86 38.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 -26.69 1.08 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.09 0.852 . . . . 0.0 112.77 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.436 ' H ' ' C ' ' A' ' 88' ' ' ILE . 16.3 mt -52.68 155.49 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 128.096 2.558 . . . . 0.0 108.453 169.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.47 20.7 0.82 Allowed Glycine 0 CA--C 1.526 0.754 0 O-C-N 121.664 -0.647 . . . . 0.0 112.58 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 124.62 1.168 . . . . 0.0 111.804 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.31 -57.5 12.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.173 0.589 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.51 -38.24 89.16 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.278 0.631 . . . . 0.0 109.359 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.13 83.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.206 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.82 -35.71 81.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.716 -1.135 . . . . 0.0 111.192 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.84 -47.93 84.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.896 1.226 . . . . 0.0 110.876 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.21 -37.02 84.55 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.142 0.977 . . . . 0.0 110.092 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -36.8 79.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.262 1.425 . . . . 0.0 111.518 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.5 m -68.96 -38.5 79.45 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.46 0.52 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.97 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.67 135.6 48.45 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.305 1.553 . . . . 0.0 108.986 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -84.23 141.62 30.86 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.05 113.38 19.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -72.28 146.26 47.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.8 -119.77 17.1 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 170.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.22 159.51 44.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.64 1.576 . . . . 0.0 107.388 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.5 m -48.8 125.11 9.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.976 1.31 . . . . 0.0 111.358 -175.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.51 147.78 35.64 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.647 1.579 . . . . 0.0 107.817 -173.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -116.13 142.82 46.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 169.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -169.233 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.234 0.245 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -46.94 81.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.106 172.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.16 -47.2 81.79 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.191 0.596 . . . . 0.0 109.827 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.66 -49.32 79.79 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.5 t -62.94 -43.97 97.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.177 0.988 . . . . 0.0 110.822 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.4 t90 -63.56 -38.37 90.88 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.621 1.568 . . . . 0.0 110.677 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.31 -46.63 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.962 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.79 -28.41 69.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.761 -1.212 . . . . 0.0 111.456 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.77 -47.18 40.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.077 0.951 . . . . 0.0 110.686 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -71.45 -33.39 69.31 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.569 0.622 . . . . 0.0 112.04 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.1 mttm . . . . . 0 C--O 1.249 1.044 0 C-N-CA 125.292 1.437 . . . . 0.0 110.004 173.468 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 mtt . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.816 0.341 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.95 173.12 0.65 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.009 1.324 . . . . 0.0 112.24 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.39 -24.86 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.982 0.913 . . . . 0.0 110.872 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.0 mt -138.47 125.81 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.066 0.947 . . . . 0.0 109.28 -171.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -85.63 133.03 34.06 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 mp -111.58 100.33 8.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 mt -71.82 96.75 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 170.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -88.48 21.5 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.099 2.16 . . . . 0.0 112.201 -168.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 179.26 41.03 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -138.33 -27.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.643 0.777 . . . . 0.0 112.383 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 p -121.66 42.84 3.0 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp 56.12 37.33 28.73 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.449 1.5 . . . . 0.0 111.045 -169.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.06 163.24 27.15 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.265 1.888 . . . . 0.0 108.983 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -161.75 34.8 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.996 0.808 . . . . 0.0 111.336 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 60.05 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.346 1.859 . . . . 0.0 112.209 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -55.85 -31.45 62.76 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.629 0.771 . . . . 0.0 112.642 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -61.19 -42.05 97.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.236 0.926 . . . . 0.0 111.008 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.44 -39.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.568 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.55 -39.75 92.07 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.752 175.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -65.18 -38.54 90.81 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.383 -0.823 . . . . 0.0 110.699 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.94 -49.8 71.18 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.89 0.876 . . . . 0.0 110.185 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.42 -42.63 54.17 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.535 1.134 . . . . 0.0 111.117 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -54.9 -54.34 43.89 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.051 0.841 . . . . 0.0 110.157 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -60.94 -42.31 97.94 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.2 -39.94 95.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.441 0.696 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.89 -33.17 62.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.177 -0.952 . . . . 0.0 110.323 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.41 -32.16 72.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.972 0.805 . . . . 0.0 111.026 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -20.53 63.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.561 0.618 . . . . 0.0 111.518 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.95 -4.64 6.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.57 -1.128 . . . . 0.0 113.588 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -89.36 -170.79 2.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.211 1.505 . . . . 0.0 109.925 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -129.16 148.01 51.06 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -139.69 150.72 45.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.144 0.497 . . . . 0.0 111.939 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -113.57 90.7 3.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.891 1.677 . . . . 0.0 107.219 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -70.61 120.08 15.7 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -148.05 137.89 22.52 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.783 0.833 . . . . 0.0 110.725 -169.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -80.04 36.91 0.36 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.551 -1.343 . . . . 0.0 111.404 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.64 49.47 33.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.922 1.725 . . . . 0.0 114.86 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.77 -22.13 69.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.004 2.47 . . . . 0.0 113.888 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 42' ' ' GLU . 70.1 mt -128.74 12.03 6.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.03 1.732 . . . . 0.0 109.418 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 tp 62.11 -25.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.994 2.518 . . . . 0.0 114.161 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 40' ' ' LEU . 8.2 pt-20 -160.37 78.46 0.64 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.407 1.083 . . . . 0.0 108.924 -168.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.2 -46.07 85.54 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.656 -0.653 . . . . 0.0 110.032 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 mt -81.48 154.26 71.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.29 179.3 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.846 3.03 . . . . 0.0 113.584 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.84 32.25 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.116 1.766 . . . . 0.0 112.591 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.1 m -153.89 133.78 13.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.782 2.433 . . . . 0.0 106.536 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.86 -138.95 11.7 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 mm -121.24 135.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.462 ' CD1' HG21 ' A' ' 83' ' ' VAL . 6.0 m0 -125.65 138.9 53.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.5 mt -128.36 146.7 50.7 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.23 133.76 55.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -125.94 108.53 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -170.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -156.72 -163.1 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.506 1.122 . . . . 0.0 108.611 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.96 144.04 25.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 119.289 0.95 . . . . 0.0 110.714 -171.582 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.62 135.9 57.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -122.55 -64.4 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 117.266 -1.349 . . . . 0.0 111.375 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.6 -39.34 9.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 122.073 1.776 . . . . 0.0 110.103 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -61.22 -46.44 90.41 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.864 1.266 . . . . 0.0 110.088 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.6 -51.24 69.39 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.303 1.041 . . . . 0.0 110.399 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.55 -45.34 90.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.833 0.742 . . . . 0.0 110.98 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.76 82.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.65 -55.57 33.19 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 123.264 0.626 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -68.35 -18.98 64.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.49 -32.92 66.59 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.4 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.55 -25.3 5.58 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 32.42 63.04 1.33 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.631 1.972 . . . . 0.0 112.954 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -63.93 167.54 13.81 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.02 2.48 . . . . 0.0 113.39 -169.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -78.97 63.74 3.73 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.181 1.392 . . . . 0.0 111.454 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.07 8.85 0.66 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.757 1.223 . . . . 0.0 112.738 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 m -62.3 -6.83 3.51 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.637 2.775 . . . . 0.0 112.911 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.59 9.33 19.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.265 1.426 . . . . 0.0 111.12 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.1 p -131.31 154.63 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.824 0.738 . . . . 0.0 112.403 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -109.21 149.35 29.51 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.745 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.89 153.87 23.87 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.997 1.319 . . . . 0.0 108.059 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.16 106.65 0.46 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 106.026 -2.829 . . . . 0.0 106.026 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.08 29.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 mt -140.07 132.73 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -169.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -28.44 1.61 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.619 1.104 . . . . 0.0 113.01 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 mt -48.99 142.05 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.297 2.239 . . . . 0.0 108.778 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.3 -36.65 8.05 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 126.194 1.798 . . . . 0.0 111.0 174.282 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.33 -53.06 62.56 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.781 0.832 . . . . 0.0 109.575 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -39.69 92.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.9 75.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.562 1.145 . . . . 0.0 110.238 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -63.26 -39.37 94.41 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.979 0.809 . . . . 0.0 110.981 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -70.14 -41.89 73.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.887 0.767 . . . . 0.0 111.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -61.69 -37.7 85.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.466 1.507 . . . . 0.0 109.223 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -37.11 73.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.078 1.351 . . . . 0.0 111.92 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -67.24 -35.92 80.57 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.108 0.563 . . . . 0.0 110.59 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.87 -28.43 0.36 Allowed Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.015 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.14 170.41 8.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.765 1.283 . . . . 0.0 110.663 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -130.36 137.28 49.82 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -72.04 124.61 25.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.8 m -86.82 154.43 20.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.78 -117.27 10.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 173.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.25 175.9 12.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.9 1.68 . . . . 0.0 107.002 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.5 m -60.04 128.21 35.7 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.52 -0.738 . . . . 0.0 110.115 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.43 HD21 ' H ' ' A' ' 122' ' ' LYS . 1.8 tt -79.88 156.49 27.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.991 1.316 . . . . 0.0 107.822 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.43 ' H ' HD21 ' A' ' 121' ' ' LEU . 7.8 mptt -126.91 140.11 52.57 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.625 1.17 . . . . 0.0 108.083 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 109.011 -175.583 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 119.383 -0.341 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.418 ' CG ' ' HG ' ' A' ' 121' ' ' LEU . 6.8 t90 -57.5 -52.35 65.73 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.618 1.167 . . . . 0.0 110.12 171.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.36 -56.21 12.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.691 1.596 . . . . 0.0 108.509 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.42 -45.37 94.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.433 0.54 . . . . 0.0 112.656 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.4 m -62.19 -60.44 3.59 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.237 1.415 . . . . 0.0 110.457 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -52.93 -41.65 64.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.115 1.766 . . . . 0.0 111.567 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.12 -57.65 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.783 0.833 . . . . 0.0 109.946 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -14.43 62.48 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.47 -0.769 . . . . 0.0 112.398 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.0 mp -80.78 -49.15 11.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 110.782 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.19 -33.62 70.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 111.596 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.519 1.127 . . . . 0.0 109.647 173.917 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.93 164.31 38.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.117 0.967 . . . . 0.0 110.157 -172.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -98.51 -22.83 15.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.778 1.231 . . . . 0.0 110.887 169.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 mt -131.95 126.22 56.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 t -90.98 128.28 36.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -95.76 103.93 15.84 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -96.43 86.84 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 159.16 16.27 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 111.646 -169.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.73 79.56 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.15 -45.02 8.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.228 2.211 . . . . 0.0 115.531 -169.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.7 m -127.89 54.72 1.69 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt 52.91 37.0 23.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.545 1.938 . . . . 0.0 111.929 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.78 4.5 69.4 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.645 1.117 . . . . 0.0 113.235 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.55 -79.39 1.84 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.817 1.199 . . . . 0.0 111.118 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.7 18.08 0.45 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.354 1.862 . . . . 0.0 113.889 -169.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.31 -26.03 67.12 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.354 -0.841 . . . . 0.0 111.834 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.97 -47.65 84.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.73 0.695 . . . . 0.0 110.584 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.65 -38.77 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.3 80.32 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.838 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.58 -40.46 76.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.868 0.758 . . . . 0.0 110.357 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -62.48 -47.69 82.87 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.949 -0.47 . . . . 0.0 110.238 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.18 -51.66 67.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.402 1.081 . . . . 0.0 110.868 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.58 -41.05 66.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.748 0.819 . . . . 0.0 111.393 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -58.09 -47.78 82.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.421 1.009 . . . . 0.0 111.079 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -58.04 -44.32 87.34 Favored 'General case' 0 C--N 1.337 0.034 0 C-N-CA 122.671 0.389 . . . . 0.0 111.308 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.29 -33.02 74.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.56 -45.55 78.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.018 0.826 . . . . 0.0 109.581 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -71.2 -17.3 62.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.813 0.733 . . . . 0.0 112.157 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.04 -15.5 62.03 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.919 0.781 . . . . 0.0 111.442 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.98 22.41 5.96 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.491 169.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -129.08 171.87 11.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.59 1.195 . . . . 0.0 110.28 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 p -105.71 154.47 20.42 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -141.53 155.23 45.81 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.771 -0.581 . . . . 0.0 111.449 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.71 93.51 4.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -70.53 120.95 16.92 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.7 mt -148.51 170.16 18.68 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 124.37 1.068 . . . . 0.0 109.477 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -110.23 37.81 2.61 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.133 1.773 . . . . 0.0 108.603 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.53 48.77 22.01 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.842 1.686 . . . . 0.0 115.086 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.56 -20.5 69.59 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 CA-C-N 121.083 2.442 . . . . 0.0 114.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 42' ' ' GLU . 80.4 mt -122.99 13.25 9.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 109.701 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.84 -28.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.278 2.631 . . . . 0.0 112.649 -169.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 40' ' ' LEU . 9.0 pt-20 -160.37 88.24 0.79 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.371 1.469 . . . . 0.0 107.674 -168.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.36 -43.21 82.02 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.64 154.08 68.18 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.56 -175.53 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.176 3.25 . . . . 0.0 113.186 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 33.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.799 1.64 . . . . 0.0 112.574 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -158.14 135.92 10.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.605 1.962 . . . . 0.0 106.801 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.48 -140.27 11.9 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.88 134.24 66.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -118.96 133.25 55.94 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -122.95 137.91 54.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.1 t -122.11 126.23 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -175.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.02 67.08 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -169.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -135.31 48.48 2.25 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.726 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.1 m -30.79 98.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.977 2.911 . . . . 0.0 115.652 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 125.795 1.638 . . . . 0.0 111.92 177.018 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.46 146.12 52.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -122.3 -65.6 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 117.279 -1.344 . . . . 0.0 110.578 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.25 -41.37 7.07 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.862 1.701 . . . . 0.0 110.171 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -61.09 -48.5 81.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.453 1.101 . . . . 0.0 109.436 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -62.03 -49.55 75.56 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.298 0.499 . . . . 0.0 110.694 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.18 -43.79 98.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.591 0.632 . . . . 0.0 110.512 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -29.49 69.28 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.87 -57.45 11.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.559 1.072 . . . . 0.0 108.96 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -62.99 -26.01 68.65 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.1 -31.56 72.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.966 0.506 . . . . 0.0 111.424 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.99 -26.76 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.943 -1.027 . . . . 0.0 113.768 -175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 31.48 62.99 1.14 Allowed Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 126.291 1.837 . . . . 0.0 112.148 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.21 162.31 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.875 2.383 . . . . 0.0 113.466 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.74 67.43 4.47 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.0 111.131 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 15.17 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.607 1.563 . . . . 0.0 112.811 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.0 p -64.13 -5.37 4.7 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.147 -1.596 . . . . 0.0 112.426 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.58 10.55 14.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.282 1.833 . . . . 0.0 111.004 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.51 149.66 33.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.831 0.825 . . . . 0.0 111.131 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.1 ptm85 -100.57 151.26 21.8 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.55 110.25 0.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.46 136.61 44.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.439 ' C ' ' H ' ' A' ' 90' ' ' ILE . 15.0 mt -138.1 129.7 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.12 -25.59 2.63 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.837 0.732 . . . . 0.0 111.962 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.439 ' H ' ' C ' ' A' ' 88' ' ' ILE . 27.3 mm -48.57 134.78 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 127.5 2.32 . . . . 0.0 106.752 168.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.72 -21.87 4.51 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.957 0.789 . . . . 0.0 111.993 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.233 0.22 0 C-N-CA 128.46 2.704 . . . . 0.0 114.331 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--O 1.227 -0.095 0 CA-C-O 118.851 -0.595 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.53 -57.39 12.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.749 0.704 . . . . 0.0 110.43 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.9 -39.14 93.49 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.31 74.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.053 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.61 -36.46 83.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.271 0.941 . . . . 0.0 111.183 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.7 mt -65.23 -45.0 86.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.06 0.845 . . . . 0.0 110.738 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -68.57 -36.03 78.18 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 123.796 0.838 . . . . 0.0 110.021 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -37.81 87.33 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.193 1.397 . . . . 0.0 111.058 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -39.85 83.82 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.23 -17.54 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.195 169.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.19 137.12 53.0 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.656 1.728 . . . . 0.0 109.777 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.35 110.19 17.29 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -65.74 111.99 3.48 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.7 m -88.4 152.51 21.86 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.66 -124.27 35.52 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.06 157.59 43.29 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 62.4 m -46.17 127.78 8.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.31 1.844 . . . . 0.0 112.541 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.09 160.88 19.88 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.242 1.417 . . . . 0.0 108.512 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -134.59 146.85 49.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 C--N 1.329 -0.316 0 C-N-CA 126.824 2.05 . . . . 0.0 109.116 -172.191 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 119.028 -0.511 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -42.94 97.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.035 0.834 . . . . 0.0 111.23 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -51.94 66.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.803 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.26 -43.24 95.61 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.816 0.722 . . . . 0.0 112.422 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.9 m -59.57 -60.64 3.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.068 1.347 . . . . 0.0 109.996 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -57.37 -43.87 83.91 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.207 0.603 . . . . 0.0 112.097 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.6 t -61.49 -52.89 55.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 C-N-CA 123.201 0.6 . . . . 0.0 109.955 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -16.15 63.02 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.628 1.104 . . . . 0.0 112.129 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.08 -44.85 21.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.482 0.713 . . . . 0.0 111.252 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.35 73.67 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.965 0.802 . . . . 0.0 111.462 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 53.7 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.317 1.447 . . . . 0.0 109.72 174.436 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.85 164.08 37.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.342 1.057 . . . . 0.0 110.079 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.43 -24.36 18.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.445 1.498 . . . . 0.0 110.924 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.41 124.23 44.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.666 1.186 . . . . 0.0 108.3 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -85.74 132.91 34.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.68 92.01 3.88 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -77.81 111.56 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -127.83 -162.7 1.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.258 1.823 . . . . 0.0 107.168 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 28.89 58.59 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.785 -1.197 . . . . 0.0 112.266 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -32.92 -48.97 0.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.975 2.91 . . . . 0.0 115.136 -170.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -125.83 51.72 1.73 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 108.05 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.3 tp 58.69 31.27 20.97 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.976 1.71 . . . . 0.0 110.188 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.81 154.54 8.21 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 128.027 2.727 . . . . 0.0 107.586 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.08 -160.03 22.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.049 0.924 . . . . 0.0 110.914 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.14 41.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.612 1.565 . . . . 0.0 112.541 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.9 -32.16 65.62 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.17 -0.956 . . . . 0.0 112.542 -172.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.93 -42.54 98.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.845 0.748 . . . . 0.0 110.833 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 t -72.75 -39.58 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.16 -39.88 83.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.24 0.473 . . . . 0.0 110.875 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.56 -40.49 92.87 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.893 0.77 . . . . 0.0 110.94 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -64.15 -44.73 91.23 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 110.295 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.92 -50.03 75.59 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.635 1.174 . . . . 0.0 110.498 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.58 -47.8 63.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.274 1.03 . . . . 0.0 110.807 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.31 -52.75 64.08 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.558 0.743 . . . . 0.0 110.595 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm -56.16 -39.0 71.66 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.886 0.474 . . . . 0.0 112.029 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.7 mt -73.49 -26.39 60.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.429 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.05 -38.73 72.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 120.566 1.53 . . . . 0.0 109.55 169.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -62.32 -26.19 68.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 111.409 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.65 55.1 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.549 174.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.21 23.93 6.76 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.163 0.892 . . . . 0.0 113.334 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.73 -169.44 2.05 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.404 1.082 . . . . 0.0 109.277 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 p -128.35 149.14 50.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.0 p -141.63 154.86 45.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.89 0.376 . . . . 0.0 111.223 -169.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.82 94.95 4.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.196 0.999 . . . . 0.0 108.413 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -68.65 120.87 15.34 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.8 mt -145.63 143.56 29.92 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 122.551 0.341 . . . . 0.0 111.158 -170.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -88.28 33.25 0.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 169.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.91 55.85 7.1 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.577 2.036 . . . . 0.0 114.38 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.84 -20.46 68.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.032 2.488 . . . . 0.0 113.695 -174.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 42' ' ' GLU . 78.0 mt -123.56 17.99 9.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.07 1.748 . . . . 0.0 109.066 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.9 tp 64.48 -30.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.399 2.68 . . . . 0.0 113.79 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 40' ' ' LEU . 6.9 pt-20 -165.4 87.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.412 1.885 . . . . 0.0 106.539 -169.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.18 -41.52 97.08 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.9 -0.5 . . . . 0.0 110.446 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt -89.11 150.04 44.34 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.25 -175.83 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.162 3.241 . . . . 0.0 113.116 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.58 33.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 112.43 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -158.68 134.55 8.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.86 2.064 . . . . 0.0 106.351 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.15 -142.86 13.86 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.41 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -123.39 151.79 42.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.8 mt -137.74 142.67 40.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.47 126.99 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.37 108.21 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -145.76 -166.89 2.56 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.828 0.851 . . . . 0.0 109.281 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 p -156.28 66.06 0.57 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 122.2 1.0 . . . . 0.0 112.194 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 123.307 0.643 . . . . 0.0 111.763 -178.008 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mp -70.5 137.01 49.86 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 170.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.74 -62.87 0.21 Allowed Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.142 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.35 -39.83 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 121.733 1.622 . . . . 0.0 111.745 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -63.48 -46.1 87.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 122.86 0.464 . . . . 0.0 110.537 -171.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -60.81 -48.54 81.32 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.927 0.331 . . . . 0.0 110.207 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -62.34 -45.79 91.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.137 0.426 . . . . 0.0 110.259 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.07 79.31 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.378 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.89 -55.65 31.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.241 0.928 . . . . 0.0 108.937 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.32 -27.67 68.66 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.21 -31.25 69.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.707 0.403 . . . . 0.0 111.648 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -122.4 -25.26 4.83 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 29.54 63.41 0.82 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 126.996 2.118 . . . . 0.0 112.307 -173.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.67 164.45 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.898 2.399 . . . . 0.0 113.063 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -77.57 64.91 2.98 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.266 1.426 . . . . 0.0 111.239 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.46 9.03 1.15 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.037 1.335 . . . . 0.0 112.601 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -61.45 -6.39 2.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.213 2.605 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.62 10.38 18.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.99 1.716 . . . . 0.0 111.03 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.14 153.62 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.783 0.719 . . . . 0.0 111.292 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -103.56 150.41 23.97 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 169.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -122.58 159.01 28.68 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.96 140.37 11.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 169.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.46 141.65 43.28 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mt -139.09 138.85 40.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.53 -30.43 2.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.721 1.153 . . . . 0.0 111.766 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 mt -50.64 127.34 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.867 2.067 . . . . 0.0 106.974 169.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.55 -13.77 40.09 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.603 0.621 . . . . 0.0 112.877 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 C--N 1.329 -0.314 0 C-N-CA 128.636 2.774 . . . . 0.0 116.602 -169.142 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 mttm . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -53.84 -57.31 11.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.331 0.968 . . . . 0.0 109.622 172.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.51 -40.63 97.56 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -48.59 81.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.859 0.464 . . . . 0.0 110.202 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.78 -31.86 72.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.687 -1.149 . . . . 0.0 111.739 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.9 mt -66.68 -44.27 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.101 1.318 . . . . 0.0 110.78 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -63.15 -40.47 97.67 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.656 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -36.81 83.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.157 1.383 . . . . 0.0 111.303 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.9 m -70.86 -39.79 72.7 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.84 -20.45 0.68 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.101 -1.388 . . . . 0.0 114.881 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 136.65 54.89 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.568 1.684 . . . . 0.0 108.834 -172.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -79.25 126.97 31.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -74.51 112.73 10.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.5 m -85.46 154.94 21.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.29 -125.38 37.49 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.6 pt-20 -154.41 169.0 24.79 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.269 1.428 . . . . 0.0 107.592 169.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.9 m -51.98 129.92 28.31 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.07 146.15 23.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.505 1.922 . . . . 0.0 107.405 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -121.56 145.88 47.52 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--N 1.326 -0.435 0 C-N-CA 125.303 1.441 . . . . 0.0 107.782 -175.416 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.428 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -55.95 -41.76 75.18 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.487 0.715 . . . . 0.0 110.849 173.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 tp -61.63 -50.11 73.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.69 72.42 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.99 0.806 . . . . 0.0 111.822 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 m -60.01 -57.05 14.54 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -53.11 -44.67 67.82 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.505 1.522 . . . . 0.0 111.691 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -56.5 -58.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 110.077 173.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -16.73 63.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.307 0.958 . . . . 0.0 112.176 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.03 -50.32 15.12 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.099 0.959 . . . . 0.0 110.432 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.35 -27.21 59.11 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.494 1.118 . . . . 0.0 109.634 171.102 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 tpp . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.29 148.23 32.2 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.221 1.008 . . . . 0.0 108.365 170.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.64 -22.97 15.2 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.607 1.563 . . . . 0.0 110.438 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.35 130.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 109.214 -172.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 t -86.2 130.25 34.58 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 169.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.9 94.21 4.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -87.2 98.15 7.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 51.93 2.3 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.82 8.55 59.43 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 117.306 -1.83 . . . . 0.0 115.098 -169.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.0 -42.71 2.92 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.032 1.733 . . . . 0.0 113.983 -169.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 t -149.17 53.09 0.96 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 169.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tp 56.33 38.99 30.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.468 1.507 . . . . 0.0 110.699 -169.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.43 154.38 7.43 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.202 2.81 . . . . 0.0 107.073 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.95 -151.16 6.9 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.928 0.864 . . . . 0.0 110.951 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 65.76 1.21 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.323 1.449 . . . . 0.0 111.0 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -53.74 -37.37 63.3 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.64 0.776 . . . . 0.0 112.63 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -59.81 -45.13 93.3 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.441 0.564 . . . . 0.0 110.255 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -32.69 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.61 97.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.658 0.663 . . . . 0.0 110.853 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.42 -39.55 89.02 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.994 0.518 . . . . 0.0 110.681 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -62.86 -46.51 87.55 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.469 -0.77 . . . . 0.0 110.501 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.8 mt -55.77 -52.68 63.12 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.486 1.114 . . . . 0.0 109.92 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.82 -52.09 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.165 0.986 . . . . 0.0 110.532 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -55.34 -54.26 45.84 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.358 0.663 . . . . 0.0 110.775 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -59.88 -38.87 83.45 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -68.96 -32.7 72.48 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.157 0.583 . . . . 0.0 111.691 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.58 -37.35 71.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.757 1.162 . . . . 0.0 110.152 173.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -63.6 -29.77 70.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 111.217 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.77 -21.74 62.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.562 0.745 . . . . 0.0 111.259 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.02 -5.01 5.37 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.062 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.52 -167.07 1.55 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.686 1.743 . . . . 0.0 109.602 -174.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 p -130.19 151.09 51.09 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.9 p -143.74 160.28 41.0 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -170.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 106.31 8.93 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -71.94 121.09 18.48 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 mt -139.11 157.98 44.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.401 0.68 . . . . 0.0 110.71 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -95.23 21.88 7.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.421 1.088 . . . . 0.0 110.766 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.11 42.89 73.01 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 117.912 -1.493 . . . . 0.0 113.139 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.12 -22.29 61.83 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.201 2.601 . . . . 0.0 114.825 -169.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 42' ' ' GLU . 84.5 mt -115.24 13.53 16.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.523 1.529 . . . . 0.0 109.666 -177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 tp 65.57 -25.69 0.1 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.016 2.527 . . . . 0.0 112.916 -169.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.0 pt-20 -169.13 85.81 0.15 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.034 1.734 . . . . 0.0 107.331 -169.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.44 -42.9 98.66 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.594 -0.691 . . . . 0.0 110.249 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -90.81 149.32 40.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.38 -179.33 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.919 3.079 . . . . 0.0 113.449 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.83 30.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.671 1.988 . . . . 0.0 113.102 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.7 p -161.72 107.83 1.33 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.367 1.867 . . . . 0.0 106.393 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.38 -147.48 16.75 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mm -127.53 131.72 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -119.69 152.75 36.64 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.3 mt -143.59 141.16 30.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.16 136.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.66 123.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -162.43 -172.86 3.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 108.158 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.98 69.77 1.03 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.535 -1.353 . . . . 0.0 108.088 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.465 0.297 0 C-N-CA 126.591 1.957 . . . . 0.0 115.657 -169.595 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.3 t30 . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.42 84.43 0.27 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 126.629 1.972 . . . . 0.0 106.701 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -54.4 25.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 124.54 1.136 . . . . 0.0 111.091 -168.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.18 -41.85 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.118 1.879 . . . . 0.0 110.776 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -65.62 -50.96 63.11 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.209 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.95 -44.9 95.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.954 0.797 . . . . 0.0 110.023 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.44 -47.16 80.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.254 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.03 -35.91 74.09 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.204 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -59.59 5.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.603 1.092 . . . . 0.0 109.266 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -16.82 63.73 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.25 -32.55 70.43 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.415 0.552 . . . . 0.0 111.259 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -124.23 -29.35 3.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt 28.98 66.64 0.68 Allowed Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 126.482 1.913 . . . . 0.0 113.251 -171.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.08 173.28 2.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.558 2.172 . . . . 0.0 111.381 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -84.98 124.45 31.71 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.35 14.59 10.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.069 1.348 . . . . 0.0 110.657 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -69.07 -3.88 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 119.82 -1.8 . . . . 0.0 112.81 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.25 4.59 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.034 1.334 . . . . 0.0 110.789 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.78 157.36 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.886 0.874 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -113.38 149.43 34.09 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -128.01 164.82 21.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.546 0.689 . . . . 0.0 109.507 174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.1 153.73 21.96 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.62 136.66 53.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.24 135.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -169.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.82 -27.35 1.64 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.081 1.324 . . . . 0.0 112.709 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 mt -48.35 130.04 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.048 2.139 . . . . 0.0 109.273 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -95.03 7.26 69.69 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.027 1.299 . . . . 0.0 111.759 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 125.602 1.561 . . . . 0.0 113.161 -179.28 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.22 -54.74 40.42 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.253 0.933 . . . . 0.0 109.894 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -40.12 95.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.9 88.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.334 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.28 -34.32 77.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.222 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.14 -43.87 85.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.724 1.147 . . . . 0.0 110.5 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -65.03 -37.43 87.57 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 109.911 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -35.12 79.09 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.562 . . . . 0.0 111.282 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.9 m -72.4 -27.29 62.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.562 0.345 . . . . 0.0 110.229 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.28 -23.46 2.86 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.541 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 135.57 54.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.2 1.5 . . . . 0.0 108.554 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -80.78 132.62 35.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -77.87 100.0 6.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 m -73.91 153.21 39.92 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.04 -122.06 24.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.519 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.8 pt-20 -157.47 174.78 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.981 1.712 . . . . 0.0 107.831 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -54.34 127.84 28.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.809 0.844 . . . . 0.0 109.537 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 tt -99.24 155.27 17.58 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.641 1.576 . . . . 0.0 108.834 -171.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.65 147.85 44.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.318 -176.707 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.519 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.88 -44.88 91.7 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.135 0.879 . . . . 0.0 109.214 174.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.24 -51.63 68.16 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.11 -42.12 98.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.403 0.525 . . . . 0.0 112.111 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 m -58.54 -61.58 2.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 0.0 109.821 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -55.2 -46.06 75.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.7 0.8 . . . . 0.0 112.277 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.03 -54.62 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.556 0.742 . . . . 0.0 109.387 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -16.8 61.94 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.004 0.82 . . . . 0.0 112.471 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 mp -80.74 -44.18 19.06 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.329 0.652 . . . . 0.0 111.034 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -37.05 75.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.923 0.783 . . . . 0.0 110.976 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.7 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.938 1.295 . . . . 0.0 109.93 174.198 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.18 170.07 22.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.934 1.294 . . . . 0.0 109.29 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.64 -23.32 17.66 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.591 1.157 . . . . 0.0 110.895 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.92 127.74 55.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 108.946 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -92.33 129.3 38.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.99 98.63 8.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.83 89.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -92.12 49.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.598 2.359 . . . . 0.0 111.079 -168.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.85 174.26 46.7 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 121.45 -0.781 . . . . 0.0 112.558 175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.8 p -129.34 -48.21 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.621 1.168 . . . . 0.0 110.299 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 p -86.44 -72.21 0.51 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.4 tp -157.14 23.36 0.31 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 110.379 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.94 169.29 42.19 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.37 46.5 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.047 1.784 . . . . 0.0 108.809 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 102.61 0.45 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.303 1.041 . . . . 0.0 111.533 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.97 -38.64 89.3 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.515 0.726 . . . . 0.0 110.637 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.35 -42.59 91.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.283 0.633 . . . . 0.0 110.705 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.14 -49.33 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.96 93.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.104 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.91 -41.35 91.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.008 0.523 . . . . 0.0 110.819 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -61.99 -47.77 83.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.65 0.659 . . . . 0.0 110.066 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.42 -53.43 57.54 Favored 'General case' 0 N--CA 1.46 0.039 0 C-N-CA 124.057 0.943 . . . . 0.0 110.173 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.35 59.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.256 1.022 . . . . 0.0 110.712 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.17 -54.51 46.12 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -58.3 -37.3 74.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -70.81 -28.07 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.859 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.71 -39.65 73.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.632 1.56 . . . . 0.0 109.804 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.57 -28.17 69.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.463 0.705 . . . . 0.0 111.332 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.34 -10.82 60.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 112.348 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 16.92 8.7 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.912 -0.938 . . . . 0.0 113.424 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -117.73 -167.9 1.41 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.485 1.142 . . . . 0.0 108.84 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -130.82 150.29 52.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 p -140.84 156.99 46.01 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.911 -0.493 . . . . 0.0 110.446 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -133.15 105.47 7.05 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.09 122.79 21.55 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.386 1.074 . . . . 0.0 108.533 175.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -149.75 138.59 21.0 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 122.79 0.436 . . . . 0.0 111.014 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -85.48 43.86 1.06 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.667 -1.27 . . . . 0.0 108.393 168.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.31 56.21 1.2 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 127.358 2.408 . . . . 0.0 115.757 -169.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.62 -24.78 46.97 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.343 2.572 . . . . 0.0 115.367 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 42' ' ' GLU . 85.4 mt -118.45 15.58 13.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.977 1.711 . . . . 0.0 109.363 -176.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp 66.06 -30.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.506 2.722 . . . . 0.0 113.106 -169.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.3 pt-20 -168.13 94.45 0.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.334 1.854 . . . . 0.0 106.342 -169.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.29 -44.35 83.73 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.95 153.02 69.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.812 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.65 -171.51 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.443 3.428 . . . . 0.0 112.231 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.35 27.61 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.852 1.661 . . . . 0.0 113.42 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -156.49 138.0 14.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.99 2.116 . . . . 0.0 106.81 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.41 -140.4 11.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mm -128.46 133.83 65.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -117.71 135.31 54.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.9 mt -128.95 142.37 50.96 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.93 133.08 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.29 104.58 6.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 123.791 0.836 . . . . 0.0 108.856 -169.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -171.56 131.1 0.71 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.574 1.949 . . . . 0.0 107.409 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.7 m -72.36 102.41 3.14 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 119.113 0.869 . . . . 0.0 108.686 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 115.349 -169.785 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 117.92 -1.038 . . . . 0.0 113.777 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.34 147.74 51.85 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.286 1.434 . . . . 0.0 107.263 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 -61.28 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.527 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -87.91 -40.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.449 2.1 . . . . 0.0 112.418 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -59.58 -52.65 64.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -62.99 -43.92 97.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.923 0.329 . . . . 0.0 110.458 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -63.54 -46.91 83.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.068 0.394 . . . . 0.0 109.969 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.75 71.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.522 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.3 -58.0 10.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.374 0.988 . . . . 0.0 109.079 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -62.64 -26.41 68.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.95 -30.77 71.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.072 0.549 . . . . 0.0 111.658 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -124.91 -23.8 4.2 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 30.78 66.4 0.87 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.65 1.98 . . . . 0.0 112.056 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -57.89 160.5 15.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.404 2.736 . . . . 0.0 113.123 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -79.9 61.12 3.71 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 122.37 1.081 . . . . 0.0 110.779 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.2 mt -71.63 10.47 0.65 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.772 1.629 . . . . 0.0 112.792 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -62.46 -7.42 4.51 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 129.665 3.186 . . . . 0.0 113.042 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.83 11.31 17.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.577 1.551 . . . . 0.0 110.791 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 p -130.28 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.966 0.889 . . . . 0.0 111.154 173.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -95.01 151.02 19.53 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.88 145.47 45.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.47 115.23 1.33 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 140.0 47.33 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.6 mt -137.32 128.34 40.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.99 -10.92 2.15 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.314 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mt -48.52 129.93 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.791 2.036 . . . . 0.0 109.465 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.67 -20.35 66.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.243 0.925 . . . . 0.0 112.163 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 127.953 2.501 . . . . 0.0 114.95 -177.574 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.56 -54.18 46.48 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.71 -41.81 95.97 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.84 76.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -67.78 -30.88 70.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.168 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.84 -44.07 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.755 1.161 . . . . 0.0 110.769 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.06 -35.06 73.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.432 0.693 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -32.21 71.4 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 125.954 1.702 . . . . 0.0 111.902 174.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.8 m -64.76 -48.35 74.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.6 -15.74 0.38 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.059 -1.412 . . . . 0.0 115.393 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.05 138.46 58.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.588 1.694 . . . . 0.0 110.61 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -84.03 111.53 19.37 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.64 111.76 2.89 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 42.5 m -84.17 152.51 24.23 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.96 -121.31 26.24 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.535 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 3.0 pt-20 -150.3 -176.35 5.44 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.909 2.083 . . . . 0.0 106.049 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -41.36 111.46 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.622 1.569 . . . . 0.0 111.376 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 161.54 28.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -133.79 149.37 51.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -170.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.535 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.63 -42.24 98.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.292 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 tp -57.99 -53.32 59.59 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.77 -42.68 98.13 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 m -59.0 -62.19 2.07 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 125.146 1.378 . . . . 0.0 110.149 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -57.15 -44.36 83.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.75 0.82 . . . . 0.0 112.016 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.48 -53.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.439 0.696 . . . . 0.0 109.475 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.23 -17.42 62.5 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.31 0.959 . . . . 0.0 112.407 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -79.18 -42.87 25.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.564 0.62 . . . . 0.0 111.227 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -37.56 75.12 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.947 0.794 . . . . 0.0 111.079 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.9 mttm . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.39 1.476 . . . . 0.0 109.937 174.068 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.24 159.59 44.13 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.509 1.124 . . . . 0.0 108.853 173.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -111.85 -23.13 10.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.444 1.898 . . . . 0.0 110.872 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.03 122.85 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -85.06 128.58 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.34 95.33 6.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -82.74 83.21 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -83.72 31.97 0.47 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 128.804 2.841 . . . . 0.0 112.682 -168.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.42 155.62 26.61 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 121.599 -0.688 . . . . 0.0 112.173 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.33 -37.8 1.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 110.387 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.5 p -130.6 49.56 2.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.8 tp 52.22 42.41 30.75 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.126 1.771 . . . . 0.0 111.101 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.18 159.18 16.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 128.042 2.734 . . . . 0.0 106.798 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.36 -160.4 32.52 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.357 1.078 . . . . 0.0 111.301 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.43 46.26 0.33 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.475 1.91 . . . . 0.0 113.525 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -53.52 -35.22 60.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.192 0.997 . . . . 0.0 112.828 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.01 -45.75 93.56 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.772 . . . . 0.0 110.736 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.05 -40.9 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.534 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.11 -41.52 94.83 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.177 0.899 . . . . 0.0 110.984 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -64.8 -45.5 85.99 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.745 -0.597 . . . . 0.0 109.904 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.24 -51.24 68.82 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.225 1.01 . . . . 0.0 110.271 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.36 -49.83 60.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 110.897 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.16 -53.48 57.8 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.193 0.997 . . . . 0.0 110.244 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.71 -37.95 77.23 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mp -69.71 -26.51 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.86 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -70.04 -43.82 70.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.854 1.661 . . . . 0.0 109.316 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.0 -26.33 67.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.48 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.34 -16.26 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.713 0.805 . . . . 0.0 112.219 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.07 15.66 2.05 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.523 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -131.66 -165.25 1.55 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.304 1.552 . . . . 0.0 110.041 -169.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 p -131.18 151.68 51.22 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.9 p -144.11 159.78 42.04 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.038 0.535 . . . . 0.0 109.796 -169.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.1 107.23 7.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 m -78.17 120.15 22.56 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -147.07 137.47 23.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.194 0.598 . . . . 0.0 110.057 -169.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -82.39 41.49 0.7 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.608 -1.307 . . . . 0.0 109.677 169.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 38.7 55.12 2.22 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.636 2.065 . . . . 0.0 115.022 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.39 -20.3 54.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.808 2.339 . . . . 0.0 113.499 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 42' ' ' GLU . 83.4 mt -118.07 15.18 14.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.293 1.837 . . . . 0.0 109.068 177.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tp 63.84 -28.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.088 2.955 . . . . 0.0 113.97 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 40' ' ' LEU . 9.7 pt-20 -164.98 93.45 0.62 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.408 1.483 . . . . 0.0 107.111 -168.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.08 -43.78 77.77 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.467 -0.771 . . . . 0.0 110.007 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.35 154.5 74.34 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.52 -173.68 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.934 3.089 . . . . 0.0 112.554 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 29.94 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.178 1.391 . . . . 0.0 112.661 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.0 m -152.33 136.91 16.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.967 2.507 . . . . 0.0 106.41 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.13 -141.59 12.74 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mm -123.76 139.83 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -122.04 135.12 54.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.8 mt -128.79 140.7 51.59 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.58 134.43 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -137.68 113.78 11.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -170.93 -156.51 0.12 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.935 2.494 . . . . 0.0 105.668 174.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m -147.6 138.78 23.62 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 121.06 1.755 . . . . 0.0 109.305 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.0 p . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.619 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.34 146.16 55.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.721 1.208 . . . . 0.0 108.69 174.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.8 m -122.22 -63.67 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 117.248 -1.358 . . . . 0.0 111.172 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.75 -39.31 15.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.92 1.722 . . . . 0.0 110.993 -175.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -60.28 -50.35 73.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.35 0.66 . . . . 0.0 110.091 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.28 -48.97 78.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.67 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -60.94 -45.81 93.23 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.772 0.714 . . . . 0.0 110.462 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.4 72.61 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.43 -58.02 8.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 119.202 0.91 . . . . 0.0 109.233 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -63.6 -24.64 67.88 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.56 -33.69 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.022 0.529 . . . . 0.0 111.38 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -123.47 -23.76 4.73 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 29.91 66.53 0.78 Allowed Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 126.885 2.074 . . . . 0.0 112.086 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.75 163.88 17.58 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.037 2.492 . . . . 0.0 113.529 -169.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.99 59.86 2.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.285 1.834 . . . . 0.0 112.009 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 7.16 2.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.036 1.334 . . . . 0.0 113.163 -171.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -63.52 -4.06 2.57 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.259 -1.526 . . . . 0.0 112.614 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.9 6.56 25.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.3 1.44 . . . . 0.0 111.459 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.71 162.07 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.914 0.885 . . . . 0.0 109.966 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -118.0 152.74 34.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -119.92 151.56 38.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.922 1.689 . . . . 0.0 108.134 -169.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.39 150.85 23.16 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.9 138.95 53.82 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.7 mt -137.08 124.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -169.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.23 -30.27 1.39 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.801 1.191 . . . . 0.0 111.803 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.43 143.45 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.452 1.901 . . . . 0.0 108.005 169.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 15.54 0.11 Allowed Glycine 0 CA--C 1.523 0.563 0 CA-C-O 119.055 -0.858 . . . . 0.0 113.8 -174.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 125.037 1.335 . . . . 0.0 112.878 178.629 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.2 mttm . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.21 -58.82 5.92 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.788 1.177 . . . . 0.0 109.842 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.57 -37.68 84.73 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -175.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.2 -51.75 67.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.009 0.923 . . . . 0.0 109.953 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.69 -35.22 80.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.428 1.013 . . . . 0.0 111.158 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.62 -50.1 72.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.174 0.897 . . . . 0.0 110.942 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.322 11.7 ptmt -71.78 -28.1 63.4 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.938 -0.476 . . . . 0.0 112.204 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -36.19 82.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.333 1.053 . . . . 0.0 111.009 169.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.6 m -68.52 -33.7 74.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.948 0.34 . . . . 0.0 110.561 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.69 -28.9 0.37 Allowed Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.668 169.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.47 141.2 57.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.654 1.227 . . . . 0.0 110.11 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -80.69 129.16 34.36 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -75.6 100.95 4.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 170.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 99.6 m -73.32 149.87 42.31 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.34 -124.43 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.0 pt-20 -152.1 166.05 32.84 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.337 1.055 . . . . 0.0 108.301 169.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.5 m -51.03 130.89 26.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.842 1.257 . . . . 0.0 111.222 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.64 160.47 14.99 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.928 2.091 . . . . 0.0 108.429 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -131.36 144.05 50.95 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--N 1.324 -0.535 0 C-N-CA 127.747 2.419 . . . . 0.0 106.448 -179.583 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 . . . . . 0 CA--C 1.538 0.513 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.437 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.87 -48.47 78.05 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.335 0.654 . . . . 0.0 109.711 171.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.62 -49.14 77.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.074 0.95 . . . . 0.0 109.217 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.0 -52.51 46.3 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.932 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -63.24 -44.74 94.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.286 0.543 . . . . 0.0 110.524 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.39 -41.84 94.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.274 1.43 . . . . 0.0 110.804 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.77 -48.03 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.084 0.953 . . . . 0.0 109.547 172.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.35 -29.74 70.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.257 0.935 . . . . 0.0 111.612 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.21 -46.99 25.65 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.363 1.065 . . . . 0.0 110.505 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.01 -29.91 62.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.353 0.524 . . . . 0.0 112.054 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.3 mttt . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.374 1.07 . . . . 0.0 109.86 171.815 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.81 158.8 35.73 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.1 -22.25 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.1 1.76 . . . . 0.0 110.712 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.5 mt -134.81 128.94 51.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.547 1.139 . . . . 0.0 108.065 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -89.01 131.88 34.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 95.1 5.39 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.1 mt -89.94 110.39 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.35 143.67 44.06 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 122.813 0.445 . . . . 0.0 111.622 -169.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.5 168.29 12.22 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 124.598 1.094 . . . . 0.0 112.002 169.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 p -117.88 -8.8 10.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 0.0 112.516 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t -141.79 -54.44 0.45 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -149.4 17.12 0.93 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.485 1.039 . . . . 0.0 111.661 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.93 172.1 28.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 127.432 2.444 . . . . 0.0 107.68 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.71 10.07 4.12 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.015 -1.436 . . . . 0.0 115.053 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 2.86 1.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.077 1.938 . . . . 0.0 113.405 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.8 -31.55 62.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.486 1.114 . . . . 0.0 112.125 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -58.1 -53.5 57.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.458 0.703 . . . . 0.0 111.525 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.09 -30.54 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.03 77.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.001 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.35 -41.22 89.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.015 0.825 . . . . 0.0 111.083 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -63.07 -46.9 85.28 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.1 mt -57.12 -51.17 70.35 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.044 0.937 . . . . 0.0 110.461 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.72 -48.53 63.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.761 1.224 . . . . 0.0 110.685 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.71 -53.89 52.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.484 0.714 . . . . 0.0 110.345 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -57.92 -38.12 75.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.92 -33.13 75.02 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.254 0.621 . . . . 0.0 111.183 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -70.04 -38.21 75.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 119.921 1.237 . . . . 0.0 110.325 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.51 -28.96 70.3 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.165 0.893 . . . . 0.0 111.42 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.34 63.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.393 0.677 . . . . 0.0 111.597 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.26 -6.49 5.34 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.493 -1.171 . . . . 0.0 113.706 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.9 -165.44 1.34 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.341 1.57 . . . . 0.0 109.395 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.5 p -144.88 160.08 41.87 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.701 -0.624 . . . . 0.0 110.618 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.07 115.61 15.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 m -78.93 123.82 27.64 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 mt -140.5 156.79 46.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.112 0.565 . . . . 0.0 110.396 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -105.03 35.8 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.432 1.093 . . . . 0.0 108.77 169.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.57 48.05 28.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.727 1.632 . . . . 0.0 115.048 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.38 -20.57 61.47 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 121.046 2.423 . . . . 0.0 113.808 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 42' ' ' GLU . 80.5 mt -122.31 14.92 10.49 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.022 1.729 . . . . 0.0 109.094 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.6 tp 64.9 -30.09 0.12 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.979 2.512 . . . . 0.0 113.543 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.3 pt-20 -165.31 86.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.223 1.409 . . . . 0.0 107.452 -168.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.7 -41.74 99.28 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.956 -0.465 . . . . 0.0 110.185 176.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.47 150.11 36.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.58 -178.92 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.88 3.053 . . . . 0.0 113.239 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 32.55 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.994 1.718 . . . . 0.0 112.549 171.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 m -157.36 125.34 5.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 106.044 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.86 -143.36 14.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 mm -124.38 130.97 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -118.89 144.62 46.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.2 mt -137.14 135.77 37.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -132.6 137.55 53.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -173.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -128.07 96.71 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.169 1.388 . . . . 0.0 107.258 -170.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.5 p -145.52 -6.29 0.63 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -173.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m 37.98 60.95 1.14 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.468 0.431 0 C-N-CA 124.122 0.969 . . . . 0.0 112.384 169.932 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.0 mt 37.66 58.81 1.33 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.078 1.418 . . . . 0.0 108.395 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -63.61 -48.01 81.45 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.488 1.915 . . . . 0.0 114.174 -168.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.14 -34.07 70.42 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 121.176 1.456 . . . . 0.0 110.647 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -72.33 -42.84 64.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.403 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -53.52 -51.56 62.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.99 1.316 . . . . 0.0 110.261 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -61.8 -42.52 99.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.822 0.737 . . . . 0.0 110.87 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.6 86.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.219 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.49 -56.34 23.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.241 0.928 . . . . 0.0 109.106 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -20.18 65.06 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.84 -31.06 63.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.876 0.762 . . . . 0.0 111.635 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -121.11 -28.56 4.72 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 23.75 70.91 0.33 Allowed Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 127.722 2.409 . . . . 0.0 113.7 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -58.84 175.38 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.605 2.204 . . . . 0.0 111.729 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -89.96 79.16 6.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.995 0.918 . . . . 0.0 110.022 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.39 3.17 9.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.264 0.626 . . . . 0.0 112.174 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -63.8 -6.74 6.23 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.026 2.13 . . . . 0.0 112.926 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.13 6.21 38.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.774 1.629 . . . . 0.0 110.792 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.31 145.66 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 122.147 0.975 . . . . 0.0 111.732 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -94.67 144.55 25.52 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -113.07 146.5 39.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.09 121.81 3.67 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.09 132.16 43.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.24 108.28 18.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -30.03 0.43 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.227 0.918 . . . . 0.0 113.049 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.76 123.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.0 45.74 0.29 Allowed Glycine 0 CA--C 1.502 -0.722 0 CA-C-O 121.722 0.623 . . . . 0.0 111.75 -169.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.83 -56.49 19.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.721 0.808 . . . . 0.0 110.138 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.14 -38.87 92.0 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.63 72.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -63.24 -42.12 99.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.775 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -57.28 -47.59 81.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.304 0.956 . . . . 0.0 110.714 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -73.51 -36.0 65.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.852 0.861 . . . . 0.0 109.688 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -34.38 78.23 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.377 1.471 . . . . 0.0 111.629 173.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -73.65 -17.72 61.12 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.251 0.22 . . . . 0.0 110.636 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.25 -17.64 5.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 117.921 -1.488 . . . . 0.0 114.085 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 130.75 44.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.649 1.725 . . . . 0.0 109.258 -170.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -86.37 111.08 20.15 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.04 117.51 5.18 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 94.7 m -129.38 143.13 50.72 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.244 0.618 . . . . 0.0 110.737 -169.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.38 -103.34 2.99 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -165.03 -175.88 3.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.357 1.863 . . . . 0.0 107.448 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.4 m -63.01 113.64 3.22 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.411 ' HG ' ' CG ' ' A' ' 138' ' ' TRP . 1.3 tt -71.37 153.62 42.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -130.8 143.0 50.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 125.722 1.609 . . . . 0.0 107.213 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.533 0.305 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.411 ' CG ' ' HG ' ' A' ' 121' ' ' LEU . 13.8 t90 -59.08 -54.92 41.57 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.307 0.643 . . . . 0.0 109.538 173.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -55.91 20.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.631 1.573 . . . . 0.0 109.09 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.1 -42.59 98.02 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.737 -0.48 . . . . 0.0 112.133 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -60.17 -60.35 3.96 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.82 0.81 . . . . 0.0 109.03 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -56.85 -46.54 81.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.386 1.074 . . . . 0.0 111.485 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.01 -55.78 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.702 0.801 . . . . 0.0 109.683 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -15.96 62.49 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.059 0.845 . . . . 0.0 112.421 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.61 -48.47 13.71 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.467 0.707 . . . . 0.0 110.769 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.73 -32.58 65.8 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.766 0.712 . . . . 0.0 111.958 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.1 mttt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.228 1.011 . . . . 0.0 109.74 174.006 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.62 152.59 45.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.273 0.942 . . . . 0.0 111.628 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.43 -22.51 16.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.193 1.797 . . . . 0.0 110.865 170.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.21 129.49 53.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.781 1.233 . . . . 0.0 108.144 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -90.42 127.96 36.35 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.91 95.62 5.66 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.64 131.54 33.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.83 -174.35 3.7 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.058 1.743 . . . . 0.0 109.038 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.27 42.44 90.58 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.547 -0.721 . . . . 0.0 112.476 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -44.91 -44.56 9.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.396 2.278 . . . . 0.0 114.329 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -82.23 22.78 0.79 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.188 1.795 . . . . 0.0 112.188 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt 59.04 54.17 5.13 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.74 1.257 . . . . 0.0 107.654 -168.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.32 -135.98 3.33 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.096 1.808 . . . . 0.0 108.739 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.46 149.32 21.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.18 16.27 0.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.321 1.849 . . . . 0.0 111.108 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.24 -16.91 37.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 0.0 113.683 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.64 -48.08 66.63 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.283 1.402 . . . . 0.0 112.14 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.07 -31.72 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.967 -0.458 . . . . 0.0 110.177 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.53 78.07 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.074 0.55 . . . . 0.0 111.114 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.31 -37.45 80.61 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.055 0.942 . . . . 0.0 110.371 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -65.25 -42.44 93.31 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.72 -0.612 . . . . 0.0 110.008 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 mt -61.49 -51.73 67.43 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.93 64.96 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.451 1.501 . . . . 0.0 111.312 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 -54.74 40.16 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.517 0.675 . . . . 0.0 109.954 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.56 -38.74 91.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -60.93 -40.17 92.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.478 0.711 . . . . 0.0 110.897 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.55 -36.52 68.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.16 -0.962 . . . . 0.0 110.469 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.8 -31.3 71.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.481 0.712 . . . . 0.0 111.262 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.5 -21.49 62.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.375 0.67 . . . . 0.0 111.736 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.99 -7.82 3.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.178 -1.345 . . . . 0.0 114.295 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -94.99 -168.86 1.88 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.802 1.801 . . . . 0.0 110.205 -171.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -128.89 149.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.7 p -142.71 155.64 44.91 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.823 -0.548 . . . . 0.0 111.065 -170.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -121.73 90.67 3.36 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.906 1.283 . . . . 0.0 108.331 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -67.53 120.66 14.33 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.1 mt -146.86 168.37 21.59 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.834 0.854 . . . . 0.0 111.534 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -109.52 31.88 5.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.884 1.273 . . . . 0.0 109.584 169.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.86 49.73 46.93 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.602 1.572 . . . . 0.0 114.537 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 -21.01 64.96 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.061 2.507 . . . . 0.0 113.99 -172.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 42' ' ' GLU . 83.4 mt -120.11 12.76 11.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.674 1.59 . . . . 0.0 109.577 -177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 tp 63.91 -25.8 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.939 2.496 . . . . 0.0 113.455 -169.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.3 pt-20 -166.75 82.67 0.25 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -169.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.98 -43.89 97.54 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.879 -0.513 . . . . 0.0 109.841 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.48 151.28 44.07 Favored Pre-proline 0 C--N 1.345 0.409 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 169.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.07 -175.12 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 124.151 3.234 . . . . 0.0 113.005 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.04 29.77 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.645 1.578 . . . . 0.0 113.193 171.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.3 m -152.56 127.17 9.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.964 2.506 . . . . 0.0 106.157 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.08 -140.92 12.19 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.3 mm -127.97 135.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -119.52 130.02 54.98 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.3 mt -126.97 133.58 50.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.37 103.5 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -169.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.0 mp -78.72 126.04 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.9 m -159.57 176.95 11.43 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.128 1.771 . . . . 0.0 107.05 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 m -149.92 65.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 p . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 126.749 2.019 . . . . 0.0 113.399 -169.835 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 119.968 3.322 . . . . 0.0 119.968 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.29 72.57 10.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.8 m -67.21 -51.3 35.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.746 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 -38.73 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.453 1.435 . . . . 0.0 110.18 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.31 -52.33 54.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.592 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -59.38 -46.26 89.16 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.286 0.948 . . . . 0.0 110.845 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -63.5 -49.54 73.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.512 0.596 . . . . 0.0 110.274 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.26 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -60.52 -56.29 23.21 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.836 0.855 . . . . 0.0 109.577 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.41 -23.57 66.99 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.49 -33.7 73.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.746 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -124.59 -21.83 4.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 30.26 64.53 0.89 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 127.068 2.147 . . . . 0.0 112.911 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.7 165.24 18.84 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.938 2.425 . . . . 0.0 113.375 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.34 63.96 4.99 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.731 1.212 . . . . 0.0 111.232 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 9.95 0.33 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.45 1.5 . . . . 0.0 113.281 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 m -64.04 -2.43 1.98 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.756 2.823 . . . . 0.0 113.171 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.85 9.1 11.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.741 1.616 . . . . 0.0 110.981 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.5 154.13 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.689 0.677 . . . . 0.0 110.75 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.36 143.26 32.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -103.01 154.61 19.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.98 115.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.1 133.92 47.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.32 116.67 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.46 -11.37 18.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.625 1.107 . . . . 0.0 114.36 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.64 130.5 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.012 1.725 . . . . 0.0 108.609 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.96 -38.88 3.71 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 -170.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 125.705 1.602 . . . . 0.0 111.565 170.363 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.37 -59.04 6.08 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.292 0.951 . . . . 0.0 109.442 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.06 -38.61 79.78 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.318 0.508 . . . . 0.0 110.852 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.91 88.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.879 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -64.84 -36.59 84.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.967 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.67 -47.25 86.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.255 0.934 . . . . 0.0 110.814 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -69.46 -35.47 75.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.993 0.517 . . . . 0.0 110.217 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -36.48 84.18 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.293 1.437 . . . . 0.0 111.037 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.8 m -67.16 -36.14 81.18 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.607 0.363 . . . . 0.0 110.097 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.66 -25.66 0.25 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.29 -1.284 . . . . 0.0 115.396 169.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.35 139.98 55.87 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.344 1.572 . . . . 0.0 110.524 -170.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -83.73 146.14 28.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -92.58 98.37 11.4 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.8 m -75.3 151.72 38.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.82 -116.89 8.63 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.453 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 7.3 pt-20 -146.8 178.99 7.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.334 1.053 . . . . 0.0 108.561 170.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -54.43 119.53 5.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.5 1.12 . . . . 0.0 108.8 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.09 151.35 37.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -138.87 141.84 38.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.324 -0.533 0 C-N-CA 127.501 2.321 . . . . 0.0 108.657 -171.613 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 119.601 -0.237 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.453 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 8.3 m-90 -63.22 -51.29 66.84 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.007 0.523 . . . . 0.0 109.833 177.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.8 mt -58.62 -55.7 31.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.693 0.621 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.51 -49.16 75.61 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.383 -0.676 . . . . 0.0 111.414 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -48.03 77.71 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.155 0.977 . . . . 0.0 110.176 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -60.16 -42.96 96.07 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.569 -0.707 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.8 t -57.39 -50.33 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.555 1.142 . . . . 0.0 109.727 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.74 -26.96 68.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.129 0.877 . . . . 0.0 111.986 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.8 -45.98 16.1 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.671 0.789 . . . . 0.0 110.401 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.05 -34.69 68.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.375 0.534 . . . . 0.0 111.754 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.2 mttt . . . . . 0 C--O 1.248 0.98 0 C-N-CA 124.155 0.982 . . . . 0.0 110.026 176.14 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 tpp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.71 163.22 40.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.369 1.068 . . . . 0.0 109.924 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.14 -24.3 16.91 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.752 1.221 . . . . 0.0 110.891 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.7 mt -132.48 124.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 127.8 35.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.16 103.4 14.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mt -89.92 74.45 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -78.83 138.88 38.38 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.783 -0.573 . . . . 0.0 109.988 -170.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.63 136.11 3.15 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 124.563 1.078 . . . . 0.0 111.082 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -87.21 -7.22 58.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.931 0.892 . . . . 0.0 110.509 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 13' ' ' GLY . 6.4 t -143.74 -144.35 0.15 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.992 3.317 . . . . 0.0 102.954 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.62 8.12 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 11' ' ' THR . . . 177.44 -176.52 48.08 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 128.931 3.158 . . . . 0.0 107.413 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 7.87 5.29 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.232 -1.316 . . . . 0.0 114.709 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.82 -2.48 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.638 1.719 . . . . 0.0 113.732 -175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.01 -33.39 64.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.425 1.09 . . . . 0.0 112.432 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.59 -42.65 88.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.515 0.726 . . . . 0.0 111.469 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.77 -28.18 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.01 77.59 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.145 0.884 . . . . 0.0 111.338 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.08 -42.05 93.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.918 0.781 . . . . 0.0 111.278 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -68.59 -43.2 77.01 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.698 -0.627 . . . . 0.0 110.663 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.73 -50.5 73.01 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.001 0.92 . . . . 0.0 110.432 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.97 67.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.732 1.213 . . . . 0.0 110.995 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.98 -52.99 61.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.683 0.674 . . . . 0.0 110.18 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -60.35 -40.55 91.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.91 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.518 175.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.53 -39.98 80.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.388 0.995 . . . . 0.0 109.737 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.94 -29.1 70.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.389 0.995 . . . . 0.0 111.6 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.3 -17.73 63.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.716 0.806 . . . . 0.0 111.622 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.35 14.03 4.6 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.323 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.72 -172.38 2.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.442 1.621 . . . . 0.0 110.419 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -122.86 153.58 39.44 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p -141.61 154.56 45.48 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.875 -0.516 . . . . 0.0 111.615 -169.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -117.94 91.92 3.7 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.634 1.574 . . . . 0.0 106.923 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -69.21 118.44 12.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 172.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.09 166.0 27.43 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.747 1.219 . . . . 0.0 108.738 -173.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -101.44 31.18 3.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.493 0.717 . . . . 0.0 110.653 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.62 50.79 47.39 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 118.143 -1.365 . . . . 0.0 113.935 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.2 -21.36 67.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.082 2.521 . . . . 0.0 113.638 -171.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 42' ' ' GLU . 75.2 mt -125.74 15.87 8.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.739 1.616 . . . . 0.0 109.54 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.6 tp 63.0 -26.69 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.328 2.651 . . . . 0.0 114.31 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 40' ' ' LEU . 8.2 pt-20 -161.17 82.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.536 1.134 . . . . 0.0 108.22 -168.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.36 -43.96 84.52 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.777 -0.577 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.3 mt -85.65 151.36 55.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.24 -178.29 1.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.968 3.112 . . . . 0.0 113.292 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 31.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.758 2.023 . . . . 0.0 112.941 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -159.87 116.87 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.928 2.091 . . . . 0.0 106.312 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.0 -146.01 15.4 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -173.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mm -123.64 136.18 60.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -118.36 148.78 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.5 mt -134.54 142.91 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.75 130.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.41 110.4 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -168.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 m -149.51 -174.67 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.23 1.012 . . . . 0.0 109.361 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -154.48 134.73 13.24 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.622 1.169 . . . . 0.0 108.313 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 CA--C 1.531 0.218 0 C-N-CA 122.903 0.481 . . . . 0.0 111.237 -170.562 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 t30 . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.36 61.27 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.012 1.725 . . . . 0.0 108.66 170.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.5 m -65.94 -48.02 62.38 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 125.957 1.703 . . . . 0.0 110.838 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -72.71 -39.95 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 120.414 1.184 . . . . 0.0 110.251 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -60.21 3.53 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -169.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -59.79 -43.21 94.55 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.984 0.913 . . . . 0.0 110.336 -169.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -69.31 -46.87 66.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.001 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -26.91 68.59 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.651 1.114 . . . . 0.0 112.886 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.9 mt -61.98 -61.34 2.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -57.48 -25.8 60.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.096 1.758 . . . . 0.0 113.719 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -30.81 70.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -126.88 -29.95 2.78 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt 23.81 67.85 0.38 Allowed Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 127.153 2.181 . . . . 0.0 113.401 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.6 175.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.833 1.689 . . . . 0.0 110.672 171.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -87.87 125.93 34.75 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.27 11.79 11.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.619 1.168 . . . . 0.0 111.145 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.7 m -67.0 -4.87 10.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 119.662 -1.899 . . . . 0.0 113.033 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.1 5.06 42.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.308 1.443 . . . . 0.0 110.734 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.06 157.17 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.961 0.886 . . . . 0.0 110.896 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -110.46 151.99 26.86 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -121.44 157.22 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.85 118.84 2.4 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.17 140.6 31.63 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.79 125.89 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -170.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.58 52.78 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.381 0.991 . . . . 0.0 113.796 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.55 80.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 108.151 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.54 -11.39 2.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 127.174 2.321 . . . . 0.0 117.806 -168.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 CA--C 1.541 0.603 0 CA-C-N 120.525 2.162 . . . . 0.0 109.692 172.397 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.35 -55.4 35.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.471 1.108 . . . . 0.0 109.545 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.56 -39.85 92.16 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.837 -171.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.38 78.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.224 1.01 . . . . 0.0 109.889 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -63.72 -35.74 81.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.422 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.8 -42.5 94.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.206 1.366 . . . . 0.0 111.289 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -65.55 -38.85 90.81 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.111 0.565 . . . . 0.0 109.764 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -31.32 71.23 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.986 1.314 . . . . 0.0 111.684 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.5 m -73.52 -29.91 62.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.855 0.462 . . . . 0.0 109.847 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.71 -17.35 4.44 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-O 118.457 -1.19 . . . . 0.0 113.599 169.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 136.23 56.67 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.892 1.346 . . . . 0.0 108.287 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -84.56 126.81 33.65 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -77.27 98.65 5.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.8 m -73.45 151.33 41.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.59 -117.35 10.83 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 10.3 pt-20 -157.0 170.08 23.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.123 1.769 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -55.3 126.44 24.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.603 0.761 . . . . 0.0 109.739 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.25 161.42 20.5 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.065 1.746 . . . . 0.0 107.674 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -136.52 150.87 48.87 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.327 0 C-N-CA 123.394 0.678 . . . . 0.0 110.387 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.527 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -61.93 -40.54 95.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.836 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -55.73 27.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.64 -49.0 67.61 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.266 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.7 m -60.61 -55.53 32.24 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 111.83 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -55.99 -42.7 76.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.65 1.18 . . . . 0.0 111.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 t -58.23 -49.35 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.145 0.578 . . . . 0.0 109.83 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.59 -30.12 70.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.372 0.987 . . . . 0.0 111.397 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.9 -46.12 25.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.014 0.925 . . . . 0.0 110.452 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.69 -33.66 66.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.058 0.543 . . . . 0.0 111.586 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 83.7 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.484 1.114 . . . . 0.0 110.09 173.227 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.76 168.7 24.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.359 1.064 . . . . 0.0 109.988 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.37 -23.77 14.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 111.224 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.13 121.94 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -85.12 133.89 34.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.69 96.52 6.13 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 174.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.3 mt -92.9 107.38 19.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -92.12 95.27 9.66 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.24 0.22 23.82 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 118.291 -1.283 . . . . 0.0 114.803 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.89 106.12 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.451 1.625 . . . . 0.0 109.648 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m 46.83 44.45 14.31 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.068 1.347 . . . . 0.0 110.357 -170.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.89 47.9 21.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.649 1.58 . . . . 0.0 111.985 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.19 -173.19 40.76 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.538 1.542 . . . . 0.0 110.723 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.97 -165.82 39.0 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.68 55.56 0.67 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 111.221 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -54.24 -31.44 53.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.085 1.354 . . . . 0.0 112.105 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -55.7 -40.77 72.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.861 0.864 . . . . 0.0 111.721 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.58 -29.94 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.18 74.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.09 0.859 . . . . 0.0 110.638 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.13 -38.91 93.06 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.557 0.617 . . . . 0.0 110.907 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -67.11 -42.62 84.22 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.697 -0.627 . . . . 0.0 110.29 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -59.35 -52.54 65.2 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.697 0.799 . . . . 0.0 109.919 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.99 -49.55 63.06 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.162 1.385 . . . . 0.0 110.931 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.19 -54.35 47.92 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 110.426 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.16 -25.03 65.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.34 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.64 -43.38 80.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 120.738 1.608 . . . . 0.0 109.319 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.85 -26.21 68.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.749 -0.594 . . . . 0.0 111.597 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -13.02 62.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.943 0.897 . . . . 0.0 112.549 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.33 19.04 2.95 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.087 169.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -132.0 -165.48 1.59 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.63 1.215 . . . . 0.0 109.837 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 p -132.36 151.75 51.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -141.77 154.91 45.56 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.971 -0.456 . . . . 0.0 111.468 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -125.72 95.66 4.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.518 1.127 . . . . 0.0 108.647 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.7 m -70.2 121.46 17.6 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.47 165.01 29.82 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.395 0.617 . . . . 0.0 111.469 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -107.46 31.1 5.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.728 1.211 . . . . 0.0 110.165 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.88 45.41 70.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.854 -1.526 . . . . 0.0 115.113 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.43 -21.41 66.39 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.049 2.499 . . . . 0.0 114.118 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 42' ' ' GLU . 83.9 mt -116.45 11.72 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.529 1.532 . . . . 0.0 109.887 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 tp 64.21 -23.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.787 2.435 . . . . 0.0 113.467 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 40' ' ' LEU . 6.4 pt-20 -169.82 82.63 0.12 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.963 1.705 . . . . 0.0 106.65 -169.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.45 -43.82 96.3 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.876 -0.515 . . . . 0.0 109.666 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.8 mt -96.06 150.8 37.72 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 169.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.31 -177.6 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.742 2.962 . . . . 0.0 113.154 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.17 35.75 0.05 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.73 1.612 . . . . 0.0 112.037 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 m -160.51 130.24 5.11 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.186 2.195 . . . . 0.0 106.008 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.28 -143.45 14.54 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -172.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mm -127.39 141.07 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.41 ' CD1' HG22 ' A' ' 83' ' ' VAL . 5.1 m0 -128.92 146.86 50.84 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.8 mt -132.55 140.12 48.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.22 121.98 58.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.95 60.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -120.77 41.31 3.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.256 -169.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -26.53 107.76 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 128.584 2.754 . . . . 0.0 113.914 -172.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.224 -0.287 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.723 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.3 t30 . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.29 72.52 1.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.4 -51.92 57.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.513 0.725 . . . . 0.0 112.454 -168.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.8 -39.58 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.612 1.541 . . . . 0.0 110.516 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.36 -51.43 60.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.699 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -60.09 -49.85 76.03 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.519 0.6 . . . . 0.0 110.261 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.44 -44.7 95.79 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.541 0.609 . . . . 0.0 110.387 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.06 91.78 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.198 0.453 . . . . 0.0 111.919 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.5 mt -58.71 -55.68 31.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.952 0.796 . . . . 0.0 109.739 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -65.59 -20.01 66.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.25 -34.11 65.66 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.37 0.532 . . . . 0.0 111.598 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -122.85 -21.36 5.58 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 29.24 65.95 0.73 Allowed Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 127.07 2.148 . . . . 0.0 113.034 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.87 165.29 14.41 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.533 2.155 . . . . 0.0 112.738 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -80.74 63.93 5.33 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.05 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.37 4.53 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.139 0.976 . . . . 0.0 112.789 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -62.09 -8.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.812 2.845 . . . . 0.0 113.104 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.55 10.4 19.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.713 1.605 . . . . 0.0 110.752 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.41 HG22 ' CD1' ' A' ' 50' ' ' TRP . 1.5 p -132.27 153.08 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 110.813 175.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -107.34 152.42 24.18 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -120.05 156.41 30.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.07 126.59 3.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 106.524 -2.63 . . . . 0.0 106.524 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.22 138.92 31.68 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 mt -139.31 124.45 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.72 -12.05 3.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.066 0.841 . . . . 0.0 114.352 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.7 mm -55.14 133.81 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.229 1.412 . . . . 0.0 107.857 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.88 -21.72 17.72 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -169.702 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.85 -57.38 12.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.677 0.671 . . . . 0.0 109.788 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.39 -36.08 81.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.498 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.8 -50.42 73.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.421 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.81 -42.34 93.26 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.604 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 mt -60.18 -48.15 82.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.844 0.747 . . . . 0.0 111.167 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -67.99 -36.2 79.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.198 0.599 . . . . 0.0 109.867 -177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -31.89 72.8 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.7 1.2 . . . . 0.0 111.798 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.0 m -69.54 -33.49 72.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.803 0.441 . . . . 0.0 110.508 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.65 -38.39 0.3 Allowed Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 169.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.92 174.12 6.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.442 1.121 . . . . 0.0 111.664 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -132.12 145.93 51.71 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -74.25 126.06 29.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.0 m -88.8 157.95 18.31 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.42 -133.02 30.3 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.33 161.68 38.36 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.427 1.091 . . . . 0.0 108.378 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 m -57.45 123.97 17.32 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.85 0.86 . . . . 0.0 111.632 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.21 171.14 15.5 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.161 1.784 . . . . 0.0 108.285 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -137.95 156.81 47.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 121.149 -0.97 . . . . 0.0 109.093 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 119.042 -0.504 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -50.79 72.48 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.839 0.745 . . . . 0.0 110.657 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.54 -52.09 62.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.26 -47.39 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.5 t -61.76 -57.51 11.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -57.24 -43.31 82.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.605 0.762 . . . . 0.0 111.916 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.6 t -59.25 -55.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.726 1.21 . . . . 0.0 109.98 175.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -13.78 62.64 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.591 1.087 . . . . 0.0 112.213 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.95 -48.12 13.91 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.058 0.943 . . . . 0.0 110.825 170.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -71.56 -33.46 69.13 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.892 0.769 . . . . 0.0 112.176 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.3 mttt . . . . . 0 C--O 1.248 1.021 0 C-N-CA 125.022 1.329 . . . . 0.0 109.49 173.614 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.09 37.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.15 0.98 . . . . 0.0 110.117 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.89 -23.76 17.3 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.4 1.48 . . . . 0.0 110.753 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.78 130.38 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.543 1.137 . . . . 0.0 108.327 -174.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 t -89.88 129.07 36.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -111.2 93.68 4.6 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.7 mm -72.16 98.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -86.49 13.85 7.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.541 1.937 . . . . 0.0 114.305 -168.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.98 158.81 31.77 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 118.929 0.786 . . . . 0.0 112.623 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -93.76 -30.72 14.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.446 1.498 . . . . 0.0 111.547 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -124.37 48.51 1.92 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.461 1.124 . . . . 0.0 108.948 -169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.5 tp 56.01 27.87 11.93 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.4 1.48 . . . . 0.0 111.334 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.7 165.05 26.44 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 128.328 2.87 . . . . 0.0 106.869 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.69 -146.6 11.76 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 118.211 1.006 . . . . 0.0 110.862 -173.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.68 50.77 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.499 1.919 . . . . 0.0 112.076 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.62 -29.23 66.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.683 1.193 . . . . 0.0 112.144 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -60.08 -51.31 70.17 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.7 0.682 . . . . 0.0 111.078 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.55 -28.52 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.84 -0.537 . . . . 0.0 109.667 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.9 98.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.646 0.657 . . . . 0.0 110.736 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.55 -40.55 92.98 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.178 0.591 . . . . 0.0 110.566 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.26 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.714 -0.616 . . . . 0.0 110.622 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -60.46 -51.02 71.23 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.563 1.145 . . . . 0.0 109.719 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.19 66.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 111.073 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.89 -52.19 66.11 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.131 0.973 . . . . 0.0 110.653 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -57.33 -37.76 73.04 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.68 -29.72 69.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.833 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -70.64 -44.23 67.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.542 1.519 . . . . 0.0 109.847 171.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.04 -26.53 67.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 0.0 111.406 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.69 -21.12 64.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.809 0.843 . . . . 0.0 111.963 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.28 12.05 1.48 Allowed Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.516 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -127.36 -165.97 1.54 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.603 1.701 . . . . 0.0 109.626 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -131.44 149.94 52.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 p -140.38 153.27 46.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.095 0.474 . . . . 0.0 110.461 -170.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -117.57 89.95 3.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -173.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 m -67.69 120.33 13.89 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -146.0 136.95 24.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.528 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -80.83 35.42 0.37 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.923 -1.111 . . . . 0.0 111.344 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.48 41.79 49.61 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.989 1.757 . . . . 0.0 115.605 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.98 -21.12 50.19 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.718 2.759 . . . . 0.0 114.137 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 42' ' ' GLU . 79.2 mt -121.4 13.13 10.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.743 1.617 . . . . 0.0 108.936 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.4 tp 64.16 -29.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.269 2.627 . . . . 0.0 113.734 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.5 pt-20 -168.13 91.22 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.004 1.322 . . . . 0.0 107.677 -168.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.77 -43.35 79.99 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.62 152.94 67.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 -173.42 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.99 3.127 . . . . 0.0 112.953 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.8 34.14 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.785 1.634 . . . . 0.0 112.29 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 m -158.08 133.7 8.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.668 1.987 . . . . 0.0 106.893 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.55 -143.17 14.13 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.4 mm -123.49 140.1 48.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -117.76 149.88 40.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -138.63 142.87 39.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.68 123.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.77 117.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -160.44 -175.7 5.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.178 1.791 . . . . 0.0 108.008 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -152.47 72.9 1.0 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.313 -1.492 . . . . 0.0 110.897 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 CA--C 1.547 0.841 0 C-N-CA 126.348 1.859 . . . . 0.0 114.873 175.288 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.8 140.56 36.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.37 -57.88 0.11 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.911 -171.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.81 -37.17 0.94 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.04 1.407 . . . . 0.0 111.715 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -59.58 5.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.801 0.84 . . . . 0.0 111.133 -169.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.12 -48.26 79.07 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 124.055 0.847 . . . . 0.0 110.69 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.02 -45.94 83.38 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.852 0.296 . . . . 0.0 110.712 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.133 -0.46 . . . . 0.0 111.73 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -56.77 -55.67 31.27 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.812 0.733 . . . . 0.0 109.511 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -68.18 -18.66 64.65 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.53 -32.1 64.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.449 0.568 . . . . 0.0 111.693 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -122.45 -25.18 4.82 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 32.26 62.78 1.3 Allowed Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 127.139 2.175 . . . . 0.0 112.375 -176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.87 164.52 21.49 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -79.75 65.32 4.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 -174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.39 16.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.914 1.686 . . . . 0.0 113.039 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.7 p -66.03 -2.34 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 119.746 -1.846 . . . . 0.0 112.87 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.6 12.78 9.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.186 1.794 . . . . 0.0 110.777 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.6 158.83 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.654 0.74 . . . . 0.0 110.989 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -128.58 154.56 46.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.152 1.381 . . . . 0.0 107.469 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -113.77 167.83 10.3 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.34 120.04 2.12 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.47 34.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.8 mt -133.45 126.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.68 -18.55 2.96 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.953 1.263 . . . . 0.0 113.507 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -46.53 142.37 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.71 2.404 . . . . 0.0 110.539 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.35 15.02 8.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.042 1.782 . . . . 0.0 111.373 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 CA--C 1.536 0.406 0 C-N-CA 124.954 1.302 . . . . 0.0 112.359 175.068 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 C--O 1.227 -0.085 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.48 -55.79 30.45 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.324 0.965 . . . . 0.0 109.54 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -71.14 -34.27 70.86 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.341 0.656 . . . . 0.0 109.684 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.94 87.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.003 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.66 -38.26 88.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.572 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.04 -50.27 74.72 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.298 0.954 . . . . 0.0 111.018 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.335 4.8 ptmm? -73.49 -27.98 61.68 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.897 -0.502 . . . . 0.0 112.321 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -37.74 87.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.453 1.101 . . . . 0.0 110.574 169.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -69.18 -36.24 77.12 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.543 0.337 . . . . 0.0 110.136 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.03 -20.69 0.36 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.52 -1.156 . . . . 0.0 114.99 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.31 -177.51 3.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.738 1.269 . . . . 0.0 111.139 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -141.59 152.87 44.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.104 1.362 . . . . 0.0 107.342 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -76.23 128.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -81.54 141.68 33.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.61 0.61 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.338 0.97 . . . . 0.0 111.871 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.14 178.11 10.66 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.266 2.226 . . . . 0.0 107.051 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.2 m -70.87 131.18 43.39 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.012 -1.055 . . . . 0.0 108.576 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.6 tt -83.01 147.83 27.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -131.9 136.58 47.51 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 C-N-CA 123.924 0.89 . . . . 0.0 109.284 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -56.08 -57.92 10.12 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 109.244 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tp -53.07 -53.05 55.97 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.635 1.209 . . . . 0.0 110.062 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.97 -53.09 48.02 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -64.67 -45.26 87.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.471 0.635 . . . . 0.0 110.357 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -61.6 -41.37 97.36 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.214 1.006 . . . . 0.0 110.864 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.35 -48.53 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.135 0.574 . . . . 0.0 109.569 172.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.44 -28.86 70.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.193 0.906 . . . . 0.0 111.785 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mp -78.8 -45.78 20.2 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.263 1.025 . . . . 0.0 110.504 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.5 65.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.348 0.522 . . . . 0.0 111.702 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.302 1.041 . . . . 0.0 110.049 171.863 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.59 156.97 43.34 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 0.0 108.431 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.86 -24.12 12.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 110.817 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.2 mt -130.0 122.86 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 t -88.37 132.76 34.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.85 97.24 7.87 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 mm -83.92 70.55 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.57 165.56 23.57 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.298 0.57 . . . . 0.0 110.704 -177.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.08 -174.34 50.95 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 p -144.66 -53.95 0.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.8 p -87.1 40.09 0.9 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.177 1.791 . . . . 0.0 109.631 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp 62.88 24.86 14.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.821 1.648 . . . . 0.0 112.003 -169.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.14 164.44 33.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.76 170.72 20.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.069 1.319 . . . . 0.0 111.198 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 55.63 -1.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.238 2.615 . . . . 0.0 117.449 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.58 -32.95 69.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.43 1.468 . . . . 0.0 112.262 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -58.64 -43.58 89.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.979 0.512 . . . . 0.0 111.163 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.31 -37.86 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.93 83.89 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.089 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.53 -45.12 95.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.917 0.781 . . . . 0.0 110.421 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -64.97 -46.51 81.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.973 0.352 . . . . 0.0 110.093 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.16 -54.17 48.38 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.023 0.929 . . . . 0.0 110.301 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.22 -43.59 74.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.341 1.056 . . . . 0.0 111.17 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -61.31 -54.11 48.15 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.813 0.733 . . . . 0.0 110.596 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -57.94 -36.23 72.22 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.4 mt -71.95 -26.23 62.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.092 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.38 -41.23 73.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 120.241 1.382 . . . . 0.0 108.911 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.18 -26.31 68.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.534 0.734 . . . . 0.0 111.458 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.54 -14.0 62.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.966 0.907 . . . . 0.0 111.745 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.92 17.23 6.95 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.845 -0.975 . . . . 0.0 113.594 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -122.73 -168.99 1.84 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.684 1.242 . . . . 0.0 109.853 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -126.15 153.2 44.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.7 p -143.33 159.31 42.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.827 -0.546 . . . . 0.0 110.06 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.31 97.81 4.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -69.91 122.56 19.53 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -147.07 175.72 10.49 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.982 1.313 . . . . 0.0 108.663 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -120.21 39.97 3.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 108.482 169.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.99 46.41 32.68 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 117.599 -1.667 . . . . 0.0 115.108 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -64.37 -22.09 66.27 Favored 'Trans proline' 0 C--N 1.35 0.651 0 CA-C-N 121.205 2.502 . . . . 0.0 113.616 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.71 8.78 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.028 1.731 . . . . 0.0 109.832 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 58.33 -14.79 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.502 2.721 . . . . 0.0 115.197 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -159.26 76.32 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 120.004 1.274 . . . . 0.0 109.438 -169.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.32 -47.85 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.593 -0.692 . . . . 0.0 109.529 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.65 153.43 58.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.32 -176.5 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.14 3.227 . . . . 0.0 113.301 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.43 33.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.874 1.67 . . . . 0.0 112.567 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -159.76 133.42 7.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.238 2.215 . . . . 0.0 106.792 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.7 -144.96 16.4 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -121.35 146.99 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.416 ' CD1' HG22 ' A' ' 83' ' ' VAL . 4.9 m95 -133.34 153.81 51.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.5 mt -136.61 143.35 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -123.24 131.85 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.7 91.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -142.57 -170.78 3.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.264 1.825 . . . . 0.0 107.908 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m -144.61 133.27 22.23 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -171.508 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.2 55.63 3.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -54.7 52.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.433 -0.792 . . . . 0.0 112.445 -168.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -77.84 -41.36 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.568 2.178 . . . . 0.0 110.514 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.12 -51.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.347 0.659 . . . . 0.0 110.937 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.23 -43.55 91.06 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.99 0.814 . . . . 0.0 110.476 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -62.54 -47.27 84.64 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.832 0.742 . . . . 0.0 110.256 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.13 -32.09 72.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.89 -59.69 4.97 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.178 0.899 . . . . 0.0 109.437 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.28 -17.2 62.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.01 -35.06 79.08 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.242 0.617 . . . . 0.0 111.129 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.0 -22.03 4.21 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 33.7 63.22 1.66 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.81 164.23 16.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.027 2.485 . . . . 0.0 113.634 -169.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -80.42 64.97 5.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.54 1.136 . . . . 0.0 111.234 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.12 17.05 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 113.063 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 p -66.78 -2.87 5.56 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 119.922 -1.736 . . . . 0.0 112.789 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.1 11.97 9.56 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.1 1.76 . . . . 0.0 110.946 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -130.29 156.11 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.73 0.776 . . . . 0.0 111.439 176.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -121.33 152.47 38.92 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 108.323 169.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.401 ' CZ ' ' CE3' ' A' ' 50' ' ' TRP . 5.8 m-85 -123.69 166.96 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.599 -169.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.91 144.48 12.96 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.969 -2.852 . . . . 0.0 105.969 168.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.36 125.54 50.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.434 ' C ' ' H ' ' A' ' 90' ' ' ILE . 34.3 mt -129.59 133.12 65.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -169.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.64 -28.42 1.54 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.799 1.19 . . . . 0.0 112.091 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.434 ' H ' ' C ' ' A' ' 88' ' ' ILE . 62.2 mt -48.83 138.77 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.509 2.724 . . . . 0.0 108.404 173.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.2 -0.0 35.39 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.344 1.45 . . . . 0.0 111.468 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 127.995 2.518 . . . . 0.0 115.81 -172.061 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.68 -57.28 13.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.653 0.661 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -34.66 78.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.846 0.458 . . . . 0.0 110.245 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.54 94.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.03 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.53 -38.49 90.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.995 0.816 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.48 -44.36 87.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.835 0.743 . . . . 0.0 111.408 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -67.33 -36.05 80.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.537 0.735 . . . . 0.0 109.816 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -36.26 82.44 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.207 1.403 . . . . 0.0 111.332 172.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.6 m -67.56 -35.4 78.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.861 0.464 . . . . 0.0 110.521 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.86 -24.6 0.3 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.686 -1.063 . . . . 0.0 115.061 169.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.94 170.96 11.61 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.617 1.208 . . . . 0.0 111.384 -173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -121.62 133.18 54.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -78.78 102.27 8.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 169.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 m -70.77 150.79 45.52 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.86 -129.24 26.96 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.3 pt-20 -153.99 174.93 14.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.908 1.283 . . . . 0.0 108.592 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -59.52 129.79 43.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.108 0.963 . . . . 0.0 110.604 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.4 148.51 22.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.21 2.204 . . . . 0.0 107.946 -173.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -125.99 146.51 49.85 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--N 1.33 -0.271 0 C-N-CA 125.265 1.426 . . . . 0.0 109.374 -169.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.428 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.34 -42.3 77.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.018 172.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.98 -48.84 77.1 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.92 -47.42 59.52 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.074 0.858 . . . . 0.0 111.437 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -62.57 -55.0 31.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.529 0.665 . . . . 0.0 110.166 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -55.04 -39.78 69.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.49 1.916 . . . . 0.0 111.34 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.31 -58.83 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 109.733 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -16.01 63.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.274 0.943 . . . . 0.0 112.303 -172.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.12 -38.46 61.1 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.023 0.929 . . . . 0.0 111.236 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -34.8 44.87 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.647 0.779 . . . . 0.0 111.878 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttm . . . . . 0 C--O 1.248 1.015 0 C-N-CA 125.233 1.413 . . . . 0.0 109.867 171.193 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.3 161.06 43.18 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.004 0.922 . . . . 0.0 110.179 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.88 -23.9 16.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.769 1.627 . . . . 0.0 110.479 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.5 mt -135.18 127.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.532 1.133 . . . . 0.0 108.023 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 t -88.2 126.66 35.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.68 95.58 6.14 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.856 1.262 . . . . 0.0 108.885 -169.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -76.36 159.38 30.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.52 9.17 0.03 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.02 123.81 17.15 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.227 2.014 . . . . 0.0 109.587 175.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p 38.21 57.57 1.62 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.57 1.948 . . . . 0.0 113.573 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.1 tp 51.26 63.18 2.35 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 111.372 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.16 -149.77 17.28 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.3 -179.69 38.98 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 117.736 0.768 . . . . 0.0 111.929 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.06 56.16 0.76 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.008 1.323 . . . . 0.0 109.642 171.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.44 -28.91 67.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.363 -0.836 . . . . 0.0 112.228 -172.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -62.14 -40.9 97.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.971 0.805 . . . . 0.0 110.854 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.16 -37.73 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.72 87.6 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.885 0.766 . . . . 0.0 110.952 174.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.21 -40.05 82.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.298 0.639 . . . . 0.0 110.931 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.11 -46.22 88.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.457 -0.777 . . . . 0.0 110.396 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.1 mt -55.99 -52.69 63.28 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.599 1.159 . . . . 0.0 109.894 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.12 -49.97 59.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.533 1.133 . . . . 0.0 110.924 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.29 -53.93 49.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 110.576 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -60.61 -39.39 87.99 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.51 -33.68 76.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.166 0.587 . . . . 0.0 111.52 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.73 -37.14 67.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.846 -1.159 . . . . 0.0 110.265 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.03 -30.15 70.77 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.668 0.667 . . . . 0.0 111.113 170.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.65 62.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 111.797 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.27 -2.53 6.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.247 -1.307 . . . . 0.0 114.257 169.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -101.25 -168.23 1.53 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.564 1.682 . . . . 0.0 110.104 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -128.36 150.92 49.89 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.3 p -142.9 154.59 44.26 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.9 -0.5 . . . . 0.0 111.836 -169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -119.81 99.37 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.463 1.505 . . . . 0.0 107.966 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -73.97 122.58 22.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.61 169.95 17.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.849 0.859 . . . . 0.0 111.06 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -119.6 39.57 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.197 1.799 . . . . 0.0 108.789 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 51.62 11.58 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.858 -1.523 . . . . 0.0 114.801 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -21.94 64.67 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 120.662 2.231 . . . . 0.0 113.389 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.87 16.75 6.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.552 1.941 . . . . 0.0 108.741 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 tp 59.9 -25.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.354 3.062 . . . . 0.0 115.076 -169.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.42 85.68 0.86 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -168.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.91 -44.8 88.37 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.536 -0.727 . . . . 0.0 109.847 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.22 151.29 59.59 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.52 -176.79 1.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 124.128 3.219 . . . . 0.0 113.087 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.26 31.88 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.989 1.716 . . . . 0.0 112.933 172.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.4 m -158.93 121.79 3.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.699 2.0 . . . . 0.0 106.445 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.16 -142.88 11.49 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -122.29 136.26 59.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.413 ' CD1' HG21 ' A' ' 83' ' ' VAL . 12.1 m0 -119.41 137.31 53.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 172.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 mt -131.81 137.69 48.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 173.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.82 137.72 53.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.07 113.01 23.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -161.73 -178.18 6.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.117 1.367 . . . . 0.0 108.457 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 m -133.18 124.85 28.2 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 124.024 0.93 . . . . 0.0 113.301 -169.261 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -129.68 90.28 2.96 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -53.74 31.51 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 124.857 1.263 . . . . 0.0 113.209 -168.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.47 -38.59 8.21 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.175 1.25 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -57.83 8.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.774 -170.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.58 -47.16 86.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.704 -171.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -64.5 -48.64 74.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.626 0.648 . . . . 0.0 110.539 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.41 -26.24 67.89 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.8 mt -62.34 -62.4 1.78 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.238 0.926 . . . . 0.0 108.868 170.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -67.18 -19.57 65.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.45 -34.49 78.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.601 0.76 . . . . 0.0 111.462 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.39 -23.19 2.4 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.84 63.13 1.01 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 127.13 2.172 . . . . 0.0 113.077 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 166.85 17.89 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.968 2.445 . . . . 0.0 113.164 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.66 63.8 5.21 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.954 1.302 . . . . 0.0 111.343 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.91 9.87 0.48 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.273 1.429 . . . . 0.0 113.074 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -63.93 -2.48 1.93 Allowed 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.105 2.962 . . . . 0.0 113.235 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.06 9.71 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.991 1.716 . . . . 0.0 110.919 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.413 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -124.65 146.44 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.916 0.865 . . . . 0.0 111.401 172.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -97.67 141.26 30.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.63 153.04 32.0 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.581 1.952 . . . . 0.0 107.537 -174.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.67 149.55 21.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.96 134.95 54.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.8 mt -134.8 128.79 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.17 -29.08 1.65 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.389 0.995 . . . . 0.0 112.461 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.1 mt -47.97 117.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.784 2.434 . . . . 0.0 107.849 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.01 -41.01 28.62 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.888 1.708 . . . . 0.0 111.079 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.535 0.379 0 C-N-CA 126.085 1.754 . . . . 0.0 110.208 178.22 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.57 -54.32 48.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.41 1.004 . . . . 0.0 109.678 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -67.66 -37.66 82.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.761 1.224 . . . . 0.0 108.673 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.9 79.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.527 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.82 -34.95 79.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.136 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.55 -49.99 75.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.745 1.157 . . . . 0.0 111.201 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -69.28 -34.28 74.48 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.727 0.811 . . . . 0.0 109.938 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -37.78 84.16 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.763 1.625 . . . . 0.0 111.231 172.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -65.86 -40.49 91.72 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.35 -20.61 0.4 Allowed Glycine 0 C--N 1.341 0.827 0 CA-C-O 117.811 -1.55 . . . . 0.0 115.135 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 132.82 49.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.699 1.749 . . . . 0.0 109.453 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -83.84 114.67 21.81 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -64.02 114.67 4.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 170.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.4 m -126.65 115.08 18.9 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.32 103.78 2.37 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -169.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -52.95 137.26 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.149 -1.526 . . . . 0.0 107.379 169.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.2 m -47.87 116.42 1.49 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.722 1.609 . . . . 0.0 111.347 -169.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.69 153.8 26.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.188 1.795 . . . . 0.0 107.718 -169.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -129.09 146.5 51.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.328 -0.365 0 C-N-CA 124.549 1.139 . . . . 0.0 111.252 -169.841 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -45.26 77.92 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.437 0.695 . . . . 0.0 109.871 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.69 -52.6 65.02 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.48 95.01 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.047 0.84 . . . . 0.0 112.051 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -59.29 -62.94 1.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.074 1.35 . . . . 0.0 110.239 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -56.09 -44.78 79.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.612 1.165 . . . . 0.0 111.978 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.4 -55.92 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.848 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -16.29 63.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.81 1.186 . . . . 0.0 112.053 -174.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.1 mp -78.2 -47.22 18.52 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.535 0.734 . . . . 0.0 111.029 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.18 -32.54 64.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.0 0.818 . . . . 0.0 112.329 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.7 mttt . . . . . 0 C--O 1.249 1.028 0 C-N-CA 124.752 1.221 . . . . 0.0 109.611 173.34 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 tpp . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.02 160.16 43.14 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.575 1.15 . . . . 0.0 108.917 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.61 -25.13 13.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.43 1.492 . . . . 0.0 111.059 175.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.56 121.77 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -83.88 130.55 34.91 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.56 109.6 21.33 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.5 mt -103.66 94.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.22 14.82 27.07 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.06 0.944 . . . . 0.0 112.075 -171.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.64 58.87 4.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.128 -171.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -54.6 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.741 1.27 . . . . 0.0 110.25 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m 57.7 42.3 23.95 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.78 0.832 . . . . 0.0 110.804 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.1 39.56 29.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.236 1.815 . . . . 0.0 111.398 -169.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.94 -145.3 7.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.493 1.996 . . . . 0.0 109.7 173.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 16' ' ' GLU . . . -160.72 62.12 0.29 Allowed Glycine 0 C--N 1.334 0.447 0 CA-C-N 117.556 0.678 . . . . 0.0 111.902 -172.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.53 19.96 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.5 1.12 . . . . 0.0 112.476 172.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 14' ' ' GLY . 44.7 mt-10 -62.9 -20.19 64.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 112.482 -170.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.93 -40.4 76.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.237 0.926 . . . . 0.0 111.326 176.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.96 -41.42 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.776 -176.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.23 -43.55 94.61 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 110.43 175.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -66.35 -44.41 83.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.044 -0.41 . . . . 0.0 110.039 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.46 -52.45 65.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.159 0.584 . . . . 0.0 110.733 177.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.27 -45.37 65.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.287 1.035 . . . . 0.0 110.76 176.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.33 -54.2 48.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.158 0.89 . . . . 0.0 110.484 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -57.66 -43.75 85.19 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 123.646 0.778 . . . . 0.0 112.275 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -69.15 -34.49 75.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.919 0.887 . . . . 0.0 111.356 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.9 -44.05 73.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.316 -0.865 . . . . 0.0 109.642 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -71.65 -18.52 62.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.174 0.897 . . . . 0.0 111.954 174.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -18.95 63.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.83 0.741 . . . . 0.0 111.083 169.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.09 12.54 5.78 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.267 -1.296 . . . . 0.0 114.442 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -117.8 -172.08 2.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.411 1.606 . . . . 0.0 109.93 -174.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -124.13 153.99 40.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 170.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -142.54 158.91 43.18 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.838 -0.539 . . . . 0.0 109.93 -169.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.2 99.24 5.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 m -72.18 118.88 15.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.0 mt -149.48 164.95 33.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.625 0.726 . . . . 0.0 111.585 -169.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -106.12 35.68 2.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.393 1.477 . . . . 0.0 108.506 168.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.74 14.26 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.963 -175.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.5 -20.31 65.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 120.871 2.335 . . . . 0.0 113.864 -173.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 42' ' ' GLU . 85.3 mt -116.25 9.89 14.69 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.654 . . . . 0.0 109.766 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt 60.38 -18.19 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.406 2.682 . . . . 0.0 114.627 -169.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 40' ' ' LEU . 6.3 pt-20 -166.3 75.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.498 1.519 . . . . 0.0 107.232 -169.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.38 -44.61 96.04 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.773 -0.579 . . . . 0.0 109.818 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.6 mt -89.24 150.39 44.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.42 -177.45 1.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.674 2.916 . . . . 0.0 113.106 -175.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.08 35.51 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.65 1.58 . . . . 0.0 111.898 169.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -157.69 125.15 5.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.973 2.109 . . . . 0.0 106.272 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.96 -145.23 17.19 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -174.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.4 mm -126.48 144.34 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -127.1 158.12 37.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -143.28 143.79 31.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.15 135.35 62.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.17 124.59 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -170.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.0 m -163.98 -167.48 1.37 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.216 2.206 . . . . 0.0 107.1 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.1 m -148.88 62.57 1.06 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.435 -1.415 . . . . 0.0 108.0 172.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 125.569 1.548 . . . . 0.0 114.128 -169.506 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 31.2 t30 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.1 mt 52.75 46.23 27.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 108.575 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 m -75.88 -49.5 3.43 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 124.549 1.14 . . . . 0.0 111.833 -170.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 -34.45 41.59 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.97 1.382 . . . . 0.0 110.584 176.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -59.69 -51.3 70.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.976 0.911 . . . . 0.0 110.125 173.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -55.46 -48.29 74.73 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.48 1.112 . . . . 0.0 110.846 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -65.65 -41.65 92.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.523 0.601 . . . . 0.0 111.453 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.6 84.83 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.666 0.666 . . . . 0.0 111.326 -178.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.63 -57.35 12.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.777 0.717 . . . . 0.0 109.816 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -69.2 -15.57 63.42 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.65 -32.09 63.83 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.85 0.75 . . . . 0.0 111.295 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.78 -30.1 4.52 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -173.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 26.64 70.37 0.43 Allowed Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.06 2.144 . . . . 0.0 113.331 -172.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -58.15 176.65 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.791 2.327 . . . . 0.0 112.004 174.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -90.02 76.16 7.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.73 0.812 . . . . 0.0 110.342 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.74 5.63 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.617 0.767 . . . . 0.0 112.557 -175.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 m -65.14 -5.51 6.9 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 127.839 2.456 . . . . 0.0 113.268 -176.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.93 8.74 26.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.469 1.508 . . . . 0.0 110.702 176.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.94 160.54 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 122.146 0.974 . . . . 0.0 110.945 176.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -129.11 154.11 47.02 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.08 1.752 . . . . 0.0 106.929 172.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -127.38 173.9 9.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.534 0.683 . . . . 0.0 109.428 178.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.13 157.87 26.17 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.64 125.13 41.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 90' ' ' ILE . 33.0 mt -129.31 134.08 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -168.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.71 -31.78 1.69 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.537 1.541 . . . . 0.0 112.009 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.423 ' H ' ' C ' ' A' ' 88' ' ' ILE . 75.3 mt -47.88 154.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 129.583 3.153 . . . . 0.0 110.857 176.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.63 -15.1 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.051 -0.86 . . . . 0.0 114.73 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.45 -0.447 0 CA-C-N 118.304 1.052 . . . . 0.0 109.805 177.349 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.55 -53.15 58.98 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 47.9 mp0 -61.24 -41.18 96.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.595 1.158 . . . . 0.0 110.455 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.77 76.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.49 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.246 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 mt -58.65 -46.64 86.7 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.427 1.012 . . . . 0.0 110.867 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -67.34 -41.26 85.48 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.462 0.705 . . . . 0.0 109.723 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -30.85 71.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.043 1.337 . . . . 0.0 111.331 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 m -74.16 -13.88 60.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.25 0.22 . . . . 0.0 111.496 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.48 -24.33 3.73 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 121.174 -0.954 . . . . 0.0 113.033 169.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.25 167.8 15.54 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.053 0.927 . . . . 0.0 110.631 -177.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -120.54 144.3 48.13 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -83.68 104.73 14.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 83.2 m -70.38 153.46 42.97 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 -131.29 21.43 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 178.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.426 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.4 pt-20 -150.43 178.56 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.192 1.397 . . . . 0.0 107.862 169.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.49 123.08 9.03 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.927 1.291 . . . . 0.0 109.824 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.55 155.75 17.13 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.61 1.564 . . . . 0.0 107.712 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -139.33 151.4 46.36 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 C-N-CA 126.125 1.77 . . . . 0.0 106.718 -169.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . 0.426 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -61.11 -42.04 97.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.599 0.76 . . . . 0.0 110.281 172.257 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.93 -49.68 73.82 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.96 -46.62 68.61 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 123.823 0.702 . . . . 0.0 111.721 177.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.1 m -62.47 -59.17 5.34 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.345 1.458 . . . . 0.0 110.818 177.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -49.8 -41.72 45.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.969 2.108 . . . . 0.0 111.872 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.0 t -63.96 -58.41 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 125.182 1.393 . . . . 0.0 109.813 173.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -15.74 63.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.311 0.959 . . . . 0.0 112.324 -173.085 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.87 -41.55 59.57 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.022 0.929 . . . . 0.0 111.168 170.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.5 -31.27 42.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -176.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.1 1.36 . . . . 0.0 109.721 169.972 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 tpp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.23 161.9 41.89 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.887 0.875 . . . . 10.0 110.287 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.11 -18.62 21.6 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.751 1.22 . . . . 10.0 110.984 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mt -137.22 129.15 42.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 C-N-CA 124.399 1.08 . . . . 10.0 108.429 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 t -91.41 137.62 32.22 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.645 -1.242 . . . . 10.0 107.645 168.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -112.4 91.75 3.77 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 104.614 -2.365 . . . . 10.0 104.614 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.4 104.08 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.4 1.48 . . . . 10.0 107.195 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -128.69 46.09 2.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.469 0.708 . . . . 10.0 111.868 -154.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.39 56.33 0.44 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-O 117.968 -1.462 . . . . 10.0 114.103 -161.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 m -33.39 -52.86 0.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.124 1.77 . . . . 10.0 113.646 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.35 42.33 2.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.514 1.125 . . . . 10.0 108.491 -170.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.9 tp 56.9 28.8 15.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.658 1.583 . . . . 10.0 111.075 -164.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.33 155.22 17.34 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.965 2.698 . . . . 10.0 106.485 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.05 -164.78 35.55 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 117.932 0.866 . . . . 10.0 111.669 -166.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.47 52.23 0.62 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.578 1.951 . . . . 10.0 112.882 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -55.8 -31.63 62.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.241 1.016 . . . . 10.0 112.212 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -60.92 -50.07 74.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.981 0.81 . . . . 10.0 110.768 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.45 -39.97 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.29 84.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.897 -0.573 . . . . 10.0 111.813 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.37 -39.48 85.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.974 0.807 . . . . 10.0 110.331 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -63.65 -46.82 83.88 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.93 -0.482 . . . . 10.0 110.279 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.4 mt -57.96 -47.28 83.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.811 0.844 . . . . 10.0 110.15 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.18 83.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.209 1.004 . . . . 10.0 110.028 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.54 -47.06 87.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.371 0.532 . . . . 10.0 110.687 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -61.58 -34.7 76.07 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.673 -0.642 . . . . 10.0 111.33 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.17 -32.89 67.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.516 0.598 . . . . 10.0 111.185 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -70.79 -38.94 73.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.708 1.14 . . . . 10.0 109.865 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.68 -32.45 71.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.244 0.618 . . . . 10.0 111.087 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.19 -17.07 64.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.733 0.813 . . . . 10.0 112.799 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.38 18.96 4.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.836 -0.98 . . . . 10.0 113.555 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -120.82 -170.88 2.08 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.808 1.304 . . . . 10.0 109.797 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 p -131.66 145.26 51.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.146 -1.427 . . . . 10.0 107.146 172.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -136.65 158.86 43.45 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.125 -0.359 . . . . 10.0 110.912 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.01 92.59 3.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -65.17 119.84 11.59 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.307 1.043 . . . . 10.0 108.42 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -148.39 149.01 31.0 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 123.584 0.754 . . . . 10.0 108.988 -171.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -90.49 35.43 0.88 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.292 -0.88 . . . . 10.0 110.184 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.22 51.02 21.48 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.983 1.754 . . . . 10.0 114.572 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.04 -15.68 49.56 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.858 2.372 . . . . 10.0 113.435 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.11 13.6 11.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.404 1.482 . . . . 10.0 110.704 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 tp 62.42 -43.89 0.18 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.557 2.743 . . . . 10.0 113.316 -166.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -148.8 78.11 1.39 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.873 1.669 . . . . 10.0 108.121 -167.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.473 -0.767 . . . . 10.0 111.357 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.2 mt -84.48 147.42 49.62 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.947 -1.131 . . . . 10.0 107.947 164.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 47' ' ' SER . 72.1 Cg_endo -69.64 -175.4 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.08 2.52 . . . . 10.0 111.873 -176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.61 21.94 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.896 1.678 . . . . 10.0 113.694 173.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' PRO . 17.9 m -142.39 136.08 29.21 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.321 1.848 . . . . 10.0 106.797 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.01 -136.88 10.11 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.92 -1.272 . . . . 10.0 109.92 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -130.35 136.34 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.159 -1.793 . . . . 10.0 106.159 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -117.87 157.5 26.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -141.72 145.87 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.021 -1.844 . . . . 10.0 106.021 168.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.3 t -130.88 124.34 56.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.37 97.36 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.669 -1.604 . . . . 10.0 106.669 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -148.7 174.12 12.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 10.0 108.372 -170.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 m -137.52 70.47 1.4 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.597 1.09 . . . . 10.0 110.312 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.2 p -69.62 -15.71 63.25 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -169.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -79.35 -106.56 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.873 1.215 . . . . 10.0 109.765 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.72 3.89 47.28 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 120.183 -1.573 . . . . 10.0 114.056 -167.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.19 14.21 4.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.124 1.77 . . . . 10.0 110.31 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.01 112.22 4.44 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 109.027 -1.629 . . . . 10.0 109.027 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -64.11 156.61 27.85 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.019 0.41 . . . . 10.0 111.387 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -26.72 -60.3 0.18 Allowed Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 129.426 3.09 . . . . 10.0 115.375 -170.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.73 -33.02 6.91 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 121.939 1.728 . . . . 10.0 113.392 -166.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 t70 176.73 -47.52 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.08 1.352 . . . . 10.0 108.481 -161.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 126.28 -34.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 1 C-N-CA 132.096 4.159 . . . . 10.0 110.298 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.19 58.48 1.31 Allowed 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.486 0.714 . . . . 10.0 110.038 -170.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -45.95 -56.17 11.09 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.228 -1.368 . . . . 10.0 114.566 -167.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.57 -44.34 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 122.034 1.762 . . . . 10.0 111.633 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -65.41 -43.35 90.82 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 10.0 111.264 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.36 -45.49 83.9 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.921 0.782 . . . . 10.0 110.158 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.18 -42.79 99.42 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.12 96.03 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.03 0.377 . . . . 10.0 111.461 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -59.69 -51.56 69.26 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.703 0.683 . . . . 10.0 109.47 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.19 -31.27 72.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.667 0.667 . . . . 10.0 111.81 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.87 -30.95 71.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.724 0.81 . . . . 10.0 112.251 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -124.21 -27.3 3.84 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.491 1.293 . . . . 10.0 114.491 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 32.45 61.78 1.38 Allowed Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.286 1.834 . . . . 10.0 112.572 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.47 160.26 40.33 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.12 2.546 . . . . 10.0 110.955 -172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -73.23 76.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.071 0.949 . . . . 10.0 111.187 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 9.22 1.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.93 1.292 . . . . 10.0 112.269 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.0 m -60.84 -17.5 50.34 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.219 -1.551 . . . . 10.0 113.344 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.44 10.83 39.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.78 1.232 . . . . 10.0 112.594 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.95 160.79 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.229 1.012 . . . . 10.0 108.997 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -123.81 150.81 44.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.296 -1.742 . . . . 10.0 106.296 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.63 163.53 25.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.606 0.717 . . . . 10.0 110.476 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.04 116.66 1.69 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.394 -2.682 . . . . 10.0 106.394 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.04 144.32 56.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.38 131.23 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.521 -1.659 . . . . 10.0 106.521 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.09 -27.54 1.71 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.757 1.17 . . . . 10.0 113.012 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.24 139.29 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 127.15 2.18 . . . . 10.0 107.606 171.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.58 0.72 8.67 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.269 -0.739 . . . . 10.0 112.387 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -53.2 56.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.518 1.127 . . . . 10.0 109.834 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 19.97 -97.3 0.0 OUTLIER 'General case' 0 C--N 1.346 0.45 0 C-N-CA 128.787 2.835 . . . . 10.0 114.197 171.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -148.42 5.1 0.71 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.22 1.808 . . . . 10.0 108.858 -159.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -149.09 -27.67 0.28 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.613 0.365 . . . . 10.0 110.751 -143.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -119.77 34.91 5.03 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 122.471 1.129 . . . . 10.0 109.95 159.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.2 p -70.22 35.81 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.822 1.649 . . . . 10.0 110.591 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -105.12 -37.22 7.0 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.741 -1.225 . . . . 10.0 112.949 -144.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 62.9 m -115.71 8.14 14.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.234 1.014 . . . . 10.0 110.773 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.88 -163.53 35.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 108.601 -1.8 . . . . 10.0 108.601 -172.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.02 58.84 1.75 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.475 1.11 . . . . 10.0 109.782 -174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 pt -60.53 -4.16 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.492 1.117 . . . . 10.0 113.083 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -48.25 -17.86 0.17 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.391 1.876 . . . . 10.0 112.844 158.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -34.61 -43.44 0.17 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.636 1.575 . . . . 10.0 113.491 164.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.84 -52.8 62.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.23 0.923 . . . . 10.0 110.813 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.52 -43.77 98.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.1 93.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.046 0.938 . . . . 10.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -67.97 -36.79 80.65 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.416 1.007 . . . . 10.0 111.222 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.05 -45.14 94.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.278 0.944 . . . . 10.0 110.06 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -65.87 -39.21 90.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.22 0.608 . . . . 10.0 110.524 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.58 97.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.066 . . . . 10.0 110.975 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 m -72.45 -29.08 63.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.727 0.411 . . . . 10.0 110.651 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.89 -13.15 1.49 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.426 -1.208 . . . . 10.0 114.327 160.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.08 116.55 9.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.241 1.521 . . . . 10.0 108.131 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -61.73 139.02 58.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 167.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -80.84 128.78 34.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.154 -2.165 . . . . 10.0 105.154 158.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 m -105.06 148.45 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.8 -133.93 46.84 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.09 -1.604 . . . . 10.0 109.09 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.93 163.65 33.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.535 -1.654 . . . . 10.0 106.535 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -48.59 123.32 6.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.293 1.037 . . . . 10.0 112.082 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.33 147.36 48.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.793 1.237 . . . . 10.0 107.92 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -118.6 136.75 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.838 -1.171 . . . . 10.0 107.838 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.77 140.71 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 158.33 30.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.516 -0.55 . . . . 10.0 109.516 174.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.3 pt -146.24 -168.54 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 126.36 1.864 . . . . 10.0 107.379 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.8 tp 7.09 -69.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 130.173 3.389 . . . . 10.0 116.575 164.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -119.08 139.05 52.39 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.435 1.094 . . . . 10.0 108.891 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -53.62 150.46 7.0 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.858 0.863 . . . . 10.0 110.037 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -142.67 -88.25 0.14 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 118.366 -0.825 . . . . 10.0 110.515 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.0 mm -130.72 -58.08 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 117.426 -1.273 . . . . 10.0 110.542 -170.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -82.06 -6.28 12.15 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.318 2.012 . . . . 10.0 113.355 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 76.41 -35.9 0.26 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.421 2.688 . . . . 10.0 114.407 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -139.88 132.1 14.84 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 119.356 0.98 . . . . 10.0 111.181 -158.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.63 159.5 47.9 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.116 2.544 . . . . 10.0 112.055 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.75 52.56 1.4 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.456 1.103 . . . . 10.0 110.119 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.22 -23.65 62.49 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.879 -1.138 . . . . 10.0 111.013 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.21 -36.16 81.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.588 -0.72 . . . . 10.0 111.223 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.81 -44.92 93.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.483 1.038 . . . . 10.0 108.934 171.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.47 -46.03 91.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.42 97.3 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.409 0.528 . . . . 10.0 112.672 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.6 m -61.57 -56.79 16.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.341 1.071 . . . . 10.0 110.75 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -59.51 -40.69 87.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.942 1.297 . . . . 10.0 110.699 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.27 -56.18 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.849 -0.596 . . . . 10.0 110.042 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -69.68 -21.86 63.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 10.0 112.136 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.45 -45.25 76.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.708 0.685 . . . . 10.0 110.631 168.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -22.43 57.69 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.973 0.806 . . . . 10.0 112.61 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.9 mttt . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.252 1.021 . . . . 10.0 108.406 169.521 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.55 167.21 31.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.126 1.371 . . . . 0.0 108.921 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.36 -25.07 25.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.697 0.799 . . . . 0.0 110.893 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.6 mt -138.27 127.63 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.749 1.22 . . . . 0.0 107.943 -171.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.18 135.21 33.39 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.4 104.64 13.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.7 mt -96.46 100.57 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -102.64 20.12 17.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.241 1.016 . . . . 0.0 110.735 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 36.51 2.17 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.072 1.32 . . . . 0.0 115.163 -169.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -47.65 -50.84 23.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.215 1.406 . . . . 0.0 112.268 -172.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -127.33 50.77 1.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.7 tp 63.29 20.05 12.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.813 2.045 . . . . 0.0 111.283 -169.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.14 178.1 36.64 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.248 3.308 . . . . 0.0 106.661 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -3.19 1.51 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.009 -1.439 . . . . 0.0 115.026 169.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.14 2.14 0.76 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.877 1.839 . . . . 0.0 113.966 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -53.29 -36.39 61.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.297 1.039 . . . . 0.0 112.07 -172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -54.97 -30.75 59.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.779 1.232 . . . . 0.0 112.825 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.99 -26.33 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.776 0.83 . . . . 0.0 109.522 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.36 72.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.228 0.922 . . . . 0.0 111.346 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.88 -39.3 93.32 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.238 0.926 . . . . 0.0 111.243 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -67.97 -45.4 74.27 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.804 -0.56 . . . . 0.0 109.617 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -54.13 -50.82 66.04 Favored 'General case' 0 C--N 1.337 0.035 0 C-N-CA 124.359 1.064 . . . . 0.0 110.323 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -48.69 72.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.895 0.878 . . . . 0.0 110.88 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.81 -53.56 56.81 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.69 0.677 . . . . 0.0 110.675 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -54.91 -42.51 72.26 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 123.838 0.855 . . . . 0.0 111.816 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -32.2 67.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.88 -46.67 74.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.472 1.033 . . . . 0.0 109.842 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -67.38 -14.13 62.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.658 0.663 . . . . 0.0 112.312 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.12 63.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.128 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.56 17.64 0.74 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.274 -1.292 . . . . 0.0 115.887 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -139.18 -171.44 3.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.602 1.701 . . . . 0.0 111.236 -169.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 p -124.71 147.61 48.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.6 p -140.66 157.86 44.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.12 98.98 4.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.76 123.43 19.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.3 mt -142.26 153.99 44.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.558 0.743 . . . . 0.0 109.298 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -89.76 31.68 0.94 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.675 0.79 . . . . 0.0 110.968 172.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.13 48.77 38.78 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.587 1.565 . . . . 0.0 114.533 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.49 -21.45 66.07 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.683 2.255 . . . . 0.0 113.503 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 42' ' ' GLU . 78.7 mt -124.31 10.15 8.61 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.967 1.707 . . . . 0.0 109.89 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 tp 60.86 -19.15 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.85 2.46 . . . . 0.0 114.31 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.1 pt-20 -166.47 87.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.68 -44.81 76.9 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.723 -0.611 . . . . 0.0 109.989 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.8 mt -80.23 151.58 72.7 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.38 -175.31 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.056 3.171 . . . . 0.0 112.621 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.74 34.42 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.147 1.379 . . . . 0.0 112.377 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.1 m -158.62 132.12 7.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.01 2.124 . . . . 0.0 106.311 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.79 -142.97 14.44 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -174.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.1 mm -126.53 140.32 49.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -121.76 152.52 39.37 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.7 mt -138.76 142.8 38.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.6 t -128.5 125.52 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.2 103.21 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -148.85 -177.3 5.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.876 1.271 . . . . 0.0 108.795 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.2 m -150.65 65.56 0.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.749 -1.219 . . . . 0.0 108.366 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.1 p -47.92 -32.53 6.46 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.99 2.116 . . . . 0.0 112.916 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -130.94 128.32 40.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 102.85 -3.018 . . . . 0.0 102.85 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.72 -39.95 2.41 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.344 0.973 . . . . 0.0 111.016 -170.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.73 36.85 2.64 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.425 1.49 . . . . 0.0 108.67 170.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.78 -148.37 5.97 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 126.495 1.997 . . . . 0.0 109.021 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -148.7 -46.95 0.15 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.793 1.237 . . . . 0.0 110.35 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.7 pt -149.74 171.19 6.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 128.23 2.612 . . . . 0.0 106.743 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -47.18 -34.41 17.7 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.648 2.899 . . . . 0.0 115.549 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.78 -11.44 7.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.182 0.993 . . . . 0.0 113.42 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -52.12 -40.02 60.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.024 0.93 . . . . 0.0 110.589 169.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.41 120.73 24.24 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.63 -58.52 0.43 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.55 -169.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 -42.34 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.873 1.715 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -64.0 1.09 Allowed 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.218 1.007 . . . . 0.0 111.624 -168.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.56 -41.8 95.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.128 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -71.17 -45.98 62.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.958 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.58 79.06 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.714 0.688 . . . . 0.0 111.271 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.1 mt -55.12 -57.29 12.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.411 0.551 . . . . 0.0 110.002 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -74.11 -15.7 61.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.42 -38.21 65.65 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.692 0.678 . . . . 0.0 111.231 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -114.42 -26.49 7.94 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 32.88 60.43 1.51 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.683 1.993 . . . . 0.0 113.133 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -65.16 165.41 22.0 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.587 2.191 . . . . 0.0 112.538 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.53 63.38 2.66 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.405 1.482 . . . . 0.0 111.561 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.41 9.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.15 1.38 . . . . 0.0 112.391 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.4 m -61.1 -7.09 2.33 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.299 2.64 . . . . 0.0 112.871 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.24 10.02 17.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.795 1.638 . . . . 0.0 111.217 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.81 163.68 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 122.192 0.996 . . . . 0.0 110.283 174.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -122.09 149.83 43.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 171.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -123.61 166.84 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.721 0.638 . . . . 0.0 110.036 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.08 115.43 1.02 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 106.831 -2.507 . . . . 0.0 106.831 169.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.81 143.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.2 mt -139.42 131.34 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.98 -23.57 1.35 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.293 0.949 . . . . 0.0 114.082 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -50.19 128.46 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 126.137 1.775 . . . . 0.0 108.415 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.06 -27.69 6.48 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m -61.33 107.23 0.73 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.441 1.096 . . . . 0.0 108.77 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -147.03 159.0 44.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.275 1.43 . . . . 0.0 107.885 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -59.06 -22.66 61.11 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.492 1.517 . . . . 0.0 112.874 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -117.69 14.33 14.38 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.194 1.798 . . . . 0.0 111.467 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -134.31 22.76 3.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.423 1.089 . . . . 0.0 110.739 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -73.8 14.32 0.4 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.395 1.878 . . . . 0.0 114.264 -171.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -60.46 -23.78 64.72 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.299 1.44 . . . . 0.0 113.946 -169.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 65.6 m -115.35 24.2 11.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.538 1.135 . . . . 0.0 111.101 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.42 20.96 79.98 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.669 0.652 . . . . 0.0 111.785 -172.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.12 54.74 1.09 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.038 1.735 . . . . 0.0 111.135 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.0 mm -58.59 143.5 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -66.92 26.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.678 2.391 . . . . 0.0 115.403 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -57.84 -26.84 62.58 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.637 -1.29 . . . . 0.0 113.948 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -63.32 -56.04 19.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.514 1.052 . . . . 0.0 109.394 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -60.59 -39.49 88.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.294 0.638 . . . . 0.0 109.568 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.3 -46.6 89.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.967 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -62.43 -37.75 87.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.158 0.89 . . . . 0.0 111.029 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.07 -48.25 76.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.05 0.841 . . . . 0.0 111.057 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.331 6.9 ptmt -71.8 -28.35 63.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -37.72 86.33 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.961 0.904 . . . . 0.0 110.852 169.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -66.99 -40.96 87.5 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.92 -22.97 0.53 Allowed Glycine 0 C--N 1.34 0.75 0 CA-C-O 118.243 -1.31 . . . . 0.0 114.987 169.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.9 137.92 56.92 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.216 1.508 . . . . 0.0 108.869 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.95 134.04 35.63 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.6 99.47 8.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 97.4 m -73.54 145.59 45.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.32 -123.58 29.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.433 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.4 pt-20 -153.11 176.11 12.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.598 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 m -49.8 121.73 5.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.085 1.354 . . . . 0.0 109.922 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.1 153.33 26.14 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -127.65 144.23 51.09 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.29 162.01 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.965 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.03 175.49 7.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.514 1.926 . . . . 0.0 108.306 169.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.4 tt -154.62 145.62 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.0 tp 63.22 -21.84 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 128.534 2.734 . . . . 0.0 115.073 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -151.64 -169.35 3.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.917 2.487 . . . . 0.0 106.584 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -125.81 155.87 40.42 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.388 1.475 . . . . 0.0 107.142 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.41 -176.69 5.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.139 0.976 . . . . 0.0 109.598 -174.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.1 mm -31.26 -53.4 0.44 Allowed Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 127.539 2.335 . . . . 0.0 116.488 -170.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -59.88 -53.35 3.28 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 122.482 1.922 . . . . 0.0 110.117 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . 0.26 38.6 tt0 146.37 -103.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 1 C-N-CA 133.097 4.559 . . . . 0.0 105.6 169.557 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -167.65 -43.92 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 116.412 -1.756 . . . . 0.0 114.335 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.89 131.36 45.53 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.808 2.338 . . . . 0.0 112.833 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.5 -43.54 0.69 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.45 -35.09 79.79 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.697 0.68 . . . . 0.0 110.921 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 -64.46 -43.87 92.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.988 0.915 . . . . 0.0 110.034 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.433 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.7 m-90 -65.6 -50.65 64.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.195 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.1 mt -55.08 -51.29 66.84 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.13 -51.96 54.25 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -64.16 -46.24 84.92 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.495 1.148 . . . . 0.0 110.774 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -61.56 -39.04 89.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.398 1.079 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.9 t -64.85 -47.58 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.835 1.254 . . . . 0.0 110.381 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -60.38 -24.4 65.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.551 1.069 . . . . 0.0 111.288 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.06 -28.63 43.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.409 0.684 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -36.49 19.28 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.04 0.936 . . . . 0.0 111.531 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 125.448 1.499 . . . . 0.0 109.824 172.036 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.07 161.01 43.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -95.52 -24.12 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.674 1.59 . . . . 0.0 110.492 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.7 mt -136.22 128.94 46.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.33 1.052 . . . . 0.0 108.223 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -85.92 126.98 34.49 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.91 97.53 7.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -96.38 89.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 108.694 -169.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -75.9 141.07 42.43 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 168.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.99 1.1 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 117.913 -1.493 . . . . 0.0 116.774 -175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 115.28 2.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.984 1.892 . . . . 0.0 109.714 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m 46.06 40.86 7.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.217 1.807 . . . . 0.0 111.811 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp 47.84 69.64 0.51 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 126.003 1.721 . . . . 0.0 111.16 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 163.14 25.59 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.534 1.54 . . . . 0.0 109.423 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.38 -29.92 2.82 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.415 -1.214 . . . . 0.0 114.244 -169.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 41.47 43.96 2.36 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.955 1.302 . . . . 0.0 111.412 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -50.7 -33.29 22.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.966 1.306 . . . . 0.0 113.592 -169.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -59.37 -52.22 66.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.735 1.152 . . . . 0.0 111.431 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.09 -29.05 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.646 -0.659 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.46 91.12 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.575 0.625 . . . . 0.0 110.87 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.47 -38.19 71.26 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.686 -0.633 . . . . 0.0 110.242 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -58.73 -44.18 90.37 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.57 0.623 . . . . 0.0 110.368 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.02 -55.82 30.2 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.393 0.677 . . . . 0.0 109.989 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.4 -40.42 65.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -53.77 -54.03 43.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.358 0.663 . . . . 0.0 110.083 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -62.44 -41.76 98.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -58.22 -45.3 87.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.446 0.566 . . . . 0.0 109.799 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.21 -35.97 71.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.833 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.16 -29.65 70.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.665 0.786 . . . . 0.0 111.586 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.45 -18.1 63.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.861 0.755 . . . . 0.0 111.795 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.1 -4.8 4.98 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.499 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -100.41 -170.31 1.85 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.568 1.684 . . . . 0.0 109.82 -169.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.8 p -128.88 148.58 50.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -139.89 149.95 44.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 111.826 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.26 92.13 3.92 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 m -69.29 118.02 11.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.9 mt -149.35 153.76 37.92 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.281 0.562 . . . . 0.0 112.186 -169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -93.7 39.22 1.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.386 1.074 . . . . 0.0 108.432 168.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 39.14 54.66 2.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.724 2.107 . . . . 0.0 115.42 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.48 -20.69 54.09 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.792 2.328 . . . . 0.0 113.731 -173.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 42' ' ' GLU . 83.0 mt -112.94 8.3 18.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.661 1.584 . . . . 0.0 109.772 177.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tt 60.29 -17.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.557 2.743 . . . . 0.0 114.563 -169.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' A' ' 40' ' ' LEU . 6.5 pt-20 -169.46 76.82 0.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.94 -45.38 93.94 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.744 -0.598 . . . . 0.0 109.566 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.63 149.43 44.09 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.28 -175.46 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.793 2.995 . . . . 0.0 112.798 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.88 36.63 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.61 1.564 . . . . 0.0 111.334 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.7 m -158.3 128.69 6.13 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.31 2.244 . . . . 0.0 106.321 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.55 -145.98 17.54 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.2 mm -124.55 142.0 42.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -122.12 151.21 41.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.8 mt -137.44 138.9 40.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.07 134.25 66.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.12 111.91 30.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -156.53 -176.4 5.95 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 108.638 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -153.07 62.82 0.77 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.4 1.095 . . . . 0.0 110.344 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.1 p -64.5 -14.85 59.35 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.301 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -59.27 167.62 1.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.769 1.227 . . . . 0.0 112.261 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.54 -65.81 3.07 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.036 1.303 . . . . 0.0 111.507 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.78 -8.42 0.22 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.281 1.032 . . . . 0.0 113.71 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.96 -146.65 38.84 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 119.787 1.176 . . . . 0.0 110.735 -170.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -143.78 169.49 17.66 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.098 1.359 . . . . 0.0 108.147 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 90.9 mt -46.35 -52.72 27.39 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.534 1.533 . . . . 0.0 112.836 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.87 -44.28 1.38 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 CA-C-N 121.86 1.7 . . . . 0.0 111.465 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -172.2 -61.81 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.767 1.627 . . . . 0.0 108.608 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 178.78 -53.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.84 2.456 . . . . 0.0 106.403 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mp -75.48 131.16 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 169.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.44 -58.87 0.33 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.045 0.839 . . . . 0.0 110.228 -170.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -81.18 -38.56 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.325 2.016 . . . . 0.0 111.989 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -59.29 -49.9 76.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.432 0.693 . . . . 0.0 111.511 -169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -60.26 -44.28 95.44 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.348 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.37 -47.56 75.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.31 0.504 . . . . 0.0 110.467 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.21 89.28 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.01 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 mt -53.72 -55.62 24.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.914 0.779 . . . . 0.0 109.463 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.14 -17.27 61.97 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.87 -32.25 65.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.732 0.413 . . . . 0.0 111.337 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.9 -29.97 5.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 mttt 27.45 66.28 0.57 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.804 2.042 . . . . 0.0 113.273 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.94 176.81 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.824 2.349 . . . . 0.0 112.715 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -82.13 68.67 8.63 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.383 1.073 . . . . 0.0 111.125 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.22 3.11 1.8 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.875 0.87 . . . . 0.0 112.886 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -64.67 -6.25 7.41 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.365 2.666 . . . . 0.0 113.336 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.78 9.04 24.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.85 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 p -134.62 157.22 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.573 0.749 . . . . 0.0 110.529 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -121.01 152.02 39.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 168.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -118.1 173.87 6.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.03 160.11 28.08 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 106.68 -2.568 . . . . 0.0 106.68 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.81 145.87 50.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.45 121.1 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.09 -14.4 6.32 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.818 1.199 . . . . 0.0 114.593 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.9 141.34 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.981 1.313 . . . . 0.0 108.799 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.47 -15.01 60.84 Favored Glycine 0 N--CA 1.468 0.768 0 O-C-N 121.083 -1.01 . . . . 0.0 112.919 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.4 m -54.75 -14.87 1.54 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.553 2.341 . . . . 0.0 115.195 -174.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -125.01 2.3 8.0 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.651 1.114 . . . . 0.0 113.095 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -142.95 -24.1 0.62 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -170.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -116.69 -33.9 4.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.321 1.048 . . . . 0.0 111.419 -172.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 98' ' ' PHE . 29.5 t70 -106.44 10.87 31.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.753 1.263 . . . . 0.0 112.952 -172.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 p -69.58 20.05 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.732 2.413 . . . . 0.0 113.696 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 96' ' ' ASP . 52.3 t80 -136.24 -14.53 1.76 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.297 1.839 . . . . 0.0 111.595 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 57.0 m -132.92 -5.07 3.14 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 41.59 31.22 0.66 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 127.292 2.377 . . . . 0.0 115.445 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.82 -30.97 66.06 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.037 1.418 . . . . 0.0 112.018 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.6 -0.01 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.549 1.54 . . . . 0.0 112.027 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -51.75 -28.73 16.13 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.317 1.447 . . . . 0.0 110.618 168.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -46.34 -37.48 7.53 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 128.648 2.779 . . . . 0.0 113.149 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.41 -57.25 13.79 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.581 0.628 . . . . 0.0 109.433 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.38 -31.17 65.34 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.093 0.557 . . . . 0.0 109.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.89 94.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.002 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.53 -37.98 83.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.503 1.047 . . . . 0.0 110.449 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.43 -40.48 96.72 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.536 0.734 . . . . 0.0 111.626 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.297 7.6 ptmm? -79.92 -29.54 39.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.544 -0.722 . . . . 0.0 112.509 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.42 86.46 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.162 0.985 . . . . 0.0 110.995 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 p -77.49 -20.48 54.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.07 -37.48 0.46 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.715 0.689 . . . . 0.0 113.597 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.91 -177.99 2.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.97 0.891 . . . . 0.0 111.435 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -135.14 150.14 50.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -77.11 126.98 31.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 m -77.58 140.93 39.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.45 -121.31 19.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -153.81 162.33 41.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.877 1.271 . . . . 0.0 108.927 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.9 m -53.41 124.18 14.07 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.811 -169.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.51 164.66 26.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.864 1.666 . . . . 0.0 108.283 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -135.99 144.4 45.32 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.014 -1.053 . . . . 0.0 109.318 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 pp -144.92 155.28 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 127.003 2.121 . . . . 0.0 108.697 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -162.5 154.09 18.17 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.59 24.39 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.244 1.417 . . . . 0.0 111.009 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.0 mt -125.43 -178.12 4.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.611 1.564 . . . . 0.0 107.965 173.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.85 -42.87 98.68 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.812 0.445 . . . . 0.0 111.337 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -164.34 164.26 22.3 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.034 1.334 . . . . 0.0 109.893 173.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -162.96 -162.41 0.77 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.887 2.875 . . . . 0.0 104.015 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 46.8 mm -67.01 -50.35 42.44 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 117.407 -1.283 . . . . 0.0 111.735 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.58 -40.1 10.91 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.05 1.833 . . . . 0.0 111.019 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 68.78 -28.51 0.16 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.113 2.565 . . . . 0.0 116.016 169.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -150.01 141.26 14.73 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 120.059 1.3 . . . . 0.0 111.911 -169.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.58 99.24 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.014 3.143 . . . . 0.0 110.759 169.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.24 67.53 1.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.723 1.609 . . . . 0.0 110.182 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -55.44 -34.49 64.52 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.523 1.129 . . . . 0.0 111.036 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.64 -30.65 71.68 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.345 0.658 . . . . 0.0 111.603 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -44.85 83.01 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.599 0.759 . . . . 0.0 109.579 175.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -61.59 -52.05 66.0 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.9 -49.74 40.76 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 124.518 1.136 . . . . 0.0 111.475 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.1 m -61.47 -54.55 41.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 125.111 1.364 . . . . 0.0 111.54 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -55.7 -41.18 73.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.151 0.98 . . . . 0.0 111.365 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t -60.56 -49.54 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.358 1.063 . . . . 0.0 109.83 173.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.81 -27.65 68.2 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.474 1.033 . . . . 0.0 111.651 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.79 -45.01 19.59 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.513 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 pp -71.15 -36.01 71.88 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.607 0.64 . . . . 0.0 111.592 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.6 mttm . . . . . 0 C--O 1.248 0.991 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 175.799 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 119.244 -0.408 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.92 164.05 36.47 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.777 1.231 . . . . 0.0 109.147 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.46 -23.34 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.354 1.462 . . . . 0.0 110.64 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mt -133.11 126.19 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.813 1.245 . . . . 0.0 108.078 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -88.09 126.81 35.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.37 91.19 4.16 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.4 mt -86.09 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 t -111.54 -162.2 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.311 1.044 . . . . 0.0 108.319 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.32 57.29 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 123.646 0.641 . . . . 0.0 111.858 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -44.37 121.77 2.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.108 1.363 . . . . 0.0 111.095 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.272 39.1 m 67.31 53.15 0.78 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.884 1.273 . . . . 0.0 110.478 -171.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 52.92 37.85 25.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.954 2.101 . . . . 0.0 114.494 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.83 156.52 10.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.246 0.926 . . . . 0.0 111.478 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.16 -171.06 41.11 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.39 68.38 2.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.217 1.407 . . . . 0.0 110.893 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.85 -24.46 6.2 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.763 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -51.95 -34.78 43.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.148 0.979 . . . . 0.0 112.906 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 p -71.69 -34.2 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.641 1.109 . . . . 0.0 109.853 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.47 61.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.378 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.73 -40.45 84.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.031 0.832 . . . . 0.0 110.361 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -57.88 -51.16 70.75 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.509 0.724 . . . . 0.0 109.347 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.32 -49.89 73.03 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.096 0.558 . . . . 0.0 110.487 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.25 -40.8 64.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.671 1.188 . . . . 0.0 111.796 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.98 -58.5 7.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.336 0.971 . . . . 0.0 109.998 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -53.89 -43.4 69.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.657 1.183 . . . . 0.0 112.188 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.1 -36.83 82.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.733 0.813 . . . . 0.0 111.967 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.67 -36.99 73.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.703 1.138 . . . . 0.0 109.732 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.83 -23.2 67.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.287 0.635 . . . . 0.0 111.801 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.97 -10.92 60.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.853 0.861 . . . . 0.0 112.108 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 21.61 5.98 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.319 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -125.87 -171.81 2.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.465 1.132 . . . . 0.0 109.584 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 p -125.16 151.02 46.34 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -142.29 159.8 41.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.861 -0.524 . . . . 0.0 110.336 -170.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 110.96 11.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m -76.01 124.6 27.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.9 mt -141.88 159.45 42.21 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.268 0.627 . . . . 0.0 110.718 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -110.74 39.39 2.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.165 1.386 . . . . 0.0 109.022 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.78 46.67 39.48 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.906 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.62 -21.16 70.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 121.398 2.599 . . . . 0.0 113.736 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 42' ' ' GLU . 73.1 mt -126.32 14.2 7.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.43 1.892 . . . . 0.0 109.309 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 66.12 -31.72 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.366 2.667 . . . . 0.0 112.436 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 40' ' ' LEU . 8.9 pt-20 -158.12 89.8 1.02 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.132 1.773 . . . . 0.0 107.075 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.54 -42.49 91.86 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.667 -0.645 . . . . 0.0 110.409 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.59 154.5 59.1 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.35 -175.27 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.055 3.17 . . . . 0.0 113.173 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.57 28.84 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.63 1.572 . . . . 0.0 113.067 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -153.56 137.33 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.817 2.447 . . . . 0.0 106.342 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.23 -140.58 12.42 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mm -121.55 137.3 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -122.34 137.23 54.92 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 mt -129.83 134.18 47.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.09 128.09 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.23 59.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.335 1.854 . . . . 0.0 106.689 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -67.92 -32.36 72.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.661 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 m 28.54 55.31 0.09 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 127.905 2.482 . . . . 0.0 113.505 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.7 p -42.37 -40.0 2.36 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 127.63 2.372 . . . . 0.0 114.715 -169.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -140.59 17.37 2.36 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.825 0.739 . . . . 0.0 111.397 168.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.5 -25.95 29.08 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.42 1.009 . . . . 0.0 111.182 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.34 54.7 0.86 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.868 2.467 . . . . 0.0 105.107 169.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.41 -146.62 4.91 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.424 1.011 . . . . 0.0 111.479 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -151.91 -34.4 0.13 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.614 1.165 . . . . 0.0 112.829 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 pt -156.37 167.04 15.19 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.789 2.036 . . . . 0.0 108.547 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.25 -28.71 8.36 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.819 3.013 . . . . 0.0 115.131 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -77.76 9.03 3.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.104 1.362 . . . . 0.0 113.48 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -54.03 -27.23 30.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.222 1.409 . . . . 0.0 113.785 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.36 84.45 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 169.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.5 m -70.51 -56.49 6.43 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.644 -167.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.12 -37.91 39.48 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.428 1.189 . . . . 0.0 110.006 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -68.19 -50.43 54.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.58 -46.36 83.04 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.883 0.765 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.46 -40.44 94.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.841 1.2 . . . . 0.0 110.922 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.29 90.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.314 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.2 mt -54.65 -52.72 61.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.512 1.051 . . . . 0.0 109.78 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -67.03 -22.59 65.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -75.42 -43.64 48.8 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.486 0.585 . . . . 0.0 111.083 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -98.88 -29.16 13.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.54 62.68 0.98 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 127.014 2.126 . . . . 0.0 112.609 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.75 164.63 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.259 2.639 . . . . 0.0 113.278 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.13 64.41 2.57 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.372 1.469 . . . . 0.0 111.613 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.19 9.53 0.97 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 112.737 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m -60.55 -6.87 1.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 127.858 2.463 . . . . 0.0 112.717 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.62 8.75 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.758 1.623 . . . . 0.0 111.183 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.69 152.84 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.93 0.871 . . . . 0.0 111.808 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -105.0 152.69 22.4 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -122.8 147.89 46.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.911 1.285 . . . . 0.0 107.561 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.05 116.98 1.65 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.116 -2.793 . . . . 0.0 106.116 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.23 145.19 35.65 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 mt -139.37 124.11 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.61 -2.82 20.75 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.714 1.626 . . . . 0.0 113.996 173.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -60.3 117.51 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.532 . . . . 0.0 107.955 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.13 -29.96 63.77 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.5 m -64.59 54.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 129.719 3.208 . . . . 0.0 111.768 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.05 -44.86 0.79 Allowed 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 126.968 2.107 . . . . 0.0 109.723 174.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -151.71 -36.12 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.099 0.959 . . . . 0.0 111.113 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -71.82 -20.97 61.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.47 1.108 . . . . 0.0 112.374 -172.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -83.34 33.14 0.45 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.25 1.42 . . . . 0.0 113.216 -169.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 p -72.0 9.75 0.87 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.315 1.446 . . . . 0.0 113.409 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -62.58 -38.62 90.83 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.774 1.23 . . . . 0.0 110.059 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.9 p -142.21 20.26 2.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.785 1.234 . . . . 0.0 111.395 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.53 27.2 70.53 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.376 0.989 . . . . 0.0 112.586 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.89 21.74 1.85 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.276 1.038 . . . . 0.0 112.485 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.4 pt -60.62 16.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 129.215 3.006 . . . . 0.0 116.655 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -160.65 2.62 0.07 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.175 0.99 . . . . 0.0 112.727 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -57.64 -41.3 81.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -168.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.6 -57.31 7.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.586 1.084 . . . . 0.0 108.461 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -58.46 -37.78 76.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.083 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.56 67.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 126.157 1.783 . . . . 0.0 109.873 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.93 -34.17 77.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.132 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.1 -40.65 74.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.903 1.229 . . . . 0.0 110.402 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -63.97 -41.54 97.52 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.966 1.306 . . . . 0.0 109.586 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -34.11 73.38 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.057 1.743 . . . . 0.0 111.742 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -67.56 -42.16 83.06 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.81 -17.32 0.56 Allowed Glycine 0 CA--C 1.528 0.898 0 CA-C-O 117.956 -1.469 . . . . 0.0 115.391 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 140.16 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.809 1.804 . . . . 0.0 109.43 -170.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -89.12 112.91 24.0 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.16 128.67 36.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.7 m -106.39 149.97 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.86 -122.4 29.86 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.83 168.67 26.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.19 1.396 . . . . 0.0 108.315 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.1 m -43.91 116.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.09 169.51 15.87 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.879 1.672 . . . . 0.0 108.095 172.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 138.96 42.79 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 120.948 -1.095 . . . . 0.0 111.123 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.66 159.36 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 127.247 2.219 . . . . 0.0 105.372 169.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -147.02 122.36 10.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 118.319 0.509 . . . . 0.0 110.337 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.6 tp -158.7 162.12 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.574 1.55 . . . . 0.0 107.418 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.5 tp 64.2 -9.39 0.16 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.297 2.239 . . . . 0.0 115.411 169.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -151.84 170.69 19.19 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.81 1.644 . . . . 0.0 108.82 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -59.3 160.52 6.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.211 1.405 . . . . 0.0 110.983 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.25 140.54 45.07 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.84 0.829 . . . . 0.0 111.283 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.1 mm -146.05 -55.66 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 128.276 2.63 . . . . 0.0 106.02 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -78.54 -131.58 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 122.52 2.147 . . . . 0.0 110.11 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.5 -177.3 5.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.281 2.632 . . . . 0.0 105.606 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.504 ' H ' ' HD2' ' A' ' 134' ' ' PRO . 21.7 t70 -142.02 -34.56 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 117.226 2.306 . . . . 0.0 117.226 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.504 ' HD2' ' H ' ' A' ' 133' ' ' ASP . 69.0 Cg_endo -79.6 36.7 0.63 Allowed 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 122.684 2.256 . . . . 0.0 112.522 -177.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.07 26.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.836 2.055 . . . . 0.0 113.772 -171.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -61.96 -33.27 73.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.735 -1.228 . . . . 0.0 110.678 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.18 -33.68 76.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.55 -0.719 . . . . 0.0 111.111 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.65 -44.63 93.27 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.12 -52.64 64.85 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.265 1.026 . . . . 0.0 108.807 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.53 -44.91 85.72 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.252 0.93 . . . . 0.0 111.844 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -61.71 -55.01 34.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.567 0.683 . . . . 0.0 109.548 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -57.69 -40.52 79.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.525 0.73 . . . . 0.0 111.666 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.41 -55.28 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 124.924 1.29 . . . . 0.0 109.699 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -15.05 63.34 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.442 1.019 . . . . 0.0 112.197 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.69 -45.85 20.4 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.796 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.7 -36.87 76.32 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.57 0.623 . . . . 0.0 111.639 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.032 0 C-N-CA 125.435 1.494 . . . . 0.0 109.658 175.264 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.41 165.61 33.6 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.05 0.94 . . . . 0.0 110.37 -173.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.15 -23.07 15.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.721 1.608 . . . . 0.0 110.808 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.69 126.69 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.411 1.084 . . . . 0.0 108.328 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -85.73 128.91 34.92 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -108.7 88.33 2.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.8 mt -77.74 91.41 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -93.02 17.1 11.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.812 2.045 . . . . 0.0 112.98 -168.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.89 77.78 0.11 Allowed Glycine 0 N--CA 1.446 -0.657 0 O-C-N 121.707 -0.621 . . . . 0.0 112.086 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -56.44 -14.4 3.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.247 1.019 . . . . 0.0 113.344 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -122.08 33.42 5.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.722 2.009 . . . . 0.0 109.92 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.8 mt 58.11 23.97 10.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.699 1.999 . . . . 0.0 112.854 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.0 161.96 16.25 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 128.585 2.993 . . . . 0.0 106.223 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.35 -36.33 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.917 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.82 16.42 0.98 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.034 1.417 . . . . 0.0 113.826 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.26 -36.49 63.66 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.535 1.061 . . . . 0.0 113.288 -170.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -60.65 -50.56 73.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.559 0.618 . . . . 0.0 111.313 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.8 -32.24 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 122.029 -0.419 . . . . 0.0 110.094 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.61 87.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.919 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -62.17 -40.06 94.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.323 0.965 . . . . 0.0 111.147 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -64.98 -47.6 76.96 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.639 -0.663 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.41 -49.54 72.12 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.984 0.914 . . . . 0.0 110.606 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.58 -48.23 72.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.999 1.319 . . . . 0.0 110.774 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.59 -50.75 72.27 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.962 0.905 . . . . 0.0 110.524 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.1 -22.64 62.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.567 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -72.79 -41.5 64.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 121.156 1.798 . . . . 0.0 109.024 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -62.9 -25.08 68.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.779 0.832 . . . . 0.0 111.462 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -11.99 60.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.149 0.98 . . . . 0.0 112.546 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 19.85 7.03 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.241 172.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -124.21 -166.78 1.55 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.354 1.061 . . . . 0.0 108.642 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -132.1 150.73 52.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.9 p -141.71 153.88 44.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 110.806 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -123.13 90.48 3.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.231 1.012 . . . . 0.0 108.524 -172.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -66.61 118.9 10.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.2 mt -145.59 138.07 25.76 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.815 0.846 . . . . 0.0 109.167 -170.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -83.66 40.88 0.76 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.035 -1.041 . . . . 0.0 110.601 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.16 44.98 34.2 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 117.892 -1.504 . . . . 0.0 115.863 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.69 -20.99 39.64 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.175 2.487 . . . . 0.0 114.005 -170.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 42' ' ' GLU . 79.6 mt -119.37 13.41 12.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.53 1.532 . . . . 0.0 109.391 -175.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.0 tp 64.52 -27.2 0.09 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.886 2.474 . . . . 0.0 113.568 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 40' ' ' LEU . 6.7 pt-20 -174.1 87.77 0.05 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.507 1.523 . . . . 0.0 107.378 -169.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.37 -43.29 91.23 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.816 -0.553 . . . . 0.0 110.298 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.81 151.1 49.42 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.69 -174.33 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.139 3.226 . . . . 0.0 112.962 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.44 29.02 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.527 1.531 . . . . 0.0 113.115 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -152.23 131.93 13.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.949 2.5 . . . . 0.0 106.287 -175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.39 -139.73 11.19 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mm -126.89 137.07 58.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -121.76 133.95 54.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -127.62 138.12 52.76 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.22 133.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.93 107.58 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -171.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -163.53 -160.52 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.08 2.152 . . . . 0.0 105.598 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 m -148.02 155.12 41.15 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.199 -1.563 . . . . 0.0 109.045 170.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.7 p -128.65 -26.65 2.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.207 0.603 . . . . 0.0 111.872 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -66.58 -26.48 67.13 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.52 -0.738 . . . . 0.0 111.271 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.39 -177.3 36.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 45.74 44.88 11.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.904 1.282 . . . . 0.0 110.683 -170.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.3 -148.64 5.5 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.064 1.316 . . . . 0.0 109.923 -169.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t70 47.75 -45.22 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.49 1 C-N-CA 131.858 4.063 . . . . 0.0 118.536 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.2 mt -56.9 -52.47 73.75 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 120.298 1.408 . . . . 0.0 111.048 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -80.92 40.08 0.95 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.406 2.737 . . . . 0.0 111.133 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t70 52.28 30.23 7.69 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.995 1.718 . . . . 0.0 111.589 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.72 -18.6 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.521 3.129 . . . . 0.0 115.742 -170.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.25 120.94 8.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -54.89 0.56 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.3 -172.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -99.3 -34.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.18 2.587 . . . . 0.0 113.554 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.93 -54.68 44.44 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.722 0.809 . . . . 0.0 112.063 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -65.42 -40.3 93.17 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.659 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.47 -49.62 76.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.246 0.475 . . . . 0.0 110.038 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.13 93.22 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.01 -53.75 54.58 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.773 0.715 . . . . 0.0 110.305 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -72.92 -19.0 61.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.6 -49.82 56.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.368 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -100.8 -26.53 13.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 29.36 64.66 0.78 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 127.19 2.196 . . . . 0.0 113.011 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -63.65 164.81 19.91 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.605 2.203 . . . . 0.0 112.443 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -82.39 66.19 7.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.661 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.43 7.52 0.6 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.306 1.042 . . . . 0.0 113.041 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -62.82 -6.12 3.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.517 2.727 . . . . 0.0 113.041 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.21 8.77 19.95 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.271 1.428 . . . . 0.0 110.983 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.46 147.22 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.709 0.686 . . . . 0.0 110.911 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -97.75 154.05 17.85 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -119.52 152.11 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.6 146.78 17.55 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.8 135.71 53.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.55 127.88 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.48 -19.99 3.62 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.352 0.977 . . . . 0.0 113.662 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.67 144.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.3 1.84 . . . . 0.0 108.677 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.09 -19.61 1.1 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.783 1.182 . . . . 0.0 113.308 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p -52.99 -25.4 11.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.396 1.878 . . . . 0.0 113.34 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -74.66 -26.63 59.98 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -146.75 -22.54 0.42 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 -168.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -126.65 -35.41 2.34 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -168.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.69 11.36 9.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.164 0.983 . . . . 0.0 112.239 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 p -67.78 7.13 0.55 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.952 2.501 . . . . 0.0 115.051 -169.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -77.69 -39.27 45.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.539 1.136 . . . . 0.0 110.354 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.2 p -153.52 19.51 0.54 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.851 0.86 . . . . 0.0 112.563 -174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.07 58.73 4.32 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 125.553 1.549 . . . . 0.0 113.096 -169.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.53 -22.58 34.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.124 0.97 . . . . 0.0 113.053 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -11.79 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 118.641 -0.695 . . . . 0.0 112.694 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.08 -28.23 0.69 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.159 2.184 . . . . 0.0 112.907 169.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -56.75 -23.12 40.54 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.101 0.96 . . . . 0.0 112.73 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.45 -59.12 5.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 120.013 1.279 . . . . 0.0 109.185 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.88 -39.52 81.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.109 0.413 . . . . 0.0 110.597 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.21 81.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.269 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.56 -38.18 90.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.048 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.97 -46.91 88.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.29 0.95 . . . . 0.0 110.592 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -65.69 -38.34 88.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.798 0.839 . . . . 0.0 110.074 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -34.24 77.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.688 1.195 . . . . 0.0 111.324 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.1 m -71.67 -31.25 66.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.388 -0.339 . . . . 0.0 111.336 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.97 -33.15 0.56 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 118.994 -0.892 . . . . 0.0 114.781 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.6 171.97 6.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.433 1.116 . . . . 0.0 110.465 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -132.72 141.93 48.8 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -75.78 111.13 10.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.0 m -74.58 152.69 39.24 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.08 -104.13 1.68 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.79 -177.34 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.812 2.445 . . . . 0.0 106.541 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 124.99 31.51 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.431 ' HG ' ' CG ' ' A' ' 138' ' ' TRP . 2.3 tt -79.65 151.02 30.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -129.85 146.67 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.814 1.188 . . . . 0.0 108.798 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.69 170.17 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 110.9 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 108.83 141.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.655 1 C-N-CA 132.042 4.137 . . . . 0.0 110.879 169.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.05 5.76 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.936 1.694 . . . . 0.0 110.906 169.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.5 -47.32 86.18 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.015 0.926 . . . . 0.0 109.852 -171.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -141.32 18.84 2.24 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.535 1.134 . . . . 0.0 110.329 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 47.48 55.47 8.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.691 1.596 . . . . 0.0 110.572 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -65.88 -178.85 0.63 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.857 1.263 . . . . 0.0 110.28 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.274 98.0 mt 6.37 -78.86 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.878 1 C-N-CA 132.475 4.31 . . . . 0.0 115.358 -172.086 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -69.9 -31.0 20.74 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.489 2.126 . . . . 0.0 112.359 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 86.59 -16.07 0.43 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.12 2.968 . . . . 0.0 111.625 170.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -145.77 122.33 5.94 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.645 1.178 . . . . 0.0 108.484 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -72.91 165.9 31.51 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.755 2.304 . . . . 0.0 111.272 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.74 49.51 2.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.996 1.318 . . . . 0.0 109.382 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.71 -21.75 55.68 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.85 -24.87 67.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.256 1.023 . . . . 0.0 112.042 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.431 ' CG ' ' HG ' ' A' ' 121' ' ' LEU . 9.2 t90 -51.85 -50.34 61.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 110.653 173.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.82 -55.96 24.53 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.483 1.114 . . . . 0.0 109.359 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.28 -42.38 99.76 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 123.319 0.387 . . . . 0.0 112.179 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -60.28 -63.35 1.33 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 125.194 1.397 . . . . 0.0 110.171 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -53.95 -46.72 71.66 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.846 1.658 . . . . 0.0 111.849 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.5 t -59.77 -55.89 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -18.17 63.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.461 1.028 . . . . 0.0 112.201 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.24 -47.1 21.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.545 0.611 . . . . 0.0 111.0 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.17 -30.69 62.36 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 112.261 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.9 mttm . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.804 1.242 . . . . 0.0 109.781 171.491 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.2 167.63 29.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.842 1.257 . . . . 0.0 109.309 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.07 -27.59 18.49 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.882 0.873 . . . . 0.0 110.025 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -132.71 132.09 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.941 0.896 . . . . 0.0 109.319 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -89.46 129.86 35.89 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.57 95.11 5.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.2 mt -88.27 77.51 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -74.27 153.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.31 -0.869 . . . . 0.0 109.54 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.93 -175.64 32.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-O 122.576 1.098 . . . . 0.0 114.973 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 p -150.51 -50.07 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.05 -1.575 . . . . 0.0 109.508 -169.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 48.0 m -121.48 58.64 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.0 tp 48.89 48.08 20.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.067 2.147 . . . . 0.0 112.549 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.72 153.34 10.98 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.21 -174.51 41.09 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 118.31 1.055 . . . . 0.0 113.745 -169.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.06 59.5 1.32 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.296 1.838 . . . . 0.0 110.52 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -56.67 -27.38 58.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.148 -0.97 . . . . 0.0 112.05 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -58.91 -44.81 91.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.932 0.787 . . . . 0.0 111.324 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.71 -43.14 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.33 91.38 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.549 -0.262 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.66 -41.45 75.51 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.363 0.665 . . . . 0.0 110.886 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -61.27 -45.55 94.04 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.736 -0.602 . . . . 0.0 110.147 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.13 -52.57 65.0 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.093 0.957 . . . . 0.0 110.469 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.55 -46.25 57.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.224 1.009 . . . . 0.0 110.886 177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -56.69 -54.23 48.53 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.549 0.613 . . . . 0.0 110.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -61.65 -39.45 91.38 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.87 -37.59 84.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.396 0.678 . . . . 0.0 110.779 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.36 -39.41 89.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.592 0.633 . . . . 0.0 110.369 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -63.14 -30.01 71.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.867 0.758 . . . . 0.0 111.388 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -20.62 60.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.623 0.769 . . . . 0.0 111.676 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 16.92 6.73 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 118.514 -1.159 . . . . 0.0 114.228 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.03 142.58 51.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.066 1.433 . . . . 0.0 108.49 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -83.15 151.84 25.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -138.32 158.62 43.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.03 104.46 7.8 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 m -68.82 123.21 20.33 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.271 1.028 . . . . 0.0 108.344 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -145.43 166.35 25.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.163 0.985 . . . . 0.0 110.042 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -110.36 39.33 2.21 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.622 1.169 . . . . 0.0 109.141 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.85 50.9 14.1 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.718 1.627 . . . . 0.0 114.867 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 -21.75 62.61 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.846 2.364 . . . . 0.0 113.775 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 42' ' ' GLU . 74.0 mt -124.1 13.93 9.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.18 1.792 . . . . 0.0 108.93 177.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.7 tp 61.59 -25.57 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.654 2.782 . . . . 0.0 114.464 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 40' ' ' LEU . 8.5 pt-20 -161.3 86.44 0.68 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -168.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.57 -45.25 87.82 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.685 -0.634 . . . . 0.0 110.081 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.13 151.34 59.93 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.48 -178.9 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.584 2.856 . . . . 0.0 112.996 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.54 35.92 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.882 1.673 . . . . 0.0 111.807 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -158.49 123.99 4.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.293 2.237 . . . . 0.0 105.773 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.48 -147.9 19.38 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.6 mm -123.5 128.91 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -119.79 152.25 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 mt -140.43 138.16 34.51 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.76 132.29 44.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -125.11 68.44 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.931 1.292 . . . . 0.0 108.292 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -103.09 16.24 27.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.524 1.13 . . . . 0.0 112.241 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m 2.22 83.49 0.0 OUTLIER 'General case' 0 C--N 1.344 0.357 0 C-N-CA 129.999 3.319 . . . . 0.0 114.516 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.6 p -64.79 -48.31 74.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.148 0.979 . . . . 0.0 109.609 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -83.1 61.88 6.29 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.288 1.035 . . . . 0.0 108.306 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.98 60.74 0.23 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.57 40.38 29.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.326 1.45 . . . . 0.0 111.654 -169.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.14 -138.2 5.44 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 125.563 1.554 . . . . 0.0 109.822 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.2 t70 47.59 -51.81 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 1 C-N-CA 131.886 4.074 . . . . 0.0 117.945 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.9 mt -54.92 -53.12 64.64 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 120.172 1.351 . . . . 0.0 112.302 -170.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -82.24 49.14 3.03 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.212 2.608 . . . . 0.0 110.485 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t0 47.43 41.48 12.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.225 1.41 . . . . 0.0 109.641 -169.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.35 -47.52 0.13 Allowed 'General case' 0 C--N 1.338 0.08 0 C-N-CA 130.473 3.509 . . . . 0.0 114.533 -168.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -150.09 108.07 3.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 m -82.65 -63.04 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.948 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.86 -40.57 16.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.695 1.596 . . . . 0.0 110.625 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -63.46 -49.87 71.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.976 0.51 . . . . 0.0 110.718 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.53 -45.83 88.81 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.801 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -61.07 -46.43 90.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.746 0.703 . . . . 0.0 110.231 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -24.02 67.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.6 mt -67.71 -61.24 1.98 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.469 1.031 . . . . 0.0 108.657 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -73.62 -13.14 60.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.19 -36.11 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.202 1.001 . . . . 0.0 110.356 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -120.72 -30.11 4.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.798 -172.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.3 mttt 25.62 68.69 0.43 Allowed Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.043 1.737 . . . . 0.0 112.872 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.45 173.95 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.309 2.006 . . . . 0.0 111.883 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -81.15 95.6 6.94 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.37 -0.832 . . . . 0.0 108.992 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -88.45 6.25 38.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.992 0.517 . . . . 0.0 111.561 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.6 p -68.06 -5.26 16.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 119.694 -1.879 . . . . 0.0 112.583 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.56 43.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.461 1.504 . . . . 0.0 110.939 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.61 155.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.246 1.022 . . . . 0.0 111.095 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -114.91 147.48 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -125.61 156.92 38.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 109.791 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.45 116.42 2.15 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.6 146.36 44.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.1 mt -139.99 129.45 28.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.92 -9.36 2.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.442 1.02 . . . . 0.0 113.775 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.85 136.17 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.35 14.22 7.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.799 1.19 . . . . 0.0 112.052 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -68.85 -9.98 54.44 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.308 1.443 . . . . 0.0 113.392 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -157.58 175.19 14.27 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.996 2.119 . . . . 0.0 107.854 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 77.33 -25.95 0.19 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 129.287 3.035 . . . . 0.0 112.475 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -136.67 -26.49 1.07 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.632 1.173 . . . . 0.0 112.76 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -149.27 87.44 1.52 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-N 119.283 0.947 . . . . 0.0 108.655 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.8 p -75.7 4.3 8.07 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -87.96 -17.95 30.15 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.295 0.638 . . . . 0.0 109.713 169.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 87.4 m -76.14 19.68 0.23 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.122 0.969 . . . . 0.0 112.3 169.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -55.17 -29.92 53.48 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.102 0.858 . . . . 0.0 111.829 171.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.57 -16.6 16.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.401 1.08 . . . . 0.0 113.662 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.3 pt -125.45 19.24 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.916 1.286 . . . . 0.0 110.726 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -0.05 24.28 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.666 -1.271 . . . . 0.0 112.348 169.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -51.07 -40.89 59.39 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.977 1.711 . . . . 0.0 112.874 -170.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.5 -57.81 11.36 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.13 -40.31 95.49 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.8 68.12 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 117.329 -1.32 . . . . 0.0 111.603 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.98 -45.0 94.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.736 1.607 . . . . 0.0 110.805 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.84 -39.47 90.83 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -30.71 70.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.161 1.384 . . . . 0.0 111.948 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.9 m -80.58 -18.65 47.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.953 0.501 . . . . 0.0 111.098 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.5 -19.58 4.5 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.694 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.49 136.89 55.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.674 1.737 . . . . 0.0 108.829 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -86.23 132.77 33.92 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -85.63 103.23 14.26 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -77.09 150.26 35.68 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.322 -0.236 . . . . 0.0 110.487 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.65 -95.45 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.413 1.006 . . . . 0.0 111.195 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.34 176.99 6.31 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 128.439 2.696 . . . . 0.0 106.511 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.3 m -63.72 131.03 46.62 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 tt -73.78 139.93 45.54 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.51 139.77 51.45 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.06 169.18 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.924 1.29 . . . . 0.0 108.702 -174.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.37 157.97 44.49 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.7 pt -134.51 165.37 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.03 -35.18 74.54 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.955 0.502 . . . . 0.0 111.104 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -64.93 -44.91 87.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.08 0.552 . . . . 0.0 112.168 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -168.18 157.76 9.64 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.23 1.012 . . . . 0.0 109.823 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -72.83 152.33 41.58 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.322 40.2 mm -108.38 -91.1 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 116.12 -1.895 . . . . 0.0 108.459 -174.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.44 -53.99 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 CA-C-N 123.967 2.452 . . . . 0.0 110.583 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -168.44 -49.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.807 1.643 . . . . 0.0 108.795 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.84 142.76 15.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.429 1.092 . . . . 0.0 109.01 -169.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.2 162.45 40.56 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.764 2.309 . . . . 0.0 112.353 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.05 46.87 1.0 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.363 1.465 . . . . 0.0 109.167 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.46 -19.02 13.27 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -55.37 -23.41 24.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.35 1.46 . . . . 0.0 112.394 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -44.14 -56.66 3.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 125.359 1.464 . . . . 0.0 110.943 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -59.17 4.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.809 1.644 . . . . 0.0 109.002 -174.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.07 60.32 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 123.874 0.734 . . . . 0.0 111.349 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 t -65.27 -47.86 75.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.671 0.735 . . . . 0.0 110.566 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -60.67 -41.66 95.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.655 1.182 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t -59.4 -49.94 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.557 0.743 . . . . 0.0 109.675 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -61.26 -30.33 70.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.241 0.928 . . . . 0.0 111.247 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.23 -46.83 26.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.442 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -74.16 -32.01 62.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.188 0.449 . . . . 0.0 112.129 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.443 1.097 . . . . 0.0 109.825 173.376 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.43 164.62 37.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.184 0.994 . . . . 0.0 109.96 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.92 -24.0 15.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.672 1.589 . . . . 0.0 110.577 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.15 126.6 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.291 1.036 . . . . 0.0 108.413 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.48 127.2 35.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.44 95.55 6.15 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.1 mt -91.26 117.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.29 168.65 17.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.315 0.646 . . . . 0.0 110.525 -169.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.64 38.77 93.49 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.918 -0.379 . . . . 0.0 112.34 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 m -61.64 0.31 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.521 2.329 . . . . 0.0 116.343 -169.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -123.31 31.53 5.94 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.118 1.767 . . . . 0.0 108.183 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.2 tp 53.66 63.92 2.03 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 126.223 1.809 . . . . 0.0 109.952 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.56 -144.7 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.07 1.795 . . . . 0.0 109.189 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.97 163.37 34.77 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 37.22 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.128 1.771 . . . . 0.0 108.125 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.56 -36.4 61.82 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 0.0 113.244 -169.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -58.62 -47.02 85.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.099 0.863 . . . . 0.0 110.819 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -72.82 -47.09 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.85 99.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.99 -38.59 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.904 0.482 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -61.81 -48.0 82.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.764 0.711 . . . . 0.0 110.031 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.91 -54.06 49.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.856 0.863 . . . . 0.0 109.878 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.06 63.9 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.408 1.083 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.61 -54.92 40.85 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.567 0.747 . . . . 0.0 110.476 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -59.52 -37.12 77.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.2 mt -66.08 -34.31 77.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.213 0.605 . . . . 0.0 111.42 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -70.66 -38.3 73.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.046 1.294 . . . . 0.0 110.263 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.05 -29.76 70.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.37 0.668 . . . . 0.0 111.134 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.46 -14.77 62.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.819 0.848 . . . . 0.0 112.112 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.04 7.32 6.61 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.197 -1.335 . . . . 0.0 114.522 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -112.1 -167.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.668 1.734 . . . . 0.0 110.131 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -128.7 150.22 50.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.1 p -142.0 154.46 45.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.264 0.554 . . . . 0.0 112.061 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -121.26 98.03 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.579 1.552 . . . . 0.0 108.013 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -72.42 121.0 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.1 mt -146.16 149.0 33.15 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.996 0.518 . . . . 0.0 111.456 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -90.87 34.9 0.9 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.112 0.965 . . . . 0.0 110.319 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 49.94 27.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.735 1.636 . . . . 0.0 114.791 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.64 -21.89 65.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.82 2.347 . . . . 0.0 114.007 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -132.16 10.54 4.54 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.78 2.032 . . . . 0.0 107.099 -175.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 62.99 -26.66 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.628 2.771 . . . . 0.0 114.03 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 40' ' ' LEU . 8.7 pt-20 -157.59 80.43 0.88 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.857 0.863 . . . . 0.0 109.271 -168.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.97 -44.73 96.14 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.586 -0.696 . . . . 0.0 110.523 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.11 151.25 69.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 47' ' ' SER . 43.4 Cg_endo -67.92 -173.93 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.261 3.307 . . . . 0.0 113.021 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.45 27.56 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.422 1.489 . . . . 0.0 113.262 170.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 45' ' ' PRO . 15.5 m -150.76 133.28 15.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.768 2.427 . . . . 0.0 106.403 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.88 -142.07 13.28 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 mm -124.29 142.77 39.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 17.2 m0 -121.41 150.45 41.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.9 mt -141.07 141.2 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -133.71 121.19 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.72 103.09 14.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.324 1.85 . . . . 0.0 107.138 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -146.09 -161.0 1.22 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.334 1.054 . . . . 0.0 108.685 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.0 m -150.43 150.61 31.58 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.663 -1.273 . . . . 0.0 108.414 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p -146.85 -39.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.658 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.1 t60 51.89 21.82 1.57 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.116 1.366 . . . . 0.0 113.718 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.76 -28.67 5.62 Favored Glycine 0 C--N 1.339 0.726 0 O-C-N 120.868 -1.145 . . . . 0.0 112.864 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.68 -68.17 0.09 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.526 1.13 . . . . 0.0 108.267 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.95 -160.83 28.44 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.62 -28.42 69.11 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 169.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.6 pt -139.47 160.72 60.56 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.654 2.382 . . . . 0.0 107.076 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -55.69 -26.58 56.74 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.38 2.72 . . . . 0.0 114.39 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.23 43.12 1.21 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.781 1.632 . . . . 0.0 109.285 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -56.75 -19.77 18.6 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -169.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.68 77.8 1.76 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -66.64 -55.12 19.29 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 127.706 2.402 . . . . 0.0 112.411 -168.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.39 -34.53 54.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.117 1.211 . . . . 0.0 110.071 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.77 -59.42 5.45 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 123.783 0.677 . . . . 0.0 109.689 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.55 -46.81 87.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.957 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.12 -46.13 90.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.274 0.943 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.27 -23.53 65.69 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.1 mt -67.06 -62.35 1.47 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.61 -20.11 65.92 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.98 -34.49 77.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.545 0.738 . . . . 0.0 111.11 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -128.86 -24.41 2.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 mttt 28.58 65.1 0.69 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 127.108 2.163 . . . . 0.0 112.763 -170.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.28 163.29 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.679 2.253 . . . . 0.0 113.195 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -80.79 66.76 6.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.734 1.214 . . . . 0.0 110.731 -174.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.91 17.42 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.578 1.551 . . . . 0.0 112.886 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 p -65.99 -4.29 6.85 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 119.955 -1.715 . . . . 0.0 112.6 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 11.14 13.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.877 1.671 . . . . 0.0 111.081 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.99 157.16 40.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.815 0.817 . . . . 0.0 110.926 176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -120.02 148.56 43.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -115.46 169.25 9.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.06 120.19 1.58 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.31 139.93 41.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 90' ' ' ILE . 17.5 mt -138.59 130.86 38.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 -26.69 1.08 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.09 0.852 . . . . 0.0 112.77 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.436 ' H ' ' C ' ' A' ' 88' ' ' ILE . 16.3 mt -52.68 155.49 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 128.096 2.558 . . . . 0.0 108.453 169.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.47 20.7 0.82 Allowed Glycine 0 CA--C 1.526 0.754 0 O-C-N 121.664 -0.647 . . . . 0.0 112.58 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.46 -13.31 60.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.62 1.168 . . . . 0.0 111.804 174.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.15 145.67 36.17 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -54.29 -25.38 23.31 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.0 1.32 . . . . 0.0 113.753 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -72.2 -17.62 61.91 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -131.88 19.53 4.59 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.519 1.054 . . . . 0.0 113.353 -169.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.6 p -70.09 95.35 0.96 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.133 1.373 . . . . 0.0 110.302 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -133.3 -16.36 2.43 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 76.1 m -120.65 20.78 11.7 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.124 1.37 . . . . 0.0 110.987 173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.76 -177.38 37.19 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.13 1.824 . . . . 0.0 108.987 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.41 40.48 1.21 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.454 1.101 . . . . 0.0 110.324 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.8 pt -126.97 158.25 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.751 1.22 . . . . 0.0 109.384 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -148.55 25.24 0.97 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.848 0.859 . . . . 0.0 112.195 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -52.43 -34.46 48.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.422 1.089 . . . . 0.0 112.794 -173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.31 -57.5 12.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.173 0.589 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.51 -38.24 89.16 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.278 0.631 . . . . 0.0 109.359 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.13 83.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.206 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.82 -35.71 81.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.716 -1.135 . . . . 0.0 111.192 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.84 -47.93 84.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.896 1.226 . . . . 0.0 110.876 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.21 -37.02 84.55 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.142 0.977 . . . . 0.0 110.092 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -36.8 79.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.262 1.425 . . . . 0.0 111.518 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.5 m -68.96 -38.5 79.45 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.46 0.52 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.97 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.67 135.6 48.45 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.305 1.553 . . . . 0.0 108.986 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -84.23 141.62 30.86 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.05 113.38 19.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -72.28 146.26 47.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.8 -119.77 17.1 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 170.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.22 159.51 44.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.64 1.576 . . . . 0.0 107.388 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.5 m -48.8 125.11 9.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.976 1.31 . . . . 0.0 111.358 -175.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.51 147.78 35.64 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.647 1.579 . . . . 0.0 107.817 -173.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -116.13 142.82 46.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 169.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.59 161.32 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -169.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 58.96 157.25 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 131.037 3.735 . . . . 0.0 116.045 172.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 pp -142.27 16.28 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 125.55 1.54 . . . . 0.0 110.821 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.0 tp -63.82 -35.69 81.45 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 121.393 -0.817 . . . . 0.0 110.692 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -153.51 176.97 11.43 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.309 1.844 . . . . 0.0 106.889 173.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -57.77 140.65 51.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.385 1.474 . . . . 0.0 109.224 170.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -154.08 -166.31 2.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.37 1.468 . . . . 0.0 108.253 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.0 mt -74.24 -58.17 2.02 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-O 117.672 -1.156 . . . . 0.0 109.36 171.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.04 -51.38 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.586 1.524 . . . . 0.0 112.35 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 37.57 58.48 1.33 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.98 2.512 . . . . 0.0 114.397 174.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.6 139.46 13.58 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.031 0.933 . . . . 0.0 109.081 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.28 132.34 23.89 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.208 1.939 . . . . 0.0 111.258 -175.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.92 -25.85 65.69 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -170.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.03 -34.33 68.08 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -169.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.45 -41.04 69.95 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.964 0.802 . . . . 0.0 110.152 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -46.94 81.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.106 172.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.16 -47.2 81.79 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.191 0.596 . . . . 0.0 109.827 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.66 -49.32 79.79 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.5 t -62.94 -43.97 97.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.177 0.988 . . . . 0.0 110.822 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.4 t90 -63.56 -38.37 90.88 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.621 1.568 . . . . 0.0 110.677 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.31 -46.63 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.962 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.79 -28.41 69.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.761 -1.212 . . . . 0.0 111.456 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.77 -47.18 40.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.077 0.951 . . . . 0.0 110.686 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -71.45 -33.39 69.31 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.569 0.622 . . . . 0.0 112.04 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.1 mttm . . . . . 0 C--O 1.249 1.044 0 C-N-CA 125.292 1.437 . . . . 0.0 110.004 173.468 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 mtt . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.816 0.341 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.95 173.12 0.65 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.009 1.324 . . . . 0.0 112.24 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.39 -24.86 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.982 0.913 . . . . 0.0 110.872 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.0 mt -138.47 125.81 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.066 0.947 . . . . 0.0 109.28 -171.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -85.63 133.03 34.06 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 mp -111.58 100.33 8.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 mt -71.82 96.75 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 170.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -88.48 21.5 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.099 2.16 . . . . 0.0 112.201 -168.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 179.26 41.03 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -138.33 -27.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.643 0.777 . . . . 0.0 112.383 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 p -121.66 42.84 3.0 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp 56.12 37.33 28.73 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.449 1.5 . . . . 0.0 111.045 -169.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.06 163.24 27.15 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.265 1.888 . . . . 0.0 108.983 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -161.75 34.8 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.996 0.808 . . . . 0.0 111.336 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 60.05 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.346 1.859 . . . . 0.0 112.209 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -55.85 -31.45 62.76 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.629 0.771 . . . . 0.0 112.642 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -61.19 -42.05 97.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.236 0.926 . . . . 0.0 111.008 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.44 -39.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.568 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.55 -39.75 92.07 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.752 175.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -65.18 -38.54 90.81 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.383 -0.823 . . . . 0.0 110.699 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.94 -49.8 71.18 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.89 0.876 . . . . 0.0 110.185 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.42 -42.63 54.17 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.535 1.134 . . . . 0.0 111.117 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -54.9 -54.34 43.89 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.051 0.841 . . . . 0.0 110.157 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -60.94 -42.31 97.94 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.2 -39.94 95.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.441 0.696 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.89 -33.17 62.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.177 -0.952 . . . . 0.0 110.323 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.41 -32.16 72.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.972 0.805 . . . . 0.0 111.026 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -20.53 63.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.561 0.618 . . . . 0.0 111.518 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.95 -4.64 6.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.57 -1.128 . . . . 0.0 113.588 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -89.36 -170.79 2.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.211 1.505 . . . . 0.0 109.925 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -129.16 148.01 51.06 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -139.69 150.72 45.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.144 0.497 . . . . 0.0 111.939 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -113.57 90.7 3.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.891 1.677 . . . . 0.0 107.219 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -70.61 120.08 15.7 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -148.05 137.89 22.52 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.783 0.833 . . . . 0.0 110.725 -169.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -80.04 36.91 0.36 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.551 -1.343 . . . . 0.0 111.404 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.64 49.47 33.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.922 1.725 . . . . 0.0 114.86 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.77 -22.13 69.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.004 2.47 . . . . 0.0 113.888 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 42' ' ' GLU . 70.1 mt -128.74 12.03 6.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.03 1.732 . . . . 0.0 109.418 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 tp 62.11 -25.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.994 2.518 . . . . 0.0 114.161 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 40' ' ' LEU . 8.2 pt-20 -160.37 78.46 0.64 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.407 1.083 . . . . 0.0 108.924 -168.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.2 -46.07 85.54 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.656 -0.653 . . . . 0.0 110.032 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 mt -81.48 154.26 71.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.29 179.3 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.846 3.03 . . . . 0.0 113.584 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.84 32.25 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.116 1.766 . . . . 0.0 112.591 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.1 m -153.89 133.78 13.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.782 2.433 . . . . 0.0 106.536 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.86 -138.95 11.7 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 mm -121.24 135.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.462 ' CD1' HG21 ' A' ' 83' ' ' VAL . 6.0 m0 -125.65 138.9 53.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.5 mt -128.36 146.7 50.7 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.23 133.76 55.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -125.94 108.53 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -170.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -156.72 -163.1 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.506 1.122 . . . . 0.0 108.611 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.96 144.04 25.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.6 p -128.84 -81.64 0.57 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.289 0.95 . . . . 0.0 110.714 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -58.56 122.01 12.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.19 -7.28 81.24 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.226 0.917 . . . . 0.0 114.498 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.0 30.84 1.28 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.765 1.626 . . . . 0.0 110.32 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.66 -172.98 47.92 Favored Glycine 0 CA--C 1.525 0.676 0 O-C-N 121.433 -0.792 . . . . 0.0 113.546 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -137.78 177.63 7.73 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.573 1.949 . . . . 0.0 107.635 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.56 -52.44 63.73 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.113 1.365 . . . . 0.0 111.541 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.49 -53.29 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 121.674 1.633 . . . . 0.0 110.992 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -167.08 -60.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.989 1.316 . . . . 0.0 108.841 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -171.26 -51.8 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.914 2.486 . . . . 0.0 105.351 170.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.62 135.9 57.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -122.55 -64.4 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 117.266 -1.349 . . . . 0.0 111.375 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.6 -39.34 9.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 122.073 1.776 . . . . 0.0 110.103 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -61.22 -46.44 90.41 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.864 1.266 . . . . 0.0 110.088 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.6 -51.24 69.39 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.303 1.041 . . . . 0.0 110.399 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.55 -45.34 90.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.833 0.742 . . . . 0.0 110.98 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.76 82.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.65 -55.57 33.19 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 123.264 0.626 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -68.35 -18.98 64.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.49 -32.92 66.59 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.4 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.55 -25.3 5.58 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 32.42 63.04 1.33 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.631 1.972 . . . . 0.0 112.954 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -63.93 167.54 13.81 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.02 2.48 . . . . 0.0 113.39 -169.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -78.97 63.74 3.73 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.181 1.392 . . . . 0.0 111.454 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.07 8.85 0.66 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.757 1.223 . . . . 0.0 112.738 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 m -62.3 -6.83 3.51 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.637 2.775 . . . . 0.0 112.911 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.59 9.33 19.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.265 1.426 . . . . 0.0 111.12 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.1 p -131.31 154.63 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.824 0.738 . . . . 0.0 112.403 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -109.21 149.35 29.51 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.745 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.89 153.87 23.87 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.997 1.319 . . . . 0.0 108.059 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.16 106.65 0.46 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 106.026 -2.829 . . . . 0.0 106.026 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.08 29.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 mt -140.07 132.73 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -169.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -28.44 1.61 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.619 1.104 . . . . 0.0 113.01 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 mt -48.99 142.05 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.297 2.239 . . . . 0.0 108.778 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.3 -36.65 8.05 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 m -51.35 140.73 16.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.194 1.798 . . . . 0.0 111.0 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -158.74 172.06 18.95 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -57.84 -25.62 60.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.92 0.488 . . . . 0.0 112.051 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -144.91 105.1 4.06 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.331 1.052 . . . . 0.0 109.097 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -148.68 19.58 1.03 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.103 1.361 . . . . 0.0 109.715 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.7 t -161.31 167.68 25.41 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.956 -1.09 . . . . 0.0 109.199 -169.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -156.82 -42.36 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.093 1.357 . . . . 0.0 109.303 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.8 m -137.57 43.26 2.3 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.754 1.621 . . . . 0.0 109.437 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.94 -161.32 8.67 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.738 1.161 . . . . 0.0 110.814 -175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.67 158.25 6.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.33 0.652 . . . . 0.0 110.149 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.9 pt -134.19 167.27 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.754 0.821 . . . . 0.0 109.56 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.71 39.04 0.13 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.271 2.229 . . . . 0.0 113.719 -173.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -47.1 -44.43 21.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.515 1.126 . . . . 0.0 113.035 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.33 -53.06 62.56 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.781 0.832 . . . . 0.0 109.575 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -39.69 92.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.9 75.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.562 1.145 . . . . 0.0 110.238 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -63.26 -39.37 94.41 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.979 0.809 . . . . 0.0 110.981 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -70.14 -41.89 73.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.887 0.767 . . . . 0.0 111.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -61.69 -37.7 85.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.466 1.507 . . . . 0.0 109.223 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -37.11 73.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.078 1.351 . . . . 0.0 111.92 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -67.24 -35.92 80.57 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.108 0.563 . . . . 0.0 110.59 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.87 -28.43 0.36 Allowed Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.015 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.14 170.41 8.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.765 1.283 . . . . 0.0 110.663 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -130.36 137.28 49.82 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -72.04 124.61 25.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.8 m -86.82 154.43 20.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.78 -117.27 10.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 173.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.25 175.9 12.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.9 1.68 . . . . 0.0 107.002 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.5 m -60.04 128.21 35.7 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.52 -0.738 . . . . 0.0 110.115 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.43 HD21 ' H ' ' A' ' 122' ' ' LYS . 1.8 tt -79.88 156.49 27.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.991 1.316 . . . . 0.0 107.822 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.43 ' H ' HD21 ' A' ' 121' ' ' LEU . 7.8 mptt -126.91 140.11 52.57 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.625 1.17 . . . . 0.0 108.083 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 pp -138.36 153.65 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 109.011 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.14 17.63 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.18 24.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 125.188 1.395 . . . . 0.0 113.517 -172.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -143.26 -57.89 0.41 Allowed 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.796 1.239 . . . . 0.0 109.515 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -161.94 164.41 28.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.962 1.305 . . . . 0.0 108.342 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -60.09 160.53 7.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.385 1.074 . . . . 0.0 110.895 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.71 -69.76 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.498 ' H ' ' HD2' ' A' ' 131' ' ' PRO . 24.1 mm -142.3 -56.5 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.906 1.683 . . . . 0.0 110.659 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' A' ' 130' ' ' ILE . 70.5 Cg_endo -71.98 -38.97 3.51 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 121.904 1.716 . . . . 0.0 111.454 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 65.2 17.67 11.12 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.697 1.599 . . . . 0.0 112.081 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -154.68 114.98 2.43 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.634 1.174 . . . . 0.0 109.082 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.76 154.56 48.64 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.841 2.361 . . . . 0.0 112.062 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.63 46.9 1.68 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.367 1.067 . . . . 0.0 110.135 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -62.26 -14.69 41.27 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.155 -0.966 . . . . 0.0 113.273 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -59.92 -27.17 66.53 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.193 -0.942 . . . . 0.0 111.366 169.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.418 ' CG ' ' HG ' ' A' ' 121' ' ' LEU . 6.8 t90 -57.5 -52.35 65.73 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.618 1.167 . . . . 0.0 110.12 171.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.36 -56.21 12.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.691 1.596 . . . . 0.0 108.509 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.42 -45.37 94.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.433 0.54 . . . . 0.0 112.656 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.4 m -62.19 -60.44 3.59 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.237 1.415 . . . . 0.0 110.457 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -52.93 -41.65 64.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.115 1.766 . . . . 0.0 111.567 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.12 -57.65 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.783 0.833 . . . . 0.0 109.946 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -14.43 62.48 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.47 -0.769 . . . . 0.0 112.398 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.0 mp -80.78 -49.15 11.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 110.782 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.19 -33.62 70.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 111.596 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.519 1.127 . . . . 0.0 109.647 173.917 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.93 164.31 38.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.117 0.967 . . . . 0.0 110.157 -172.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -98.51 -22.83 15.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.778 1.231 . . . . 0.0 110.887 169.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 mt -131.95 126.22 56.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 t -90.98 128.28 36.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -95.76 103.93 15.84 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -96.43 86.84 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 159.16 16.27 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 111.646 -169.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.73 79.56 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.15 -45.02 8.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.228 2.211 . . . . 0.0 115.531 -169.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.7 m -127.89 54.72 1.69 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt 52.91 37.0 23.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.545 1.938 . . . . 0.0 111.929 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.78 4.5 69.4 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.645 1.117 . . . . 0.0 113.235 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.55 -79.39 1.84 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.817 1.199 . . . . 0.0 111.118 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.7 18.08 0.45 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.354 1.862 . . . . 0.0 113.889 -169.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.31 -26.03 67.12 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.354 -0.841 . . . . 0.0 111.834 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.97 -47.65 84.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.73 0.695 . . . . 0.0 110.584 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.65 -38.77 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.3 80.32 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.838 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.58 -40.46 76.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.868 0.758 . . . . 0.0 110.357 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -62.48 -47.69 82.87 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.949 -0.47 . . . . 0.0 110.238 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.18 -51.66 67.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.402 1.081 . . . . 0.0 110.868 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.58 -41.05 66.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.748 0.819 . . . . 0.0 111.393 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -58.09 -47.78 82.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.421 1.009 . . . . 0.0 111.079 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -58.04 -44.32 87.34 Favored 'General case' 0 C--N 1.337 0.034 0 C-N-CA 122.671 0.389 . . . . 0.0 111.308 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.29 -33.02 74.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.56 -45.55 78.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.018 0.826 . . . . 0.0 109.581 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -71.2 -17.3 62.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.813 0.733 . . . . 0.0 112.157 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.04 -15.5 62.03 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.919 0.781 . . . . 0.0 111.442 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.98 22.41 5.96 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.491 169.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -129.08 171.87 11.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.59 1.195 . . . . 0.0 110.28 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 p -105.71 154.47 20.42 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -141.53 155.23 45.81 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.771 -0.581 . . . . 0.0 111.449 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.71 93.51 4.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -70.53 120.95 16.92 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.7 mt -148.51 170.16 18.68 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 124.37 1.068 . . . . 0.0 109.477 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -110.23 37.81 2.61 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.133 1.773 . . . . 0.0 108.603 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.53 48.77 22.01 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.842 1.686 . . . . 0.0 115.086 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.56 -20.5 69.59 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 CA-C-N 121.083 2.442 . . . . 0.0 114.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 42' ' ' GLU . 80.4 mt -122.99 13.25 9.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 109.701 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.84 -28.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.278 2.631 . . . . 0.0 112.649 -169.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 40' ' ' LEU . 9.0 pt-20 -160.37 88.24 0.79 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.371 1.469 . . . . 0.0 107.674 -168.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.36 -43.21 82.02 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.64 154.08 68.18 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.56 -175.53 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.176 3.25 . . . . 0.0 113.186 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 33.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.799 1.64 . . . . 0.0 112.574 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -158.14 135.92 10.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.605 1.962 . . . . 0.0 106.801 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.48 -140.27 11.9 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.88 134.24 66.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -118.96 133.25 55.94 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -122.95 137.91 54.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.1 t -122.11 126.23 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -175.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.02 67.08 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -169.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -135.31 48.48 2.25 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.726 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.1 m -30.79 98.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.977 2.911 . . . . 0.0 115.652 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -57.35 -42.31 81.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.795 1.638 . . . . 0.0 111.92 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 48.44 176.33 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.247 3.019 . . . . 0.0 115.425 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.96 38.1 1.09 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.3 1.429 . . . . 0.0 114.702 -169.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.52 -34.26 0.12 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.068 1.347 . . . . 0.0 111.259 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.54 -156.2 17.1 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 118.378 0.535 . . . . 0.0 111.975 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -146.49 171.36 15.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.314 1.446 . . . . 0.0 107.749 169.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 91.9 mt -45.85 -52.54 24.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.69 1.596 . . . . 0.0 112.82 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.59 -43.6 1.89 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 CA-C-N 121.907 1.717 . . . . 0.0 111.527 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -174.42 -60.62 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.216 1.807 . . . . 0.0 107.691 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 168.02 -54.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 130.249 3.42 . . . . 0.0 104.282 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.46 146.12 52.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -122.3 -65.6 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 117.279 -1.344 . . . . 0.0 110.578 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.25 -41.37 7.07 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.862 1.701 . . . . 0.0 110.171 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -61.09 -48.5 81.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.453 1.101 . . . . 0.0 109.436 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -62.03 -49.55 75.56 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.298 0.499 . . . . 0.0 110.694 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.18 -43.79 98.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.591 0.632 . . . . 0.0 110.512 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -29.49 69.28 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.87 -57.45 11.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.559 1.072 . . . . 0.0 108.96 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -62.99 -26.01 68.65 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.1 -31.56 72.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.966 0.506 . . . . 0.0 111.424 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.99 -26.76 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.943 -1.027 . . . . 0.0 113.768 -175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 31.48 62.99 1.14 Allowed Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 126.291 1.837 . . . . 0.0 112.148 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.21 162.31 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.875 2.383 . . . . 0.0 113.466 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.74 67.43 4.47 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.0 111.131 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 15.17 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.607 1.563 . . . . 0.0 112.811 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.0 p -64.13 -5.37 4.7 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.147 -1.596 . . . . 0.0 112.426 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.58 10.55 14.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.282 1.833 . . . . 0.0 111.004 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.51 149.66 33.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.831 0.825 . . . . 0.0 111.131 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.1 ptm85 -100.57 151.26 21.8 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.55 110.25 0.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.46 136.61 44.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.439 ' C ' ' H ' ' A' ' 90' ' ' ILE . 15.0 mt -138.1 129.7 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.12 -25.59 2.63 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.837 0.732 . . . . 0.0 111.962 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.439 ' H ' ' C ' ' A' ' 88' ' ' ILE . 27.3 mm -48.57 134.78 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 127.5 2.32 . . . . 0.0 106.752 168.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.72 -21.87 4.51 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.957 0.789 . . . . 0.0 111.993 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -48.39 -29.1 3.67 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 128.46 2.704 . . . . 0.0 114.331 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.58 -45.11 73.5 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.547 0.739 . . . . 0.0 111.672 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 178.12 -46.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.305 1.442 . . . . 0.0 110.768 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -56.78 -30.15 63.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -148.74 50.39 0.99 Allowed 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.1 t -76.47 176.94 7.79 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.944 0.878 . . . . 0.0 110.782 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -132.18 76.57 1.71 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.466 -2.049 . . . . 0.0 105.466 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.4 m 50.42 27.81 2.98 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.204 1.802 . . . . 0.0 113.855 -175.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.22 -1.04 28.46 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.97 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.12 -1.52 7.94 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.629 1.715 . . . . 0.0 113.086 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.7 pt -126.27 9.25 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.885 2.074 . . . . 0.0 110.862 -172.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.83 -9.4 14.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.594 1.158 . . . . 0.0 112.206 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -53.21 -44.59 68.12 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 126.493 1.917 . . . . 0.0 112.056 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.53 -57.39 12.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.749 0.704 . . . . 0.0 110.43 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.9 -39.14 93.49 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.31 74.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.053 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.61 -36.46 83.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.271 0.941 . . . . 0.0 111.183 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.7 mt -65.23 -45.0 86.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.06 0.845 . . . . 0.0 110.738 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -68.57 -36.03 78.18 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 123.796 0.838 . . . . 0.0 110.021 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -37.81 87.33 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.193 1.397 . . . . 0.0 111.058 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -39.85 83.82 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.23 -17.54 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.195 169.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.19 137.12 53.0 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.656 1.728 . . . . 0.0 109.777 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.35 110.19 17.29 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -65.74 111.99 3.48 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.7 m -88.4 152.51 21.86 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.66 -124.27 35.52 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.06 157.59 43.29 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 62.4 m -46.17 127.78 8.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.31 1.844 . . . . 0.0 112.541 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.09 160.88 19.88 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.242 1.417 . . . . 0.0 108.512 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -134.59 146.85 49.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.02 170.15 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 126.824 2.05 . . . . 0.0 109.116 -172.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -135.55 170.1 16.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.506 1.923 . . . . 0.0 106.504 169.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.5 tt -108.32 4.89 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.522 0.729 . . . . 0.0 110.66 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.7 mt 70.39 -42.01 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 129.441 3.097 . . . . 0.0 112.132 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.04 -24.36 65.99 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.968 0.907 . . . . 0.0 110.667 169.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -154.66 172.16 18.34 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.0 1.72 . . . . 0.0 108.478 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -140.81 153.12 45.67 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.908 2.083 . . . . 0.0 108.204 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 mm -130.07 -70.17 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 116.706 -1.616 . . . . 0.0 109.831 -171.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.16 -56.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 CA-C-N 122.379 1.885 . . . . 0.0 111.449 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -174.39 -176.44 1.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.708 2.803 . . . . 0.0 106.499 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.85 117.95 56.26 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.118 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.14 174.98 11.93 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.779 2.986 . . . . 0.0 112.082 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.93 139.73 29.3 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.369 1.068 . . . . 0.0 108.766 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.29 -16.1 63.76 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.081 0.953 . . . . 0.0 112.172 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.9 -30.19 65.69 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.868 0.867 . . . . 0.0 111.487 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -42.94 97.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.035 0.834 . . . . 0.0 111.23 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -51.94 66.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.803 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.26 -43.24 95.61 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.816 0.722 . . . . 0.0 112.422 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.9 m -59.57 -60.64 3.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.068 1.347 . . . . 0.0 109.996 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -57.37 -43.87 83.91 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.207 0.603 . . . . 0.0 112.097 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.6 t -61.49 -52.89 55.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 C-N-CA 123.201 0.6 . . . . 0.0 109.955 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -16.15 63.02 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.628 1.104 . . . . 0.0 112.129 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.08 -44.85 21.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.482 0.713 . . . . 0.0 111.252 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.35 73.67 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.965 0.802 . . . . 0.0 111.462 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 53.7 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.317 1.447 . . . . 0.0 109.72 174.436 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.85 164.08 37.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.342 1.057 . . . . 0.0 110.079 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.43 -24.36 18.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.445 1.498 . . . . 0.0 110.924 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.41 124.23 44.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.666 1.186 . . . . 0.0 108.3 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -85.74 132.91 34.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.68 92.01 3.88 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -77.81 111.56 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -127.83 -162.7 1.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.258 1.823 . . . . 0.0 107.168 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 28.89 58.59 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.785 -1.197 . . . . 0.0 112.266 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -32.92 -48.97 0.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.975 2.91 . . . . 0.0 115.136 -170.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -125.83 51.72 1.73 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 108.05 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.3 tp 58.69 31.27 20.97 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.976 1.71 . . . . 0.0 110.188 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.81 154.54 8.21 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 128.027 2.727 . . . . 0.0 107.586 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.08 -160.03 22.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.049 0.924 . . . . 0.0 110.914 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.14 41.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.612 1.565 . . . . 0.0 112.541 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.9 -32.16 65.62 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.17 -0.956 . . . . 0.0 112.542 -172.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.93 -42.54 98.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.845 0.748 . . . . 0.0 110.833 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 t -72.75 -39.58 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.16 -39.88 83.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.24 0.473 . . . . 0.0 110.875 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.56 -40.49 92.87 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.893 0.77 . . . . 0.0 110.94 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -64.15 -44.73 91.23 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 110.295 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.92 -50.03 75.59 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.635 1.174 . . . . 0.0 110.498 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.58 -47.8 63.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.274 1.03 . . . . 0.0 110.807 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.31 -52.75 64.08 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.558 0.743 . . . . 0.0 110.595 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm -56.16 -39.0 71.66 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.886 0.474 . . . . 0.0 112.029 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.7 mt -73.49 -26.39 60.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.429 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.05 -38.73 72.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 120.566 1.53 . . . . 0.0 109.55 169.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -62.32 -26.19 68.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 111.409 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.65 55.1 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.549 174.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.21 23.93 6.76 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.163 0.892 . . . . 0.0 113.334 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.73 -169.44 2.05 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.404 1.082 . . . . 0.0 109.277 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 p -128.35 149.14 50.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.0 p -141.63 154.86 45.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.89 0.376 . . . . 0.0 111.223 -169.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.82 94.95 4.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.196 0.999 . . . . 0.0 108.413 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -68.65 120.87 15.34 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.8 mt -145.63 143.56 29.92 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 122.551 0.341 . . . . 0.0 111.158 -170.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -88.28 33.25 0.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 169.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.91 55.85 7.1 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.577 2.036 . . . . 0.0 114.38 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.84 -20.46 68.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.032 2.488 . . . . 0.0 113.695 -174.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 42' ' ' GLU . 78.0 mt -123.56 17.99 9.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.07 1.748 . . . . 0.0 109.066 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.9 tp 64.48 -30.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.399 2.68 . . . . 0.0 113.79 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 40' ' ' LEU . 6.9 pt-20 -165.4 87.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.412 1.885 . . . . 0.0 106.539 -169.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.18 -41.52 97.08 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.9 -0.5 . . . . 0.0 110.446 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt -89.11 150.04 44.34 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.25 -175.83 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.162 3.241 . . . . 0.0 113.116 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.58 33.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 112.43 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -158.68 134.55 8.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.86 2.064 . . . . 0.0 106.351 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.15 -142.86 13.86 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.41 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -123.39 151.79 42.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.8 mt -137.74 142.67 40.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.47 126.99 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.37 108.21 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -145.76 -166.89 2.56 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.828 0.851 . . . . 0.0 109.281 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 p -156.28 66.06 0.57 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 122.2 1.0 . . . . 0.0 112.194 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p -62.98 -36.78 84.65 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.307 0.643 . . . . 0.0 111.763 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -65.86 -43.9 87.02 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.306 0.642 . . . . 0.0 111.759 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.03 -33.65 26.07 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.579 -0.567 . . . . 0.0 113.531 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.14 33.84 0.82 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.345 1.058 . . . . 0.0 111.047 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -50.22 147.38 7.62 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -146.3 170.09 17.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 117.303 0.551 . . . . 0.0 110.925 -169.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.9 mm -50.59 -49.73 76.66 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.911 1.684 . . . . 0.0 112.732 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.31 -55.89 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 122.049 1.768 . . . . 0.0 110.339 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -168.74 -51.21 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.835 1.254 . . . . 0.0 109.195 169.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -171.43 -55.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.372 1.469 . . . . 0.0 109.012 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 mp -70.5 137.01 49.86 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 170.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.74 -62.87 0.21 Allowed Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.142 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.35 -39.83 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 121.733 1.622 . . . . 0.0 111.745 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -63.48 -46.1 87.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 122.86 0.464 . . . . 0.0 110.537 -171.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -60.81 -48.54 81.32 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.927 0.331 . . . . 0.0 110.207 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -62.34 -45.79 91.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.137 0.426 . . . . 0.0 110.259 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.07 79.31 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.378 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.89 -55.65 31.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.241 0.928 . . . . 0.0 108.937 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.32 -27.67 68.66 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.21 -31.25 69.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.707 0.403 . . . . 0.0 111.648 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -122.4 -25.26 4.83 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 29.54 63.41 0.82 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 126.996 2.118 . . . . 0.0 112.307 -173.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.67 164.45 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.898 2.399 . . . . 0.0 113.063 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -77.57 64.91 2.98 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.266 1.426 . . . . 0.0 111.239 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.46 9.03 1.15 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.037 1.335 . . . . 0.0 112.601 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -61.45 -6.39 2.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.213 2.605 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.62 10.38 18.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.99 1.716 . . . . 0.0 111.03 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.14 153.62 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.783 0.719 . . . . 0.0 111.292 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -103.56 150.41 23.97 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 169.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -122.58 159.01 28.68 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.96 140.37 11.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 169.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.46 141.65 43.28 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mt -139.09 138.85 40.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.53 -30.43 2.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.721 1.153 . . . . 0.0 111.766 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 mt -50.64 127.34 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.867 2.067 . . . . 0.0 106.974 169.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.55 -13.77 40.09 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.603 0.621 . . . . 0.0 112.877 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 m -48.82 -27.37 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 128.636 2.774 . . . . 0.0 116.602 -169.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -72.89 -20.71 61.04 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.992 0.814 . . . . 0.0 112.004 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -140.98 -23.23 0.77 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -128.53 155.23 45.19 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.908 1.283 . . . . 0.0 111.609 -169.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.61 35.62 8.97 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.079 2.152 . . . . 0.0 114.139 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.0 p -119.97 18.79 12.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.557 1.543 . . . . 0.0 110.561 173.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -71.07 -25.95 62.85 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.532 1.133 . . . . 0.0 111.929 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 12.6 p -148.48 23.73 1.01 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.121 1.368 . . . . 0.0 111.572 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.27 -172.69 42.95 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.6 143.7 41.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.389 1.076 . . . . 0.0 109.183 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.7 pt -144.75 24.2 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.995 1.718 . . . . 0.0 109.798 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -106.4 9.85 31.67 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.835 1.254 . . . . 0.0 111.757 -171.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -65.94 -29.39 69.78 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.516 -169.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -53.84 -57.31 11.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.331 0.968 . . . . 0.0 109.622 172.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.51 -40.63 97.56 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -48.59 81.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.859 0.464 . . . . 0.0 110.202 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.78 -31.86 72.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.687 -1.149 . . . . 0.0 111.739 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.9 mt -66.68 -44.27 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.101 1.318 . . . . 0.0 110.78 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -63.15 -40.47 97.67 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.656 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -36.81 83.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.157 1.383 . . . . 0.0 111.303 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.9 m -70.86 -39.79 72.7 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.84 -20.45 0.68 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.101 -1.388 . . . . 0.0 114.881 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 136.65 54.89 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.568 1.684 . . . . 0.0 108.834 -172.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -79.25 126.97 31.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -74.51 112.73 10.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.5 m -85.46 154.94 21.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.29 -125.38 37.49 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.6 pt-20 -154.41 169.0 24.79 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.269 1.428 . . . . 0.0 107.592 169.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.9 m -51.98 129.92 28.31 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.07 146.15 23.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.505 1.922 . . . . 0.0 107.405 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -121.56 145.88 47.52 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.7 154.82 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.303 1.441 . . . . 0.0 107.782 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.03 176.45 9.33 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.603 -0.685 . . . . 0.0 111.576 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.4 pt -129.24 -22.88 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.054 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.3 tt -158.27 -66.73 0.09 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.939 1.245 . . . . 0.0 108.753 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -148.16 -13.58 0.36 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.25 1.02 . . . . 0.0 112.338 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -148.95 156.14 41.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -159.57 -63.95 0.07 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 mm -133.87 -62.11 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 111.318 -2.674 . . . . 0.0 105.607 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -90.54 -137.46 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.882 0 N-CA-C 105.906 -2.382 . . . . 0.0 105.906 168.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.33 -1.8 0.91 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -152.43 122.1 3.41 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 118.228 -0.892 . . . . 0.0 108.846 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.58 152.39 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.234 1.956 . . . . 0.0 110.167 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -138.71 39.62 2.19 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.517 1.127 . . . . 0.0 109.852 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -52.41 -28.58 20.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.58 1.552 . . . . 0.0 113.235 -173.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.21 -28.63 42.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.382 1.073 . . . . 0.0 112.331 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.428 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -55.95 -41.76 75.18 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.487 0.715 . . . . 0.0 110.849 173.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 tp -61.63 -50.11 73.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.69 72.42 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.99 0.806 . . . . 0.0 111.822 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 m -60.01 -57.05 14.54 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -53.11 -44.67 67.82 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.505 1.522 . . . . 0.0 111.691 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -56.5 -58.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 110.077 173.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -16.73 63.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.307 0.958 . . . . 0.0 112.176 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.03 -50.32 15.12 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.099 0.959 . . . . 0.0 110.432 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.35 -27.21 59.11 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.494 1.118 . . . . 0.0 109.634 171.102 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 tpp . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.29 148.23 32.2 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.221 1.008 . . . . 0.0 108.365 170.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.64 -22.97 15.2 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.607 1.563 . . . . 0.0 110.438 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.35 130.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 109.214 -172.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 t -86.2 130.25 34.58 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 169.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.9 94.21 4.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -87.2 98.15 7.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 51.93 2.3 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.82 8.55 59.43 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 117.306 -1.83 . . . . 0.0 115.098 -169.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.0 -42.71 2.92 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.032 1.733 . . . . 0.0 113.983 -169.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 t -149.17 53.09 0.96 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 169.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tp 56.33 38.99 30.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.468 1.507 . . . . 0.0 110.699 -169.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.43 154.38 7.43 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.202 2.81 . . . . 0.0 107.073 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.95 -151.16 6.9 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.928 0.864 . . . . 0.0 110.951 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 65.76 1.21 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.323 1.449 . . . . 0.0 111.0 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -53.74 -37.37 63.3 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.64 0.776 . . . . 0.0 112.63 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -59.81 -45.13 93.3 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.441 0.564 . . . . 0.0 110.255 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -32.69 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.61 97.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.658 0.663 . . . . 0.0 110.853 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.42 -39.55 89.02 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.994 0.518 . . . . 0.0 110.681 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -62.86 -46.51 87.55 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.469 -0.77 . . . . 0.0 110.501 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.8 mt -55.77 -52.68 63.12 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.486 1.114 . . . . 0.0 109.92 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.82 -52.09 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.165 0.986 . . . . 0.0 110.532 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -55.34 -54.26 45.84 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.358 0.663 . . . . 0.0 110.775 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -59.88 -38.87 83.45 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -68.96 -32.7 72.48 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.157 0.583 . . . . 0.0 111.691 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.58 -37.35 71.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.757 1.162 . . . . 0.0 110.152 173.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -63.6 -29.77 70.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 111.217 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.77 -21.74 62.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.562 0.745 . . . . 0.0 111.259 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.02 -5.01 5.37 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.062 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.52 -167.07 1.55 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.686 1.743 . . . . 0.0 109.602 -174.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 p -130.19 151.09 51.09 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.9 p -143.74 160.28 41.0 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -170.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 106.31 8.93 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -71.94 121.09 18.48 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 mt -139.11 157.98 44.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.401 0.68 . . . . 0.0 110.71 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -95.23 21.88 7.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.421 1.088 . . . . 0.0 110.766 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.11 42.89 73.01 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 117.912 -1.493 . . . . 0.0 113.139 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.12 -22.29 61.83 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.201 2.601 . . . . 0.0 114.825 -169.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 42' ' ' GLU . 84.5 mt -115.24 13.53 16.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.523 1.529 . . . . 0.0 109.666 -177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 tp 65.57 -25.69 0.1 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.016 2.527 . . . . 0.0 112.916 -169.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.0 pt-20 -169.13 85.81 0.15 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.034 1.734 . . . . 0.0 107.331 -169.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.44 -42.9 98.66 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.594 -0.691 . . . . 0.0 110.249 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -90.81 149.32 40.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.38 -179.33 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.919 3.079 . . . . 0.0 113.449 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.83 30.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.671 1.988 . . . . 0.0 113.102 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.7 p -161.72 107.83 1.33 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.367 1.867 . . . . 0.0 106.393 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.38 -147.48 16.75 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mm -127.53 131.72 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -119.69 152.75 36.64 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.3 mt -143.59 141.16 30.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.16 136.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.66 123.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -162.43 -172.86 3.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 108.158 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.98 69.77 1.03 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.535 -1.353 . . . . 0.0 108.088 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 p -50.97 -27.04 6.81 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.591 1.957 . . . . 0.0 115.657 -169.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -127.3 25.44 6.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.879 0.872 . . . . 0.0 111.525 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.58 -30.92 0.28 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.146 0.879 . . . . 0.0 112.307 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.79 34.37 2.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.736 1.615 . . . . 0.0 108.913 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.33 -175.69 40.46 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.38 0.99 . . . . 0.0 112.817 -174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -145.47 153.36 41.07 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.6 pt -53.31 -35.61 28.75 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.72 -31.01 8.95 Favored 'Trans proline' 0 C--N 1.356 0.953 0 CA-C-N 123.894 2.426 . . . . 0.0 111.768 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -176.06 -57.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.391 1.876 . . . . 0.0 107.579 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.3 t30 136.48 -55.77 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 130.389 3.476 . . . . 0.0 107.335 -175.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.42 84.43 0.27 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 126.629 1.972 . . . . 0.0 106.701 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -54.4 25.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 124.54 1.136 . . . . 0.0 111.091 -168.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.18 -41.85 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.118 1.879 . . . . 0.0 110.776 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -65.62 -50.96 63.11 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.209 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.95 -44.9 95.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.954 0.797 . . . . 0.0 110.023 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.44 -47.16 80.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.254 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.03 -35.91 74.09 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.204 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -59.59 5.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.603 1.092 . . . . 0.0 109.266 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -16.82 63.73 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.25 -32.55 70.43 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.415 0.552 . . . . 0.0 111.259 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -124.23 -29.35 3.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt 28.98 66.64 0.68 Allowed Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 126.482 1.913 . . . . 0.0 113.251 -171.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.08 173.28 2.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.558 2.172 . . . . 0.0 111.381 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -84.98 124.45 31.71 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.35 14.59 10.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.069 1.348 . . . . 0.0 110.657 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -69.07 -3.88 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 119.82 -1.8 . . . . 0.0 112.81 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.25 4.59 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.034 1.334 . . . . 0.0 110.789 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.78 157.36 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.886 0.874 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -113.38 149.43 34.09 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -128.01 164.82 21.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.546 0.689 . . . . 0.0 109.507 174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.1 153.73 21.96 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.62 136.66 53.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.24 135.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -169.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.82 -27.35 1.64 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.081 1.324 . . . . 0.0 112.709 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 mt -48.35 130.04 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.048 2.139 . . . . 0.0 109.273 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -95.03 7.26 69.69 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.027 1.299 . . . . 0.0 111.759 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m -82.15 6.42 16.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.602 1.561 . . . . 0.0 113.161 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -51.73 -46.05 63.85 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.953 1.301 . . . . 0.0 114.138 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -140.94 -79.92 0.26 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.338 0.655 . . . . 0.0 110.778 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -141.69 11.72 2.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.247 1.019 . . . . 0.0 112.786 -169.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -79.18 37.84 0.33 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.135 0.974 . . . . 0.0 110.645 175.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.2 p -69.15 160.08 31.75 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.984 1.714 . . . . 0.0 112.309 -171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -154.55 -174.79 5.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.157 2.183 . . . . 0.0 106.401 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 61.9 m -66.22 79.32 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.645 1.178 . . . . 0.0 109.265 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -161.05 -150.1 5.8 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.244 1.402 . . . . 0.0 110.329 -171.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.63 -30.65 71.73 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -169.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . 0.267 47.1 pt 42.0 48.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.375 1.47 . . . . 0.0 112.332 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.7 t70 81.2 -16.82 0.61 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.337 2.655 . . . . 0.0 113.904 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.25 -35.24 76.72 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.993 -1.067 . . . . 0.0 113.039 -171.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.22 -54.74 40.42 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.253 0.933 . . . . 0.0 109.894 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -40.12 95.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.9 88.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.334 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.28 -34.32 77.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.222 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.14 -43.87 85.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.724 1.147 . . . . 0.0 110.5 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -65.03 -37.43 87.57 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 109.911 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -35.12 79.09 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.562 . . . . 0.0 111.282 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.9 m -72.4 -27.29 62.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.562 0.345 . . . . 0.0 110.229 178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.28 -23.46 2.86 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.541 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 135.57 54.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.2 1.5 . . . . 0.0 108.554 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -80.78 132.62 35.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -77.87 100.0 6.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 m -73.91 153.21 39.92 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.04 -122.06 24.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.519 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.8 pt-20 -157.47 174.78 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.981 1.712 . . . . 0.0 107.831 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -54.34 127.84 28.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.809 0.844 . . . . 0.0 109.537 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 tt -99.24 155.27 17.58 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.641 1.576 . . . . 0.0 108.834 -171.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.65 147.85 44.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.65 167.46 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.318 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.84 143.48 24.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 169.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.8 pt -76.73 -171.04 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.815 0.846 . . . . 0.0 110.464 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.25 1.07 0.53 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.62 1.568 . . . . 0.0 114.915 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -147.81 160.23 42.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.219 2.208 . . . . 0.0 106.523 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -56.59 138.67 51.84 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.78 0.832 . . . . 0.0 111.281 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -152.76 167.97 27.24 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.207 1.403 . . . . 0.0 110.074 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.28 49.6 mm -5.98 -77.2 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 130.529 3.532 . . . . 0.0 116.877 -169.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.28 -30.4 8.54 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.489 2.126 . . . . 0.0 111.971 -172.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 62.88 40.59 9.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.045 2.138 . . . . 0.0 109.991 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -147.66 101.14 3.72 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.726 1.211 . . . . 0.0 109.33 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.03 -15.55 34.15 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.845 3.03 . . . . 0.0 115.522 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 36.73 50.18 0.81 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.793 2.437 . . . . 0.0 114.603 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.79 -28.59 64.15 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.472 -0.768 . . . . 0.0 111.182 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.18 -36.91 82.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.634 0.774 . . . . 0.0 111.327 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.519 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.88 -44.88 91.7 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.135 0.879 . . . . 0.0 109.214 174.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.24 -51.63 68.16 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.11 -42.12 98.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.403 0.525 . . . . 0.0 112.111 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 m -58.54 -61.58 2.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 0.0 109.821 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -55.2 -46.06 75.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.7 0.8 . . . . 0.0 112.277 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.03 -54.62 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.556 0.742 . . . . 0.0 109.387 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -16.8 61.94 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.004 0.82 . . . . 0.0 112.471 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 mp -80.74 -44.18 19.06 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.329 0.652 . . . . 0.0 111.034 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -37.05 75.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.923 0.783 . . . . 0.0 110.976 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.7 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.938 1.295 . . . . 0.0 109.93 174.198 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.18 170.07 22.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.934 1.294 . . . . 0.0 109.29 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.64 -23.32 17.66 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.591 1.157 . . . . 0.0 110.895 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.92 127.74 55.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 108.946 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -92.33 129.3 38.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.99 98.63 8.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.83 89.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -92.12 49.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.598 2.359 . . . . 0.0 111.079 -168.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.85 174.26 46.7 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 121.45 -0.781 . . . . 0.0 112.558 175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.8 p -129.34 -48.21 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.621 1.168 . . . . 0.0 110.299 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 p -86.44 -72.21 0.51 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.4 tp -157.14 23.36 0.31 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 110.379 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.94 169.29 42.19 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.37 46.5 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.047 1.784 . . . . 0.0 108.809 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 102.61 0.45 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.303 1.041 . . . . 0.0 111.533 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.97 -38.64 89.3 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.515 0.726 . . . . 0.0 110.637 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.35 -42.59 91.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.283 0.633 . . . . 0.0 110.705 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.14 -49.33 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.96 93.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.104 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.91 -41.35 91.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.008 0.523 . . . . 0.0 110.819 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -61.99 -47.77 83.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.65 0.659 . . . . 0.0 110.066 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.42 -53.43 57.54 Favored 'General case' 0 N--CA 1.46 0.039 0 C-N-CA 124.057 0.943 . . . . 0.0 110.173 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.35 59.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.256 1.022 . . . . 0.0 110.712 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.17 -54.51 46.12 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -58.3 -37.3 74.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -70.81 -28.07 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.859 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.71 -39.65 73.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.632 1.56 . . . . 0.0 109.804 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.57 -28.17 69.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.463 0.705 . . . . 0.0 111.332 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.34 -10.82 60.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 112.348 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 16.92 8.7 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.912 -0.938 . . . . 0.0 113.424 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -117.73 -167.9 1.41 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.485 1.142 . . . . 0.0 108.84 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -130.82 150.29 52.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 p -140.84 156.99 46.01 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.911 -0.493 . . . . 0.0 110.446 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -133.15 105.47 7.05 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.09 122.79 21.55 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.386 1.074 . . . . 0.0 108.533 175.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -149.75 138.59 21.0 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 122.79 0.436 . . . . 0.0 111.014 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -85.48 43.86 1.06 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.667 -1.27 . . . . 0.0 108.393 168.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.31 56.21 1.2 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 127.358 2.408 . . . . 0.0 115.757 -169.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.62 -24.78 46.97 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.343 2.572 . . . . 0.0 115.367 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 42' ' ' GLU . 85.4 mt -118.45 15.58 13.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.977 1.711 . . . . 0.0 109.363 -176.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp 66.06 -30.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.506 2.722 . . . . 0.0 113.106 -169.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.3 pt-20 -168.13 94.45 0.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.334 1.854 . . . . 0.0 106.342 -169.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.29 -44.35 83.73 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.95 153.02 69.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.812 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.65 -171.51 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.443 3.428 . . . . 0.0 112.231 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.35 27.61 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.852 1.661 . . . . 0.0 113.42 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -156.49 138.0 14.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.99 2.116 . . . . 0.0 106.81 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.41 -140.4 11.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mm -128.46 133.83 65.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -117.71 135.31 54.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.9 mt -128.95 142.37 50.96 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.93 133.08 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.29 104.58 6.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 123.791 0.836 . . . . 0.0 108.856 -169.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -171.56 131.1 0.71 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.574 1.949 . . . . 0.0 107.409 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.7 m -72.36 102.41 3.14 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 119.113 0.869 . . . . 0.0 108.686 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p -56.25 -16.77 5.92 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 115.349 -169.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -116.42 -54.14 2.48 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.714 1.143 . . . . 0.0 110.235 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.87 61.11 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.059 0.838 . . . . 0.0 114.417 -174.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.53 39.01 2.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.7 2.0 . . . . 0.0 108.357 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.29 -141.97 3.28 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.654 1.121 . . . . 0.0 110.868 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 t70 44.22 -53.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 1 C-N-CA 132.231 4.212 . . . . 0.0 117.962 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.7 mm -51.57 -49.95 79.78 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 120.16 1.346 . . . . 0.0 112.601 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.94 43.06 1.4 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.292 2.662 . . . . 0.0 110.969 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.5 t0 52.42 32.03 10.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.93 1.692 . . . . 0.0 110.686 -168.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.97 -51.38 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 129.673 3.189 . . . . 0.0 113.777 -169.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.34 147.74 51.85 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.286 1.434 . . . . 0.0 107.263 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 -61.28 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.527 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -87.91 -40.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.449 2.1 . . . . 0.0 112.418 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -59.58 -52.65 64.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -62.99 -43.92 97.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.923 0.329 . . . . 0.0 110.458 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -63.54 -46.91 83.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.068 0.394 . . . . 0.0 109.969 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.75 71.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.522 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.3 -58.0 10.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.374 0.988 . . . . 0.0 109.079 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -62.64 -26.41 68.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.95 -30.77 71.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.072 0.549 . . . . 0.0 111.658 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -124.91 -23.8 4.2 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 30.78 66.4 0.87 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.65 1.98 . . . . 0.0 112.056 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -57.89 160.5 15.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.404 2.736 . . . . 0.0 113.123 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -79.9 61.12 3.71 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 122.37 1.081 . . . . 0.0 110.779 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.2 mt -71.63 10.47 0.65 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.772 1.629 . . . . 0.0 112.792 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -62.46 -7.42 4.51 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 129.665 3.186 . . . . 0.0 113.042 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.83 11.31 17.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.577 1.551 . . . . 0.0 110.791 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 p -130.28 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.966 0.889 . . . . 0.0 111.154 173.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -95.01 151.02 19.53 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.88 145.47 45.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.47 115.23 1.33 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 140.0 47.33 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.6 mt -137.32 128.34 40.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.99 -10.92 2.15 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.314 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mt -48.52 129.93 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.791 2.036 . . . . 0.0 109.465 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.67 -20.35 66.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.243 0.925 . . . . 0.0 112.163 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -56.08 -6.17 0.23 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.953 2.501 . . . . 0.0 114.95 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -63.2 -15.64 57.6 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.65 168.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 101.87 -23.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 131.176 3.791 . . . . 0.0 110.109 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -64.21 -14.75 57.44 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.611 1.565 . . . . 0.0 112.871 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.06 86.51 1.98 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.387 1.075 . . . . 0.0 108.849 171.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.5 t -159.76 168.5 25.76 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.498 1.119 . . . . 0.0 108.092 169.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -146.02 11.58 1.21 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.033 1.733 . . . . 0.0 109.342 169.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.1 m -135.59 26.19 3.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.514 1.126 . . . . 0.0 112.084 -169.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.27 -173.33 35.77 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.73 -27.34 67.85 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.2 pt 43.74 33.98 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.629 1.971 . . . . 0.0 113.59 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -83.7 2.29 38.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.62 1.168 . . . . 0.0 113.071 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -54.85 -37.8 66.67 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.185 0.994 . . . . 0.0 112.785 -171.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.56 -54.18 46.48 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.71 -41.81 95.97 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.84 76.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -67.78 -30.88 70.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.168 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.84 -44.07 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.755 1.161 . . . . 0.0 110.769 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.06 -35.06 73.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.432 0.693 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -32.21 71.4 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 125.954 1.702 . . . . 0.0 111.902 174.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.8 m -64.76 -48.35 74.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.6 -15.74 0.38 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.059 -1.412 . . . . 0.0 115.393 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.05 138.46 58.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.588 1.694 . . . . 0.0 110.61 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -84.03 111.53 19.37 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.64 111.76 2.89 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 42.5 m -84.17 152.51 24.23 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.96 -121.31 26.24 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.535 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 3.0 pt-20 -150.3 -176.35 5.44 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.909 2.083 . . . . 0.0 106.049 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -41.36 111.46 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.622 1.569 . . . . 0.0 111.376 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 161.54 28.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -133.79 149.37 51.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -170.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.44 155.92 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.74 52.05 0.28 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -172.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.9 tt -132.31 147.91 32.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 123.954 0.902 . . . . 0.0 109.806 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.2 tp 60.65 -62.72 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.304 3.042 . . . . 0.0 113.615 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -153.98 -5.65 0.17 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.713 1.605 . . . . 0.0 111.668 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -87.98 45.66 1.3 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.201 1.4 . . . . 0.0 110.535 -169.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -70.84 -16.97 62.75 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.296 1.438 . . . . 0.0 113.143 -172.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.0 mt -15.63 -65.85 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 128.975 2.91 . . . . 0.0 114.276 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.65 -82.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.959 1.735 . . . . 0.0 113.065 -174.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -174.63 155.24 2.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.947 1.699 . . . . 0.0 108.88 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.94 -35.73 37.23 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -173.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -59.84 23.47 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.153 1 C-N-CA 125.928 4.418 . . . . 0.0 119.434 -173.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.75 -49.43 38.45 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.517 1.527 . . . . 0.0 112.732 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.75 -36.93 81.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.887 0.475 . . . . 0.0 110.787 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -65.44 -41.06 93.88 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.935 0.494 . . . . 0.0 109.738 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.535 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.63 -42.24 98.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.292 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 tp -57.99 -53.32 59.59 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.77 -42.68 98.13 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 m -59.0 -62.19 2.07 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 125.146 1.378 . . . . 0.0 110.149 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -57.15 -44.36 83.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.75 0.82 . . . . 0.0 112.016 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.48 -53.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.439 0.696 . . . . 0.0 109.475 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.23 -17.42 62.5 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.31 0.959 . . . . 0.0 112.407 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -79.18 -42.87 25.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.564 0.62 . . . . 0.0 111.227 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -37.56 75.12 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.947 0.794 . . . . 0.0 111.079 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.9 mttm . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.39 1.476 . . . . 0.0 109.937 174.068 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.24 159.59 44.13 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.509 1.124 . . . . 0.0 108.853 173.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -111.85 -23.13 10.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.444 1.898 . . . . 0.0 110.872 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.03 122.85 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -85.06 128.58 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.34 95.33 6.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -82.74 83.21 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -83.72 31.97 0.47 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 128.804 2.841 . . . . 0.0 112.682 -168.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.42 155.62 26.61 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 121.599 -0.688 . . . . 0.0 112.173 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.33 -37.8 1.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 110.387 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.5 p -130.6 49.56 2.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.8 tp 52.22 42.41 30.75 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.126 1.771 . . . . 0.0 111.101 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.18 159.18 16.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 128.042 2.734 . . . . 0.0 106.798 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.36 -160.4 32.52 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.357 1.078 . . . . 0.0 111.301 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.43 46.26 0.33 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.475 1.91 . . . . 0.0 113.525 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -53.52 -35.22 60.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.192 0.997 . . . . 0.0 112.828 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.01 -45.75 93.56 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.772 . . . . 0.0 110.736 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.05 -40.9 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.534 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.11 -41.52 94.83 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.177 0.899 . . . . 0.0 110.984 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -64.8 -45.5 85.99 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.745 -0.597 . . . . 0.0 109.904 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.24 -51.24 68.82 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.225 1.01 . . . . 0.0 110.271 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.36 -49.83 60.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 110.897 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.16 -53.48 57.8 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.193 0.997 . . . . 0.0 110.244 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.71 -37.95 77.23 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mp -69.71 -26.51 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.86 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -70.04 -43.82 70.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.854 1.661 . . . . 0.0 109.316 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.0 -26.33 67.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.48 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.34 -16.26 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.713 0.805 . . . . 0.0 112.219 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.07 15.66 2.05 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.523 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -131.66 -165.25 1.55 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.304 1.552 . . . . 0.0 110.041 -169.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 p -131.18 151.68 51.22 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.9 p -144.11 159.78 42.04 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.038 0.535 . . . . 0.0 109.796 -169.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.1 107.23 7.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 m -78.17 120.15 22.56 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -147.07 137.47 23.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.194 0.598 . . . . 0.0 110.057 -169.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -82.39 41.49 0.7 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.608 -1.307 . . . . 0.0 109.677 169.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 38.7 55.12 2.22 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.636 2.065 . . . . 0.0 115.022 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.39 -20.3 54.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.808 2.339 . . . . 0.0 113.499 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 42' ' ' GLU . 83.4 mt -118.07 15.18 14.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.293 1.837 . . . . 0.0 109.068 177.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tp 63.84 -28.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.088 2.955 . . . . 0.0 113.97 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 40' ' ' LEU . 9.7 pt-20 -164.98 93.45 0.62 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.408 1.483 . . . . 0.0 107.111 -168.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.08 -43.78 77.77 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.467 -0.771 . . . . 0.0 110.007 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.35 154.5 74.34 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.52 -173.68 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.934 3.089 . . . . 0.0 112.554 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 29.94 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.178 1.391 . . . . 0.0 112.661 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.0 m -152.33 136.91 16.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.967 2.507 . . . . 0.0 106.41 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.13 -141.59 12.74 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mm -123.76 139.83 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.3 m0 -122.04 135.12 54.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.8 mt -128.79 140.7 51.59 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.58 134.43 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -137.68 113.78 11.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -170.93 -156.51 0.12 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.935 2.494 . . . . 0.0 105.668 174.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m -147.6 138.78 23.62 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 121.06 1.755 . . . . 0.0 109.305 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.0 p -138.1 -6.49 1.62 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -56.29 145.39 27.03 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.03 -157.62 16.43 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.88 -32.24 69.31 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.263 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.98 -140.87 30.39 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -144.18 166.98 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 169.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.0 mm -48.83 -46.12 73.1 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 117.407 -1.282 . . . . 0.0 112.984 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.02 -5.06 16.13 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.318 2.012 . . . . 0.0 114.837 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 t70 133.95 -54.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.978 1 C-N-CA 131.791 4.036 . . . . 0.0 106.809 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 165.58 -45.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.105 2.962 . . . . 0.0 107.001 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.34 146.16 55.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.721 1.208 . . . . 0.0 108.69 174.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.8 m -122.22 -63.67 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 117.248 -1.358 . . . . 0.0 111.172 176.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.75 -39.31 15.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.92 1.722 . . . . 0.0 110.993 -175.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -60.28 -50.35 73.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.35 0.66 . . . . 0.0 110.091 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.28 -48.97 78.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.67 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -60.94 -45.81 93.23 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.772 0.714 . . . . 0.0 110.462 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.4 72.61 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.43 -58.02 8.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 119.202 0.91 . . . . 0.0 109.233 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -63.6 -24.64 67.88 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.56 -33.69 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.022 0.529 . . . . 0.0 111.38 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -123.47 -23.76 4.73 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 29.91 66.53 0.78 Allowed Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 126.885 2.074 . . . . 0.0 112.086 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.75 163.88 17.58 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.037 2.492 . . . . 0.0 113.529 -169.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.99 59.86 2.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.285 1.834 . . . . 0.0 112.009 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 7.16 2.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.036 1.334 . . . . 0.0 113.163 -171.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -63.52 -4.06 2.57 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.259 -1.526 . . . . 0.0 112.614 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.9 6.56 25.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.3 1.44 . . . . 0.0 111.459 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.71 162.07 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.914 0.885 . . . . 0.0 109.966 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -118.0 152.74 34.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -119.92 151.56 38.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.922 1.689 . . . . 0.0 108.134 -169.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.39 150.85 23.16 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.9 138.95 53.82 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.7 mt -137.08 124.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -169.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.23 -30.27 1.39 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.801 1.191 . . . . 0.0 111.803 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.43 143.45 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.452 1.901 . . . . 0.0 108.005 169.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 15.54 0.11 Allowed Glycine 0 CA--C 1.523 0.563 0 CA-C-O 119.055 -0.858 . . . . 0.0 113.8 -174.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 p -60.61 -15.05 24.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.037 1.335 . . . . 0.0 112.878 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 95' ' ' TYR . 14.6 ptp180 -62.18 -27.06 68.7 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.826 -1.171 . . . . 0.0 112.668 169.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 66.73 -12.89 0.2 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.746 2.819 . . . . 0.0 114.559 169.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.465 ' H ' ' C ' ' A' ' 93' ' ' ARG . 56.5 t80 -52.65 -12.65 0.31 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.487 2.715 . . . . 0.0 113.747 175.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.98 -2.8 8.25 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.72 1.208 . . . . 0.0 113.739 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.4 t -152.26 -172.7 4.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 129.291 3.037 . . . . 0.0 107.602 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -75.12 -17.55 60.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.495 1.118 . . . . 0.0 113.009 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 65.3 m -63.11 153.59 33.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.272 1.029 . . . . 0.0 112.058 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.62 153.86 30.48 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 123.884 0.754 . . . . 0.0 111.72 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.81 153.12 42.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.852 0.861 . . . . 0.0 112.938 -171.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 pt -138.6 25.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 128.456 2.703 . . . . 0.0 108.808 169.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.38 31.16 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.063 2.945 . . . . 0.0 115.876 -169.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -55.51 -30.28 60.38 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.0 -1.063 . . . . 0.0 112.054 -173.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.21 -58.82 5.92 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.788 1.177 . . . . 0.0 109.842 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.57 -37.68 84.73 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -175.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.2 -51.75 67.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.009 0.923 . . . . 0.0 109.953 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.69 -35.22 80.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.428 1.013 . . . . 0.0 111.158 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.62 -50.1 72.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.174 0.897 . . . . 0.0 110.942 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.322 11.7 ptmt -71.78 -28.1 63.4 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.938 -0.476 . . . . 0.0 112.204 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -36.19 82.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.333 1.053 . . . . 0.0 111.009 169.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.6 m -68.52 -33.7 74.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.948 0.34 . . . . 0.0 110.561 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.69 -28.9 0.37 Allowed Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.668 169.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.47 141.2 57.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.654 1.227 . . . . 0.0 110.11 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -80.69 129.16 34.36 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -75.6 100.95 4.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 170.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 99.6 m -73.32 149.87 42.31 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.34 -124.43 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.0 pt-20 -152.1 166.05 32.84 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.337 1.055 . . . . 0.0 108.301 169.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.5 m -51.03 130.89 26.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.842 1.257 . . . . 0.0 111.222 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.64 160.47 14.99 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.928 2.091 . . . . 0.0 108.429 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -131.36 144.05 50.95 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.17 162.72 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.747 2.419 . . . . 0.0 106.448 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -157.24 155.84 31.51 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.716 -0.615 . . . . 0.0 111.233 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.9 pt -141.61 168.83 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.721 2.008 . . . . 0.0 107.404 174.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.2 mt 56.56 -167.3 0.12 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.001 1.32 . . . . 0.0 110.594 -172.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.65 -38.38 90.79 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.547 -0.721 . . . . 0.0 111.368 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -164.97 174.33 10.62 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.106 1.762 . . . . 0.0 108.876 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.09 -71.66 0.15 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 23.4 mt -139.37 -63.67 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.644 1.578 . . . . 0.0 110.22 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.29 -42.52 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 121.589 1.603 . . . . 0.0 111.337 -172.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 58.56 23.6 11.03 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.502 1.521 . . . . 0.0 111.909 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -151.71 77.16 7.23 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.2 -0.938 . . . . 0.0 110.402 -172.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.48 148.34 20.37 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.158 2.572 . . . . 0.0 112.706 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.64 38.72 1.51 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.48 1.512 . . . . 0.0 109.513 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -59.77 -16.25 26.44 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.28 1.432 . . . . 0.0 113.785 -172.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -57.15 -27.79 62.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.594 0.757 . . . . 0.0 111.423 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.437 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.87 -48.47 78.05 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.335 0.654 . . . . 0.0 109.711 171.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.62 -49.14 77.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.074 0.95 . . . . 0.0 109.217 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.0 -52.51 46.3 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.932 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -63.24 -44.74 94.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.286 0.543 . . . . 0.0 110.524 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.39 -41.84 94.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.274 1.43 . . . . 0.0 110.804 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.77 -48.03 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.084 0.953 . . . . 0.0 109.547 172.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.35 -29.74 70.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.257 0.935 . . . . 0.0 111.612 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.21 -46.99 25.65 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.363 1.065 . . . . 0.0 110.505 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.01 -29.91 62.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.353 0.524 . . . . 0.0 112.054 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.3 mttt . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.374 1.07 . . . . 0.0 109.86 171.815 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.81 158.8 35.73 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.1 -22.25 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.1 1.76 . . . . 0.0 110.712 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.5 mt -134.81 128.94 51.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.547 1.139 . . . . 0.0 108.065 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -89.01 131.88 34.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 95.1 5.39 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.1 mt -89.94 110.39 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.35 143.67 44.06 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 122.813 0.445 . . . . 0.0 111.622 -169.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.5 168.29 12.22 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 124.598 1.094 . . . . 0.0 112.002 169.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 p -117.88 -8.8 10.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 0.0 112.516 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t -141.79 -54.44 0.45 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -149.4 17.12 0.93 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.485 1.039 . . . . 0.0 111.661 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.93 172.1 28.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 127.432 2.444 . . . . 0.0 107.68 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.71 10.07 4.12 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.015 -1.436 . . . . 0.0 115.053 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 2.86 1.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.077 1.938 . . . . 0.0 113.405 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.8 -31.55 62.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.486 1.114 . . . . 0.0 112.125 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -58.1 -53.5 57.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.458 0.703 . . . . 0.0 111.525 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.09 -30.54 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.03 77.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.001 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.35 -41.22 89.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.015 0.825 . . . . 0.0 111.083 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -63.07 -46.9 85.28 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.1 mt -57.12 -51.17 70.35 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.044 0.937 . . . . 0.0 110.461 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.72 -48.53 63.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.761 1.224 . . . . 0.0 110.685 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.71 -53.89 52.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.484 0.714 . . . . 0.0 110.345 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -57.92 -38.12 75.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.92 -33.13 75.02 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.254 0.621 . . . . 0.0 111.183 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -70.04 -38.21 75.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 119.921 1.237 . . . . 0.0 110.325 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.51 -28.96 70.3 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.165 0.893 . . . . 0.0 111.42 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.34 63.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.393 0.677 . . . . 0.0 111.597 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.26 -6.49 5.34 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.493 -1.171 . . . . 0.0 113.706 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.9 -165.44 1.34 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.341 1.57 . . . . 0.0 109.395 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.5 p -144.88 160.08 41.87 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.701 -0.624 . . . . 0.0 110.618 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.07 115.61 15.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 m -78.93 123.82 27.64 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 mt -140.5 156.79 46.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.112 0.565 . . . . 0.0 110.396 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -105.03 35.8 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.432 1.093 . . . . 0.0 108.77 169.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.57 48.05 28.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.727 1.632 . . . . 0.0 115.048 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.38 -20.57 61.47 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 121.046 2.423 . . . . 0.0 113.808 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.436 ' C ' ' H ' ' A' ' 42' ' ' GLU . 80.5 mt -122.31 14.92 10.49 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.022 1.729 . . . . 0.0 109.094 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.6 tp 64.9 -30.09 0.12 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.979 2.512 . . . . 0.0 113.543 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.3 pt-20 -165.31 86.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.223 1.409 . . . . 0.0 107.452 -168.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.7 -41.74 99.28 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.956 -0.465 . . . . 0.0 110.185 176.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.47 150.11 36.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.58 -178.92 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.88 3.053 . . . . 0.0 113.239 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 32.55 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.994 1.718 . . . . 0.0 112.549 171.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 m -157.36 125.34 5.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 106.044 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.86 -143.36 14.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 mm -124.38 130.97 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -118.89 144.62 46.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.2 mt -137.14 135.77 37.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -132.6 137.55 53.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -173.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -128.07 96.71 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.169 1.388 . . . . 0.0 107.258 -170.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.5 p -145.52 -6.29 0.63 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -173.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m 37.98 60.95 1.14 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p -49.73 -36.8 26.82 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.122 0.969 . . . . 0.0 112.384 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -44.09 -29.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.052 2.141 . . . . 0.0 114.13 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.08 16.56 0.18 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-N 120.449 1.477 . . . . 0.0 115.617 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.74 46.38 0.94 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.506 1.922 . . . . 0.0 109.232 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.54 -179.15 10.09 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.137 -0.977 . . . . 0.0 111.735 170.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -134.1 164.52 27.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.061 1.345 . . . . 0.0 107.719 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.3 mm -61.28 -47.85 93.08 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-O 117.345 -1.312 . . . . 0.0 111.371 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.64 -49.83 3.91 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.009 1.806 . . . . 0.0 112.152 171.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -162.87 -60.31 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.329 0.652 . . . . 0.0 111.958 170.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 155.96 139.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 130.426 3.49 . . . . 0.0 104.402 -169.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.0 mt 37.66 58.81 1.33 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.078 1.418 . . . . 0.0 108.395 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -63.61 -48.01 81.45 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.488 1.915 . . . . 0.0 114.174 -168.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.14 -34.07 70.42 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 121.176 1.456 . . . . 0.0 110.647 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -72.33 -42.84 64.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.403 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -53.52 -51.56 62.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.99 1.316 . . . . 0.0 110.261 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -61.8 -42.52 99.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.822 0.737 . . . . 0.0 110.87 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.6 86.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.219 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.49 -56.34 23.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.241 0.928 . . . . 0.0 109.106 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -20.18 65.06 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.84 -31.06 63.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.876 0.762 . . . . 0.0 111.635 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -121.11 -28.56 4.72 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 23.75 70.91 0.33 Allowed Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 127.722 2.409 . . . . 0.0 113.7 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -58.84 175.38 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.605 2.204 . . . . 0.0 111.729 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -89.96 79.16 6.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.995 0.918 . . . . 0.0 110.022 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.39 3.17 9.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.264 0.626 . . . . 0.0 112.174 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -63.8 -6.74 6.23 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.026 2.13 . . . . 0.0 112.926 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.13 6.21 38.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.774 1.629 . . . . 0.0 110.792 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.31 145.66 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 122.147 0.975 . . . . 0.0 111.732 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -94.67 144.55 25.52 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -113.07 146.5 39.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.09 121.81 3.67 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.09 132.16 43.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.24 108.28 18.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -30.03 0.43 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.227 0.918 . . . . 0.0 113.049 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.76 123.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.0 45.74 0.29 Allowed Glycine 0 CA--C 1.502 -0.722 0 CA-C-O 121.722 0.623 . . . . 0.0 111.75 -169.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -37.85 68.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 26.09 -70.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 1 C-N-CA 133.186 4.594 . . . . 0.0 117.132 169.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -57.47 -26.78 61.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.864 0.865 . . . . 0.0 111.643 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -120.81 10.35 10.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.621 2.769 . . . . 0.0 110.595 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -80.24 62.61 4.45 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.2 t -154.31 177.4 11.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.747 1.619 . . . . 0.0 109.603 -173.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -57.96 -19.18 28.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.284 1.834 . . . . 0.0 114.836 -169.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 18.4 p -116.92 17.63 14.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.767 1.227 . . . . 0.0 112.718 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.42 166.43 54.61 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.607 0.623 . . . . 0.0 112.027 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.44 14.01 1.24 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.689 1.195 . . . . 0.0 112.187 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.1 tt -149.12 23.76 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 125.315 1.446 . . . . 0.0 108.885 -177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -135.2 -3.01 2.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.265 2.226 . . . . 0.0 112.038 -169.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -63.29 -25.39 68.29 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.661 -0.649 . . . . 0.0 111.552 -169.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.83 -56.49 19.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.721 0.808 . . . . 0.0 110.138 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.14 -38.87 92.0 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.63 72.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -63.24 -42.12 99.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.775 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -57.28 -47.59 81.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.304 0.956 . . . . 0.0 110.714 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -73.51 -36.0 65.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.852 0.861 . . . . 0.0 109.688 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -34.38 78.23 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.377 1.471 . . . . 0.0 111.629 173.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -73.65 -17.72 61.12 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.251 0.22 . . . . 0.0 110.636 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.25 -17.64 5.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 117.921 -1.488 . . . . 0.0 114.085 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 130.75 44.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.649 1.725 . . . . 0.0 109.258 -170.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -86.37 111.08 20.15 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.04 117.51 5.18 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 94.7 m -129.38 143.13 50.72 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.244 0.618 . . . . 0.0 110.737 -169.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.38 -103.34 2.99 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -165.03 -175.88 3.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.357 1.863 . . . . 0.0 107.448 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.4 m -63.01 113.64 3.22 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.411 ' HG ' ' CG ' ' A' ' 138' ' ' TRP . 1.3 tt -71.37 153.62 42.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -130.8 143.0 50.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.12 156.25 33.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.722 1.609 . . . . 0.0 107.213 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.66 28.29 0.79 Allowed 'General case' 0 C--O 1.232 0.171 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.1 157.37 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 168.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 tp -51.95 -37.03 51.38 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.946 0.898 . . . . 0.0 113.327 -169.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.96 -22.56 62.19 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -140.35 60.65 1.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.751 1.62 . . . . 0.0 109.416 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -65.57 -18.88 65.65 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.241 -0.912 . . . . 0.0 111.563 169.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 83.9 mt -2.37 -72.37 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 130.398 3.479 . . . . 0.0 114.755 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -79.09 -78.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.682 1.994 . . . . 0.0 112.859 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -177.79 158.55 1.32 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.441 2.296 . . . . 0.0 107.512 -169.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -55.0 -45.74 99.78 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -169.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.36 160.82 41.39 Favored 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 122.577 1.956 . . . . 0.0 113.069 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.29 -47.76 0.13 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.329 1.052 . . . . 0.0 111.036 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.94 -24.22 67.46 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -170.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.28 -34.21 77.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.708 0.403 . . . . 0.0 110.636 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.411 ' CG ' ' HG ' ' A' ' 121' ' ' LEU . 13.8 t90 -59.08 -54.92 41.57 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.307 0.643 . . . . 0.0 109.538 173.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -55.91 20.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.631 1.573 . . . . 0.0 109.09 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.1 -42.59 98.02 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.737 -0.48 . . . . 0.0 112.133 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -60.17 -60.35 3.96 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.82 0.81 . . . . 0.0 109.03 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -56.85 -46.54 81.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.386 1.074 . . . . 0.0 111.485 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.01 -55.78 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.702 0.801 . . . . 0.0 109.683 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -15.96 62.49 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.059 0.845 . . . . 0.0 112.421 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.61 -48.47 13.71 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.467 0.707 . . . . 0.0 110.769 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.73 -32.58 65.8 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.766 0.712 . . . . 0.0 111.958 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.1 mttt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.228 1.011 . . . . 0.0 109.74 174.006 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.62 152.59 45.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.273 0.942 . . . . 0.0 111.628 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.43 -22.51 16.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.193 1.797 . . . . 0.0 110.865 170.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.21 129.49 53.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.781 1.233 . . . . 0.0 108.144 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -90.42 127.96 36.35 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.91 95.62 5.66 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.64 131.54 33.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.83 -174.35 3.7 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.058 1.743 . . . . 0.0 109.038 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.27 42.44 90.58 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.547 -0.721 . . . . 0.0 112.476 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -44.91 -44.56 9.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.396 2.278 . . . . 0.0 114.329 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -82.23 22.78 0.79 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.188 1.795 . . . . 0.0 112.188 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt 59.04 54.17 5.13 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.74 1.257 . . . . 0.0 107.654 -168.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.32 -135.98 3.33 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.096 1.808 . . . . 0.0 108.739 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.46 149.32 21.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.18 16.27 0.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.321 1.849 . . . . 0.0 111.108 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.24 -16.91 37.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 0.0 113.683 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.64 -48.08 66.63 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.283 1.402 . . . . 0.0 112.14 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.07 -31.72 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.967 -0.458 . . . . 0.0 110.177 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.53 78.07 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.074 0.55 . . . . 0.0 111.114 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.31 -37.45 80.61 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.055 0.942 . . . . 0.0 110.371 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -65.25 -42.44 93.31 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.72 -0.612 . . . . 0.0 110.008 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 mt -61.49 -51.73 67.43 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.93 64.96 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.451 1.501 . . . . 0.0 111.312 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 -54.74 40.16 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.517 0.675 . . . . 0.0 109.954 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.56 -38.74 91.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -60.93 -40.17 92.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.478 0.711 . . . . 0.0 110.897 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.55 -36.52 68.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.16 -0.962 . . . . 0.0 110.469 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.8 -31.3 71.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.481 0.712 . . . . 0.0 111.262 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.5 -21.49 62.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.375 0.67 . . . . 0.0 111.736 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.99 -7.82 3.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.178 -1.345 . . . . 0.0 114.295 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -94.99 -168.86 1.88 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.802 1.801 . . . . 0.0 110.205 -171.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -128.89 149.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.7 p -142.71 155.64 44.91 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.823 -0.548 . . . . 0.0 111.065 -170.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -121.73 90.67 3.36 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.906 1.283 . . . . 0.0 108.331 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -67.53 120.66 14.33 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.1 mt -146.86 168.37 21.59 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.834 0.854 . . . . 0.0 111.534 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -109.52 31.88 5.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.884 1.273 . . . . 0.0 109.584 169.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.86 49.73 46.93 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.602 1.572 . . . . 0.0 114.537 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 -21.01 64.96 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.061 2.507 . . . . 0.0 113.99 -172.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 42' ' ' GLU . 83.4 mt -120.11 12.76 11.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.674 1.59 . . . . 0.0 109.577 -177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 tp 63.91 -25.8 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.939 2.496 . . . . 0.0 113.455 -169.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.3 pt-20 -166.75 82.67 0.25 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -169.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.98 -43.89 97.54 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.879 -0.513 . . . . 0.0 109.841 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.48 151.28 44.07 Favored Pre-proline 0 C--N 1.345 0.409 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 169.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.07 -175.12 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 124.151 3.234 . . . . 0.0 113.005 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.04 29.77 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.645 1.578 . . . . 0.0 113.193 171.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.3 m -152.56 127.17 9.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.964 2.506 . . . . 0.0 106.157 -176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.08 -140.92 12.19 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.3 mm -127.97 135.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -119.52 130.02 54.98 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.3 mt -126.97 133.58 50.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.37 103.5 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -169.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.0 mp -78.72 126.04 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.9 m -159.57 176.95 11.43 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.128 1.771 . . . . 0.0 107.05 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 m -149.92 65.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 p -51.73 -26.27 9.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.749 2.019 . . . . 0.0 113.399 -169.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.482 ' CD2' ' HG ' ' A' ' 92' ' ' SER . 6.0 m-70 -133.13 44.35 2.84 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.146 1.378 . . . . 0.0 109.637 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.98 -36.89 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 O-C-N 121.439 -0.788 . . . . 0.0 113.428 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.38 58.45 0.64 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.967 1.307 . . . . 0.0 107.802 178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.72 168.39 35.5 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 123.827 0.727 . . . . 0.0 111.313 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.15 85.44 5.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.341 8.0 pt -38.97 -38.84 0.73 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 119.654 3.205 . . . . 0.0 119.654 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.19 -8.16 12.94 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 CA-C-N 123.827 2.402 . . . . 0.0 114.017 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -149.92 -41.09 0.14 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.293 1.406 . . . . 0.0 114.629 -169.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.5 t30 31.46 -56.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 1 C-N-CA 132.694 4.398 . . . . 0.0 119.968 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.29 72.57 10.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.8 m -67.21 -51.3 35.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.746 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 -38.73 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.453 1.435 . . . . 0.0 110.18 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.31 -52.33 54.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.592 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -59.38 -46.26 89.16 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.286 0.948 . . . . 0.0 110.845 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -63.5 -49.54 73.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.512 0.596 . . . . 0.0 110.274 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.26 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -60.52 -56.29 23.21 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.836 0.855 . . . . 0.0 109.577 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.41 -23.57 66.99 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.49 -33.7 73.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.746 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -124.59 -21.83 4.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 30.26 64.53 0.89 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 127.068 2.147 . . . . 0.0 112.911 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.7 165.24 18.84 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.938 2.425 . . . . 0.0 113.375 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.34 63.96 4.99 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.731 1.212 . . . . 0.0 111.232 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 9.95 0.33 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.45 1.5 . . . . 0.0 113.281 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 m -64.04 -2.43 1.98 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.756 2.823 . . . . 0.0 113.171 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.85 9.1 11.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.741 1.616 . . . . 0.0 110.981 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 p -128.5 154.13 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.689 0.677 . . . . 0.0 110.75 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.36 143.26 32.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -103.01 154.61 19.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.98 115.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.1 133.92 47.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.32 116.67 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.46 -11.37 18.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.625 1.107 . . . . 0.0 114.36 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.64 130.5 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.012 1.725 . . . . 0.0 108.609 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.96 -38.88 3.71 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 -170.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.482 ' HG ' ' CD2' ' A' ' 57' ' ' HIS . 1.4 m -53.08 -33.49 52.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.705 1.602 . . . . 0.0 111.565 170.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -66.88 -25.23 66.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.943 0.897 . . . . 0.0 112.464 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -105.61 -73.62 0.68 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.856 0.753 . . . . 0.0 112.624 -168.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -155.51 -25.74 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -87.92 33.87 0.72 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.638 1.108 . . . . 0.0 111.377 -169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.4 p -50.55 119.86 4.15 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.133 1.773 . . . . 0.0 110.838 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -62.7 165.92 5.98 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.395 0.678 . . . . 0.0 109.521 170.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.6 m -71.21 39.0 0.06 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.185 1.794 . . . . 0.0 111.727 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.84 42.76 0.02 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.488 1.994 . . . . 0.0 108.164 -169.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.46 158.84 11.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.014 0.926 . . . . 0.0 111.523 -170.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 tp -112.28 22.09 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.278 1.031 . . . . 0.0 110.204 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.03 -15.92 10.9 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.419 1.088 . . . . 0.0 113.049 176.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -56.37 -25.69 50.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.94 0.896 . . . . 0.0 111.769 170.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.37 -59.04 6.08 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.292 0.951 . . . . 0.0 109.442 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.06 -38.61 79.78 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.318 0.508 . . . . 0.0 110.852 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.91 88.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.879 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -64.84 -36.59 84.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.967 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.67 -47.25 86.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.255 0.934 . . . . 0.0 110.814 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -69.46 -35.47 75.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.993 0.517 . . . . 0.0 110.217 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -36.48 84.18 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.293 1.437 . . . . 0.0 111.037 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.8 m -67.16 -36.14 81.18 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.607 0.363 . . . . 0.0 110.097 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.66 -25.66 0.25 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.29 -1.284 . . . . 0.0 115.396 169.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.35 139.98 55.87 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.344 1.572 . . . . 0.0 110.524 -170.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -83.73 146.14 28.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -92.58 98.37 11.4 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.8 m -75.3 151.72 38.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.82 -116.89 8.63 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.453 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 7.3 pt-20 -146.8 178.99 7.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.334 1.053 . . . . 0.0 108.561 170.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -54.43 119.53 5.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.5 1.12 . . . . 0.0 108.8 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.09 151.35 37.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -138.87 141.84 38.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp -149.76 160.1 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 127.501 2.321 . . . . 0.0 108.657 -171.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -159.93 -179.49 7.85 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.233 0.613 . . . . 0.0 109.497 169.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.0 pt -124.72 2.78 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 125.315 1.446 . . . . 0.0 111.105 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -142.71 144.2 32.6 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.96 131.31 44.36 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.761 0.824 . . . . 0.0 112.299 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.3 t60 32.78 95.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.816 3.246 . . . . 0.0 115.719 175.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -127.72 -160.66 1.03 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.386 1.474 . . . . 0.0 108.001 169.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.8 mm -44.73 -52.22 19.09 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.314 1.846 . . . . 0.0 113.6 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.77 -98.41 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.577 2.184 . . . . 0.0 109.864 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.03 158.5 10.48 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.345 1.858 . . . . 0.0 106.411 170.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.64 -54.12 1.44 Allowed Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.34 -1.314 . . . . 0.0 113.577 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.6 152.36 48.18 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.023 1.815 . . . . 0.0 111.276 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.29 -20.96 0.62 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.285 1.034 . . . . 0.0 113.034 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.38 -25.03 67.71 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.501 0.591 . . . . 0.0 111.927 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -64.31 -42.83 96.16 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.362 0.665 . . . . 0.0 110.412 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.453 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 8.3 m-90 -63.22 -51.29 66.84 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.007 0.523 . . . . 0.0 109.833 177.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.8 mt -58.62 -55.7 31.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.693 0.621 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.51 -49.16 75.61 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.383 -0.676 . . . . 0.0 111.414 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -48.03 77.71 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.155 0.977 . . . . 0.0 110.176 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -60.16 -42.96 96.07 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.569 -0.707 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.8 t -57.39 -50.33 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.555 1.142 . . . . 0.0 109.727 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.74 -26.96 68.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.129 0.877 . . . . 0.0 111.986 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.8 -45.98 16.1 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.671 0.789 . . . . 0.0 110.401 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.05 -34.69 68.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.375 0.534 . . . . 0.0 111.754 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.2 mttt . . . . . 0 C--O 1.248 0.98 0 C-N-CA 124.155 0.982 . . . . 0.0 110.026 176.14 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 tpp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.71 163.22 40.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.369 1.068 . . . . 0.0 109.924 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.14 -24.3 16.91 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.752 1.221 . . . . 0.0 110.891 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.7 mt -132.48 124.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 127.8 35.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.16 103.4 14.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mt -89.92 74.45 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -78.83 138.88 38.38 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.783 -0.573 . . . . 0.0 109.988 -170.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.63 136.11 3.15 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 124.563 1.078 . . . . 0.0 111.082 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -87.21 -7.22 58.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.931 0.892 . . . . 0.0 110.509 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 13' ' ' GLY . 6.4 t -143.74 -144.35 0.15 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.992 3.317 . . . . 0.0 102.954 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.62 8.12 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 11' ' ' THR . . . 177.44 -176.52 48.08 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 128.931 3.158 . . . . 0.0 107.413 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 7.87 5.29 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.232 -1.316 . . . . 0.0 114.709 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.82 -2.48 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.638 1.719 . . . . 0.0 113.732 -175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.01 -33.39 64.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.425 1.09 . . . . 0.0 112.432 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.59 -42.65 88.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.515 0.726 . . . . 0.0 111.469 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.77 -28.18 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.01 77.59 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.145 0.884 . . . . 0.0 111.338 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.08 -42.05 93.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.918 0.781 . . . . 0.0 111.278 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -68.59 -43.2 77.01 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.698 -0.627 . . . . 0.0 110.663 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.73 -50.5 73.01 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.001 0.92 . . . . 0.0 110.432 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.97 67.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.732 1.213 . . . . 0.0 110.995 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.98 -52.99 61.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.683 0.674 . . . . 0.0 110.18 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -60.35 -40.55 91.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.91 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.518 175.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.53 -39.98 80.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.388 0.995 . . . . 0.0 109.737 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.94 -29.1 70.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.389 0.995 . . . . 0.0 111.6 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.3 -17.73 63.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.716 0.806 . . . . 0.0 111.622 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.35 14.03 4.6 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.323 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.72 -172.38 2.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.442 1.621 . . . . 0.0 110.419 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -122.86 153.58 39.44 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p -141.61 154.56 45.48 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.875 -0.516 . . . . 0.0 111.615 -169.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -117.94 91.92 3.7 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.634 1.574 . . . . 0.0 106.923 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -69.21 118.44 12.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 172.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.09 166.0 27.43 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.747 1.219 . . . . 0.0 108.738 -173.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -101.44 31.18 3.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.493 0.717 . . . . 0.0 110.653 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.62 50.79 47.39 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 118.143 -1.365 . . . . 0.0 113.935 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.2 -21.36 67.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.082 2.521 . . . . 0.0 113.638 -171.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 42' ' ' GLU . 75.2 mt -125.74 15.87 8.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.739 1.616 . . . . 0.0 109.54 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.6 tp 63.0 -26.69 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.328 2.651 . . . . 0.0 114.31 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 40' ' ' LEU . 8.2 pt-20 -161.17 82.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.536 1.134 . . . . 0.0 108.22 -168.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.36 -43.96 84.52 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.777 -0.577 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.3 mt -85.65 151.36 55.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.24 -178.29 1.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.968 3.112 . . . . 0.0 113.292 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 31.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.758 2.023 . . . . 0.0 112.941 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -159.87 116.87 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.928 2.091 . . . . 0.0 106.312 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.0 -146.01 15.4 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -173.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mm -123.64 136.18 60.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -118.36 148.78 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.5 mt -134.54 142.91 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.75 130.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.41 110.4 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -168.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 m -149.51 -174.67 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.23 1.012 . . . . 0.0 109.361 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -154.48 134.73 13.24 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.622 1.169 . . . . 0.0 108.313 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 p -140.76 -64.94 0.45 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.903 0.481 . . . . 0.0 111.237 -170.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.0 t60 52.12 28.98 5.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.163 1.385 . . . . 0.0 112.112 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.53 21.93 15.29 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.615 1.102 . . . . 0.0 113.976 -172.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.6 41.54 0.61 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.343 1.857 . . . . 0.0 109.277 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.21 -172.74 7.11 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.777 0.703 . . . . 0.0 111.412 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -57.52 -27.74 62.86 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.194 -0.592 . . . . 0.0 111.695 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.442 ' C ' ' H ' ' A' ' 64' ' ' ASP . 9.1 tp -148.97 153.44 38.4 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.718 2.407 . . . . 0.0 104.963 169.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -59.45 16.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.937 3.758 . . . . 0.0 116.297 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 62' ' ' ILE . 26.1 t70 -145.08 37.5 1.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.655 2.382 . . . . 0.0 107.552 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -51.89 -42.48 62.73 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.213 1.405 . . . . 0.0 112.299 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.36 61.27 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.012 1.725 . . . . 0.0 108.66 170.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.5 m -65.94 -48.02 62.38 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 125.957 1.703 . . . . 0.0 110.838 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -72.71 -39.95 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 120.414 1.184 . . . . 0.0 110.251 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -60.21 3.53 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -169.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -59.79 -43.21 94.55 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.984 0.913 . . . . 0.0 110.336 -169.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -69.31 -46.87 66.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.001 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -26.91 68.59 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.651 1.114 . . . . 0.0 112.886 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.9 mt -61.98 -61.34 2.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -57.48 -25.8 60.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.096 1.758 . . . . 0.0 113.719 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -30.81 70.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -126.88 -29.95 2.78 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt 23.81 67.85 0.38 Allowed Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 127.153 2.181 . . . . 0.0 113.401 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.6 175.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.833 1.689 . . . . 0.0 110.672 171.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -87.87 125.93 34.75 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.27 11.79 11.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.619 1.168 . . . . 0.0 111.145 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.7 m -67.0 -4.87 10.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 119.662 -1.899 . . . . 0.0 113.033 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.1 5.06 42.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.308 1.443 . . . . 0.0 110.734 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.06 157.17 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.961 0.886 . . . . 0.0 110.896 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -110.46 151.99 26.86 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -121.44 157.22 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.85 118.84 2.4 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.17 140.6 31.63 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.79 125.89 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -170.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.58 52.78 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.381 0.991 . . . . 0.0 113.796 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.55 80.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 108.151 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.54 -11.39 2.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 127.174 2.321 . . . . 0.0 117.806 -168.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -67.18 -41.98 84.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.525 2.162 . . . . 0.0 109.692 172.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.2 ttt85 55.55 -76.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.139 2.575 . . . . 0.0 114.038 173.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -159.83 -42.56 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.65 1.98 . . . . 0.0 108.473 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -146.18 1.08 0.84 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.414 1.486 . . . . 0.0 112.031 -171.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -87.73 34.48 0.71 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.205 -0.934 . . . . 0.0 111.133 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.1 t -154.63 169.36 24.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.083 2.153 . . . . 0.0 107.448 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -117.89 7.22 12.32 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.423 1.489 . . . . 0.0 110.258 171.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 62.9 m -132.73 22.21 4.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.413 1.485 . . . . 0.0 111.149 -172.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.2 -169.35 38.26 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.253 0.93 . . . . 0.0 111.167 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.72 -135.45 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.329 1.852 . . . . 0.0 106.101 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.8 140.5 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 168.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' ' 106' ' ' GLU . 2.0 t70 -63.55 150.12 44.69 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -169.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -56.3 -41.14 75.48 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 169.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.35 -55.4 35.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.471 1.108 . . . . 0.0 109.545 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.457 ' H ' ' HB3' ' A' ' 103' ' ' ASP . 48.6 mt-10 -65.56 -39.85 92.16 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.837 -171.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.38 78.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.224 1.01 . . . . 0.0 109.889 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -63.72 -35.74 81.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.422 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.8 -42.5 94.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.206 1.366 . . . . 0.0 111.289 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -65.55 -38.85 90.81 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.111 0.565 . . . . 0.0 109.764 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -31.32 71.23 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.986 1.314 . . . . 0.0 111.684 176.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.5 m -73.52 -29.91 62.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.855 0.462 . . . . 0.0 109.847 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.71 -17.35 4.44 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-O 118.457 -1.19 . . . . 0.0 113.599 169.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 136.23 56.67 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.892 1.346 . . . . 0.0 108.287 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -84.56 126.81 33.65 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -77.27 98.65 5.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.8 m -73.45 151.33 41.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.59 -117.35 10.83 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 10.3 pt-20 -157.0 170.08 23.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.123 1.769 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -55.3 126.44 24.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.603 0.761 . . . . 0.0 109.739 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.25 161.42 20.5 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.065 1.746 . . . . 0.0 107.674 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -136.52 150.87 48.87 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.45 157.38 24.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 123.394 0.678 . . . . 0.0 110.387 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.32 170.28 14.85 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.881 0.872 . . . . 0.0 109.788 169.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.6 mm -126.31 -62.7 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.1 tp -160.04 -57.26 0.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.717 0.807 . . . . 0.0 109.574 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.87 126.84 31.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -67.16 162.37 22.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.062 0.945 . . . . 0.0 111.227 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -147.94 -166.23 2.47 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.075 1.75 . . . . 0.0 107.692 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.67 -54.15 56.89 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.916 1.286 . . . . 0.0 111.025 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.5 -47.15 0.75 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.13 1.887 . . . . 0.0 112.29 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . 0.261 16.7 pt-20 45.68 37.71 3.54 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.683 1.993 . . . . 0.0 114.698 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -146.98 112.6 4.16 Favored Pre-proline 0 N--CA 1.467 0.384 0 CA-C-O 118.104 -0.95 . . . . 0.0 108.674 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.21 -29.49 46.77 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.006 3.137 . . . . 0.0 115.658 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 35.87 40.23 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.961 2.504 . . . . 0.0 115.333 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.39 -23.95 64.73 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -59.78 -29.96 68.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.287 1.035 . . . . 0.0 111.208 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.527 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -61.93 -40.54 95.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.836 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -55.73 27.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.64 -49.0 67.61 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.266 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.7 m -60.61 -55.53 32.24 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 111.83 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -55.99 -42.7 76.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.65 1.18 . . . . 0.0 111.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 t -58.23 -49.35 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.145 0.578 . . . . 0.0 109.83 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.59 -30.12 70.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.372 0.987 . . . . 0.0 111.397 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.9 -46.12 25.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.014 0.925 . . . . 0.0 110.452 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.69 -33.66 66.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.058 0.543 . . . . 0.0 111.586 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 83.7 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.484 1.114 . . . . 0.0 110.09 173.227 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.76 168.7 24.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.359 1.064 . . . . 0.0 109.988 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.37 -23.77 14.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 111.224 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.13 121.94 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -85.12 133.89 34.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.69 96.52 6.13 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 174.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.3 mt -92.9 107.38 19.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -92.12 95.27 9.66 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.24 0.22 23.82 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 118.291 -1.283 . . . . 0.0 114.803 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.89 106.12 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.451 1.625 . . . . 0.0 109.648 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m 46.83 44.45 14.31 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.068 1.347 . . . . 0.0 110.357 -170.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.89 47.9 21.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.649 1.58 . . . . 0.0 111.985 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.19 -173.19 40.76 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.538 1.542 . . . . 0.0 110.723 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.97 -165.82 39.0 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.68 55.56 0.67 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 111.221 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -54.24 -31.44 53.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.085 1.354 . . . . 0.0 112.105 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -55.7 -40.77 72.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.861 0.864 . . . . 0.0 111.721 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.58 -29.94 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.18 74.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.09 0.859 . . . . 0.0 110.638 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.13 -38.91 93.06 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.557 0.617 . . . . 0.0 110.907 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -67.11 -42.62 84.22 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.697 -0.627 . . . . 0.0 110.29 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -59.35 -52.54 65.2 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.697 0.799 . . . . 0.0 109.919 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.99 -49.55 63.06 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.162 1.385 . . . . 0.0 110.931 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.19 -54.35 47.92 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 110.426 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.16 -25.03 65.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.34 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.64 -43.38 80.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 120.738 1.608 . . . . 0.0 109.319 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.85 -26.21 68.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.749 -0.594 . . . . 0.0 111.597 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -13.02 62.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.943 0.897 . . . . 0.0 112.549 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.33 19.04 2.95 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.087 169.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -132.0 -165.48 1.59 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.63 1.215 . . . . 0.0 109.837 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 p -132.36 151.75 51.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -141.77 154.91 45.56 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.971 -0.456 . . . . 0.0 111.468 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -125.72 95.66 4.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.518 1.127 . . . . 0.0 108.647 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.7 m -70.2 121.46 17.6 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.47 165.01 29.82 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.395 0.617 . . . . 0.0 111.469 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -107.46 31.1 5.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.728 1.211 . . . . 0.0 110.165 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.88 45.41 70.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.854 -1.526 . . . . 0.0 115.113 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.43 -21.41 66.39 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.049 2.499 . . . . 0.0 114.118 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 42' ' ' GLU . 83.9 mt -116.45 11.72 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.529 1.532 . . . . 0.0 109.887 -176.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 tp 64.21 -23.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.787 2.435 . . . . 0.0 113.467 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 40' ' ' LEU . 6.4 pt-20 -169.82 82.63 0.12 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.963 1.705 . . . . 0.0 106.65 -169.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.45 -43.82 96.3 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.876 -0.515 . . . . 0.0 109.666 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.8 mt -96.06 150.8 37.72 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 169.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.31 -177.6 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.742 2.962 . . . . 0.0 113.154 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.17 35.75 0.05 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.73 1.612 . . . . 0.0 112.037 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 m -160.51 130.24 5.11 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.186 2.195 . . . . 0.0 106.008 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.28 -143.45 14.54 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -172.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mm -127.39 141.07 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.41 ' CD1' HG22 ' A' ' 83' ' ' VAL . 5.1 m0 -128.92 146.86 50.84 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.8 mt -132.55 140.12 48.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.22 121.98 58.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.95 60.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -120.77 41.31 3.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.256 -169.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -26.53 107.76 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 128.584 2.754 . . . . 0.0 113.914 -172.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.6 p -80.12 -20.03 45.94 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.723 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.3 m80 51.03 22.73 1.29 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.607 1.094 . . . . 0.0 112.86 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.45 -64.95 3.16 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.841 1.21 . . . . 0.0 111.871 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.28 -7.1 54.27 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -170.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.36 146.14 6.59 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.624 1.583 . . . . 0.0 110.451 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.64 -27.36 65.94 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.0 pt -136.51 159.61 69.88 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 128.05 2.54 . . . . 0.0 106.135 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.37 -17.73 22.24 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.711 2.94 . . . . 0.0 115.794 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -133.47 61.24 1.68 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.599 1.56 . . . . 0.0 107.727 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -52.44 -23.37 5.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.269 2.228 . . . . 0.0 116.182 -169.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.29 72.52 1.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.4 -51.92 57.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.513 0.725 . . . . 0.0 112.454 -168.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.8 -39.58 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.612 1.541 . . . . 0.0 110.516 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.36 -51.43 60.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.699 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -60.09 -49.85 76.03 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.519 0.6 . . . . 0.0 110.261 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.44 -44.7 95.79 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.541 0.609 . . . . 0.0 110.387 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.06 91.78 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.198 0.453 . . . . 0.0 111.919 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.5 mt -58.71 -55.68 31.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.952 0.796 . . . . 0.0 109.739 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -65.59 -20.01 66.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.25 -34.11 65.66 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.37 0.532 . . . . 0.0 111.598 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -122.85 -21.36 5.58 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 29.24 65.95 0.73 Allowed Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 127.07 2.148 . . . . 0.0 113.034 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.87 165.29 14.41 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.533 2.155 . . . . 0.0 112.738 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -80.74 63.93 5.33 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.05 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.37 4.53 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.139 0.976 . . . . 0.0 112.789 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -62.09 -8.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.812 2.845 . . . . 0.0 113.104 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.55 10.4 19.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.713 1.605 . . . . 0.0 110.752 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.41 HG22 ' CD1' ' A' ' 50' ' ' TRP . 1.5 p -132.27 153.08 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 110.813 175.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -107.34 152.42 24.18 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -120.05 156.41 30.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.07 126.59 3.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 106.524 -2.63 . . . . 0.0 106.524 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.22 138.92 31.68 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 mt -139.31 124.45 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.72 -12.05 3.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.066 0.841 . . . . 0.0 114.352 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.7 mm -55.14 133.81 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.229 1.412 . . . . 0.0 107.857 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.88 -21.72 17.72 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.9 m -58.77 -28.85 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -71.09 -22.12 62.14 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.288 0.635 . . . . 0.0 111.844 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -146.21 -62.3 0.31 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -168.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -53.34 -39.35 64.04 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.778 1.631 . . . . 0.0 113.327 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -133.76 15.54 3.97 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.276 0.56 . . . . 0.0 112.316 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.6 p 60.69 160.55 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.757 2.823 . . . . 0.0 115.959 172.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -59.16 -21.24 59.07 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.768 1.227 . . . . 0.0 112.779 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.9 p -115.68 23.6 12.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.632 1.573 . . . . 0.0 111.676 -172.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.5 -42.08 0.04 OUTLIER Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.949 0.785 . . . . 0.0 111.234 176.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.74 171.4 5.26 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.822 0.849 . . . . 0.0 112.462 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.5 pt -73.03 36.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 125.891 1.676 . . . . 0.0 111.482 169.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.18 -16.62 21.39 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.655 1.982 . . . . 0.0 113.6 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -53.09 -27.42 20.23 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.969 0.908 . . . . 0.0 112.639 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.85 -57.38 12.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.677 0.671 . . . . 0.0 109.788 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.39 -36.08 81.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.498 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.8 -50.42 73.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.421 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.81 -42.34 93.26 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.604 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 mt -60.18 -48.15 82.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.844 0.747 . . . . 0.0 111.167 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -67.99 -36.2 79.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.198 0.599 . . . . 0.0 109.867 -177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -31.89 72.8 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.7 1.2 . . . . 0.0 111.798 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.0 m -69.54 -33.49 72.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.803 0.441 . . . . 0.0 110.508 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.65 -38.39 0.3 Allowed Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 169.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.92 174.12 6.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.442 1.121 . . . . 0.0 111.664 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -132.12 145.93 51.71 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -74.25 126.06 29.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.0 m -88.8 157.95 18.31 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.42 -133.02 30.3 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.33 161.68 38.36 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.427 1.091 . . . . 0.0 108.378 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 m -57.45 123.97 17.32 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.85 0.86 . . . . 0.0 111.632 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.21 171.14 15.5 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.161 1.784 . . . . 0.0 108.285 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -137.95 156.81 47.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 121.149 -0.97 . . . . 0.0 109.093 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 138.93 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.01 173.33 4.42 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.907 1.283 . . . . 0.0 108.958 169.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.0 pt -142.87 159.36 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.804 1.241 . . . . 0.0 109.011 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.2 tp 65.29 -45.89 0.36 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 129.228 3.011 . . . . 0.0 116.359 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -156.09 171.32 20.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.064 1.302 . . . . 0.0 110.96 -169.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -58.67 159.8 6.28 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.128 1.371 . . . . 0.0 110.066 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.4 ' HB3' ' H ' ' A' ' 130' ' ' ILE . 40.9 t0 -150.92 -92.84 0.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 122.41 1.1 . . . . 0.0 109.289 -171.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.4 ' H ' ' HB3' ' A' ' 129' ' ' ASP . 29.4 mm -130.95 -48.35 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 128.823 2.849 . . . . 0.0 105.616 169.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -179.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 124.653 3.569 . . . . 0.0 117.846 167.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -124.33 164.84 18.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 109.664 -3.426 . . . . 0.0 107.735 169.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -56.87 116.65 13.88 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.626 1.171 . . . . 0.0 111.561 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.76 160.39 12.14 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.517 2.811 . . . . 0.0 112.541 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.26 144.23 25.44 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.8 0.84 . . . . 0.0 109.277 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.11 -25.83 68.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.208 1.003 . . . . 0.0 110.988 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.45 -32.18 62.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.305 1.042 . . . . 0.0 112.049 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -50.79 72.48 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.839 0.745 . . . . 0.0 110.657 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.54 -52.09 62.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.26 -47.39 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.5 t -61.76 -57.51 11.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -57.24 -43.31 82.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.605 0.762 . . . . 0.0 111.916 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.6 t -59.25 -55.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.726 1.21 . . . . 0.0 109.98 175.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -13.78 62.64 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.591 1.087 . . . . 0.0 112.213 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.95 -48.12 13.91 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.058 0.943 . . . . 0.0 110.825 170.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -71.56 -33.46 69.13 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.892 0.769 . . . . 0.0 112.176 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.3 mttt . . . . . 0 C--O 1.248 1.021 0 C-N-CA 125.022 1.329 . . . . 0.0 109.49 173.614 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.09 37.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.15 0.98 . . . . 0.0 110.117 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.89 -23.76 17.3 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.4 1.48 . . . . 0.0 110.753 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.78 130.38 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.543 1.137 . . . . 0.0 108.327 -174.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 t -89.88 129.07 36.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -111.2 93.68 4.6 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.7 mm -72.16 98.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -86.49 13.85 7.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.541 1.937 . . . . 0.0 114.305 -168.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.98 158.81 31.77 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 118.929 0.786 . . . . 0.0 112.623 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -93.76 -30.72 14.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.446 1.498 . . . . 0.0 111.547 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -124.37 48.51 1.92 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.461 1.124 . . . . 0.0 108.948 -169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.5 tp 56.01 27.87 11.93 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.4 1.48 . . . . 0.0 111.334 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.7 165.05 26.44 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 128.328 2.87 . . . . 0.0 106.869 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.69 -146.6 11.76 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 118.211 1.006 . . . . 0.0 110.862 -173.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.68 50.77 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.499 1.919 . . . . 0.0 112.076 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.62 -29.23 66.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.683 1.193 . . . . 0.0 112.144 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -60.08 -51.31 70.17 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.7 0.682 . . . . 0.0 111.078 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.55 -28.52 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.84 -0.537 . . . . 0.0 109.667 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.9 98.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.646 0.657 . . . . 0.0 110.736 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.55 -40.55 92.98 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.178 0.591 . . . . 0.0 110.566 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.26 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.714 -0.616 . . . . 0.0 110.622 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -60.46 -51.02 71.23 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.563 1.145 . . . . 0.0 109.719 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.19 66.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 111.073 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.89 -52.19 66.11 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.131 0.973 . . . . 0.0 110.653 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -57.33 -37.76 73.04 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.68 -29.72 69.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.833 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -70.64 -44.23 67.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.542 1.519 . . . . 0.0 109.847 171.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.04 -26.53 67.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 0.0 111.406 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.69 -21.12 64.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.809 0.843 . . . . 0.0 111.963 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.28 12.05 1.48 Allowed Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.516 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -127.36 -165.97 1.54 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.603 1.701 . . . . 0.0 109.626 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -131.44 149.94 52.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 p -140.38 153.27 46.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.095 0.474 . . . . 0.0 110.461 -170.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -117.57 89.95 3.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -173.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 m -67.69 120.33 13.89 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -146.0 136.95 24.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.528 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -80.83 35.42 0.37 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.923 -1.111 . . . . 0.0 111.344 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.48 41.79 49.61 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.989 1.757 . . . . 0.0 115.605 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.98 -21.12 50.19 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.718 2.759 . . . . 0.0 114.137 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 42' ' ' GLU . 79.2 mt -121.4 13.13 10.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.743 1.617 . . . . 0.0 108.936 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.4 tp 64.16 -29.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.269 2.627 . . . . 0.0 113.734 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 40' ' ' LEU . 7.5 pt-20 -168.13 91.22 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.004 1.322 . . . . 0.0 107.677 -168.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.77 -43.35 79.99 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.62 152.94 67.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 -173.42 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.99 3.127 . . . . 0.0 112.953 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.8 34.14 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.785 1.634 . . . . 0.0 112.29 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 m -158.08 133.7 8.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.668 1.987 . . . . 0.0 106.893 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.55 -143.17 14.13 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.4 mm -123.49 140.1 48.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -117.76 149.88 40.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -138.63 142.87 39.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.68 123.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.77 117.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -160.44 -175.7 5.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.178 1.791 . . . . 0.0 108.008 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -152.47 72.9 1.0 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.313 -1.492 . . . . 0.0 110.897 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 p -64.52 9.92 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.348 1.859 . . . . 0.0 114.873 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -48.77 158.94 0.27 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.181 1.393 . . . . 0.0 113.08 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.47 -149.09 43.54 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.54 4.48 6.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.95 -146.79 40.39 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -171.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -140.27 168.67 19.27 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.541 1.136 . . . . 0.0 108.654 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.267 20.1 tt -49.93 -38.73 37.85 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -170.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.94 -21.5 15.93 Favored 'Trans proline' 0 C--N 1.356 0.97 0 CA-C-N 123.63 2.332 . . . . 0.0 112.772 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 150.64 -58.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 130.896 3.678 . . . . 0.0 106.438 -169.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 158.65 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 130.661 3.584 . . . . 0.0 105.239 -175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.8 140.56 36.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.37 -57.88 0.11 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.911 -171.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.81 -37.17 0.94 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.04 1.407 . . . . 0.0 111.715 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -59.58 5.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.801 0.84 . . . . 0.0 111.133 -169.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.12 -48.26 79.07 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 124.055 0.847 . . . . 0.0 110.69 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.02 -45.94 83.38 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.852 0.296 . . . . 0.0 110.712 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.133 -0.46 . . . . 0.0 111.73 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -56.77 -55.67 31.27 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.812 0.733 . . . . 0.0 109.511 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -68.18 -18.66 64.65 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.53 -32.1 64.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.449 0.568 . . . . 0.0 111.693 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -122.45 -25.18 4.82 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 32.26 62.78 1.3 Allowed Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 127.139 2.175 . . . . 0.0 112.375 -176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.87 164.52 21.49 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -79.75 65.32 4.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 -174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.39 16.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.914 1.686 . . . . 0.0 113.039 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.7 p -66.03 -2.34 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 119.746 -1.846 . . . . 0.0 112.87 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.6 12.78 9.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.186 1.794 . . . . 0.0 110.777 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.6 158.83 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.654 0.74 . . . . 0.0 110.989 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -128.58 154.56 46.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.152 1.381 . . . . 0.0 107.469 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -113.77 167.83 10.3 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.34 120.04 2.12 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.47 34.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.8 mt -133.45 126.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.68 -18.55 2.96 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.953 1.263 . . . . 0.0 113.507 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -46.53 142.37 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.71 2.404 . . . . 0.0 110.539 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.35 15.02 8.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.042 1.782 . . . . 0.0 111.373 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.5 m -64.33 -18.79 64.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.954 1.302 . . . . 0.0 112.359 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -158.1 167.12 30.74 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.719 1.607 . . . . 0.0 108.786 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 73.7 -27.26 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 129.978 3.311 . . . . 0.0 113.287 169.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -154.98 138.48 15.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.054 0.942 . . . . 0.0 111.027 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.9 t0 38.36 45.73 0.85 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.289 2.636 . . . . 0.0 114.475 174.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.82 169.11 8.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.215 1.406 . . . . 0.0 111.919 174.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -146.45 157.97 43.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.023 1.729 . . . . 0.0 106.895 169.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.8 m -76.05 67.97 2.45 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.555 1.142 . . . . 0.0 109.706 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.28 -178.04 21.39 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 123.961 0.791 . . . . 0.0 112.015 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.58 -1.01 4.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.267 1.427 . . . . 0.0 114.495 -171.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.1 pt -54.18 -30.53 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.296 1.438 . . . . 0.0 113.279 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.2 -29.39 69.04 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.801 0.84 . . . . 0.0 112.41 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.42 -23.84 67.05 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.705 -169.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.48 -55.79 30.45 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.324 0.965 . . . . 0.0 109.54 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -71.14 -34.27 70.86 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.341 0.656 . . . . 0.0 109.684 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.94 87.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.003 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.66 -38.26 88.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.572 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.04 -50.27 74.72 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.298 0.954 . . . . 0.0 111.018 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.335 4.8 ptmm? -73.49 -27.98 61.68 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.897 -0.502 . . . . 0.0 112.321 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -37.74 87.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.453 1.101 . . . . 0.0 110.574 169.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -69.18 -36.24 77.12 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.543 0.337 . . . . 0.0 110.136 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.03 -20.69 0.36 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.52 -1.156 . . . . 0.0 114.99 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.31 -177.51 3.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.738 1.269 . . . . 0.0 111.139 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -141.59 152.87 44.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.104 1.362 . . . . 0.0 107.342 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -76.23 128.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -81.54 141.68 33.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.61 0.61 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.338 0.97 . . . . 0.0 111.871 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.14 178.11 10.66 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.266 2.226 . . . . 0.0 107.051 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.2 m -70.87 131.18 43.39 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.012 -1.055 . . . . 0.0 108.576 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.6 tt -83.01 147.83 27.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -131.9 136.58 47.51 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.04 136.07 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 123.924 0.89 . . . . 0.0 109.284 -174.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.02 171.57 12.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.229 1.811 . . . . 0.0 107.59 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 39.9 pt -136.5 -173.38 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.103 1.761 . . . . 0.0 107.611 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.9 tp -53.99 -38.03 64.64 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.388 0.675 . . . . 0.0 111.16 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -76.21 64.59 2.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.878 1.271 . . . . 0.0 108.789 169.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -66.44 165.72 13.8 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.907 2.083 . . . . 0.0 112.001 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.89 -63.1 0.26 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.065 0.946 . . . . 0.0 112.254 -170.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.5 mt -133.65 -66.64 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 117.095 -1.431 . . . . 0.0 111.251 -169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.43 -33.24 2.55 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.338 2.025 . . . . 0.0 112.36 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 68.29 19.54 8.98 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.086 1.754 . . . . 0.0 112.402 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -144.95 139.94 15.72 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.482 1.113 . . . . 0.0 109.835 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -83.99 -13.01 8.09 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.627 2.885 . . . . 0.0 115.149 -175.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 33.61 45.34 0.09 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.123 2.569 . . . . 0.0 114.807 -174.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.76 -22.56 66.67 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.308 -0.87 . . . . 0.0 112.692 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.85 -28.23 69.35 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.926 0.89 . . . . 0.0 111.614 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -56.08 -57.92 10.12 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 109.244 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tp -53.07 -53.05 55.97 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.635 1.209 . . . . 0.0 110.062 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.97 -53.09 48.02 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -64.67 -45.26 87.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.471 0.635 . . . . 0.0 110.357 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -61.6 -41.37 97.36 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.214 1.006 . . . . 0.0 110.864 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.35 -48.53 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.135 0.574 . . . . 0.0 109.569 172.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.44 -28.86 70.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.193 0.906 . . . . 0.0 111.785 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mp -78.8 -45.78 20.2 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.263 1.025 . . . . 0.0 110.504 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.5 65.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.348 0.522 . . . . 0.0 111.702 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.302 1.041 . . . . 0.0 110.049 171.863 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.59 156.97 43.34 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 0.0 108.431 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.86 -24.12 12.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 110.817 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.2 mt -130.0 122.86 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 t -88.37 132.76 34.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.85 97.24 7.87 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 mm -83.92 70.55 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.57 165.56 23.57 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.298 0.57 . . . . 0.0 110.704 -177.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.08 -174.34 50.95 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 p -144.66 -53.95 0.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.8 p -87.1 40.09 0.9 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.177 1.791 . . . . 0.0 109.631 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp 62.88 24.86 14.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.821 1.648 . . . . 0.0 112.003 -169.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.14 164.44 33.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.76 170.72 20.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.069 1.319 . . . . 0.0 111.198 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 55.63 -1.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.238 2.615 . . . . 0.0 117.449 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.58 -32.95 69.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.43 1.468 . . . . 0.0 112.262 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -58.64 -43.58 89.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.979 0.512 . . . . 0.0 111.163 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.31 -37.86 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.93 83.89 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.089 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.53 -45.12 95.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.917 0.781 . . . . 0.0 110.421 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -64.97 -46.51 81.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.973 0.352 . . . . 0.0 110.093 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.16 -54.17 48.38 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.023 0.929 . . . . 0.0 110.301 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.22 -43.59 74.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.341 1.056 . . . . 0.0 111.17 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -61.31 -54.11 48.15 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.813 0.733 . . . . 0.0 110.596 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -57.94 -36.23 72.22 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.4 mt -71.95 -26.23 62.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.092 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.38 -41.23 73.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 120.241 1.382 . . . . 0.0 108.911 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.18 -26.31 68.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.534 0.734 . . . . 0.0 111.458 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.54 -14.0 62.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.966 0.907 . . . . 0.0 111.745 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.92 17.23 6.95 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.845 -0.975 . . . . 0.0 113.594 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -122.73 -168.99 1.84 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.684 1.242 . . . . 0.0 109.853 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -126.15 153.2 44.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.7 p -143.33 159.31 42.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.827 -0.546 . . . . 0.0 110.06 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.31 97.81 4.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -69.91 122.56 19.53 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -147.07 175.72 10.49 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.982 1.313 . . . . 0.0 108.663 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -120.21 39.97 3.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 108.482 169.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.99 46.41 32.68 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 117.599 -1.667 . . . . 0.0 115.108 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -64.37 -22.09 66.27 Favored 'Trans proline' 0 C--N 1.35 0.651 0 CA-C-N 121.205 2.502 . . . . 0.0 113.616 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.71 8.78 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.028 1.731 . . . . 0.0 109.832 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 58.33 -14.79 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.502 2.721 . . . . 0.0 115.197 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -159.26 76.32 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 120.004 1.274 . . . . 0.0 109.438 -169.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.32 -47.85 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.593 -0.692 . . . . 0.0 109.529 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.65 153.43 58.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.32 -176.5 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.14 3.227 . . . . 0.0 113.301 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.43 33.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.874 1.67 . . . . 0.0 112.567 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -159.76 133.42 7.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.238 2.215 . . . . 0.0 106.792 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.7 -144.96 16.4 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -121.35 146.99 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.416 ' CD1' HG22 ' A' ' 83' ' ' VAL . 4.9 m95 -133.34 153.81 51.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.5 mt -136.61 143.35 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -123.24 131.85 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.7 91.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -142.57 -170.78 3.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.264 1.825 . . . . 0.0 107.908 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m -144.61 133.27 22.23 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p -133.81 1.17 3.3 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -171.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -58.78 135.19 57.4 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.747 1.158 . . . . 0.0 108.287 169.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.96 32.42 75.26 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -173.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.65 6.77 1.65 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.874 2.47 . . . . 0.0 114.544 -169.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.26 -164.97 12.4 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.932 1.254 . . . . 0.0 111.286 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.44 -24.22 66.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.689 0.796 . . . . 0.0 112.86 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 pt -138.4 163.34 47.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.719 2.007 . . . . 0.0 107.629 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -56.01 -16.04 15.37 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.154 3.236 . . . . 0.0 116.74 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -142.96 63.74 1.37 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.751 1.22 . . . . 0.0 107.926 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -60.95 -34.16 74.3 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.379 1.072 . . . . 0.0 113.839 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.2 55.63 3.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -54.7 52.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.433 -0.792 . . . . 0.0 112.445 -168.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -77.84 -41.36 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.568 2.178 . . . . 0.0 110.514 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.12 -51.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.347 0.659 . . . . 0.0 110.937 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.23 -43.55 91.06 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.99 0.814 . . . . 0.0 110.476 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -62.54 -47.27 84.64 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.832 0.742 . . . . 0.0 110.256 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.13 -32.09 72.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.89 -59.69 4.97 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.178 0.899 . . . . 0.0 109.437 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.28 -17.2 62.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.01 -35.06 79.08 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.242 0.617 . . . . 0.0 111.129 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.0 -22.03 4.21 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 33.7 63.22 1.66 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.81 164.23 16.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.027 2.485 . . . . 0.0 113.634 -169.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -80.42 64.97 5.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.54 1.136 . . . . 0.0 111.234 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.12 17.05 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 113.063 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 p -66.78 -2.87 5.56 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 119.922 -1.736 . . . . 0.0 112.789 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.1 11.97 9.56 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.1 1.76 . . . . 0.0 110.946 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -130.29 156.11 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.73 0.776 . . . . 0.0 111.439 176.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -121.33 152.47 38.92 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 108.323 169.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.401 ' CZ ' ' CE3' ' A' ' 50' ' ' TRP . 5.8 m-85 -123.69 166.96 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.599 -169.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.91 144.48 12.96 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.969 -2.852 . . . . 0.0 105.969 168.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.36 125.54 50.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.434 ' C ' ' H ' ' A' ' 90' ' ' ILE . 34.3 mt -129.59 133.12 65.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -169.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.64 -28.42 1.54 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.799 1.19 . . . . 0.0 112.091 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.434 ' H ' ' C ' ' A' ' 88' ' ' ILE . 62.2 mt -48.83 138.77 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.509 2.724 . . . . 0.0 108.404 173.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.2 -0.0 35.39 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.344 1.45 . . . . 0.0 111.468 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 m -58.17 -0.11 0.08 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.995 2.518 . . . . 0.0 115.81 -172.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.408 ' C ' ' H ' ' A' ' 95' ' ' TYR . 4.6 mmp_? -144.56 146.56 32.41 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 168.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 70.87 -21.07 0.2 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.675 2.79 . . . . 0.0 113.252 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 93' ' ' ARG . 4.9 t80 -132.54 -0.17 3.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.1 1.36 . . . . 0.0 111.862 -169.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -94.42 3.54 55.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.636 1.574 . . . . 0.0 113.569 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.5 p -76.32 -3.6 37.61 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.41 1.484 . . . . 0.0 113.334 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -76.58 -19.45 57.86 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.52 1.928 . . . . 0.0 110.987 170.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.3 31.52 3.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.991 1.716 . . . . 0.0 109.701 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.28 -80.84 1.24 Allowed Glycine 0 C--N 1.338 0.667 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -161.16 148.16 15.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.1 1.36 . . . . 0.0 108.582 169.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.0 mm -127.27 2.71 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 126.732 2.013 . . . . 0.0 108.728 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -43.22 -29.14 0.36 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.68 1.992 . . . . 0.0 113.965 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -45.51 -35.71 4.04 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.64 1.576 . . . . 0.0 113.099 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.68 -57.28 13.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.653 0.661 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -34.66 78.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.846 0.458 . . . . 0.0 110.245 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.54 94.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.03 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.53 -38.49 90.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.995 0.816 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.48 -44.36 87.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.835 0.743 . . . . 0.0 111.408 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -67.33 -36.05 80.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.537 0.735 . . . . 0.0 109.816 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -36.26 82.44 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.207 1.403 . . . . 0.0 111.332 172.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.6 m -67.56 -35.4 78.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.861 0.464 . . . . 0.0 110.521 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.86 -24.6 0.3 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.686 -1.063 . . . . 0.0 115.061 169.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.94 170.96 11.61 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.617 1.208 . . . . 0.0 111.384 -173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -121.62 133.18 54.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -78.78 102.27 8.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 169.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 m -70.77 150.79 45.52 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.86 -129.24 26.96 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.3 pt-20 -153.99 174.93 14.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.908 1.283 . . . . 0.0 108.592 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -59.52 129.79 43.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.108 0.963 . . . . 0.0 110.604 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.4 148.51 22.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.21 2.204 . . . . 0.0 107.946 -173.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -125.99 146.51 49.85 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.61 157.16 26.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 125.265 1.426 . . . . 0.0 109.374 -169.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -164.07 29.6 0.08 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.317 0.647 . . . . 0.0 111.359 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.6 tp -64.81 100.04 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.274 1.03 . . . . 0.0 110.254 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.0 tp 47.96 32.0 2.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.687 1.995 . . . . 0.0 112.447 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -160.72 155.01 23.2 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.57 1.548 . . . . 0.0 108.067 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.07 153.62 51.69 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.115 1.366 . . . . 0.0 108.834 -177.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -151.76 -70.88 0.16 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.76 0.791 . . . . 0.0 110.944 -169.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.5 ' H ' ' HD2' ' A' ' 131' ' ' PRO . 8.3 mm -145.83 -52.6 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.454 1.901 . . . . 0.0 113.038 -169.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.5 ' HD2' ' H ' ' A' ' 130' ' ' ILE . 63.8 Cg_endo -75.51 -46.4 0.22 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 121.876 1.706 . . . . 0.0 112.47 -171.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 49.99 34.85 8.66 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.162 1.785 . . . . 0.0 111.991 -174.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -153.71 81.43 4.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.364 1.466 . . . . 0.0 108.504 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.68 153.53 75.77 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.637 2.224 . . . . 0.0 111.533 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -144.87 41.84 1.31 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.026 1.33 . . . . 0.0 109.967 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -58.16 -19.73 35.3 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.319 1.448 . . . . 0.0 114.304 -169.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -57.64 -25.86 60.77 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.09 0.956 . . . . 0.0 111.731 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.428 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.34 -42.3 77.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.018 172.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.98 -48.84 77.1 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.92 -47.42 59.52 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.074 0.858 . . . . 0.0 111.437 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -62.57 -55.0 31.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.529 0.665 . . . . 0.0 110.166 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -55.04 -39.78 69.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.49 1.916 . . . . 0.0 111.34 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.31 -58.83 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 109.733 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -16.01 63.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.274 0.943 . . . . 0.0 112.303 -172.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.12 -38.46 61.1 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.023 0.929 . . . . 0.0 111.236 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -34.8 44.87 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.647 0.779 . . . . 0.0 111.878 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttm . . . . . 0 C--O 1.248 1.015 0 C-N-CA 125.233 1.413 . . . . 0.0 109.867 171.193 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.3 161.06 43.18 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.004 0.922 . . . . 0.0 110.179 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.88 -23.9 16.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.769 1.627 . . . . 0.0 110.479 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.5 mt -135.18 127.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.532 1.133 . . . . 0.0 108.023 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 t -88.2 126.66 35.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.68 95.58 6.14 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.856 1.262 . . . . 0.0 108.885 -169.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -76.36 159.38 30.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.52 9.17 0.03 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.02 123.81 17.15 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.227 2.014 . . . . 0.0 109.587 175.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p 38.21 57.57 1.62 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.57 1.948 . . . . 0.0 113.573 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.1 tp 51.26 63.18 2.35 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 111.372 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.16 -149.77 17.28 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.3 -179.69 38.98 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 117.736 0.768 . . . . 0.0 111.929 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.06 56.16 0.76 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.008 1.323 . . . . 0.0 109.642 171.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.44 -28.91 67.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.363 -0.836 . . . . 0.0 112.228 -172.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -62.14 -40.9 97.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.971 0.805 . . . . 0.0 110.854 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.16 -37.73 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.72 87.6 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.885 0.766 . . . . 0.0 110.952 174.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.21 -40.05 82.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.298 0.639 . . . . 0.0 110.931 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.11 -46.22 88.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.457 -0.777 . . . . 0.0 110.396 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.1 mt -55.99 -52.69 63.28 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.599 1.159 . . . . 0.0 109.894 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.12 -49.97 59.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.533 1.133 . . . . 0.0 110.924 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.29 -53.93 49.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 110.576 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -60.61 -39.39 87.99 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.51 -33.68 76.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.166 0.587 . . . . 0.0 111.52 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.73 -37.14 67.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.846 -1.159 . . . . 0.0 110.265 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.03 -30.15 70.77 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.668 0.667 . . . . 0.0 111.113 170.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.65 62.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 111.797 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.27 -2.53 6.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.247 -1.307 . . . . 0.0 114.257 169.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -101.25 -168.23 1.53 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.564 1.682 . . . . 0.0 110.104 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -128.36 150.92 49.89 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.3 p -142.9 154.59 44.26 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.9 -0.5 . . . . 0.0 111.836 -169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -119.81 99.37 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.463 1.505 . . . . 0.0 107.966 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -73.97 122.58 22.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.61 169.95 17.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.849 0.859 . . . . 0.0 111.06 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -119.6 39.57 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.197 1.799 . . . . 0.0 108.789 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 51.62 11.58 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.858 -1.523 . . . . 0.0 114.801 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -21.94 64.67 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 120.662 2.231 . . . . 0.0 113.389 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.87 16.75 6.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.552 1.941 . . . . 0.0 108.741 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 tp 59.9 -25.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.354 3.062 . . . . 0.0 115.076 -169.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.42 85.68 0.86 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -168.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.91 -44.8 88.37 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.536 -0.727 . . . . 0.0 109.847 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.22 151.29 59.59 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.52 -176.79 1.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 124.128 3.219 . . . . 0.0 113.087 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.26 31.88 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.989 1.716 . . . . 0.0 112.933 172.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.4 m -158.93 121.79 3.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.699 2.0 . . . . 0.0 106.445 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.16 -142.88 11.49 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -122.29 136.26 59.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.413 ' CD1' HG21 ' A' ' 83' ' ' VAL . 12.1 m0 -119.41 137.31 53.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 172.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 mt -131.81 137.69 48.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 173.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.82 137.72 53.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.07 113.01 23.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -161.73 -178.18 6.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.117 1.367 . . . . 0.0 108.457 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 m -133.18 124.85 28.2 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 p -122.05 2.41 9.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.024 0.93 . . . . 0.0 113.301 -169.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -142.94 148.43 36.88 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 170.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.76 -33.45 0.72 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.014 1.292 . . . . 0.0 114.875 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.34 44.74 1.42 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.602 1.561 . . . . 0.0 110.42 -170.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.42 -158.78 7.82 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -149.45 77.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.794 1.638 . . . . 0.0 106.76 -172.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.1 pt -46.96 -29.99 1.12 Allowed Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 -169.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -57.84 -31.93 93.68 Favored 'Trans proline' 0 C--N 1.353 0.788 0 CA-C-N 123.833 2.405 . . . . 0.0 113.982 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -160.11 45.21 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.368 1.08 . . . . 0.0 109.799 -171.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -31.69 65.41 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.237 1.815 . . . . 0.0 114.662 -169.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -129.68 90.28 2.96 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -53.74 31.51 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 124.857 1.263 . . . . 0.0 113.209 -168.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.47 -38.59 8.21 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.175 1.25 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -57.83 8.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.774 -170.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.58 -47.16 86.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.704 -171.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -64.5 -48.64 74.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.626 0.648 . . . . 0.0 110.539 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.41 -26.24 67.89 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.8 mt -62.34 -62.4 1.78 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.238 0.926 . . . . 0.0 108.868 170.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -67.18 -19.57 65.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.45 -34.49 78.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.601 0.76 . . . . 0.0 111.462 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.39 -23.19 2.4 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.84 63.13 1.01 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 127.13 2.172 . . . . 0.0 113.077 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 166.85 17.89 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.968 2.445 . . . . 0.0 113.164 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.66 63.8 5.21 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.954 1.302 . . . . 0.0 111.343 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.91 9.87 0.48 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.273 1.429 . . . . 0.0 113.074 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -63.93 -2.48 1.93 Allowed 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.105 2.962 . . . . 0.0 113.235 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.06 9.71 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.991 1.716 . . . . 0.0 110.919 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.413 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -124.65 146.44 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.916 0.865 . . . . 0.0 111.401 172.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -97.67 141.26 30.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.63 153.04 32.0 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.581 1.952 . . . . 0.0 107.537 -174.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.67 149.55 21.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.96 134.95 54.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.8 mt -134.8 128.79 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.17 -29.08 1.65 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.389 0.995 . . . . 0.0 112.461 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.1 mt -47.97 117.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.784 2.434 . . . . 0.0 107.849 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.01 -41.01 28.62 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.888 1.708 . . . . 0.0 111.079 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -51.37 106.56 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.085 1.754 . . . . 0.0 110.208 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -150.55 -172.29 4.15 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.232 1.813 . . . . 0.0 107.19 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -60.85 -20.75 62.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.8 1.24 . . . . 0.0 111.537 169.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -139.31 -173.49 3.61 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.498 2.719 . . . . 0.0 108.413 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t0 48.01 43.63 18.11 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.793 1.282 . . . . 0.0 111.122 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.7 m -151.82 66.55 0.86 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -169.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -126.7 -16.16 5.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.9 p -134.05 16.66 3.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.294 0.952 . . . . 0.0 112.219 175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.71 166.54 30.6 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.221 1.391 . . . . 0.0 110.11 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.69 150.2 24.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.115 1.366 . . . . 0.0 108.131 171.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 40.64 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.69 -22.88 25.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.148 1.379 . . . . 0.0 112.068 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -52.71 -29.83 28.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.594 1.157 . . . . 0.0 112.748 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.57 -54.32 48.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.41 1.004 . . . . 0.0 109.678 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -67.66 -37.66 82.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.761 1.224 . . . . 0.0 108.673 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.9 79.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.527 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.82 -34.95 79.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.136 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.55 -49.99 75.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.745 1.157 . . . . 0.0 111.201 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -69.28 -34.28 74.48 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.727 0.811 . . . . 0.0 109.938 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -37.78 84.16 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.763 1.625 . . . . 0.0 111.231 172.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -65.86 -40.49 91.72 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.35 -20.61 0.4 Allowed Glycine 0 C--N 1.341 0.827 0 CA-C-O 117.811 -1.55 . . . . 0.0 115.135 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 132.82 49.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.699 1.749 . . . . 0.0 109.453 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -83.84 114.67 21.81 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -64.02 114.67 4.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 170.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.4 m -126.65 115.08 18.9 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.32 103.78 2.37 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -169.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -52.95 137.26 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.149 -1.526 . . . . 0.0 107.379 169.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.2 m -47.87 116.42 1.49 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.722 1.609 . . . . 0.0 111.347 -169.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.69 153.8 26.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.188 1.795 . . . . 0.0 107.718 -169.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -129.09 146.5 51.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp -135.39 163.0 36.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 124.549 1.139 . . . . 0.0 111.252 -169.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.89 141.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 130.262 3.425 . . . . 0.0 115.31 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 7.7 tp -150.01 9.8 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 124.402 1.081 . . . . 0.0 110.936 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.29 -29.42 70.42 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.155 -0.966 . . . . 0.0 111.436 -176.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -149.18 167.92 24.64 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.555 1.942 . . . . 0.0 106.704 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -56.72 148.06 21.27 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.1 0.56 . . . . 0.0 109.668 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -154.93 -126.38 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.473 0.709 . . . . 0.0 110.184 -173.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.5 mm -135.6 -61.92 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 127.394 2.278 . . . . 0.0 109.037 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.92 -48.91 2.46 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.271 1.981 . . . . 0.0 110.039 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 44.53 68.0 0.61 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.878 2.071 . . . . 0.0 113.107 169.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -150.64 140.59 13.99 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 121.407 -0.808 . . . . 0.0 111.293 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.1 -19.15 19.53 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.337 3.358 . . . . 0.0 116.731 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 68.68 -36.92 0.34 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.661 2.784 . . . . 0.0 115.153 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.16 -33.04 70.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.545 0.738 . . . . 0.0 112.702 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.08 -37.39 72.45 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.027 -0.421 . . . . 0.0 110.443 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -45.26 77.92 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.437 0.695 . . . . 0.0 109.871 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.69 -52.6 65.02 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.48 95.01 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.047 0.84 . . . . 0.0 112.051 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -59.29 -62.94 1.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.074 1.35 . . . . 0.0 110.239 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -56.09 -44.78 79.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.612 1.165 . . . . 0.0 111.978 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.4 -55.92 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.848 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -16.29 63.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.81 1.186 . . . . 0.0 112.053 -174.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.1 mp -78.2 -47.22 18.52 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.535 0.734 . . . . 0.0 111.029 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.18 -32.54 64.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.0 0.818 . . . . 0.0 112.329 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.7 mttt . . . . . 0 C--O 1.249 1.028 0 C-N-CA 124.752 1.221 . . . . 0.0 109.611 173.34 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 tpp . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.02 160.16 43.14 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.575 1.15 . . . . 0.0 108.917 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.61 -25.13 13.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.43 1.492 . . . . 0.0 111.059 175.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.56 121.77 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -83.88 130.55 34.91 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.56 109.6 21.33 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.5 mt -103.66 94.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.22 14.82 27.07 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.06 0.944 . . . . 0.0 112.075 -171.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.64 58.87 4.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.128 -171.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -54.6 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.741 1.27 . . . . 0.0 110.25 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m 57.7 42.3 23.95 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.78 0.832 . . . . 0.0 110.804 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.1 39.56 29.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.236 1.815 . . . . 0.0 111.398 -169.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.94 -145.3 7.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.493 1.996 . . . . 0.0 109.7 173.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 16' ' ' GLU . . . -160.72 62.12 0.29 Allowed Glycine 0 C--N 1.334 0.447 0 CA-C-N 117.556 0.678 . . . . 0.0 111.902 -172.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.53 19.96 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.5 1.12 . . . . 0.0 112.476 172.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 14' ' ' GLY . 44.7 mt-10 -62.9 -20.19 64.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 112.482 -170.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.93 -40.4 76.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.237 0.926 . . . . 0.0 111.326 176.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.96 -41.42 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.776 -176.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.23 -43.55 94.61 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 110.43 175.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -66.35 -44.41 83.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.044 -0.41 . . . . 0.0 110.039 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.46 -52.45 65.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.159 0.584 . . . . 0.0 110.733 177.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.27 -45.37 65.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.287 1.035 . . . . 0.0 110.76 176.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.33 -54.2 48.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.158 0.89 . . . . 0.0 110.484 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -57.66 -43.75 85.19 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 123.646 0.778 . . . . 0.0 112.275 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -69.15 -34.49 75.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.919 0.887 . . . . 0.0 111.356 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.9 -44.05 73.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.316 -0.865 . . . . 0.0 109.642 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -71.65 -18.52 62.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.174 0.897 . . . . 0.0 111.954 174.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -18.95 63.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.83 0.741 . . . . 0.0 111.083 169.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.09 12.54 5.78 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.267 -1.296 . . . . 0.0 114.442 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -117.8 -172.08 2.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.411 1.606 . . . . 0.0 109.93 -174.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -124.13 153.99 40.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 170.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -142.54 158.91 43.18 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.838 -0.539 . . . . 0.0 109.93 -169.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.2 99.24 5.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 m -72.18 118.88 15.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.0 mt -149.48 164.95 33.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.625 0.726 . . . . 0.0 111.585 -169.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -106.12 35.68 2.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.393 1.477 . . . . 0.0 108.506 168.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.74 14.26 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.963 -175.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.5 -20.31 65.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 120.871 2.335 . . . . 0.0 113.864 -173.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 42' ' ' GLU . 85.3 mt -116.25 9.89 14.69 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.654 . . . . 0.0 109.766 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt 60.38 -18.19 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.406 2.682 . . . . 0.0 114.627 -169.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 40' ' ' LEU . 6.3 pt-20 -166.3 75.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.498 1.519 . . . . 0.0 107.232 -169.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.38 -44.61 96.04 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.773 -0.579 . . . . 0.0 109.818 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.6 mt -89.24 150.39 44.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.42 -177.45 1.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.674 2.916 . . . . 0.0 113.106 -175.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.08 35.51 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.65 1.58 . . . . 0.0 111.898 169.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -157.69 125.15 5.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.973 2.109 . . . . 0.0 106.272 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.96 -145.23 17.19 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -174.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.4 mm -126.48 144.34 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -127.1 158.12 37.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -143.28 143.79 31.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.15 135.35 62.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.17 124.59 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -170.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.0 m -163.98 -167.48 1.37 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.216 2.206 . . . . 0.0 107.1 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.1 m -148.88 62.57 1.06 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.435 -1.415 . . . . 0.0 108.0 172.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -55.51 -26.75 44.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.569 1.548 . . . . 0.0 114.128 -169.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -61.08 -22.82 64.97 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 176.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 171.31 16.15 0.02 OUTLIER Glycine 0 C--N 1.341 0.857 0 N-CA-C 117.436 1.735 . . . . 0.0 117.436 176.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.58 24.12 2.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.384 1.073 . . . . 0.0 111.095 176.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.7 163.58 51.74 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 169.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.67 -24.18 61.79 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.981 -0.717 . . . . 0.0 112.188 -175.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.7 tp -143.94 152.22 54.69 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 171.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.81 -34.08 63.72 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.526 2.151 . . . . 0.0 115.532 -176.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.54 -47.09 70.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.866 0.757 . . . . 0.0 110.84 174.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 31.2 t30 58.32 143.4 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 130.701 3.601 . . . . 0.0 115.269 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.1 mt 52.75 46.23 27.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 108.575 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 m -75.88 -49.5 3.43 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 124.549 1.14 . . . . 0.0 111.833 -170.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 -34.45 41.59 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.97 1.382 . . . . 0.0 110.584 176.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -59.69 -51.3 70.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.976 0.911 . . . . 0.0 110.125 173.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -55.46 -48.29 74.73 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.48 1.112 . . . . 0.0 110.846 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -65.65 -41.65 92.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.523 0.601 . . . . 0.0 111.453 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.6 84.83 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.666 0.666 . . . . 0.0 111.326 -178.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.63 -57.35 12.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.777 0.717 . . . . 0.0 109.816 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -69.2 -15.57 63.42 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.65 -32.09 63.83 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.85 0.75 . . . . 0.0 111.295 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.78 -30.1 4.52 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -173.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 26.64 70.37 0.43 Allowed Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.06 2.144 . . . . 0.0 113.331 -172.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -58.15 176.65 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.791 2.327 . . . . 0.0 112.004 174.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -90.02 76.16 7.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.73 0.812 . . . . 0.0 110.342 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.74 5.63 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.617 0.767 . . . . 0.0 112.557 -175.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 m -65.14 -5.51 6.9 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 127.839 2.456 . . . . 0.0 113.268 -176.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.93 8.74 26.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.469 1.508 . . . . 0.0 110.702 176.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.94 160.54 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 122.146 0.974 . . . . 0.0 110.945 176.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -129.11 154.11 47.02 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.08 1.752 . . . . 0.0 106.929 172.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -127.38 173.9 9.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.534 0.683 . . . . 0.0 109.428 178.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.13 157.87 26.17 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.64 125.13 41.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 90' ' ' ILE . 33.0 mt -129.31 134.08 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -168.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.71 -31.78 1.69 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.537 1.541 . . . . 0.0 112.009 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.423 ' H ' ' C ' ' A' ' 88' ' ' ILE . 75.3 mt -47.88 154.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 129.583 3.153 . . . . 0.0 110.857 176.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.63 -15.1 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.051 -0.86 . . . . 0.0 114.73 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.9 m -61.57 132.32 52.95 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.304 1.052 . . . . 0.0 109.805 177.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -148.73 170.64 17.73 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.807 2.043 . . . . 0.0 106.939 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -55.4 -21.52 16.0 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.518 1.527 . . . . 0.0 113.363 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -117.74 4.77 12.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.541 1.537 . . . . 0.0 112.37 -177.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.01 17.2 23.81 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.101 0.953 . . . . 0.0 110.731 175.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 p -70.2 17.53 0.06 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.39 2.676 . . . . 0.0 115.157 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -128.45 -9.55 5.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.546 1.538 . . . . 0.0 111.026 174.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.44 24.46 2.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.903 1.281 . . . . 0.0 111.04 -173.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 102' ' ' ILE . . . -155.22 -167.27 16.6 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -176.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.52 18.8 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.087 2.155 . . . . 0.0 113.163 179.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.405 ' H ' ' C ' ' A' ' 100' ' ' GLY . 2.3 mt 49.3 32.43 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 126.539 1.936 . . . . 0.0 110.452 -169.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 57.04 11.12 0.91 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.571 1.948 . . . . 0.0 114.022 -177.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -64.91 -42.17 94.96 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.541 -1.349 . . . . 0.0 113.33 -169.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.55 -53.15 58.98 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 47.9 mp0 -61.24 -41.18 96.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.595 1.158 . . . . 0.0 110.455 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.77 76.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.49 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.246 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 mt -58.65 -46.64 86.7 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.427 1.012 . . . . 0.0 110.867 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -67.34 -41.26 85.48 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.462 0.705 . . . . 0.0 109.723 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -30.85 71.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.043 1.337 . . . . 0.0 111.331 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 m -74.16 -13.88 60.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.25 0.22 . . . . 0.0 111.496 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.48 -24.33 3.73 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 121.174 -0.954 . . . . 0.0 113.033 169.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.25 167.8 15.54 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.053 0.927 . . . . 0.0 110.631 -177.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -120.54 144.3 48.13 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -83.68 104.73 14.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 83.2 m -70.38 153.46 42.97 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 -131.29 21.43 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 178.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.426 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.4 pt-20 -150.43 178.56 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.192 1.397 . . . . 0.0 107.862 169.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.49 123.08 9.03 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.927 1.291 . . . . 0.0 109.824 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.55 155.75 17.13 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.61 1.564 . . . . 0.0 107.712 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -139.33 151.4 46.36 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.112 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -144.05 124.77 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 126.125 1.77 . . . . 0.0 106.718 -169.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -164.06 -177.8 5.23 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.332 -0.855 . . . . 0.0 112.23 176.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.6 tt -151.39 174.66 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.058 1.743 . . . . 0.0 107.773 -171.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.42 -35.64 60.64 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.986 1.315 . . . . 0.0 112.225 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -75.03 77.09 2.22 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -56.75 156.15 6.84 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -169.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -140.46 -170.21 2.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.995 2.518 . . . . 0.0 107.873 171.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.99 -50.3 75.77 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.352 1.861 . . . . 0.0 113.384 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -63.9 -38.93 35.67 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.405 2.07 . . . . 0.0 111.502 178.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 72.34 -26.35 0.18 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.812 2.445 . . . . 0.0 114.532 169.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -144.73 124.49 7.18 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 123.995 0.918 . . . . 0.0 109.826 -171.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.22 157.38 57.37 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.682 2.255 . . . . 0.0 111.64 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -139.82 41.08 2.0 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.194 1.398 . . . . 0.0 109.707 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.15 -19.01 17.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.254 1.422 . . . . 0.0 114.804 -169.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.62 -26.32 65.37 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.416 -0.803 . . . . 0.0 111.458 173.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . 0.426 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -61.11 -42.04 97.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.599 0.76 . . . . 0.0 110.281 172.257 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.93 -49.68 73.82 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.96 -46.62 68.61 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 123.823 0.702 . . . . 0.0 111.721 177.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.1 m -62.47 -59.17 5.34 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.345 1.458 . . . . 0.0 110.818 177.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -49.8 -41.72 45.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.969 2.108 . . . . 0.0 111.872 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.0 t -63.96 -58.41 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 125.182 1.393 . . . . 0.0 109.813 173.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -15.74 63.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.311 0.959 . . . . 0.0 112.324 -173.085 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.87 -41.55 59.57 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.022 0.929 . . . . 0.0 111.168 170.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.5 -31.27 42.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -176.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.1 1.36 . . . . 0.0 109.721 169.972 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 tpp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.23 161.9 41.89 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.887 0.875 . . . . 10.0 110.287 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.11 -18.62 21.6 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.751 1.22 . . . . 10.0 110.984 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mt -137.22 129.15 42.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 C-N-CA 124.399 1.08 . . . . 10.0 108.429 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 t -91.41 137.62 32.22 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.645 -1.242 . . . . 10.0 107.645 168.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -112.4 91.75 3.77 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 104.614 -2.365 . . . . 10.0 104.614 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.4 104.08 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.4 1.48 . . . . 10.0 107.195 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -128.69 46.09 2.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.469 0.708 . . . . 10.0 111.868 -154.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.39 56.33 0.44 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-O 117.968 -1.462 . . . . 10.0 114.103 -161.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 m -33.39 -52.86 0.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.124 1.77 . . . . 10.0 113.646 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.35 42.33 2.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.514 1.125 . . . . 10.0 108.491 -170.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.9 tp 56.9 28.8 15.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.658 1.583 . . . . 10.0 111.075 -164.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.33 155.22 17.34 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.965 2.698 . . . . 10.0 106.485 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.05 -164.78 35.55 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 117.932 0.866 . . . . 10.0 111.669 -166.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.47 52.23 0.62 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.578 1.951 . . . . 10.0 112.882 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -55.8 -31.63 62.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.241 1.016 . . . . 10.0 112.212 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -60.92 -50.07 74.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.981 0.81 . . . . 10.0 110.768 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.45 -39.97 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.29 84.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.897 -0.573 . . . . 10.0 111.813 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.37 -39.48 85.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.974 0.807 . . . . 10.0 110.331 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -63.65 -46.82 83.88 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.93 -0.482 . . . . 10.0 110.279 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.4 mt -57.96 -47.28 83.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.811 0.844 . . . . 10.0 110.15 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.18 83.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.209 1.004 . . . . 10.0 110.028 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.54 -47.06 87.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.371 0.532 . . . . 10.0 110.687 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -61.58 -34.7 76.07 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.673 -0.642 . . . . 10.0 111.33 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.17 -32.89 67.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.516 0.598 . . . . 10.0 111.185 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -70.79 -38.94 73.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.708 1.14 . . . . 10.0 109.865 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.68 -32.45 71.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.244 0.618 . . . . 10.0 111.087 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.19 -17.07 64.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.733 0.813 . . . . 10.0 112.799 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.38 18.96 4.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.836 -0.98 . . . . 10.0 113.555 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -120.82 -170.88 2.08 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.808 1.304 . . . . 10.0 109.797 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 p -131.66 145.26 51.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.146 -1.427 . . . . 10.0 107.146 172.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -136.65 158.86 43.45 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.125 -0.359 . . . . 10.0 110.912 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.01 92.59 3.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -65.17 119.84 11.59 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.307 1.043 . . . . 10.0 108.42 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -148.39 149.01 31.0 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 123.584 0.754 . . . . 10.0 108.988 -171.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -90.49 35.43 0.88 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.292 -0.88 . . . . 10.0 110.184 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.22 51.02 21.48 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.983 1.754 . . . . 10.0 114.572 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.04 -15.68 49.56 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.858 2.372 . . . . 10.0 113.435 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.11 13.6 11.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.404 1.482 . . . . 10.0 110.704 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 tp 62.42 -43.89 0.18 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.557 2.743 . . . . 10.0 113.316 -166.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -148.8 78.11 1.39 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.873 1.669 . . . . 10.0 108.121 -167.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.473 -0.767 . . . . 10.0 111.357 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.2 mt -84.48 147.42 49.62 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.947 -1.131 . . . . 10.0 107.947 164.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.64 -175.4 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.08 2.52 . . . . 10.0 111.873 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.61 21.94 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.896 1.678 . . . . 10.0 113.694 173.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.9 m -142.39 136.08 29.21 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.321 1.848 . . . . 10.0 106.797 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.01 -136.88 10.11 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.92 -1.272 . . . . 10.0 109.92 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -130.35 136.34 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.159 -1.793 . . . . 10.0 106.159 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -117.87 157.5 26.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -141.72 145.87 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.021 -1.844 . . . . 10.0 106.021 168.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.3 t -130.88 124.34 56.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.37 97.36 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.669 -1.604 . . . . 10.0 106.669 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -148.7 174.12 12.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 10.0 108.372 -170.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 m -137.52 70.47 1.4 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.597 1.09 . . . . 10.0 110.312 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -169.169 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 110.298 -0.26 . . . . 10.0 110.298 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.19 58.48 1.31 Allowed 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.486 0.714 . . . . 10.0 110.038 -170.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -45.95 -56.17 11.09 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.228 -1.368 . . . . 10.0 114.566 -167.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.57 -44.34 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 122.034 1.762 . . . . 10.0 111.633 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -65.41 -43.35 90.82 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 10.0 111.264 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.36 -45.49 83.9 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.921 0.782 . . . . 10.0 110.158 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.18 -42.79 99.42 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.12 96.03 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.03 0.377 . . . . 10.0 111.461 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -59.69 -51.56 69.26 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.703 0.683 . . . . 10.0 109.47 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.19 -31.27 72.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.667 0.667 . . . . 10.0 111.81 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.87 -30.95 71.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.724 0.81 . . . . 10.0 112.251 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -124.21 -27.3 3.84 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.491 1.293 . . . . 10.0 114.491 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 32.45 61.78 1.38 Allowed Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.286 1.834 . . . . 10.0 112.572 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.47 160.26 40.33 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.12 2.546 . . . . 10.0 110.955 -172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -73.23 76.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.071 0.949 . . . . 10.0 111.187 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 9.22 1.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.93 1.292 . . . . 10.0 112.269 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.0 m -60.84 -17.5 50.34 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.219 -1.551 . . . . 10.0 113.344 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.44 10.83 39.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.78 1.232 . . . . 10.0 112.594 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.95 160.79 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.229 1.012 . . . . 10.0 108.997 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -123.81 150.81 44.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.296 -1.742 . . . . 10.0 106.296 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.63 163.53 25.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.606 0.717 . . . . 10.0 110.476 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.04 116.66 1.69 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.394 -2.682 . . . . 10.0 106.394 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.04 144.32 56.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.38 131.23 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.521 -1.659 . . . . 10.0 106.521 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.09 -27.54 1.71 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.757 1.17 . . . . 10.0 113.012 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.24 139.29 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 127.15 2.18 . . . . 10.0 107.606 171.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.58 0.72 8.67 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.269 -0.739 . . . . 10.0 112.387 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 C-N-CA 124.518 1.127 . . . . 10.0 109.834 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 mttt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 113.491 0.923 . . . . 10.0 113.491 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.84 -52.8 62.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.23 0.923 . . . . 10.0 110.813 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.52 -43.77 98.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.1 93.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.046 0.938 . . . . 10.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -67.97 -36.79 80.65 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.416 1.007 . . . . 10.0 111.222 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.05 -45.14 94.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.278 0.944 . . . . 10.0 110.06 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -65.87 -39.21 90.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.22 0.608 . . . . 10.0 110.524 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.58 97.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.066 . . . . 10.0 110.975 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 m -72.45 -29.08 63.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.727 0.411 . . . . 10.0 110.651 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.89 -13.15 1.49 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.426 -1.208 . . . . 10.0 114.327 160.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.08 116.55 9.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.241 1.521 . . . . 10.0 108.131 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -61.73 139.02 58.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 167.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -80.84 128.78 34.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.154 -2.165 . . . . 10.0 105.154 158.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 m -105.06 148.45 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.8 -133.93 46.84 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.09 -1.604 . . . . 10.0 109.09 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.93 163.65 33.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.535 -1.654 . . . . 10.0 106.535 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -48.59 123.32 6.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.293 1.037 . . . . 10.0 112.082 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.33 147.36 48.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.793 1.237 . . . . 10.0 107.92 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -118.6 136.75 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.838 -1.171 . . . . 10.0 107.838 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 -174.263 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 118.588 -0.72 . . . . 10.0 111.223 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.81 -44.92 93.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.483 1.038 . . . . 10.0 108.934 171.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.47 -46.03 91.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.42 97.3 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.409 0.528 . . . . 10.0 112.672 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.6 m -61.57 -56.79 16.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.341 1.071 . . . . 10.0 110.75 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -59.51 -40.69 87.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.942 1.297 . . . . 10.0 110.699 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.27 -56.18 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.849 -0.596 . . . . 10.0 110.042 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -69.68 -21.86 63.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 10.0 112.136 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.45 -45.25 76.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.708 0.685 . . . . 10.0 110.631 168.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -22.43 57.69 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.973 0.806 . . . . 10.0 112.61 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.9 mttt . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.252 1.021 . . . . 10.0 108.406 169.521 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.55 167.21 31.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.126 1.371 . . . . 0.0 108.921 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.36 -25.07 25.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.697 0.799 . . . . 0.0 110.893 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.6 mt -138.27 127.63 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.749 1.22 . . . . 0.0 107.943 -171.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.18 135.21 33.39 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.4 104.64 13.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.7 mt -96.46 100.57 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -102.64 20.12 17.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.241 1.016 . . . . 0.0 110.735 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 36.51 2.17 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.072 1.32 . . . . 0.0 115.163 -169.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -47.65 -50.84 23.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.215 1.406 . . . . 0.0 112.268 -172.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -127.33 50.77 1.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.7 tp 63.29 20.05 12.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.813 2.045 . . . . 0.0 111.283 -169.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.14 178.1 36.64 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.248 3.308 . . . . 0.0 106.661 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -3.19 1.51 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.009 -1.439 . . . . 0.0 115.026 169.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.14 2.14 0.76 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.877 1.839 . . . . 0.0 113.966 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -53.29 -36.39 61.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.297 1.039 . . . . 0.0 112.07 -172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -54.97 -30.75 59.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.779 1.232 . . . . 0.0 112.825 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.99 -26.33 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.776 0.83 . . . . 0.0 109.522 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.36 72.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.228 0.922 . . . . 0.0 111.346 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.88 -39.3 93.32 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.238 0.926 . . . . 0.0 111.243 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -67.97 -45.4 74.27 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.804 -0.56 . . . . 0.0 109.617 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -54.13 -50.82 66.04 Favored 'General case' 0 C--N 1.337 0.035 0 C-N-CA 124.359 1.064 . . . . 0.0 110.323 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -48.69 72.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.895 0.878 . . . . 0.0 110.88 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.81 -53.56 56.81 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.69 0.677 . . . . 0.0 110.675 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -54.91 -42.51 72.26 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 123.838 0.855 . . . . 0.0 111.816 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -32.2 67.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.88 -46.67 74.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.472 1.033 . . . . 0.0 109.842 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -67.38 -14.13 62.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.658 0.663 . . . . 0.0 112.312 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.12 63.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.128 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.56 17.64 0.74 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.274 -1.292 . . . . 0.0 115.887 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -139.18 -171.44 3.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.602 1.701 . . . . 0.0 111.236 -169.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 p -124.71 147.61 48.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.6 p -140.66 157.86 44.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.12 98.98 4.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.76 123.43 19.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.3 mt -142.26 153.99 44.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.558 0.743 . . . . 0.0 109.298 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -89.76 31.68 0.94 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.675 0.79 . . . . 0.0 110.968 172.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.13 48.77 38.78 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.587 1.565 . . . . 0.0 114.533 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.49 -21.45 66.07 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.683 2.255 . . . . 0.0 113.503 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.7 mt -124.31 10.15 8.61 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.967 1.707 . . . . 0.0 109.89 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 tp 60.86 -19.15 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.85 2.46 . . . . 0.0 114.31 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -166.47 87.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.68 -44.81 76.9 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.723 -0.611 . . . . 0.0 109.989 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.8 mt -80.23 151.58 72.7 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.38 -175.31 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.056 3.171 . . . . 0.0 112.621 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.74 34.42 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.147 1.379 . . . . 0.0 112.377 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.1 m -158.62 132.12 7.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.01 2.124 . . . . 0.0 106.311 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.79 -142.97 14.44 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.1 mm -126.53 140.32 49.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -121.76 152.52 39.37 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.7 mt -138.76 142.8 38.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.6 t -128.5 125.52 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.2 103.21 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -148.85 -177.3 5.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.876 1.271 . . . . 0.0 108.795 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.2 m -150.65 65.56 0.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.749 -1.219 . . . . 0.0 108.366 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 126.99 2.116 . . . . 0.0 112.916 -178.688 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.5 t30 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.807 0.337 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.41 120.73 24.24 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.63 -58.52 0.43 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.55 -169.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 -42.34 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.873 1.715 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -64.0 1.09 Allowed 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.218 1.007 . . . . 0.0 111.624 -168.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.56 -41.8 95.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.128 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -71.17 -45.98 62.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.958 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.58 79.06 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.714 0.688 . . . . 0.0 111.271 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.1 mt -55.12 -57.29 12.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.411 0.551 . . . . 0.0 110.002 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -74.11 -15.7 61.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.42 -38.21 65.65 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.692 0.678 . . . . 0.0 111.231 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -114.42 -26.49 7.94 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 32.88 60.43 1.51 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.683 1.993 . . . . 0.0 113.133 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -65.16 165.41 22.0 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.587 2.191 . . . . 0.0 112.538 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.53 63.38 2.66 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.405 1.482 . . . . 0.0 111.561 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.41 9.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.15 1.38 . . . . 0.0 112.391 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.4 m -61.1 -7.09 2.33 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.299 2.64 . . . . 0.0 112.871 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.24 10.02 17.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.795 1.638 . . . . 0.0 111.217 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.81 163.68 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 122.192 0.996 . . . . 0.0 110.283 174.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -122.09 149.83 43.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 171.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -123.61 166.84 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.721 0.638 . . . . 0.0 110.036 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.08 115.43 1.02 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 106.831 -2.507 . . . . 0.0 106.831 169.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.81 143.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.2 mt -139.42 131.34 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.98 -23.57 1.35 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.293 0.949 . . . . 0.0 114.082 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -50.19 128.46 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 126.137 1.775 . . . . 0.0 108.415 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.06 -27.69 6.48 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 124.441 1.096 . . . . 0.0 108.77 176.466 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . 45.2 mtpt . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -63.32 -56.04 19.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.514 1.052 . . . . 0.0 109.394 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -60.59 -39.49 88.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.294 0.638 . . . . 0.0 109.568 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . . . -61.3 -46.6 89.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.967 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -62.43 -37.75 87.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.158 0.89 . . . . 0.0 111.029 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.07 -48.25 76.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.05 0.841 . . . . 0.0 111.057 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.331 6.9 ptmt -71.8 -28.35 63.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -37.72 86.33 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.961 0.904 . . . . 0.0 110.852 169.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -66.99 -40.96 87.5 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.92 -22.97 0.53 Allowed Glycine 0 C--N 1.34 0.75 0 CA-C-O 118.243 -1.31 . . . . 0.0 114.987 169.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.9 137.92 56.92 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.216 1.508 . . . . 0.0 108.869 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.95 134.04 35.63 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.6 99.47 8.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 97.4 m -73.54 145.59 45.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.32 -123.58 29.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.482 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.4 pt-20 -153.11 176.11 12.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.598 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 m -49.8 121.73 5.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.085 1.354 . . . . 0.0 109.922 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.1 153.33 26.14 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -127.65 144.23 51.09 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.965 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.482 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.7 m-90 -65.6 -50.65 64.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.195 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.1 mt -55.08 -51.29 66.84 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.13 -51.96 54.25 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -64.16 -46.24 84.92 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.495 1.148 . . . . 0.0 110.774 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -61.56 -39.04 89.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.398 1.079 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.9 t -64.85 -47.58 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.835 1.254 . . . . 0.0 110.381 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -60.38 -24.4 65.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.551 1.069 . . . . 0.0 111.288 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.06 -28.63 43.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.409 0.684 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -36.49 19.28 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.04 0.936 . . . . 0.0 111.531 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 125.448 1.499 . . . . 0.0 109.824 172.036 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.07 161.01 43.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -95.52 -24.12 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.674 1.59 . . . . 0.0 110.492 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.7 mt -136.22 128.94 46.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.33 1.052 . . . . 0.0 108.223 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -85.92 126.98 34.49 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.91 97.53 7.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -96.38 89.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 108.694 -169.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -75.9 141.07 42.43 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 168.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.99 1.1 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 117.913 -1.493 . . . . 0.0 116.774 -175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 115.28 2.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.984 1.892 . . . . 0.0 109.714 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m 46.06 40.86 7.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.217 1.807 . . . . 0.0 111.811 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp 47.84 69.64 0.51 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 126.003 1.721 . . . . 0.0 111.16 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 163.14 25.59 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.534 1.54 . . . . 0.0 109.423 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.38 -29.92 2.82 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.415 -1.214 . . . . 0.0 114.244 -169.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 41.47 43.96 2.36 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.955 1.302 . . . . 0.0 111.412 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -50.7 -33.29 22.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.966 1.306 . . . . 0.0 113.592 -169.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -59.37 -52.22 66.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.735 1.152 . . . . 0.0 111.431 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.09 -29.05 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.646 -0.659 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.46 91.12 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.575 0.625 . . . . 0.0 110.87 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.47 -38.19 71.26 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.686 -0.633 . . . . 0.0 110.242 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -58.73 -44.18 90.37 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.57 0.623 . . . . 0.0 110.368 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.02 -55.82 30.2 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.393 0.677 . . . . 0.0 109.989 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.4 -40.42 65.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -53.77 -54.03 43.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.358 0.663 . . . . 0.0 110.083 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -62.44 -41.76 98.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -58.22 -45.3 87.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.446 0.566 . . . . 0.0 109.799 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.21 -35.97 71.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.833 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.16 -29.65 70.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.665 0.786 . . . . 0.0 111.586 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.45 -18.1 63.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.861 0.755 . . . . 0.0 111.795 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.1 -4.8 4.98 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.499 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -100.41 -170.31 1.85 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.568 1.684 . . . . 0.0 109.82 -169.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.8 p -128.88 148.58 50.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -139.89 149.95 44.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 111.826 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.26 92.13 3.92 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 m -69.29 118.02 11.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.9 mt -149.35 153.76 37.92 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.281 0.562 . . . . 0.0 112.186 -169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -93.7 39.22 1.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.386 1.074 . . . . 0.0 108.432 168.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 39.14 54.66 2.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.724 2.107 . . . . 0.0 115.42 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.48 -20.69 54.09 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.792 2.328 . . . . 0.0 113.731 -173.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.0 mt -112.94 8.3 18.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.661 1.584 . . . . 0.0 109.772 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tt 60.29 -17.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.557 2.743 . . . . 0.0 114.563 -169.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -169.46 76.82 0.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.94 -45.38 93.94 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.744 -0.598 . . . . 0.0 109.566 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.63 149.43 44.09 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.28 -175.46 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.793 2.995 . . . . 0.0 112.798 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.88 36.63 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.61 1.564 . . . . 0.0 111.334 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.7 m -158.3 128.69 6.13 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.31 2.244 . . . . 0.0 106.321 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.55 -145.98 17.54 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.2 mm -124.55 142.0 42.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -122.12 151.21 41.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.8 mt -137.44 138.9 40.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.07 134.25 66.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.12 111.91 30.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -156.53 -176.4 5.95 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 108.638 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -153.07 62.82 0.77 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.4 1.095 . . . . 0.0 110.344 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 CA--C 1.542 0.669 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.301 175.89 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 . . . . . 0 N--CA 1.466 0.368 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' H ' ' A' ' 66' ' ' LEU . 4.5 mp -75.48 131.16 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 169.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.44 -58.87 0.33 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.045 0.839 . . . . 0.0 110.228 -170.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -81.18 -38.56 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.325 2.016 . . . . 0.0 111.989 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -59.29 -49.9 76.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.432 0.693 . . . . 0.0 111.511 -169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -60.26 -44.28 95.44 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.348 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.37 -47.56 75.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.31 0.504 . . . . 0.0 110.467 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.21 89.28 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.01 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 mt -53.72 -55.62 24.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.914 0.779 . . . . 0.0 109.463 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.14 -17.27 61.97 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.87 -32.25 65.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.732 0.413 . . . . 0.0 111.337 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.9 -29.97 5.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 mttt 27.45 66.28 0.57 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.804 2.042 . . . . 0.0 113.273 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.94 176.81 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.824 2.349 . . . . 0.0 112.715 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -82.13 68.67 8.63 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.383 1.073 . . . . 0.0 111.125 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.22 3.11 1.8 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.875 0.87 . . . . 0.0 112.886 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -64.67 -6.25 7.41 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.365 2.666 . . . . 0.0 113.336 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.78 9.04 24.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.85 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 p -134.62 157.22 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.573 0.749 . . . . 0.0 110.529 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -121.01 152.02 39.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 168.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -118.1 173.87 6.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.03 160.11 28.08 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 106.68 -2.568 . . . . 0.0 106.68 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.81 145.87 50.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.45 121.1 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.09 -14.4 6.32 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.818 1.199 . . . . 0.0 114.593 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.9 141.34 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.981 1.313 . . . . 0.0 108.799 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.47 -15.01 60.84 Favored Glycine 0 N--CA 1.468 0.768 0 O-C-N 121.083 -1.01 . . . . 0.0 112.919 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.4 m . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 127.553 2.341 . . . . 0.0 115.195 -174.241 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.8 mttt . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.41 -57.25 13.79 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.581 0.628 . . . . 0.0 109.433 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.38 -31.17 65.34 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.093 0.557 . . . . 0.0 109.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.89 94.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.002 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.53 -37.98 83.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.503 1.047 . . . . 0.0 110.449 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.43 -40.48 96.72 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.536 0.734 . . . . 0.0 111.626 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.297 7.6 ptmm? -79.92 -29.54 39.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.544 -0.722 . . . . 0.0 112.509 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.42 86.46 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.162 0.985 . . . . 0.0 110.995 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 p -77.49 -20.48 54.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.07 -37.48 0.46 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.715 0.689 . . . . 0.0 113.597 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.91 -177.99 2.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.97 0.891 . . . . 0.0 111.435 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -135.14 150.14 50.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -77.11 126.98 31.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 m -77.58 140.93 39.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.45 -121.31 19.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -153.81 162.33 41.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.877 1.271 . . . . 0.0 108.927 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.9 m -53.41 124.18 14.07 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.811 -169.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.51 164.66 26.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.864 1.666 . . . . 0.0 108.283 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -135.99 144.4 45.32 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.014 -1.053 . . . . 0.0 109.318 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.328 -0.349 0 C-N-CA 127.003 2.121 . . . . 0.0 108.697 178.336 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 119.47 -0.3 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -44.85 83.01 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.599 0.759 . . . . 0.0 109.579 175.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -61.59 -52.05 66.0 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.9 -49.74 40.76 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 124.518 1.136 . . . . 0.0 111.475 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.1 m -61.47 -54.55 41.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 125.111 1.364 . . . . 0.0 111.54 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -55.7 -41.18 73.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.151 0.98 . . . . 0.0 111.365 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t -60.56 -49.54 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.358 1.063 . . . . 0.0 109.83 173.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.81 -27.65 68.2 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.474 1.033 . . . . 0.0 111.651 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.79 -45.01 19.59 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.513 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 pp -71.15 -36.01 71.88 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.607 0.64 . . . . 0.0 111.592 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.6 mttm . . . . . 0 C--O 1.248 0.991 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 175.799 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 119.244 -0.408 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.92 164.05 36.47 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.777 1.231 . . . . 0.0 109.147 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.46 -23.34 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.354 1.462 . . . . 0.0 110.64 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mt -133.11 126.19 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.813 1.245 . . . . 0.0 108.078 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -88.09 126.81 35.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.37 91.19 4.16 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.4 mt -86.09 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 t -111.54 -162.2 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.311 1.044 . . . . 0.0 108.319 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.32 57.29 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 123.646 0.641 . . . . 0.0 111.858 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -44.37 121.77 2.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.108 1.363 . . . . 0.0 111.095 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.272 39.1 m 67.31 53.15 0.78 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.884 1.273 . . . . 0.0 110.478 -171.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 52.92 37.85 25.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.954 2.101 . . . . 0.0 114.494 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.83 156.52 10.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.246 0.926 . . . . 0.0 111.478 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.16 -171.06 41.11 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.39 68.38 2.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.217 1.407 . . . . 0.0 110.893 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.85 -24.46 6.2 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.763 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -51.95 -34.78 43.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.148 0.979 . . . . 0.0 112.906 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 p -71.69 -34.2 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.641 1.109 . . . . 0.0 109.853 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.47 61.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.378 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.73 -40.45 84.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.031 0.832 . . . . 0.0 110.361 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -57.88 -51.16 70.75 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.509 0.724 . . . . 0.0 109.347 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.32 -49.89 73.03 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.096 0.558 . . . . 0.0 110.487 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.25 -40.8 64.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.671 1.188 . . . . 0.0 111.796 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.98 -58.5 7.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.336 0.971 . . . . 0.0 109.998 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -53.89 -43.4 69.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.657 1.183 . . . . 0.0 112.188 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.1 -36.83 82.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.733 0.813 . . . . 0.0 111.967 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.67 -36.99 73.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.703 1.138 . . . . 0.0 109.732 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.83 -23.2 67.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.287 0.635 . . . . 0.0 111.801 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.97 -10.92 60.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.853 0.861 . . . . 0.0 112.108 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 21.61 5.98 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.319 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -125.87 -171.81 2.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.465 1.132 . . . . 0.0 109.584 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 p -125.16 151.02 46.34 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -142.29 159.8 41.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.861 -0.524 . . . . 0.0 110.336 -170.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 110.96 11.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m -76.01 124.6 27.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.9 mt -141.88 159.45 42.21 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.268 0.627 . . . . 0.0 110.718 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -110.74 39.39 2.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.165 1.386 . . . . 0.0 109.022 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.78 46.67 39.48 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.906 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.62 -21.16 70.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 121.398 2.599 . . . . 0.0 113.736 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -126.32 14.2 7.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.43 1.892 . . . . 0.0 109.309 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 66.12 -31.72 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.366 2.667 . . . . 0.0 112.436 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.12 89.8 1.02 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.132 1.773 . . . . 0.0 107.075 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.54 -42.49 91.86 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.667 -0.645 . . . . 0.0 110.409 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.59 154.5 59.1 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.35 -175.27 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.055 3.17 . . . . 0.0 113.173 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.57 28.84 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.63 1.572 . . . . 0.0 113.067 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -153.56 137.33 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.817 2.447 . . . . 0.0 106.342 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.23 -140.58 12.42 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mm -121.55 137.3 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -122.34 137.23 54.92 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 mt -129.83 134.18 47.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.09 128.09 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.23 59.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.335 1.854 . . . . 0.0 106.689 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -67.92 -32.36 72.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.661 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 m 28.54 55.31 0.09 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 127.905 2.482 . . . . 0.0 113.505 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.226 -0.18 0 C-N-CA 127.63 2.372 . . . . 0.0 114.715 -169.114 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.5 t30 . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.704 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -107.36 84.45 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 169.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.5 m -70.51 -56.49 6.43 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.644 -167.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.12 -37.91 39.48 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.428 1.189 . . . . 0.0 110.006 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -68.19 -50.43 54.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.58 -46.36 83.04 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.883 0.765 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.46 -40.44 94.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.841 1.2 . . . . 0.0 110.922 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.29 90.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.314 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.2 mt -54.65 -52.72 61.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.512 1.051 . . . . 0.0 109.78 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -67.03 -22.59 65.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -75.42 -43.64 48.8 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.486 0.585 . . . . 0.0 111.083 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -98.88 -29.16 13.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.54 62.68 0.98 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 127.014 2.126 . . . . 0.0 112.609 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.75 164.63 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.259 2.639 . . . . 0.0 113.278 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.13 64.41 2.57 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.372 1.469 . . . . 0.0 111.613 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.19 9.53 0.97 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 112.737 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m -60.55 -6.87 1.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 127.858 2.463 . . . . 0.0 112.717 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.62 8.75 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.758 1.623 . . . . 0.0 111.183 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.69 152.84 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.93 0.871 . . . . 0.0 111.808 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -105.0 152.69 22.4 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -122.8 147.89 46.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.911 1.285 . . . . 0.0 107.561 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.05 116.98 1.65 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.116 -2.793 . . . . 0.0 106.116 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.23 145.19 35.65 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 mt -139.37 124.11 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.61 -2.82 20.75 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.714 1.626 . . . . 0.0 113.996 173.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -60.3 117.51 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.532 . . . . 0.0 107.955 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.13 -29.96 63.77 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 129.719 3.208 . . . . 0.0 111.768 169.873 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.6 -57.31 7.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.586 1.084 . . . . 0.0 108.461 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -58.46 -37.78 76.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.083 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.56 67.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 126.157 1.783 . . . . 0.0 109.873 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.93 -34.17 77.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.132 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.1 -40.65 74.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.903 1.229 . . . . 0.0 110.402 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -63.97 -41.54 97.52 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.966 1.306 . . . . 0.0 109.586 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -34.11 73.38 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.057 1.743 . . . . 0.0 111.742 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -67.56 -42.16 83.06 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.81 -17.32 0.56 Allowed Glycine 0 CA--C 1.528 0.898 0 CA-C-O 117.956 -1.469 . . . . 0.0 115.391 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 140.16 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.809 1.804 . . . . 0.0 109.43 -170.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -89.12 112.91 24.0 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.16 128.67 36.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.7 m -106.39 149.97 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.86 -122.4 29.86 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.83 168.67 26.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.19 1.396 . . . . 0.0 108.315 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.1 m -43.91 116.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.09 169.51 15.87 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.879 1.672 . . . . 0.0 108.095 172.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 138.96 42.79 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 120.948 -1.095 . . . . 0.0 111.123 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.325 -0.486 0 C-N-CA 127.247 2.219 . . . . 0.0 105.372 169.406 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.65 -44.63 93.27 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.12 -52.64 64.85 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.265 1.026 . . . . 0.0 108.807 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.53 -44.91 85.72 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.252 0.93 . . . . 0.0 111.844 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -61.71 -55.01 34.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.567 0.683 . . . . 0.0 109.548 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -57.69 -40.52 79.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.525 0.73 . . . . 0.0 111.666 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.41 -55.28 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 124.924 1.29 . . . . 0.0 109.699 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -15.05 63.34 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.442 1.019 . . . . 0.0 112.197 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.69 -45.85 20.4 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.796 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.7 -36.87 76.32 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.57 0.623 . . . . 0.0 111.639 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.032 0 C-N-CA 125.435 1.494 . . . . 0.0 109.658 175.264 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.41 165.61 33.6 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.05 0.94 . . . . 0.0 110.37 -173.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.15 -23.07 15.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.721 1.608 . . . . 0.0 110.808 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.69 126.69 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.411 1.084 . . . . 0.0 108.328 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -85.73 128.91 34.92 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -108.7 88.33 2.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.8 mt -77.74 91.41 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -93.02 17.1 11.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.812 2.045 . . . . 0.0 112.98 -168.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.89 77.78 0.11 Allowed Glycine 0 N--CA 1.446 -0.657 0 O-C-N 121.707 -0.621 . . . . 0.0 112.086 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -56.44 -14.4 3.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.247 1.019 . . . . 0.0 113.344 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -122.08 33.42 5.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.722 2.009 . . . . 0.0 109.92 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.8 mt 58.11 23.97 10.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.699 1.999 . . . . 0.0 112.854 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.0 161.96 16.25 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 128.585 2.993 . . . . 0.0 106.223 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.35 -36.33 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.917 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.82 16.42 0.98 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.034 1.417 . . . . 0.0 113.826 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.26 -36.49 63.66 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.535 1.061 . . . . 0.0 113.288 -170.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -60.65 -50.56 73.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.559 0.618 . . . . 0.0 111.313 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.8 -32.24 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 122.029 -0.419 . . . . 0.0 110.094 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.61 87.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.919 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -62.17 -40.06 94.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.323 0.965 . . . . 0.0 111.147 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -64.98 -47.6 76.96 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.639 -0.663 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.41 -49.54 72.12 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.984 0.914 . . . . 0.0 110.606 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.58 -48.23 72.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.999 1.319 . . . . 0.0 110.774 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.59 -50.75 72.27 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.962 0.905 . . . . 0.0 110.524 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.1 -22.64 62.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.567 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -72.79 -41.5 64.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 121.156 1.798 . . . . 0.0 109.024 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -62.9 -25.08 68.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.779 0.832 . . . . 0.0 111.462 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -11.99 60.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.149 0.98 . . . . 0.0 112.546 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 19.85 7.03 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.241 172.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -124.21 -166.78 1.55 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.354 1.061 . . . . 0.0 108.642 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -132.1 150.73 52.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.9 p -141.71 153.88 44.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 110.806 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -123.13 90.48 3.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.231 1.012 . . . . 0.0 108.524 -172.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -66.61 118.9 10.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.2 mt -145.59 138.07 25.76 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.815 0.846 . . . . 0.0 109.167 -170.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -83.66 40.88 0.76 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.035 -1.041 . . . . 0.0 110.601 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.16 44.98 34.2 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 117.892 -1.504 . . . . 0.0 115.863 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.69 -20.99 39.64 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.175 2.487 . . . . 0.0 114.005 -170.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.37 13.41 12.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.53 1.532 . . . . 0.0 109.391 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.0 tp 64.52 -27.2 0.09 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.886 2.474 . . . . 0.0 113.568 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -174.1 87.77 0.05 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.507 1.523 . . . . 0.0 107.378 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.37 -43.29 91.23 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.816 -0.553 . . . . 0.0 110.298 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.81 151.1 49.42 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 47' ' ' SER . 40.1 Cg_endo -67.69 -174.33 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.139 3.226 . . . . 0.0 112.962 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.44 29.02 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.527 1.531 . . . . 0.0 113.115 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' PRO . 18.7 m -152.23 131.93 13.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.949 2.5 . . . . 0.0 106.287 -175.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.39 -139.73 11.19 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mm -126.89 137.07 58.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.473 ' CD1' HG21 ' A' ' 83' ' ' VAL . 11.1 m0 -121.76 133.95 54.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 175.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -127.62 138.12 52.76 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.22 133.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.93 107.58 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -171.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -163.53 -160.52 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.08 2.152 . . . . 0.0 105.598 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 m -148.02 155.12 41.15 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.199 -1.563 . . . . 0.0 109.045 170.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 123.207 0.603 . . . . 0.0 111.872 -175.103 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.25 120.94 8.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -54.89 0.56 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.3 -172.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -99.3 -34.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.18 2.587 . . . . 0.0 113.554 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.93 -54.68 44.44 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.722 0.809 . . . . 0.0 112.063 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -65.42 -40.3 93.17 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.659 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.47 -49.62 76.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.246 0.475 . . . . 0.0 110.038 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.13 93.22 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.01 -53.75 54.58 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.773 0.715 . . . . 0.0 110.305 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -72.92 -19.0 61.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.6 -49.82 56.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.368 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -100.8 -26.53 13.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 29.36 64.66 0.78 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 127.19 2.196 . . . . 0.0 113.011 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -63.65 164.81 19.91 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.605 2.203 . . . . 0.0 112.443 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -82.39 66.19 7.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.661 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.43 7.52 0.6 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.306 1.042 . . . . 0.0 113.041 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -62.82 -6.12 3.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.517 2.727 . . . . 0.0 113.041 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.21 8.77 19.95 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.271 1.428 . . . . 0.0 110.983 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.6 p -132.46 147.22 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.709 0.686 . . . . 0.0 110.911 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -97.75 154.05 17.85 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -119.52 152.11 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.6 146.78 17.55 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.8 135.71 53.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.55 127.88 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.48 -19.99 3.62 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.352 0.977 . . . . 0.0 113.662 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.67 144.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.3 1.84 . . . . 0.0 108.677 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.09 -19.61 1.1 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.783 1.182 . . . . 0.0 113.308 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.466 0.371 0 C-N-CA 126.396 1.878 . . . . 0.0 113.34 171.98 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 118.137 -0.935 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.45 -59.12 5.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 120.013 1.279 . . . . 0.0 109.185 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.88 -39.52 81.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.109 0.413 . . . . 0.0 110.597 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.21 81.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.269 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.56 -38.18 90.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.048 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.97 -46.91 88.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.29 0.95 . . . . 0.0 110.592 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -65.69 -38.34 88.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.798 0.839 . . . . 0.0 110.074 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -34.24 77.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.688 1.195 . . . . 0.0 111.324 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.1 m -71.67 -31.25 66.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.388 -0.339 . . . . 0.0 111.336 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.97 -33.15 0.56 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 118.994 -0.892 . . . . 0.0 114.781 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.6 171.97 6.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.433 1.116 . . . . 0.0 110.465 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -132.72 141.93 48.8 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -75.78 111.13 10.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.0 m -74.58 152.69 39.24 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.08 -104.13 1.68 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.79 -177.34 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.812 2.445 . . . . 0.0 106.541 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 124.99 31.51 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.427 HD12 ' CE3' ' A' ' 138' ' ' TRP . 2.3 tt -79.65 151.02 30.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -129.85 146.67 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.814 1.188 . . . . 0.0 108.798 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 110.9 178.043 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.427 ' CE3' HD12 ' A' ' 121' ' ' LEU . 9.2 t90 -51.85 -50.34 61.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 110.653 173.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.82 -55.96 24.53 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.483 1.114 . . . . 0.0 109.359 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.28 -42.38 99.76 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 123.319 0.387 . . . . 0.0 112.179 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -60.28 -63.35 1.33 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 125.194 1.397 . . . . 0.0 110.171 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -53.95 -46.72 71.66 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.846 1.658 . . . . 0.0 111.849 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.5 t -59.77 -55.89 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -18.17 63.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.461 1.028 . . . . 0.0 112.201 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.24 -47.1 21.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.545 0.611 . . . . 0.0 111.0 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.17 -30.69 62.36 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 112.261 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.9 mttm . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.804 1.242 . . . . 0.0 109.781 171.491 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.2 167.63 29.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.842 1.257 . . . . 0.0 109.309 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.07 -27.59 18.49 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.882 0.873 . . . . 0.0 110.025 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -132.71 132.09 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.941 0.896 . . . . 0.0 109.319 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -89.46 129.86 35.89 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.57 95.11 5.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.2 mt -88.27 77.51 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -74.27 153.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.31 -0.869 . . . . 0.0 109.54 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.93 -175.64 32.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-O 122.576 1.098 . . . . 0.0 114.973 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 p -150.51 -50.07 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.05 -1.575 . . . . 0.0 109.508 -169.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 48.0 m -121.48 58.64 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.0 tp 48.89 48.08 20.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.067 2.147 . . . . 0.0 112.549 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.72 153.34 10.98 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.21 -174.51 41.09 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 118.31 1.055 . . . . 0.0 113.745 -169.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.06 59.5 1.32 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.296 1.838 . . . . 0.0 110.52 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -56.67 -27.38 58.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.148 -0.97 . . . . 0.0 112.05 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -58.91 -44.81 91.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.932 0.787 . . . . 0.0 111.324 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.71 -43.14 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.33 91.38 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.549 -0.262 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.66 -41.45 75.51 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.363 0.665 . . . . 0.0 110.886 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -61.27 -45.55 94.04 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.736 -0.602 . . . . 0.0 110.147 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.13 -52.57 65.0 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.093 0.957 . . . . 0.0 110.469 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.55 -46.25 57.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.224 1.009 . . . . 0.0 110.886 177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -56.69 -54.23 48.53 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.549 0.613 . . . . 0.0 110.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -61.65 -39.45 91.38 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.87 -37.59 84.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.396 0.678 . . . . 0.0 110.779 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.36 -39.41 89.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.592 0.633 . . . . 0.0 110.369 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -63.14 -30.01 71.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.867 0.758 . . . . 0.0 111.388 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -20.62 60.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.623 0.769 . . . . 0.0 111.676 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 16.92 6.73 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 118.514 -1.159 . . . . 0.0 114.228 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.03 142.58 51.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.066 1.433 . . . . 0.0 108.49 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -83.15 151.84 25.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -138.32 158.62 43.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.03 104.46 7.8 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 m -68.82 123.21 20.33 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.271 1.028 . . . . 0.0 108.344 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -145.43 166.35 25.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.163 0.985 . . . . 0.0 110.042 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -110.36 39.33 2.21 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.622 1.169 . . . . 0.0 109.141 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.85 50.9 14.1 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.718 1.627 . . . . 0.0 114.867 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 -21.75 62.61 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.846 2.364 . . . . 0.0 113.775 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.0 mt -124.1 13.93 9.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.18 1.792 . . . . 0.0 108.93 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.7 tp 61.59 -25.57 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.654 2.782 . . . . 0.0 114.464 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -161.3 86.44 0.68 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -168.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.57 -45.25 87.82 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.685 -0.634 . . . . 0.0 110.081 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.13 151.34 59.93 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.48 -178.9 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.584 2.856 . . . . 0.0 112.996 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.54 35.92 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.882 1.673 . . . . 0.0 111.807 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -158.49 123.99 4.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.293 2.237 . . . . 0.0 105.773 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.48 -147.9 19.38 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.6 mm -123.5 128.91 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -119.79 152.25 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 mt -140.43 138.16 34.51 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.76 132.29 44.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -125.11 68.44 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.931 1.292 . . . . 0.0 108.292 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -103.09 16.24 27.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.524 1.13 . . . . 0.0 112.241 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m 2.22 83.49 0.0 OUTLIER 'General case' 0 C--N 1.344 0.357 0 C-N-CA 129.999 3.319 . . . . 0.0 114.516 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.6 p . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 124.148 0.979 . . . . 0.0 109.609 -169.96 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 C--O 1.228 -0.065 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -150.09 108.07 3.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 m -82.65 -63.04 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.948 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.86 -40.57 16.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.695 1.596 . . . . 0.0 110.625 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -63.46 -49.87 71.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.976 0.51 . . . . 0.0 110.718 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.53 -45.83 88.81 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.801 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -61.07 -46.43 90.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.746 0.703 . . . . 0.0 110.231 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -24.02 67.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.6 mt -67.71 -61.24 1.98 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.469 1.031 . . . . 0.0 108.657 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -73.62 -13.14 60.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.19 -36.11 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.202 1.001 . . . . 0.0 110.356 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -120.72 -30.11 4.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.798 -172.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.3 mttt 25.62 68.69 0.43 Allowed Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.043 1.737 . . . . 0.0 112.872 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.45 173.95 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.309 2.006 . . . . 0.0 111.883 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -81.15 95.6 6.94 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.37 -0.832 . . . . 0.0 108.992 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.487 HD23 ' HB3' ' A' ' 112' ' ' SER . 3.0 mm? -88.45 6.25 38.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.992 0.517 . . . . 0.0 111.561 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.6 p -68.06 -5.26 16.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 119.694 -1.879 . . . . 0.0 112.583 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.56 43.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.461 1.504 . . . . 0.0 110.939 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.61 155.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.246 1.022 . . . . 0.0 111.095 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -114.91 147.48 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -125.61 156.92 38.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 109.791 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.45 116.42 2.15 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.6 146.36 44.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.1 mt -139.99 129.45 28.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.92 -9.36 2.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.442 1.02 . . . . 0.0 113.775 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.85 136.17 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.35 14.22 7.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.799 1.19 . . . . 0.0 112.052 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 125.308 1.443 . . . . 0.0 113.392 -178.469 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.2 mttt . . . . . 0 N--CA 1.463 0.211 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.5 -57.81 11.36 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.13 -40.31 95.49 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.8 68.12 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 117.329 -1.32 . . . . 0.0 111.603 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.98 -45.0 94.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.736 1.607 . . . . 0.0 110.805 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.84 -39.47 90.83 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -30.71 70.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.161 1.384 . . . . 0.0 111.948 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.487 ' HB3' HD23 ' A' ' 80' ' ' LEU . 13.9 m -80.58 -18.65 47.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.953 0.501 . . . . 0.0 111.098 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.5 -19.58 4.5 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.694 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.49 136.89 55.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.674 1.737 . . . . 0.0 108.829 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -86.23 132.77 33.92 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -85.63 103.23 14.26 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -77.09 150.26 35.68 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.322 -0.236 . . . . 0.0 110.487 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.65 -95.45 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.413 1.006 . . . . 0.0 111.195 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.34 176.99 6.31 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 128.439 2.696 . . . . 0.0 106.511 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.3 m -63.72 131.03 46.62 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.48 HD12 ' CE3' ' A' ' 138' ' ' TRP . 3.5 tt -73.78 139.93 45.54 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.51 139.77 51.45 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 124.924 1.29 . . . . 0.0 108.702 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.48 ' CE3' HD12 ' A' ' 121' ' ' LEU . 10.7 t90 -44.14 -56.66 3.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 125.359 1.464 . . . . 0.0 110.943 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -59.17 4.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.809 1.644 . . . . 0.0 109.002 -174.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.07 60.32 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 123.874 0.734 . . . . 0.0 111.349 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 t -65.27 -47.86 75.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.671 0.735 . . . . 0.0 110.566 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -60.67 -41.66 95.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.655 1.182 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t -59.4 -49.94 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.557 0.743 . . . . 0.0 109.675 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -61.26 -30.33 70.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.241 0.928 . . . . 0.0 111.247 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.23 -46.83 26.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.442 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -74.16 -32.01 62.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.188 0.449 . . . . 0.0 112.129 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.443 1.097 . . . . 0.0 109.825 173.376 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.43 164.62 37.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.184 0.994 . . . . 0.0 109.96 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.92 -24.0 15.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.672 1.589 . . . . 0.0 110.577 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.15 126.6 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.291 1.036 . . . . 0.0 108.413 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.48 127.2 35.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.44 95.55 6.15 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.1 mt -91.26 117.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.29 168.65 17.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.315 0.646 . . . . 0.0 110.525 -169.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.64 38.77 93.49 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.918 -0.379 . . . . 0.0 112.34 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 m -61.64 0.31 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.521 2.329 . . . . 0.0 116.343 -169.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -123.31 31.53 5.94 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.118 1.767 . . . . 0.0 108.183 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.2 tp 53.66 63.92 2.03 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 126.223 1.809 . . . . 0.0 109.952 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.56 -144.7 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.07 1.795 . . . . 0.0 109.189 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.97 163.37 34.77 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 37.22 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.128 1.771 . . . . 0.0 108.125 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.56 -36.4 61.82 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 0.0 113.244 -169.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -58.62 -47.02 85.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.099 0.863 . . . . 0.0 110.819 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -72.82 -47.09 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.85 99.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.99 -38.59 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.904 0.482 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -61.81 -48.0 82.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.764 0.711 . . . . 0.0 110.031 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.91 -54.06 49.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.856 0.863 . . . . 0.0 109.878 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.06 63.9 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.408 1.083 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.61 -54.92 40.85 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.567 0.747 . . . . 0.0 110.476 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -59.52 -37.12 77.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.2 mt -66.08 -34.31 77.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.213 0.605 . . . . 0.0 111.42 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -70.66 -38.3 73.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.046 1.294 . . . . 0.0 110.263 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.05 -29.76 70.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.37 0.668 . . . . 0.0 111.134 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.46 -14.77 62.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.819 0.848 . . . . 0.0 112.112 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.04 7.32 6.61 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.197 -1.335 . . . . 0.0 114.522 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -112.1 -167.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.668 1.734 . . . . 0.0 110.131 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -128.7 150.22 50.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.1 p -142.0 154.46 45.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.264 0.554 . . . . 0.0 112.061 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -121.26 98.03 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.579 1.552 . . . . 0.0 108.013 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -72.42 121.0 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.1 mt -146.16 149.0 33.15 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.996 0.518 . . . . 0.0 111.456 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -90.87 34.9 0.9 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.112 0.965 . . . . 0.0 110.319 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 49.94 27.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.735 1.636 . . . . 0.0 114.791 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.64 -21.89 65.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.82 2.347 . . . . 0.0 114.007 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.16 10.54 4.54 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.78 2.032 . . . . 0.0 107.099 -175.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 62.99 -26.66 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.628 2.771 . . . . 0.0 114.03 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -157.59 80.43 0.88 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.857 0.863 . . . . 0.0 109.271 -168.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.97 -44.73 96.14 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.586 -0.696 . . . . 0.0 110.523 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.11 151.25 69.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 47' ' ' SER . 43.4 Cg_endo -67.92 -173.93 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.261 3.307 . . . . 0.0 113.021 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.45 27.56 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.422 1.489 . . . . 0.0 113.262 170.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 45' ' ' PRO . 15.5 m -150.76 133.28 15.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.768 2.427 . . . . 0.0 106.403 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.88 -142.07 13.28 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 mm -124.29 142.77 39.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CD1' HG21 ' A' ' 83' ' ' VAL . 17.2 m0 -121.41 150.45 41.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.9 mt -141.07 141.2 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -133.71 121.19 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.72 103.09 14.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.324 1.85 . . . . 0.0 107.138 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -146.09 -161.0 1.22 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.334 1.054 . . . . 0.0 108.685 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.0 m -150.43 150.61 31.58 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.663 -1.273 . . . . 0.0 108.414 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.658 177.069 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 t30 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.68 77.8 1.76 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -66.64 -55.12 19.29 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 127.706 2.402 . . . . 0.0 112.411 -168.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.39 -34.53 54.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.117 1.211 . . . . 0.0 110.071 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.77 -59.42 5.45 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 123.783 0.677 . . . . 0.0 109.689 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.55 -46.81 87.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.957 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.12 -46.13 90.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.274 0.943 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.27 -23.53 65.69 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.1 mt -67.06 -62.35 1.47 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.61 -20.11 65.92 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.98 -34.49 77.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.545 0.738 . . . . 0.0 111.11 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -128.86 -24.41 2.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 mttt 28.58 65.1 0.69 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 127.108 2.163 . . . . 0.0 112.763 -170.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.28 163.29 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.679 2.253 . . . . 0.0 113.195 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -80.79 66.76 6.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.734 1.214 . . . . 0.0 110.731 -174.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.91 17.42 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.578 1.551 . . . . 0.0 112.886 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 p -65.99 -4.29 6.85 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 119.955 -1.715 . . . . 0.0 112.6 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 11.14 13.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.877 1.671 . . . . 0.0 111.081 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.407 HG21 ' CD1' ' A' ' 50' ' ' TRP . 3.1 p -134.99 157.16 40.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.815 0.817 . . . . 0.0 110.926 176.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.403 HH22 HD22 ' A' ' 146' ' ' LEU . 3.9 ptt-85 -120.02 148.56 43.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -115.46 169.25 9.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.06 120.19 1.58 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.31 139.93 41.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.5 mt -138.59 130.86 38.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 -26.69 1.08 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.09 0.852 . . . . 0.0 112.77 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.3 mt -52.68 155.49 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 128.096 2.558 . . . . 0.0 108.453 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.47 20.7 0.82 Allowed Glycine 0 CA--C 1.526 0.754 0 O-C-N 121.664 -0.647 . . . . 0.0 112.58 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 124.62 1.168 . . . . 0.0 111.804 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.31 -57.5 12.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.173 0.589 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.51 -38.24 89.16 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.278 0.631 . . . . 0.0 109.359 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.13 83.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.206 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.82 -35.71 81.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.716 -1.135 . . . . 0.0 111.192 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.84 -47.93 84.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.896 1.226 . . . . 0.0 110.876 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.21 -37.02 84.55 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.142 0.977 . . . . 0.0 110.092 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -36.8 79.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.262 1.425 . . . . 0.0 111.518 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.5 m -68.96 -38.5 79.45 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.46 0.52 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.97 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.67 135.6 48.45 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.305 1.553 . . . . 0.0 108.986 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -84.23 141.62 30.86 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.05 113.38 19.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -72.28 146.26 47.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.8 -119.77 17.1 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 170.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.22 159.51 44.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.64 1.576 . . . . 0.0 107.388 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.5 m -48.8 125.11 9.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.976 1.31 . . . . 0.0 111.358 -175.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.51 147.78 35.64 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.647 1.579 . . . . 0.0 107.817 -173.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -116.13 142.82 46.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 169.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -169.233 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.234 0.245 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -46.94 81.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.106 172.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.16 -47.2 81.79 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.191 0.596 . . . . 0.0 109.827 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.66 -49.32 79.79 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.5 t -62.94 -43.97 97.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.177 0.988 . . . . 0.0 110.822 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.4 t90 -63.56 -38.37 90.88 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.621 1.568 . . . . 0.0 110.677 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.31 -46.63 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.962 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.79 -28.41 69.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.761 -1.212 . . . . 0.0 111.456 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.77 -47.18 40.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.077 0.951 . . . . 0.0 110.686 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.403 HD22 HH22 ' A' ' 84' ' ' ARG . 1.6 pp -71.45 -33.39 69.31 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.569 0.622 . . . . 0.0 112.04 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.1 mttm . . . . . 0 C--O 1.249 1.044 0 C-N-CA 125.292 1.437 . . . . 0.0 110.004 173.468 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 mtt . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.816 0.341 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.95 173.12 0.65 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.009 1.324 . . . . 0.0 112.24 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.39 -24.86 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.982 0.913 . . . . 0.0 110.872 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.0 mt -138.47 125.81 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.066 0.947 . . . . 0.0 109.28 -171.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -85.63 133.03 34.06 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 mp -111.58 100.33 8.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 mt -71.82 96.75 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 170.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -88.48 21.5 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.099 2.16 . . . . 0.0 112.201 -168.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 179.26 41.03 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -138.33 -27.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.643 0.777 . . . . 0.0 112.383 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 p -121.66 42.84 3.0 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp 56.12 37.33 28.73 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.449 1.5 . . . . 0.0 111.045 -169.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.06 163.24 27.15 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.265 1.888 . . . . 0.0 108.983 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -161.75 34.8 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.996 0.808 . . . . 0.0 111.336 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 60.05 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.346 1.859 . . . . 0.0 112.209 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -55.85 -31.45 62.76 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.629 0.771 . . . . 0.0 112.642 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -61.19 -42.05 97.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.236 0.926 . . . . 0.0 111.008 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.44 -39.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.568 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.55 -39.75 92.07 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.752 175.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -65.18 -38.54 90.81 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.383 -0.823 . . . . 0.0 110.699 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.94 -49.8 71.18 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.89 0.876 . . . . 0.0 110.185 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.42 -42.63 54.17 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.535 1.134 . . . . 0.0 111.117 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -54.9 -54.34 43.89 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.051 0.841 . . . . 0.0 110.157 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -60.94 -42.31 97.94 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.2 -39.94 95.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.441 0.696 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.89 -33.17 62.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.177 -0.952 . . . . 0.0 110.323 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.41 -32.16 72.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.972 0.805 . . . . 0.0 111.026 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -20.53 63.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.561 0.618 . . . . 0.0 111.518 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.95 -4.64 6.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.57 -1.128 . . . . 0.0 113.588 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -89.36 -170.79 2.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.211 1.505 . . . . 0.0 109.925 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -129.16 148.01 51.06 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -139.69 150.72 45.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.144 0.497 . . . . 0.0 111.939 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -113.57 90.7 3.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.891 1.677 . . . . 0.0 107.219 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -70.61 120.08 15.7 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -148.05 137.89 22.52 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.783 0.833 . . . . 0.0 110.725 -169.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -80.04 36.91 0.36 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.551 -1.343 . . . . 0.0 111.404 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.64 49.47 33.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.922 1.725 . . . . 0.0 114.86 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.77 -22.13 69.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.004 2.47 . . . . 0.0 113.888 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.1 mt -128.74 12.03 6.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.03 1.732 . . . . 0.0 109.418 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 tp 62.11 -25.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.994 2.518 . . . . 0.0 114.161 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -160.37 78.46 0.64 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.407 1.083 . . . . 0.0 108.924 -168.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.2 -46.07 85.54 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.656 -0.653 . . . . 0.0 110.032 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 mt -81.48 154.26 71.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.29 179.3 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.846 3.03 . . . . 0.0 113.584 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.84 32.25 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.116 1.766 . . . . 0.0 112.591 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.1 m -153.89 133.78 13.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.782 2.433 . . . . 0.0 106.536 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.86 -138.95 11.7 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 mm -121.24 135.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.455 ' CD1' HG21 ' A' ' 83' ' ' VAL . 6.0 m0 -125.65 138.9 53.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.5 mt -128.36 146.7 50.7 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.23 133.76 55.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -125.94 108.53 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -170.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -156.72 -163.1 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.506 1.122 . . . . 0.0 108.611 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.96 144.04 25.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 119.289 0.95 . . . . 0.0 110.714 -171.582 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.62 135.9 57.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -122.55 -64.4 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 117.266 -1.349 . . . . 0.0 111.375 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.6 -39.34 9.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 122.073 1.776 . . . . 0.0 110.103 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -61.22 -46.44 90.41 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.864 1.266 . . . . 0.0 110.088 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.6 -51.24 69.39 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.303 1.041 . . . . 0.0 110.399 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.55 -45.34 90.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.833 0.742 . . . . 0.0 110.98 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.76 82.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.65 -55.57 33.19 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 123.264 0.626 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -68.35 -18.98 64.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.49 -32.92 66.59 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.4 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.55 -25.3 5.58 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 32.42 63.04 1.33 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.631 1.972 . . . . 0.0 112.954 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -63.93 167.54 13.81 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.02 2.48 . . . . 0.0 113.39 -169.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -78.97 63.74 3.73 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.181 1.392 . . . . 0.0 111.454 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.07 8.85 0.66 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.757 1.223 . . . . 0.0 112.738 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 m -62.3 -6.83 3.51 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.637 2.775 . . . . 0.0 112.911 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.59 9.33 19.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.265 1.426 . . . . 0.0 111.12 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.1 p -131.31 154.63 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.824 0.738 . . . . 0.0 112.403 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -109.21 149.35 29.51 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.745 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.89 153.87 23.87 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.997 1.319 . . . . 0.0 108.059 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.16 106.65 0.46 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 106.026 -2.829 . . . . 0.0 106.026 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.08 29.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 mt -140.07 132.73 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -169.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -28.44 1.61 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.619 1.104 . . . . 0.0 113.01 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 mt -48.99 142.05 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.297 2.239 . . . . 0.0 108.778 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.3 -36.65 8.05 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 126.194 1.798 . . . . 0.0 111.0 174.282 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.33 -53.06 62.56 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.781 0.832 . . . . 0.0 109.575 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -39.69 92.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.9 75.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.562 1.145 . . . . 0.0 110.238 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -63.26 -39.37 94.41 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.979 0.809 . . . . 0.0 110.981 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -70.14 -41.89 73.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.887 0.767 . . . . 0.0 111.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -61.69 -37.7 85.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.466 1.507 . . . . 0.0 109.223 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -37.11 73.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.078 1.351 . . . . 0.0 111.92 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -67.24 -35.92 80.57 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.108 0.563 . . . . 0.0 110.59 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.87 -28.43 0.36 Allowed Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.015 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.14 170.41 8.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.765 1.283 . . . . 0.0 110.663 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -130.36 137.28 49.82 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -72.04 124.61 25.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.8 m -86.82 154.43 20.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.78 -117.27 10.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 173.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.25 175.9 12.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.9 1.68 . . . . 0.0 107.002 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.5 m -60.04 128.21 35.7 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.52 -0.738 . . . . 0.0 110.115 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 122' ' ' LYS . 1.8 tt -79.88 156.49 27.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.991 1.316 . . . . 0.0 107.822 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.618 ' H ' HD23 ' A' ' 121' ' ' LEU . 7.8 mptt -126.91 140.11 52.57 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.625 1.17 . . . . 0.0 108.083 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 109.011 -175.583 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 119.383 -0.341 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.405 ' CG ' ' HG ' ' A' ' 121' ' ' LEU . 6.8 t90 -57.5 -52.35 65.73 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.618 1.167 . . . . 0.0 110.12 171.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.36 -56.21 12.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.691 1.596 . . . . 0.0 108.509 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.42 -45.37 94.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.433 0.54 . . . . 0.0 112.656 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.4 m -62.19 -60.44 3.59 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.237 1.415 . . . . 0.0 110.457 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -52.93 -41.65 64.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.115 1.766 . . . . 0.0 111.567 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.12 -57.65 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.783 0.833 . . . . 0.0 109.946 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -14.43 62.48 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.47 -0.769 . . . . 0.0 112.398 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.0 mp -80.78 -49.15 11.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 110.782 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.19 -33.62 70.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 111.596 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.519 1.127 . . . . 0.0 109.647 173.917 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.93 164.31 38.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.117 0.967 . . . . 0.0 110.157 -172.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -98.51 -22.83 15.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.778 1.231 . . . . 0.0 110.887 169.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 mt -131.95 126.22 56.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 t -90.98 128.28 36.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -95.76 103.93 15.84 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -96.43 86.84 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 159.16 16.27 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 111.646 -169.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.73 79.56 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.15 -45.02 8.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.228 2.211 . . . . 0.0 115.531 -169.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.7 m -127.89 54.72 1.69 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt 52.91 37.0 23.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.545 1.938 . . . . 0.0 111.929 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.78 4.5 69.4 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.645 1.117 . . . . 0.0 113.235 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.55 -79.39 1.84 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.817 1.199 . . . . 0.0 111.118 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.7 18.08 0.45 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.354 1.862 . . . . 0.0 113.889 -169.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.31 -26.03 67.12 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.354 -0.841 . . . . 0.0 111.834 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.97 -47.65 84.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.73 0.695 . . . . 0.0 110.584 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.65 -38.77 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.3 80.32 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.838 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.58 -40.46 76.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.868 0.758 . . . . 0.0 110.357 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -62.48 -47.69 82.87 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.949 -0.47 . . . . 0.0 110.238 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.18 -51.66 67.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.402 1.081 . . . . 0.0 110.868 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.58 -41.05 66.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.748 0.819 . . . . 0.0 111.393 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -58.09 -47.78 82.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.421 1.009 . . . . 0.0 111.079 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -58.04 -44.32 87.34 Favored 'General case' 0 C--N 1.337 0.034 0 C-N-CA 122.671 0.389 . . . . 0.0 111.308 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 26' ' ' LEU . 3.3 mm? -66.29 -33.02 74.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.56 -45.55 78.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.018 0.826 . . . . 0.0 109.581 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -71.2 -17.3 62.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.813 0.733 . . . . 0.0 112.157 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.04 -15.5 62.03 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.919 0.781 . . . . 0.0 111.442 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.98 22.41 5.96 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.491 169.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -129.08 171.87 11.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.59 1.195 . . . . 0.0 110.28 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 p -105.71 154.47 20.42 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -141.53 155.23 45.81 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.771 -0.581 . . . . 0.0 111.449 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.71 93.51 4.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -70.53 120.95 16.92 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.7 mt -148.51 170.16 18.68 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 124.37 1.068 . . . . 0.0 109.477 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -110.23 37.81 2.61 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.133 1.773 . . . . 0.0 108.603 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.53 48.77 22.01 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.842 1.686 . . . . 0.0 115.086 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.56 -20.5 69.59 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 CA-C-N 121.083 2.442 . . . . 0.0 114.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -122.99 13.25 9.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 109.701 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.84 -28.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.278 2.631 . . . . 0.0 112.649 -169.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -160.37 88.24 0.79 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.371 1.469 . . . . 0.0 107.674 -168.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.36 -43.21 82.02 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.64 154.08 68.18 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.56 -175.53 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.176 3.25 . . . . 0.0 113.186 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 33.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.799 1.64 . . . . 0.0 112.574 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -158.14 135.92 10.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.605 1.962 . . . . 0.0 106.801 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.48 -140.27 11.9 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.88 134.24 66.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -118.96 133.25 55.94 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -122.95 137.91 54.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.1 t -122.11 126.23 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -175.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.02 67.08 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -169.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -135.31 48.48 2.25 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.726 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.1 m -30.79 98.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.977 2.911 . . . . 0.0 115.652 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 125.795 1.638 . . . . 0.0 111.92 177.018 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.46 146.12 52.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.431 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 1.5 m -122.3 -65.6 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 117.279 -1.344 . . . . 0.0 110.578 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HD2' ' H ' ' A' ' 67' ' ' SER . 58.8 Cg_endo -68.25 -41.37 7.07 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.862 1.701 . . . . 0.0 110.171 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -61.09 -48.5 81.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.453 1.101 . . . . 0.0 109.436 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -62.03 -49.55 75.56 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.298 0.499 . . . . 0.0 110.694 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.18 -43.79 98.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.591 0.632 . . . . 0.0 110.512 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -29.49 69.28 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.87 -57.45 11.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.559 1.072 . . . . 0.0 108.96 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -62.99 -26.01 68.65 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.1 -31.56 72.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.966 0.506 . . . . 0.0 111.424 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.99 -26.76 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.943 -1.027 . . . . 0.0 113.768 -175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 31.48 62.99 1.14 Allowed Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 126.291 1.837 . . . . 0.0 112.148 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.21 162.31 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.875 2.383 . . . . 0.0 113.466 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.74 67.43 4.47 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.0 111.131 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 15.17 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.607 1.563 . . . . 0.0 112.811 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.0 p -64.13 -5.37 4.7 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.147 -1.596 . . . . 0.0 112.426 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.58 10.55 14.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.282 1.833 . . . . 0.0 111.004 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.51 149.66 33.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.831 0.825 . . . . 0.0 111.131 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.1 ptm85 -100.57 151.26 21.8 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.55 110.25 0.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.46 136.61 44.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.0 mt -138.1 129.7 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.12 -25.59 2.63 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.837 0.732 . . . . 0.0 111.962 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.3 mm -48.57 134.78 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 127.5 2.32 . . . . 0.0 106.752 168.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.72 -21.87 4.51 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.957 0.789 . . . . 0.0 111.993 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.233 0.22 0 C-N-CA 128.46 2.704 . . . . 0.0 114.331 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--O 1.227 -0.095 0 CA-C-O 118.851 -0.595 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.53 -57.39 12.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.749 0.704 . . . . 0.0 110.43 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.9 -39.14 93.49 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.31 74.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.053 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.61 -36.46 83.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.271 0.941 . . . . 0.0 111.183 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.7 mt -65.23 -45.0 86.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.06 0.845 . . . . 0.0 110.738 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -68.57 -36.03 78.18 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 123.796 0.838 . . . . 0.0 110.021 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -37.81 87.33 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.193 1.397 . . . . 0.0 111.058 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -39.85 83.82 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.23 -17.54 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.195 169.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.19 137.12 53.0 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.656 1.728 . . . . 0.0 109.777 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.35 110.19 17.29 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -65.74 111.99 3.48 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.7 m -88.4 152.51 21.86 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.66 -124.27 35.52 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.06 157.59 43.29 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 62.4 m -46.17 127.78 8.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.31 1.844 . . . . 0.0 112.541 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.09 160.88 19.88 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.242 1.417 . . . . 0.0 108.512 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -134.59 146.85 49.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 C--N 1.329 -0.316 0 C-N-CA 126.824 2.05 . . . . 0.0 109.116 -172.191 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 119.028 -0.511 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -42.94 97.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.035 0.834 . . . . 0.0 111.23 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -51.94 66.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.803 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.26 -43.24 95.61 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.816 0.722 . . . . 0.0 112.422 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.9 m -59.57 -60.64 3.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.068 1.347 . . . . 0.0 109.996 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.4 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 49.2 t90 -57.37 -43.87 83.91 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.207 0.603 . . . . 0.0 112.097 -177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.6 t -61.49 -52.89 55.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 C-N-CA 123.201 0.6 . . . . 0.0 109.955 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -16.15 63.02 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.628 1.104 . . . . 0.0 112.129 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.08 -44.85 21.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.482 0.713 . . . . 0.0 111.252 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.35 73.67 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.965 0.802 . . . . 0.0 111.462 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 53.7 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.317 1.447 . . . . 0.0 109.72 174.436 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.85 164.08 37.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.342 1.057 . . . . 0.0 110.079 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.43 -24.36 18.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.445 1.498 . . . . 0.0 110.924 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.41 124.23 44.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.666 1.186 . . . . 0.0 108.3 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -85.74 132.91 34.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.68 92.01 3.88 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -77.81 111.56 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -127.83 -162.7 1.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.258 1.823 . . . . 0.0 107.168 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 28.89 58.59 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.785 -1.197 . . . . 0.0 112.266 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -32.92 -48.97 0.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.975 2.91 . . . . 0.0 115.136 -170.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -125.83 51.72 1.73 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 108.05 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.3 tp 58.69 31.27 20.97 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.976 1.71 . . . . 0.0 110.188 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.81 154.54 8.21 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 128.027 2.727 . . . . 0.0 107.586 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.08 -160.03 22.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.049 0.924 . . . . 0.0 110.914 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.14 41.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.612 1.565 . . . . 0.0 112.541 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.9 -32.16 65.62 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.17 -0.956 . . . . 0.0 112.542 -172.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.93 -42.54 98.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.845 0.748 . . . . 0.0 110.833 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 t -72.75 -39.58 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.16 -39.88 83.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.24 0.473 . . . . 0.0 110.875 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.56 -40.49 92.87 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.893 0.77 . . . . 0.0 110.94 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -64.15 -44.73 91.23 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 110.295 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.92 -50.03 75.59 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.635 1.174 . . . . 0.0 110.498 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.58 -47.8 63.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.274 1.03 . . . . 0.0 110.807 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.31 -52.75 64.08 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.558 0.743 . . . . 0.0 110.595 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm -56.16 -39.0 71.66 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.886 0.474 . . . . 0.0 112.029 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.7 mt -73.49 -26.39 60.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.429 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.05 -38.73 72.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 120.566 1.53 . . . . 0.0 109.55 169.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -62.32 -26.19 68.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 111.409 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.65 55.1 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.549 174.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.21 23.93 6.76 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.163 0.892 . . . . 0.0 113.334 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.73 -169.44 2.05 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.404 1.082 . . . . 0.0 109.277 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 p -128.35 149.14 50.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.0 p -141.63 154.86 45.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.89 0.376 . . . . 0.0 111.223 -169.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.82 94.95 4.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.196 0.999 . . . . 0.0 108.413 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -68.65 120.87 15.34 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.8 mt -145.63 143.56 29.92 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 122.551 0.341 . . . . 0.0 111.158 -170.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -88.28 33.25 0.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 169.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.91 55.85 7.1 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.577 2.036 . . . . 0.0 114.38 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.84 -20.46 68.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.032 2.488 . . . . 0.0 113.695 -174.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.0 mt -123.56 17.99 9.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.07 1.748 . . . . 0.0 109.066 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.9 tp 64.48 -30.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.399 2.68 . . . . 0.0 113.79 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -165.4 87.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.412 1.885 . . . . 0.0 106.539 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.18 -41.52 97.08 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.9 -0.5 . . . . 0.0 110.446 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt -89.11 150.04 44.34 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.25 -175.83 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.162 3.241 . . . . 0.0 113.116 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.58 33.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 112.43 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -158.68 134.55 8.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.86 2.064 . . . . 0.0 106.351 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.15 -142.86 13.86 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.41 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -123.39 151.79 42.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.8 mt -137.74 142.67 40.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.47 126.99 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.37 108.21 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -145.76 -166.89 2.56 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.828 0.851 . . . . 0.0 109.281 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 p -156.28 66.06 0.57 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 122.2 1.0 . . . . 0.0 112.194 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 123.307 0.643 . . . . 0.0 111.763 -178.008 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.549 HD12 ' H ' ' A' ' 66' ' ' LEU . 3.3 mp -70.5 137.01 49.86 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 170.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.74 -62.87 0.21 Allowed Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.142 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.35 -39.83 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 121.733 1.622 . . . . 0.0 111.745 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -63.48 -46.1 87.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 122.86 0.464 . . . . 0.0 110.537 -171.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -60.81 -48.54 81.32 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.927 0.331 . . . . 0.0 110.207 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -62.34 -45.79 91.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.137 0.426 . . . . 0.0 110.259 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.07 79.31 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.378 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.89 -55.65 31.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.241 0.928 . . . . 0.0 108.937 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.32 -27.67 68.66 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.21 -31.25 69.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.707 0.403 . . . . 0.0 111.648 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -122.4 -25.26 4.83 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 29.54 63.41 0.82 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 126.996 2.118 . . . . 0.0 112.307 -173.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.67 164.45 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.898 2.399 . . . . 0.0 113.063 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -77.57 64.91 2.98 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.266 1.426 . . . . 0.0 111.239 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.46 9.03 1.15 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.037 1.335 . . . . 0.0 112.601 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -61.45 -6.39 2.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.213 2.605 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.62 10.38 18.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.99 1.716 . . . . 0.0 111.03 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.14 153.62 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.783 0.719 . . . . 0.0 111.292 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -103.56 150.41 23.97 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 169.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -122.58 159.01 28.68 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.96 140.37 11.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 169.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.46 141.65 43.28 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mt -139.09 138.85 40.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -169.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.53 -30.43 2.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.721 1.153 . . . . 0.0 111.766 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 mt -50.64 127.34 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.867 2.067 . . . . 0.0 106.974 169.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.55 -13.77 40.09 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.603 0.621 . . . . 0.0 112.877 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 C--N 1.329 -0.314 0 C-N-CA 128.636 2.774 . . . . 0.0 116.602 -169.142 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 mttm . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.9 tm? -53.84 -57.31 11.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.331 0.968 . . . . 0.0 109.622 172.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.51 -40.63 97.56 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -48.59 81.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.859 0.464 . . . . 0.0 110.202 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.78 -31.86 72.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.687 -1.149 . . . . 0.0 111.739 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.9 mt -66.68 -44.27 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.101 1.318 . . . . 0.0 110.78 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -63.15 -40.47 97.67 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.656 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -36.81 83.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.157 1.383 . . . . 0.0 111.303 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.9 m -70.86 -39.79 72.7 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.84 -20.45 0.68 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.101 -1.388 . . . . 0.0 114.881 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 136.65 54.89 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.568 1.684 . . . . 0.0 108.834 -172.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -79.25 126.97 31.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -74.51 112.73 10.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.5 m -85.46 154.94 21.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.29 -125.38 37.49 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.455 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.6 pt-20 -154.41 169.0 24.79 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.269 1.428 . . . . 0.0 107.592 169.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.9 m -51.98 129.92 28.31 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.07 146.15 23.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.505 1.922 . . . . 0.0 107.405 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -121.56 145.88 47.52 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--N 1.326 -0.435 0 C-N-CA 125.303 1.441 . . . . 0.0 107.782 -175.416 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.455 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -55.95 -41.76 75.18 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.487 0.715 . . . . 0.0 110.849 173.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 tp -61.63 -50.11 73.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.69 72.42 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.99 0.806 . . . . 0.0 111.822 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 m -60.01 -57.05 14.54 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -53.11 -44.67 67.82 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.505 1.522 . . . . 0.0 111.691 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -56.5 -58.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 110.077 173.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -16.73 63.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.307 0.958 . . . . 0.0 112.176 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.03 -50.32 15.12 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.099 0.959 . . . . 0.0 110.432 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.35 -27.21 59.11 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.494 1.118 . . . . 0.0 109.634 171.102 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 tpp . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.29 148.23 32.2 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.221 1.008 . . . . 0.0 108.365 170.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.64 -22.97 15.2 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.607 1.563 . . . . 0.0 110.438 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.35 130.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 109.214 -172.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 t -86.2 130.25 34.58 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 169.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.9 94.21 4.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -87.2 98.15 7.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 51.93 2.3 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.82 8.55 59.43 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 117.306 -1.83 . . . . 0.0 115.098 -169.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.0 -42.71 2.92 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.032 1.733 . . . . 0.0 113.983 -169.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 t -149.17 53.09 0.96 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 169.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tp 56.33 38.99 30.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.468 1.507 . . . . 0.0 110.699 -169.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.43 154.38 7.43 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.202 2.81 . . . . 0.0 107.073 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.95 -151.16 6.9 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.928 0.864 . . . . 0.0 110.951 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 65.76 1.21 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.323 1.449 . . . . 0.0 111.0 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -53.74 -37.37 63.3 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.64 0.776 . . . . 0.0 112.63 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -59.81 -45.13 93.3 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.441 0.564 . . . . 0.0 110.255 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -32.69 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.61 97.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.658 0.663 . . . . 0.0 110.853 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.42 -39.55 89.02 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.994 0.518 . . . . 0.0 110.681 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -62.86 -46.51 87.55 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.469 -0.77 . . . . 0.0 110.501 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.8 mt -55.77 -52.68 63.12 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.486 1.114 . . . . 0.0 109.92 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.82 -52.09 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.165 0.986 . . . . 0.0 110.532 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -55.34 -54.26 45.84 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.358 0.663 . . . . 0.0 110.775 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -59.88 -38.87 83.45 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -68.96 -32.7 72.48 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.157 0.583 . . . . 0.0 111.691 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.58 -37.35 71.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.757 1.162 . . . . 0.0 110.152 173.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -63.6 -29.77 70.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 111.217 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.77 -21.74 62.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.562 0.745 . . . . 0.0 111.259 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.02 -5.01 5.37 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.062 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.52 -167.07 1.55 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.686 1.743 . . . . 0.0 109.602 -174.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 p -130.19 151.09 51.09 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.9 p -143.74 160.28 41.0 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -170.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 106.31 8.93 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -71.94 121.09 18.48 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 mt -139.11 157.98 44.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.401 0.68 . . . . 0.0 110.71 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -95.23 21.88 7.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.421 1.088 . . . . 0.0 110.766 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.11 42.89 73.01 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 117.912 -1.493 . . . . 0.0 113.139 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.12 -22.29 61.83 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.201 2.601 . . . . 0.0 114.825 -169.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -115.24 13.53 16.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.523 1.529 . . . . 0.0 109.666 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 tp 65.57 -25.69 0.1 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.016 2.527 . . . . 0.0 112.916 -169.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -169.13 85.81 0.15 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.034 1.734 . . . . 0.0 107.331 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.44 -42.9 98.66 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.594 -0.691 . . . . 0.0 110.249 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -90.81 149.32 40.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.38 -179.33 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.919 3.079 . . . . 0.0 113.449 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.83 30.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.671 1.988 . . . . 0.0 113.102 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.7 p -161.72 107.83 1.33 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.367 1.867 . . . . 0.0 106.393 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.38 -147.48 16.75 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mm -127.53 131.72 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -119.69 152.75 36.64 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.3 mt -143.59 141.16 30.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.16 136.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.66 123.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -162.43 -172.86 3.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 108.158 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.98 69.77 1.03 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.535 -1.353 . . . . 0.0 108.088 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.465 0.297 0 C-N-CA 126.591 1.957 . . . . 0.0 115.657 -169.595 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.3 t30 . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.42 84.43 0.27 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 126.629 1.972 . . . . 0.0 106.701 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -54.4 25.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 124.54 1.136 . . . . 0.0 111.091 -168.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.18 -41.85 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.118 1.879 . . . . 0.0 110.776 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -65.62 -50.96 63.11 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.209 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.95 -44.9 95.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.954 0.797 . . . . 0.0 110.023 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.44 -47.16 80.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.254 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.03 -35.91 74.09 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.204 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -59.59 5.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.603 1.092 . . . . 0.0 109.266 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -16.82 63.73 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.25 -32.55 70.43 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.415 0.552 . . . . 0.0 111.259 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -124.23 -29.35 3.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt 28.98 66.64 0.68 Allowed Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 126.482 1.913 . . . . 0.0 113.251 -171.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.08 173.28 2.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.558 2.172 . . . . 0.0 111.381 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -84.98 124.45 31.71 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 112' ' ' SER . 3.1 mm? -122.35 14.59 10.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.069 1.348 . . . . 0.0 110.657 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -69.07 -3.88 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 119.82 -1.8 . . . . 0.0 112.81 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.25 4.59 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.034 1.334 . . . . 0.0 110.789 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.78 157.36 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.886 0.874 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -113.38 149.43 34.09 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -128.01 164.82 21.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.546 0.689 . . . . 0.0 109.507 174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.1 153.73 21.96 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.62 136.66 53.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.24 135.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -169.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.82 -27.35 1.64 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.081 1.324 . . . . 0.0 112.709 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 mt -48.35 130.04 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.048 2.139 . . . . 0.0 109.273 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -95.03 7.26 69.69 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.027 1.299 . . . . 0.0 111.759 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 125.602 1.561 . . . . 0.0 113.161 -179.28 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.22 -54.74 40.42 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.253 0.933 . . . . 0.0 109.894 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -40.12 95.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.9 88.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.334 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.28 -34.32 77.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.222 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.14 -43.87 85.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.724 1.147 . . . . 0.0 110.5 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -65.03 -37.43 87.57 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 109.911 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -35.12 79.09 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.562 . . . . 0.0 111.282 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.587 ' HB3' HD23 ' A' ' 80' ' ' LEU . 17.9 m -72.4 -27.29 62.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.562 0.345 . . . . 0.0 110.229 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.28 -23.46 2.86 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.541 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 135.57 54.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.2 1.5 . . . . 0.0 108.554 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -80.78 132.62 35.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -77.87 100.0 6.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 m -73.91 153.21 39.92 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.04 -122.06 24.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.8 pt-20 -157.47 174.78 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.981 1.712 . . . . 0.0 107.831 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -54.34 127.84 28.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.809 0.844 . . . . 0.0 109.537 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 tt -99.24 155.27 17.58 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.641 1.576 . . . . 0.0 108.834 -171.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.65 147.85 44.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.318 -176.707 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.527 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.88 -44.88 91.7 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.135 0.879 . . . . 0.0 109.214 174.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.24 -51.63 68.16 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.11 -42.12 98.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.403 0.525 . . . . 0.0 112.111 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 m -58.54 -61.58 2.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 0.0 109.821 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -55.2 -46.06 75.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.7 0.8 . . . . 0.0 112.277 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.03 -54.62 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.556 0.742 . . . . 0.0 109.387 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -16.8 61.94 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.004 0.82 . . . . 0.0 112.471 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 mp -80.74 -44.18 19.06 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.329 0.652 . . . . 0.0 111.034 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -37.05 75.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.923 0.783 . . . . 0.0 110.976 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.7 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.938 1.295 . . . . 0.0 109.93 174.198 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.18 170.07 22.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.934 1.294 . . . . 0.0 109.29 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.64 -23.32 17.66 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.591 1.157 . . . . 0.0 110.895 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.92 127.74 55.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 108.946 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -92.33 129.3 38.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.99 98.63 8.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.83 89.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -92.12 49.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.598 2.359 . . . . 0.0 111.079 -168.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.85 174.26 46.7 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 121.45 -0.781 . . . . 0.0 112.558 175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.8 p -129.34 -48.21 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.621 1.168 . . . . 0.0 110.299 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 p -86.44 -72.21 0.51 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.4 tp -157.14 23.36 0.31 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 110.379 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.94 169.29 42.19 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.37 46.5 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.047 1.784 . . . . 0.0 108.809 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 102.61 0.45 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.303 1.041 . . . . 0.0 111.533 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.97 -38.64 89.3 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.515 0.726 . . . . 0.0 110.637 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.35 -42.59 91.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.283 0.633 . . . . 0.0 110.705 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.14 -49.33 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.96 93.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.104 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.91 -41.35 91.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.008 0.523 . . . . 0.0 110.819 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -61.99 -47.77 83.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.65 0.659 . . . . 0.0 110.066 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.42 -53.43 57.54 Favored 'General case' 0 N--CA 1.46 0.039 0 C-N-CA 124.057 0.943 . . . . 0.0 110.173 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.35 59.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.256 1.022 . . . . 0.0 110.712 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.17 -54.51 46.12 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -58.3 -37.3 74.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -70.81 -28.07 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.859 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.71 -39.65 73.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.632 1.56 . . . . 0.0 109.804 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.57 -28.17 69.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.463 0.705 . . . . 0.0 111.332 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.34 -10.82 60.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 112.348 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 16.92 8.7 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.912 -0.938 . . . . 0.0 113.424 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -117.73 -167.9 1.41 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.485 1.142 . . . . 0.0 108.84 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -130.82 150.29 52.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 p -140.84 156.99 46.01 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.911 -0.493 . . . . 0.0 110.446 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -133.15 105.47 7.05 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.09 122.79 21.55 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.386 1.074 . . . . 0.0 108.533 175.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -149.75 138.59 21.0 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 122.79 0.436 . . . . 0.0 111.014 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -85.48 43.86 1.06 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.667 -1.27 . . . . 0.0 108.393 168.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.31 56.21 1.2 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 127.358 2.408 . . . . 0.0 115.757 -169.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.62 -24.78 46.97 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.343 2.572 . . . . 0.0 115.367 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.4 mt -118.45 15.58 13.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.977 1.711 . . . . 0.0 109.363 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp 66.06 -30.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.506 2.722 . . . . 0.0 113.106 -169.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -168.13 94.45 0.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.334 1.854 . . . . 0.0 106.342 -169.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.29 -44.35 83.73 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.95 153.02 69.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.812 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.65 -171.51 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.443 3.428 . . . . 0.0 112.231 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.35 27.61 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.852 1.661 . . . . 0.0 113.42 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -156.49 138.0 14.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.99 2.116 . . . . 0.0 106.81 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.41 -140.4 11.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mm -128.46 133.83 65.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.524 ' CD1' HG21 ' A' ' 83' ' ' VAL . 8.3 m0 -117.71 135.31 54.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.9 mt -128.95 142.37 50.96 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.93 133.08 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.29 104.58 6.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 123.791 0.836 . . . . 0.0 108.856 -169.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -171.56 131.1 0.71 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.574 1.949 . . . . 0.0 107.409 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.7 m -72.36 102.41 3.14 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 119.113 0.869 . . . . 0.0 108.686 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 115.349 -169.785 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 117.92 -1.038 . . . . 0.0 113.777 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.34 147.74 51.85 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.286 1.434 . . . . 0.0 107.263 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 -61.28 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.527 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -87.91 -40.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.449 2.1 . . . . 0.0 112.418 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -59.58 -52.65 64.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -62.99 -43.92 97.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.923 0.329 . . . . 0.0 110.458 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -63.54 -46.91 83.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.068 0.394 . . . . 0.0 109.969 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.75 71.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.522 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.3 -58.0 10.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.374 0.988 . . . . 0.0 109.079 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -62.64 -26.41 68.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.95 -30.77 71.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.072 0.549 . . . . 0.0 111.658 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -124.91 -23.8 4.2 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 30.78 66.4 0.87 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.65 1.98 . . . . 0.0 112.056 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -57.89 160.5 15.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.404 2.736 . . . . 0.0 113.123 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -79.9 61.12 3.71 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 122.37 1.081 . . . . 0.0 110.779 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.2 mt -71.63 10.47 0.65 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.772 1.629 . . . . 0.0 112.792 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -62.46 -7.42 4.51 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 129.665 3.186 . . . . 0.0 113.042 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.83 11.31 17.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.577 1.551 . . . . 0.0 110.791 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -130.28 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.966 0.889 . . . . 0.0 111.154 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -95.01 151.02 19.53 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.88 145.47 45.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.47 115.23 1.33 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 140.0 47.33 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.6 mt -137.32 128.34 40.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.99 -10.92 2.15 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.314 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mt -48.52 129.93 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.791 2.036 . . . . 0.0 109.465 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.67 -20.35 66.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.243 0.925 . . . . 0.0 112.163 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 127.953 2.501 . . . . 0.0 114.95 -177.574 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.56 -54.18 46.48 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.71 -41.81 95.97 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.84 76.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -67.78 -30.88 70.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.168 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.84 -44.07 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.755 1.161 . . . . 0.0 110.769 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.06 -35.06 73.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.432 0.693 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -32.21 71.4 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 125.954 1.702 . . . . 0.0 111.902 174.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.8 m -64.76 -48.35 74.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.6 -15.74 0.38 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.059 -1.412 . . . . 0.0 115.393 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.05 138.46 58.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.588 1.694 . . . . 0.0 110.61 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -84.03 111.53 19.37 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.64 111.76 2.89 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 42.5 m -84.17 152.51 24.23 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.96 -121.31 26.24 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.562 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 3.0 pt-20 -150.3 -176.35 5.44 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.909 2.083 . . . . 0.0 106.049 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -41.36 111.46 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.622 1.569 . . . . 0.0 111.376 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 161.54 28.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -133.79 149.37 51.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -170.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.562 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.63 -42.24 98.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.292 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 tp -57.99 -53.32 59.59 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.77 -42.68 98.13 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 m -59.0 -62.19 2.07 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 125.146 1.378 . . . . 0.0 110.149 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -57.15 -44.36 83.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.75 0.82 . . . . 0.0 112.016 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.48 -53.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.439 0.696 . . . . 0.0 109.475 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.23 -17.42 62.5 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.31 0.959 . . . . 0.0 112.407 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -79.18 -42.87 25.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.564 0.62 . . . . 0.0 111.227 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -37.56 75.12 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.947 0.794 . . . . 0.0 111.079 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.9 mttm . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.39 1.476 . . . . 0.0 109.937 174.068 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.24 159.59 44.13 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.509 1.124 . . . . 0.0 108.853 173.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -111.85 -23.13 10.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.444 1.898 . . . . 0.0 110.872 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.03 122.85 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -85.06 128.58 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.34 95.33 6.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -82.74 83.21 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -83.72 31.97 0.47 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 128.804 2.841 . . . . 0.0 112.682 -168.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.42 155.62 26.61 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 121.599 -0.688 . . . . 0.0 112.173 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.33 -37.8 1.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 110.387 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.5 p -130.6 49.56 2.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.8 tp 52.22 42.41 30.75 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.126 1.771 . . . . 0.0 111.101 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.18 159.18 16.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 128.042 2.734 . . . . 0.0 106.798 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.36 -160.4 32.52 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.357 1.078 . . . . 0.0 111.301 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.43 46.26 0.33 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.475 1.91 . . . . 0.0 113.525 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -53.52 -35.22 60.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.192 0.997 . . . . 0.0 112.828 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.01 -45.75 93.56 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.772 . . . . 0.0 110.736 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.05 -40.9 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.534 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.11 -41.52 94.83 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.177 0.899 . . . . 0.0 110.984 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -64.8 -45.5 85.99 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.745 -0.597 . . . . 0.0 109.904 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.24 -51.24 68.82 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.225 1.01 . . . . 0.0 110.271 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.36 -49.83 60.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 110.897 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.16 -53.48 57.8 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.193 0.997 . . . . 0.0 110.244 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.71 -37.95 77.23 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mp -69.71 -26.51 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.86 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -70.04 -43.82 70.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.854 1.661 . . . . 0.0 109.316 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.0 -26.33 67.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.48 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.34 -16.26 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.713 0.805 . . . . 0.0 112.219 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.07 15.66 2.05 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.523 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -131.66 -165.25 1.55 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.304 1.552 . . . . 0.0 110.041 -169.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 p -131.18 151.68 51.22 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.9 p -144.11 159.78 42.04 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.038 0.535 . . . . 0.0 109.796 -169.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.1 107.23 7.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 m -78.17 120.15 22.56 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -147.07 137.47 23.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.194 0.598 . . . . 0.0 110.057 -169.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -82.39 41.49 0.7 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.608 -1.307 . . . . 0.0 109.677 169.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 38.7 55.12 2.22 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.636 2.065 . . . . 0.0 115.022 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.39 -20.3 54.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.808 2.339 . . . . 0.0 113.499 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.4 mt -118.07 15.18 14.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.293 1.837 . . . . 0.0 109.068 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tp 63.84 -28.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.088 2.955 . . . . 0.0 113.97 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -164.98 93.45 0.62 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.408 1.483 . . . . 0.0 107.111 -168.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.08 -43.78 77.77 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.467 -0.771 . . . . 0.0 110.007 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.35 154.5 74.34 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 47' ' ' SER . 41.8 Cg_endo -66.52 -173.68 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.934 3.089 . . . . 0.0 112.554 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 29.94 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.178 1.391 . . . . 0.0 112.661 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 45' ' ' PRO . 18.0 m -152.33 136.91 16.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.967 2.507 . . . . 0.0 106.41 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.13 -141.59 12.74 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mm -123.76 139.83 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CD1' HG21 ' A' ' 83' ' ' VAL . 10.3 m0 -122.04 135.12 54.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.8 mt -128.79 140.7 51.59 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.58 134.43 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -137.68 113.78 11.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -170.93 -156.51 0.12 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.935 2.494 . . . . 0.0 105.668 174.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m -147.6 138.78 23.62 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 121.06 1.755 . . . . 0.0 109.305 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.0 p . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.619 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.448 HD12 ' H ' ' A' ' 66' ' ' LEU . 5.9 mp -65.34 146.16 55.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.721 1.208 . . . . 0.0 108.69 174.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.454 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 29.8 m -122.22 -63.67 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 117.248 -1.358 . . . . 0.0 111.172 176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 67' ' ' SER . 43.9 Cg_endo -66.75 -39.31 15.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.92 1.722 . . . . 0.0 110.993 -175.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -60.28 -50.35 73.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.35 0.66 . . . . 0.0 110.091 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.28 -48.97 78.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.67 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -60.94 -45.81 93.23 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.772 0.714 . . . . 0.0 110.462 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.4 72.61 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.43 -58.02 8.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 119.202 0.91 . . . . 0.0 109.233 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -63.6 -24.64 67.88 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.56 -33.69 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.022 0.529 . . . . 0.0 111.38 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -123.47 -23.76 4.73 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 29.91 66.53 0.78 Allowed Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 126.885 2.074 . . . . 0.0 112.086 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.75 163.88 17.58 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.037 2.492 . . . . 0.0 113.529 -169.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.99 59.86 2.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.285 1.834 . . . . 0.0 112.009 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 7.16 2.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.036 1.334 . . . . 0.0 113.163 -171.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -63.52 -4.06 2.57 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.259 -1.526 . . . . 0.0 112.614 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.9 6.56 25.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.3 1.44 . . . . 0.0 111.459 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.1 p -130.71 162.07 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.914 0.885 . . . . 0.0 109.966 175.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -118.0 152.74 34.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -119.92 151.56 38.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.922 1.689 . . . . 0.0 108.134 -169.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.39 150.85 23.16 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.9 138.95 53.82 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.7 mt -137.08 124.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -169.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.23 -30.27 1.39 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.801 1.191 . . . . 0.0 111.803 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.43 143.45 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.452 1.901 . . . . 0.0 108.005 169.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 15.54 0.11 Allowed Glycine 0 CA--C 1.523 0.563 0 CA-C-O 119.055 -0.858 . . . . 0.0 113.8 -174.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 125.037 1.335 . . . . 0.0 112.878 178.629 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.2 mttm . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.21 -58.82 5.92 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.788 1.177 . . . . 0.0 109.842 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.57 -37.68 84.73 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -175.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.2 -51.75 67.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.009 0.923 . . . . 0.0 109.953 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.69 -35.22 80.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.428 1.013 . . . . 0.0 111.158 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.62 -50.1 72.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.174 0.897 . . . . 0.0 110.942 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.322 11.7 ptmt -71.78 -28.1 63.4 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.938 -0.476 . . . . 0.0 112.204 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -36.19 82.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.333 1.053 . . . . 0.0 111.009 169.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.6 m -68.52 -33.7 74.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.948 0.34 . . . . 0.0 110.561 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.69 -28.9 0.37 Allowed Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.668 169.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.47 141.2 57.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.654 1.227 . . . . 0.0 110.11 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -80.69 129.16 34.36 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -75.6 100.95 4.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 170.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 99.6 m -73.32 149.87 42.31 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.34 -124.43 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.474 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.0 pt-20 -152.1 166.05 32.84 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.337 1.055 . . . . 0.0 108.301 169.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.5 m -51.03 130.89 26.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.842 1.257 . . . . 0.0 111.222 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -92.64 160.47 14.99 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.928 2.091 . . . . 0.0 108.429 -176.377 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.414 ' H ' HD23 ' A' ' 121' ' ' LEU . 47.3 mtmt -131.36 144.05 50.95 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--N 1.324 -0.535 0 C-N-CA 127.747 2.419 . . . . 0.0 106.448 -179.583 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 . . . . . 0 CA--C 1.538 0.513 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.474 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.87 -48.47 78.05 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.335 0.654 . . . . 0.0 109.711 171.355 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.62 -49.14 77.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.074 0.95 . . . . 0.0 109.217 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.0 -52.51 46.3 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.932 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -63.24 -44.74 94.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.286 0.543 . . . . 0.0 110.524 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.39 -41.84 94.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.274 1.43 . . . . 0.0 110.804 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.77 -48.03 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.084 0.953 . . . . 0.0 109.547 172.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.35 -29.74 70.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.257 0.935 . . . . 0.0 111.612 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.21 -46.99 25.65 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.363 1.065 . . . . 0.0 110.505 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.01 -29.91 62.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.353 0.524 . . . . 0.0 112.054 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.3 mttt . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.374 1.07 . . . . 0.0 109.86 171.815 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.81 158.8 35.73 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.1 -22.25 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.1 1.76 . . . . 0.0 110.712 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.5 mt -134.81 128.94 51.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.547 1.139 . . . . 0.0 108.065 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -89.01 131.88 34.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 95.1 5.39 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.1 mt -89.94 110.39 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.35 143.67 44.06 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 122.813 0.445 . . . . 0.0 111.622 -169.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.5 168.29 12.22 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 124.598 1.094 . . . . 0.0 112.002 169.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 p -117.88 -8.8 10.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 0.0 112.516 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t -141.79 -54.44 0.45 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -149.4 17.12 0.93 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.485 1.039 . . . . 0.0 111.661 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.93 172.1 28.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 127.432 2.444 . . . . 0.0 107.68 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.71 10.07 4.12 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.015 -1.436 . . . . 0.0 115.053 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 2.86 1.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.077 1.938 . . . . 0.0 113.405 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.8 -31.55 62.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.486 1.114 . . . . 0.0 112.125 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -58.1 -53.5 57.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.458 0.703 . . . . 0.0 111.525 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.09 -30.54 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.03 77.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.001 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.35 -41.22 89.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.015 0.825 . . . . 0.0 111.083 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -63.07 -46.9 85.28 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.1 mt -57.12 -51.17 70.35 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.044 0.937 . . . . 0.0 110.461 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.72 -48.53 63.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.761 1.224 . . . . 0.0 110.685 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.71 -53.89 52.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.484 0.714 . . . . 0.0 110.345 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -57.92 -38.12 75.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.92 -33.13 75.02 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.254 0.621 . . . . 0.0 111.183 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -70.04 -38.21 75.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 119.921 1.237 . . . . 0.0 110.325 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.51 -28.96 70.3 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.165 0.893 . . . . 0.0 111.42 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.34 63.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.393 0.677 . . . . 0.0 111.597 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.26 -6.49 5.34 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.493 -1.171 . . . . 0.0 113.706 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.9 -165.44 1.34 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.341 1.57 . . . . 0.0 109.395 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.5 p -144.88 160.08 41.87 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.701 -0.624 . . . . 0.0 110.618 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.07 115.61 15.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 m -78.93 123.82 27.64 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 mt -140.5 156.79 46.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.112 0.565 . . . . 0.0 110.396 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -105.03 35.8 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.432 1.093 . . . . 0.0 108.77 169.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.57 48.05 28.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.727 1.632 . . . . 0.0 115.048 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.38 -20.57 61.47 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 121.046 2.423 . . . . 0.0 113.808 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -122.31 14.92 10.49 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.022 1.729 . . . . 0.0 109.094 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.6 tp 64.9 -30.09 0.12 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.979 2.512 . . . . 0.0 113.543 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -165.31 86.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.223 1.409 . . . . 0.0 107.452 -168.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.7 -41.74 99.28 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.956 -0.465 . . . . 0.0 110.185 176.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.47 150.11 36.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.58 -178.92 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.88 3.053 . . . . 0.0 113.239 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 32.55 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.994 1.718 . . . . 0.0 112.549 171.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 m -157.36 125.34 5.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 106.044 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.86 -143.36 14.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 mm -124.38 130.97 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -118.89 144.62 46.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.2 mt -137.14 135.77 37.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -132.6 137.55 53.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -173.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -128.07 96.71 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.169 1.388 . . . . 0.0 107.258 -170.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.5 p -145.52 -6.29 0.63 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -173.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m 37.98 60.95 1.14 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.468 0.431 0 C-N-CA 124.122 0.969 . . . . 0.0 112.384 169.932 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.0 mt 37.66 58.81 1.33 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.078 1.418 . . . . 0.0 108.395 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.402 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 50.5 m -63.61 -48.01 81.45 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.488 1.915 . . . . 0.0 114.174 -168.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 67' ' ' SER . 37.2 Cg_endo -63.14 -34.07 70.42 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 121.176 1.456 . . . . 0.0 110.647 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -72.33 -42.84 64.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.403 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -53.52 -51.56 62.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.99 1.316 . . . . 0.0 110.261 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -61.8 -42.52 99.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.822 0.737 . . . . 0.0 110.87 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.6 86.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.219 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.49 -56.34 23.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.241 0.928 . . . . 0.0 109.106 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -20.18 65.06 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.84 -31.06 63.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.876 0.762 . . . . 0.0 111.635 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -121.11 -28.56 4.72 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 23.75 70.91 0.33 Allowed Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 127.722 2.409 . . . . 0.0 113.7 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -58.84 175.38 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.605 2.204 . . . . 0.0 111.729 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -89.96 79.16 6.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.995 0.918 . . . . 0.0 110.022 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.557 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.1 mm? -75.39 3.17 9.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.264 0.626 . . . . 0.0 112.174 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -63.8 -6.74 6.23 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.026 2.13 . . . . 0.0 112.926 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.13 6.21 38.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.774 1.629 . . . . 0.0 110.792 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.31 145.66 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 122.147 0.975 . . . . 0.0 111.732 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.407 HH11 ' HG3' ' A' ' 84' ' ' ARG . 1.6 ptm180 -94.67 144.55 25.52 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -113.07 146.5 39.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.09 121.81 3.67 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.09 132.16 43.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.24 108.28 18.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -30.03 0.43 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.227 0.918 . . . . 0.0 113.049 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.76 123.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.0 45.74 0.29 Allowed Glycine 0 CA--C 1.502 -0.722 0 CA-C-O 121.722 0.623 . . . . 0.0 111.75 -169.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.83 -56.49 19.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.721 0.808 . . . . 0.0 110.138 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.14 -38.87 92.0 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.63 72.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -63.24 -42.12 99.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.775 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -57.28 -47.59 81.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.304 0.956 . . . . 0.0 110.714 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -73.51 -36.0 65.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.852 0.861 . . . . 0.0 109.688 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.86 -34.38 78.23 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.377 1.471 . . . . 0.0 111.629 173.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.557 ' HB3' HD23 ' A' ' 80' ' ' LEU . 14.8 m -73.65 -17.72 61.12 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.251 0.22 . . . . 0.0 110.636 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.25 -17.64 5.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 117.921 -1.488 . . . . 0.0 114.085 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 130.75 44.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.649 1.725 . . . . 0.0 109.258 -170.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -86.37 111.08 20.15 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.04 117.51 5.18 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 94.7 m -129.38 143.13 50.72 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.244 0.618 . . . . 0.0 110.737 -169.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.38 -103.34 2.99 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -165.03 -175.88 3.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.357 1.863 . . . . 0.0 107.448 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.4 m -63.01 113.64 3.22 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 122' ' ' LYS . 1.3 tt -71.37 153.62 42.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.511 ' H ' HD23 ' A' ' 121' ' ' LEU . 37.6 mttp -130.8 143.0 50.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 125.722 1.609 . . . . 0.0 107.213 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.533 0.305 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.451 ' CE3' HD12 ' A' ' 121' ' ' LEU . 13.8 t90 -59.08 -54.92 41.57 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.307 0.643 . . . . 0.0 109.538 173.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -55.91 20.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.631 1.573 . . . . 0.0 109.09 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.1 -42.59 98.02 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.737 -0.48 . . . . 0.0 112.133 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -60.17 -60.35 3.96 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.82 0.81 . . . . 0.0 109.03 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -56.85 -46.54 81.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.386 1.074 . . . . 0.0 111.485 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.01 -55.78 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.702 0.801 . . . . 0.0 109.683 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -15.96 62.49 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.059 0.845 . . . . 0.0 112.421 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.61 -48.47 13.71 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.467 0.707 . . . . 0.0 110.769 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.73 -32.58 65.8 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.766 0.712 . . . . 0.0 111.958 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.1 mttt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.228 1.011 . . . . 0.0 109.74 174.006 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.62 152.59 45.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.273 0.942 . . . . 0.0 111.628 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.43 -22.51 16.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.193 1.797 . . . . 0.0 110.865 170.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.21 129.49 53.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.781 1.233 . . . . 0.0 108.144 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -90.42 127.96 36.35 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.91 95.62 5.66 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.64 131.54 33.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.83 -174.35 3.7 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.058 1.743 . . . . 0.0 109.038 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.27 42.44 90.58 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.547 -0.721 . . . . 0.0 112.476 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -44.91 -44.56 9.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.396 2.278 . . . . 0.0 114.329 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -82.23 22.78 0.79 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.188 1.795 . . . . 0.0 112.188 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt 59.04 54.17 5.13 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.74 1.257 . . . . 0.0 107.654 -168.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.32 -135.98 3.33 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.096 1.808 . . . . 0.0 108.739 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.46 149.32 21.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.18 16.27 0.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.321 1.849 . . . . 0.0 111.108 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.24 -16.91 37.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 0.0 113.683 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.64 -48.08 66.63 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.283 1.402 . . . . 0.0 112.14 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.07 -31.72 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.967 -0.458 . . . . 0.0 110.177 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.53 78.07 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.074 0.55 . . . . 0.0 111.114 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.31 -37.45 80.61 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.055 0.942 . . . . 0.0 110.371 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -65.25 -42.44 93.31 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.72 -0.612 . . . . 0.0 110.008 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 mt -61.49 -51.73 67.43 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.93 64.96 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.451 1.501 . . . . 0.0 111.312 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 -54.74 40.16 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.517 0.675 . . . . 0.0 109.954 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.56 -38.74 91.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -60.93 -40.17 92.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.478 0.711 . . . . 0.0 110.897 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.55 -36.52 68.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.16 -0.962 . . . . 0.0 110.469 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.8 -31.3 71.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.481 0.712 . . . . 0.0 111.262 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.5 -21.49 62.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.375 0.67 . . . . 0.0 111.736 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.99 -7.82 3.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.178 -1.345 . . . . 0.0 114.295 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -94.99 -168.86 1.88 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.802 1.801 . . . . 0.0 110.205 -171.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -128.89 149.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.7 p -142.71 155.64 44.91 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.823 -0.548 . . . . 0.0 111.065 -170.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -121.73 90.67 3.36 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.906 1.283 . . . . 0.0 108.331 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -67.53 120.66 14.33 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.1 mt -146.86 168.37 21.59 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.834 0.854 . . . . 0.0 111.534 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -109.52 31.88 5.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.884 1.273 . . . . 0.0 109.584 169.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.86 49.73 46.93 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.602 1.572 . . . . 0.0 114.537 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 -21.01 64.96 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.061 2.507 . . . . 0.0 113.99 -172.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.11 12.76 11.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.674 1.59 . . . . 0.0 109.577 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 tp 63.91 -25.8 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.939 2.496 . . . . 0.0 113.455 -169.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -166.75 82.67 0.25 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -169.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.98 -43.89 97.54 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.879 -0.513 . . . . 0.0 109.841 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.48 151.28 44.07 Favored Pre-proline 0 C--N 1.345 0.409 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 169.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 47' ' ' SER . 37.5 Cg_endo -67.07 -175.12 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 124.151 3.234 . . . . 0.0 113.005 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.04 29.77 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.645 1.578 . . . . 0.0 113.193 171.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' PRO . 20.3 m -152.56 127.17 9.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.964 2.506 . . . . 0.0 106.157 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.08 -140.92 12.19 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.3 mm -127.97 135.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CD1' HG21 ' A' ' 83' ' ' VAL . 18.2 m0 -119.52 130.02 54.98 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.3 mt -126.97 133.58 50.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.37 103.5 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -169.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.0 mp -78.72 126.04 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.9 m -159.57 176.95 11.43 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.128 1.771 . . . . 0.0 107.05 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 m -149.92 65.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 p . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 126.749 2.019 . . . . 0.0 113.399 -169.835 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 119.968 3.322 . . . . 0.0 119.968 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.29 72.57 10.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.8 m -67.21 -51.3 35.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.746 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 -38.73 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.453 1.435 . . . . 0.0 110.18 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.31 -52.33 54.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.592 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -59.38 -46.26 89.16 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.286 0.948 . . . . 0.0 110.845 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -63.5 -49.54 73.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.512 0.596 . . . . 0.0 110.274 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.26 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -60.52 -56.29 23.21 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.836 0.855 . . . . 0.0 109.577 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.41 -23.57 66.99 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.49 -33.7 73.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.746 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -124.59 -21.83 4.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 30.26 64.53 0.89 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 127.068 2.147 . . . . 0.0 112.911 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.7 165.24 18.84 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.938 2.425 . . . . 0.0 113.375 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.34 63.96 4.99 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.731 1.212 . . . . 0.0 111.232 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 9.95 0.33 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.45 1.5 . . . . 0.0 113.281 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 m -64.04 -2.43 1.98 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.756 2.823 . . . . 0.0 113.171 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.85 9.1 11.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.741 1.616 . . . . 0.0 110.981 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -128.5 154.13 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.689 0.677 . . . . 0.0 110.75 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.36 143.26 32.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -103.01 154.61 19.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.98 115.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.1 133.92 47.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.32 116.67 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.46 -11.37 18.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.625 1.107 . . . . 0.0 114.36 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.64 130.5 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.012 1.725 . . . . 0.0 108.609 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.96 -38.88 3.71 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 -170.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 125.705 1.602 . . . . 0.0 111.565 170.363 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.404 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.9 tm? -59.37 -59.04 6.08 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.292 0.951 . . . . 0.0 109.442 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.06 -38.61 79.78 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.318 0.508 . . . . 0.0 110.852 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.91 88.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.879 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -64.84 -36.59 84.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.967 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.67 -47.25 86.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.255 0.934 . . . . 0.0 110.814 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -69.46 -35.47 75.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.993 0.517 . . . . 0.0 110.217 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -36.48 84.18 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.293 1.437 . . . . 0.0 111.037 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.8 m -67.16 -36.14 81.18 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.607 0.363 . . . . 0.0 110.097 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.66 -25.66 0.25 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.29 -1.284 . . . . 0.0 115.396 169.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.35 139.98 55.87 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.344 1.572 . . . . 0.0 110.524 -170.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -83.73 146.14 28.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -92.58 98.37 11.4 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.8 m -75.3 151.72 38.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.82 -116.89 8.63 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 7.3 pt-20 -146.8 178.99 7.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.334 1.053 . . . . 0.0 108.561 170.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -54.43 119.53 5.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.5 1.12 . . . . 0.0 108.8 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.7 OUTLIER -76.09 151.35 37.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.463 ' H ' HD23 ' A' ' 121' ' ' LEU . 28.0 mtmm -138.87 141.84 38.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.324 -0.533 0 C-N-CA 127.501 2.321 . . . . 0.0 108.657 -171.613 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 119.601 -0.237 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.438 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 8.3 m-90 -63.22 -51.29 66.84 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.007 0.523 . . . . 0.0 109.833 177.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.8 mt -58.62 -55.7 31.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.693 0.621 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.51 -49.16 75.61 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.383 -0.676 . . . . 0.0 111.414 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -48.03 77.71 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.155 0.977 . . . . 0.0 110.176 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -60.16 -42.96 96.07 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.569 -0.707 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.8 t -57.39 -50.33 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.555 1.142 . . . . 0.0 109.727 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.74 -26.96 68.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.129 0.877 . . . . 0.0 111.986 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.8 -45.98 16.1 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.671 0.789 . . . . 0.0 110.401 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.05 -34.69 68.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.375 0.534 . . . . 0.0 111.754 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.2 mttt . . . . . 0 C--O 1.248 0.98 0 C-N-CA 124.155 0.982 . . . . 0.0 110.026 176.14 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 tpp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.71 163.22 40.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.369 1.068 . . . . 0.0 109.924 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.14 -24.3 16.91 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.752 1.221 . . . . 0.0 110.891 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.7 mt -132.48 124.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 127.8 35.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.16 103.4 14.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mt -89.92 74.45 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -78.83 138.88 38.38 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.783 -0.573 . . . . 0.0 109.988 -170.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.63 136.11 3.15 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 124.563 1.078 . . . . 0.0 111.082 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -87.21 -7.22 58.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.931 0.892 . . . . 0.0 110.509 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -143.74 -144.35 0.15 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.992 3.317 . . . . 0.0 102.954 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.62 8.12 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.44 -176.52 48.08 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 128.931 3.158 . . . . 0.0 107.413 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 7.87 5.29 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.232 -1.316 . . . . 0.0 114.709 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.82 -2.48 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.638 1.719 . . . . 0.0 113.732 -175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.01 -33.39 64.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.425 1.09 . . . . 0.0 112.432 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.59 -42.65 88.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.515 0.726 . . . . 0.0 111.469 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.77 -28.18 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.01 77.59 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.145 0.884 . . . . 0.0 111.338 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.08 -42.05 93.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.918 0.781 . . . . 0.0 111.278 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -68.59 -43.2 77.01 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.698 -0.627 . . . . 0.0 110.663 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.73 -50.5 73.01 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.001 0.92 . . . . 0.0 110.432 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.97 67.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.732 1.213 . . . . 0.0 110.995 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.98 -52.99 61.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.683 0.674 . . . . 0.0 110.18 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -60.35 -40.55 91.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.91 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.518 175.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.53 -39.98 80.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.388 0.995 . . . . 0.0 109.737 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.94 -29.1 70.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.389 0.995 . . . . 0.0 111.6 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.3 -17.73 63.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.716 0.806 . . . . 0.0 111.622 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.35 14.03 4.6 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.323 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.72 -172.38 2.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.442 1.621 . . . . 0.0 110.419 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -122.86 153.58 39.44 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p -141.61 154.56 45.48 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.875 -0.516 . . . . 0.0 111.615 -169.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -117.94 91.92 3.7 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.634 1.574 . . . . 0.0 106.923 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -69.21 118.44 12.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 172.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.09 166.0 27.43 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.747 1.219 . . . . 0.0 108.738 -173.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -101.44 31.18 3.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.493 0.717 . . . . 0.0 110.653 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.62 50.79 47.39 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 118.143 -1.365 . . . . 0.0 113.935 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.2 -21.36 67.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.082 2.521 . . . . 0.0 113.638 -171.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.2 mt -125.74 15.87 8.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.739 1.616 . . . . 0.0 109.54 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.6 tp 63.0 -26.69 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.328 2.651 . . . . 0.0 114.31 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -161.17 82.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.536 1.134 . . . . 0.0 108.22 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.36 -43.96 84.52 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.777 -0.577 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.3 mt -85.65 151.36 55.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.24 -178.29 1.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.968 3.112 . . . . 0.0 113.292 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 31.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.758 2.023 . . . . 0.0 112.941 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -159.87 116.87 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.928 2.091 . . . . 0.0 106.312 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.0 -146.01 15.4 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -173.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mm -123.64 136.18 60.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -118.36 148.78 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.5 mt -134.54 142.91 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.75 130.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.41 110.4 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -168.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 m -149.51 -174.67 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.23 1.012 . . . . 0.0 109.361 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -154.48 134.73 13.24 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.622 1.169 . . . . 0.0 108.313 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 CA--C 1.531 0.218 0 C-N-CA 122.903 0.481 . . . . 0.0 111.237 -170.562 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 t30 . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.36 61.27 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.012 1.725 . . . . 0.0 108.66 170.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.5 m -65.94 -48.02 62.38 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 125.957 1.703 . . . . 0.0 110.838 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -72.71 -39.95 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 120.414 1.184 . . . . 0.0 110.251 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -60.21 3.53 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -169.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -59.79 -43.21 94.55 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.984 0.913 . . . . 0.0 110.336 -169.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -69.31 -46.87 66.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.001 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -26.91 68.59 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.651 1.114 . . . . 0.0 112.886 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.9 mt -61.98 -61.34 2.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -57.48 -25.8 60.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.096 1.758 . . . . 0.0 113.719 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -30.81 70.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -126.88 -29.95 2.78 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HD2' HD21 ' A' ' 111' ' ' ASN . 36.6 mtmt 23.81 67.85 0.38 Allowed Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 127.153 2.181 . . . . 0.0 113.401 -169.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.6 175.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.833 1.689 . . . . 0.0 110.672 171.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -87.87 125.93 34.75 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.9 mm? -120.27 11.79 11.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.619 1.168 . . . . 0.0 111.145 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.7 m -67.0 -4.87 10.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 119.662 -1.899 . . . . 0.0 113.033 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.1 5.06 42.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.308 1.443 . . . . 0.0 110.734 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.06 157.17 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.961 0.886 . . . . 0.0 110.896 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -110.46 151.99 26.86 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -121.44 157.22 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.85 118.84 2.4 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.17 140.6 31.63 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.79 125.89 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -170.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.58 52.78 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.381 0.991 . . . . 0.0 113.796 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.55 80.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 108.151 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.54 -11.39 2.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 127.174 2.321 . . . . 0.0 117.806 -168.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 CA--C 1.541 0.603 0 CA-C-N 120.525 2.162 . . . . 0.0 109.692 172.397 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.35 -55.4 35.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.471 1.108 . . . . 0.0 109.545 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.56 -39.85 92.16 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.837 -171.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.38 78.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.224 1.01 . . . . 0.0 109.889 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -63.72 -35.74 81.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.422 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.8 -42.5 94.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.206 1.366 . . . . 0.0 111.289 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -65.55 -38.85 90.81 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.111 0.565 . . . . 0.0 109.764 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.471 HD21 ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.65 -31.32 71.23 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.986 1.314 . . . . 0.0 111.684 176.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.627 ' HB3' HD23 ' A' ' 80' ' ' LEU . 15.5 m -73.52 -29.91 62.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.855 0.462 . . . . 0.0 109.847 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.71 -17.35 4.44 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-O 118.457 -1.19 . . . . 0.0 113.599 169.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 136.23 56.67 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.892 1.346 . . . . 0.0 108.287 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -84.56 126.81 33.65 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -77.27 98.65 5.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.8 m -73.45 151.33 41.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.59 -117.35 10.83 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.571 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 10.3 pt-20 -157.0 170.08 23.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.123 1.769 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -55.3 126.44 24.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.603 0.761 . . . . 0.0 109.739 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -84.25 161.42 20.5 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.065 1.746 . . . . 0.0 107.674 176.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.437 ' H ' HD23 ' A' ' 121' ' ' LEU . 60.6 mtpt -136.52 150.87 48.87 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.327 0 C-N-CA 123.394 0.678 . . . . 0.0 110.387 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.571 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -61.93 -40.54 95.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.836 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -55.73 27.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.64 -49.0 67.61 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.266 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.7 m -60.61 -55.53 32.24 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 111.83 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -55.99 -42.7 76.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.65 1.18 . . . . 0.0 111.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 t -58.23 -49.35 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.145 0.578 . . . . 0.0 109.83 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.59 -30.12 70.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.372 0.987 . . . . 0.0 111.397 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.9 -46.12 25.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.014 0.925 . . . . 0.0 110.452 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.69 -33.66 66.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.058 0.543 . . . . 0.0 111.586 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 83.7 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.484 1.114 . . . . 0.0 110.09 173.227 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.76 168.7 24.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.359 1.064 . . . . 0.0 109.988 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.37 -23.77 14.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 111.224 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.13 121.94 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -85.12 133.89 34.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.69 96.52 6.13 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 174.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.3 mt -92.9 107.38 19.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -92.12 95.27 9.66 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.24 0.22 23.82 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 118.291 -1.283 . . . . 0.0 114.803 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.89 106.12 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.451 1.625 . . . . 0.0 109.648 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m 46.83 44.45 14.31 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.068 1.347 . . . . 0.0 110.357 -170.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.89 47.9 21.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.649 1.58 . . . . 0.0 111.985 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.19 -173.19 40.76 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.538 1.542 . . . . 0.0 110.723 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.97 -165.82 39.0 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.68 55.56 0.67 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 111.221 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -54.24 -31.44 53.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.085 1.354 . . . . 0.0 112.105 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -55.7 -40.77 72.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.861 0.864 . . . . 0.0 111.721 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.58 -29.94 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.18 74.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.09 0.859 . . . . 0.0 110.638 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.13 -38.91 93.06 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.557 0.617 . . . . 0.0 110.907 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -67.11 -42.62 84.22 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.697 -0.627 . . . . 0.0 110.29 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -59.35 -52.54 65.2 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.697 0.799 . . . . 0.0 109.919 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.99 -49.55 63.06 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.162 1.385 . . . . 0.0 110.931 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.19 -54.35 47.92 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 110.426 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.16 -25.03 65.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.34 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.64 -43.38 80.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 120.738 1.608 . . . . 0.0 109.319 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.85 -26.21 68.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.749 -0.594 . . . . 0.0 111.597 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -13.02 62.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.943 0.897 . . . . 0.0 112.549 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.33 19.04 2.95 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.087 169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -132.0 -165.48 1.59 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.63 1.215 . . . . 0.0 109.837 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 p -132.36 151.75 51.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -141.77 154.91 45.56 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.971 -0.456 . . . . 0.0 111.468 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -125.72 95.66 4.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.518 1.127 . . . . 0.0 108.647 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.7 m -70.2 121.46 17.6 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.47 165.01 29.82 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.395 0.617 . . . . 0.0 111.469 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -107.46 31.1 5.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.728 1.211 . . . . 0.0 110.165 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.88 45.41 70.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.854 -1.526 . . . . 0.0 115.113 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.43 -21.41 66.39 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.049 2.499 . . . . 0.0 114.118 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.9 mt -116.45 11.72 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.529 1.532 . . . . 0.0 109.887 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 tp 64.21 -23.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.787 2.435 . . . . 0.0 113.467 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -169.82 82.63 0.12 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.963 1.705 . . . . 0.0 106.65 -169.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.45 -43.82 96.3 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.876 -0.515 . . . . 0.0 109.666 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.8 mt -96.06 150.8 37.72 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 169.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.31 -177.6 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.742 2.962 . . . . 0.0 113.154 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.17 35.75 0.05 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.73 1.612 . . . . 0.0 112.037 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 m -160.51 130.24 5.11 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.186 2.195 . . . . 0.0 106.008 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.28 -143.45 14.54 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -172.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mm -127.39 141.07 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CD1' HG21 ' A' ' 83' ' ' VAL . 5.1 m0 -128.92 146.86 50.84 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.8 mt -132.55 140.12 48.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.22 121.98 58.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.95 60.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -120.77 41.31 3.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.256 -169.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -26.53 107.76 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 128.584 2.754 . . . . 0.0 113.914 -172.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.224 -0.287 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.723 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.3 t30 . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.29 72.52 1.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.4 -51.92 57.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.513 0.725 . . . . 0.0 112.454 -168.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.8 -39.58 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.612 1.541 . . . . 0.0 110.516 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.36 -51.43 60.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.699 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -60.09 -49.85 76.03 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.519 0.6 . . . . 0.0 110.261 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.44 -44.7 95.79 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.541 0.609 . . . . 0.0 110.387 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.06 91.78 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.198 0.453 . . . . 0.0 111.919 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.5 mt -58.71 -55.68 31.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.952 0.796 . . . . 0.0 109.739 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -65.59 -20.01 66.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.25 -34.11 65.66 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.37 0.532 . . . . 0.0 111.598 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -122.85 -21.36 5.58 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 29.24 65.95 0.73 Allowed Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 127.07 2.148 . . . . 0.0 113.034 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.87 165.29 14.41 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.533 2.155 . . . . 0.0 112.738 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -80.74 63.93 5.33 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.05 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -68.37 4.53 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.139 0.976 . . . . 0.0 112.789 -177.38 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -62.09 -8.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.812 2.845 . . . . 0.0 113.104 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.55 10.4 19.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.713 1.605 . . . . 0.0 110.752 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 50' ' ' TRP . 1.5 p -132.27 153.08 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 110.813 175.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -107.34 152.42 24.18 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -120.05 156.41 30.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.07 126.59 3.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 106.524 -2.63 . . . . 0.0 106.524 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.22 138.92 31.68 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 mt -139.31 124.45 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.72 -12.05 3.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.066 0.841 . . . . 0.0 114.352 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.7 mm -55.14 133.81 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.229 1.412 . . . . 0.0 107.857 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.88 -21.72 17.72 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -169.702 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.85 -57.38 12.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.677 0.671 . . . . 0.0 109.788 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.39 -36.08 81.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.498 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.8 -50.42 73.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.421 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.81 -42.34 93.26 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.604 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 mt -60.18 -48.15 82.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.844 0.747 . . . . 0.0 111.167 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -67.99 -36.2 79.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.198 0.599 . . . . 0.0 109.867 -177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -31.89 72.8 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.7 1.2 . . . . 0.0 111.798 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.0 m -69.54 -33.49 72.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.803 0.441 . . . . 0.0 110.508 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.65 -38.39 0.3 Allowed Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 169.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . . . -70.92 174.12 6.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.442 1.121 . . . . 0.0 111.664 -174.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -132.12 145.93 51.71 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -74.25 126.06 29.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.0 m -88.8 157.95 18.31 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.42 -133.02 30.3 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.33 161.68 38.36 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.427 1.091 . . . . 0.0 108.378 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 m -57.45 123.97 17.32 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.85 0.86 . . . . 0.0 111.632 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.21 171.14 15.5 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.161 1.784 . . . . 0.0 108.285 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -137.95 156.81 47.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 121.149 -0.97 . . . . 0.0 109.093 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 119.042 -0.504 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -50.79 72.48 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.839 0.745 . . . . 0.0 110.657 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.54 -52.09 62.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.26 -47.39 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.5 t -61.76 -57.51 11.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -57.24 -43.31 82.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.605 0.762 . . . . 0.0 111.916 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.6 t -59.25 -55.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.726 1.21 . . . . 0.0 109.98 175.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -13.78 62.64 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.591 1.087 . . . . 0.0 112.213 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.95 -48.12 13.91 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.058 0.943 . . . . 0.0 110.825 170.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -71.56 -33.46 69.13 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.892 0.769 . . . . 0.0 112.176 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.3 mttt . . . . . 0 C--O 1.248 1.021 0 C-N-CA 125.022 1.329 . . . . 0.0 109.49 173.614 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.09 37.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.15 0.98 . . . . 0.0 110.117 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.89 -23.76 17.3 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.4 1.48 . . . . 0.0 110.753 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.78 130.38 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.543 1.137 . . . . 0.0 108.327 -174.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 t -89.88 129.07 36.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -111.2 93.68 4.6 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.7 mm -72.16 98.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -86.49 13.85 7.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.541 1.937 . . . . 0.0 114.305 -168.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.98 158.81 31.77 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 118.929 0.786 . . . . 0.0 112.623 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -93.76 -30.72 14.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.446 1.498 . . . . 0.0 111.547 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -124.37 48.51 1.92 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.461 1.124 . . . . 0.0 108.948 -169.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.5 tp 56.01 27.87 11.93 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.4 1.48 . . . . 0.0 111.334 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.7 165.05 26.44 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 128.328 2.87 . . . . 0.0 106.869 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.69 -146.6 11.76 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 118.211 1.006 . . . . 0.0 110.862 -173.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.68 50.77 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.499 1.919 . . . . 0.0 112.076 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.62 -29.23 66.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.683 1.193 . . . . 0.0 112.144 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -60.08 -51.31 70.17 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.7 0.682 . . . . 0.0 111.078 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.55 -28.52 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.84 -0.537 . . . . 0.0 109.667 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.9 98.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.646 0.657 . . . . 0.0 110.736 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.55 -40.55 92.98 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.178 0.591 . . . . 0.0 110.566 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.26 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.714 -0.616 . . . . 0.0 110.622 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -60.46 -51.02 71.23 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.563 1.145 . . . . 0.0 109.719 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.19 66.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 111.073 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.89 -52.19 66.11 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.131 0.973 . . . . 0.0 110.653 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -57.33 -37.76 73.04 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.68 -29.72 69.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.833 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -70.64 -44.23 67.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.542 1.519 . . . . 0.0 109.847 171.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.04 -26.53 67.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 0.0 111.406 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.69 -21.12 64.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.809 0.843 . . . . 0.0 111.963 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.28 12.05 1.48 Allowed Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.516 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -127.36 -165.97 1.54 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.603 1.701 . . . . 0.0 109.626 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -131.44 149.94 52.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 p -140.38 153.27 46.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.095 0.474 . . . . 0.0 110.461 -170.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -117.57 89.95 3.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -173.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 m -67.69 120.33 13.89 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -146.0 136.95 24.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.528 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -80.83 35.42 0.37 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.923 -1.111 . . . . 0.0 111.344 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.48 41.79 49.61 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.989 1.757 . . . . 0.0 115.605 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.98 -21.12 50.19 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.718 2.759 . . . . 0.0 114.137 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.2 mt -121.4 13.13 10.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.743 1.617 . . . . 0.0 108.936 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.4 tp 64.16 -29.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.269 2.627 . . . . 0.0 113.734 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -168.13 91.22 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.004 1.322 . . . . 0.0 107.677 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.77 -43.35 79.99 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.62 152.94 67.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 -173.42 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.99 3.127 . . . . 0.0 112.953 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.8 34.14 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.785 1.634 . . . . 0.0 112.29 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 m -158.08 133.7 8.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.668 1.987 . . . . 0.0 106.893 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.55 -143.17 14.13 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.4 mm -123.49 140.1 48.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -117.76 149.88 40.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -138.63 142.87 39.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.68 123.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.77 117.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -160.44 -175.7 5.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.178 1.791 . . . . 0.0 108.008 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -152.47 72.9 1.0 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.313 -1.492 . . . . 0.0 110.897 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 65' ' ' ASN . 3.1 p . . . . . 0 CA--C 1.547 0.841 0 C-N-CA 126.348 1.859 . . . . 0.0 114.873 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' A' ' 56' ' ' THR . 26.6 t-20 . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.8 140.56 36.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.37 -57.88 0.11 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.911 -171.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.81 -37.17 0.94 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.04 1.407 . . . . 0.0 111.715 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -59.58 5.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.801 0.84 . . . . 0.0 111.133 -169.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.12 -48.26 79.07 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 124.055 0.847 . . . . 0.0 110.69 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.02 -45.94 83.38 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.852 0.296 . . . . 0.0 110.712 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.133 -0.46 . . . . 0.0 111.73 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -56.77 -55.67 31.27 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.812 0.733 . . . . 0.0 109.511 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -68.18 -18.66 64.65 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.53 -32.1 64.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.449 0.568 . . . . 0.0 111.693 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -122.45 -25.18 4.82 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 32.26 62.78 1.3 Allowed Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 127.139 2.175 . . . . 0.0 112.375 -176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.87 164.52 21.49 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -79.75 65.32 4.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 -174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.39 16.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.914 1.686 . . . . 0.0 113.039 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.7 p -66.03 -2.34 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 119.746 -1.846 . . . . 0.0 112.87 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.6 12.78 9.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.186 1.794 . . . . 0.0 110.777 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.6 158.83 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.654 0.74 . . . . 0.0 110.989 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -128.58 154.56 46.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.152 1.381 . . . . 0.0 107.469 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -113.77 167.83 10.3 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.34 120.04 2.12 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.47 34.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.8 mt -133.45 126.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.68 -18.55 2.96 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.953 1.263 . . . . 0.0 113.507 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -46.53 142.37 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.71 2.404 . . . . 0.0 110.539 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.35 15.02 8.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.042 1.782 . . . . 0.0 111.373 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 CA--C 1.536 0.406 0 C-N-CA 124.954 1.302 . . . . 0.0 112.359 175.068 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 C--O 1.227 -0.085 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.48 -55.79 30.45 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.324 0.965 . . . . 0.0 109.54 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -71.14 -34.27 70.86 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.341 0.656 . . . . 0.0 109.684 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.94 87.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.003 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.66 -38.26 88.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.572 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.04 -50.27 74.72 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.298 0.954 . . . . 0.0 111.018 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.335 4.8 ptmm? -73.49 -27.98 61.68 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.897 -0.502 . . . . 0.0 112.321 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -37.74 87.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.453 1.101 . . . . 0.0 110.574 169.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -69.18 -36.24 77.12 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.543 0.337 . . . . 0.0 110.136 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.03 -20.69 0.36 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.52 -1.156 . . . . 0.0 114.99 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.31 -177.51 3.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.738 1.269 . . . . 0.0 111.139 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -141.59 152.87 44.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.104 1.362 . . . . 0.0 107.342 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -76.23 128.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -81.54 141.68 33.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.61 0.61 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.338 0.97 . . . . 0.0 111.871 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.14 178.11 10.66 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.266 2.226 . . . . 0.0 107.051 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.2 m -70.87 131.18 43.39 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.012 -1.055 . . . . 0.0 108.576 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.539 HD12 ' CE3' ' A' ' 138' ' ' TRP . 2.6 tt -83.01 147.83 27.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.411 ' N ' HD23 ' A' ' 121' ' ' LEU . 6.0 mptt -131.9 136.58 47.51 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 C-N-CA 123.924 0.89 . . . . 0.0 109.284 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.539 ' CE3' HD12 ' A' ' 121' ' ' LEU . 8.2 t90 -56.08 -57.92 10.12 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 109.244 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tp -53.07 -53.05 55.97 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.635 1.209 . . . . 0.0 110.062 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.97 -53.09 48.02 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -64.67 -45.26 87.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.471 0.635 . . . . 0.0 110.357 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -61.6 -41.37 97.36 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.214 1.006 . . . . 0.0 110.864 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.35 -48.53 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.135 0.574 . . . . 0.0 109.569 172.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.44 -28.86 70.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.193 0.906 . . . . 0.0 111.785 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mp -78.8 -45.78 20.2 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.263 1.025 . . . . 0.0 110.504 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.5 65.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.348 0.522 . . . . 0.0 111.702 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.302 1.041 . . . . 0.0 110.049 171.863 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.59 156.97 43.34 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 0.0 108.431 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.86 -24.12 12.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 110.817 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.2 mt -130.0 122.86 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 t -88.37 132.76 34.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.85 97.24 7.87 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 mm -83.92 70.55 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.57 165.56 23.57 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.298 0.57 . . . . 0.0 110.704 -177.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.08 -174.34 50.95 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 p -144.66 -53.95 0.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.8 p -87.1 40.09 0.9 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.177 1.791 . . . . 0.0 109.631 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp 62.88 24.86 14.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.821 1.648 . . . . 0.0 112.003 -169.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.14 164.44 33.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.76 170.72 20.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.069 1.319 . . . . 0.0 111.198 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 55.63 -1.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.238 2.615 . . . . 0.0 117.449 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.58 -32.95 69.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.43 1.468 . . . . 0.0 112.262 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -58.64 -43.58 89.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.979 0.512 . . . . 0.0 111.163 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.31 -37.86 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.93 83.89 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.089 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.53 -45.12 95.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.917 0.781 . . . . 0.0 110.421 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -64.97 -46.51 81.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.973 0.352 . . . . 0.0 110.093 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.16 -54.17 48.38 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.023 0.929 . . . . 0.0 110.301 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.22 -43.59 74.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.341 1.056 . . . . 0.0 111.17 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -61.31 -54.11 48.15 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.813 0.733 . . . . 0.0 110.596 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -57.94 -36.23 72.22 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.4 mt -71.95 -26.23 62.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.092 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.38 -41.23 73.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 120.241 1.382 . . . . 0.0 108.911 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.18 -26.31 68.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.534 0.734 . . . . 0.0 111.458 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.54 -14.0 62.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.966 0.907 . . . . 0.0 111.745 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.92 17.23 6.95 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.845 -0.975 . . . . 0.0 113.594 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -122.73 -168.99 1.84 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.684 1.242 . . . . 0.0 109.853 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -126.15 153.2 44.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.7 p -143.33 159.31 42.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.827 -0.546 . . . . 0.0 110.06 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.31 97.81 4.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -69.91 122.56 19.53 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -147.07 175.72 10.49 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.982 1.313 . . . . 0.0 108.663 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -120.21 39.97 3.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 108.482 169.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.99 46.41 32.68 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 117.599 -1.667 . . . . 0.0 115.108 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -64.37 -22.09 66.27 Favored 'Trans proline' 0 C--N 1.35 0.651 0 CA-C-N 121.205 2.502 . . . . 0.0 113.616 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.71 8.78 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.028 1.731 . . . . 0.0 109.832 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 58.33 -14.79 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.502 2.721 . . . . 0.0 115.197 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -159.26 76.32 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 120.004 1.274 . . . . 0.0 109.438 -169.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.32 -47.85 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.593 -0.692 . . . . 0.0 109.529 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.65 153.43 58.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.32 -176.5 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.14 3.227 . . . . 0.0 113.301 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.43 33.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.874 1.67 . . . . 0.0 112.567 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -159.76 133.42 7.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.238 2.215 . . . . 0.0 106.792 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.7 -144.96 16.4 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -121.35 146.99 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.409 ' CD1' HG21 ' A' ' 83' ' ' VAL . 4.9 m95 -133.34 153.81 51.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.5 mt -136.61 143.35 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -123.24 131.85 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.7 91.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -142.57 -170.78 3.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.264 1.825 . . . . 0.0 107.908 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m -144.61 133.27 22.23 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -171.508 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.2 55.63 3.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -54.7 52.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.433 -0.792 . . . . 0.0 112.445 -168.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -77.84 -41.36 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.568 2.178 . . . . 0.0 110.514 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.12 -51.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.347 0.659 . . . . 0.0 110.937 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.23 -43.55 91.06 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.99 0.814 . . . . 0.0 110.476 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -62.54 -47.27 84.64 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.832 0.742 . . . . 0.0 110.256 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.13 -32.09 72.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.89 -59.69 4.97 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.178 0.899 . . . . 0.0 109.437 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.28 -17.2 62.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.01 -35.06 79.08 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.242 0.617 . . . . 0.0 111.129 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.0 -22.03 4.21 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 33.7 63.22 1.66 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.81 164.23 16.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.027 2.485 . . . . 0.0 113.634 -169.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -80.42 64.97 5.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.54 1.136 . . . . 0.0 111.234 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.12 17.05 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 113.063 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 p -66.78 -2.87 5.56 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 119.922 -1.736 . . . . 0.0 112.789 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.1 11.97 9.56 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.1 1.76 . . . . 0.0 110.946 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -130.29 156.11 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.73 0.776 . . . . 0.0 111.439 176.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -121.33 152.47 38.92 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 108.323 169.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.401 ' CZ ' ' CE3' ' A' ' 50' ' ' TRP . 5.8 m-85 -123.69 166.96 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.599 -169.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.91 144.48 12.96 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.969 -2.852 . . . . 0.0 105.969 168.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.36 125.54 50.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 90' ' ' ILE . 34.3 mt -129.59 133.12 65.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -169.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.64 -28.42 1.54 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.799 1.19 . . . . 0.0 112.091 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' H ' ' C ' ' A' ' 88' ' ' ILE . 62.2 mt -48.83 138.77 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.509 2.724 . . . . 0.0 108.404 173.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.2 -0.0 35.39 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.344 1.45 . . . . 0.0 111.468 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 127.995 2.518 . . . . 0.0 115.81 -172.061 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.68 -57.28 13.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.653 0.661 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -34.66 78.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.846 0.458 . . . . 0.0 110.245 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.54 94.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.03 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.53 -38.49 90.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.995 0.816 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.48 -44.36 87.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.835 0.743 . . . . 0.0 111.408 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -67.33 -36.05 80.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.537 0.735 . . . . 0.0 109.816 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -36.26 82.44 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.207 1.403 . . . . 0.0 111.332 172.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.6 m -67.56 -35.4 78.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.861 0.464 . . . . 0.0 110.521 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.86 -24.6 0.3 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.686 -1.063 . . . . 0.0 115.061 169.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.94 170.96 11.61 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.617 1.208 . . . . 0.0 111.384 -173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -121.62 133.18 54.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -78.78 102.27 8.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 169.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 m -70.77 150.79 45.52 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.86 -129.24 26.96 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.3 pt-20 -153.99 174.93 14.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.908 1.283 . . . . 0.0 108.592 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -59.52 129.79 43.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.108 0.963 . . . . 0.0 110.604 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.4 148.51 22.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.21 2.204 . . . . 0.0 107.946 -173.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -125.99 146.51 49.85 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--N 1.33 -0.271 0 C-N-CA 125.265 1.426 . . . . 0.0 109.374 -169.979 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.428 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.34 -42.3 77.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.018 172.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.98 -48.84 77.1 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.92 -47.42 59.52 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.074 0.858 . . . . 0.0 111.437 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -62.57 -55.0 31.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.529 0.665 . . . . 0.0 110.166 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -55.04 -39.78 69.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.49 1.916 . . . . 0.0 111.34 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.31 -58.83 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 109.733 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -16.01 63.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.274 0.943 . . . . 0.0 112.303 -172.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.12 -38.46 61.1 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.023 0.929 . . . . 0.0 111.236 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -34.8 44.87 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.647 0.779 . . . . 0.0 111.878 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttm . . . . . 0 C--O 1.248 1.015 0 C-N-CA 125.233 1.413 . . . . 0.0 109.867 171.193 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.3 161.06 43.18 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.004 0.922 . . . . 0.0 110.179 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.88 -23.9 16.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.769 1.627 . . . . 0.0 110.479 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.5 mt -135.18 127.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.532 1.133 . . . . 0.0 108.023 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 t -88.2 126.66 35.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.68 95.58 6.14 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.856 1.262 . . . . 0.0 108.885 -169.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -76.36 159.38 30.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.52 9.17 0.03 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.02 123.81 17.15 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.227 2.014 . . . . 0.0 109.587 175.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p 38.21 57.57 1.62 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.57 1.948 . . . . 0.0 113.573 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.1 tp 51.26 63.18 2.35 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 111.372 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.16 -149.77 17.28 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.3 -179.69 38.98 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 117.736 0.768 . . . . 0.0 111.929 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.06 56.16 0.76 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.008 1.323 . . . . 0.0 109.642 171.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.44 -28.91 67.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.363 -0.836 . . . . 0.0 112.228 -172.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -62.14 -40.9 97.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.971 0.805 . . . . 0.0 110.854 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.16 -37.73 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.72 87.6 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.885 0.766 . . . . 0.0 110.952 174.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.21 -40.05 82.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.298 0.639 . . . . 0.0 110.931 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.11 -46.22 88.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.457 -0.777 . . . . 0.0 110.396 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.1 mt -55.99 -52.69 63.28 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.599 1.159 . . . . 0.0 109.894 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.12 -49.97 59.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.533 1.133 . . . . 0.0 110.924 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.29 -53.93 49.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 110.576 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -60.61 -39.39 87.99 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.51 -33.68 76.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.166 0.587 . . . . 0.0 111.52 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.73 -37.14 67.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.846 -1.159 . . . . 0.0 110.265 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.03 -30.15 70.77 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.668 0.667 . . . . 0.0 111.113 170.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.65 62.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 111.797 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.27 -2.53 6.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.247 -1.307 . . . . 0.0 114.257 169.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -101.25 -168.23 1.53 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.564 1.682 . . . . 0.0 110.104 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -128.36 150.92 49.89 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.3 p -142.9 154.59 44.26 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.9 -0.5 . . . . 0.0 111.836 -169.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -119.81 99.37 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.463 1.505 . . . . 0.0 107.966 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -73.97 122.58 22.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.61 169.95 17.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.849 0.859 . . . . 0.0 111.06 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -119.6 39.57 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.197 1.799 . . . . 0.0 108.789 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 51.62 11.58 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.858 -1.523 . . . . 0.0 114.801 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -21.94 64.67 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 120.662 2.231 . . . . 0.0 113.389 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.87 16.75 6.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.552 1.941 . . . . 0.0 108.741 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 tp 59.9 -25.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.354 3.062 . . . . 0.0 115.076 -169.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.42 85.68 0.86 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -168.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.91 -44.8 88.37 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.536 -0.727 . . . . 0.0 109.847 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.22 151.29 59.59 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.52 -176.79 1.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 124.128 3.219 . . . . 0.0 113.087 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.26 31.88 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.989 1.716 . . . . 0.0 112.933 172.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.4 m -158.93 121.79 3.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.699 2.0 . . . . 0.0 106.445 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.16 -142.88 11.49 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -122.29 136.26 59.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.464 ' CD1' HG21 ' A' ' 83' ' ' VAL . 12.1 m0 -119.41 137.31 53.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 172.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 mt -131.81 137.69 48.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 173.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.82 137.72 53.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.07 113.01 23.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -161.73 -178.18 6.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.117 1.367 . . . . 0.0 108.457 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 m -133.18 124.85 28.2 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 124.024 0.93 . . . . 0.0 113.301 -169.261 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -129.68 90.28 2.96 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -53.74 31.51 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 124.857 1.263 . . . . 0.0 113.209 -168.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.47 -38.59 8.21 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.175 1.25 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -57.83 8.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.774 -170.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.58 -47.16 86.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.704 -171.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -64.5 -48.64 74.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.626 0.648 . . . . 0.0 110.539 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.41 -26.24 67.89 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.8 mt -62.34 -62.4 1.78 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.238 0.926 . . . . 0.0 108.868 170.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -67.18 -19.57 65.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.45 -34.49 78.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.601 0.76 . . . . 0.0 111.462 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.39 -23.19 2.4 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.84 63.13 1.01 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 127.13 2.172 . . . . 0.0 113.077 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 166.85 17.89 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.968 2.445 . . . . 0.0 113.164 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.66 63.8 5.21 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.954 1.302 . . . . 0.0 111.343 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.91 9.87 0.48 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.273 1.429 . . . . 0.0 113.074 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -63.93 -2.48 1.93 Allowed 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.105 2.962 . . . . 0.0 113.235 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.06 9.71 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.991 1.716 . . . . 0.0 110.919 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -124.65 146.44 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.916 0.865 . . . . 0.0 111.401 172.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -97.67 141.26 30.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.63 153.04 32.0 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.581 1.952 . . . . 0.0 107.537 -174.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.67 149.55 21.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.96 134.95 54.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -175.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.8 mt -134.8 128.79 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.17 -29.08 1.65 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.389 0.995 . . . . 0.0 112.461 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.1 mt -47.97 117.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.784 2.434 . . . . 0.0 107.849 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.01 -41.01 28.62 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.888 1.708 . . . . 0.0 111.079 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.535 0.379 0 C-N-CA 126.085 1.754 . . . . 0.0 110.208 178.22 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.57 -54.32 48.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.41 1.004 . . . . 0.0 109.678 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -67.66 -37.66 82.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.761 1.224 . . . . 0.0 108.673 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.9 79.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.527 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.82 -34.95 79.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.136 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.55 -49.99 75.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.745 1.157 . . . . 0.0 111.201 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -69.28 -34.28 74.48 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.727 0.811 . . . . 0.0 109.938 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -37.78 84.16 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.763 1.625 . . . . 0.0 111.231 172.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -65.86 -40.49 91.72 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.35 -20.61 0.4 Allowed Glycine 0 C--N 1.341 0.827 0 CA-C-O 117.811 -1.55 . . . . 0.0 115.135 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 132.82 49.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.699 1.749 . . . . 0.0 109.453 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -83.84 114.67 21.81 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -64.02 114.67 4.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 170.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.4 m -126.65 115.08 18.9 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.32 103.78 2.37 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -169.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -52.95 137.26 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.149 -1.526 . . . . 0.0 107.379 169.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.2 m -47.87 116.42 1.49 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.722 1.609 . . . . 0.0 111.347 -169.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.69 153.8 26.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.188 1.795 . . . . 0.0 107.718 -169.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -129.09 146.5 51.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.328 -0.365 0 C-N-CA 124.549 1.139 . . . . 0.0 111.252 -169.841 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -45.26 77.92 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.437 0.695 . . . . 0.0 109.871 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.69 -52.6 65.02 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.48 95.01 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.047 0.84 . . . . 0.0 112.051 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -59.29 -62.94 1.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.074 1.35 . . . . 0.0 110.239 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -56.09 -44.78 79.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.612 1.165 . . . . 0.0 111.978 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.4 -55.92 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.848 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -16.29 63.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.81 1.186 . . . . 0.0 112.053 -174.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.1 mp -78.2 -47.22 18.52 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.535 0.734 . . . . 0.0 111.029 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.18 -32.54 64.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.0 0.818 . . . . 0.0 112.329 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.7 mttt . . . . . 0 C--O 1.249 1.028 0 C-N-CA 124.752 1.221 . . . . 0.0 109.611 173.34 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 tpp . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.02 160.16 43.14 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.575 1.15 . . . . 0.0 108.917 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.61 -25.13 13.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.43 1.492 . . . . 0.0 111.059 175.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.56 121.77 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -83.88 130.55 34.91 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.56 109.6 21.33 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.308 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.5 mt -103.66 94.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.22 14.82 27.07 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.06 0.944 . . . . 0.0 112.075 -171.118 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.64 58.87 4.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.128 -171.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -54.6 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.741 1.27 . . . . 0.0 110.25 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m 57.7 42.3 23.95 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.78 0.832 . . . . 0.0 110.804 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.1 39.56 29.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.236 1.815 . . . . 0.0 111.398 -169.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.94 -145.3 7.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.493 1.996 . . . . 0.0 109.7 173.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.72 62.12 0.29 Allowed Glycine 0 C--N 1.334 0.447 0 CA-C-N 117.556 0.678 . . . . 0.0 111.902 -172.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.53 19.96 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.5 1.12 . . . . 0.0 112.476 172.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.9 -20.19 64.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 112.482 -170.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.93 -40.4 76.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.237 0.926 . . . . 0.0 111.326 176.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.96 -41.42 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.776 -176.545 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.23 -43.55 94.61 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 110.43 175.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -66.35 -44.41 83.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.044 -0.41 . . . . 0.0 110.039 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.46 -52.45 65.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.159 0.584 . . . . 0.0 110.733 177.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.27 -45.37 65.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.287 1.035 . . . . 0.0 110.76 176.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.33 -54.2 48.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.158 0.89 . . . . 0.0 110.484 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -57.66 -43.75 85.19 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 123.646 0.778 . . . . 0.0 112.275 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -69.15 -34.49 75.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.919 0.887 . . . . 0.0 111.356 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.9 -44.05 73.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.316 -0.865 . . . . 0.0 109.642 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -71.65 -18.52 62.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.174 0.897 . . . . 0.0 111.954 174.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -18.95 63.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.83 0.741 . . . . 0.0 111.083 169.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.09 12.54 5.78 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.267 -1.296 . . . . 0.0 114.442 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -117.8 -172.08 2.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.411 1.606 . . . . 0.0 109.93 -174.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -124.13 153.99 40.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 170.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -142.54 158.91 43.18 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.838 -0.539 . . . . 0.0 109.93 -169.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.2 99.24 5.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 m -72.18 118.88 15.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.0 mt -149.48 164.95 33.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.625 0.726 . . . . 0.0 111.585 -169.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -106.12 35.68 2.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.393 1.477 . . . . 0.0 108.506 168.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.74 14.26 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.963 -175.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.5 -20.31 65.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 120.871 2.335 . . . . 0.0 113.864 -173.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.25 9.89 14.69 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.654 . . . . 0.0 109.766 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt 60.38 -18.19 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.406 2.682 . . . . 0.0 114.627 -169.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -166.3 75.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.498 1.519 . . . . 0.0 107.232 -169.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.38 -44.61 96.04 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.773 -0.579 . . . . 0.0 109.818 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.6 mt -89.24 150.39 44.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.42 -177.45 1.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.674 2.916 . . . . 0.0 113.106 -175.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.08 35.51 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.65 1.58 . . . . 0.0 111.898 169.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -157.69 125.15 5.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.973 2.109 . . . . 0.0 106.272 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.96 -145.23 17.19 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -174.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.4 mm -126.48 144.34 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -127.1 158.12 37.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -143.28 143.79 31.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.15 135.35 62.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.17 124.59 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -170.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.0 m -163.98 -167.48 1.37 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.216 2.206 . . . . 0.0 107.1 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.1 m -148.88 62.57 1.06 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.435 -1.415 . . . . 0.0 108.0 172.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 125.569 1.548 . . . . 0.0 114.128 -169.506 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 31.2 t30 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.1 mt 52.75 46.23 27.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 108.575 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 m -75.88 -49.5 3.43 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 124.549 1.14 . . . . 0.0 111.833 -170.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 -34.45 41.59 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.97 1.382 . . . . 0.0 110.584 176.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -59.69 -51.3 70.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.976 0.911 . . . . 0.0 110.125 173.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 104' ' ' LYS . 39.0 t80 -55.46 -48.29 74.73 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.48 1.112 . . . . 0.0 110.846 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -65.65 -41.65 92.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.523 0.601 . . . . 0.0 111.453 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.6 84.83 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.666 0.666 . . . . 0.0 111.326 -178.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.63 -57.35 12.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.777 0.717 . . . . 0.0 109.816 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -69.2 -15.57 63.42 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.65 -32.09 63.83 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.85 0.75 . . . . 0.0 111.295 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.78 -30.1 4.52 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -173.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 26.64 70.37 0.43 Allowed Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.06 2.144 . . . . 0.0 113.331 -172.203 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -58.15 176.65 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.791 2.327 . . . . 0.0 112.004 174.065 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -90.02 76.16 7.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.73 0.812 . . . . 0.0 110.342 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.588 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.1 mm? -74.74 5.63 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.617 0.767 . . . . 0.0 112.557 -175.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 m -65.14 -5.51 6.9 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 127.839 2.456 . . . . 0.0 113.268 -176.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.93 8.74 26.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.469 1.508 . . . . 0.0 110.702 176.122 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.94 160.54 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 122.146 0.974 . . . . 0.0 110.945 176.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -129.11 154.11 47.02 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.08 1.752 . . . . 0.0 106.929 172.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -127.38 173.9 9.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.534 0.683 . . . . 0.0 109.428 178.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.13 157.87 26.17 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.64 125.13 41.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.0 mt -129.31 134.08 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -168.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.71 -31.78 1.69 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.537 1.541 . . . . 0.0 112.009 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.3 mt -47.88 154.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 129.583 3.153 . . . . 0.0 110.857 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.63 -15.1 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.051 -0.86 . . . . 0.0 114.73 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.45 -0.447 0 CA-C-N 118.304 1.052 . . . . 0.0 109.805 177.349 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 51.5 mtmt . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.55 -53.15 58.98 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 47.9 mp0 -61.24 -41.18 96.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.595 1.158 . . . . 0.0 110.455 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.77 76.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.49 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.246 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 mt -58.65 -46.64 86.7 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.427 1.012 . . . . 0.0 110.867 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -67.34 -41.26 85.48 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.462 0.705 . . . . 0.0 109.723 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -30.85 71.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.043 1.337 . . . . 0.0 111.331 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.588 ' HB3' HD23 ' A' ' 80' ' ' LEU . 16.2 m -74.16 -13.88 60.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.25 0.22 . . . . 0.0 111.496 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.48 -24.33 3.73 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 121.174 -0.954 . . . . 0.0 113.033 169.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.25 167.8 15.54 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.053 0.927 . . . . 0.0 110.631 -177.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -120.54 144.3 48.13 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -83.68 104.73 14.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 83.2 m -70.38 153.46 42.97 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 -131.29 21.43 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 178.286 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.4 pt-20 -150.43 178.56 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.192 1.397 . . . . 0.0 107.862 169.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.49 123.08 9.03 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.927 1.291 . . . . 0.0 109.824 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.55 155.75 17.13 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.61 1.564 . . . . 0.0 107.712 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -139.33 151.4 46.36 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.112 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 C-N-CA 126.125 1.77 . . . . 0.0 106.718 -169.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 138' ' ' TRP . . . . . 0.451 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -61.11 -42.04 97.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.599 0.76 . . . . 0.0 110.281 172.257 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.93 -49.68 73.82 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.96 -46.62 68.61 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 123.823 0.702 . . . . 0.0 111.721 177.034 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.1 m -62.47 -59.17 5.34 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.345 1.458 . . . . 0.0 110.818 177.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -49.8 -41.72 45.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.969 2.108 . . . . 0.0 111.872 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.0 t -63.96 -58.41 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 125.182 1.393 . . . . 0.0 109.813 173.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -15.74 63.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.311 0.959 . . . . 0.0 112.324 -173.085 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.87 -41.55 59.57 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.022 0.929 . . . . 0.0 111.168 170.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.5 -31.27 42.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -176.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.1 1.36 . . . . 0.0 109.721 169.972 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 tpp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.23 161.9 41.89 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.887 0.875 . . . . 10.0 110.287 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.11 -18.62 21.6 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.751 1.22 . . . . 10.0 110.984 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mt -137.22 129.15 42.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 C-N-CA 124.399 1.08 . . . . 10.0 108.429 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 t -91.41 137.62 32.22 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.645 -1.242 . . . . 10.0 107.645 168.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -112.4 91.75 3.77 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 104.614 -2.365 . . . . 10.0 104.614 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.4 104.08 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.4 1.48 . . . . 10.0 107.195 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -128.69 46.09 2.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.469 0.708 . . . . 10.0 111.868 -154.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.39 56.33 0.44 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-O 117.968 -1.462 . . . . 10.0 114.103 -161.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 m -33.39 -52.86 0.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.124 1.77 . . . . 10.0 113.646 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.35 42.33 2.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.514 1.125 . . . . 10.0 108.491 -170.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.9 tp 56.9 28.8 15.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.658 1.583 . . . . 10.0 111.075 -164.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.33 155.22 17.34 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.965 2.698 . . . . 10.0 106.485 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.05 -164.78 35.55 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 117.932 0.866 . . . . 10.0 111.669 -166.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.47 52.23 0.62 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.578 1.951 . . . . 10.0 112.882 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -55.8 -31.63 62.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.241 1.016 . . . . 10.0 112.212 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -60.92 -50.07 74.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.981 0.81 . . . . 10.0 110.768 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.45 -39.97 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.29 84.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.897 -0.573 . . . . 10.0 111.813 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.37 -39.48 85.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.974 0.807 . . . . 10.0 110.331 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -63.65 -46.82 83.88 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.93 -0.482 . . . . 10.0 110.279 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.4 mt -57.96 -47.28 83.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.811 0.844 . . . . 10.0 110.15 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.18 83.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.209 1.004 . . . . 10.0 110.028 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.54 -47.06 87.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.371 0.532 . . . . 10.0 110.687 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -61.58 -34.7 76.07 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.673 -0.642 . . . . 10.0 111.33 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.17 -32.89 67.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.516 0.598 . . . . 10.0 111.185 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -70.79 -38.94 73.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.708 1.14 . . . . 10.0 109.865 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.68 -32.45 71.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.244 0.618 . . . . 10.0 111.087 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.19 -17.07 64.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.733 0.813 . . . . 10.0 112.799 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.38 18.96 4.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.836 -0.98 . . . . 10.0 113.555 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -120.82 -170.88 2.08 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.808 1.304 . . . . 10.0 109.797 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 p -131.66 145.26 51.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.146 -1.427 . . . . 10.0 107.146 172.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -136.65 158.86 43.45 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.125 -0.359 . . . . 10.0 110.912 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.01 92.59 3.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -65.17 119.84 11.59 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.307 1.043 . . . . 10.0 108.42 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -148.39 149.01 31.0 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 123.584 0.754 . . . . 10.0 108.988 -171.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -90.49 35.43 0.88 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.292 -0.88 . . . . 10.0 110.184 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.22 51.02 21.48 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.983 1.754 . . . . 10.0 114.572 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.04 -15.68 49.56 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.858 2.372 . . . . 10.0 113.435 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.11 13.6 11.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.404 1.482 . . . . 10.0 110.704 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 tp 62.42 -43.89 0.18 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.557 2.743 . . . . 10.0 113.316 -166.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -148.8 78.11 1.39 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.873 1.669 . . . . 10.0 108.121 -167.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.473 -0.767 . . . . 10.0 111.357 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.2 mt -84.48 147.42 49.62 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.947 -1.131 . . . . 10.0 107.947 164.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.64 -175.4 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.08 2.52 . . . . 10.0 111.873 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.61 21.94 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.896 1.678 . . . . 10.0 113.694 173.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.9 m -142.39 136.08 29.21 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.321 1.848 . . . . 10.0 106.797 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.01 -136.88 10.11 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.92 -1.272 . . . . 10.0 109.92 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -130.35 136.34 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.159 -1.793 . . . . 10.0 106.159 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -117.87 157.5 26.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -141.72 145.87 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.021 -1.844 . . . . 10.0 106.021 168.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.3 t -130.88 124.34 56.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.37 97.36 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.669 -1.604 . . . . 10.0 106.669 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -148.7 174.12 12.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 10.0 108.372 -170.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 m -137.52 70.47 1.4 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.597 1.09 . . . . 10.0 110.312 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.2 p -69.62 -15.71 63.25 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -169.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.35 -106.56 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.873 1.215 . . . . 10.0 109.765 -172.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.72 3.89 47.28 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 120.183 -1.573 . . . . 10.0 114.056 -167.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.19 14.21 4.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.124 1.77 . . . . 10.0 110.31 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.01 112.22 4.44 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 109.027 -1.629 . . . . 10.0 109.027 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -64.11 156.61 27.85 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.019 0.41 . . . . 10.0 111.387 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -26.72 -60.3 0.18 Allowed Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 129.426 3.09 . . . . 10.0 115.375 -170.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.73 -33.02 6.91 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 121.939 1.728 . . . . 10.0 113.392 -166.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 t70 176.73 -47.52 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.08 1.352 . . . . 10.0 108.481 -161.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 126.28 -34.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 1 C-N-CA 132.096 4.159 . . . . 10.0 110.298 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.19 58.48 1.31 Allowed 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.486 0.714 . . . . 10.0 110.038 -170.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -45.95 -56.17 11.09 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.228 -1.368 . . . . 10.0 114.566 -167.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.57 -44.34 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 122.034 1.762 . . . . 10.0 111.633 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -65.41 -43.35 90.82 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 10.0 111.264 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.36 -45.49 83.9 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.921 0.782 . . . . 10.0 110.158 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.18 -42.79 99.42 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.12 96.03 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.03 0.377 . . . . 10.0 111.461 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -59.69 -51.56 69.26 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.703 0.683 . . . . 10.0 109.47 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.19 -31.27 72.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.667 0.667 . . . . 10.0 111.81 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.87 -30.95 71.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.724 0.81 . . . . 10.0 112.251 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -124.21 -27.3 3.84 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.491 1.293 . . . . 10.0 114.491 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 32.45 61.78 1.38 Allowed Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.286 1.834 . . . . 10.0 112.572 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.47 160.26 40.33 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.12 2.546 . . . . 10.0 110.955 -172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -73.23 76.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.071 0.949 . . . . 10.0 111.187 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 9.22 1.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.93 1.292 . . . . 10.0 112.269 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.0 m -60.84 -17.5 50.34 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.219 -1.551 . . . . 10.0 113.344 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.44 10.83 39.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.78 1.232 . . . . 10.0 112.594 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.95 160.79 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.229 1.012 . . . . 10.0 108.997 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -123.81 150.81 44.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.296 -1.742 . . . . 10.0 106.296 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.63 163.53 25.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.606 0.717 . . . . 10.0 110.476 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.04 116.66 1.69 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.394 -2.682 . . . . 10.0 106.394 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.04 144.32 56.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.38 131.23 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.521 -1.659 . . . . 10.0 106.521 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.09 -27.54 1.71 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.757 1.17 . . . . 10.0 113.012 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.24 139.29 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 127.15 2.18 . . . . 10.0 107.606 171.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.58 0.72 8.67 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.269 -0.739 . . . . 10.0 112.387 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -53.2 56.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.518 1.127 . . . . 10.0 109.834 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 19.97 -97.3 0.0 OUTLIER 'General case' 0 C--N 1.346 0.45 0 C-N-CA 128.787 2.835 . . . . 10.0 114.197 171.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -148.42 5.1 0.71 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.22 1.808 . . . . 10.0 108.858 -159.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -149.09 -27.67 0.28 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.613 0.365 . . . . 10.0 110.751 -143.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -119.77 34.91 5.03 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 122.471 1.129 . . . . 10.0 109.95 159.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.2 p -70.22 35.81 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.822 1.649 . . . . 10.0 110.591 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -105.12 -37.22 7.0 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.741 -1.225 . . . . 10.0 112.949 -144.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 62.9 m -115.71 8.14 14.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.234 1.014 . . . . 10.0 110.773 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.88 -163.53 35.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 108.601 -1.8 . . . . 10.0 108.601 -172.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.02 58.84 1.75 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.475 1.11 . . . . 10.0 109.782 -174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 pt -60.53 -4.16 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.492 1.117 . . . . 10.0 113.083 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -48.25 -17.86 0.17 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.391 1.876 . . . . 10.0 112.844 158.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -34.61 -43.44 0.17 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.636 1.575 . . . . 10.0 113.491 164.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.84 -52.8 62.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.23 0.923 . . . . 10.0 110.813 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.52 -43.77 98.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.1 93.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.046 0.938 . . . . 10.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -67.97 -36.79 80.65 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.416 1.007 . . . . 10.0 111.222 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.05 -45.14 94.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.278 0.944 . . . . 10.0 110.06 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -65.87 -39.21 90.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.22 0.608 . . . . 10.0 110.524 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.58 97.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.066 . . . . 10.0 110.975 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 m -72.45 -29.08 63.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.727 0.411 . . . . 10.0 110.651 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.89 -13.15 1.49 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.426 -1.208 . . . . 10.0 114.327 160.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.08 116.55 9.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.241 1.521 . . . . 10.0 108.131 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -61.73 139.02 58.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 167.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -80.84 128.78 34.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.154 -2.165 . . . . 10.0 105.154 158.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 m -105.06 148.45 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.8 -133.93 46.84 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.09 -1.604 . . . . 10.0 109.09 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.93 163.65 33.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.535 -1.654 . . . . 10.0 106.535 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -48.59 123.32 6.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.293 1.037 . . . . 10.0 112.082 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.33 147.36 48.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.793 1.237 . . . . 10.0 107.92 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -118.6 136.75 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.838 -1.171 . . . . 10.0 107.838 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.77 140.71 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 158.33 30.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.516 -0.55 . . . . 10.0 109.516 174.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.3 pt -146.24 -168.54 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 126.36 1.864 . . . . 10.0 107.379 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.8 tp 7.09 -69.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 130.173 3.389 . . . . 10.0 116.575 164.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -119.08 139.05 52.39 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.435 1.094 . . . . 10.0 108.891 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -53.62 150.46 7.0 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.858 0.863 . . . . 10.0 110.037 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -142.67 -88.25 0.14 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 118.366 -0.825 . . . . 10.0 110.515 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.0 mm -130.72 -58.08 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 117.426 -1.273 . . . . 10.0 110.542 -170.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -82.06 -6.28 12.15 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.318 2.012 . . . . 10.0 113.355 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 76.41 -35.9 0.26 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.421 2.688 . . . . 10.0 114.407 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -139.88 132.1 14.84 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 119.356 0.98 . . . . 10.0 111.181 -158.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.63 159.5 47.9 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.116 2.544 . . . . 10.0 112.055 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.75 52.56 1.4 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.456 1.103 . . . . 10.0 110.119 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.22 -23.65 62.49 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.879 -1.138 . . . . 10.0 111.013 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.21 -36.16 81.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.588 -0.72 . . . . 10.0 111.223 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.81 -44.92 93.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.483 1.038 . . . . 10.0 108.934 171.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.47 -46.03 91.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.42 97.3 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.409 0.528 . . . . 10.0 112.672 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.6 m -61.57 -56.79 16.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.341 1.071 . . . . 10.0 110.75 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -59.51 -40.69 87.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.942 1.297 . . . . 10.0 110.699 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.27 -56.18 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.849 -0.596 . . . . 10.0 110.042 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -69.68 -21.86 63.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 10.0 112.136 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.45 -45.25 76.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.708 0.685 . . . . 10.0 110.631 168.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -22.43 57.69 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.973 0.806 . . . . 10.0 112.61 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.9 mttt . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.252 1.021 . . . . 10.0 108.406 169.521 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.55 167.21 31.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.126 1.371 . . . . 0.0 108.921 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.36 -25.07 25.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.697 0.799 . . . . 0.0 110.893 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.6 mt -138.27 127.63 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.749 1.22 . . . . 0.0 107.943 -171.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.18 135.21 33.39 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.4 104.64 13.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.7 mt -96.46 100.57 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -102.64 20.12 17.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.241 1.016 . . . . 0.0 110.735 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 36.51 2.17 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.072 1.32 . . . . 0.0 115.163 -169.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -47.65 -50.84 23.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.215 1.406 . . . . 0.0 112.268 -172.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -127.33 50.77 1.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.7 tp 63.29 20.05 12.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.813 2.045 . . . . 0.0 111.283 -169.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.14 178.1 36.64 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.248 3.308 . . . . 0.0 106.661 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -3.19 1.51 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.009 -1.439 . . . . 0.0 115.026 169.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.14 2.14 0.76 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.877 1.839 . . . . 0.0 113.966 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -53.29 -36.39 61.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.297 1.039 . . . . 0.0 112.07 -172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -54.97 -30.75 59.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.779 1.232 . . . . 0.0 112.825 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.99 -26.33 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.776 0.83 . . . . 0.0 109.522 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.36 72.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.228 0.922 . . . . 0.0 111.346 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.88 -39.3 93.32 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.238 0.926 . . . . 0.0 111.243 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -67.97 -45.4 74.27 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.804 -0.56 . . . . 0.0 109.617 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -54.13 -50.82 66.04 Favored 'General case' 0 C--N 1.337 0.035 0 C-N-CA 124.359 1.064 . . . . 0.0 110.323 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -48.69 72.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.895 0.878 . . . . 0.0 110.88 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.81 -53.56 56.81 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.69 0.677 . . . . 0.0 110.675 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -54.91 -42.51 72.26 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 123.838 0.855 . . . . 0.0 111.816 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -32.2 67.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.88 -46.67 74.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.472 1.033 . . . . 0.0 109.842 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -67.38 -14.13 62.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.658 0.663 . . . . 0.0 112.312 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.12 63.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.128 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.56 17.64 0.74 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.274 -1.292 . . . . 0.0 115.887 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -139.18 -171.44 3.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.602 1.701 . . . . 0.0 111.236 -169.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 p -124.71 147.61 48.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.6 p -140.66 157.86 44.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.12 98.98 4.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.76 123.43 19.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.3 mt -142.26 153.99 44.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.558 0.743 . . . . 0.0 109.298 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -89.76 31.68 0.94 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.675 0.79 . . . . 0.0 110.968 172.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.13 48.77 38.78 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.587 1.565 . . . . 0.0 114.533 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.49 -21.45 66.07 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.683 2.255 . . . . 0.0 113.503 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.7 mt -124.31 10.15 8.61 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.967 1.707 . . . . 0.0 109.89 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 tp 60.86 -19.15 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.85 2.46 . . . . 0.0 114.31 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -166.47 87.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.68 -44.81 76.9 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.723 -0.611 . . . . 0.0 109.989 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.8 mt -80.23 151.58 72.7 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.38 -175.31 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.056 3.171 . . . . 0.0 112.621 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.74 34.42 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.147 1.379 . . . . 0.0 112.377 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.1 m -158.62 132.12 7.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.01 2.124 . . . . 0.0 106.311 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.79 -142.97 14.44 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.1 mm -126.53 140.32 49.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -121.76 152.52 39.37 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.7 mt -138.76 142.8 38.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.6 t -128.5 125.52 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.2 103.21 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -148.85 -177.3 5.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.876 1.271 . . . . 0.0 108.795 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.2 m -150.65 65.56 0.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.749 -1.219 . . . . 0.0 108.366 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.1 p -47.92 -32.53 6.46 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.99 2.116 . . . . 0.0 112.916 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -130.94 128.32 40.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 102.85 -3.018 . . . . 0.0 102.85 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.72 -39.95 2.41 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.344 0.973 . . . . 0.0 111.016 -170.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.73 36.85 2.64 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.425 1.49 . . . . 0.0 108.67 170.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.78 -148.37 5.97 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 126.495 1.997 . . . . 0.0 109.021 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -148.7 -46.95 0.15 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.793 1.237 . . . . 0.0 110.35 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.7 pt -149.74 171.19 6.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 128.23 2.612 . . . . 0.0 106.743 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -47.18 -34.41 17.7 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.648 2.899 . . . . 0.0 115.549 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.78 -11.44 7.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.182 0.993 . . . . 0.0 113.42 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -52.12 -40.02 60.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.024 0.93 . . . . 0.0 110.589 169.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.41 120.73 24.24 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.63 -58.52 0.43 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.55 -169.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 -42.34 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.873 1.715 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -64.0 1.09 Allowed 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.218 1.007 . . . . 0.0 111.624 -168.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.56 -41.8 95.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.128 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -71.17 -45.98 62.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.958 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.58 79.06 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.714 0.688 . . . . 0.0 111.271 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.1 mt -55.12 -57.29 12.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.411 0.551 . . . . 0.0 110.002 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -74.11 -15.7 61.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.42 -38.21 65.65 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.692 0.678 . . . . 0.0 111.231 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -114.42 -26.49 7.94 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 32.88 60.43 1.51 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.683 1.993 . . . . 0.0 113.133 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -65.16 165.41 22.0 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.587 2.191 . . . . 0.0 112.538 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.53 63.38 2.66 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.405 1.482 . . . . 0.0 111.561 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.41 9.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.15 1.38 . . . . 0.0 112.391 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.4 m -61.1 -7.09 2.33 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.299 2.64 . . . . 0.0 112.871 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.24 10.02 17.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.795 1.638 . . . . 0.0 111.217 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.81 163.68 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 122.192 0.996 . . . . 0.0 110.283 174.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -122.09 149.83 43.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 171.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -123.61 166.84 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.721 0.638 . . . . 0.0 110.036 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.08 115.43 1.02 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 106.831 -2.507 . . . . 0.0 106.831 169.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.81 143.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.2 mt -139.42 131.34 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.98 -23.57 1.35 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.293 0.949 . . . . 0.0 114.082 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -50.19 128.46 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 126.137 1.775 . . . . 0.0 108.415 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.06 -27.69 6.48 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m -61.33 107.23 0.73 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.441 1.096 . . . . 0.0 108.77 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -147.03 159.0 44.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.275 1.43 . . . . 0.0 107.885 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -59.06 -22.66 61.11 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.492 1.517 . . . . 0.0 112.874 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -117.69 14.33 14.38 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.194 1.798 . . . . 0.0 111.467 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -134.31 22.76 3.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.423 1.089 . . . . 0.0 110.739 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -73.8 14.32 0.4 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.395 1.878 . . . . 0.0 114.264 -171.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -60.46 -23.78 64.72 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.299 1.44 . . . . 0.0 113.946 -169.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 65.6 m -115.35 24.2 11.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.538 1.135 . . . . 0.0 111.101 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.42 20.96 79.98 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.669 0.652 . . . . 0.0 111.785 -172.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.12 54.74 1.09 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.038 1.735 . . . . 0.0 111.135 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.0 mm -58.59 143.5 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -66.92 26.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.678 2.391 . . . . 0.0 115.403 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . 45.2 mtpt -57.84 -26.84 62.58 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.637 -1.29 . . . . 0.0 113.948 -169.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -63.32 -56.04 19.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.514 1.052 . . . . 0.0 109.394 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -60.59 -39.49 88.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.294 0.638 . . . . 0.0 109.568 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . . . -61.3 -46.6 89.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.967 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -62.43 -37.75 87.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.158 0.89 . . . . 0.0 111.029 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.07 -48.25 76.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.05 0.841 . . . . 0.0 111.057 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.331 6.9 ptmt -71.8 -28.35 63.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -37.72 86.33 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.961 0.904 . . . . 0.0 110.852 169.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -66.99 -40.96 87.5 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.92 -22.97 0.53 Allowed Glycine 0 C--N 1.34 0.75 0 CA-C-O 118.243 -1.31 . . . . 0.0 114.987 169.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.9 137.92 56.92 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.216 1.508 . . . . 0.0 108.869 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.95 134.04 35.63 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.6 99.47 8.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 97.4 m -73.54 145.59 45.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.32 -123.58 29.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.482 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.4 pt-20 -153.11 176.11 12.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.598 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 m -49.8 121.73 5.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.085 1.354 . . . . 0.0 109.922 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.1 153.33 26.14 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -127.65 144.23 51.09 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.29 162.01 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.965 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.03 175.49 7.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.514 1.926 . . . . 0.0 108.306 169.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.4 tt -154.62 145.62 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.0 tp 63.22 -21.84 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 128.534 2.734 . . . . 0.0 115.073 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -151.64 -169.35 3.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.917 2.487 . . . . 0.0 106.584 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -125.81 155.87 40.42 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.388 1.475 . . . . 0.0 107.142 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.41 -176.69 5.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.139 0.976 . . . . 0.0 109.598 -174.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.1 mm -31.26 -53.4 0.44 Allowed Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 127.539 2.335 . . . . 0.0 116.488 -170.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -59.88 -53.35 3.28 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 122.482 1.922 . . . . 0.0 110.117 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . 0.26 38.6 tt0 146.37 -103.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 1 C-N-CA 133.097 4.559 . . . . 0.0 105.6 169.557 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -167.65 -43.92 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 116.412 -1.756 . . . . 0.0 114.335 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.89 131.36 45.53 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.808 2.338 . . . . 0.0 112.833 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.5 -43.54 0.69 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.45 -35.09 79.79 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.697 0.68 . . . . 0.0 110.921 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 -64.46 -43.87 92.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.988 0.915 . . . . 0.0 110.034 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.482 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.7 m-90 -65.6 -50.65 64.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.195 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.1 mt -55.08 -51.29 66.84 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.13 -51.96 54.25 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -64.16 -46.24 84.92 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.495 1.148 . . . . 0.0 110.774 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -61.56 -39.04 89.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.398 1.079 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.9 t -64.85 -47.58 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.835 1.254 . . . . 0.0 110.381 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -60.38 -24.4 65.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.551 1.069 . . . . 0.0 111.288 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.06 -28.63 43.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.409 0.684 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -36.49 19.28 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.04 0.936 . . . . 0.0 111.531 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 125.448 1.499 . . . . 0.0 109.824 172.036 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.07 161.01 43.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -95.52 -24.12 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.674 1.59 . . . . 0.0 110.492 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.7 mt -136.22 128.94 46.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.33 1.052 . . . . 0.0 108.223 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -85.92 126.98 34.49 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.91 97.53 7.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -96.38 89.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 108.694 -169.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -75.9 141.07 42.43 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 168.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.99 1.1 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 117.913 -1.493 . . . . 0.0 116.774 -175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 115.28 2.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.984 1.892 . . . . 0.0 109.714 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m 46.06 40.86 7.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.217 1.807 . . . . 0.0 111.811 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp 47.84 69.64 0.51 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 126.003 1.721 . . . . 0.0 111.16 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 163.14 25.59 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.534 1.54 . . . . 0.0 109.423 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.38 -29.92 2.82 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.415 -1.214 . . . . 0.0 114.244 -169.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 41.47 43.96 2.36 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.955 1.302 . . . . 0.0 111.412 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -50.7 -33.29 22.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.966 1.306 . . . . 0.0 113.592 -169.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -59.37 -52.22 66.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.735 1.152 . . . . 0.0 111.431 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.09 -29.05 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.646 -0.659 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.46 91.12 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.575 0.625 . . . . 0.0 110.87 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.47 -38.19 71.26 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.686 -0.633 . . . . 0.0 110.242 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -58.73 -44.18 90.37 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.57 0.623 . . . . 0.0 110.368 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.02 -55.82 30.2 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.393 0.677 . . . . 0.0 109.989 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.4 -40.42 65.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -53.77 -54.03 43.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.358 0.663 . . . . 0.0 110.083 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -62.44 -41.76 98.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -58.22 -45.3 87.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.446 0.566 . . . . 0.0 109.799 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.21 -35.97 71.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.833 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.16 -29.65 70.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.665 0.786 . . . . 0.0 111.586 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.45 -18.1 63.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.861 0.755 . . . . 0.0 111.795 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.1 -4.8 4.98 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.499 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -100.41 -170.31 1.85 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.568 1.684 . . . . 0.0 109.82 -169.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.8 p -128.88 148.58 50.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -139.89 149.95 44.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 111.826 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.26 92.13 3.92 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 m -69.29 118.02 11.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.9 mt -149.35 153.76 37.92 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.281 0.562 . . . . 0.0 112.186 -169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -93.7 39.22 1.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.386 1.074 . . . . 0.0 108.432 168.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 39.14 54.66 2.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.724 2.107 . . . . 0.0 115.42 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.48 -20.69 54.09 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.792 2.328 . . . . 0.0 113.731 -173.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.0 mt -112.94 8.3 18.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.661 1.584 . . . . 0.0 109.772 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tt 60.29 -17.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.557 2.743 . . . . 0.0 114.563 -169.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -169.46 76.82 0.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.94 -45.38 93.94 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.744 -0.598 . . . . 0.0 109.566 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.63 149.43 44.09 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.28 -175.46 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.793 2.995 . . . . 0.0 112.798 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.88 36.63 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.61 1.564 . . . . 0.0 111.334 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.7 m -158.3 128.69 6.13 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.31 2.244 . . . . 0.0 106.321 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.55 -145.98 17.54 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.2 mm -124.55 142.0 42.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -122.12 151.21 41.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.8 mt -137.44 138.9 40.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.07 134.25 66.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.12 111.91 30.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -156.53 -176.4 5.95 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 108.638 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -153.07 62.82 0.77 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.4 1.095 . . . . 0.0 110.344 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.1 p -64.5 -14.85 59.35 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.301 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -59.27 167.62 1.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.769 1.227 . . . . 0.0 112.261 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.54 -65.81 3.07 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.036 1.303 . . . . 0.0 111.507 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.78 -8.42 0.22 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.281 1.032 . . . . 0.0 113.71 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.96 -146.65 38.84 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 119.787 1.176 . . . . 0.0 110.735 -170.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -143.78 169.49 17.66 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.098 1.359 . . . . 0.0 108.147 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 90.9 mt -46.35 -52.72 27.39 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.534 1.533 . . . . 0.0 112.836 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.87 -44.28 1.38 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 CA-C-N 121.86 1.7 . . . . 0.0 111.465 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -172.2 -61.81 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.767 1.627 . . . . 0.0 108.608 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 178.78 -53.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.84 2.456 . . . . 0.0 106.403 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' H ' ' A' ' 66' ' ' LEU . 4.5 mp -75.48 131.16 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 169.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.44 -58.87 0.33 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.045 0.839 . . . . 0.0 110.228 -170.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -81.18 -38.56 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.325 2.016 . . . . 0.0 111.989 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -59.29 -49.9 76.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.432 0.693 . . . . 0.0 111.511 -169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -60.26 -44.28 95.44 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.348 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.37 -47.56 75.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.31 0.504 . . . . 0.0 110.467 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.21 89.28 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.01 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 mt -53.72 -55.62 24.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.914 0.779 . . . . 0.0 109.463 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.14 -17.27 61.97 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.87 -32.25 65.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.732 0.413 . . . . 0.0 111.337 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.9 -29.97 5.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 mttt 27.45 66.28 0.57 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.804 2.042 . . . . 0.0 113.273 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.94 176.81 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.824 2.349 . . . . 0.0 112.715 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -82.13 68.67 8.63 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.383 1.073 . . . . 0.0 111.125 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.22 3.11 1.8 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.875 0.87 . . . . 0.0 112.886 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -64.67 -6.25 7.41 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.365 2.666 . . . . 0.0 113.336 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.78 9.04 24.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.85 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 p -134.62 157.22 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.573 0.749 . . . . 0.0 110.529 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -121.01 152.02 39.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 168.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -118.1 173.87 6.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.03 160.11 28.08 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 106.68 -2.568 . . . . 0.0 106.68 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.81 145.87 50.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.45 121.1 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.09 -14.4 6.32 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.818 1.199 . . . . 0.0 114.593 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.9 141.34 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.981 1.313 . . . . 0.0 108.799 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.47 -15.01 60.84 Favored Glycine 0 N--CA 1.468 0.768 0 O-C-N 121.083 -1.01 . . . . 0.0 112.919 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.4 m -54.75 -14.87 1.54 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.553 2.341 . . . . 0.0 115.195 -174.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -125.01 2.3 8.0 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.651 1.114 . . . . 0.0 113.095 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -142.95 -24.1 0.62 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -170.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -116.69 -33.9 4.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.321 1.048 . . . . 0.0 111.419 -172.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -106.44 10.87 31.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.753 1.263 . . . . 0.0 112.952 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 p -69.58 20.05 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.732 2.413 . . . . 0.0 113.696 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -136.24 -14.53 1.76 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.297 1.839 . . . . 0.0 111.595 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 57.0 m -132.92 -5.07 3.14 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 41.59 31.22 0.66 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 127.292 2.377 . . . . 0.0 115.445 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.82 -30.97 66.06 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.037 1.418 . . . . 0.0 112.018 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.6 -0.01 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.549 1.54 . . . . 0.0 112.027 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -51.75 -28.73 16.13 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.317 1.447 . . . . 0.0 110.618 168.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -46.34 -37.48 7.53 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 128.648 2.779 . . . . 0.0 113.149 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.41 -57.25 13.79 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.581 0.628 . . . . 0.0 109.433 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.38 -31.17 65.34 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.093 0.557 . . . . 0.0 109.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.89 94.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.002 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.53 -37.98 83.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.503 1.047 . . . . 0.0 110.449 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.43 -40.48 96.72 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.536 0.734 . . . . 0.0 111.626 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.297 7.6 ptmm? -79.92 -29.54 39.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.544 -0.722 . . . . 0.0 112.509 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.42 86.46 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.162 0.985 . . . . 0.0 110.995 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 p -77.49 -20.48 54.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.07 -37.48 0.46 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.715 0.689 . . . . 0.0 113.597 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.91 -177.99 2.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.97 0.891 . . . . 0.0 111.435 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -135.14 150.14 50.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -77.11 126.98 31.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 m -77.58 140.93 39.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.45 -121.31 19.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -153.81 162.33 41.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.877 1.271 . . . . 0.0 108.927 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.9 m -53.41 124.18 14.07 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.811 -169.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.51 164.66 26.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.864 1.666 . . . . 0.0 108.283 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -135.99 144.4 45.32 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.014 -1.053 . . . . 0.0 109.318 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 pp -144.92 155.28 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 127.003 2.121 . . . . 0.0 108.697 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -162.5 154.09 18.17 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.59 24.39 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.244 1.417 . . . . 0.0 111.009 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.0 mt -125.43 -178.12 4.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.611 1.564 . . . . 0.0 107.965 173.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.85 -42.87 98.68 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.812 0.445 . . . . 0.0 111.337 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -164.34 164.26 22.3 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.034 1.334 . . . . 0.0 109.893 173.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -162.96 -162.41 0.77 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.887 2.875 . . . . 0.0 104.015 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 46.8 mm -67.01 -50.35 42.44 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 117.407 -1.283 . . . . 0.0 111.735 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.58 -40.1 10.91 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.05 1.833 . . . . 0.0 111.019 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 68.78 -28.51 0.16 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.113 2.565 . . . . 0.0 116.016 169.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -150.01 141.26 14.73 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 120.059 1.3 . . . . 0.0 111.911 -169.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.58 99.24 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.014 3.143 . . . . 0.0 110.759 169.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.24 67.53 1.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.723 1.609 . . . . 0.0 110.182 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -55.44 -34.49 64.52 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.523 1.129 . . . . 0.0 111.036 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.64 -30.65 71.68 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.345 0.658 . . . . 0.0 111.603 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -44.85 83.01 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.599 0.759 . . . . 0.0 109.579 175.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -61.59 -52.05 66.0 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.9 -49.74 40.76 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 124.518 1.136 . . . . 0.0 111.475 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.1 m -61.47 -54.55 41.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 125.111 1.364 . . . . 0.0 111.54 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -55.7 -41.18 73.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.151 0.98 . . . . 0.0 111.365 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t -60.56 -49.54 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.358 1.063 . . . . 0.0 109.83 173.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.81 -27.65 68.2 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.474 1.033 . . . . 0.0 111.651 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.79 -45.01 19.59 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.513 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 pp -71.15 -36.01 71.88 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.607 0.64 . . . . 0.0 111.592 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.6 mttm . . . . . 0 C--O 1.248 0.991 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 175.799 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 119.244 -0.408 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.92 164.05 36.47 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.777 1.231 . . . . 0.0 109.147 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.46 -23.34 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.354 1.462 . . . . 0.0 110.64 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mt -133.11 126.19 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.813 1.245 . . . . 0.0 108.078 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -88.09 126.81 35.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.37 91.19 4.16 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.4 mt -86.09 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 t -111.54 -162.2 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.311 1.044 . . . . 0.0 108.319 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.32 57.29 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 123.646 0.641 . . . . 0.0 111.858 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -44.37 121.77 2.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.108 1.363 . . . . 0.0 111.095 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.272 39.1 m 67.31 53.15 0.78 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.884 1.273 . . . . 0.0 110.478 -171.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 52.92 37.85 25.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.954 2.101 . . . . 0.0 114.494 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.83 156.52 10.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.246 0.926 . . . . 0.0 111.478 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.16 -171.06 41.11 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.39 68.38 2.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.217 1.407 . . . . 0.0 110.893 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.85 -24.46 6.2 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.763 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -51.95 -34.78 43.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.148 0.979 . . . . 0.0 112.906 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 p -71.69 -34.2 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.641 1.109 . . . . 0.0 109.853 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.47 61.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.378 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.73 -40.45 84.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.031 0.832 . . . . 0.0 110.361 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -57.88 -51.16 70.75 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.509 0.724 . . . . 0.0 109.347 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.32 -49.89 73.03 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.096 0.558 . . . . 0.0 110.487 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.25 -40.8 64.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.671 1.188 . . . . 0.0 111.796 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.98 -58.5 7.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.336 0.971 . . . . 0.0 109.998 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -53.89 -43.4 69.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.657 1.183 . . . . 0.0 112.188 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.1 -36.83 82.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.733 0.813 . . . . 0.0 111.967 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.67 -36.99 73.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.703 1.138 . . . . 0.0 109.732 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.83 -23.2 67.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.287 0.635 . . . . 0.0 111.801 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.97 -10.92 60.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.853 0.861 . . . . 0.0 112.108 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 21.61 5.98 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.319 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -125.87 -171.81 2.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.465 1.132 . . . . 0.0 109.584 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 p -125.16 151.02 46.34 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -142.29 159.8 41.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.861 -0.524 . . . . 0.0 110.336 -170.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 110.96 11.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m -76.01 124.6 27.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.9 mt -141.88 159.45 42.21 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.268 0.627 . . . . 0.0 110.718 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -110.74 39.39 2.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.165 1.386 . . . . 0.0 109.022 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.78 46.67 39.48 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.906 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.62 -21.16 70.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 121.398 2.599 . . . . 0.0 113.736 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -126.32 14.2 7.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.43 1.892 . . . . 0.0 109.309 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 66.12 -31.72 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.366 2.667 . . . . 0.0 112.436 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.12 89.8 1.02 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.132 1.773 . . . . 0.0 107.075 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.54 -42.49 91.86 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.667 -0.645 . . . . 0.0 110.409 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.59 154.5 59.1 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.35 -175.27 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.055 3.17 . . . . 0.0 113.173 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.57 28.84 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.63 1.572 . . . . 0.0 113.067 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -153.56 137.33 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.817 2.447 . . . . 0.0 106.342 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.23 -140.58 12.42 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mm -121.55 137.3 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -122.34 137.23 54.92 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 mt -129.83 134.18 47.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.09 128.09 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.23 59.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.335 1.854 . . . . 0.0 106.689 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -67.92 -32.36 72.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.661 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 m 28.54 55.31 0.09 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 127.905 2.482 . . . . 0.0 113.505 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.7 p -42.37 -40.0 2.36 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 127.63 2.372 . . . . 0.0 114.715 -169.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -140.59 17.37 2.36 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.825 0.739 . . . . 0.0 111.397 168.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.5 -25.95 29.08 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.42 1.009 . . . . 0.0 111.182 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.34 54.7 0.86 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.868 2.467 . . . . 0.0 105.107 169.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.41 -146.62 4.91 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.424 1.011 . . . . 0.0 111.479 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -151.91 -34.4 0.13 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.614 1.165 . . . . 0.0 112.829 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 pt -156.37 167.04 15.19 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.789 2.036 . . . . 0.0 108.547 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.25 -28.71 8.36 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.819 3.013 . . . . 0.0 115.131 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -77.76 9.03 3.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.104 1.362 . . . . 0.0 113.48 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -54.03 -27.23 30.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.222 1.409 . . . . 0.0 113.785 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.704 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -107.36 84.45 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 169.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.5 m -70.51 -56.49 6.43 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.644 -167.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.12 -37.91 39.48 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.428 1.189 . . . . 0.0 110.006 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -68.19 -50.43 54.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.58 -46.36 83.04 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.883 0.765 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.46 -40.44 94.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.841 1.2 . . . . 0.0 110.922 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.29 90.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.314 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.2 mt -54.65 -52.72 61.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.512 1.051 . . . . 0.0 109.78 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -67.03 -22.59 65.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -75.42 -43.64 48.8 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.486 0.585 . . . . 0.0 111.083 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -98.88 -29.16 13.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.54 62.68 0.98 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 127.014 2.126 . . . . 0.0 112.609 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.75 164.63 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.259 2.639 . . . . 0.0 113.278 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.13 64.41 2.57 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.372 1.469 . . . . 0.0 111.613 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.19 9.53 0.97 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 112.737 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m -60.55 -6.87 1.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 127.858 2.463 . . . . 0.0 112.717 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.62 8.75 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.758 1.623 . . . . 0.0 111.183 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.69 152.84 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.93 0.871 . . . . 0.0 111.808 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -105.0 152.69 22.4 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -122.8 147.89 46.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.911 1.285 . . . . 0.0 107.561 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.05 116.98 1.65 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.116 -2.793 . . . . 0.0 106.116 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.23 145.19 35.65 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 mt -139.37 124.11 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.61 -2.82 20.75 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.714 1.626 . . . . 0.0 113.996 173.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -60.3 117.51 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.532 . . . . 0.0 107.955 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.13 -29.96 63.77 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.5 m -64.59 54.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 129.719 3.208 . . . . 0.0 111.768 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.05 -44.86 0.79 Allowed 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 126.968 2.107 . . . . 0.0 109.723 174.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -151.71 -36.12 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.099 0.959 . . . . 0.0 111.113 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -71.82 -20.97 61.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.47 1.108 . . . . 0.0 112.374 -172.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -83.34 33.14 0.45 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.25 1.42 . . . . 0.0 113.216 -169.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 p -72.0 9.75 0.87 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.315 1.446 . . . . 0.0 113.409 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -62.58 -38.62 90.83 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.774 1.23 . . . . 0.0 110.059 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.9 p -142.21 20.26 2.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.785 1.234 . . . . 0.0 111.395 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.53 27.2 70.53 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.376 0.989 . . . . 0.0 112.586 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.89 21.74 1.85 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.276 1.038 . . . . 0.0 112.485 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.4 pt -60.62 16.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 129.215 3.006 . . . . 0.0 116.655 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -160.65 2.62 0.07 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.175 0.99 . . . . 0.0 112.727 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -57.64 -41.3 81.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -168.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.6 -57.31 7.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.586 1.084 . . . . 0.0 108.461 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -58.46 -37.78 76.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.083 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.56 67.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 126.157 1.783 . . . . 0.0 109.873 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.93 -34.17 77.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.132 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.1 -40.65 74.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.903 1.229 . . . . 0.0 110.402 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -63.97 -41.54 97.52 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.966 1.306 . . . . 0.0 109.586 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -34.11 73.38 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.057 1.743 . . . . 0.0 111.742 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -67.56 -42.16 83.06 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.81 -17.32 0.56 Allowed Glycine 0 CA--C 1.528 0.898 0 CA-C-O 117.956 -1.469 . . . . 0.0 115.391 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 140.16 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.809 1.804 . . . . 0.0 109.43 -170.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -89.12 112.91 24.0 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.16 128.67 36.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.7 m -106.39 149.97 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.86 -122.4 29.86 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.83 168.67 26.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.19 1.396 . . . . 0.0 108.315 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.1 m -43.91 116.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.09 169.51 15.87 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.879 1.672 . . . . 0.0 108.095 172.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 138.96 42.79 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 120.948 -1.095 . . . . 0.0 111.123 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.66 159.36 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 127.247 2.219 . . . . 0.0 105.372 169.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -147.02 122.36 10.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 118.319 0.509 . . . . 0.0 110.337 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.6 tp -158.7 162.12 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.574 1.55 . . . . 0.0 107.418 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.5 tp 64.2 -9.39 0.16 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.297 2.239 . . . . 0.0 115.411 169.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -151.84 170.69 19.19 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.81 1.644 . . . . 0.0 108.82 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -59.3 160.52 6.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.211 1.405 . . . . 0.0 110.983 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.25 140.54 45.07 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.84 0.829 . . . . 0.0 111.283 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.474 ' H ' ' HD2' ' A' ' 131' ' ' PRO . 7.1 mm -146.05 -55.66 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 128.276 2.63 . . . . 0.0 106.02 175.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.474 ' HD2' ' H ' ' A' ' 130' ' ' ILE . 26.0 Cg_endo -78.54 -131.58 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 122.52 2.147 . . . . 0.0 110.11 171.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.5 -177.3 5.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.281 2.632 . . . . 0.0 105.606 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.601 ' H ' ' HD2' ' A' ' 134' ' ' PRO . 21.7 t70 -142.02 -34.56 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 117.226 2.306 . . . . 0.0 117.226 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.601 ' HD2' ' H ' ' A' ' 133' ' ' ASP . 69.0 Cg_endo -79.6 36.7 0.63 Allowed 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 122.684 2.256 . . . . 0.0 112.522 -177.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.07 26.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.836 2.055 . . . . 0.0 113.772 -171.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -61.96 -33.27 73.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.735 -1.228 . . . . 0.0 110.678 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.18 -33.68 76.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.55 -0.719 . . . . 0.0 111.111 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.65 -44.63 93.27 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.12 -52.64 64.85 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.265 1.026 . . . . 0.0 108.807 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.53 -44.91 85.72 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.252 0.93 . . . . 0.0 111.844 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -61.71 -55.01 34.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.567 0.683 . . . . 0.0 109.548 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -57.69 -40.52 79.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.525 0.73 . . . . 0.0 111.666 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.41 -55.28 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 124.924 1.29 . . . . 0.0 109.699 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -15.05 63.34 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.442 1.019 . . . . 0.0 112.197 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.69 -45.85 20.4 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.796 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.7 -36.87 76.32 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.57 0.623 . . . . 0.0 111.639 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.032 0 C-N-CA 125.435 1.494 . . . . 0.0 109.658 175.264 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.41 165.61 33.6 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.05 0.94 . . . . 0.0 110.37 -173.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.15 -23.07 15.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.721 1.608 . . . . 0.0 110.808 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.69 126.69 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.411 1.084 . . . . 0.0 108.328 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -85.73 128.91 34.92 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -108.7 88.33 2.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.8 mt -77.74 91.41 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -93.02 17.1 11.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.812 2.045 . . . . 0.0 112.98 -168.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.89 77.78 0.11 Allowed Glycine 0 N--CA 1.446 -0.657 0 O-C-N 121.707 -0.621 . . . . 0.0 112.086 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -56.44 -14.4 3.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.247 1.019 . . . . 0.0 113.344 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -122.08 33.42 5.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.722 2.009 . . . . 0.0 109.92 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.8 mt 58.11 23.97 10.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.699 1.999 . . . . 0.0 112.854 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.0 161.96 16.25 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 128.585 2.993 . . . . 0.0 106.223 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.35 -36.33 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.917 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.82 16.42 0.98 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.034 1.417 . . . . 0.0 113.826 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.26 -36.49 63.66 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.535 1.061 . . . . 0.0 113.288 -170.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -60.65 -50.56 73.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.559 0.618 . . . . 0.0 111.313 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.8 -32.24 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 122.029 -0.419 . . . . 0.0 110.094 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.61 87.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.919 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -62.17 -40.06 94.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.323 0.965 . . . . 0.0 111.147 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -64.98 -47.6 76.96 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.639 -0.663 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.41 -49.54 72.12 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.984 0.914 . . . . 0.0 110.606 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.58 -48.23 72.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.999 1.319 . . . . 0.0 110.774 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.59 -50.75 72.27 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.962 0.905 . . . . 0.0 110.524 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.1 -22.64 62.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.567 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -72.79 -41.5 64.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 121.156 1.798 . . . . 0.0 109.024 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -62.9 -25.08 68.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.779 0.832 . . . . 0.0 111.462 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -11.99 60.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.149 0.98 . . . . 0.0 112.546 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 19.85 7.03 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.241 172.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -124.21 -166.78 1.55 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.354 1.061 . . . . 0.0 108.642 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -132.1 150.73 52.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.9 p -141.71 153.88 44.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 110.806 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -123.13 90.48 3.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.231 1.012 . . . . 0.0 108.524 -172.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -66.61 118.9 10.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.2 mt -145.59 138.07 25.76 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.815 0.846 . . . . 0.0 109.167 -170.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -83.66 40.88 0.76 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.035 -1.041 . . . . 0.0 110.601 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.16 44.98 34.2 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 117.892 -1.504 . . . . 0.0 115.863 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.69 -20.99 39.64 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.175 2.487 . . . . 0.0 114.005 -170.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.37 13.41 12.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.53 1.532 . . . . 0.0 109.391 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.0 tp 64.52 -27.2 0.09 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.886 2.474 . . . . 0.0 113.568 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -174.1 87.77 0.05 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.507 1.523 . . . . 0.0 107.378 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.37 -43.29 91.23 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.816 -0.553 . . . . 0.0 110.298 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.81 151.1 49.42 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 47' ' ' SER . 40.1 Cg_endo -67.69 -174.33 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.139 3.226 . . . . 0.0 112.962 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.44 29.02 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.527 1.531 . . . . 0.0 113.115 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' PRO . 18.7 m -152.23 131.93 13.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.949 2.5 . . . . 0.0 106.287 -175.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.39 -139.73 11.19 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mm -126.89 137.07 58.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.473 ' CD1' HG21 ' A' ' 83' ' ' VAL . 11.1 m0 -121.76 133.95 54.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 175.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -127.62 138.12 52.76 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.22 133.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.93 107.58 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -171.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -163.53 -160.52 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.08 2.152 . . . . 0.0 105.598 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 m -148.02 155.12 41.15 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.199 -1.563 . . . . 0.0 109.045 170.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.7 p -128.65 -26.65 2.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.207 0.603 . . . . 0.0 111.872 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -66.58 -26.48 67.13 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.52 -0.738 . . . . 0.0 111.271 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.39 -177.3 36.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 45.74 44.88 11.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.904 1.282 . . . . 0.0 110.683 -170.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.3 -148.64 5.5 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.064 1.316 . . . . 0.0 109.923 -169.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t70 47.75 -45.22 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.49 1 C-N-CA 131.858 4.063 . . . . 0.0 118.536 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.2 mt -56.9 -52.47 73.75 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 120.298 1.408 . . . . 0.0 111.048 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -80.92 40.08 0.95 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.406 2.737 . . . . 0.0 111.133 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t70 52.28 30.23 7.69 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.995 1.718 . . . . 0.0 111.589 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.72 -18.6 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.521 3.129 . . . . 0.0 115.742 -170.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.25 120.94 8.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -54.89 0.56 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.3 -172.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -99.3 -34.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.18 2.587 . . . . 0.0 113.554 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.93 -54.68 44.44 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.722 0.809 . . . . 0.0 112.063 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -65.42 -40.3 93.17 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.659 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.47 -49.62 76.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.246 0.475 . . . . 0.0 110.038 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.13 93.22 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.01 -53.75 54.58 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.773 0.715 . . . . 0.0 110.305 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -72.92 -19.0 61.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.6 -49.82 56.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.368 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -100.8 -26.53 13.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 29.36 64.66 0.78 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 127.19 2.196 . . . . 0.0 113.011 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -63.65 164.81 19.91 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.605 2.203 . . . . 0.0 112.443 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -82.39 66.19 7.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.661 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.43 7.52 0.6 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.306 1.042 . . . . 0.0 113.041 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -62.82 -6.12 3.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.517 2.727 . . . . 0.0 113.041 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.21 8.77 19.95 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.271 1.428 . . . . 0.0 110.983 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.6 p -132.46 147.22 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.709 0.686 . . . . 0.0 110.911 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -97.75 154.05 17.85 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -119.52 152.11 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.6 146.78 17.55 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.8 135.71 53.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.55 127.88 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.48 -19.99 3.62 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.352 0.977 . . . . 0.0 113.662 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.67 144.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.3 1.84 . . . . 0.0 108.677 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.09 -19.61 1.1 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.783 1.182 . . . . 0.0 113.308 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p -52.99 -25.4 11.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.396 1.878 . . . . 0.0 113.34 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -74.66 -26.63 59.98 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -146.75 -22.54 0.42 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 -168.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -126.65 -35.41 2.34 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -168.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.69 11.36 9.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.164 0.983 . . . . 0.0 112.239 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 p -67.78 7.13 0.55 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.952 2.501 . . . . 0.0 115.051 -169.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -77.69 -39.27 45.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.539 1.136 . . . . 0.0 110.354 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.2 p -153.52 19.51 0.54 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.851 0.86 . . . . 0.0 112.563 -174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.07 58.73 4.32 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 125.553 1.549 . . . . 0.0 113.096 -169.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.53 -22.58 34.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.124 0.97 . . . . 0.0 113.053 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -11.79 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 118.641 -0.695 . . . . 0.0 112.694 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.08 -28.23 0.69 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.159 2.184 . . . . 0.0 112.907 169.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -56.75 -23.12 40.54 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.101 0.96 . . . . 0.0 112.73 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.45 -59.12 5.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 120.013 1.279 . . . . 0.0 109.185 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.88 -39.52 81.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.109 0.413 . . . . 0.0 110.597 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.21 81.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.269 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.56 -38.18 90.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.048 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.97 -46.91 88.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.29 0.95 . . . . 0.0 110.592 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -65.69 -38.34 88.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.798 0.839 . . . . 0.0 110.074 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -34.24 77.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.688 1.195 . . . . 0.0 111.324 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.1 m -71.67 -31.25 66.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.388 -0.339 . . . . 0.0 111.336 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.97 -33.15 0.56 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 118.994 -0.892 . . . . 0.0 114.781 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.6 171.97 6.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.433 1.116 . . . . 0.0 110.465 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -132.72 141.93 48.8 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -75.78 111.13 10.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.0 m -74.58 152.69 39.24 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.08 -104.13 1.68 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.79 -177.34 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.812 2.445 . . . . 0.0 106.541 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 124.99 31.51 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD12 ' CE3' ' A' ' 138' ' ' TRP . 2.3 tt -79.65 151.02 30.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -129.85 146.67 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.814 1.188 . . . . 0.0 108.798 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.69 170.17 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 110.9 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 108.83 141.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.655 1 C-N-CA 132.042 4.137 . . . . 0.0 110.879 169.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.05 5.76 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.936 1.694 . . . . 0.0 110.906 169.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.5 -47.32 86.18 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.015 0.926 . . . . 0.0 109.852 -171.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -141.32 18.84 2.24 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.535 1.134 . . . . 0.0 110.329 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 47.48 55.47 8.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.691 1.596 . . . . 0.0 110.572 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -65.88 -178.85 0.63 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.857 1.263 . . . . 0.0 110.28 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.274 98.0 mt 6.37 -78.86 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.878 1 C-N-CA 132.475 4.31 . . . . 0.0 115.358 -172.086 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -69.9 -31.0 20.74 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.489 2.126 . . . . 0.0 112.359 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 86.59 -16.07 0.43 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.12 2.968 . . . . 0.0 111.625 170.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -145.77 122.33 5.94 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.645 1.178 . . . . 0.0 108.484 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -72.91 165.9 31.51 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.755 2.304 . . . . 0.0 111.272 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.74 49.51 2.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.996 1.318 . . . . 0.0 109.382 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.71 -21.75 55.68 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.85 -24.87 67.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.256 1.023 . . . . 0.0 112.042 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.427 ' CE3' HD12 ' A' ' 121' ' ' LEU . 9.2 t90 -51.85 -50.34 61.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 110.653 173.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.82 -55.96 24.53 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.483 1.114 . . . . 0.0 109.359 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.28 -42.38 99.76 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 123.319 0.387 . . . . 0.0 112.179 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -60.28 -63.35 1.33 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 125.194 1.397 . . . . 0.0 110.171 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -53.95 -46.72 71.66 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.846 1.658 . . . . 0.0 111.849 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.5 t -59.77 -55.89 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -18.17 63.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.461 1.028 . . . . 0.0 112.201 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.24 -47.1 21.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.545 0.611 . . . . 0.0 111.0 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.17 -30.69 62.36 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 112.261 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.9 mttm . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.804 1.242 . . . . 0.0 109.781 171.491 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.2 167.63 29.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.842 1.257 . . . . 0.0 109.309 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.07 -27.59 18.49 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.882 0.873 . . . . 0.0 110.025 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -132.71 132.09 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.941 0.896 . . . . 0.0 109.319 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -89.46 129.86 35.89 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.57 95.11 5.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.2 mt -88.27 77.51 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -74.27 153.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.31 -0.869 . . . . 0.0 109.54 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.93 -175.64 32.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-O 122.576 1.098 . . . . 0.0 114.973 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 p -150.51 -50.07 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.05 -1.575 . . . . 0.0 109.508 -169.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 48.0 m -121.48 58.64 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.0 tp 48.89 48.08 20.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.067 2.147 . . . . 0.0 112.549 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.72 153.34 10.98 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.21 -174.51 41.09 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 118.31 1.055 . . . . 0.0 113.745 -169.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.06 59.5 1.32 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.296 1.838 . . . . 0.0 110.52 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -56.67 -27.38 58.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.148 -0.97 . . . . 0.0 112.05 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -58.91 -44.81 91.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.932 0.787 . . . . 0.0 111.324 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.71 -43.14 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.33 91.38 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.549 -0.262 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.66 -41.45 75.51 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.363 0.665 . . . . 0.0 110.886 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -61.27 -45.55 94.04 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.736 -0.602 . . . . 0.0 110.147 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.13 -52.57 65.0 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.093 0.957 . . . . 0.0 110.469 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.55 -46.25 57.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.224 1.009 . . . . 0.0 110.886 177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -56.69 -54.23 48.53 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.549 0.613 . . . . 0.0 110.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -61.65 -39.45 91.38 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.87 -37.59 84.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.396 0.678 . . . . 0.0 110.779 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.36 -39.41 89.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.592 0.633 . . . . 0.0 110.369 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -63.14 -30.01 71.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.867 0.758 . . . . 0.0 111.388 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -20.62 60.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.623 0.769 . . . . 0.0 111.676 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 16.92 6.73 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 118.514 -1.159 . . . . 0.0 114.228 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.03 142.58 51.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.066 1.433 . . . . 0.0 108.49 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -83.15 151.84 25.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -138.32 158.62 43.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.03 104.46 7.8 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 m -68.82 123.21 20.33 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.271 1.028 . . . . 0.0 108.344 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -145.43 166.35 25.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.163 0.985 . . . . 0.0 110.042 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -110.36 39.33 2.21 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.622 1.169 . . . . 0.0 109.141 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.85 50.9 14.1 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.718 1.627 . . . . 0.0 114.867 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 -21.75 62.61 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.846 2.364 . . . . 0.0 113.775 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.0 mt -124.1 13.93 9.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.18 1.792 . . . . 0.0 108.93 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.7 tp 61.59 -25.57 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.654 2.782 . . . . 0.0 114.464 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -161.3 86.44 0.68 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -168.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.57 -45.25 87.82 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.685 -0.634 . . . . 0.0 110.081 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.13 151.34 59.93 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.48 -178.9 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.584 2.856 . . . . 0.0 112.996 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.54 35.92 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.882 1.673 . . . . 0.0 111.807 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -158.49 123.99 4.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.293 2.237 . . . . 0.0 105.773 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.48 -147.9 19.38 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.6 mm -123.5 128.91 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -119.79 152.25 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 mt -140.43 138.16 34.51 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.76 132.29 44.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -125.11 68.44 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.931 1.292 . . . . 0.0 108.292 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -103.09 16.24 27.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.524 1.13 . . . . 0.0 112.241 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m 2.22 83.49 0.0 OUTLIER 'General case' 0 C--N 1.344 0.357 0 C-N-CA 129.999 3.319 . . . . 0.0 114.516 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.6 p -64.79 -48.31 74.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.148 0.979 . . . . 0.0 109.609 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -83.1 61.88 6.29 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.288 1.035 . . . . 0.0 108.306 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.98 60.74 0.23 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.57 40.38 29.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.326 1.45 . . . . 0.0 111.654 -169.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.14 -138.2 5.44 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 125.563 1.554 . . . . 0.0 109.822 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.2 t70 47.59 -51.81 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 1 C-N-CA 131.886 4.074 . . . . 0.0 117.945 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.9 mt -54.92 -53.12 64.64 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 120.172 1.351 . . . . 0.0 112.302 -170.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -82.24 49.14 3.03 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.212 2.608 . . . . 0.0 110.485 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t0 47.43 41.48 12.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.225 1.41 . . . . 0.0 109.641 -169.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.35 -47.52 0.13 Allowed 'General case' 0 C--N 1.338 0.08 0 C-N-CA 130.473 3.509 . . . . 0.0 114.533 -168.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -150.09 108.07 3.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 m -82.65 -63.04 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.948 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.86 -40.57 16.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.695 1.596 . . . . 0.0 110.625 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -63.46 -49.87 71.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.976 0.51 . . . . 0.0 110.718 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.53 -45.83 88.81 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.801 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -61.07 -46.43 90.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.746 0.703 . . . . 0.0 110.231 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -24.02 67.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.6 mt -67.71 -61.24 1.98 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.469 1.031 . . . . 0.0 108.657 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -73.62 -13.14 60.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.19 -36.11 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.202 1.001 . . . . 0.0 110.356 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -120.72 -30.11 4.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.798 -172.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.3 mttt 25.62 68.69 0.43 Allowed Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.043 1.737 . . . . 0.0 112.872 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.45 173.95 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.309 2.006 . . . . 0.0 111.883 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -81.15 95.6 6.94 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.37 -0.832 . . . . 0.0 108.992 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.487 HD23 ' HB3' ' A' ' 112' ' ' SER . 3.0 mm? -88.45 6.25 38.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.992 0.517 . . . . 0.0 111.561 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.6 p -68.06 -5.26 16.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 119.694 -1.879 . . . . 0.0 112.583 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.56 43.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.461 1.504 . . . . 0.0 110.939 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.61 155.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.246 1.022 . . . . 0.0 111.095 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -114.91 147.48 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -125.61 156.92 38.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 109.791 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.45 116.42 2.15 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.6 146.36 44.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.1 mt -139.99 129.45 28.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.92 -9.36 2.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.442 1.02 . . . . 0.0 113.775 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.85 136.17 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.35 14.22 7.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.799 1.19 . . . . 0.0 112.052 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -68.85 -9.98 54.44 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.308 1.443 . . . . 0.0 113.392 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -157.58 175.19 14.27 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.996 2.119 . . . . 0.0 107.854 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 77.33 -25.95 0.19 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 129.287 3.035 . . . . 0.0 112.475 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -136.67 -26.49 1.07 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.632 1.173 . . . . 0.0 112.76 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -149.27 87.44 1.52 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-N 119.283 0.947 . . . . 0.0 108.655 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.8 p -75.7 4.3 8.07 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -87.96 -17.95 30.15 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.295 0.638 . . . . 0.0 109.713 169.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 87.4 m -76.14 19.68 0.23 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.122 0.969 . . . . 0.0 112.3 169.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -55.17 -29.92 53.48 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.102 0.858 . . . . 0.0 111.829 171.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.57 -16.6 16.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.401 1.08 . . . . 0.0 113.662 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.3 pt -125.45 19.24 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.916 1.286 . . . . 0.0 110.726 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -0.05 24.28 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.666 -1.271 . . . . 0.0 112.348 169.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -51.07 -40.89 59.39 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.977 1.711 . . . . 0.0 112.874 -170.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.5 -57.81 11.36 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.13 -40.31 95.49 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.8 68.12 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 117.329 -1.32 . . . . 0.0 111.603 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.98 -45.0 94.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.736 1.607 . . . . 0.0 110.805 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.84 -39.47 90.83 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -30.71 70.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.161 1.384 . . . . 0.0 111.948 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.487 ' HB3' HD23 ' A' ' 80' ' ' LEU . 13.9 m -80.58 -18.65 47.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.953 0.501 . . . . 0.0 111.098 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.5 -19.58 4.5 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.694 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.49 136.89 55.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.674 1.737 . . . . 0.0 108.829 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -86.23 132.77 33.92 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -85.63 103.23 14.26 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -77.09 150.26 35.68 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.322 -0.236 . . . . 0.0 110.487 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.65 -95.45 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.413 1.006 . . . . 0.0 111.195 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.34 176.99 6.31 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 128.439 2.696 . . . . 0.0 106.511 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.3 m -63.72 131.03 46.62 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.48 HD12 ' CE3' ' A' ' 138' ' ' TRP . 3.5 tt -73.78 139.93 45.54 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.51 139.77 51.45 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.06 169.18 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.924 1.29 . . . . 0.0 108.702 -174.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.37 157.97 44.49 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.7 pt -134.51 165.37 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.03 -35.18 74.54 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.955 0.502 . . . . 0.0 111.104 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -64.93 -44.91 87.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.08 0.552 . . . . 0.0 112.168 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -168.18 157.76 9.64 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.23 1.012 . . . . 0.0 109.823 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -72.83 152.33 41.58 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.322 40.2 mm -108.38 -91.1 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 116.12 -1.895 . . . . 0.0 108.459 -174.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.44 -53.99 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 CA-C-N 123.967 2.452 . . . . 0.0 110.583 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -168.44 -49.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.807 1.643 . . . . 0.0 108.795 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.84 142.76 15.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.429 1.092 . . . . 0.0 109.01 -169.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.2 162.45 40.56 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.764 2.309 . . . . 0.0 112.353 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.05 46.87 1.0 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.363 1.465 . . . . 0.0 109.167 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.46 -19.02 13.27 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -55.37 -23.41 24.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.35 1.46 . . . . 0.0 112.394 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.48 ' CE3' HD12 ' A' ' 121' ' ' LEU . 10.7 t90 -44.14 -56.66 3.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 125.359 1.464 . . . . 0.0 110.943 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -59.17 4.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.809 1.644 . . . . 0.0 109.002 -174.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.07 60.32 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 123.874 0.734 . . . . 0.0 111.349 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 t -65.27 -47.86 75.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.671 0.735 . . . . 0.0 110.566 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -60.67 -41.66 95.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.655 1.182 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t -59.4 -49.94 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.557 0.743 . . . . 0.0 109.675 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -61.26 -30.33 70.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.241 0.928 . . . . 0.0 111.247 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.23 -46.83 26.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.442 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -74.16 -32.01 62.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.188 0.449 . . . . 0.0 112.129 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.443 1.097 . . . . 0.0 109.825 173.376 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.43 164.62 37.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.184 0.994 . . . . 0.0 109.96 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.92 -24.0 15.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.672 1.589 . . . . 0.0 110.577 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.15 126.6 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.291 1.036 . . . . 0.0 108.413 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.48 127.2 35.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.44 95.55 6.15 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.1 mt -91.26 117.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.29 168.65 17.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.315 0.646 . . . . 0.0 110.525 -169.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.64 38.77 93.49 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.918 -0.379 . . . . 0.0 112.34 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 m -61.64 0.31 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.521 2.329 . . . . 0.0 116.343 -169.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -123.31 31.53 5.94 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.118 1.767 . . . . 0.0 108.183 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.2 tp 53.66 63.92 2.03 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 126.223 1.809 . . . . 0.0 109.952 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.56 -144.7 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.07 1.795 . . . . 0.0 109.189 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.97 163.37 34.77 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 37.22 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.128 1.771 . . . . 0.0 108.125 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.56 -36.4 61.82 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 0.0 113.244 -169.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -58.62 -47.02 85.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.099 0.863 . . . . 0.0 110.819 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -72.82 -47.09 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.85 99.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.99 -38.59 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.904 0.482 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -61.81 -48.0 82.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.764 0.711 . . . . 0.0 110.031 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.91 -54.06 49.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.856 0.863 . . . . 0.0 109.878 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.06 63.9 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.408 1.083 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.61 -54.92 40.85 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.567 0.747 . . . . 0.0 110.476 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -59.52 -37.12 77.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.2 mt -66.08 -34.31 77.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.213 0.605 . . . . 0.0 111.42 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -70.66 -38.3 73.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.046 1.294 . . . . 0.0 110.263 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.05 -29.76 70.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.37 0.668 . . . . 0.0 111.134 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.46 -14.77 62.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.819 0.848 . . . . 0.0 112.112 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.04 7.32 6.61 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.197 -1.335 . . . . 0.0 114.522 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -112.1 -167.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.668 1.734 . . . . 0.0 110.131 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -128.7 150.22 50.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.1 p -142.0 154.46 45.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.264 0.554 . . . . 0.0 112.061 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -121.26 98.03 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.579 1.552 . . . . 0.0 108.013 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -72.42 121.0 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.1 mt -146.16 149.0 33.15 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.996 0.518 . . . . 0.0 111.456 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -90.87 34.9 0.9 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.112 0.965 . . . . 0.0 110.319 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 49.94 27.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.735 1.636 . . . . 0.0 114.791 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.64 -21.89 65.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.82 2.347 . . . . 0.0 114.007 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.16 10.54 4.54 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.78 2.032 . . . . 0.0 107.099 -175.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 62.99 -26.66 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.628 2.771 . . . . 0.0 114.03 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -157.59 80.43 0.88 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.857 0.863 . . . . 0.0 109.271 -168.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.97 -44.73 96.14 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.586 -0.696 . . . . 0.0 110.523 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.11 151.25 69.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 47' ' ' SER . 43.4 Cg_endo -67.92 -173.93 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.261 3.307 . . . . 0.0 113.021 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.45 27.56 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.422 1.489 . . . . 0.0 113.262 170.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 45' ' ' PRO . 15.5 m -150.76 133.28 15.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.768 2.427 . . . . 0.0 106.403 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.88 -142.07 13.28 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 mm -124.29 142.77 39.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CD1' HG21 ' A' ' 83' ' ' VAL . 17.2 m0 -121.41 150.45 41.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.9 mt -141.07 141.2 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -133.71 121.19 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.72 103.09 14.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.324 1.85 . . . . 0.0 107.138 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -146.09 -161.0 1.22 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.334 1.054 . . . . 0.0 108.685 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.0 m -150.43 150.61 31.58 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.663 -1.273 . . . . 0.0 108.414 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p -146.85 -39.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.658 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.1 t60 51.89 21.82 1.57 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.116 1.366 . . . . 0.0 113.718 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.76 -28.67 5.62 Favored Glycine 0 C--N 1.339 0.726 0 O-C-N 120.868 -1.145 . . . . 0.0 112.864 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.68 -68.17 0.09 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.526 1.13 . . . . 0.0 108.267 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.95 -160.83 28.44 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.62 -28.42 69.11 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 169.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.6 pt -139.47 160.72 60.56 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.654 2.382 . . . . 0.0 107.076 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -55.69 -26.58 56.74 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.38 2.72 . . . . 0.0 114.39 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.23 43.12 1.21 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.781 1.632 . . . . 0.0 109.285 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -56.75 -19.77 18.6 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -169.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.68 77.8 1.76 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -66.64 -55.12 19.29 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 127.706 2.402 . . . . 0.0 112.411 -168.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.39 -34.53 54.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.117 1.211 . . . . 0.0 110.071 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.77 -59.42 5.45 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 123.783 0.677 . . . . 0.0 109.689 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.55 -46.81 87.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.957 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.12 -46.13 90.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.274 0.943 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.27 -23.53 65.69 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.1 mt -67.06 -62.35 1.47 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.61 -20.11 65.92 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.98 -34.49 77.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.545 0.738 . . . . 0.0 111.11 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -128.86 -24.41 2.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 mttt 28.58 65.1 0.69 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 127.108 2.163 . . . . 0.0 112.763 -170.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.28 163.29 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.679 2.253 . . . . 0.0 113.195 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -80.79 66.76 6.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.734 1.214 . . . . 0.0 110.731 -174.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.91 17.42 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.578 1.551 . . . . 0.0 112.886 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 p -65.99 -4.29 6.85 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 119.955 -1.715 . . . . 0.0 112.6 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 11.14 13.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.877 1.671 . . . . 0.0 111.081 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.407 HG21 ' CD1' ' A' ' 50' ' ' TRP . 3.1 p -134.99 157.16 40.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.815 0.817 . . . . 0.0 110.926 176.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.403 HH22 HD22 ' A' ' 146' ' ' LEU . 3.9 ptt-85 -120.02 148.56 43.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -115.46 169.25 9.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.06 120.19 1.58 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.31 139.93 41.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.5 mt -138.59 130.86 38.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 -26.69 1.08 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.09 0.852 . . . . 0.0 112.77 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.3 mt -52.68 155.49 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 128.096 2.558 . . . . 0.0 108.453 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.47 20.7 0.82 Allowed Glycine 0 CA--C 1.526 0.754 0 O-C-N 121.664 -0.647 . . . . 0.0 112.58 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.46 -13.31 60.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.62 1.168 . . . . 0.0 111.804 174.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.15 145.67 36.17 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -54.29 -25.38 23.31 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.0 1.32 . . . . 0.0 113.753 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -72.2 -17.62 61.91 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -131.88 19.53 4.59 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.519 1.054 . . . . 0.0 113.353 -169.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.6 p -70.09 95.35 0.96 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.133 1.373 . . . . 0.0 110.302 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -133.3 -16.36 2.43 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 76.1 m -120.65 20.78 11.7 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.124 1.37 . . . . 0.0 110.987 173.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.76 -177.38 37.19 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.13 1.824 . . . . 0.0 108.987 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.41 40.48 1.21 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.454 1.101 . . . . 0.0 110.324 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.8 pt -126.97 158.25 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.751 1.22 . . . . 0.0 109.384 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -148.55 25.24 0.97 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.848 0.859 . . . . 0.0 112.195 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -52.43 -34.46 48.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.422 1.089 . . . . 0.0 112.794 -173.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.31 -57.5 12.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.173 0.589 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.51 -38.24 89.16 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.278 0.631 . . . . 0.0 109.359 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.13 83.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.206 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.82 -35.71 81.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.716 -1.135 . . . . 0.0 111.192 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.84 -47.93 84.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.896 1.226 . . . . 0.0 110.876 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.21 -37.02 84.55 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.142 0.977 . . . . 0.0 110.092 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -36.8 79.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.262 1.425 . . . . 0.0 111.518 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.5 m -68.96 -38.5 79.45 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.46 0.52 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.97 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.67 135.6 48.45 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.305 1.553 . . . . 0.0 108.986 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -84.23 141.62 30.86 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.05 113.38 19.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -72.28 146.26 47.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.8 -119.77 17.1 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 170.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.22 159.51 44.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.64 1.576 . . . . 0.0 107.388 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.5 m -48.8 125.11 9.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.976 1.31 . . . . 0.0 111.358 -175.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.51 147.78 35.64 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.647 1.579 . . . . 0.0 107.817 -173.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -116.13 142.82 46.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 169.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.59 161.32 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -169.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 58.96 157.25 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 131.037 3.735 . . . . 0.0 116.045 172.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 pp -142.27 16.28 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 125.55 1.54 . . . . 0.0 110.821 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.0 tp -63.82 -35.69 81.45 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 121.393 -0.817 . . . . 0.0 110.692 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -153.51 176.97 11.43 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.309 1.844 . . . . 0.0 106.889 173.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -57.77 140.65 51.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.385 1.474 . . . . 0.0 109.224 170.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -154.08 -166.31 2.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.37 1.468 . . . . 0.0 108.253 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.0 mt -74.24 -58.17 2.02 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-O 117.672 -1.156 . . . . 0.0 109.36 171.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.04 -51.38 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.586 1.524 . . . . 0.0 112.35 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 37.57 58.48 1.33 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.98 2.512 . . . . 0.0 114.397 174.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.6 139.46 13.58 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.031 0.933 . . . . 0.0 109.081 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.28 132.34 23.89 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.208 1.939 . . . . 0.0 111.258 -175.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.92 -25.85 65.69 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -170.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.03 -34.33 68.08 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -169.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.45 -41.04 69.95 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.964 0.802 . . . . 0.0 110.152 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -46.94 81.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.106 172.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.16 -47.2 81.79 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.191 0.596 . . . . 0.0 109.827 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.66 -49.32 79.79 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.5 t -62.94 -43.97 97.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.177 0.988 . . . . 0.0 110.822 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.4 t90 -63.56 -38.37 90.88 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.621 1.568 . . . . 0.0 110.677 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.31 -46.63 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.962 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.79 -28.41 69.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.761 -1.212 . . . . 0.0 111.456 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.77 -47.18 40.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.077 0.951 . . . . 0.0 110.686 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.403 HD22 HH22 ' A' ' 84' ' ' ARG . 1.6 pp -71.45 -33.39 69.31 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.569 0.622 . . . . 0.0 112.04 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.1 mttm . . . . . 0 C--O 1.249 1.044 0 C-N-CA 125.292 1.437 . . . . 0.0 110.004 173.468 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 mtt . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.816 0.341 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.95 173.12 0.65 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.009 1.324 . . . . 0.0 112.24 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.39 -24.86 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.982 0.913 . . . . 0.0 110.872 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.0 mt -138.47 125.81 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.066 0.947 . . . . 0.0 109.28 -171.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -85.63 133.03 34.06 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 mp -111.58 100.33 8.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 mt -71.82 96.75 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 170.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -88.48 21.5 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.099 2.16 . . . . 0.0 112.201 -168.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 179.26 41.03 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -138.33 -27.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.643 0.777 . . . . 0.0 112.383 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 p -121.66 42.84 3.0 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp 56.12 37.33 28.73 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.449 1.5 . . . . 0.0 111.045 -169.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.06 163.24 27.15 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.265 1.888 . . . . 0.0 108.983 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -161.75 34.8 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.996 0.808 . . . . 0.0 111.336 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 60.05 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.346 1.859 . . . . 0.0 112.209 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -55.85 -31.45 62.76 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.629 0.771 . . . . 0.0 112.642 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -61.19 -42.05 97.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.236 0.926 . . . . 0.0 111.008 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.44 -39.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.568 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.55 -39.75 92.07 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.752 175.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -65.18 -38.54 90.81 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.383 -0.823 . . . . 0.0 110.699 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.94 -49.8 71.18 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.89 0.876 . . . . 0.0 110.185 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.42 -42.63 54.17 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.535 1.134 . . . . 0.0 111.117 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -54.9 -54.34 43.89 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.051 0.841 . . . . 0.0 110.157 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -60.94 -42.31 97.94 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.2 -39.94 95.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.441 0.696 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.89 -33.17 62.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.177 -0.952 . . . . 0.0 110.323 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.41 -32.16 72.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.972 0.805 . . . . 0.0 111.026 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -20.53 63.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.561 0.618 . . . . 0.0 111.518 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.95 -4.64 6.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.57 -1.128 . . . . 0.0 113.588 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -89.36 -170.79 2.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.211 1.505 . . . . 0.0 109.925 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -129.16 148.01 51.06 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -139.69 150.72 45.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.144 0.497 . . . . 0.0 111.939 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -113.57 90.7 3.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.891 1.677 . . . . 0.0 107.219 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -70.61 120.08 15.7 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -148.05 137.89 22.52 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.783 0.833 . . . . 0.0 110.725 -169.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -80.04 36.91 0.36 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.551 -1.343 . . . . 0.0 111.404 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.64 49.47 33.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.922 1.725 . . . . 0.0 114.86 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.77 -22.13 69.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.004 2.47 . . . . 0.0 113.888 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.1 mt -128.74 12.03 6.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.03 1.732 . . . . 0.0 109.418 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 tp 62.11 -25.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.994 2.518 . . . . 0.0 114.161 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -160.37 78.46 0.64 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.407 1.083 . . . . 0.0 108.924 -168.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.2 -46.07 85.54 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.656 -0.653 . . . . 0.0 110.032 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 mt -81.48 154.26 71.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.29 179.3 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.846 3.03 . . . . 0.0 113.584 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.84 32.25 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.116 1.766 . . . . 0.0 112.591 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.1 m -153.89 133.78 13.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.782 2.433 . . . . 0.0 106.536 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.86 -138.95 11.7 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 mm -121.24 135.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.455 ' CD1' HG21 ' A' ' 83' ' ' VAL . 6.0 m0 -125.65 138.9 53.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.5 mt -128.36 146.7 50.7 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.23 133.76 55.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -125.94 108.53 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -170.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -156.72 -163.1 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.506 1.122 . . . . 0.0 108.611 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.96 144.04 25.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.6 p -128.84 -81.64 0.57 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.289 0.95 . . . . 0.0 110.714 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -58.56 122.01 12.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.19 -7.28 81.24 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.226 0.917 . . . . 0.0 114.498 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.0 30.84 1.28 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.765 1.626 . . . . 0.0 110.32 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.66 -172.98 47.92 Favored Glycine 0 CA--C 1.525 0.676 0 O-C-N 121.433 -0.792 . . . . 0.0 113.546 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -137.78 177.63 7.73 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.573 1.949 . . . . 0.0 107.635 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.56 -52.44 63.73 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.113 1.365 . . . . 0.0 111.541 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.49 -53.29 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 121.674 1.633 . . . . 0.0 110.992 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -167.08 -60.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.989 1.316 . . . . 0.0 108.841 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -171.26 -51.8 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.914 2.486 . . . . 0.0 105.351 170.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.62 135.9 57.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -122.55 -64.4 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 117.266 -1.349 . . . . 0.0 111.375 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.6 -39.34 9.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 122.073 1.776 . . . . 0.0 110.103 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -61.22 -46.44 90.41 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.864 1.266 . . . . 0.0 110.088 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.6 -51.24 69.39 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.303 1.041 . . . . 0.0 110.399 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.55 -45.34 90.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.833 0.742 . . . . 0.0 110.98 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.76 82.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.65 -55.57 33.19 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 123.264 0.626 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -68.35 -18.98 64.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.49 -32.92 66.59 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.4 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.55 -25.3 5.58 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 32.42 63.04 1.33 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.631 1.972 . . . . 0.0 112.954 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -63.93 167.54 13.81 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.02 2.48 . . . . 0.0 113.39 -169.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -78.97 63.74 3.73 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.181 1.392 . . . . 0.0 111.454 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.07 8.85 0.66 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.757 1.223 . . . . 0.0 112.738 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 m -62.3 -6.83 3.51 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.637 2.775 . . . . 0.0 112.911 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.59 9.33 19.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.265 1.426 . . . . 0.0 111.12 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.1 p -131.31 154.63 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.824 0.738 . . . . 0.0 112.403 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -109.21 149.35 29.51 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.745 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.89 153.87 23.87 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.997 1.319 . . . . 0.0 108.059 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.16 106.65 0.46 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 106.026 -2.829 . . . . 0.0 106.026 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.08 29.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 mt -140.07 132.73 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -169.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -28.44 1.61 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.619 1.104 . . . . 0.0 113.01 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 mt -48.99 142.05 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.297 2.239 . . . . 0.0 108.778 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.3 -36.65 8.05 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 m -51.35 140.73 16.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.194 1.798 . . . . 0.0 111.0 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -158.74 172.06 18.95 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -57.84 -25.62 60.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.92 0.488 . . . . 0.0 112.051 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -144.91 105.1 4.06 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.331 1.052 . . . . 0.0 109.097 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -148.68 19.58 1.03 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.103 1.361 . . . . 0.0 109.715 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.7 t -161.31 167.68 25.41 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.956 -1.09 . . . . 0.0 109.199 -169.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -156.82 -42.36 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.093 1.357 . . . . 0.0 109.303 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.8 m -137.57 43.26 2.3 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.754 1.621 . . . . 0.0 109.437 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.94 -161.32 8.67 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.738 1.161 . . . . 0.0 110.814 -175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.67 158.25 6.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.33 0.652 . . . . 0.0 110.149 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.9 pt -134.19 167.27 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.754 0.821 . . . . 0.0 109.56 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.71 39.04 0.13 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.271 2.229 . . . . 0.0 113.719 -173.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -47.1 -44.43 21.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.515 1.126 . . . . 0.0 113.035 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.33 -53.06 62.56 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.781 0.832 . . . . 0.0 109.575 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -39.69 92.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.9 75.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.562 1.145 . . . . 0.0 110.238 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -63.26 -39.37 94.41 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.979 0.809 . . . . 0.0 110.981 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -70.14 -41.89 73.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.887 0.767 . . . . 0.0 111.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -61.69 -37.7 85.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.466 1.507 . . . . 0.0 109.223 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -37.11 73.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.078 1.351 . . . . 0.0 111.92 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -67.24 -35.92 80.57 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.108 0.563 . . . . 0.0 110.59 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.87 -28.43 0.36 Allowed Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.015 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.14 170.41 8.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.765 1.283 . . . . 0.0 110.663 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -130.36 137.28 49.82 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -72.04 124.61 25.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.8 m -86.82 154.43 20.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.78 -117.27 10.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 173.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.25 175.9 12.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.9 1.68 . . . . 0.0 107.002 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.5 m -60.04 128.21 35.7 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.52 -0.738 . . . . 0.0 110.115 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 122' ' ' LYS . 1.8 tt -79.88 156.49 27.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.991 1.316 . . . . 0.0 107.822 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.618 ' H ' HD23 ' A' ' 121' ' ' LEU . 7.8 mptt -126.91 140.11 52.57 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.625 1.17 . . . . 0.0 108.083 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 pp -138.36 153.65 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 109.011 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.14 17.63 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.18 24.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 125.188 1.395 . . . . 0.0 113.517 -172.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -143.26 -57.89 0.41 Allowed 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.796 1.239 . . . . 0.0 109.515 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -161.94 164.41 28.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.962 1.305 . . . . 0.0 108.342 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -60.09 160.53 7.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.385 1.074 . . . . 0.0 110.895 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.71 -69.76 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.558 ' H ' ' HD2' ' A' ' 131' ' ' PRO . 24.1 mm -142.3 -56.5 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.906 1.683 . . . . 0.0 110.659 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.558 ' HD2' ' H ' ' A' ' 130' ' ' ILE . 70.5 Cg_endo -71.98 -38.97 3.51 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 121.904 1.716 . . . . 0.0 111.454 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 65.2 17.67 11.12 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.697 1.599 . . . . 0.0 112.081 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -154.68 114.98 2.43 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.634 1.174 . . . . 0.0 109.082 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.76 154.56 48.64 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.841 2.361 . . . . 0.0 112.062 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.63 46.9 1.68 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.367 1.067 . . . . 0.0 110.135 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -62.26 -14.69 41.27 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.155 -0.966 . . . . 0.0 113.273 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -59.92 -27.17 66.53 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.193 -0.942 . . . . 0.0 111.366 169.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.405 ' CG ' ' HG ' ' A' ' 121' ' ' LEU . 6.8 t90 -57.5 -52.35 65.73 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.618 1.167 . . . . 0.0 110.12 171.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.36 -56.21 12.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.691 1.596 . . . . 0.0 108.509 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.42 -45.37 94.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.433 0.54 . . . . 0.0 112.656 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.4 m -62.19 -60.44 3.59 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.237 1.415 . . . . 0.0 110.457 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -52.93 -41.65 64.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.115 1.766 . . . . 0.0 111.567 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.12 -57.65 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.783 0.833 . . . . 0.0 109.946 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -14.43 62.48 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.47 -0.769 . . . . 0.0 112.398 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.0 mp -80.78 -49.15 11.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 110.782 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.19 -33.62 70.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 111.596 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.519 1.127 . . . . 0.0 109.647 173.917 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.93 164.31 38.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.117 0.967 . . . . 0.0 110.157 -172.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -98.51 -22.83 15.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.778 1.231 . . . . 0.0 110.887 169.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 mt -131.95 126.22 56.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 t -90.98 128.28 36.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -95.76 103.93 15.84 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -96.43 86.84 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 159.16 16.27 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 111.646 -169.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.73 79.56 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.15 -45.02 8.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.228 2.211 . . . . 0.0 115.531 -169.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.7 m -127.89 54.72 1.69 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt 52.91 37.0 23.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.545 1.938 . . . . 0.0 111.929 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.78 4.5 69.4 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.645 1.117 . . . . 0.0 113.235 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.55 -79.39 1.84 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.817 1.199 . . . . 0.0 111.118 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.7 18.08 0.45 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.354 1.862 . . . . 0.0 113.889 -169.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.31 -26.03 67.12 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.354 -0.841 . . . . 0.0 111.834 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.97 -47.65 84.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.73 0.695 . . . . 0.0 110.584 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.65 -38.77 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.3 80.32 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.838 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.58 -40.46 76.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.868 0.758 . . . . 0.0 110.357 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -62.48 -47.69 82.87 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.949 -0.47 . . . . 0.0 110.238 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.18 -51.66 67.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.402 1.081 . . . . 0.0 110.868 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.58 -41.05 66.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.748 0.819 . . . . 0.0 111.393 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -58.09 -47.78 82.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.421 1.009 . . . . 0.0 111.079 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -58.04 -44.32 87.34 Favored 'General case' 0 C--N 1.337 0.034 0 C-N-CA 122.671 0.389 . . . . 0.0 111.308 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 26' ' ' LEU . 3.3 mm? -66.29 -33.02 74.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.56 -45.55 78.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.018 0.826 . . . . 0.0 109.581 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -71.2 -17.3 62.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.813 0.733 . . . . 0.0 112.157 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.04 -15.5 62.03 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.919 0.781 . . . . 0.0 111.442 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.98 22.41 5.96 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.491 169.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -129.08 171.87 11.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.59 1.195 . . . . 0.0 110.28 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 p -105.71 154.47 20.42 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -141.53 155.23 45.81 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.771 -0.581 . . . . 0.0 111.449 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.71 93.51 4.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -70.53 120.95 16.92 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.7 mt -148.51 170.16 18.68 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 124.37 1.068 . . . . 0.0 109.477 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -110.23 37.81 2.61 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.133 1.773 . . . . 0.0 108.603 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.53 48.77 22.01 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.842 1.686 . . . . 0.0 115.086 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.56 -20.5 69.59 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 CA-C-N 121.083 2.442 . . . . 0.0 114.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -122.99 13.25 9.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 109.701 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.84 -28.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.278 2.631 . . . . 0.0 112.649 -169.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -160.37 88.24 0.79 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.371 1.469 . . . . 0.0 107.674 -168.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.36 -43.21 82.02 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.64 154.08 68.18 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.56 -175.53 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.176 3.25 . . . . 0.0 113.186 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 33.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.799 1.64 . . . . 0.0 112.574 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -158.14 135.92 10.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.605 1.962 . . . . 0.0 106.801 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.48 -140.27 11.9 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.88 134.24 66.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -118.96 133.25 55.94 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -122.95 137.91 54.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.1 t -122.11 126.23 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -175.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.02 67.08 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -169.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -135.31 48.48 2.25 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.726 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.1 m -30.79 98.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.977 2.911 . . . . 0.0 115.652 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -57.35 -42.31 81.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.795 1.638 . . . . 0.0 111.92 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 48.44 176.33 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.247 3.019 . . . . 0.0 115.425 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.96 38.1 1.09 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.3 1.429 . . . . 0.0 114.702 -169.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.52 -34.26 0.12 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.068 1.347 . . . . 0.0 111.259 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.54 -156.2 17.1 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 118.378 0.535 . . . . 0.0 111.975 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -146.49 171.36 15.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.314 1.446 . . . . 0.0 107.749 169.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 91.9 mt -45.85 -52.54 24.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.69 1.596 . . . . 0.0 112.82 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.59 -43.6 1.89 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 CA-C-N 121.907 1.717 . . . . 0.0 111.527 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -174.42 -60.62 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.216 1.807 . . . . 0.0 107.691 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 168.02 -54.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 130.249 3.42 . . . . 0.0 104.282 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.46 146.12 52.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.431 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 1.5 m -122.3 -65.6 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 117.279 -1.344 . . . . 0.0 110.578 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HD2' ' H ' ' A' ' 67' ' ' SER . 58.8 Cg_endo -68.25 -41.37 7.07 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.862 1.701 . . . . 0.0 110.171 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -61.09 -48.5 81.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.453 1.101 . . . . 0.0 109.436 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -62.03 -49.55 75.56 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.298 0.499 . . . . 0.0 110.694 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.18 -43.79 98.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.591 0.632 . . . . 0.0 110.512 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -29.49 69.28 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.87 -57.45 11.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.559 1.072 . . . . 0.0 108.96 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -62.99 -26.01 68.65 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.1 -31.56 72.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.966 0.506 . . . . 0.0 111.424 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.99 -26.76 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.943 -1.027 . . . . 0.0 113.768 -175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 31.48 62.99 1.14 Allowed Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 126.291 1.837 . . . . 0.0 112.148 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.21 162.31 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.875 2.383 . . . . 0.0 113.466 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.74 67.43 4.47 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.0 111.131 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 15.17 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.607 1.563 . . . . 0.0 112.811 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.0 p -64.13 -5.37 4.7 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.147 -1.596 . . . . 0.0 112.426 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.58 10.55 14.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.282 1.833 . . . . 0.0 111.004 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.51 149.66 33.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.831 0.825 . . . . 0.0 111.131 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.1 ptm85 -100.57 151.26 21.8 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.55 110.25 0.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.46 136.61 44.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.0 mt -138.1 129.7 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.12 -25.59 2.63 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.837 0.732 . . . . 0.0 111.962 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.3 mm -48.57 134.78 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 127.5 2.32 . . . . 0.0 106.752 168.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.72 -21.87 4.51 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.957 0.789 . . . . 0.0 111.993 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -48.39 -29.1 3.67 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 128.46 2.704 . . . . 0.0 114.331 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.58 -45.11 73.5 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.547 0.739 . . . . 0.0 111.672 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 178.12 -46.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.305 1.442 . . . . 0.0 110.768 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -56.78 -30.15 63.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -148.74 50.39 0.99 Allowed 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.1 t -76.47 176.94 7.79 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.944 0.878 . . . . 0.0 110.782 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -132.18 76.57 1.71 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.466 -2.049 . . . . 0.0 105.466 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.4 m 50.42 27.81 2.98 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.204 1.802 . . . . 0.0 113.855 -175.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.22 -1.04 28.46 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.97 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.12 -1.52 7.94 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.629 1.715 . . . . 0.0 113.086 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.7 pt -126.27 9.25 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.885 2.074 . . . . 0.0 110.862 -172.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.83 -9.4 14.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.594 1.158 . . . . 0.0 112.206 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -53.21 -44.59 68.12 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 126.493 1.917 . . . . 0.0 112.056 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.53 -57.39 12.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.749 0.704 . . . . 0.0 110.43 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.9 -39.14 93.49 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.31 74.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.053 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.61 -36.46 83.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.271 0.941 . . . . 0.0 111.183 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.7 mt -65.23 -45.0 86.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.06 0.845 . . . . 0.0 110.738 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -68.57 -36.03 78.18 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 123.796 0.838 . . . . 0.0 110.021 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -37.81 87.33 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.193 1.397 . . . . 0.0 111.058 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -39.85 83.82 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.23 -17.54 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.195 169.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.19 137.12 53.0 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.656 1.728 . . . . 0.0 109.777 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.35 110.19 17.29 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -65.74 111.99 3.48 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.7 m -88.4 152.51 21.86 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.66 -124.27 35.52 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.06 157.59 43.29 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 62.4 m -46.17 127.78 8.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.31 1.844 . . . . 0.0 112.541 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.09 160.88 19.88 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.242 1.417 . . . . 0.0 108.512 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -134.59 146.85 49.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.02 170.15 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 126.824 2.05 . . . . 0.0 109.116 -172.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -135.55 170.1 16.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.506 1.923 . . . . 0.0 106.504 169.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.5 tt -108.32 4.89 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.522 0.729 . . . . 0.0 110.66 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.7 mt 70.39 -42.01 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 129.441 3.097 . . . . 0.0 112.132 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.04 -24.36 65.99 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.968 0.907 . . . . 0.0 110.667 169.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -154.66 172.16 18.34 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.0 1.72 . . . . 0.0 108.478 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -140.81 153.12 45.67 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.908 2.083 . . . . 0.0 108.204 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 mm -130.07 -70.17 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 116.706 -1.616 . . . . 0.0 109.831 -171.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.16 -56.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 CA-C-N 122.379 1.885 . . . . 0.0 111.449 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -174.39 -176.44 1.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.708 2.803 . . . . 0.0 106.499 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.85 117.95 56.26 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.118 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.14 174.98 11.93 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.779 2.986 . . . . 0.0 112.082 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.93 139.73 29.3 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.369 1.068 . . . . 0.0 108.766 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.29 -16.1 63.76 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.081 0.953 . . . . 0.0 112.172 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.9 -30.19 65.69 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.868 0.867 . . . . 0.0 111.487 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -42.94 97.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.035 0.834 . . . . 0.0 111.23 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -51.94 66.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.803 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.26 -43.24 95.61 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.816 0.722 . . . . 0.0 112.422 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.9 m -59.57 -60.64 3.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.068 1.347 . . . . 0.0 109.996 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.4 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 49.2 t90 -57.37 -43.87 83.91 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.207 0.603 . . . . 0.0 112.097 -177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.6 t -61.49 -52.89 55.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 C-N-CA 123.201 0.6 . . . . 0.0 109.955 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -16.15 63.02 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.628 1.104 . . . . 0.0 112.129 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.08 -44.85 21.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.482 0.713 . . . . 0.0 111.252 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.35 73.67 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.965 0.802 . . . . 0.0 111.462 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 53.7 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.317 1.447 . . . . 0.0 109.72 174.436 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.85 164.08 37.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.342 1.057 . . . . 0.0 110.079 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.43 -24.36 18.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.445 1.498 . . . . 0.0 110.924 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.41 124.23 44.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.666 1.186 . . . . 0.0 108.3 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -85.74 132.91 34.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.68 92.01 3.88 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -77.81 111.56 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -127.83 -162.7 1.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.258 1.823 . . . . 0.0 107.168 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 28.89 58.59 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.785 -1.197 . . . . 0.0 112.266 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -32.92 -48.97 0.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.975 2.91 . . . . 0.0 115.136 -170.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -125.83 51.72 1.73 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 108.05 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.3 tp 58.69 31.27 20.97 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.976 1.71 . . . . 0.0 110.188 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.81 154.54 8.21 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 128.027 2.727 . . . . 0.0 107.586 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.08 -160.03 22.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.049 0.924 . . . . 0.0 110.914 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.14 41.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.612 1.565 . . . . 0.0 112.541 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.9 -32.16 65.62 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.17 -0.956 . . . . 0.0 112.542 -172.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.93 -42.54 98.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.845 0.748 . . . . 0.0 110.833 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 t -72.75 -39.58 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.16 -39.88 83.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.24 0.473 . . . . 0.0 110.875 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.56 -40.49 92.87 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.893 0.77 . . . . 0.0 110.94 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -64.15 -44.73 91.23 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 110.295 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.92 -50.03 75.59 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.635 1.174 . . . . 0.0 110.498 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.58 -47.8 63.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.274 1.03 . . . . 0.0 110.807 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.31 -52.75 64.08 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.558 0.743 . . . . 0.0 110.595 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm -56.16 -39.0 71.66 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.886 0.474 . . . . 0.0 112.029 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.7 mt -73.49 -26.39 60.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.429 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.05 -38.73 72.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 120.566 1.53 . . . . 0.0 109.55 169.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -62.32 -26.19 68.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 111.409 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.65 55.1 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.549 174.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.21 23.93 6.76 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.163 0.892 . . . . 0.0 113.334 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.73 -169.44 2.05 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.404 1.082 . . . . 0.0 109.277 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 p -128.35 149.14 50.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.0 p -141.63 154.86 45.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.89 0.376 . . . . 0.0 111.223 -169.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.82 94.95 4.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.196 0.999 . . . . 0.0 108.413 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -68.65 120.87 15.34 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.8 mt -145.63 143.56 29.92 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 122.551 0.341 . . . . 0.0 111.158 -170.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -88.28 33.25 0.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 169.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.91 55.85 7.1 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.577 2.036 . . . . 0.0 114.38 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.84 -20.46 68.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.032 2.488 . . . . 0.0 113.695 -174.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.0 mt -123.56 17.99 9.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.07 1.748 . . . . 0.0 109.066 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.9 tp 64.48 -30.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.399 2.68 . . . . 0.0 113.79 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -165.4 87.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.412 1.885 . . . . 0.0 106.539 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.18 -41.52 97.08 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.9 -0.5 . . . . 0.0 110.446 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt -89.11 150.04 44.34 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.25 -175.83 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.162 3.241 . . . . 0.0 113.116 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.58 33.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 112.43 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -158.68 134.55 8.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.86 2.064 . . . . 0.0 106.351 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.15 -142.86 13.86 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.41 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -123.39 151.79 42.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.8 mt -137.74 142.67 40.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.47 126.99 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.37 108.21 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -145.76 -166.89 2.56 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.828 0.851 . . . . 0.0 109.281 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 p -156.28 66.06 0.57 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 122.2 1.0 . . . . 0.0 112.194 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p -62.98 -36.78 84.65 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.307 0.643 . . . . 0.0 111.763 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -65.86 -43.9 87.02 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.306 0.642 . . . . 0.0 111.759 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.03 -33.65 26.07 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.579 -0.567 . . . . 0.0 113.531 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.14 33.84 0.82 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.345 1.058 . . . . 0.0 111.047 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -50.22 147.38 7.62 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -146.3 170.09 17.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 117.303 0.551 . . . . 0.0 110.925 -169.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.9 mm -50.59 -49.73 76.66 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.911 1.684 . . . . 0.0 112.732 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.31 -55.89 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 122.049 1.768 . . . . 0.0 110.339 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -168.74 -51.21 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.835 1.254 . . . . 0.0 109.195 169.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -171.43 -55.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.372 1.469 . . . . 0.0 109.012 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.549 HD12 ' H ' ' A' ' 66' ' ' LEU . 3.3 mp -70.5 137.01 49.86 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 170.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.74 -62.87 0.21 Allowed Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.142 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.35 -39.83 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 121.733 1.622 . . . . 0.0 111.745 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -63.48 -46.1 87.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 122.86 0.464 . . . . 0.0 110.537 -171.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -60.81 -48.54 81.32 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.927 0.331 . . . . 0.0 110.207 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -62.34 -45.79 91.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.137 0.426 . . . . 0.0 110.259 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.07 79.31 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.378 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.89 -55.65 31.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.241 0.928 . . . . 0.0 108.937 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.32 -27.67 68.66 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.21 -31.25 69.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.707 0.403 . . . . 0.0 111.648 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -122.4 -25.26 4.83 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 29.54 63.41 0.82 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 126.996 2.118 . . . . 0.0 112.307 -173.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.67 164.45 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.898 2.399 . . . . 0.0 113.063 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -77.57 64.91 2.98 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.266 1.426 . . . . 0.0 111.239 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.46 9.03 1.15 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.037 1.335 . . . . 0.0 112.601 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -61.45 -6.39 2.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.213 2.605 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.62 10.38 18.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.99 1.716 . . . . 0.0 111.03 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.14 153.62 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.783 0.719 . . . . 0.0 111.292 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -103.56 150.41 23.97 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 169.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -122.58 159.01 28.68 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.96 140.37 11.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 169.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.46 141.65 43.28 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mt -139.09 138.85 40.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -169.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.53 -30.43 2.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.721 1.153 . . . . 0.0 111.766 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 mt -50.64 127.34 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.867 2.067 . . . . 0.0 106.974 169.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.55 -13.77 40.09 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.603 0.621 . . . . 0.0 112.877 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 m -48.82 -27.37 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 128.636 2.774 . . . . 0.0 116.602 -169.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -72.89 -20.71 61.04 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.992 0.814 . . . . 0.0 112.004 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -140.98 -23.23 0.77 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -128.53 155.23 45.19 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.908 1.283 . . . . 0.0 111.609 -169.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.61 35.62 8.97 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.079 2.152 . . . . 0.0 114.139 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.0 p -119.97 18.79 12.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.557 1.543 . . . . 0.0 110.561 173.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -71.07 -25.95 62.85 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.532 1.133 . . . . 0.0 111.929 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 12.6 p -148.48 23.73 1.01 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.121 1.368 . . . . 0.0 111.572 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.27 -172.69 42.95 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.6 143.7 41.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.389 1.076 . . . . 0.0 109.183 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.7 pt -144.75 24.2 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.995 1.718 . . . . 0.0 109.798 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -106.4 9.85 31.67 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.835 1.254 . . . . 0.0 111.757 -171.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -65.94 -29.39 69.78 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.516 -169.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.9 tm? -53.84 -57.31 11.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.331 0.968 . . . . 0.0 109.622 172.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.51 -40.63 97.56 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -48.59 81.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.859 0.464 . . . . 0.0 110.202 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.78 -31.86 72.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.687 -1.149 . . . . 0.0 111.739 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.9 mt -66.68 -44.27 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.101 1.318 . . . . 0.0 110.78 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -63.15 -40.47 97.67 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.656 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -36.81 83.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.157 1.383 . . . . 0.0 111.303 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.9 m -70.86 -39.79 72.7 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.84 -20.45 0.68 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.101 -1.388 . . . . 0.0 114.881 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 136.65 54.89 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.568 1.684 . . . . 0.0 108.834 -172.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -79.25 126.97 31.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -74.51 112.73 10.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.5 m -85.46 154.94 21.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.29 -125.38 37.49 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.455 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.6 pt-20 -154.41 169.0 24.79 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.269 1.428 . . . . 0.0 107.592 169.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.9 m -51.98 129.92 28.31 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.07 146.15 23.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.505 1.922 . . . . 0.0 107.405 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -121.56 145.88 47.52 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.7 154.82 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.303 1.441 . . . . 0.0 107.782 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.03 176.45 9.33 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.603 -0.685 . . . . 0.0 111.576 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.4 pt -129.24 -22.88 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.054 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.3 tt -158.27 -66.73 0.09 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.939 1.245 . . . . 0.0 108.753 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -148.16 -13.58 0.36 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.25 1.02 . . . . 0.0 112.338 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -148.95 156.14 41.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -159.57 -63.95 0.07 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 mm -133.87 -62.11 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 111.318 -2.674 . . . . 0.0 105.607 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -90.54 -137.46 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.882 0 N-CA-C 105.906 -2.382 . . . . 0.0 105.906 168.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.33 -1.8 0.91 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -152.43 122.1 3.41 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 118.228 -0.892 . . . . 0.0 108.846 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.58 152.39 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.234 1.956 . . . . 0.0 110.167 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -138.71 39.62 2.19 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.517 1.127 . . . . 0.0 109.852 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -52.41 -28.58 20.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.58 1.552 . . . . 0.0 113.235 -173.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.21 -28.63 42.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.382 1.073 . . . . 0.0 112.331 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.455 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -55.95 -41.76 75.18 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.487 0.715 . . . . 0.0 110.849 173.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 tp -61.63 -50.11 73.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.69 72.42 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.99 0.806 . . . . 0.0 111.822 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 m -60.01 -57.05 14.54 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -53.11 -44.67 67.82 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.505 1.522 . . . . 0.0 111.691 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -56.5 -58.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 110.077 173.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -16.73 63.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.307 0.958 . . . . 0.0 112.176 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.03 -50.32 15.12 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.099 0.959 . . . . 0.0 110.432 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.35 -27.21 59.11 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.494 1.118 . . . . 0.0 109.634 171.102 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 tpp . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.29 148.23 32.2 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.221 1.008 . . . . 0.0 108.365 170.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.64 -22.97 15.2 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.607 1.563 . . . . 0.0 110.438 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.35 130.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 109.214 -172.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 t -86.2 130.25 34.58 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 169.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.9 94.21 4.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -87.2 98.15 7.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 51.93 2.3 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.82 8.55 59.43 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 117.306 -1.83 . . . . 0.0 115.098 -169.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.0 -42.71 2.92 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.032 1.733 . . . . 0.0 113.983 -169.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 t -149.17 53.09 0.96 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 169.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tp 56.33 38.99 30.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.468 1.507 . . . . 0.0 110.699 -169.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.43 154.38 7.43 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.202 2.81 . . . . 0.0 107.073 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.95 -151.16 6.9 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.928 0.864 . . . . 0.0 110.951 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 65.76 1.21 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.323 1.449 . . . . 0.0 111.0 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -53.74 -37.37 63.3 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.64 0.776 . . . . 0.0 112.63 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -59.81 -45.13 93.3 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.441 0.564 . . . . 0.0 110.255 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -32.69 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.61 97.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.658 0.663 . . . . 0.0 110.853 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.42 -39.55 89.02 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.994 0.518 . . . . 0.0 110.681 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -62.86 -46.51 87.55 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.469 -0.77 . . . . 0.0 110.501 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.8 mt -55.77 -52.68 63.12 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.486 1.114 . . . . 0.0 109.92 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.82 -52.09 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.165 0.986 . . . . 0.0 110.532 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -55.34 -54.26 45.84 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.358 0.663 . . . . 0.0 110.775 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -59.88 -38.87 83.45 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -68.96 -32.7 72.48 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.157 0.583 . . . . 0.0 111.691 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.58 -37.35 71.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.757 1.162 . . . . 0.0 110.152 173.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -63.6 -29.77 70.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 111.217 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.77 -21.74 62.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.562 0.745 . . . . 0.0 111.259 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.02 -5.01 5.37 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.062 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.52 -167.07 1.55 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.686 1.743 . . . . 0.0 109.602 -174.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 p -130.19 151.09 51.09 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.9 p -143.74 160.28 41.0 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -170.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 106.31 8.93 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -71.94 121.09 18.48 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 mt -139.11 157.98 44.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.401 0.68 . . . . 0.0 110.71 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -95.23 21.88 7.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.421 1.088 . . . . 0.0 110.766 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.11 42.89 73.01 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 117.912 -1.493 . . . . 0.0 113.139 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.12 -22.29 61.83 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.201 2.601 . . . . 0.0 114.825 -169.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -115.24 13.53 16.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.523 1.529 . . . . 0.0 109.666 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 tp 65.57 -25.69 0.1 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.016 2.527 . . . . 0.0 112.916 -169.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -169.13 85.81 0.15 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.034 1.734 . . . . 0.0 107.331 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.44 -42.9 98.66 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.594 -0.691 . . . . 0.0 110.249 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -90.81 149.32 40.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.38 -179.33 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.919 3.079 . . . . 0.0 113.449 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.83 30.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.671 1.988 . . . . 0.0 113.102 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.7 p -161.72 107.83 1.33 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.367 1.867 . . . . 0.0 106.393 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.38 -147.48 16.75 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mm -127.53 131.72 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -119.69 152.75 36.64 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.3 mt -143.59 141.16 30.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.16 136.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.66 123.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -162.43 -172.86 3.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 108.158 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.98 69.77 1.03 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.535 -1.353 . . . . 0.0 108.088 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 p -50.97 -27.04 6.81 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.591 1.957 . . . . 0.0 115.657 -169.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -127.3 25.44 6.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.879 0.872 . . . . 0.0 111.525 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.58 -30.92 0.28 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.146 0.879 . . . . 0.0 112.307 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.79 34.37 2.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.736 1.615 . . . . 0.0 108.913 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.33 -175.69 40.46 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.38 0.99 . . . . 0.0 112.817 -174.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -145.47 153.36 41.07 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.6 pt -53.31 -35.61 28.75 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.72 -31.01 8.95 Favored 'Trans proline' 0 C--N 1.356 0.953 0 CA-C-N 123.894 2.426 . . . . 0.0 111.768 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -176.06 -57.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.391 1.876 . . . . 0.0 107.579 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.3 t30 136.48 -55.77 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 130.389 3.476 . . . . 0.0 107.335 -175.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.42 84.43 0.27 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 126.629 1.972 . . . . 0.0 106.701 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -54.4 25.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 124.54 1.136 . . . . 0.0 111.091 -168.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.18 -41.85 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.118 1.879 . . . . 0.0 110.776 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -65.62 -50.96 63.11 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.209 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.95 -44.9 95.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.954 0.797 . . . . 0.0 110.023 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.44 -47.16 80.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.254 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.03 -35.91 74.09 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.204 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -59.59 5.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.603 1.092 . . . . 0.0 109.266 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -16.82 63.73 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.25 -32.55 70.43 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.415 0.552 . . . . 0.0 111.259 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -124.23 -29.35 3.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt 28.98 66.64 0.68 Allowed Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 126.482 1.913 . . . . 0.0 113.251 -171.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.08 173.28 2.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.558 2.172 . . . . 0.0 111.381 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -84.98 124.45 31.71 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 112' ' ' SER . 3.1 mm? -122.35 14.59 10.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.069 1.348 . . . . 0.0 110.657 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -69.07 -3.88 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 119.82 -1.8 . . . . 0.0 112.81 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.25 4.59 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.034 1.334 . . . . 0.0 110.789 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.78 157.36 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.886 0.874 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -113.38 149.43 34.09 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -128.01 164.82 21.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.546 0.689 . . . . 0.0 109.507 174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.1 153.73 21.96 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.62 136.66 53.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.24 135.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -169.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.82 -27.35 1.64 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.081 1.324 . . . . 0.0 112.709 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 mt -48.35 130.04 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.048 2.139 . . . . 0.0 109.273 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -95.03 7.26 69.69 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.027 1.299 . . . . 0.0 111.759 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m -82.15 6.42 16.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.602 1.561 . . . . 0.0 113.161 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -51.73 -46.05 63.85 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.953 1.301 . . . . 0.0 114.138 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -140.94 -79.92 0.26 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.338 0.655 . . . . 0.0 110.778 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -141.69 11.72 2.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.247 1.019 . . . . 0.0 112.786 -169.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -79.18 37.84 0.33 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.135 0.974 . . . . 0.0 110.645 175.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.2 p -69.15 160.08 31.75 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.984 1.714 . . . . 0.0 112.309 -171.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -154.55 -174.79 5.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.157 2.183 . . . . 0.0 106.401 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 61.9 m -66.22 79.32 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.645 1.178 . . . . 0.0 109.265 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -161.05 -150.1 5.8 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.244 1.402 . . . . 0.0 110.329 -171.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.63 -30.65 71.73 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -169.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . 0.267 47.1 pt 42.0 48.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.375 1.47 . . . . 0.0 112.332 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.7 t70 81.2 -16.82 0.61 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.337 2.655 . . . . 0.0 113.904 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.25 -35.24 76.72 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.993 -1.067 . . . . 0.0 113.039 -171.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.22 -54.74 40.42 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.253 0.933 . . . . 0.0 109.894 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -40.12 95.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.9 88.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.334 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.28 -34.32 77.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.222 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.14 -43.87 85.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.724 1.147 . . . . 0.0 110.5 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -65.03 -37.43 87.57 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 109.911 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -35.12 79.09 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.562 . . . . 0.0 111.282 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.587 ' HB3' HD23 ' A' ' 80' ' ' LEU . 17.9 m -72.4 -27.29 62.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.562 0.345 . . . . 0.0 110.229 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.28 -23.46 2.86 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.541 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 135.57 54.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.2 1.5 . . . . 0.0 108.554 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -80.78 132.62 35.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -77.87 100.0 6.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 m -73.91 153.21 39.92 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.04 -122.06 24.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.8 pt-20 -157.47 174.78 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.981 1.712 . . . . 0.0 107.831 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -54.34 127.84 28.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.809 0.844 . . . . 0.0 109.537 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 tt -99.24 155.27 17.58 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.641 1.576 . . . . 0.0 108.834 -171.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.65 147.85 44.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.65 167.46 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.318 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.84 143.48 24.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 169.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.8 pt -76.73 -171.04 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.815 0.846 . . . . 0.0 110.464 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.25 1.07 0.53 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.62 1.568 . . . . 0.0 114.915 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -147.81 160.23 42.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.219 2.208 . . . . 0.0 106.523 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -56.59 138.67 51.84 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.78 0.832 . . . . 0.0 111.281 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -152.76 167.97 27.24 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.207 1.403 . . . . 0.0 110.074 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.28 49.6 mm -5.98 -77.2 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 130.529 3.532 . . . . 0.0 116.877 -169.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.28 -30.4 8.54 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.489 2.126 . . . . 0.0 111.971 -172.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 62.88 40.59 9.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.045 2.138 . . . . 0.0 109.991 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -147.66 101.14 3.72 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.726 1.211 . . . . 0.0 109.33 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.03 -15.55 34.15 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.845 3.03 . . . . 0.0 115.522 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 36.73 50.18 0.81 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.793 2.437 . . . . 0.0 114.603 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.79 -28.59 64.15 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.472 -0.768 . . . . 0.0 111.182 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.18 -36.91 82.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.634 0.774 . . . . 0.0 111.327 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.527 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.88 -44.88 91.7 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.135 0.879 . . . . 0.0 109.214 174.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.24 -51.63 68.16 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.11 -42.12 98.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.403 0.525 . . . . 0.0 112.111 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 m -58.54 -61.58 2.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 0.0 109.821 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -55.2 -46.06 75.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.7 0.8 . . . . 0.0 112.277 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.03 -54.62 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.556 0.742 . . . . 0.0 109.387 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -16.8 61.94 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.004 0.82 . . . . 0.0 112.471 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 mp -80.74 -44.18 19.06 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.329 0.652 . . . . 0.0 111.034 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -37.05 75.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.923 0.783 . . . . 0.0 110.976 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.7 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.938 1.295 . . . . 0.0 109.93 174.198 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.18 170.07 22.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.934 1.294 . . . . 0.0 109.29 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.64 -23.32 17.66 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.591 1.157 . . . . 0.0 110.895 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.92 127.74 55.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 108.946 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -92.33 129.3 38.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.99 98.63 8.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.83 89.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -92.12 49.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.598 2.359 . . . . 0.0 111.079 -168.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.85 174.26 46.7 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 121.45 -0.781 . . . . 0.0 112.558 175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.8 p -129.34 -48.21 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.621 1.168 . . . . 0.0 110.299 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 p -86.44 -72.21 0.51 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.4 tp -157.14 23.36 0.31 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 110.379 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.94 169.29 42.19 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.37 46.5 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.047 1.784 . . . . 0.0 108.809 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 102.61 0.45 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.303 1.041 . . . . 0.0 111.533 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.97 -38.64 89.3 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.515 0.726 . . . . 0.0 110.637 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.35 -42.59 91.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.283 0.633 . . . . 0.0 110.705 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.14 -49.33 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.96 93.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.104 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.91 -41.35 91.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.008 0.523 . . . . 0.0 110.819 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -61.99 -47.77 83.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.65 0.659 . . . . 0.0 110.066 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.42 -53.43 57.54 Favored 'General case' 0 N--CA 1.46 0.039 0 C-N-CA 124.057 0.943 . . . . 0.0 110.173 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.35 59.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.256 1.022 . . . . 0.0 110.712 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.17 -54.51 46.12 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -58.3 -37.3 74.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -70.81 -28.07 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.859 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.71 -39.65 73.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.632 1.56 . . . . 0.0 109.804 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.57 -28.17 69.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.463 0.705 . . . . 0.0 111.332 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.34 -10.82 60.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 112.348 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 16.92 8.7 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.912 -0.938 . . . . 0.0 113.424 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -117.73 -167.9 1.41 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.485 1.142 . . . . 0.0 108.84 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -130.82 150.29 52.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 p -140.84 156.99 46.01 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.911 -0.493 . . . . 0.0 110.446 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -133.15 105.47 7.05 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.09 122.79 21.55 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.386 1.074 . . . . 0.0 108.533 175.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -149.75 138.59 21.0 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 122.79 0.436 . . . . 0.0 111.014 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -85.48 43.86 1.06 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.667 -1.27 . . . . 0.0 108.393 168.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.31 56.21 1.2 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 127.358 2.408 . . . . 0.0 115.757 -169.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.62 -24.78 46.97 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.343 2.572 . . . . 0.0 115.367 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.4 mt -118.45 15.58 13.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.977 1.711 . . . . 0.0 109.363 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp 66.06 -30.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.506 2.722 . . . . 0.0 113.106 -169.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -168.13 94.45 0.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.334 1.854 . . . . 0.0 106.342 -169.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.29 -44.35 83.73 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.95 153.02 69.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.812 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.65 -171.51 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.443 3.428 . . . . 0.0 112.231 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.35 27.61 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.852 1.661 . . . . 0.0 113.42 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -156.49 138.0 14.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.99 2.116 . . . . 0.0 106.81 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.41 -140.4 11.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mm -128.46 133.83 65.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.524 ' CD1' HG21 ' A' ' 83' ' ' VAL . 8.3 m0 -117.71 135.31 54.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.9 mt -128.95 142.37 50.96 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.93 133.08 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.29 104.58 6.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 123.791 0.836 . . . . 0.0 108.856 -169.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -171.56 131.1 0.71 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.574 1.949 . . . . 0.0 107.409 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.7 m -72.36 102.41 3.14 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 119.113 0.869 . . . . 0.0 108.686 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p -56.25 -16.77 5.92 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 115.349 -169.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -116.42 -54.14 2.48 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.714 1.143 . . . . 0.0 110.235 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.87 61.11 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.059 0.838 . . . . 0.0 114.417 -174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.53 39.01 2.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.7 2.0 . . . . 0.0 108.357 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.29 -141.97 3.28 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.654 1.121 . . . . 0.0 110.868 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 t70 44.22 -53.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 1 C-N-CA 132.231 4.212 . . . . 0.0 117.962 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.7 mm -51.57 -49.95 79.78 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 120.16 1.346 . . . . 0.0 112.601 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.94 43.06 1.4 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.292 2.662 . . . . 0.0 110.969 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.5 t0 52.42 32.03 10.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.93 1.692 . . . . 0.0 110.686 -168.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.97 -51.38 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 129.673 3.189 . . . . 0.0 113.777 -169.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.34 147.74 51.85 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.286 1.434 . . . . 0.0 107.263 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 -61.28 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.527 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -87.91 -40.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.449 2.1 . . . . 0.0 112.418 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -59.58 -52.65 64.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -62.99 -43.92 97.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.923 0.329 . . . . 0.0 110.458 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -63.54 -46.91 83.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.068 0.394 . . . . 0.0 109.969 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.75 71.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.522 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.3 -58.0 10.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.374 0.988 . . . . 0.0 109.079 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -62.64 -26.41 68.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.95 -30.77 71.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.072 0.549 . . . . 0.0 111.658 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -124.91 -23.8 4.2 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 30.78 66.4 0.87 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.65 1.98 . . . . 0.0 112.056 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -57.89 160.5 15.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.404 2.736 . . . . 0.0 113.123 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -79.9 61.12 3.71 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 122.37 1.081 . . . . 0.0 110.779 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.2 mt -71.63 10.47 0.65 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.772 1.629 . . . . 0.0 112.792 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -62.46 -7.42 4.51 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 129.665 3.186 . . . . 0.0 113.042 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.83 11.31 17.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.577 1.551 . . . . 0.0 110.791 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -130.28 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.966 0.889 . . . . 0.0 111.154 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -95.01 151.02 19.53 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.88 145.47 45.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.47 115.23 1.33 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 140.0 47.33 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.6 mt -137.32 128.34 40.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.99 -10.92 2.15 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.314 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mt -48.52 129.93 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.791 2.036 . . . . 0.0 109.465 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.67 -20.35 66.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.243 0.925 . . . . 0.0 112.163 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -56.08 -6.17 0.23 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.953 2.501 . . . . 0.0 114.95 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -63.2 -15.64 57.6 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.65 168.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 101.87 -23.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 131.176 3.791 . . . . 0.0 110.109 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -64.21 -14.75 57.44 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.611 1.565 . . . . 0.0 112.871 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.06 86.51 1.98 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.387 1.075 . . . . 0.0 108.849 171.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.5 t -159.76 168.5 25.76 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.498 1.119 . . . . 0.0 108.092 169.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -146.02 11.58 1.21 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.033 1.733 . . . . 0.0 109.342 169.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.1 m -135.59 26.19 3.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.514 1.126 . . . . 0.0 112.084 -169.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.27 -173.33 35.77 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.73 -27.34 67.85 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.2 pt 43.74 33.98 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.629 1.971 . . . . 0.0 113.59 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -83.7 2.29 38.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.62 1.168 . . . . 0.0 113.071 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -54.85 -37.8 66.67 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.185 0.994 . . . . 0.0 112.785 -171.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.56 -54.18 46.48 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.71 -41.81 95.97 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.84 76.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -67.78 -30.88 70.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.168 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.84 -44.07 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.755 1.161 . . . . 0.0 110.769 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.06 -35.06 73.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.432 0.693 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -32.21 71.4 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 125.954 1.702 . . . . 0.0 111.902 174.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.8 m -64.76 -48.35 74.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.6 -15.74 0.38 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.059 -1.412 . . . . 0.0 115.393 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.05 138.46 58.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.588 1.694 . . . . 0.0 110.61 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -84.03 111.53 19.37 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.64 111.76 2.89 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 42.5 m -84.17 152.51 24.23 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.96 -121.31 26.24 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.562 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 3.0 pt-20 -150.3 -176.35 5.44 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.909 2.083 . . . . 0.0 106.049 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -41.36 111.46 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.622 1.569 . . . . 0.0 111.376 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 161.54 28.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -133.79 149.37 51.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -170.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.44 155.92 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.74 52.05 0.28 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -172.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.9 tt -132.31 147.91 32.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 123.954 0.902 . . . . 0.0 109.806 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.2 tp 60.65 -62.72 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.304 3.042 . . . . 0.0 113.615 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -153.98 -5.65 0.17 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.713 1.605 . . . . 0.0 111.668 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -87.98 45.66 1.3 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.201 1.4 . . . . 0.0 110.535 -169.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -70.84 -16.97 62.75 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.296 1.438 . . . . 0.0 113.143 -172.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.0 mt -15.63 -65.85 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 128.975 2.91 . . . . 0.0 114.276 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.65 -82.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.959 1.735 . . . . 0.0 113.065 -174.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -174.63 155.24 2.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.947 1.699 . . . . 0.0 108.88 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.94 -35.73 37.23 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -173.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -59.84 23.47 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.153 1 C-N-CA 125.928 4.418 . . . . 0.0 119.434 -173.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.75 -49.43 38.45 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.517 1.527 . . . . 0.0 112.732 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.75 -36.93 81.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.887 0.475 . . . . 0.0 110.787 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -65.44 -41.06 93.88 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.935 0.494 . . . . 0.0 109.738 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.562 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.63 -42.24 98.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.292 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 tp -57.99 -53.32 59.59 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.77 -42.68 98.13 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 m -59.0 -62.19 2.07 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 125.146 1.378 . . . . 0.0 110.149 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -57.15 -44.36 83.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.75 0.82 . . . . 0.0 112.016 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.48 -53.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.439 0.696 . . . . 0.0 109.475 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.23 -17.42 62.5 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.31 0.959 . . . . 0.0 112.407 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -79.18 -42.87 25.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.564 0.62 . . . . 0.0 111.227 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -37.56 75.12 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.947 0.794 . . . . 0.0 111.079 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.9 mttm . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.39 1.476 . . . . 0.0 109.937 174.068 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.24 159.59 44.13 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.509 1.124 . . . . 0.0 108.853 173.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -111.85 -23.13 10.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.444 1.898 . . . . 0.0 110.872 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.03 122.85 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -85.06 128.58 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.34 95.33 6.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -82.74 83.21 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -83.72 31.97 0.47 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 128.804 2.841 . . . . 0.0 112.682 -168.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.42 155.62 26.61 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 121.599 -0.688 . . . . 0.0 112.173 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.33 -37.8 1.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 110.387 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.5 p -130.6 49.56 2.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.8 tp 52.22 42.41 30.75 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.126 1.771 . . . . 0.0 111.101 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.18 159.18 16.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 128.042 2.734 . . . . 0.0 106.798 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.36 -160.4 32.52 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.357 1.078 . . . . 0.0 111.301 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.43 46.26 0.33 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.475 1.91 . . . . 0.0 113.525 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -53.52 -35.22 60.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.192 0.997 . . . . 0.0 112.828 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.01 -45.75 93.56 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.772 . . . . 0.0 110.736 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.05 -40.9 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.534 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.11 -41.52 94.83 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.177 0.899 . . . . 0.0 110.984 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -64.8 -45.5 85.99 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.745 -0.597 . . . . 0.0 109.904 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.24 -51.24 68.82 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.225 1.01 . . . . 0.0 110.271 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.36 -49.83 60.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 110.897 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.16 -53.48 57.8 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.193 0.997 . . . . 0.0 110.244 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.71 -37.95 77.23 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mp -69.71 -26.51 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.86 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -70.04 -43.82 70.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.854 1.661 . . . . 0.0 109.316 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.0 -26.33 67.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.48 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.34 -16.26 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.713 0.805 . . . . 0.0 112.219 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.07 15.66 2.05 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.523 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -131.66 -165.25 1.55 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.304 1.552 . . . . 0.0 110.041 -169.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 p -131.18 151.68 51.22 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.9 p -144.11 159.78 42.04 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.038 0.535 . . . . 0.0 109.796 -169.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.1 107.23 7.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 m -78.17 120.15 22.56 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -147.07 137.47 23.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.194 0.598 . . . . 0.0 110.057 -169.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -82.39 41.49 0.7 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.608 -1.307 . . . . 0.0 109.677 169.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 38.7 55.12 2.22 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.636 2.065 . . . . 0.0 115.022 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.39 -20.3 54.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.808 2.339 . . . . 0.0 113.499 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.4 mt -118.07 15.18 14.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.293 1.837 . . . . 0.0 109.068 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tp 63.84 -28.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.088 2.955 . . . . 0.0 113.97 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -164.98 93.45 0.62 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.408 1.483 . . . . 0.0 107.111 -168.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.08 -43.78 77.77 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.467 -0.771 . . . . 0.0 110.007 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.35 154.5 74.34 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 47' ' ' SER . 41.8 Cg_endo -66.52 -173.68 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.934 3.089 . . . . 0.0 112.554 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 29.94 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.178 1.391 . . . . 0.0 112.661 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 45' ' ' PRO . 18.0 m -152.33 136.91 16.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.967 2.507 . . . . 0.0 106.41 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.13 -141.59 12.74 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mm -123.76 139.83 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CD1' HG21 ' A' ' 83' ' ' VAL . 10.3 m0 -122.04 135.12 54.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.8 mt -128.79 140.7 51.59 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.58 134.43 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -137.68 113.78 11.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -170.93 -156.51 0.12 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.935 2.494 . . . . 0.0 105.668 174.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m -147.6 138.78 23.62 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 121.06 1.755 . . . . 0.0 109.305 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.0 p -138.1 -6.49 1.62 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -56.29 145.39 27.03 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.03 -157.62 16.43 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.88 -32.24 69.31 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.263 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.98 -140.87 30.39 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -144.18 166.98 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 169.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.0 mm -48.83 -46.12 73.1 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 117.407 -1.282 . . . . 0.0 112.984 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.02 -5.06 16.13 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.318 2.012 . . . . 0.0 114.837 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 t70 133.95 -54.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.978 1 C-N-CA 131.791 4.036 . . . . 0.0 106.809 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 165.58 -45.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.105 2.962 . . . . 0.0 107.001 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.448 HD12 ' H ' ' A' ' 66' ' ' LEU . 5.9 mp -65.34 146.16 55.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.721 1.208 . . . . 0.0 108.69 174.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.454 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 29.8 m -122.22 -63.67 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 117.248 -1.358 . . . . 0.0 111.172 176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 67' ' ' SER . 43.9 Cg_endo -66.75 -39.31 15.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.92 1.722 . . . . 0.0 110.993 -175.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -60.28 -50.35 73.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.35 0.66 . . . . 0.0 110.091 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.28 -48.97 78.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.67 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -60.94 -45.81 93.23 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.772 0.714 . . . . 0.0 110.462 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.4 72.61 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.43 -58.02 8.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 119.202 0.91 . . . . 0.0 109.233 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -63.6 -24.64 67.88 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.56 -33.69 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.022 0.529 . . . . 0.0 111.38 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -123.47 -23.76 4.73 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 29.91 66.53 0.78 Allowed Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 126.885 2.074 . . . . 0.0 112.086 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.75 163.88 17.58 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.037 2.492 . . . . 0.0 113.529 -169.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.99 59.86 2.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.285 1.834 . . . . 0.0 112.009 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 7.16 2.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.036 1.334 . . . . 0.0 113.163 -171.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -63.52 -4.06 2.57 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.259 -1.526 . . . . 0.0 112.614 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.9 6.56 25.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.3 1.44 . . . . 0.0 111.459 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.1 p -130.71 162.07 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.914 0.885 . . . . 0.0 109.966 175.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -118.0 152.74 34.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -119.92 151.56 38.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.922 1.689 . . . . 0.0 108.134 -169.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.39 150.85 23.16 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.9 138.95 53.82 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.7 mt -137.08 124.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -169.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.23 -30.27 1.39 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.801 1.191 . . . . 0.0 111.803 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.43 143.45 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.452 1.901 . . . . 0.0 108.005 169.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 15.54 0.11 Allowed Glycine 0 CA--C 1.523 0.563 0 CA-C-O 119.055 -0.858 . . . . 0.0 113.8 -174.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 p -60.61 -15.05 24.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.037 1.335 . . . . 0.0 112.878 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -62.18 -27.06 68.7 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.826 -1.171 . . . . 0.0 112.668 169.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 66.73 -12.89 0.2 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.746 2.819 . . . . 0.0 114.559 169.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -52.65 -12.65 0.31 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.487 2.715 . . . . 0.0 113.747 175.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.98 -2.8 8.25 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.72 1.208 . . . . 0.0 113.739 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.4 t -152.26 -172.7 4.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 129.291 3.037 . . . . 0.0 107.602 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -75.12 -17.55 60.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.495 1.118 . . . . 0.0 113.009 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 65.3 m -63.11 153.59 33.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.272 1.029 . . . . 0.0 112.058 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.62 153.86 30.48 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 123.884 0.754 . . . . 0.0 111.72 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.81 153.12 42.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.852 0.861 . . . . 0.0 112.938 -171.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 pt -138.6 25.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 128.456 2.703 . . . . 0.0 108.808 169.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.38 31.16 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.063 2.945 . . . . 0.0 115.876 -169.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -55.51 -30.28 60.38 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.0 -1.063 . . . . 0.0 112.054 -173.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.21 -58.82 5.92 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.788 1.177 . . . . 0.0 109.842 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.57 -37.68 84.73 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -175.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.2 -51.75 67.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.009 0.923 . . . . 0.0 109.953 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.69 -35.22 80.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.428 1.013 . . . . 0.0 111.158 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.62 -50.1 72.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.174 0.897 . . . . 0.0 110.942 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.322 11.7 ptmt -71.78 -28.1 63.4 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.938 -0.476 . . . . 0.0 112.204 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -36.19 82.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.333 1.053 . . . . 0.0 111.009 169.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.6 m -68.52 -33.7 74.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.948 0.34 . . . . 0.0 110.561 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.69 -28.9 0.37 Allowed Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.668 169.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.47 141.2 57.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.654 1.227 . . . . 0.0 110.11 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -80.69 129.16 34.36 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -75.6 100.95 4.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 170.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 99.6 m -73.32 149.87 42.31 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.34 -124.43 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.474 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.0 pt-20 -152.1 166.05 32.84 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.337 1.055 . . . . 0.0 108.301 169.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.5 m -51.03 130.89 26.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.842 1.257 . . . . 0.0 111.222 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -92.64 160.47 14.99 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.928 2.091 . . . . 0.0 108.429 -176.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.414 ' H ' HD23 ' A' ' 121' ' ' LEU . 47.3 mtmt -131.36 144.05 50.95 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.17 162.72 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.747 2.419 . . . . 0.0 106.448 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -157.24 155.84 31.51 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.716 -0.615 . . . . 0.0 111.233 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.9 pt -141.61 168.83 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.721 2.008 . . . . 0.0 107.404 174.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.2 mt 56.56 -167.3 0.12 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.001 1.32 . . . . 0.0 110.594 -172.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.65 -38.38 90.79 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.547 -0.721 . . . . 0.0 111.368 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -164.97 174.33 10.62 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.106 1.762 . . . . 0.0 108.876 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.09 -71.66 0.15 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.41 ' H ' ' HD2' ' A' ' 131' ' ' PRO . 23.4 mt -139.37 -63.67 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.644 1.578 . . . . 0.0 110.22 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 130' ' ' ILE . 74.0 Cg_endo -74.29 -42.52 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 121.589 1.603 . . . . 0.0 111.337 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 58.56 23.6 11.03 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.502 1.521 . . . . 0.0 111.909 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -151.71 77.16 7.23 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.2 -0.938 . . . . 0.0 110.402 -172.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.48 148.34 20.37 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.158 2.572 . . . . 0.0 112.706 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.64 38.72 1.51 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.48 1.512 . . . . 0.0 109.513 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -59.77 -16.25 26.44 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.28 1.432 . . . . 0.0 113.785 -172.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -57.15 -27.79 62.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.594 0.757 . . . . 0.0 111.423 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.474 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.87 -48.47 78.05 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.335 0.654 . . . . 0.0 109.711 171.355 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.62 -49.14 77.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.074 0.95 . . . . 0.0 109.217 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.0 -52.51 46.3 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.932 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -63.24 -44.74 94.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.286 0.543 . . . . 0.0 110.524 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.39 -41.84 94.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.274 1.43 . . . . 0.0 110.804 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.77 -48.03 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.084 0.953 . . . . 0.0 109.547 172.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.35 -29.74 70.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.257 0.935 . . . . 0.0 111.612 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.21 -46.99 25.65 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.363 1.065 . . . . 0.0 110.505 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.01 -29.91 62.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.353 0.524 . . . . 0.0 112.054 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.3 mttt . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.374 1.07 . . . . 0.0 109.86 171.815 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.81 158.8 35.73 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.1 -22.25 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.1 1.76 . . . . 0.0 110.712 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.5 mt -134.81 128.94 51.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.547 1.139 . . . . 0.0 108.065 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -89.01 131.88 34.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 95.1 5.39 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.1 mt -89.94 110.39 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.35 143.67 44.06 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 122.813 0.445 . . . . 0.0 111.622 -169.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.5 168.29 12.22 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 124.598 1.094 . . . . 0.0 112.002 169.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 p -117.88 -8.8 10.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 0.0 112.516 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t -141.79 -54.44 0.45 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -149.4 17.12 0.93 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.485 1.039 . . . . 0.0 111.661 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.93 172.1 28.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 127.432 2.444 . . . . 0.0 107.68 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.71 10.07 4.12 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.015 -1.436 . . . . 0.0 115.053 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 2.86 1.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.077 1.938 . . . . 0.0 113.405 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.8 -31.55 62.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.486 1.114 . . . . 0.0 112.125 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -58.1 -53.5 57.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.458 0.703 . . . . 0.0 111.525 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.09 -30.54 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.03 77.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.001 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.35 -41.22 89.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.015 0.825 . . . . 0.0 111.083 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -63.07 -46.9 85.28 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.1 mt -57.12 -51.17 70.35 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.044 0.937 . . . . 0.0 110.461 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.72 -48.53 63.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.761 1.224 . . . . 0.0 110.685 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.71 -53.89 52.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.484 0.714 . . . . 0.0 110.345 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -57.92 -38.12 75.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.92 -33.13 75.02 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.254 0.621 . . . . 0.0 111.183 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -70.04 -38.21 75.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 119.921 1.237 . . . . 0.0 110.325 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.51 -28.96 70.3 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.165 0.893 . . . . 0.0 111.42 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.34 63.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.393 0.677 . . . . 0.0 111.597 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.26 -6.49 5.34 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.493 -1.171 . . . . 0.0 113.706 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.9 -165.44 1.34 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.341 1.57 . . . . 0.0 109.395 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.5 p -144.88 160.08 41.87 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.701 -0.624 . . . . 0.0 110.618 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.07 115.61 15.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 m -78.93 123.82 27.64 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 mt -140.5 156.79 46.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.112 0.565 . . . . 0.0 110.396 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -105.03 35.8 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.432 1.093 . . . . 0.0 108.77 169.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.57 48.05 28.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.727 1.632 . . . . 0.0 115.048 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.38 -20.57 61.47 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 121.046 2.423 . . . . 0.0 113.808 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -122.31 14.92 10.49 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.022 1.729 . . . . 0.0 109.094 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.6 tp 64.9 -30.09 0.12 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.979 2.512 . . . . 0.0 113.543 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -165.31 86.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.223 1.409 . . . . 0.0 107.452 -168.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.7 -41.74 99.28 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.956 -0.465 . . . . 0.0 110.185 176.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.47 150.11 36.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.58 -178.92 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.88 3.053 . . . . 0.0 113.239 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 32.55 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.994 1.718 . . . . 0.0 112.549 171.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 m -157.36 125.34 5.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 106.044 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.86 -143.36 14.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 mm -124.38 130.97 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -118.89 144.62 46.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.2 mt -137.14 135.77 37.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -132.6 137.55 53.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -173.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -128.07 96.71 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.169 1.388 . . . . 0.0 107.258 -170.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.5 p -145.52 -6.29 0.63 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -173.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m 37.98 60.95 1.14 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p -49.73 -36.8 26.82 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.122 0.969 . . . . 0.0 112.384 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -44.09 -29.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.052 2.141 . . . . 0.0 114.13 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.08 16.56 0.18 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-N 120.449 1.477 . . . . 0.0 115.617 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.74 46.38 0.94 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.506 1.922 . . . . 0.0 109.232 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.54 -179.15 10.09 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.137 -0.977 . . . . 0.0 111.735 170.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -134.1 164.52 27.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.061 1.345 . . . . 0.0 107.719 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.3 mm -61.28 -47.85 93.08 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-O 117.345 -1.312 . . . . 0.0 111.371 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.64 -49.83 3.91 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.009 1.806 . . . . 0.0 112.152 171.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -162.87 -60.31 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.329 0.652 . . . . 0.0 111.958 170.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 155.96 139.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 130.426 3.49 . . . . 0.0 104.402 -169.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.0 mt 37.66 58.81 1.33 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.078 1.418 . . . . 0.0 108.395 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.402 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 50.5 m -63.61 -48.01 81.45 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.488 1.915 . . . . 0.0 114.174 -168.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 67' ' ' SER . 37.2 Cg_endo -63.14 -34.07 70.42 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 121.176 1.456 . . . . 0.0 110.647 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -72.33 -42.84 64.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.403 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -53.52 -51.56 62.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.99 1.316 . . . . 0.0 110.261 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -61.8 -42.52 99.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.822 0.737 . . . . 0.0 110.87 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.6 86.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.219 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.49 -56.34 23.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.241 0.928 . . . . 0.0 109.106 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -20.18 65.06 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.84 -31.06 63.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.876 0.762 . . . . 0.0 111.635 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -121.11 -28.56 4.72 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 23.75 70.91 0.33 Allowed Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 127.722 2.409 . . . . 0.0 113.7 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -58.84 175.38 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.605 2.204 . . . . 0.0 111.729 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -89.96 79.16 6.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.995 0.918 . . . . 0.0 110.022 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.557 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.1 mm? -75.39 3.17 9.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.264 0.626 . . . . 0.0 112.174 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -63.8 -6.74 6.23 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.026 2.13 . . . . 0.0 112.926 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.13 6.21 38.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.774 1.629 . . . . 0.0 110.792 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.31 145.66 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 122.147 0.975 . . . . 0.0 111.732 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.407 HH11 ' HG3' ' A' ' 84' ' ' ARG . 1.6 ptm180 -94.67 144.55 25.52 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -113.07 146.5 39.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.09 121.81 3.67 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.09 132.16 43.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.24 108.28 18.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -30.03 0.43 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.227 0.918 . . . . 0.0 113.049 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.76 123.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.0 45.74 0.29 Allowed Glycine 0 CA--C 1.502 -0.722 0 CA-C-O 121.722 0.623 . . . . 0.0 111.75 -169.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -37.85 68.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 26.09 -70.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 1 C-N-CA 133.186 4.594 . . . . 0.0 117.132 169.683 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -57.47 -26.78 61.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.864 0.865 . . . . 0.0 111.643 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -120.81 10.35 10.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.621 2.769 . . . . 0.0 110.595 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -80.24 62.61 4.45 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.2 t -154.31 177.4 11.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.747 1.619 . . . . 0.0 109.603 -173.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -57.96 -19.18 28.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.284 1.834 . . . . 0.0 114.836 -169.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 18.4 p -116.92 17.63 14.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.767 1.227 . . . . 0.0 112.718 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.42 166.43 54.61 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.607 0.623 . . . . 0.0 112.027 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.44 14.01 1.24 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.689 1.195 . . . . 0.0 112.187 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.1 tt -149.12 23.76 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 125.315 1.446 . . . . 0.0 108.885 -177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -135.2 -3.01 2.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.265 2.226 . . . . 0.0 112.038 -169.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -63.29 -25.39 68.29 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.661 -0.649 . . . . 0.0 111.552 -169.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.83 -56.49 19.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.721 0.808 . . . . 0.0 110.138 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.14 -38.87 92.0 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.63 72.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -63.24 -42.12 99.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.775 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -57.28 -47.59 81.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.304 0.956 . . . . 0.0 110.714 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -73.51 -36.0 65.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.852 0.861 . . . . 0.0 109.688 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.86 -34.38 78.23 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.377 1.471 . . . . 0.0 111.629 173.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.557 ' HB3' HD23 ' A' ' 80' ' ' LEU . 14.8 m -73.65 -17.72 61.12 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.251 0.22 . . . . 0.0 110.636 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.25 -17.64 5.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 117.921 -1.488 . . . . 0.0 114.085 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 130.75 44.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.649 1.725 . . . . 0.0 109.258 -170.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -86.37 111.08 20.15 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.04 117.51 5.18 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 94.7 m -129.38 143.13 50.72 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.244 0.618 . . . . 0.0 110.737 -169.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.38 -103.34 2.99 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -165.03 -175.88 3.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.357 1.863 . . . . 0.0 107.448 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.4 m -63.01 113.64 3.22 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 122' ' ' LYS . 1.3 tt -71.37 153.62 42.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.511 ' H ' HD23 ' A' ' 121' ' ' LEU . 37.6 mttp -130.8 143.0 50.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.12 156.25 33.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.722 1.609 . . . . 0.0 107.213 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.66 28.29 0.79 Allowed 'General case' 0 C--O 1.232 0.171 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.1 157.37 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 168.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 tp -51.95 -37.03 51.38 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.946 0.898 . . . . 0.0 113.327 -169.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.96 -22.56 62.19 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -140.35 60.65 1.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.751 1.62 . . . . 0.0 109.416 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -65.57 -18.88 65.65 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.241 -0.912 . . . . 0.0 111.563 169.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 83.9 mt -2.37 -72.37 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 130.398 3.479 . . . . 0.0 114.755 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -79.09 -78.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.682 1.994 . . . . 0.0 112.859 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -177.79 158.55 1.32 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.441 2.296 . . . . 0.0 107.512 -169.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -55.0 -45.74 99.78 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -169.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.36 160.82 41.39 Favored 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 122.577 1.956 . . . . 0.0 113.069 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.29 -47.76 0.13 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.329 1.052 . . . . 0.0 111.036 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.94 -24.22 67.46 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -170.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.28 -34.21 77.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.708 0.403 . . . . 0.0 110.636 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.451 ' CE3' HD12 ' A' ' 121' ' ' LEU . 13.8 t90 -59.08 -54.92 41.57 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.307 0.643 . . . . 0.0 109.538 173.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -55.91 20.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.631 1.573 . . . . 0.0 109.09 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.1 -42.59 98.02 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.737 -0.48 . . . . 0.0 112.133 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -60.17 -60.35 3.96 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.82 0.81 . . . . 0.0 109.03 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -56.85 -46.54 81.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.386 1.074 . . . . 0.0 111.485 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.01 -55.78 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.702 0.801 . . . . 0.0 109.683 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -15.96 62.49 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.059 0.845 . . . . 0.0 112.421 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.61 -48.47 13.71 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.467 0.707 . . . . 0.0 110.769 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.73 -32.58 65.8 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.766 0.712 . . . . 0.0 111.958 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.1 mttt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.228 1.011 . . . . 0.0 109.74 174.006 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.62 152.59 45.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.273 0.942 . . . . 0.0 111.628 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.43 -22.51 16.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.193 1.797 . . . . 0.0 110.865 170.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.21 129.49 53.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.781 1.233 . . . . 0.0 108.144 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -90.42 127.96 36.35 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.91 95.62 5.66 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.64 131.54 33.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.83 -174.35 3.7 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.058 1.743 . . . . 0.0 109.038 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.27 42.44 90.58 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.547 -0.721 . . . . 0.0 112.476 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -44.91 -44.56 9.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.396 2.278 . . . . 0.0 114.329 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -82.23 22.78 0.79 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.188 1.795 . . . . 0.0 112.188 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt 59.04 54.17 5.13 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.74 1.257 . . . . 0.0 107.654 -168.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.32 -135.98 3.33 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.096 1.808 . . . . 0.0 108.739 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.46 149.32 21.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.18 16.27 0.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.321 1.849 . . . . 0.0 111.108 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.24 -16.91 37.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 0.0 113.683 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.64 -48.08 66.63 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.283 1.402 . . . . 0.0 112.14 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.07 -31.72 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.967 -0.458 . . . . 0.0 110.177 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.53 78.07 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.074 0.55 . . . . 0.0 111.114 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.31 -37.45 80.61 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.055 0.942 . . . . 0.0 110.371 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -65.25 -42.44 93.31 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.72 -0.612 . . . . 0.0 110.008 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 mt -61.49 -51.73 67.43 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.93 64.96 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.451 1.501 . . . . 0.0 111.312 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 -54.74 40.16 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.517 0.675 . . . . 0.0 109.954 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.56 -38.74 91.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -60.93 -40.17 92.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.478 0.711 . . . . 0.0 110.897 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.55 -36.52 68.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.16 -0.962 . . . . 0.0 110.469 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.8 -31.3 71.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.481 0.712 . . . . 0.0 111.262 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.5 -21.49 62.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.375 0.67 . . . . 0.0 111.736 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.99 -7.82 3.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.178 -1.345 . . . . 0.0 114.295 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -94.99 -168.86 1.88 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.802 1.801 . . . . 0.0 110.205 -171.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -128.89 149.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.7 p -142.71 155.64 44.91 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.823 -0.548 . . . . 0.0 111.065 -170.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -121.73 90.67 3.36 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.906 1.283 . . . . 0.0 108.331 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -67.53 120.66 14.33 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.1 mt -146.86 168.37 21.59 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.834 0.854 . . . . 0.0 111.534 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -109.52 31.88 5.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.884 1.273 . . . . 0.0 109.584 169.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.86 49.73 46.93 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.602 1.572 . . . . 0.0 114.537 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 -21.01 64.96 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.061 2.507 . . . . 0.0 113.99 -172.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.11 12.76 11.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.674 1.59 . . . . 0.0 109.577 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 tp 63.91 -25.8 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.939 2.496 . . . . 0.0 113.455 -169.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -166.75 82.67 0.25 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -169.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.98 -43.89 97.54 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.879 -0.513 . . . . 0.0 109.841 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.48 151.28 44.07 Favored Pre-proline 0 C--N 1.345 0.409 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 169.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 47' ' ' SER . 37.5 Cg_endo -67.07 -175.12 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 124.151 3.234 . . . . 0.0 113.005 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.04 29.77 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.645 1.578 . . . . 0.0 113.193 171.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' PRO . 20.3 m -152.56 127.17 9.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.964 2.506 . . . . 0.0 106.157 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.08 -140.92 12.19 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.3 mm -127.97 135.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CD1' HG21 ' A' ' 83' ' ' VAL . 18.2 m0 -119.52 130.02 54.98 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.3 mt -126.97 133.58 50.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.37 103.5 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -169.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.0 mp -78.72 126.04 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.9 m -159.57 176.95 11.43 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.128 1.771 . . . . 0.0 107.05 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 m -149.92 65.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 p -51.73 -26.27 9.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.749 2.019 . . . . 0.0 113.399 -169.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -133.13 44.35 2.84 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.146 1.378 . . . . 0.0 109.637 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.98 -36.89 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 O-C-N 121.439 -0.788 . . . . 0.0 113.428 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.38 58.45 0.64 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.967 1.307 . . . . 0.0 107.802 178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.72 168.39 35.5 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 123.827 0.727 . . . . 0.0 111.313 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.15 85.44 5.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.341 8.0 pt -38.97 -38.84 0.73 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 119.654 3.205 . . . . 0.0 119.654 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.19 -8.16 12.94 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 CA-C-N 123.827 2.402 . . . . 0.0 114.017 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -149.92 -41.09 0.14 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.293 1.406 . . . . 0.0 114.629 -169.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.5 t30 31.46 -56.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 1 C-N-CA 132.694 4.398 . . . . 0.0 119.968 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.29 72.57 10.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.8 m -67.21 -51.3 35.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.746 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 -38.73 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.453 1.435 . . . . 0.0 110.18 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.31 -52.33 54.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.592 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -59.38 -46.26 89.16 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.286 0.948 . . . . 0.0 110.845 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -63.5 -49.54 73.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.512 0.596 . . . . 0.0 110.274 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.26 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -60.52 -56.29 23.21 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.836 0.855 . . . . 0.0 109.577 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.41 -23.57 66.99 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.49 -33.7 73.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.746 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -124.59 -21.83 4.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 30.26 64.53 0.89 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 127.068 2.147 . . . . 0.0 112.911 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.7 165.24 18.84 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.938 2.425 . . . . 0.0 113.375 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.34 63.96 4.99 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.731 1.212 . . . . 0.0 111.232 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 9.95 0.33 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.45 1.5 . . . . 0.0 113.281 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 m -64.04 -2.43 1.98 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.756 2.823 . . . . 0.0 113.171 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.85 9.1 11.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.741 1.616 . . . . 0.0 110.981 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -128.5 154.13 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.689 0.677 . . . . 0.0 110.75 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.36 143.26 32.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -103.01 154.61 19.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.98 115.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.1 133.92 47.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.32 116.67 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.46 -11.37 18.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.625 1.107 . . . . 0.0 114.36 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.64 130.5 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.012 1.725 . . . . 0.0 108.609 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.96 -38.88 3.71 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 -170.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -53.08 -33.49 52.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.705 1.602 . . . . 0.0 111.565 170.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -66.88 -25.23 66.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.943 0.897 . . . . 0.0 112.464 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -105.61 -73.62 0.68 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.856 0.753 . . . . 0.0 112.624 -168.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -155.51 -25.74 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -87.92 33.87 0.72 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.638 1.108 . . . . 0.0 111.377 -169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.4 p -50.55 119.86 4.15 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.133 1.773 . . . . 0.0 110.838 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -62.7 165.92 5.98 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.395 0.678 . . . . 0.0 109.521 170.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.6 m -71.21 39.0 0.06 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.185 1.794 . . . . 0.0 111.727 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.84 42.76 0.02 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.488 1.994 . . . . 0.0 108.164 -169.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.46 158.84 11.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.014 0.926 . . . . 0.0 111.523 -170.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 tp -112.28 22.09 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.278 1.031 . . . . 0.0 110.204 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.03 -15.92 10.9 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.419 1.088 . . . . 0.0 113.049 176.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -56.37 -25.69 50.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.94 0.896 . . . . 0.0 111.769 170.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.404 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.9 tm? -59.37 -59.04 6.08 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.292 0.951 . . . . 0.0 109.442 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.06 -38.61 79.78 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.318 0.508 . . . . 0.0 110.852 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.91 88.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.879 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -64.84 -36.59 84.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.967 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.67 -47.25 86.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.255 0.934 . . . . 0.0 110.814 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -69.46 -35.47 75.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.993 0.517 . . . . 0.0 110.217 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -36.48 84.18 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.293 1.437 . . . . 0.0 111.037 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.8 m -67.16 -36.14 81.18 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.607 0.363 . . . . 0.0 110.097 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.66 -25.66 0.25 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.29 -1.284 . . . . 0.0 115.396 169.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.35 139.98 55.87 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.344 1.572 . . . . 0.0 110.524 -170.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -83.73 146.14 28.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -92.58 98.37 11.4 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.8 m -75.3 151.72 38.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.82 -116.89 8.63 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 7.3 pt-20 -146.8 178.99 7.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.334 1.053 . . . . 0.0 108.561 170.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -54.43 119.53 5.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.5 1.12 . . . . 0.0 108.8 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.7 OUTLIER -76.09 151.35 37.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.463 ' H ' HD23 ' A' ' 121' ' ' LEU . 28.0 mtmm -138.87 141.84 38.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp -149.76 160.1 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 127.501 2.321 . . . . 0.0 108.657 -171.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -159.93 -179.49 7.85 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.233 0.613 . . . . 0.0 109.497 169.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.0 pt -124.72 2.78 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 125.315 1.446 . . . . 0.0 111.105 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -142.71 144.2 32.6 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.96 131.31 44.36 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.761 0.824 . . . . 0.0 112.299 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.3 t60 32.78 95.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.816 3.246 . . . . 0.0 115.719 175.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -127.72 -160.66 1.03 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.386 1.474 . . . . 0.0 108.001 169.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.8 mm -44.73 -52.22 19.09 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.314 1.846 . . . . 0.0 113.6 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.77 -98.41 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.577 2.184 . . . . 0.0 109.864 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.03 158.5 10.48 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.345 1.858 . . . . 0.0 106.411 170.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.64 -54.12 1.44 Allowed Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.34 -1.314 . . . . 0.0 113.577 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.6 152.36 48.18 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.023 1.815 . . . . 0.0 111.276 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.29 -20.96 0.62 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.285 1.034 . . . . 0.0 113.034 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.38 -25.03 67.71 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.501 0.591 . . . . 0.0 111.927 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -64.31 -42.83 96.16 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.362 0.665 . . . . 0.0 110.412 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.438 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 8.3 m-90 -63.22 -51.29 66.84 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.007 0.523 . . . . 0.0 109.833 177.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.8 mt -58.62 -55.7 31.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.693 0.621 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.51 -49.16 75.61 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.383 -0.676 . . . . 0.0 111.414 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -48.03 77.71 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.155 0.977 . . . . 0.0 110.176 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -60.16 -42.96 96.07 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.569 -0.707 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.8 t -57.39 -50.33 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.555 1.142 . . . . 0.0 109.727 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.74 -26.96 68.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.129 0.877 . . . . 0.0 111.986 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.8 -45.98 16.1 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.671 0.789 . . . . 0.0 110.401 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.05 -34.69 68.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.375 0.534 . . . . 0.0 111.754 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.2 mttt . . . . . 0 C--O 1.248 0.98 0 C-N-CA 124.155 0.982 . . . . 0.0 110.026 176.14 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 tpp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.71 163.22 40.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.369 1.068 . . . . 0.0 109.924 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.14 -24.3 16.91 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.752 1.221 . . . . 0.0 110.891 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.7 mt -132.48 124.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 127.8 35.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.16 103.4 14.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mt -89.92 74.45 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -78.83 138.88 38.38 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.783 -0.573 . . . . 0.0 109.988 -170.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.63 136.11 3.15 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 124.563 1.078 . . . . 0.0 111.082 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -87.21 -7.22 58.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.931 0.892 . . . . 0.0 110.509 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -143.74 -144.35 0.15 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.992 3.317 . . . . 0.0 102.954 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.62 8.12 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.44 -176.52 48.08 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 128.931 3.158 . . . . 0.0 107.413 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 7.87 5.29 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.232 -1.316 . . . . 0.0 114.709 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.82 -2.48 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.638 1.719 . . . . 0.0 113.732 -175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.01 -33.39 64.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.425 1.09 . . . . 0.0 112.432 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.59 -42.65 88.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.515 0.726 . . . . 0.0 111.469 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.77 -28.18 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.01 77.59 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.145 0.884 . . . . 0.0 111.338 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.08 -42.05 93.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.918 0.781 . . . . 0.0 111.278 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -68.59 -43.2 77.01 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.698 -0.627 . . . . 0.0 110.663 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.73 -50.5 73.01 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.001 0.92 . . . . 0.0 110.432 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.97 67.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.732 1.213 . . . . 0.0 110.995 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.98 -52.99 61.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.683 0.674 . . . . 0.0 110.18 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -60.35 -40.55 91.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.91 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.518 175.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.53 -39.98 80.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.388 0.995 . . . . 0.0 109.737 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.94 -29.1 70.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.389 0.995 . . . . 0.0 111.6 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.3 -17.73 63.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.716 0.806 . . . . 0.0 111.622 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.35 14.03 4.6 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.323 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.72 -172.38 2.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.442 1.621 . . . . 0.0 110.419 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -122.86 153.58 39.44 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p -141.61 154.56 45.48 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.875 -0.516 . . . . 0.0 111.615 -169.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -117.94 91.92 3.7 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.634 1.574 . . . . 0.0 106.923 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -69.21 118.44 12.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 172.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.09 166.0 27.43 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.747 1.219 . . . . 0.0 108.738 -173.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -101.44 31.18 3.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.493 0.717 . . . . 0.0 110.653 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.62 50.79 47.39 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 118.143 -1.365 . . . . 0.0 113.935 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.2 -21.36 67.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.082 2.521 . . . . 0.0 113.638 -171.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.2 mt -125.74 15.87 8.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.739 1.616 . . . . 0.0 109.54 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.6 tp 63.0 -26.69 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.328 2.651 . . . . 0.0 114.31 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -161.17 82.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.536 1.134 . . . . 0.0 108.22 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.36 -43.96 84.52 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.777 -0.577 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.3 mt -85.65 151.36 55.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.24 -178.29 1.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.968 3.112 . . . . 0.0 113.292 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 31.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.758 2.023 . . . . 0.0 112.941 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -159.87 116.87 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.928 2.091 . . . . 0.0 106.312 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.0 -146.01 15.4 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -173.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mm -123.64 136.18 60.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -118.36 148.78 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.5 mt -134.54 142.91 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.75 130.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.41 110.4 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -168.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 m -149.51 -174.67 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.23 1.012 . . . . 0.0 109.361 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -154.48 134.73 13.24 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.622 1.169 . . . . 0.0 108.313 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 p -140.76 -64.94 0.45 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.903 0.481 . . . . 0.0 111.237 -170.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.0 t60 52.12 28.98 5.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.163 1.385 . . . . 0.0 112.112 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.53 21.93 15.29 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.615 1.102 . . . . 0.0 113.976 -172.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.6 41.54 0.61 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.343 1.857 . . . . 0.0 109.277 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.21 -172.74 7.11 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.777 0.703 . . . . 0.0 111.412 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -57.52 -27.74 62.86 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.194 -0.592 . . . . 0.0 111.695 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -148.97 153.44 38.4 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.718 2.407 . . . . 0.0 104.963 169.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -59.45 16.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.937 3.758 . . . . 0.0 116.297 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -145.08 37.5 1.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.655 2.382 . . . . 0.0 107.552 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -51.89 -42.48 62.73 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.213 1.405 . . . . 0.0 112.299 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.36 61.27 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.012 1.725 . . . . 0.0 108.66 170.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.5 m -65.94 -48.02 62.38 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 125.957 1.703 . . . . 0.0 110.838 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -72.71 -39.95 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 120.414 1.184 . . . . 0.0 110.251 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -60.21 3.53 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -169.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -59.79 -43.21 94.55 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.984 0.913 . . . . 0.0 110.336 -169.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -69.31 -46.87 66.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.001 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -26.91 68.59 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.651 1.114 . . . . 0.0 112.886 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.9 mt -61.98 -61.34 2.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -57.48 -25.8 60.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.096 1.758 . . . . 0.0 113.719 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -30.81 70.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -126.88 -29.95 2.78 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HD2' HD21 ' A' ' 111' ' ' ASN . 36.6 mtmt 23.81 67.85 0.38 Allowed Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 127.153 2.181 . . . . 0.0 113.401 -169.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.6 175.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.833 1.689 . . . . 0.0 110.672 171.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -87.87 125.93 34.75 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.9 mm? -120.27 11.79 11.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.619 1.168 . . . . 0.0 111.145 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.7 m -67.0 -4.87 10.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 119.662 -1.899 . . . . 0.0 113.033 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.1 5.06 42.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.308 1.443 . . . . 0.0 110.734 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.06 157.17 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.961 0.886 . . . . 0.0 110.896 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -110.46 151.99 26.86 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -121.44 157.22 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.85 118.84 2.4 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.17 140.6 31.63 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.79 125.89 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -170.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.58 52.78 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.381 0.991 . . . . 0.0 113.796 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.55 80.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 108.151 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.54 -11.39 2.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 127.174 2.321 . . . . 0.0 117.806 -168.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -67.18 -41.98 84.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.525 2.162 . . . . 0.0 109.692 172.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.2 ttt85 55.55 -76.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.139 2.575 . . . . 0.0 114.038 173.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -159.83 -42.56 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.65 1.98 . . . . 0.0 108.473 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -146.18 1.08 0.84 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.414 1.486 . . . . 0.0 112.031 -171.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -87.73 34.48 0.71 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.205 -0.934 . . . . 0.0 111.133 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.1 t -154.63 169.36 24.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.083 2.153 . . . . 0.0 107.448 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -117.89 7.22 12.32 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.423 1.489 . . . . 0.0 110.258 171.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 62.9 m -132.73 22.21 4.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.413 1.485 . . . . 0.0 111.149 -172.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.2 -169.35 38.26 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.253 0.93 . . . . 0.0 111.167 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.72 -135.45 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.329 1.852 . . . . 0.0 106.101 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.8 140.5 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 168.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 106' ' ' GLU . 2.0 t70 -63.55 150.12 44.69 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -169.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -56.3 -41.14 75.48 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 169.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.35 -55.4 35.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.471 1.108 . . . . 0.0 109.545 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.447 ' H ' ' HB3' ' A' ' 103' ' ' ASP . 48.6 mt-10 -65.56 -39.85 92.16 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.837 -171.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.38 78.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.224 1.01 . . . . 0.0 109.889 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -63.72 -35.74 81.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.422 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.8 -42.5 94.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.206 1.366 . . . . 0.0 111.289 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -65.55 -38.85 90.81 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.111 0.565 . . . . 0.0 109.764 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.471 HD21 ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.65 -31.32 71.23 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.986 1.314 . . . . 0.0 111.684 176.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.627 ' HB3' HD23 ' A' ' 80' ' ' LEU . 15.5 m -73.52 -29.91 62.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.855 0.462 . . . . 0.0 109.847 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.71 -17.35 4.44 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-O 118.457 -1.19 . . . . 0.0 113.599 169.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 136.23 56.67 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.892 1.346 . . . . 0.0 108.287 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -84.56 126.81 33.65 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -77.27 98.65 5.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.8 m -73.45 151.33 41.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.59 -117.35 10.83 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.571 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 10.3 pt-20 -157.0 170.08 23.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.123 1.769 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -55.3 126.44 24.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.603 0.761 . . . . 0.0 109.739 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -84.25 161.42 20.5 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.065 1.746 . . . . 0.0 107.674 176.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.437 ' H ' HD23 ' A' ' 121' ' ' LEU . 60.6 mtpt -136.52 150.87 48.87 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.45 157.38 24.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 123.394 0.678 . . . . 0.0 110.387 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.32 170.28 14.85 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.881 0.872 . . . . 0.0 109.788 169.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.6 mm -126.31 -62.7 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.1 tp -160.04 -57.26 0.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.717 0.807 . . . . 0.0 109.574 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.87 126.84 31.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -67.16 162.37 22.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.062 0.945 . . . . 0.0 111.227 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -147.94 -166.23 2.47 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.075 1.75 . . . . 0.0 107.692 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.67 -54.15 56.89 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.916 1.286 . . . . 0.0 111.025 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.5 -47.15 0.75 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.13 1.887 . . . . 0.0 112.29 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . 0.261 16.7 pt-20 45.68 37.71 3.54 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.683 1.993 . . . . 0.0 114.698 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -146.98 112.6 4.16 Favored Pre-proline 0 N--CA 1.467 0.384 0 CA-C-O 118.104 -0.95 . . . . 0.0 108.674 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.21 -29.49 46.77 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.006 3.137 . . . . 0.0 115.658 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 35.87 40.23 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.961 2.504 . . . . 0.0 115.333 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.39 -23.95 64.73 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -59.78 -29.96 68.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.287 1.035 . . . . 0.0 111.208 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.571 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -61.93 -40.54 95.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.836 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -55.73 27.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.64 -49.0 67.61 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.266 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.7 m -60.61 -55.53 32.24 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 111.83 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -55.99 -42.7 76.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.65 1.18 . . . . 0.0 111.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 t -58.23 -49.35 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.145 0.578 . . . . 0.0 109.83 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.59 -30.12 70.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.372 0.987 . . . . 0.0 111.397 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.9 -46.12 25.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.014 0.925 . . . . 0.0 110.452 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.69 -33.66 66.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.058 0.543 . . . . 0.0 111.586 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 83.7 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.484 1.114 . . . . 0.0 110.09 173.227 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.76 168.7 24.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.359 1.064 . . . . 0.0 109.988 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.37 -23.77 14.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 111.224 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.13 121.94 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -85.12 133.89 34.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.69 96.52 6.13 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 174.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.3 mt -92.9 107.38 19.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -92.12 95.27 9.66 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.24 0.22 23.82 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 118.291 -1.283 . . . . 0.0 114.803 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.89 106.12 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.451 1.625 . . . . 0.0 109.648 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m 46.83 44.45 14.31 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.068 1.347 . . . . 0.0 110.357 -170.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.89 47.9 21.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.649 1.58 . . . . 0.0 111.985 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.19 -173.19 40.76 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.538 1.542 . . . . 0.0 110.723 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.97 -165.82 39.0 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.68 55.56 0.67 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 111.221 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -54.24 -31.44 53.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.085 1.354 . . . . 0.0 112.105 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -55.7 -40.77 72.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.861 0.864 . . . . 0.0 111.721 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.58 -29.94 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.18 74.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.09 0.859 . . . . 0.0 110.638 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.13 -38.91 93.06 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.557 0.617 . . . . 0.0 110.907 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -67.11 -42.62 84.22 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.697 -0.627 . . . . 0.0 110.29 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -59.35 -52.54 65.2 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.697 0.799 . . . . 0.0 109.919 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.99 -49.55 63.06 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.162 1.385 . . . . 0.0 110.931 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.19 -54.35 47.92 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 110.426 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.16 -25.03 65.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.34 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.64 -43.38 80.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 120.738 1.608 . . . . 0.0 109.319 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.85 -26.21 68.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.749 -0.594 . . . . 0.0 111.597 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -13.02 62.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.943 0.897 . . . . 0.0 112.549 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.33 19.04 2.95 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.087 169.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -132.0 -165.48 1.59 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.63 1.215 . . . . 0.0 109.837 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 p -132.36 151.75 51.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -141.77 154.91 45.56 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.971 -0.456 . . . . 0.0 111.468 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -125.72 95.66 4.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.518 1.127 . . . . 0.0 108.647 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.7 m -70.2 121.46 17.6 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.47 165.01 29.82 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.395 0.617 . . . . 0.0 111.469 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -107.46 31.1 5.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.728 1.211 . . . . 0.0 110.165 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.88 45.41 70.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.854 -1.526 . . . . 0.0 115.113 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.43 -21.41 66.39 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.049 2.499 . . . . 0.0 114.118 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.9 mt -116.45 11.72 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.529 1.532 . . . . 0.0 109.887 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 tp 64.21 -23.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.787 2.435 . . . . 0.0 113.467 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -169.82 82.63 0.12 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.963 1.705 . . . . 0.0 106.65 -169.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.45 -43.82 96.3 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.876 -0.515 . . . . 0.0 109.666 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.8 mt -96.06 150.8 37.72 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 169.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.31 -177.6 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.742 2.962 . . . . 0.0 113.154 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.17 35.75 0.05 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.73 1.612 . . . . 0.0 112.037 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 m -160.51 130.24 5.11 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.186 2.195 . . . . 0.0 106.008 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.28 -143.45 14.54 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -172.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mm -127.39 141.07 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CD1' HG21 ' A' ' 83' ' ' VAL . 5.1 m0 -128.92 146.86 50.84 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.8 mt -132.55 140.12 48.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.22 121.98 58.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.95 60.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -120.77 41.31 3.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.256 -169.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -26.53 107.76 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 128.584 2.754 . . . . 0.0 113.914 -172.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.6 p -80.12 -20.03 45.94 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.723 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.3 m80 51.03 22.73 1.29 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.607 1.094 . . . . 0.0 112.86 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.45 -64.95 3.16 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.841 1.21 . . . . 0.0 111.871 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.28 -7.1 54.27 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -170.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.36 146.14 6.59 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.624 1.583 . . . . 0.0 110.451 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.64 -27.36 65.94 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.0 pt -136.51 159.61 69.88 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 128.05 2.54 . . . . 0.0 106.135 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.37 -17.73 22.24 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.711 2.94 . . . . 0.0 115.794 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -133.47 61.24 1.68 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.599 1.56 . . . . 0.0 107.727 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -52.44 -23.37 5.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.269 2.228 . . . . 0.0 116.182 -169.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.29 72.52 1.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.4 -51.92 57.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.513 0.725 . . . . 0.0 112.454 -168.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.8 -39.58 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.612 1.541 . . . . 0.0 110.516 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.36 -51.43 60.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.699 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -60.09 -49.85 76.03 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.519 0.6 . . . . 0.0 110.261 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.44 -44.7 95.79 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.541 0.609 . . . . 0.0 110.387 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.06 91.78 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.198 0.453 . . . . 0.0 111.919 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.5 mt -58.71 -55.68 31.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.952 0.796 . . . . 0.0 109.739 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -65.59 -20.01 66.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.25 -34.11 65.66 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.37 0.532 . . . . 0.0 111.598 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -122.85 -21.36 5.58 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 29.24 65.95 0.73 Allowed Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 127.07 2.148 . . . . 0.0 113.034 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.87 165.29 14.41 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.533 2.155 . . . . 0.0 112.738 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -80.74 63.93 5.33 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.05 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -68.37 4.53 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.139 0.976 . . . . 0.0 112.789 -177.38 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -62.09 -8.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.812 2.845 . . . . 0.0 113.104 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.55 10.4 19.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.713 1.605 . . . . 0.0 110.752 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 50' ' ' TRP . 1.5 p -132.27 153.08 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 110.813 175.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -107.34 152.42 24.18 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -120.05 156.41 30.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.07 126.59 3.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 106.524 -2.63 . . . . 0.0 106.524 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.22 138.92 31.68 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 mt -139.31 124.45 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.72 -12.05 3.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.066 0.841 . . . . 0.0 114.352 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.7 mm -55.14 133.81 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.229 1.412 . . . . 0.0 107.857 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.88 -21.72 17.72 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.9 m -58.77 -28.85 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -71.09 -22.12 62.14 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.288 0.635 . . . . 0.0 111.844 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -146.21 -62.3 0.31 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -168.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -53.34 -39.35 64.04 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.778 1.631 . . . . 0.0 113.327 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -133.76 15.54 3.97 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.276 0.56 . . . . 0.0 112.316 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.6 p 60.69 160.55 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.757 2.823 . . . . 0.0 115.959 172.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -59.16 -21.24 59.07 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.768 1.227 . . . . 0.0 112.779 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.9 p -115.68 23.6 12.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.632 1.573 . . . . 0.0 111.676 -172.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.5 -42.08 0.04 OUTLIER Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.949 0.785 . . . . 0.0 111.234 176.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.74 171.4 5.26 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.822 0.849 . . . . 0.0 112.462 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.5 pt -73.03 36.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 125.891 1.676 . . . . 0.0 111.482 169.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.18 -16.62 21.39 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.655 1.982 . . . . 0.0 113.6 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -53.09 -27.42 20.23 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.969 0.908 . . . . 0.0 112.639 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.85 -57.38 12.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.677 0.671 . . . . 0.0 109.788 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.39 -36.08 81.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.498 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.8 -50.42 73.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.421 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.81 -42.34 93.26 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.604 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 mt -60.18 -48.15 82.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.844 0.747 . . . . 0.0 111.167 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -67.99 -36.2 79.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.198 0.599 . . . . 0.0 109.867 -177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -31.89 72.8 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.7 1.2 . . . . 0.0 111.798 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.0 m -69.54 -33.49 72.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.803 0.441 . . . . 0.0 110.508 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.65 -38.39 0.3 Allowed Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 169.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . . . -70.92 174.12 6.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.442 1.121 . . . . 0.0 111.664 -174.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -132.12 145.93 51.71 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -74.25 126.06 29.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.0 m -88.8 157.95 18.31 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.42 -133.02 30.3 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.33 161.68 38.36 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.427 1.091 . . . . 0.0 108.378 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 m -57.45 123.97 17.32 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.85 0.86 . . . . 0.0 111.632 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.21 171.14 15.5 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.161 1.784 . . . . 0.0 108.285 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -137.95 156.81 47.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 121.149 -0.97 . . . . 0.0 109.093 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 138.93 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.01 173.33 4.42 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.907 1.283 . . . . 0.0 108.958 169.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.0 pt -142.87 159.36 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.804 1.241 . . . . 0.0 109.011 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.2 tp 65.29 -45.89 0.36 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 129.228 3.011 . . . . 0.0 116.359 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -156.09 171.32 20.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.064 1.302 . . . . 0.0 110.96 -169.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -58.67 159.8 6.28 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.128 1.371 . . . . 0.0 110.066 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 130' ' ' ILE . 40.9 t0 -150.92 -92.84 0.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 122.41 1.1 . . . . 0.0 109.289 -171.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' H ' ' HB3' ' A' ' 129' ' ' ASP . 29.4 mm -130.95 -48.35 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 128.823 2.849 . . . . 0.0 105.616 169.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -179.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 124.653 3.569 . . . . 0.0 117.846 167.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -124.33 164.84 18.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 109.664 -3.426 . . . . 0.0 107.735 169.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -56.87 116.65 13.88 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.626 1.171 . . . . 0.0 111.561 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.76 160.39 12.14 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.517 2.811 . . . . 0.0 112.541 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.26 144.23 25.44 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.8 0.84 . . . . 0.0 109.277 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.11 -25.83 68.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.208 1.003 . . . . 0.0 110.988 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.45 -32.18 62.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.305 1.042 . . . . 0.0 112.049 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -50.79 72.48 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.839 0.745 . . . . 0.0 110.657 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.54 -52.09 62.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.26 -47.39 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.5 t -61.76 -57.51 11.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -57.24 -43.31 82.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.605 0.762 . . . . 0.0 111.916 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.6 t -59.25 -55.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.726 1.21 . . . . 0.0 109.98 175.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -13.78 62.64 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.591 1.087 . . . . 0.0 112.213 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.95 -48.12 13.91 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.058 0.943 . . . . 0.0 110.825 170.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -71.56 -33.46 69.13 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.892 0.769 . . . . 0.0 112.176 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.3 mttt . . . . . 0 C--O 1.248 1.021 0 C-N-CA 125.022 1.329 . . . . 0.0 109.49 173.614 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.09 37.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.15 0.98 . . . . 0.0 110.117 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.89 -23.76 17.3 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.4 1.48 . . . . 0.0 110.753 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.78 130.38 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.543 1.137 . . . . 0.0 108.327 -174.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 t -89.88 129.07 36.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -111.2 93.68 4.6 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.7 mm -72.16 98.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -86.49 13.85 7.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.541 1.937 . . . . 0.0 114.305 -168.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.98 158.81 31.77 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 118.929 0.786 . . . . 0.0 112.623 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -93.76 -30.72 14.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.446 1.498 . . . . 0.0 111.547 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -124.37 48.51 1.92 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.461 1.124 . . . . 0.0 108.948 -169.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.5 tp 56.01 27.87 11.93 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.4 1.48 . . . . 0.0 111.334 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.7 165.05 26.44 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 128.328 2.87 . . . . 0.0 106.869 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.69 -146.6 11.76 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 118.211 1.006 . . . . 0.0 110.862 -173.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.68 50.77 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.499 1.919 . . . . 0.0 112.076 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.62 -29.23 66.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.683 1.193 . . . . 0.0 112.144 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -60.08 -51.31 70.17 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.7 0.682 . . . . 0.0 111.078 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.55 -28.52 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.84 -0.537 . . . . 0.0 109.667 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.9 98.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.646 0.657 . . . . 0.0 110.736 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.55 -40.55 92.98 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.178 0.591 . . . . 0.0 110.566 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.26 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.714 -0.616 . . . . 0.0 110.622 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -60.46 -51.02 71.23 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.563 1.145 . . . . 0.0 109.719 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.19 66.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 111.073 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.89 -52.19 66.11 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.131 0.973 . . . . 0.0 110.653 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -57.33 -37.76 73.04 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.68 -29.72 69.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.833 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -70.64 -44.23 67.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.542 1.519 . . . . 0.0 109.847 171.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.04 -26.53 67.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 0.0 111.406 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.69 -21.12 64.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.809 0.843 . . . . 0.0 111.963 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.28 12.05 1.48 Allowed Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.516 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -127.36 -165.97 1.54 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.603 1.701 . . . . 0.0 109.626 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -131.44 149.94 52.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 p -140.38 153.27 46.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.095 0.474 . . . . 0.0 110.461 -170.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -117.57 89.95 3.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -173.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 m -67.69 120.33 13.89 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -146.0 136.95 24.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.528 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -80.83 35.42 0.37 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.923 -1.111 . . . . 0.0 111.344 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.48 41.79 49.61 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.989 1.757 . . . . 0.0 115.605 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.98 -21.12 50.19 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.718 2.759 . . . . 0.0 114.137 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.2 mt -121.4 13.13 10.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.743 1.617 . . . . 0.0 108.936 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.4 tp 64.16 -29.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.269 2.627 . . . . 0.0 113.734 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -168.13 91.22 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.004 1.322 . . . . 0.0 107.677 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.77 -43.35 79.99 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.62 152.94 67.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 -173.42 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.99 3.127 . . . . 0.0 112.953 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.8 34.14 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.785 1.634 . . . . 0.0 112.29 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 m -158.08 133.7 8.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.668 1.987 . . . . 0.0 106.893 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.55 -143.17 14.13 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.4 mm -123.49 140.1 48.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -117.76 149.88 40.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -138.63 142.87 39.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.68 123.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.77 117.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -160.44 -175.7 5.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.178 1.791 . . . . 0.0 108.008 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -152.47 72.9 1.0 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.313 -1.492 . . . . 0.0 110.897 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 65' ' ' ASN . 3.1 p -64.52 9.92 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.348 1.859 . . . . 0.0 114.873 175.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -48.77 158.94 0.27 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.181 1.393 . . . . 0.0 113.08 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.47 -149.09 43.54 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.54 4.48 6.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.95 -146.79 40.39 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -171.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -140.27 168.67 19.27 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.541 1.136 . . . . 0.0 108.654 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.267 20.1 tt -49.93 -38.73 37.85 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -170.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.94 -21.5 15.93 Favored 'Trans proline' 0 C--N 1.356 0.97 0 CA-C-N 123.63 2.332 . . . . 0.0 112.772 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 150.64 -58.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 130.896 3.678 . . . . 0.0 106.438 -169.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' A' ' 56' ' ' THR . 26.6 t-20 158.65 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 130.661 3.584 . . . . 0.0 105.239 -175.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.8 140.56 36.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.37 -57.88 0.11 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.911 -171.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.81 -37.17 0.94 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.04 1.407 . . . . 0.0 111.715 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -59.58 5.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.801 0.84 . . . . 0.0 111.133 -169.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.12 -48.26 79.07 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 124.055 0.847 . . . . 0.0 110.69 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.02 -45.94 83.38 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.852 0.296 . . . . 0.0 110.712 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.133 -0.46 . . . . 0.0 111.73 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -56.77 -55.67 31.27 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.812 0.733 . . . . 0.0 109.511 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -68.18 -18.66 64.65 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.53 -32.1 64.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.449 0.568 . . . . 0.0 111.693 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -122.45 -25.18 4.82 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 32.26 62.78 1.3 Allowed Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 127.139 2.175 . . . . 0.0 112.375 -176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.87 164.52 21.49 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -79.75 65.32 4.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 -174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.39 16.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.914 1.686 . . . . 0.0 113.039 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.7 p -66.03 -2.34 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 119.746 -1.846 . . . . 0.0 112.87 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.6 12.78 9.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.186 1.794 . . . . 0.0 110.777 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.6 158.83 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.654 0.74 . . . . 0.0 110.989 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -128.58 154.56 46.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.152 1.381 . . . . 0.0 107.469 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -113.77 167.83 10.3 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.34 120.04 2.12 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.47 34.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.8 mt -133.45 126.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.68 -18.55 2.96 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.953 1.263 . . . . 0.0 113.507 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -46.53 142.37 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.71 2.404 . . . . 0.0 110.539 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.35 15.02 8.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.042 1.782 . . . . 0.0 111.373 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.5 m -64.33 -18.79 64.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.954 1.302 . . . . 0.0 112.359 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -158.1 167.12 30.74 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.719 1.607 . . . . 0.0 108.786 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 73.7 -27.26 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 129.978 3.311 . . . . 0.0 113.287 169.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -154.98 138.48 15.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.054 0.942 . . . . 0.0 111.027 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.9 t0 38.36 45.73 0.85 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.289 2.636 . . . . 0.0 114.475 174.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.82 169.11 8.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.215 1.406 . . . . 0.0 111.919 174.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -146.45 157.97 43.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.023 1.729 . . . . 0.0 106.895 169.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.8 m -76.05 67.97 2.45 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.555 1.142 . . . . 0.0 109.706 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.28 -178.04 21.39 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 123.961 0.791 . . . . 0.0 112.015 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.58 -1.01 4.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.267 1.427 . . . . 0.0 114.495 -171.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.1 pt -54.18 -30.53 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.296 1.438 . . . . 0.0 113.279 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.2 -29.39 69.04 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.801 0.84 . . . . 0.0 112.41 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.42 -23.84 67.05 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.705 -169.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.48 -55.79 30.45 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.324 0.965 . . . . 0.0 109.54 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -71.14 -34.27 70.86 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.341 0.656 . . . . 0.0 109.684 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.94 87.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.003 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.66 -38.26 88.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.572 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.04 -50.27 74.72 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.298 0.954 . . . . 0.0 111.018 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.335 4.8 ptmm? -73.49 -27.98 61.68 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.897 -0.502 . . . . 0.0 112.321 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -37.74 87.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.453 1.101 . . . . 0.0 110.574 169.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -69.18 -36.24 77.12 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.543 0.337 . . . . 0.0 110.136 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.03 -20.69 0.36 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.52 -1.156 . . . . 0.0 114.99 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.31 -177.51 3.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.738 1.269 . . . . 0.0 111.139 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -141.59 152.87 44.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.104 1.362 . . . . 0.0 107.342 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -76.23 128.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -81.54 141.68 33.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.61 0.61 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.338 0.97 . . . . 0.0 111.871 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.14 178.11 10.66 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.266 2.226 . . . . 0.0 107.051 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.2 m -70.87 131.18 43.39 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.012 -1.055 . . . . 0.0 108.576 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.539 HD12 ' CE3' ' A' ' 138' ' ' TRP . 2.6 tt -83.01 147.83 27.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.411 ' N ' HD23 ' A' ' 121' ' ' LEU . 6.0 mptt -131.9 136.58 47.51 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.04 136.07 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 123.924 0.89 . . . . 0.0 109.284 -174.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.02 171.57 12.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.229 1.811 . . . . 0.0 107.59 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 39.9 pt -136.5 -173.38 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.103 1.761 . . . . 0.0 107.611 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.9 tp -53.99 -38.03 64.64 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.388 0.675 . . . . 0.0 111.16 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -76.21 64.59 2.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.878 1.271 . . . . 0.0 108.789 169.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -66.44 165.72 13.8 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.907 2.083 . . . . 0.0 112.001 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.89 -63.1 0.26 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.065 0.946 . . . . 0.0 112.254 -170.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.5 mt -133.65 -66.64 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 117.095 -1.431 . . . . 0.0 111.251 -169.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.43 -33.24 2.55 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.338 2.025 . . . . 0.0 112.36 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 68.29 19.54 8.98 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.086 1.754 . . . . 0.0 112.402 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -144.95 139.94 15.72 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.482 1.113 . . . . 0.0 109.835 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -83.99 -13.01 8.09 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.627 2.885 . . . . 0.0 115.149 -175.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 33.61 45.34 0.09 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.123 2.569 . . . . 0.0 114.807 -174.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.76 -22.56 66.67 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.308 -0.87 . . . . 0.0 112.692 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.85 -28.23 69.35 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.926 0.89 . . . . 0.0 111.614 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.539 ' CE3' HD12 ' A' ' 121' ' ' LEU . 8.2 t90 -56.08 -57.92 10.12 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 109.244 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tp -53.07 -53.05 55.97 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.635 1.209 . . . . 0.0 110.062 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.97 -53.09 48.02 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -64.67 -45.26 87.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.471 0.635 . . . . 0.0 110.357 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -61.6 -41.37 97.36 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.214 1.006 . . . . 0.0 110.864 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.35 -48.53 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.135 0.574 . . . . 0.0 109.569 172.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.44 -28.86 70.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.193 0.906 . . . . 0.0 111.785 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mp -78.8 -45.78 20.2 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.263 1.025 . . . . 0.0 110.504 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.5 65.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.348 0.522 . . . . 0.0 111.702 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.302 1.041 . . . . 0.0 110.049 171.863 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.59 156.97 43.34 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 0.0 108.431 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.86 -24.12 12.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 110.817 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.2 mt -130.0 122.86 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 t -88.37 132.76 34.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.85 97.24 7.87 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 mm -83.92 70.55 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.57 165.56 23.57 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.298 0.57 . . . . 0.0 110.704 -177.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.08 -174.34 50.95 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 p -144.66 -53.95 0.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.8 p -87.1 40.09 0.9 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.177 1.791 . . . . 0.0 109.631 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp 62.88 24.86 14.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.821 1.648 . . . . 0.0 112.003 -169.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.14 164.44 33.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.76 170.72 20.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.069 1.319 . . . . 0.0 111.198 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 55.63 -1.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.238 2.615 . . . . 0.0 117.449 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.58 -32.95 69.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.43 1.468 . . . . 0.0 112.262 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -58.64 -43.58 89.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.979 0.512 . . . . 0.0 111.163 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.31 -37.86 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.93 83.89 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.089 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.53 -45.12 95.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.917 0.781 . . . . 0.0 110.421 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -64.97 -46.51 81.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.973 0.352 . . . . 0.0 110.093 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.16 -54.17 48.38 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.023 0.929 . . . . 0.0 110.301 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.22 -43.59 74.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.341 1.056 . . . . 0.0 111.17 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -61.31 -54.11 48.15 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.813 0.733 . . . . 0.0 110.596 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -57.94 -36.23 72.22 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.4 mt -71.95 -26.23 62.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.092 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.38 -41.23 73.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 120.241 1.382 . . . . 0.0 108.911 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.18 -26.31 68.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.534 0.734 . . . . 0.0 111.458 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.54 -14.0 62.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.966 0.907 . . . . 0.0 111.745 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.92 17.23 6.95 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.845 -0.975 . . . . 0.0 113.594 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -122.73 -168.99 1.84 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.684 1.242 . . . . 0.0 109.853 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -126.15 153.2 44.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.7 p -143.33 159.31 42.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.827 -0.546 . . . . 0.0 110.06 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.31 97.81 4.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -69.91 122.56 19.53 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -147.07 175.72 10.49 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.982 1.313 . . . . 0.0 108.663 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -120.21 39.97 3.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 108.482 169.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.99 46.41 32.68 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 117.599 -1.667 . . . . 0.0 115.108 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -64.37 -22.09 66.27 Favored 'Trans proline' 0 C--N 1.35 0.651 0 CA-C-N 121.205 2.502 . . . . 0.0 113.616 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.71 8.78 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.028 1.731 . . . . 0.0 109.832 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 58.33 -14.79 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.502 2.721 . . . . 0.0 115.197 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -159.26 76.32 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 120.004 1.274 . . . . 0.0 109.438 -169.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.32 -47.85 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.593 -0.692 . . . . 0.0 109.529 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.65 153.43 58.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.32 -176.5 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.14 3.227 . . . . 0.0 113.301 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.43 33.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.874 1.67 . . . . 0.0 112.567 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -159.76 133.42 7.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.238 2.215 . . . . 0.0 106.792 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.7 -144.96 16.4 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -121.35 146.99 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.409 ' CD1' HG21 ' A' ' 83' ' ' VAL . 4.9 m95 -133.34 153.81 51.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.5 mt -136.61 143.35 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -123.24 131.85 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.7 91.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -142.57 -170.78 3.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.264 1.825 . . . . 0.0 107.908 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m -144.61 133.27 22.23 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p -133.81 1.17 3.3 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -171.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -58.78 135.19 57.4 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.747 1.158 . . . . 0.0 108.287 169.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.96 32.42 75.26 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -173.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.65 6.77 1.65 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.874 2.47 . . . . 0.0 114.544 -169.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.26 -164.97 12.4 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.932 1.254 . . . . 0.0 111.286 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.44 -24.22 66.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.689 0.796 . . . . 0.0 112.86 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 pt -138.4 163.34 47.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.719 2.007 . . . . 0.0 107.629 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -56.01 -16.04 15.37 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.154 3.236 . . . . 0.0 116.74 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -142.96 63.74 1.37 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.751 1.22 . . . . 0.0 107.926 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -60.95 -34.16 74.3 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.379 1.072 . . . . 0.0 113.839 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.2 55.63 3.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -54.7 52.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.433 -0.792 . . . . 0.0 112.445 -168.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -77.84 -41.36 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.568 2.178 . . . . 0.0 110.514 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.12 -51.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.347 0.659 . . . . 0.0 110.937 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.23 -43.55 91.06 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.99 0.814 . . . . 0.0 110.476 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -62.54 -47.27 84.64 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.832 0.742 . . . . 0.0 110.256 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.13 -32.09 72.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.89 -59.69 4.97 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.178 0.899 . . . . 0.0 109.437 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.28 -17.2 62.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.01 -35.06 79.08 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.242 0.617 . . . . 0.0 111.129 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.0 -22.03 4.21 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 33.7 63.22 1.66 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.81 164.23 16.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.027 2.485 . . . . 0.0 113.634 -169.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -80.42 64.97 5.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.54 1.136 . . . . 0.0 111.234 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.12 17.05 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 113.063 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 p -66.78 -2.87 5.56 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 119.922 -1.736 . . . . 0.0 112.789 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.1 11.97 9.56 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.1 1.76 . . . . 0.0 110.946 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -130.29 156.11 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.73 0.776 . . . . 0.0 111.439 176.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -121.33 152.47 38.92 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 108.323 169.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.401 ' CZ ' ' CE3' ' A' ' 50' ' ' TRP . 5.8 m-85 -123.69 166.96 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.599 -169.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.91 144.48 12.96 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.969 -2.852 . . . . 0.0 105.969 168.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.36 125.54 50.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 90' ' ' ILE . 34.3 mt -129.59 133.12 65.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -169.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.64 -28.42 1.54 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.799 1.19 . . . . 0.0 112.091 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' H ' ' C ' ' A' ' 88' ' ' ILE . 62.2 mt -48.83 138.77 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.509 2.724 . . . . 0.0 108.404 173.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.2 -0.0 35.39 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.344 1.45 . . . . 0.0 111.468 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 m -58.17 -0.11 0.08 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.995 2.518 . . . . 0.0 115.81 -172.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 93' ' ' ARG . 4.6 mmp_? -144.56 146.56 32.41 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 168.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 70.87 -21.07 0.2 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.675 2.79 . . . . 0.0 113.252 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -132.54 -0.17 3.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.1 1.36 . . . . 0.0 111.862 -169.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -94.42 3.54 55.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.636 1.574 . . . . 0.0 113.569 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.5 p -76.32 -3.6 37.61 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.41 1.484 . . . . 0.0 113.334 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -76.58 -19.45 57.86 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.52 1.928 . . . . 0.0 110.987 170.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.3 31.52 3.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.991 1.716 . . . . 0.0 109.701 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.28 -80.84 1.24 Allowed Glycine 0 C--N 1.338 0.667 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -161.16 148.16 15.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.1 1.36 . . . . 0.0 108.582 169.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.0 mm -127.27 2.71 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 126.732 2.013 . . . . 0.0 108.728 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -43.22 -29.14 0.36 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.68 1.992 . . . . 0.0 113.965 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -45.51 -35.71 4.04 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.64 1.576 . . . . 0.0 113.099 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.68 -57.28 13.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.653 0.661 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -34.66 78.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.846 0.458 . . . . 0.0 110.245 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.54 94.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.03 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.53 -38.49 90.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.995 0.816 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.48 -44.36 87.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.835 0.743 . . . . 0.0 111.408 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -67.33 -36.05 80.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.537 0.735 . . . . 0.0 109.816 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -36.26 82.44 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.207 1.403 . . . . 0.0 111.332 172.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.6 m -67.56 -35.4 78.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.861 0.464 . . . . 0.0 110.521 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.86 -24.6 0.3 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.686 -1.063 . . . . 0.0 115.061 169.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.94 170.96 11.61 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.617 1.208 . . . . 0.0 111.384 -173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -121.62 133.18 54.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -78.78 102.27 8.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 169.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 m -70.77 150.79 45.52 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.86 -129.24 26.96 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.3 pt-20 -153.99 174.93 14.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.908 1.283 . . . . 0.0 108.592 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -59.52 129.79 43.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.108 0.963 . . . . 0.0 110.604 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.4 148.51 22.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.21 2.204 . . . . 0.0 107.946 -173.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -125.99 146.51 49.85 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.61 157.16 26.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 125.265 1.426 . . . . 0.0 109.374 -169.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -164.07 29.6 0.08 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.317 0.647 . . . . 0.0 111.359 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.6 tp -64.81 100.04 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.274 1.03 . . . . 0.0 110.254 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.0 tp 47.96 32.0 2.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.687 1.995 . . . . 0.0 112.447 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -160.72 155.01 23.2 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.57 1.548 . . . . 0.0 108.067 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.07 153.62 51.69 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.115 1.366 . . . . 0.0 108.834 -177.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -151.76 -70.88 0.16 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.76 0.791 . . . . 0.0 110.944 -169.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.591 ' H ' ' HD2' ' A' ' 131' ' ' PRO . 8.3 mm -145.83 -52.6 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.454 1.901 . . . . 0.0 113.038 -169.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.591 ' HD2' ' H ' ' A' ' 130' ' ' ILE . 63.8 Cg_endo -75.51 -46.4 0.22 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 121.876 1.706 . . . . 0.0 112.47 -171.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 49.99 34.85 8.66 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.162 1.785 . . . . 0.0 111.991 -174.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -153.71 81.43 4.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.364 1.466 . . . . 0.0 108.504 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.68 153.53 75.77 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.637 2.224 . . . . 0.0 111.533 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -144.87 41.84 1.31 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.026 1.33 . . . . 0.0 109.967 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -58.16 -19.73 35.3 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.319 1.448 . . . . 0.0 114.304 -169.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -57.64 -25.86 60.77 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.09 0.956 . . . . 0.0 111.731 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.428 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.34 -42.3 77.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.018 172.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.98 -48.84 77.1 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.92 -47.42 59.52 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.074 0.858 . . . . 0.0 111.437 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -62.57 -55.0 31.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.529 0.665 . . . . 0.0 110.166 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -55.04 -39.78 69.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.49 1.916 . . . . 0.0 111.34 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.31 -58.83 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 109.733 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -16.01 63.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.274 0.943 . . . . 0.0 112.303 -172.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.12 -38.46 61.1 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.023 0.929 . . . . 0.0 111.236 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -34.8 44.87 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.647 0.779 . . . . 0.0 111.878 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttm . . . . . 0 C--O 1.248 1.015 0 C-N-CA 125.233 1.413 . . . . 0.0 109.867 171.193 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.3 161.06 43.18 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.004 0.922 . . . . 0.0 110.179 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.88 -23.9 16.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.769 1.627 . . . . 0.0 110.479 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.5 mt -135.18 127.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.532 1.133 . . . . 0.0 108.023 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 t -88.2 126.66 35.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.68 95.58 6.14 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.856 1.262 . . . . 0.0 108.885 -169.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -76.36 159.38 30.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.52 9.17 0.03 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.02 123.81 17.15 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.227 2.014 . . . . 0.0 109.587 175.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p 38.21 57.57 1.62 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.57 1.948 . . . . 0.0 113.573 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.1 tp 51.26 63.18 2.35 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 111.372 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.16 -149.77 17.28 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.3 -179.69 38.98 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 117.736 0.768 . . . . 0.0 111.929 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.06 56.16 0.76 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.008 1.323 . . . . 0.0 109.642 171.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.44 -28.91 67.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.363 -0.836 . . . . 0.0 112.228 -172.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -62.14 -40.9 97.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.971 0.805 . . . . 0.0 110.854 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.16 -37.73 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.72 87.6 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.885 0.766 . . . . 0.0 110.952 174.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.21 -40.05 82.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.298 0.639 . . . . 0.0 110.931 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.11 -46.22 88.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.457 -0.777 . . . . 0.0 110.396 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.1 mt -55.99 -52.69 63.28 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.599 1.159 . . . . 0.0 109.894 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.12 -49.97 59.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.533 1.133 . . . . 0.0 110.924 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.29 -53.93 49.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 110.576 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -60.61 -39.39 87.99 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.51 -33.68 76.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.166 0.587 . . . . 0.0 111.52 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.73 -37.14 67.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.846 -1.159 . . . . 0.0 110.265 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.03 -30.15 70.77 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.668 0.667 . . . . 0.0 111.113 170.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.65 62.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 111.797 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.27 -2.53 6.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.247 -1.307 . . . . 0.0 114.257 169.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -101.25 -168.23 1.53 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.564 1.682 . . . . 0.0 110.104 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -128.36 150.92 49.89 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.3 p -142.9 154.59 44.26 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.9 -0.5 . . . . 0.0 111.836 -169.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -119.81 99.37 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.463 1.505 . . . . 0.0 107.966 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -73.97 122.58 22.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.61 169.95 17.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.849 0.859 . . . . 0.0 111.06 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -119.6 39.57 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.197 1.799 . . . . 0.0 108.789 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 51.62 11.58 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.858 -1.523 . . . . 0.0 114.801 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -21.94 64.67 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 120.662 2.231 . . . . 0.0 113.389 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.87 16.75 6.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.552 1.941 . . . . 0.0 108.741 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 tp 59.9 -25.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.354 3.062 . . . . 0.0 115.076 -169.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.42 85.68 0.86 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -168.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.91 -44.8 88.37 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.536 -0.727 . . . . 0.0 109.847 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.22 151.29 59.59 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.52 -176.79 1.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 124.128 3.219 . . . . 0.0 113.087 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.26 31.88 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.989 1.716 . . . . 0.0 112.933 172.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.4 m -158.93 121.79 3.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.699 2.0 . . . . 0.0 106.445 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.16 -142.88 11.49 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -122.29 136.26 59.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.464 ' CD1' HG21 ' A' ' 83' ' ' VAL . 12.1 m0 -119.41 137.31 53.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 172.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 mt -131.81 137.69 48.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 173.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.82 137.72 53.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.07 113.01 23.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -161.73 -178.18 6.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.117 1.367 . . . . 0.0 108.457 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 m -133.18 124.85 28.2 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 p -122.05 2.41 9.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.024 0.93 . . . . 0.0 113.301 -169.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -142.94 148.43 36.88 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 170.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.76 -33.45 0.72 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.014 1.292 . . . . 0.0 114.875 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.34 44.74 1.42 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.602 1.561 . . . . 0.0 110.42 -170.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.42 -158.78 7.82 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -149.45 77.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.794 1.638 . . . . 0.0 106.76 -172.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.1 pt -46.96 -29.99 1.12 Allowed Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 -169.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -57.84 -31.93 93.68 Favored 'Trans proline' 0 C--N 1.353 0.788 0 CA-C-N 123.833 2.405 . . . . 0.0 113.982 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -160.11 45.21 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.368 1.08 . . . . 0.0 109.799 -171.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -31.69 65.41 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.237 1.815 . . . . 0.0 114.662 -169.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -129.68 90.28 2.96 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -53.74 31.51 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 124.857 1.263 . . . . 0.0 113.209 -168.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.47 -38.59 8.21 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.175 1.25 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -57.83 8.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.774 -170.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.58 -47.16 86.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.704 -171.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -64.5 -48.64 74.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.626 0.648 . . . . 0.0 110.539 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.41 -26.24 67.89 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.8 mt -62.34 -62.4 1.78 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.238 0.926 . . . . 0.0 108.868 170.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -67.18 -19.57 65.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.45 -34.49 78.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.601 0.76 . . . . 0.0 111.462 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.39 -23.19 2.4 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.84 63.13 1.01 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 127.13 2.172 . . . . 0.0 113.077 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 166.85 17.89 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.968 2.445 . . . . 0.0 113.164 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.66 63.8 5.21 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.954 1.302 . . . . 0.0 111.343 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.91 9.87 0.48 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.273 1.429 . . . . 0.0 113.074 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -63.93 -2.48 1.93 Allowed 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.105 2.962 . . . . 0.0 113.235 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.06 9.71 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.991 1.716 . . . . 0.0 110.919 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -124.65 146.44 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.916 0.865 . . . . 0.0 111.401 172.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -97.67 141.26 30.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.63 153.04 32.0 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.581 1.952 . . . . 0.0 107.537 -174.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.67 149.55 21.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.96 134.95 54.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -175.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.8 mt -134.8 128.79 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.17 -29.08 1.65 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.389 0.995 . . . . 0.0 112.461 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.1 mt -47.97 117.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.784 2.434 . . . . 0.0 107.849 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.01 -41.01 28.62 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.888 1.708 . . . . 0.0 111.079 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -51.37 106.56 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.085 1.754 . . . . 0.0 110.208 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -150.55 -172.29 4.15 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.232 1.813 . . . . 0.0 107.19 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -60.85 -20.75 62.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.8 1.24 . . . . 0.0 111.537 169.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -139.31 -173.49 3.61 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.498 2.719 . . . . 0.0 108.413 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t0 48.01 43.63 18.11 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.793 1.282 . . . . 0.0 111.122 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.7 m -151.82 66.55 0.86 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -169.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -126.7 -16.16 5.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.9 p -134.05 16.66 3.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.294 0.952 . . . . 0.0 112.219 175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.71 166.54 30.6 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.221 1.391 . . . . 0.0 110.11 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.69 150.2 24.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.115 1.366 . . . . 0.0 108.131 171.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 40.64 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.69 -22.88 25.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.148 1.379 . . . . 0.0 112.068 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -52.71 -29.83 28.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.594 1.157 . . . . 0.0 112.748 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.57 -54.32 48.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.41 1.004 . . . . 0.0 109.678 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -67.66 -37.66 82.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.761 1.224 . . . . 0.0 108.673 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.9 79.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.527 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.82 -34.95 79.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.136 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.55 -49.99 75.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.745 1.157 . . . . 0.0 111.201 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -69.28 -34.28 74.48 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.727 0.811 . . . . 0.0 109.938 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -37.78 84.16 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.763 1.625 . . . . 0.0 111.231 172.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -65.86 -40.49 91.72 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.35 -20.61 0.4 Allowed Glycine 0 C--N 1.341 0.827 0 CA-C-O 117.811 -1.55 . . . . 0.0 115.135 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 132.82 49.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.699 1.749 . . . . 0.0 109.453 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -83.84 114.67 21.81 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -64.02 114.67 4.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 170.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.4 m -126.65 115.08 18.9 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.32 103.78 2.37 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -169.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -52.95 137.26 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.149 -1.526 . . . . 0.0 107.379 169.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.2 m -47.87 116.42 1.49 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.722 1.609 . . . . 0.0 111.347 -169.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.69 153.8 26.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.188 1.795 . . . . 0.0 107.718 -169.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -129.09 146.5 51.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp -135.39 163.0 36.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 124.549 1.139 . . . . 0.0 111.252 -169.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.89 141.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 130.262 3.425 . . . . 0.0 115.31 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 7.7 tp -150.01 9.8 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 124.402 1.081 . . . . 0.0 110.936 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.29 -29.42 70.42 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.155 -0.966 . . . . 0.0 111.436 -176.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -149.18 167.92 24.64 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.555 1.942 . . . . 0.0 106.704 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -56.72 148.06 21.27 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.1 0.56 . . . . 0.0 109.668 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -154.93 -126.38 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.473 0.709 . . . . 0.0 110.184 -173.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.5 mm -135.6 -61.92 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 127.394 2.278 . . . . 0.0 109.037 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.92 -48.91 2.46 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.271 1.981 . . . . 0.0 110.039 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 44.53 68.0 0.61 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.878 2.071 . . . . 0.0 113.107 169.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -150.64 140.59 13.99 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 121.407 -0.808 . . . . 0.0 111.293 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.1 -19.15 19.53 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.337 3.358 . . . . 0.0 116.731 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 68.68 -36.92 0.34 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.661 2.784 . . . . 0.0 115.153 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.16 -33.04 70.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.545 0.738 . . . . 0.0 112.702 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.08 -37.39 72.45 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.027 -0.421 . . . . 0.0 110.443 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -45.26 77.92 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.437 0.695 . . . . 0.0 109.871 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.69 -52.6 65.02 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.48 95.01 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.047 0.84 . . . . 0.0 112.051 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -59.29 -62.94 1.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.074 1.35 . . . . 0.0 110.239 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -56.09 -44.78 79.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.612 1.165 . . . . 0.0 111.978 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.4 -55.92 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.848 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -16.29 63.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.81 1.186 . . . . 0.0 112.053 -174.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.1 mp -78.2 -47.22 18.52 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.535 0.734 . . . . 0.0 111.029 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.18 -32.54 64.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.0 0.818 . . . . 0.0 112.329 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.7 mttt . . . . . 0 C--O 1.249 1.028 0 C-N-CA 124.752 1.221 . . . . 0.0 109.611 173.34 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 tpp . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.02 160.16 43.14 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.575 1.15 . . . . 0.0 108.917 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.61 -25.13 13.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.43 1.492 . . . . 0.0 111.059 175.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.56 121.77 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -83.88 130.55 34.91 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.56 109.6 21.33 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.308 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.5 mt -103.66 94.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.22 14.82 27.07 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.06 0.944 . . . . 0.0 112.075 -171.118 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.64 58.87 4.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.128 -171.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -54.6 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.741 1.27 . . . . 0.0 110.25 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m 57.7 42.3 23.95 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.78 0.832 . . . . 0.0 110.804 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.1 39.56 29.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.236 1.815 . . . . 0.0 111.398 -169.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.94 -145.3 7.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.493 1.996 . . . . 0.0 109.7 173.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.72 62.12 0.29 Allowed Glycine 0 C--N 1.334 0.447 0 CA-C-N 117.556 0.678 . . . . 0.0 111.902 -172.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.53 19.96 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.5 1.12 . . . . 0.0 112.476 172.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.9 -20.19 64.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 112.482 -170.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.93 -40.4 76.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.237 0.926 . . . . 0.0 111.326 176.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.96 -41.42 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.776 -176.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.23 -43.55 94.61 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 110.43 175.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -66.35 -44.41 83.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.044 -0.41 . . . . 0.0 110.039 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.46 -52.45 65.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.159 0.584 . . . . 0.0 110.733 177.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.27 -45.37 65.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.287 1.035 . . . . 0.0 110.76 176.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.33 -54.2 48.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.158 0.89 . . . . 0.0 110.484 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -57.66 -43.75 85.19 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 123.646 0.778 . . . . 0.0 112.275 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -69.15 -34.49 75.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.919 0.887 . . . . 0.0 111.356 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.9 -44.05 73.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.316 -0.865 . . . . 0.0 109.642 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -71.65 -18.52 62.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.174 0.897 . . . . 0.0 111.954 174.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -18.95 63.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.83 0.741 . . . . 0.0 111.083 169.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.09 12.54 5.78 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.267 -1.296 . . . . 0.0 114.442 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -117.8 -172.08 2.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.411 1.606 . . . . 0.0 109.93 -174.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -124.13 153.99 40.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 170.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -142.54 158.91 43.18 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.838 -0.539 . . . . 0.0 109.93 -169.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.2 99.24 5.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 m -72.18 118.88 15.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.0 mt -149.48 164.95 33.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.625 0.726 . . . . 0.0 111.585 -169.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -106.12 35.68 2.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.393 1.477 . . . . 0.0 108.506 168.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.74 14.26 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.963 -175.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.5 -20.31 65.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 120.871 2.335 . . . . 0.0 113.864 -173.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.25 9.89 14.69 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.654 . . . . 0.0 109.766 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt 60.38 -18.19 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.406 2.682 . . . . 0.0 114.627 -169.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -166.3 75.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.498 1.519 . . . . 0.0 107.232 -169.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.38 -44.61 96.04 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.773 -0.579 . . . . 0.0 109.818 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.6 mt -89.24 150.39 44.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.42 -177.45 1.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.674 2.916 . . . . 0.0 113.106 -175.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.08 35.51 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.65 1.58 . . . . 0.0 111.898 169.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -157.69 125.15 5.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.973 2.109 . . . . 0.0 106.272 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.96 -145.23 17.19 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -174.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.4 mm -126.48 144.34 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -127.1 158.12 37.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -143.28 143.79 31.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.15 135.35 62.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.17 124.59 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -170.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.0 m -163.98 -167.48 1.37 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.216 2.206 . . . . 0.0 107.1 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.1 m -148.88 62.57 1.06 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.435 -1.415 . . . . 0.0 108.0 172.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -55.51 -26.75 44.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.569 1.548 . . . . 0.0 114.128 -169.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -61.08 -22.82 64.97 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 176.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 171.31 16.15 0.02 OUTLIER Glycine 0 C--N 1.341 0.857 0 N-CA-C 117.436 1.735 . . . . 0.0 117.436 176.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.58 24.12 2.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.384 1.073 . . . . 0.0 111.095 176.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.7 163.58 51.74 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 169.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.67 -24.18 61.79 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.981 -0.717 . . . . 0.0 112.188 -175.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 65' ' ' ASN . 10.7 tp -143.94 152.22 54.69 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 171.461 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.81 -34.08 63.72 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.526 2.151 . . . . 0.0 115.532 -176.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.54 -47.09 70.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.866 0.757 . . . . 0.0 110.84 174.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' H ' HG23 ' A' ' 62' ' ' ILE . 31.2 t30 58.32 143.4 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 130.701 3.601 . . . . 0.0 115.269 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.1 mt 52.75 46.23 27.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 108.575 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 m -75.88 -49.5 3.43 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 124.549 1.14 . . . . 0.0 111.833 -170.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 -34.45 41.59 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.97 1.382 . . . . 0.0 110.584 176.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -59.69 -51.3 70.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.976 0.911 . . . . 0.0 110.125 173.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 104' ' ' LYS . 39.0 t80 -55.46 -48.29 74.73 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.48 1.112 . . . . 0.0 110.846 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -65.65 -41.65 92.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.523 0.601 . . . . 0.0 111.453 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.6 84.83 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.666 0.666 . . . . 0.0 111.326 -178.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.63 -57.35 12.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.777 0.717 . . . . 0.0 109.816 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -69.2 -15.57 63.42 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.65 -32.09 63.83 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.85 0.75 . . . . 0.0 111.295 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.78 -30.1 4.52 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -173.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 26.64 70.37 0.43 Allowed Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.06 2.144 . . . . 0.0 113.331 -172.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -58.15 176.65 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.791 2.327 . . . . 0.0 112.004 174.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -90.02 76.16 7.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.73 0.812 . . . . 0.0 110.342 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.588 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.1 mm? -74.74 5.63 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.617 0.767 . . . . 0.0 112.557 -175.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 m -65.14 -5.51 6.9 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 127.839 2.456 . . . . 0.0 113.268 -176.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.93 8.74 26.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.469 1.508 . . . . 0.0 110.702 176.122 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.94 160.54 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 122.146 0.974 . . . . 0.0 110.945 176.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -129.11 154.11 47.02 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.08 1.752 . . . . 0.0 106.929 172.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -127.38 173.9 9.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.534 0.683 . . . . 0.0 109.428 178.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.13 157.87 26.17 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.64 125.13 41.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.0 mt -129.31 134.08 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -168.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.71 -31.78 1.69 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.537 1.541 . . . . 0.0 112.009 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.3 mt -47.88 154.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 129.583 3.153 . . . . 0.0 110.857 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.63 -15.1 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.051 -0.86 . . . . 0.0 114.73 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.9 m -61.57 132.32 52.95 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.304 1.052 . . . . 0.0 109.805 177.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -148.73 170.64 17.73 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.807 2.043 . . . . 0.0 106.939 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -55.4 -21.52 16.0 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.518 1.527 . . . . 0.0 113.363 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -117.74 4.77 12.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.541 1.537 . . . . 0.0 112.37 -177.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.01 17.2 23.81 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.101 0.953 . . . . 0.0 110.731 175.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 p -70.2 17.53 0.06 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.39 2.676 . . . . 0.0 115.157 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -128.45 -9.55 5.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.546 1.538 . . . . 0.0 111.026 174.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.44 24.46 2.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.903 1.281 . . . . 0.0 111.04 -173.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.22 -167.27 16.6 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -176.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.52 18.8 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.087 2.155 . . . . 0.0 113.163 179.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 mt 49.3 32.43 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 126.539 1.936 . . . . 0.0 110.452 -169.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 57.04 11.12 0.91 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.571 1.948 . . . . 0.0 114.022 -177.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 51.5 mtmt -64.91 -42.17 94.96 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.541 -1.349 . . . . 0.0 113.33 -169.483 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.55 -53.15 58.98 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 47.9 mp0 -61.24 -41.18 96.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.595 1.158 . . . . 0.0 110.455 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.77 76.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.49 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.246 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 mt -58.65 -46.64 86.7 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.427 1.012 . . . . 0.0 110.867 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -67.34 -41.26 85.48 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.462 0.705 . . . . 0.0 109.723 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -30.85 71.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.043 1.337 . . . . 0.0 111.331 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.588 ' HB3' HD23 ' A' ' 80' ' ' LEU . 16.2 m -74.16 -13.88 60.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.25 0.22 . . . . 0.0 111.496 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.48 -24.33 3.73 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 121.174 -0.954 . . . . 0.0 113.033 169.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.25 167.8 15.54 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.053 0.927 . . . . 0.0 110.631 -177.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -120.54 144.3 48.13 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -83.68 104.73 14.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 83.2 m -70.38 153.46 42.97 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 -131.29 21.43 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 178.286 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.4 pt-20 -150.43 178.56 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.192 1.397 . . . . 0.0 107.862 169.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.49 123.08 9.03 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.927 1.291 . . . . 0.0 109.824 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.55 155.75 17.13 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.61 1.564 . . . . 0.0 107.712 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -139.33 151.4 46.36 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.112 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -144.05 124.77 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 126.125 1.77 . . . . 0.0 106.718 -169.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -164.06 -177.8 5.23 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.332 -0.855 . . . . 0.0 112.23 176.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.6 tt -151.39 174.66 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.058 1.743 . . . . 0.0 107.773 -171.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.42 -35.64 60.64 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.986 1.315 . . . . 0.0 112.225 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -75.03 77.09 2.22 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -56.75 156.15 6.84 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -169.263 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -140.46 -170.21 2.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.995 2.518 . . . . 0.0 107.873 171.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.99 -50.3 75.77 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.352 1.861 . . . . 0.0 113.384 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -63.9 -38.93 35.67 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.405 2.07 . . . . 0.0 111.502 178.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 72.34 -26.35 0.18 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.812 2.445 . . . . 0.0 114.532 169.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -144.73 124.49 7.18 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 123.995 0.918 . . . . 0.0 109.826 -171.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.22 157.38 57.37 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.682 2.255 . . . . 0.0 111.64 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -139.82 41.08 2.0 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.194 1.398 . . . . 0.0 109.707 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.15 -19.01 17.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.254 1.422 . . . . 0.0 114.804 -169.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.62 -26.32 65.37 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.416 -0.803 . . . . 0.0 111.458 173.219 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' TRP . . . . . 0.451 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -61.11 -42.04 97.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.599 0.76 . . . . 0.0 110.281 172.257 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.93 -49.68 73.82 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.96 -46.62 68.61 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 123.823 0.702 . . . . 0.0 111.721 177.034 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.1 m -62.47 -59.17 5.34 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.345 1.458 . . . . 0.0 110.818 177.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -49.8 -41.72 45.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.969 2.108 . . . . 0.0 111.872 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.0 t -63.96 -58.41 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 125.182 1.393 . . . . 0.0 109.813 173.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -15.74 63.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.311 0.959 . . . . 0.0 112.324 -173.085 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.87 -41.55 59.57 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.022 0.929 . . . . 0.0 111.168 170.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.5 -31.27 42.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -176.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.1 1.36 . . . . 0.0 109.721 169.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 tpp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.23 161.9 41.89 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.887 0.875 . . . . 10.0 110.287 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.11 -18.62 21.6 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.751 1.22 . . . . 10.0 110.984 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mt -137.22 129.15 42.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 C-N-CA 124.399 1.08 . . . . 10.0 108.429 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 t -91.41 137.62 32.22 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.645 -1.242 . . . . 10.0 107.645 168.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -112.4 91.75 3.77 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 104.614 -2.365 . . . . 10.0 104.614 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.4 104.08 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.4 1.48 . . . . 10.0 107.195 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -128.69 46.09 2.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.469 0.708 . . . . 10.0 111.868 -154.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.39 56.33 0.44 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-O 117.968 -1.462 . . . . 10.0 114.103 -161.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 m -33.39 -52.86 0.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.124 1.77 . . . . 10.0 113.646 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.35 42.33 2.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.514 1.125 . . . . 10.0 108.491 -170.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.9 tp 56.9 28.8 15.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.658 1.583 . . . . 10.0 111.075 -164.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.33 155.22 17.34 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.965 2.698 . . . . 10.0 106.485 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.05 -164.78 35.55 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 117.932 0.866 . . . . 10.0 111.669 -166.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.47 52.23 0.62 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.578 1.951 . . . . 10.0 112.882 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -55.8 -31.63 62.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.241 1.016 . . . . 10.0 112.212 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -60.92 -50.07 74.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.981 0.81 . . . . 10.0 110.768 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.45 -39.97 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.29 84.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.897 -0.573 . . . . 10.0 111.813 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.37 -39.48 85.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.974 0.807 . . . . 10.0 110.331 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -63.65 -46.82 83.88 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.93 -0.482 . . . . 10.0 110.279 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.4 mt -57.96 -47.28 83.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.811 0.844 . . . . 10.0 110.15 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.18 83.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.209 1.004 . . . . 10.0 110.028 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.54 -47.06 87.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.371 0.532 . . . . 10.0 110.687 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -61.58 -34.7 76.07 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.673 -0.642 . . . . 10.0 111.33 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.17 -32.89 67.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.516 0.598 . . . . 10.0 111.185 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -70.79 -38.94 73.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.708 1.14 . . . . 10.0 109.865 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.68 -32.45 71.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.244 0.618 . . . . 10.0 111.087 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.19 -17.07 64.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.733 0.813 . . . . 10.0 112.799 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.38 18.96 4.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.836 -0.98 . . . . 10.0 113.555 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -120.82 -170.88 2.08 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.808 1.304 . . . . 10.0 109.797 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 p -131.66 145.26 51.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.146 -1.427 . . . . 10.0 107.146 172.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -136.65 158.86 43.45 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.125 -0.359 . . . . 10.0 110.912 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.01 92.59 3.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -65.17 119.84 11.59 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.307 1.043 . . . . 10.0 108.42 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -148.39 149.01 31.0 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 123.584 0.754 . . . . 10.0 108.988 -171.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -90.49 35.43 0.88 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.292 -0.88 . . . . 10.0 110.184 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.22 51.02 21.48 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.983 1.754 . . . . 10.0 114.572 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.04 -15.68 49.56 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.858 2.372 . . . . 10.0 113.435 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.11 13.6 11.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.404 1.482 . . . . 10.0 110.704 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 tp 62.42 -43.89 0.18 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.557 2.743 . . . . 10.0 113.316 -166.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -148.8 78.11 1.39 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.873 1.669 . . . . 10.0 108.121 -167.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.473 -0.767 . . . . 10.0 111.357 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.2 mt -84.48 147.42 49.62 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.947 -1.131 . . . . 10.0 107.947 164.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.64 -175.4 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.08 2.52 . . . . 10.0 111.873 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.61 21.94 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.896 1.678 . . . . 10.0 113.694 173.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.9 m -142.39 136.08 29.21 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.321 1.848 . . . . 10.0 106.797 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.01 -136.88 10.11 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.92 -1.272 . . . . 10.0 109.92 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -130.35 136.34 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.159 -1.793 . . . . 10.0 106.159 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -117.87 157.5 26.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -141.72 145.87 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.021 -1.844 . . . . 10.0 106.021 168.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.3 t -130.88 124.34 56.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.37 97.36 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.669 -1.604 . . . . 10.0 106.669 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -148.7 174.12 12.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 10.0 108.372 -170.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 m -137.52 70.47 1.4 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.597 1.09 . . . . 10.0 110.312 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.2 p . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -169.169 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 110.298 -0.26 . . . . 10.0 110.298 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.19 58.48 1.31 Allowed 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.486 0.714 . . . . 10.0 110.038 -170.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -45.95 -56.17 11.09 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.228 -1.368 . . . . 10.0 114.566 -167.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.57 -44.34 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 122.034 1.762 . . . . 10.0 111.633 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -65.41 -43.35 90.82 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 10.0 111.264 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.36 -45.49 83.9 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.921 0.782 . . . . 10.0 110.158 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.18 -42.79 99.42 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.12 96.03 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.03 0.377 . . . . 10.0 111.461 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -59.69 -51.56 69.26 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.703 0.683 . . . . 10.0 109.47 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.19 -31.27 72.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.667 0.667 . . . . 10.0 111.81 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.87 -30.95 71.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.724 0.81 . . . . 10.0 112.251 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -124.21 -27.3 3.84 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.491 1.293 . . . . 10.0 114.491 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 32.45 61.78 1.38 Allowed Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.286 1.834 . . . . 10.0 112.572 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.47 160.26 40.33 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.12 2.546 . . . . 10.0 110.955 -172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -73.23 76.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.071 0.949 . . . . 10.0 111.187 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 9.22 1.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.93 1.292 . . . . 10.0 112.269 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.0 m -60.84 -17.5 50.34 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.219 -1.551 . . . . 10.0 113.344 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.44 10.83 39.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.78 1.232 . . . . 10.0 112.594 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.95 160.79 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.229 1.012 . . . . 10.0 108.997 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -123.81 150.81 44.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.296 -1.742 . . . . 10.0 106.296 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.63 163.53 25.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.606 0.717 . . . . 10.0 110.476 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.04 116.66 1.69 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.394 -2.682 . . . . 10.0 106.394 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.04 144.32 56.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.38 131.23 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.521 -1.659 . . . . 10.0 106.521 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.09 -27.54 1.71 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.757 1.17 . . . . 10.0 113.012 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.24 139.29 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 127.15 2.18 . . . . 10.0 107.606 171.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.58 0.72 8.67 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.269 -0.739 . . . . 10.0 112.387 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 C-N-CA 124.518 1.127 . . . . 10.0 109.834 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 mttt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 113.491 0.923 . . . . 10.0 113.491 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.84 -52.8 62.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.23 0.923 . . . . 10.0 110.813 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.52 -43.77 98.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.1 93.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.046 0.938 . . . . 10.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -67.97 -36.79 80.65 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.416 1.007 . . . . 10.0 111.222 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.05 -45.14 94.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.278 0.944 . . . . 10.0 110.06 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -65.87 -39.21 90.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.22 0.608 . . . . 10.0 110.524 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.58 97.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.066 . . . . 10.0 110.975 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 m -72.45 -29.08 63.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.727 0.411 . . . . 10.0 110.651 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.89 -13.15 1.49 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.426 -1.208 . . . . 10.0 114.327 160.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.08 116.55 9.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.241 1.521 . . . . 10.0 108.131 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -61.73 139.02 58.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 167.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -80.84 128.78 34.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.154 -2.165 . . . . 10.0 105.154 158.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 m -105.06 148.45 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.8 -133.93 46.84 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.09 -1.604 . . . . 10.0 109.09 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.93 163.65 33.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.535 -1.654 . . . . 10.0 106.535 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -48.59 123.32 6.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.293 1.037 . . . . 10.0 112.082 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.33 147.36 48.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.793 1.237 . . . . 10.0 107.92 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -118.6 136.75 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.838 -1.171 . . . . 10.0 107.838 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 -174.263 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 118.588 -0.72 . . . . 10.0 111.223 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.81 -44.92 93.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.483 1.038 . . . . 10.0 108.934 171.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.47 -46.03 91.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.42 97.3 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.409 0.528 . . . . 10.0 112.672 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.6 m -61.57 -56.79 16.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.341 1.071 . . . . 10.0 110.75 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -59.51 -40.69 87.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.942 1.297 . . . . 10.0 110.699 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.27 -56.18 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.849 -0.596 . . . . 10.0 110.042 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -69.68 -21.86 63.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 10.0 112.136 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.45 -45.25 76.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.708 0.685 . . . . 10.0 110.631 168.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -22.43 57.69 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.973 0.806 . . . . 10.0 112.61 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.9 mttt . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.252 1.021 . . . . 10.0 108.406 169.521 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.55 167.21 31.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.126 1.371 . . . . 0.0 108.921 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.36 -25.07 25.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.697 0.799 . . . . 0.0 110.893 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.6 mt -138.27 127.63 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.749 1.22 . . . . 0.0 107.943 -171.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.18 135.21 33.39 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.4 104.64 13.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.7 mt -96.46 100.57 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -102.64 20.12 17.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.241 1.016 . . . . 0.0 110.735 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 36.51 2.17 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.072 1.32 . . . . 0.0 115.163 -169.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -47.65 -50.84 23.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.215 1.406 . . . . 0.0 112.268 -172.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -127.33 50.77 1.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.7 tp 63.29 20.05 12.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.813 2.045 . . . . 0.0 111.283 -169.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.14 178.1 36.64 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.248 3.308 . . . . 0.0 106.661 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -3.19 1.51 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.009 -1.439 . . . . 0.0 115.026 169.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.14 2.14 0.76 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.877 1.839 . . . . 0.0 113.966 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -53.29 -36.39 61.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.297 1.039 . . . . 0.0 112.07 -172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -54.97 -30.75 59.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.779 1.232 . . . . 0.0 112.825 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.99 -26.33 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.776 0.83 . . . . 0.0 109.522 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.36 72.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.228 0.922 . . . . 0.0 111.346 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.88 -39.3 93.32 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.238 0.926 . . . . 0.0 111.243 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -67.97 -45.4 74.27 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.804 -0.56 . . . . 0.0 109.617 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -54.13 -50.82 66.04 Favored 'General case' 0 C--N 1.337 0.035 0 C-N-CA 124.359 1.064 . . . . 0.0 110.323 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -48.69 72.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.895 0.878 . . . . 0.0 110.88 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.81 -53.56 56.81 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.69 0.677 . . . . 0.0 110.675 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -54.91 -42.51 72.26 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 123.838 0.855 . . . . 0.0 111.816 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -32.2 67.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.88 -46.67 74.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.472 1.033 . . . . 0.0 109.842 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -67.38 -14.13 62.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.658 0.663 . . . . 0.0 112.312 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.12 63.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.128 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.56 17.64 0.74 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.274 -1.292 . . . . 0.0 115.887 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -139.18 -171.44 3.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.602 1.701 . . . . 0.0 111.236 -169.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 p -124.71 147.61 48.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.6 p -140.66 157.86 44.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.12 98.98 4.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.76 123.43 19.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.3 mt -142.26 153.99 44.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.558 0.743 . . . . 0.0 109.298 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -89.76 31.68 0.94 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.675 0.79 . . . . 0.0 110.968 172.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.13 48.77 38.78 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.587 1.565 . . . . 0.0 114.533 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.49 -21.45 66.07 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.683 2.255 . . . . 0.0 113.503 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.7 mt -124.31 10.15 8.61 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.967 1.707 . . . . 0.0 109.89 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 tp 60.86 -19.15 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.85 2.46 . . . . 0.0 114.31 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -166.47 87.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.68 -44.81 76.9 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.723 -0.611 . . . . 0.0 109.989 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.8 mt -80.23 151.58 72.7 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.38 -175.31 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.056 3.171 . . . . 0.0 112.621 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.74 34.42 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.147 1.379 . . . . 0.0 112.377 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.1 m -158.62 132.12 7.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.01 2.124 . . . . 0.0 106.311 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.79 -142.97 14.44 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.1 mm -126.53 140.32 49.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -121.76 152.52 39.37 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.7 mt -138.76 142.8 38.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.6 t -128.5 125.52 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.2 103.21 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -148.85 -177.3 5.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.876 1.271 . . . . 0.0 108.795 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.2 m -150.65 65.56 0.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.749 -1.219 . . . . 0.0 108.366 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 126.99 2.116 . . . . 0.0 112.916 -178.688 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.5 t30 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.807 0.337 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.41 120.73 24.24 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.63 -58.52 0.43 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.55 -169.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 -42.34 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.873 1.715 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -64.0 1.09 Allowed 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.218 1.007 . . . . 0.0 111.624 -168.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.56 -41.8 95.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.128 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -71.17 -45.98 62.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.958 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.58 79.06 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.714 0.688 . . . . 0.0 111.271 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.1 mt -55.12 -57.29 12.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.411 0.551 . . . . 0.0 110.002 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -74.11 -15.7 61.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.42 -38.21 65.65 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.692 0.678 . . . . 0.0 111.231 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -114.42 -26.49 7.94 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 32.88 60.43 1.51 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.683 1.993 . . . . 0.0 113.133 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -65.16 165.41 22.0 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.587 2.191 . . . . 0.0 112.538 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.53 63.38 2.66 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.405 1.482 . . . . 0.0 111.561 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.41 9.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.15 1.38 . . . . 0.0 112.391 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.4 m -61.1 -7.09 2.33 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.299 2.64 . . . . 0.0 112.871 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.24 10.02 17.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.795 1.638 . . . . 0.0 111.217 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.81 163.68 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 122.192 0.996 . . . . 0.0 110.283 174.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -122.09 149.83 43.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 171.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -123.61 166.84 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.721 0.638 . . . . 0.0 110.036 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.08 115.43 1.02 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 106.831 -2.507 . . . . 0.0 106.831 169.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.81 143.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.2 mt -139.42 131.34 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.98 -23.57 1.35 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.293 0.949 . . . . 0.0 114.082 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -50.19 128.46 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 126.137 1.775 . . . . 0.0 108.415 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.06 -27.69 6.48 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 124.441 1.096 . . . . 0.0 108.77 176.466 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . 45.2 mtpt . . . . . 0 N--CA 1.466 0.338 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -63.32 -56.04 19.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.514 1.052 . . . . 0.0 109.394 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -60.59 -39.49 88.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.294 0.638 . . . . 0.0 109.568 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . . . -61.3 -46.6 89.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.967 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -62.43 -37.75 87.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.158 0.89 . . . . 0.0 111.029 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.07 -48.25 76.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.05 0.841 . . . . 0.0 111.057 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.331 6.9 ptmt -71.8 -28.35 63.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -37.72 86.33 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.961 0.904 . . . . 0.0 110.852 169.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -66.99 -40.96 87.5 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.92 -22.97 0.53 Allowed Glycine 0 C--N 1.34 0.75 0 CA-C-O 118.243 -1.31 . . . . 0.0 114.987 169.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.9 137.92 56.92 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.216 1.508 . . . . 0.0 108.869 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.95 134.04 35.63 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.6 99.47 8.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 97.4 m -73.54 145.59 45.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.32 -123.58 29.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.482 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.4 pt-20 -153.11 176.11 12.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.598 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 m -49.8 121.73 5.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.085 1.354 . . . . 0.0 109.922 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.1 153.33 26.14 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -127.65 144.23 51.09 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.965 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.482 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.7 m-90 -65.6 -50.65 64.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.195 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.1 mt -55.08 -51.29 66.84 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.13 -51.96 54.25 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -64.16 -46.24 84.92 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.495 1.148 . . . . 0.0 110.774 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -61.56 -39.04 89.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.398 1.079 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.9 t -64.85 -47.58 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.835 1.254 . . . . 0.0 110.381 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -60.38 -24.4 65.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.551 1.069 . . . . 0.0 111.288 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.06 -28.63 43.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.409 0.684 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -36.49 19.28 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.04 0.936 . . . . 0.0 111.531 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 125.448 1.499 . . . . 0.0 109.824 172.036 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.07 161.01 43.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -95.52 -24.12 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.674 1.59 . . . . 0.0 110.492 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.7 mt -136.22 128.94 46.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.33 1.052 . . . . 0.0 108.223 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -85.92 126.98 34.49 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.91 97.53 7.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -96.38 89.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 108.694 -169.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -75.9 141.07 42.43 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 168.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.99 1.1 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 117.913 -1.493 . . . . 0.0 116.774 -175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 115.28 2.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.984 1.892 . . . . 0.0 109.714 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m 46.06 40.86 7.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.217 1.807 . . . . 0.0 111.811 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp 47.84 69.64 0.51 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 126.003 1.721 . . . . 0.0 111.16 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 163.14 25.59 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.534 1.54 . . . . 0.0 109.423 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.38 -29.92 2.82 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.415 -1.214 . . . . 0.0 114.244 -169.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 41.47 43.96 2.36 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.955 1.302 . . . . 0.0 111.412 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -50.7 -33.29 22.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.966 1.306 . . . . 0.0 113.592 -169.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -59.37 -52.22 66.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.735 1.152 . . . . 0.0 111.431 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.09 -29.05 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.646 -0.659 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.46 91.12 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.575 0.625 . . . . 0.0 110.87 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.47 -38.19 71.26 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.686 -0.633 . . . . 0.0 110.242 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -58.73 -44.18 90.37 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.57 0.623 . . . . 0.0 110.368 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.02 -55.82 30.2 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.393 0.677 . . . . 0.0 109.989 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.4 -40.42 65.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -53.77 -54.03 43.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.358 0.663 . . . . 0.0 110.083 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -62.44 -41.76 98.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -58.22 -45.3 87.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.446 0.566 . . . . 0.0 109.799 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.21 -35.97 71.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.833 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.16 -29.65 70.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.665 0.786 . . . . 0.0 111.586 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.45 -18.1 63.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.861 0.755 . . . . 0.0 111.795 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.1 -4.8 4.98 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.499 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -100.41 -170.31 1.85 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.568 1.684 . . . . 0.0 109.82 -169.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.8 p -128.88 148.58 50.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -139.89 149.95 44.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 111.826 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.26 92.13 3.92 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 m -69.29 118.02 11.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.9 mt -149.35 153.76 37.92 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.281 0.562 . . . . 0.0 112.186 -169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -93.7 39.22 1.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.386 1.074 . . . . 0.0 108.432 168.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 39.14 54.66 2.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.724 2.107 . . . . 0.0 115.42 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.48 -20.69 54.09 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.792 2.328 . . . . 0.0 113.731 -173.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.0 mt -112.94 8.3 18.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.661 1.584 . . . . 0.0 109.772 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tt 60.29 -17.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.557 2.743 . . . . 0.0 114.563 -169.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -169.46 76.82 0.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.94 -45.38 93.94 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.744 -0.598 . . . . 0.0 109.566 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.63 149.43 44.09 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.28 -175.46 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.793 2.995 . . . . 0.0 112.798 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.88 36.63 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.61 1.564 . . . . 0.0 111.334 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.7 m -158.3 128.69 6.13 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.31 2.244 . . . . 0.0 106.321 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.55 -145.98 17.54 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.2 mm -124.55 142.0 42.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -122.12 151.21 41.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.8 mt -137.44 138.9 40.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.07 134.25 66.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.12 111.91 30.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -156.53 -176.4 5.95 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 108.638 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -153.07 62.82 0.77 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.4 1.095 . . . . 0.0 110.344 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 CA--C 1.542 0.669 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.301 175.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 . . . . . 0 N--CA 1.466 0.368 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' H ' ' A' ' 66' ' ' LEU . 4.5 mp -75.48 131.16 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 169.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.44 -58.87 0.33 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.045 0.839 . . . . 0.0 110.228 -170.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -81.18 -38.56 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.325 2.016 . . . . 0.0 111.989 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -59.29 -49.9 76.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.432 0.693 . . . . 0.0 111.511 -169.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -60.26 -44.28 95.44 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.348 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.37 -47.56 75.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.31 0.504 . . . . 0.0 110.467 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.21 89.28 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.01 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 mt -53.72 -55.62 24.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.914 0.779 . . . . 0.0 109.463 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.14 -17.27 61.97 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.87 -32.25 65.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.732 0.413 . . . . 0.0 111.337 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.9 -29.97 5.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 mttt 27.45 66.28 0.57 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.804 2.042 . . . . 0.0 113.273 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.94 176.81 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.824 2.349 . . . . 0.0 112.715 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -82.13 68.67 8.63 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.383 1.073 . . . . 0.0 111.125 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.22 3.11 1.8 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.875 0.87 . . . . 0.0 112.886 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -64.67 -6.25 7.41 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.365 2.666 . . . . 0.0 113.336 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.78 9.04 24.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.85 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 p -134.62 157.22 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.573 0.749 . . . . 0.0 110.529 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -121.01 152.02 39.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 168.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -118.1 173.87 6.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.03 160.11 28.08 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 106.68 -2.568 . . . . 0.0 106.68 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.81 145.87 50.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.45 121.1 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.09 -14.4 6.32 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.818 1.199 . . . . 0.0 114.593 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.9 141.34 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.981 1.313 . . . . 0.0 108.799 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.47 -15.01 60.84 Favored Glycine 0 N--CA 1.468 0.768 0 O-C-N 121.083 -1.01 . . . . 0.0 112.919 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.4 m . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 127.553 2.341 . . . . 0.0 115.195 -174.241 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.8 mttt . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.41 -57.25 13.79 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.581 0.628 . . . . 0.0 109.433 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.38 -31.17 65.34 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.093 0.557 . . . . 0.0 109.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.89 94.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.002 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.53 -37.98 83.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.503 1.047 . . . . 0.0 110.449 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.43 -40.48 96.72 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.536 0.734 . . . . 0.0 111.626 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.297 7.6 ptmm? -79.92 -29.54 39.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.544 -0.722 . . . . 0.0 112.509 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.42 86.46 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.162 0.985 . . . . 0.0 110.995 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 p -77.49 -20.48 54.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.07 -37.48 0.46 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.715 0.689 . . . . 0.0 113.597 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.91 -177.99 2.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.97 0.891 . . . . 0.0 111.435 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -135.14 150.14 50.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -77.11 126.98 31.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 m -77.58 140.93 39.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.45 -121.31 19.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -153.81 162.33 41.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.877 1.271 . . . . 0.0 108.927 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.9 m -53.41 124.18 14.07 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.811 -169.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.51 164.66 26.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.864 1.666 . . . . 0.0 108.283 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -135.99 144.4 45.32 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.014 -1.053 . . . . 0.0 109.318 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--N 1.328 -0.349 0 C-N-CA 127.003 2.121 . . . . 0.0 108.697 178.336 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 119.47 -0.3 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -44.85 83.01 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.599 0.759 . . . . 0.0 109.579 175.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -61.59 -52.05 66.0 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.9 -49.74 40.76 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 124.518 1.136 . . . . 0.0 111.475 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.1 m -61.47 -54.55 41.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 125.111 1.364 . . . . 0.0 111.54 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -55.7 -41.18 73.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.151 0.98 . . . . 0.0 111.365 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t -60.56 -49.54 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.358 1.063 . . . . 0.0 109.83 173.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.81 -27.65 68.2 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.474 1.033 . . . . 0.0 111.651 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.79 -45.01 19.59 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.513 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 pp -71.15 -36.01 71.88 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.607 0.64 . . . . 0.0 111.592 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.6 mttm . . . . . 0 C--O 1.248 0.991 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 175.799 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 119.244 -0.408 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.92 164.05 36.47 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.777 1.231 . . . . 0.0 109.147 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.46 -23.34 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.354 1.462 . . . . 0.0 110.64 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mt -133.11 126.19 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.813 1.245 . . . . 0.0 108.078 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -88.09 126.81 35.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.37 91.19 4.16 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.4 mt -86.09 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 t -111.54 -162.2 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.311 1.044 . . . . 0.0 108.319 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.32 57.29 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 123.646 0.641 . . . . 0.0 111.858 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -44.37 121.77 2.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.108 1.363 . . . . 0.0 111.095 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.272 39.1 m 67.31 53.15 0.78 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.884 1.273 . . . . 0.0 110.478 -171.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 52.92 37.85 25.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.954 2.101 . . . . 0.0 114.494 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.83 156.52 10.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.246 0.926 . . . . 0.0 111.478 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.16 -171.06 41.11 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.39 68.38 2.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.217 1.407 . . . . 0.0 110.893 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.85 -24.46 6.2 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.763 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -51.95 -34.78 43.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.148 0.979 . . . . 0.0 112.906 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 p -71.69 -34.2 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.641 1.109 . . . . 0.0 109.853 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.47 61.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.378 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.73 -40.45 84.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.031 0.832 . . . . 0.0 110.361 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -57.88 -51.16 70.75 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.509 0.724 . . . . 0.0 109.347 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.32 -49.89 73.03 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.096 0.558 . . . . 0.0 110.487 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.25 -40.8 64.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.671 1.188 . . . . 0.0 111.796 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.98 -58.5 7.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.336 0.971 . . . . 0.0 109.998 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -53.89 -43.4 69.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.657 1.183 . . . . 0.0 112.188 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.1 -36.83 82.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.733 0.813 . . . . 0.0 111.967 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.67 -36.99 73.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.703 1.138 . . . . 0.0 109.732 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.83 -23.2 67.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.287 0.635 . . . . 0.0 111.801 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.97 -10.92 60.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.853 0.861 . . . . 0.0 112.108 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 21.61 5.98 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.319 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -125.87 -171.81 2.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.465 1.132 . . . . 0.0 109.584 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 p -125.16 151.02 46.34 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -142.29 159.8 41.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.861 -0.524 . . . . 0.0 110.336 -170.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 110.96 11.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m -76.01 124.6 27.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.9 mt -141.88 159.45 42.21 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.268 0.627 . . . . 0.0 110.718 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -110.74 39.39 2.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.165 1.386 . . . . 0.0 109.022 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.78 46.67 39.48 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.906 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.62 -21.16 70.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 121.398 2.599 . . . . 0.0 113.736 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -126.32 14.2 7.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.43 1.892 . . . . 0.0 109.309 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 66.12 -31.72 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.366 2.667 . . . . 0.0 112.436 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.12 89.8 1.02 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.132 1.773 . . . . 0.0 107.075 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.54 -42.49 91.86 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.667 -0.645 . . . . 0.0 110.409 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.59 154.5 59.1 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.35 -175.27 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.055 3.17 . . . . 0.0 113.173 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.57 28.84 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.63 1.572 . . . . 0.0 113.067 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -153.56 137.33 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.817 2.447 . . . . 0.0 106.342 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.23 -140.58 12.42 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mm -121.55 137.3 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -122.34 137.23 54.92 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 mt -129.83 134.18 47.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.09 128.09 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.23 59.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.335 1.854 . . . . 0.0 106.689 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -67.92 -32.36 72.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.661 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 m 28.54 55.31 0.09 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 127.905 2.482 . . . . 0.0 113.505 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.226 -0.18 0 C-N-CA 127.63 2.372 . . . . 0.0 114.715 -169.114 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.5 t30 . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.704 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -107.36 84.45 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 169.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.5 m -70.51 -56.49 6.43 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.644 -167.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.12 -37.91 39.48 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.428 1.189 . . . . 0.0 110.006 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -68.19 -50.43 54.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.58 -46.36 83.04 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.883 0.765 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.46 -40.44 94.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.841 1.2 . . . . 0.0 110.922 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.29 90.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.314 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.2 mt -54.65 -52.72 61.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.512 1.051 . . . . 0.0 109.78 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -67.03 -22.59 65.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -75.42 -43.64 48.8 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.486 0.585 . . . . 0.0 111.083 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -98.88 -29.16 13.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.54 62.68 0.98 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 127.014 2.126 . . . . 0.0 112.609 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.75 164.63 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.259 2.639 . . . . 0.0 113.278 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.13 64.41 2.57 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.372 1.469 . . . . 0.0 111.613 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.19 9.53 0.97 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 112.737 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m -60.55 -6.87 1.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 127.858 2.463 . . . . 0.0 112.717 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.62 8.75 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.758 1.623 . . . . 0.0 111.183 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.69 152.84 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.93 0.871 . . . . 0.0 111.808 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -105.0 152.69 22.4 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -122.8 147.89 46.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.911 1.285 . . . . 0.0 107.561 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.05 116.98 1.65 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.116 -2.793 . . . . 0.0 106.116 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.23 145.19 35.65 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 mt -139.37 124.11 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.61 -2.82 20.75 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.714 1.626 . . . . 0.0 113.996 173.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -60.3 117.51 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.532 . . . . 0.0 107.955 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.13 -29.96 63.77 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 129.719 3.208 . . . . 0.0 111.768 169.873 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.6 -57.31 7.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.586 1.084 . . . . 0.0 108.461 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -58.46 -37.78 76.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.083 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.56 67.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 126.157 1.783 . . . . 0.0 109.873 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.93 -34.17 77.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.132 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.1 -40.65 74.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.903 1.229 . . . . 0.0 110.402 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -63.97 -41.54 97.52 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.966 1.306 . . . . 0.0 109.586 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -34.11 73.38 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.057 1.743 . . . . 0.0 111.742 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -67.56 -42.16 83.06 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.81 -17.32 0.56 Allowed Glycine 0 CA--C 1.528 0.898 0 CA-C-O 117.956 -1.469 . . . . 0.0 115.391 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 140.16 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.809 1.804 . . . . 0.0 109.43 -170.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -89.12 112.91 24.0 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.16 128.67 36.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.7 m -106.39 149.97 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.86 -122.4 29.86 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.83 168.67 26.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.19 1.396 . . . . 0.0 108.315 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.1 m -43.91 116.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.09 169.51 15.87 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.879 1.672 . . . . 0.0 108.095 172.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 138.96 42.79 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 120.948 -1.095 . . . . 0.0 111.123 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.325 -0.486 0 C-N-CA 127.247 2.219 . . . . 0.0 105.372 169.406 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.65 -44.63 93.27 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.12 -52.64 64.85 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.265 1.026 . . . . 0.0 108.807 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.53 -44.91 85.72 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.252 0.93 . . . . 0.0 111.844 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -61.71 -55.01 34.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.567 0.683 . . . . 0.0 109.548 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -57.69 -40.52 79.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.525 0.73 . . . . 0.0 111.666 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.41 -55.28 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 124.924 1.29 . . . . 0.0 109.699 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -15.05 63.34 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.442 1.019 . . . . 0.0 112.197 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.69 -45.85 20.4 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.796 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.7 -36.87 76.32 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.57 0.623 . . . . 0.0 111.639 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.032 0 C-N-CA 125.435 1.494 . . . . 0.0 109.658 175.264 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.41 165.61 33.6 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.05 0.94 . . . . 0.0 110.37 -173.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.15 -23.07 15.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.721 1.608 . . . . 0.0 110.808 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.69 126.69 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.411 1.084 . . . . 0.0 108.328 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -85.73 128.91 34.92 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -108.7 88.33 2.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.8 mt -77.74 91.41 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -93.02 17.1 11.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.812 2.045 . . . . 0.0 112.98 -168.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.89 77.78 0.11 Allowed Glycine 0 N--CA 1.446 -0.657 0 O-C-N 121.707 -0.621 . . . . 0.0 112.086 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -56.44 -14.4 3.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.247 1.019 . . . . 0.0 113.344 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -122.08 33.42 5.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.722 2.009 . . . . 0.0 109.92 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.8 mt 58.11 23.97 10.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.699 1.999 . . . . 0.0 112.854 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.0 161.96 16.25 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 128.585 2.993 . . . . 0.0 106.223 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.35 -36.33 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.917 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.82 16.42 0.98 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.034 1.417 . . . . 0.0 113.826 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.26 -36.49 63.66 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.535 1.061 . . . . 0.0 113.288 -170.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -60.65 -50.56 73.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.559 0.618 . . . . 0.0 111.313 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.8 -32.24 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 122.029 -0.419 . . . . 0.0 110.094 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.61 87.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.919 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -62.17 -40.06 94.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.323 0.965 . . . . 0.0 111.147 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -64.98 -47.6 76.96 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.639 -0.663 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.41 -49.54 72.12 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.984 0.914 . . . . 0.0 110.606 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.58 -48.23 72.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.999 1.319 . . . . 0.0 110.774 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.59 -50.75 72.27 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.962 0.905 . . . . 0.0 110.524 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.1 -22.64 62.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.567 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -72.79 -41.5 64.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 121.156 1.798 . . . . 0.0 109.024 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -62.9 -25.08 68.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.779 0.832 . . . . 0.0 111.462 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -11.99 60.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.149 0.98 . . . . 0.0 112.546 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 19.85 7.03 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.241 172.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -124.21 -166.78 1.55 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.354 1.061 . . . . 0.0 108.642 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -132.1 150.73 52.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.9 p -141.71 153.88 44.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 110.806 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -123.13 90.48 3.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.231 1.012 . . . . 0.0 108.524 -172.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -66.61 118.9 10.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.2 mt -145.59 138.07 25.76 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.815 0.846 . . . . 0.0 109.167 -170.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -83.66 40.88 0.76 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.035 -1.041 . . . . 0.0 110.601 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.16 44.98 34.2 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 117.892 -1.504 . . . . 0.0 115.863 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.69 -20.99 39.64 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.175 2.487 . . . . 0.0 114.005 -170.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.37 13.41 12.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.53 1.532 . . . . 0.0 109.391 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.0 tp 64.52 -27.2 0.09 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.886 2.474 . . . . 0.0 113.568 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -174.1 87.77 0.05 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.507 1.523 . . . . 0.0 107.378 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.37 -43.29 91.23 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.816 -0.553 . . . . 0.0 110.298 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.81 151.1 49.42 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 47' ' ' SER . 40.1 Cg_endo -67.69 -174.33 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.139 3.226 . . . . 0.0 112.962 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.44 29.02 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.527 1.531 . . . . 0.0 113.115 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' PRO . 18.7 m -152.23 131.93 13.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.949 2.5 . . . . 0.0 106.287 -175.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.39 -139.73 11.19 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mm -126.89 137.07 58.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.473 ' CD1' HG21 ' A' ' 83' ' ' VAL . 11.1 m0 -121.76 133.95 54.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 175.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -127.62 138.12 52.76 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.22 133.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.93 107.58 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -171.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -163.53 -160.52 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.08 2.152 . . . . 0.0 105.598 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 m -148.02 155.12 41.15 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.199 -1.563 . . . . 0.0 109.045 170.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 123.207 0.603 . . . . 0.0 111.872 -175.103 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 115.742 1.756 . . . . 0.0 115.742 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.25 120.94 8.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -54.89 0.56 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.3 -172.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -99.3 -34.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.18 2.587 . . . . 0.0 113.554 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.93 -54.68 44.44 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.722 0.809 . . . . 0.0 112.063 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -65.42 -40.3 93.17 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.659 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.47 -49.62 76.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.246 0.475 . . . . 0.0 110.038 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.13 93.22 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.01 -53.75 54.58 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.773 0.715 . . . . 0.0 110.305 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -72.92 -19.0 61.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.6 -49.82 56.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.368 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -100.8 -26.53 13.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 29.36 64.66 0.78 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 127.19 2.196 . . . . 0.0 113.011 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -63.65 164.81 19.91 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.605 2.203 . . . . 0.0 112.443 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -82.39 66.19 7.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.661 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.43 7.52 0.6 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.306 1.042 . . . . 0.0 113.041 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -62.82 -6.12 3.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.517 2.727 . . . . 0.0 113.041 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.21 8.77 19.95 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.271 1.428 . . . . 0.0 110.983 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.6 p -132.46 147.22 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.709 0.686 . . . . 0.0 110.911 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -97.75 154.05 17.85 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -119.52 152.11 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.6 146.78 17.55 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.8 135.71 53.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.55 127.88 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.48 -19.99 3.62 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.352 0.977 . . . . 0.0 113.662 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.67 144.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.3 1.84 . . . . 0.0 108.677 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.09 -19.61 1.1 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.783 1.182 . . . . 0.0 113.308 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.466 0.371 0 C-N-CA 126.396 1.878 . . . . 0.0 113.34 171.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 118.137 -0.935 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.45 -59.12 5.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 120.013 1.279 . . . . 0.0 109.185 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.88 -39.52 81.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.109 0.413 . . . . 0.0 110.597 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.21 81.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.269 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.56 -38.18 90.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.048 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.97 -46.91 88.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.29 0.95 . . . . 0.0 110.592 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -65.69 -38.34 88.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.798 0.839 . . . . 0.0 110.074 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -34.24 77.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.688 1.195 . . . . 0.0 111.324 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.1 m -71.67 -31.25 66.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.388 -0.339 . . . . 0.0 111.336 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.97 -33.15 0.56 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 118.994 -0.892 . . . . 0.0 114.781 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.6 171.97 6.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.433 1.116 . . . . 0.0 110.465 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -132.72 141.93 48.8 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -75.78 111.13 10.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.0 m -74.58 152.69 39.24 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.08 -104.13 1.68 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.79 -177.34 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.812 2.445 . . . . 0.0 106.541 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 124.99 31.51 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.427 HD12 ' CE3' ' A' ' 138' ' ' TRP . 2.3 tt -79.65 151.02 30.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -129.85 146.67 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.814 1.188 . . . . 0.0 108.798 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 110.9 178.043 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.427 ' CE3' HD12 ' A' ' 121' ' ' LEU . 9.2 t90 -51.85 -50.34 61.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 110.653 173.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.82 -55.96 24.53 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.483 1.114 . . . . 0.0 109.359 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.28 -42.38 99.76 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 123.319 0.387 . . . . 0.0 112.179 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -60.28 -63.35 1.33 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 125.194 1.397 . . . . 0.0 110.171 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -53.95 -46.72 71.66 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.846 1.658 . . . . 0.0 111.849 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.5 t -59.77 -55.89 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -18.17 63.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.461 1.028 . . . . 0.0 112.201 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.24 -47.1 21.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.545 0.611 . . . . 0.0 111.0 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.17 -30.69 62.36 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 112.261 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.9 mttm . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.804 1.242 . . . . 0.0 109.781 171.491 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.2 167.63 29.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.842 1.257 . . . . 0.0 109.309 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.07 -27.59 18.49 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.882 0.873 . . . . 0.0 110.025 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -132.71 132.09 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.941 0.896 . . . . 0.0 109.319 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -89.46 129.86 35.89 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.57 95.11 5.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.2 mt -88.27 77.51 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -74.27 153.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.31 -0.869 . . . . 0.0 109.54 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.93 -175.64 32.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-O 122.576 1.098 . . . . 0.0 114.973 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 p -150.51 -50.07 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.05 -1.575 . . . . 0.0 109.508 -169.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 48.0 m -121.48 58.64 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.0 tp 48.89 48.08 20.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.067 2.147 . . . . 0.0 112.549 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.72 153.34 10.98 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.21 -174.51 41.09 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 118.31 1.055 . . . . 0.0 113.745 -169.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.06 59.5 1.32 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.296 1.838 . . . . 0.0 110.52 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -56.67 -27.38 58.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.148 -0.97 . . . . 0.0 112.05 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -58.91 -44.81 91.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.932 0.787 . . . . 0.0 111.324 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.71 -43.14 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.33 91.38 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.549 -0.262 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.66 -41.45 75.51 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.363 0.665 . . . . 0.0 110.886 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -61.27 -45.55 94.04 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.736 -0.602 . . . . 0.0 110.147 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.13 -52.57 65.0 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.093 0.957 . . . . 0.0 110.469 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.55 -46.25 57.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.224 1.009 . . . . 0.0 110.886 177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -56.69 -54.23 48.53 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.549 0.613 . . . . 0.0 110.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -61.65 -39.45 91.38 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.87 -37.59 84.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.396 0.678 . . . . 0.0 110.779 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.36 -39.41 89.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.592 0.633 . . . . 0.0 110.369 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -63.14 -30.01 71.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.867 0.758 . . . . 0.0 111.388 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -20.62 60.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.623 0.769 . . . . 0.0 111.676 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 16.92 6.73 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 118.514 -1.159 . . . . 0.0 114.228 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.03 142.58 51.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.066 1.433 . . . . 0.0 108.49 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -83.15 151.84 25.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -138.32 158.62 43.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.03 104.46 7.8 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 m -68.82 123.21 20.33 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.271 1.028 . . . . 0.0 108.344 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -145.43 166.35 25.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.163 0.985 . . . . 0.0 110.042 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -110.36 39.33 2.21 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.622 1.169 . . . . 0.0 109.141 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.85 50.9 14.1 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.718 1.627 . . . . 0.0 114.867 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 -21.75 62.61 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.846 2.364 . . . . 0.0 113.775 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.0 mt -124.1 13.93 9.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.18 1.792 . . . . 0.0 108.93 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.7 tp 61.59 -25.57 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.654 2.782 . . . . 0.0 114.464 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -161.3 86.44 0.68 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -168.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.57 -45.25 87.82 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.685 -0.634 . . . . 0.0 110.081 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.13 151.34 59.93 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.48 -178.9 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.584 2.856 . . . . 0.0 112.996 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.54 35.92 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.882 1.673 . . . . 0.0 111.807 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -158.49 123.99 4.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.293 2.237 . . . . 0.0 105.773 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.48 -147.9 19.38 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.6 mm -123.5 128.91 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -119.79 152.25 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 mt -140.43 138.16 34.51 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.76 132.29 44.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -125.11 68.44 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.931 1.292 . . . . 0.0 108.292 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -103.09 16.24 27.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.524 1.13 . . . . 0.0 112.241 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m 2.22 83.49 0.0 OUTLIER 'General case' 0 C--N 1.344 0.357 0 C-N-CA 129.999 3.319 . . . . 0.0 114.516 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.6 p . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 124.148 0.979 . . . . 0.0 109.609 -169.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 C--O 1.228 -0.065 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -150.09 108.07 3.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 m -82.65 -63.04 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.948 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.86 -40.57 16.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.695 1.596 . . . . 0.0 110.625 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -63.46 -49.87 71.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.976 0.51 . . . . 0.0 110.718 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.53 -45.83 88.81 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.801 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -61.07 -46.43 90.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.746 0.703 . . . . 0.0 110.231 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -24.02 67.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.6 mt -67.71 -61.24 1.98 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.469 1.031 . . . . 0.0 108.657 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -73.62 -13.14 60.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.19 -36.11 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.202 1.001 . . . . 0.0 110.356 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -120.72 -30.11 4.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.798 -172.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.3 mttt 25.62 68.69 0.43 Allowed Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.043 1.737 . . . . 0.0 112.872 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.45 173.95 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.309 2.006 . . . . 0.0 111.883 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -81.15 95.6 6.94 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.37 -0.832 . . . . 0.0 108.992 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.487 HD23 ' HB3' ' A' ' 112' ' ' SER . 3.0 mm? -88.45 6.25 38.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.992 0.517 . . . . 0.0 111.561 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.6 p -68.06 -5.26 16.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 119.694 -1.879 . . . . 0.0 112.583 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.56 43.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.461 1.504 . . . . 0.0 110.939 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.61 155.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.246 1.022 . . . . 0.0 111.095 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -114.91 147.48 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -125.61 156.92 38.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 109.791 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.45 116.42 2.15 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.6 146.36 44.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.1 mt -139.99 129.45 28.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.92 -9.36 2.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.442 1.02 . . . . 0.0 113.775 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.85 136.17 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.35 14.22 7.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.799 1.19 . . . . 0.0 112.052 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 125.308 1.443 . . . . 0.0 113.392 -178.469 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.2 mttt . . . . . 0 N--CA 1.463 0.211 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.5 -57.81 11.36 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.13 -40.31 95.49 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.8 68.12 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 117.329 -1.32 . . . . 0.0 111.603 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.98 -45.0 94.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.736 1.607 . . . . 0.0 110.805 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.84 -39.47 90.83 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -30.71 70.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.161 1.384 . . . . 0.0 111.948 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.487 ' HB3' HD23 ' A' ' 80' ' ' LEU . 13.9 m -80.58 -18.65 47.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.953 0.501 . . . . 0.0 111.098 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.5 -19.58 4.5 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.694 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.49 136.89 55.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.674 1.737 . . . . 0.0 108.829 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -86.23 132.77 33.92 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -85.63 103.23 14.26 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -77.09 150.26 35.68 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.322 -0.236 . . . . 0.0 110.487 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.65 -95.45 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.413 1.006 . . . . 0.0 111.195 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.34 176.99 6.31 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 128.439 2.696 . . . . 0.0 106.511 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.3 m -63.72 131.03 46.62 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.48 HD12 ' CE3' ' A' ' 138' ' ' TRP . 3.5 tt -73.78 139.93 45.54 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.51 139.77 51.45 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 124.924 1.29 . . . . 0.0 108.702 -174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.48 ' CE3' HD12 ' A' ' 121' ' ' LEU . 10.7 t90 -44.14 -56.66 3.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 125.359 1.464 . . . . 0.0 110.943 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -59.17 4.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.809 1.644 . . . . 0.0 109.002 -174.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.07 60.32 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 123.874 0.734 . . . . 0.0 111.349 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 t -65.27 -47.86 75.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.671 0.735 . . . . 0.0 110.566 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -60.67 -41.66 95.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.655 1.182 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t -59.4 -49.94 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.557 0.743 . . . . 0.0 109.675 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -61.26 -30.33 70.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.241 0.928 . . . . 0.0 111.247 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.23 -46.83 26.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.442 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -74.16 -32.01 62.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.188 0.449 . . . . 0.0 112.129 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.443 1.097 . . . . 0.0 109.825 173.376 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.43 164.62 37.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.184 0.994 . . . . 0.0 109.96 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.92 -24.0 15.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.672 1.589 . . . . 0.0 110.577 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.15 126.6 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.291 1.036 . . . . 0.0 108.413 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.48 127.2 35.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.44 95.55 6.15 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.1 mt -91.26 117.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.29 168.65 17.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.315 0.646 . . . . 0.0 110.525 -169.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.64 38.77 93.49 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.918 -0.379 . . . . 0.0 112.34 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 m -61.64 0.31 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.521 2.329 . . . . 0.0 116.343 -169.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -123.31 31.53 5.94 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.118 1.767 . . . . 0.0 108.183 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.2 tp 53.66 63.92 2.03 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 126.223 1.809 . . . . 0.0 109.952 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.56 -144.7 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.07 1.795 . . . . 0.0 109.189 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.97 163.37 34.77 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 37.22 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.128 1.771 . . . . 0.0 108.125 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.56 -36.4 61.82 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 0.0 113.244 -169.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -58.62 -47.02 85.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.099 0.863 . . . . 0.0 110.819 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -72.82 -47.09 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.85 99.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.99 -38.59 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.904 0.482 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -61.81 -48.0 82.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.764 0.711 . . . . 0.0 110.031 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.91 -54.06 49.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.856 0.863 . . . . 0.0 109.878 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.06 63.9 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.408 1.083 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.61 -54.92 40.85 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.567 0.747 . . . . 0.0 110.476 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -59.52 -37.12 77.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.2 mt -66.08 -34.31 77.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.213 0.605 . . . . 0.0 111.42 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -70.66 -38.3 73.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.046 1.294 . . . . 0.0 110.263 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.05 -29.76 70.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.37 0.668 . . . . 0.0 111.134 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.46 -14.77 62.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.819 0.848 . . . . 0.0 112.112 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.04 7.32 6.61 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.197 -1.335 . . . . 0.0 114.522 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -112.1 -167.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.668 1.734 . . . . 0.0 110.131 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -128.7 150.22 50.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.1 p -142.0 154.46 45.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.264 0.554 . . . . 0.0 112.061 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -121.26 98.03 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.579 1.552 . . . . 0.0 108.013 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -72.42 121.0 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.1 mt -146.16 149.0 33.15 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.996 0.518 . . . . 0.0 111.456 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -90.87 34.9 0.9 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.112 0.965 . . . . 0.0 110.319 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 49.94 27.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.735 1.636 . . . . 0.0 114.791 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.64 -21.89 65.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.82 2.347 . . . . 0.0 114.007 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.16 10.54 4.54 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.78 2.032 . . . . 0.0 107.099 -175.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 62.99 -26.66 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.628 2.771 . . . . 0.0 114.03 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -157.59 80.43 0.88 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.857 0.863 . . . . 0.0 109.271 -168.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.97 -44.73 96.14 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.586 -0.696 . . . . 0.0 110.523 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.11 151.25 69.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 47' ' ' SER . 43.4 Cg_endo -67.92 -173.93 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.261 3.307 . . . . 0.0 113.021 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.45 27.56 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.422 1.489 . . . . 0.0 113.262 170.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 45' ' ' PRO . 15.5 m -150.76 133.28 15.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.768 2.427 . . . . 0.0 106.403 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.88 -142.07 13.28 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 mm -124.29 142.77 39.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CD1' HG21 ' A' ' 83' ' ' VAL . 17.2 m0 -121.41 150.45 41.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.9 mt -141.07 141.2 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -133.71 121.19 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.72 103.09 14.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.324 1.85 . . . . 0.0 107.138 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -146.09 -161.0 1.22 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.334 1.054 . . . . 0.0 108.685 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.0 m -150.43 150.61 31.58 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.663 -1.273 . . . . 0.0 108.414 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.658 177.069 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 t30 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.68 77.8 1.76 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -66.64 -55.12 19.29 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 127.706 2.402 . . . . 0.0 112.411 -168.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.39 -34.53 54.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.117 1.211 . . . . 0.0 110.071 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.77 -59.42 5.45 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 123.783 0.677 . . . . 0.0 109.689 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.55 -46.81 87.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.957 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.12 -46.13 90.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.274 0.943 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.27 -23.53 65.69 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.1 mt -67.06 -62.35 1.47 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.61 -20.11 65.92 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.98 -34.49 77.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.545 0.738 . . . . 0.0 111.11 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -128.86 -24.41 2.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 mttt 28.58 65.1 0.69 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 127.108 2.163 . . . . 0.0 112.763 -170.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.28 163.29 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.679 2.253 . . . . 0.0 113.195 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -80.79 66.76 6.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.734 1.214 . . . . 0.0 110.731 -174.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.91 17.42 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.578 1.551 . . . . 0.0 112.886 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 p -65.99 -4.29 6.85 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 119.955 -1.715 . . . . 0.0 112.6 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 11.14 13.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.877 1.671 . . . . 0.0 111.081 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.407 HG21 ' CD1' ' A' ' 50' ' ' TRP . 3.1 p -134.99 157.16 40.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.815 0.817 . . . . 0.0 110.926 176.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.403 HH22 HD22 ' A' ' 146' ' ' LEU . 3.9 ptt-85 -120.02 148.56 43.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -115.46 169.25 9.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.06 120.19 1.58 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.31 139.93 41.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.5 mt -138.59 130.86 38.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 -26.69 1.08 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.09 0.852 . . . . 0.0 112.77 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.3 mt -52.68 155.49 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 128.096 2.558 . . . . 0.0 108.453 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.47 20.7 0.82 Allowed Glycine 0 CA--C 1.526 0.754 0 O-C-N 121.664 -0.647 . . . . 0.0 112.58 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 124.62 1.168 . . . . 0.0 111.804 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.31 -57.5 12.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.173 0.589 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.51 -38.24 89.16 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.278 0.631 . . . . 0.0 109.359 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.13 83.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.206 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.82 -35.71 81.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.716 -1.135 . . . . 0.0 111.192 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.84 -47.93 84.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.896 1.226 . . . . 0.0 110.876 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.21 -37.02 84.55 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.142 0.977 . . . . 0.0 110.092 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -36.8 79.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.262 1.425 . . . . 0.0 111.518 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.5 m -68.96 -38.5 79.45 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.46 0.52 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.97 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.67 135.6 48.45 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.305 1.553 . . . . 0.0 108.986 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -84.23 141.62 30.86 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.05 113.38 19.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -72.28 146.26 47.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.8 -119.77 17.1 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 170.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.22 159.51 44.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.64 1.576 . . . . 0.0 107.388 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.5 m -48.8 125.11 9.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.976 1.31 . . . . 0.0 111.358 -175.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.51 147.78 35.64 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.647 1.579 . . . . 0.0 107.817 -173.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -116.13 142.82 46.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 169.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -169.233 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.234 0.245 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -46.94 81.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.106 172.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.16 -47.2 81.79 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.191 0.596 . . . . 0.0 109.827 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.66 -49.32 79.79 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.5 t -62.94 -43.97 97.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.177 0.988 . . . . 0.0 110.822 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.4 t90 -63.56 -38.37 90.88 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.621 1.568 . . . . 0.0 110.677 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.31 -46.63 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.962 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.79 -28.41 69.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.761 -1.212 . . . . 0.0 111.456 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.77 -47.18 40.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.077 0.951 . . . . 0.0 110.686 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.403 HD22 HH22 ' A' ' 84' ' ' ARG . 1.6 pp -71.45 -33.39 69.31 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.569 0.622 . . . . 0.0 112.04 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.1 mttm . . . . . 0 C--O 1.249 1.044 0 C-N-CA 125.292 1.437 . . . . 0.0 110.004 173.468 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 mtt . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.816 0.341 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.95 173.12 0.65 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.009 1.324 . . . . 0.0 112.24 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.39 -24.86 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.982 0.913 . . . . 0.0 110.872 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.0 mt -138.47 125.81 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.066 0.947 . . . . 0.0 109.28 -171.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -85.63 133.03 34.06 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 mp -111.58 100.33 8.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 mt -71.82 96.75 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 170.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -88.48 21.5 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.099 2.16 . . . . 0.0 112.201 -168.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 179.26 41.03 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -138.33 -27.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.643 0.777 . . . . 0.0 112.383 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 p -121.66 42.84 3.0 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp 56.12 37.33 28.73 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.449 1.5 . . . . 0.0 111.045 -169.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.06 163.24 27.15 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.265 1.888 . . . . 0.0 108.983 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -161.75 34.8 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.996 0.808 . . . . 0.0 111.336 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 60.05 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.346 1.859 . . . . 0.0 112.209 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -55.85 -31.45 62.76 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.629 0.771 . . . . 0.0 112.642 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -61.19 -42.05 97.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.236 0.926 . . . . 0.0 111.008 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.44 -39.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.568 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.55 -39.75 92.07 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.752 175.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -65.18 -38.54 90.81 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.383 -0.823 . . . . 0.0 110.699 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.94 -49.8 71.18 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.89 0.876 . . . . 0.0 110.185 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.42 -42.63 54.17 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.535 1.134 . . . . 0.0 111.117 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -54.9 -54.34 43.89 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.051 0.841 . . . . 0.0 110.157 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -60.94 -42.31 97.94 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.2 -39.94 95.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.441 0.696 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.89 -33.17 62.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.177 -0.952 . . . . 0.0 110.323 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.41 -32.16 72.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.972 0.805 . . . . 0.0 111.026 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -20.53 63.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.561 0.618 . . . . 0.0 111.518 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.95 -4.64 6.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.57 -1.128 . . . . 0.0 113.588 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -89.36 -170.79 2.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.211 1.505 . . . . 0.0 109.925 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -129.16 148.01 51.06 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -139.69 150.72 45.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.144 0.497 . . . . 0.0 111.939 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -113.57 90.7 3.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.891 1.677 . . . . 0.0 107.219 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -70.61 120.08 15.7 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -148.05 137.89 22.52 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.783 0.833 . . . . 0.0 110.725 -169.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -80.04 36.91 0.36 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.551 -1.343 . . . . 0.0 111.404 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.64 49.47 33.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.922 1.725 . . . . 0.0 114.86 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.77 -22.13 69.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.004 2.47 . . . . 0.0 113.888 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.1 mt -128.74 12.03 6.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.03 1.732 . . . . 0.0 109.418 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 tp 62.11 -25.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.994 2.518 . . . . 0.0 114.161 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -160.37 78.46 0.64 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.407 1.083 . . . . 0.0 108.924 -168.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.2 -46.07 85.54 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.656 -0.653 . . . . 0.0 110.032 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 mt -81.48 154.26 71.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.29 179.3 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.846 3.03 . . . . 0.0 113.584 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.84 32.25 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.116 1.766 . . . . 0.0 112.591 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.1 m -153.89 133.78 13.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.782 2.433 . . . . 0.0 106.536 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.86 -138.95 11.7 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 mm -121.24 135.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.455 ' CD1' HG21 ' A' ' 83' ' ' VAL . 6.0 m0 -125.65 138.9 53.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.5 mt -128.36 146.7 50.7 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.23 133.76 55.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -125.94 108.53 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -170.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -156.72 -163.1 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.506 1.122 . . . . 0.0 108.611 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.96 144.04 25.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.464 0.239 0 CA-C-N 119.289 0.95 . . . . 0.0 110.714 -171.582 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.62 135.9 57.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -122.55 -64.4 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 117.266 -1.349 . . . . 0.0 111.375 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.6 -39.34 9.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 122.073 1.776 . . . . 0.0 110.103 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -61.22 -46.44 90.41 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.864 1.266 . . . . 0.0 110.088 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.6 -51.24 69.39 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.303 1.041 . . . . 0.0 110.399 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.55 -45.34 90.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.833 0.742 . . . . 0.0 110.98 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.76 82.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.65 -55.57 33.19 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 123.264 0.626 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -68.35 -18.98 64.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.49 -32.92 66.59 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.4 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.55 -25.3 5.58 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 32.42 63.04 1.33 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.631 1.972 . . . . 0.0 112.954 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -63.93 167.54 13.81 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.02 2.48 . . . . 0.0 113.39 -169.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -78.97 63.74 3.73 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.181 1.392 . . . . 0.0 111.454 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.07 8.85 0.66 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.757 1.223 . . . . 0.0 112.738 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 m -62.3 -6.83 3.51 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.637 2.775 . . . . 0.0 112.911 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.59 9.33 19.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.265 1.426 . . . . 0.0 111.12 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.1 p -131.31 154.63 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.824 0.738 . . . . 0.0 112.403 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -109.21 149.35 29.51 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.745 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.89 153.87 23.87 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.997 1.319 . . . . 0.0 108.059 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.16 106.65 0.46 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 106.026 -2.829 . . . . 0.0 106.026 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.08 29.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 mt -140.07 132.73 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -169.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -28.44 1.61 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.619 1.104 . . . . 0.0 113.01 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 mt -48.99 142.05 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.297 2.239 . . . . 0.0 108.778 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.3 -36.65 8.05 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 126.194 1.798 . . . . 0.0 111.0 174.282 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.33 -53.06 62.56 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.781 0.832 . . . . 0.0 109.575 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -39.69 92.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.9 75.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.562 1.145 . . . . 0.0 110.238 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -63.26 -39.37 94.41 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.979 0.809 . . . . 0.0 110.981 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -70.14 -41.89 73.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.887 0.767 . . . . 0.0 111.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -61.69 -37.7 85.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.466 1.507 . . . . 0.0 109.223 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -37.11 73.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.078 1.351 . . . . 0.0 111.92 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -67.24 -35.92 80.57 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.108 0.563 . . . . 0.0 110.59 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.87 -28.43 0.36 Allowed Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.015 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.14 170.41 8.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.765 1.283 . . . . 0.0 110.663 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -130.36 137.28 49.82 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -72.04 124.61 25.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.8 m -86.82 154.43 20.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.78 -117.27 10.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 173.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.25 175.9 12.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.9 1.68 . . . . 0.0 107.002 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.5 m -60.04 128.21 35.7 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.52 -0.738 . . . . 0.0 110.115 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 122' ' ' LYS . 1.8 tt -79.88 156.49 27.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.991 1.316 . . . . 0.0 107.822 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.618 ' H ' HD23 ' A' ' 121' ' ' LEU . 7.8 mptt -126.91 140.11 52.57 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.625 1.17 . . . . 0.0 108.083 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 109.011 -175.583 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 119.383 -0.341 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.405 ' CG ' ' HG ' ' A' ' 121' ' ' LEU . 6.8 t90 -57.5 -52.35 65.73 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.618 1.167 . . . . 0.0 110.12 171.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.36 -56.21 12.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.691 1.596 . . . . 0.0 108.509 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.42 -45.37 94.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.433 0.54 . . . . 0.0 112.656 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.4 m -62.19 -60.44 3.59 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.237 1.415 . . . . 0.0 110.457 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -52.93 -41.65 64.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.115 1.766 . . . . 0.0 111.567 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.12 -57.65 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.783 0.833 . . . . 0.0 109.946 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -14.43 62.48 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.47 -0.769 . . . . 0.0 112.398 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.0 mp -80.78 -49.15 11.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 110.782 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.19 -33.62 70.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 111.596 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.519 1.127 . . . . 0.0 109.647 173.917 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.93 164.31 38.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.117 0.967 . . . . 0.0 110.157 -172.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -98.51 -22.83 15.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.778 1.231 . . . . 0.0 110.887 169.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 mt -131.95 126.22 56.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 t -90.98 128.28 36.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -95.76 103.93 15.84 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -96.43 86.84 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 159.16 16.27 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 111.646 -169.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.73 79.56 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.15 -45.02 8.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.228 2.211 . . . . 0.0 115.531 -169.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.7 m -127.89 54.72 1.69 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt 52.91 37.0 23.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.545 1.938 . . . . 0.0 111.929 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.78 4.5 69.4 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.645 1.117 . . . . 0.0 113.235 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.55 -79.39 1.84 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.817 1.199 . . . . 0.0 111.118 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.7 18.08 0.45 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.354 1.862 . . . . 0.0 113.889 -169.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.31 -26.03 67.12 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.354 -0.841 . . . . 0.0 111.834 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.97 -47.65 84.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.73 0.695 . . . . 0.0 110.584 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.65 -38.77 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.3 80.32 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.838 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.58 -40.46 76.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.868 0.758 . . . . 0.0 110.357 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -62.48 -47.69 82.87 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.949 -0.47 . . . . 0.0 110.238 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.18 -51.66 67.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.402 1.081 . . . . 0.0 110.868 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.58 -41.05 66.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.748 0.819 . . . . 0.0 111.393 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -58.09 -47.78 82.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.421 1.009 . . . . 0.0 111.079 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -58.04 -44.32 87.34 Favored 'General case' 0 C--N 1.337 0.034 0 C-N-CA 122.671 0.389 . . . . 0.0 111.308 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 26' ' ' LEU . 3.3 mm? -66.29 -33.02 74.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.56 -45.55 78.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.018 0.826 . . . . 0.0 109.581 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -71.2 -17.3 62.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.813 0.733 . . . . 0.0 112.157 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.04 -15.5 62.03 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.919 0.781 . . . . 0.0 111.442 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.98 22.41 5.96 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.491 169.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -129.08 171.87 11.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.59 1.195 . . . . 0.0 110.28 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 p -105.71 154.47 20.42 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -141.53 155.23 45.81 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.771 -0.581 . . . . 0.0 111.449 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.71 93.51 4.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -70.53 120.95 16.92 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.7 mt -148.51 170.16 18.68 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 124.37 1.068 . . . . 0.0 109.477 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -110.23 37.81 2.61 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.133 1.773 . . . . 0.0 108.603 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.53 48.77 22.01 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.842 1.686 . . . . 0.0 115.086 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.56 -20.5 69.59 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 CA-C-N 121.083 2.442 . . . . 0.0 114.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -122.99 13.25 9.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 109.701 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.84 -28.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.278 2.631 . . . . 0.0 112.649 -169.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -160.37 88.24 0.79 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.371 1.469 . . . . 0.0 107.674 -168.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.36 -43.21 82.02 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.64 154.08 68.18 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.56 -175.53 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.176 3.25 . . . . 0.0 113.186 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 33.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.799 1.64 . . . . 0.0 112.574 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -158.14 135.92 10.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.605 1.962 . . . . 0.0 106.801 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.48 -140.27 11.9 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.88 134.24 66.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -118.96 133.25 55.94 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -122.95 137.91 54.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.1 t -122.11 126.23 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -175.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.02 67.08 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -169.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -135.31 48.48 2.25 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.726 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.1 m -30.79 98.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.977 2.911 . . . . 0.0 115.652 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 125.795 1.638 . . . . 0.0 111.92 177.018 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.46 146.12 52.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.431 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 1.5 m -122.3 -65.6 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 117.279 -1.344 . . . . 0.0 110.578 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HD2' ' H ' ' A' ' 67' ' ' SER . 58.8 Cg_endo -68.25 -41.37 7.07 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.862 1.701 . . . . 0.0 110.171 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -61.09 -48.5 81.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.453 1.101 . . . . 0.0 109.436 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -62.03 -49.55 75.56 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.298 0.499 . . . . 0.0 110.694 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.18 -43.79 98.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.591 0.632 . . . . 0.0 110.512 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -29.49 69.28 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.87 -57.45 11.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.559 1.072 . . . . 0.0 108.96 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -62.99 -26.01 68.65 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.1 -31.56 72.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.966 0.506 . . . . 0.0 111.424 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.99 -26.76 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.943 -1.027 . . . . 0.0 113.768 -175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 31.48 62.99 1.14 Allowed Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 126.291 1.837 . . . . 0.0 112.148 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.21 162.31 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.875 2.383 . . . . 0.0 113.466 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.74 67.43 4.47 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.0 111.131 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 15.17 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.607 1.563 . . . . 0.0 112.811 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.0 p -64.13 -5.37 4.7 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.147 -1.596 . . . . 0.0 112.426 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.58 10.55 14.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.282 1.833 . . . . 0.0 111.004 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.51 149.66 33.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.831 0.825 . . . . 0.0 111.131 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.1 ptm85 -100.57 151.26 21.8 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.55 110.25 0.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.46 136.61 44.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.0 mt -138.1 129.7 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.12 -25.59 2.63 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.837 0.732 . . . . 0.0 111.962 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.3 mm -48.57 134.78 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 127.5 2.32 . . . . 0.0 106.752 168.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.72 -21.87 4.51 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.957 0.789 . . . . 0.0 111.993 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.233 0.22 0 C-N-CA 128.46 2.704 . . . . 0.0 114.331 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt . . . . . 0 C--O 1.227 -0.095 0 CA-C-O 118.851 -0.595 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.53 -57.39 12.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.749 0.704 . . . . 0.0 110.43 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.9 -39.14 93.49 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.31 74.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.053 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.61 -36.46 83.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.271 0.941 . . . . 0.0 111.183 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.7 mt -65.23 -45.0 86.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.06 0.845 . . . . 0.0 110.738 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -68.57 -36.03 78.18 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 123.796 0.838 . . . . 0.0 110.021 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -37.81 87.33 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.193 1.397 . . . . 0.0 111.058 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -39.85 83.82 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.23 -17.54 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.195 169.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.19 137.12 53.0 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.656 1.728 . . . . 0.0 109.777 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.35 110.19 17.29 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -65.74 111.99 3.48 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.7 m -88.4 152.51 21.86 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.66 -124.27 35.52 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.06 157.59 43.29 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 62.4 m -46.17 127.78 8.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.31 1.844 . . . . 0.0 112.541 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.09 160.88 19.88 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.242 1.417 . . . . 0.0 108.512 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -134.59 146.85 49.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 C--N 1.329 -0.316 0 C-N-CA 126.824 2.05 . . . . 0.0 109.116 -172.191 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 119.028 -0.511 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -42.94 97.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.035 0.834 . . . . 0.0 111.23 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -51.94 66.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.803 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.26 -43.24 95.61 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.816 0.722 . . . . 0.0 112.422 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.9 m -59.57 -60.64 3.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.068 1.347 . . . . 0.0 109.996 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.4 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 49.2 t90 -57.37 -43.87 83.91 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.207 0.603 . . . . 0.0 112.097 -177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.6 t -61.49 -52.89 55.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 C-N-CA 123.201 0.6 . . . . 0.0 109.955 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -16.15 63.02 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.628 1.104 . . . . 0.0 112.129 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.08 -44.85 21.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.482 0.713 . . . . 0.0 111.252 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.35 73.67 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.965 0.802 . . . . 0.0 111.462 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 53.7 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.317 1.447 . . . . 0.0 109.72 174.436 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.85 164.08 37.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.342 1.057 . . . . 0.0 110.079 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.43 -24.36 18.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.445 1.498 . . . . 0.0 110.924 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.41 124.23 44.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.666 1.186 . . . . 0.0 108.3 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -85.74 132.91 34.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.68 92.01 3.88 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -77.81 111.56 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -127.83 -162.7 1.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.258 1.823 . . . . 0.0 107.168 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 28.89 58.59 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.785 -1.197 . . . . 0.0 112.266 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -32.92 -48.97 0.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.975 2.91 . . . . 0.0 115.136 -170.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -125.83 51.72 1.73 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 108.05 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.3 tp 58.69 31.27 20.97 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.976 1.71 . . . . 0.0 110.188 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.81 154.54 8.21 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 128.027 2.727 . . . . 0.0 107.586 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.08 -160.03 22.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.049 0.924 . . . . 0.0 110.914 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.14 41.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.612 1.565 . . . . 0.0 112.541 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.9 -32.16 65.62 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.17 -0.956 . . . . 0.0 112.542 -172.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.93 -42.54 98.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.845 0.748 . . . . 0.0 110.833 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 t -72.75 -39.58 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.16 -39.88 83.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.24 0.473 . . . . 0.0 110.875 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.56 -40.49 92.87 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.893 0.77 . . . . 0.0 110.94 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -64.15 -44.73 91.23 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 110.295 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.92 -50.03 75.59 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.635 1.174 . . . . 0.0 110.498 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.58 -47.8 63.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.274 1.03 . . . . 0.0 110.807 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.31 -52.75 64.08 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.558 0.743 . . . . 0.0 110.595 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm -56.16 -39.0 71.66 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.886 0.474 . . . . 0.0 112.029 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.7 mt -73.49 -26.39 60.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.429 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.05 -38.73 72.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 120.566 1.53 . . . . 0.0 109.55 169.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -62.32 -26.19 68.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 111.409 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.65 55.1 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.549 174.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.21 23.93 6.76 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.163 0.892 . . . . 0.0 113.334 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.73 -169.44 2.05 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.404 1.082 . . . . 0.0 109.277 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 p -128.35 149.14 50.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.0 p -141.63 154.86 45.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.89 0.376 . . . . 0.0 111.223 -169.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.82 94.95 4.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.196 0.999 . . . . 0.0 108.413 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -68.65 120.87 15.34 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.8 mt -145.63 143.56 29.92 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 122.551 0.341 . . . . 0.0 111.158 -170.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -88.28 33.25 0.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 169.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.91 55.85 7.1 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.577 2.036 . . . . 0.0 114.38 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.84 -20.46 68.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.032 2.488 . . . . 0.0 113.695 -174.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.0 mt -123.56 17.99 9.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.07 1.748 . . . . 0.0 109.066 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.9 tp 64.48 -30.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.399 2.68 . . . . 0.0 113.79 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -165.4 87.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.412 1.885 . . . . 0.0 106.539 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.18 -41.52 97.08 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.9 -0.5 . . . . 0.0 110.446 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt -89.11 150.04 44.34 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.25 -175.83 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.162 3.241 . . . . 0.0 113.116 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.58 33.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 112.43 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -158.68 134.55 8.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.86 2.064 . . . . 0.0 106.351 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.15 -142.86 13.86 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.41 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -123.39 151.79 42.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.8 mt -137.74 142.67 40.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.47 126.99 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.37 108.21 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -145.76 -166.89 2.56 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.828 0.851 . . . . 0.0 109.281 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 p -156.28 66.06 0.57 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 122.2 1.0 . . . . 0.0 112.194 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 123.307 0.643 . . . . 0.0 111.763 -178.008 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.549 HD12 ' H ' ' A' ' 66' ' ' LEU . 3.3 mp -70.5 137.01 49.86 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 170.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.74 -62.87 0.21 Allowed Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.142 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.35 -39.83 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 121.733 1.622 . . . . 0.0 111.745 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -63.48 -46.1 87.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 122.86 0.464 . . . . 0.0 110.537 -171.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -60.81 -48.54 81.32 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.927 0.331 . . . . 0.0 110.207 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -62.34 -45.79 91.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.137 0.426 . . . . 0.0 110.259 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.07 79.31 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.378 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.89 -55.65 31.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.241 0.928 . . . . 0.0 108.937 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.32 -27.67 68.66 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.21 -31.25 69.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.707 0.403 . . . . 0.0 111.648 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -122.4 -25.26 4.83 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 29.54 63.41 0.82 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 126.996 2.118 . . . . 0.0 112.307 -173.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.67 164.45 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.898 2.399 . . . . 0.0 113.063 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -77.57 64.91 2.98 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.266 1.426 . . . . 0.0 111.239 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.46 9.03 1.15 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.037 1.335 . . . . 0.0 112.601 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -61.45 -6.39 2.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.213 2.605 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.62 10.38 18.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.99 1.716 . . . . 0.0 111.03 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.14 153.62 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.783 0.719 . . . . 0.0 111.292 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -103.56 150.41 23.97 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 169.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -122.58 159.01 28.68 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.96 140.37 11.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 169.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.46 141.65 43.28 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mt -139.09 138.85 40.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -169.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.53 -30.43 2.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.721 1.153 . . . . 0.0 111.766 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 mt -50.64 127.34 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.867 2.067 . . . . 0.0 106.974 169.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.55 -13.77 40.09 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.603 0.621 . . . . 0.0 112.877 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 C--N 1.329 -0.314 0 C-N-CA 128.636 2.774 . . . . 0.0 116.602 -169.142 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 mttm . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.9 tm? -53.84 -57.31 11.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.331 0.968 . . . . 0.0 109.622 172.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.51 -40.63 97.56 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -48.59 81.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.859 0.464 . . . . 0.0 110.202 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.78 -31.86 72.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.687 -1.149 . . . . 0.0 111.739 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.9 mt -66.68 -44.27 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.101 1.318 . . . . 0.0 110.78 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -63.15 -40.47 97.67 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.656 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -36.81 83.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.157 1.383 . . . . 0.0 111.303 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.9 m -70.86 -39.79 72.7 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.84 -20.45 0.68 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.101 -1.388 . . . . 0.0 114.881 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 136.65 54.89 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.568 1.684 . . . . 0.0 108.834 -172.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -79.25 126.97 31.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -74.51 112.73 10.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.5 m -85.46 154.94 21.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.29 -125.38 37.49 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.455 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.6 pt-20 -154.41 169.0 24.79 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.269 1.428 . . . . 0.0 107.592 169.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.9 m -51.98 129.92 28.31 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.07 146.15 23.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.505 1.922 . . . . 0.0 107.405 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -121.56 145.88 47.52 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--N 1.326 -0.435 0 C-N-CA 125.303 1.441 . . . . 0.0 107.782 -175.416 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.455 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -55.95 -41.76 75.18 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.487 0.715 . . . . 0.0 110.849 173.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 tp -61.63 -50.11 73.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.69 72.42 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.99 0.806 . . . . 0.0 111.822 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 m -60.01 -57.05 14.54 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -53.11 -44.67 67.82 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.505 1.522 . . . . 0.0 111.691 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -56.5 -58.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 110.077 173.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -16.73 63.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.307 0.958 . . . . 0.0 112.176 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.03 -50.32 15.12 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.099 0.959 . . . . 0.0 110.432 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.35 -27.21 59.11 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.494 1.118 . . . . 0.0 109.634 171.102 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 tpp . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.29 148.23 32.2 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.221 1.008 . . . . 0.0 108.365 170.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.64 -22.97 15.2 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.607 1.563 . . . . 0.0 110.438 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.35 130.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 109.214 -172.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 t -86.2 130.25 34.58 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 169.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.9 94.21 4.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -87.2 98.15 7.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 51.93 2.3 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.82 8.55 59.43 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 117.306 -1.83 . . . . 0.0 115.098 -169.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.0 -42.71 2.92 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.032 1.733 . . . . 0.0 113.983 -169.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 t -149.17 53.09 0.96 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 169.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tp 56.33 38.99 30.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.468 1.507 . . . . 0.0 110.699 -169.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.43 154.38 7.43 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.202 2.81 . . . . 0.0 107.073 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.95 -151.16 6.9 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.928 0.864 . . . . 0.0 110.951 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 65.76 1.21 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.323 1.449 . . . . 0.0 111.0 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -53.74 -37.37 63.3 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.64 0.776 . . . . 0.0 112.63 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -59.81 -45.13 93.3 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.441 0.564 . . . . 0.0 110.255 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -32.69 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.61 97.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.658 0.663 . . . . 0.0 110.853 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.42 -39.55 89.02 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.994 0.518 . . . . 0.0 110.681 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -62.86 -46.51 87.55 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.469 -0.77 . . . . 0.0 110.501 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.8 mt -55.77 -52.68 63.12 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.486 1.114 . . . . 0.0 109.92 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.82 -52.09 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.165 0.986 . . . . 0.0 110.532 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -55.34 -54.26 45.84 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.358 0.663 . . . . 0.0 110.775 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -59.88 -38.87 83.45 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -68.96 -32.7 72.48 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.157 0.583 . . . . 0.0 111.691 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.58 -37.35 71.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.757 1.162 . . . . 0.0 110.152 173.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -63.6 -29.77 70.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 111.217 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.77 -21.74 62.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.562 0.745 . . . . 0.0 111.259 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.02 -5.01 5.37 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.062 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.52 -167.07 1.55 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.686 1.743 . . . . 0.0 109.602 -174.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 p -130.19 151.09 51.09 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.9 p -143.74 160.28 41.0 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -170.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 106.31 8.93 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -71.94 121.09 18.48 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 mt -139.11 157.98 44.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.401 0.68 . . . . 0.0 110.71 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -95.23 21.88 7.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.421 1.088 . . . . 0.0 110.766 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.11 42.89 73.01 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 117.912 -1.493 . . . . 0.0 113.139 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.12 -22.29 61.83 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.201 2.601 . . . . 0.0 114.825 -169.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -115.24 13.53 16.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.523 1.529 . . . . 0.0 109.666 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 tp 65.57 -25.69 0.1 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.016 2.527 . . . . 0.0 112.916 -169.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -169.13 85.81 0.15 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.034 1.734 . . . . 0.0 107.331 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.44 -42.9 98.66 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.594 -0.691 . . . . 0.0 110.249 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -90.81 149.32 40.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.38 -179.33 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.919 3.079 . . . . 0.0 113.449 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.83 30.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.671 1.988 . . . . 0.0 113.102 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.7 p -161.72 107.83 1.33 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.367 1.867 . . . . 0.0 106.393 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.38 -147.48 16.75 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mm -127.53 131.72 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -119.69 152.75 36.64 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.3 mt -143.59 141.16 30.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.16 136.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.66 123.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -162.43 -172.86 3.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 108.158 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.98 69.77 1.03 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.535 -1.353 . . . . 0.0 108.088 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.465 0.297 0 C-N-CA 126.591 1.957 . . . . 0.0 115.657 -169.595 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.3 t30 . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.42 84.43 0.27 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 126.629 1.972 . . . . 0.0 106.701 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -54.4 25.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 124.54 1.136 . . . . 0.0 111.091 -168.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.18 -41.85 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.118 1.879 . . . . 0.0 110.776 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -65.62 -50.96 63.11 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.209 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.95 -44.9 95.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.954 0.797 . . . . 0.0 110.023 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.44 -47.16 80.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.254 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.03 -35.91 74.09 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.204 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -59.59 5.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.603 1.092 . . . . 0.0 109.266 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -16.82 63.73 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.25 -32.55 70.43 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.415 0.552 . . . . 0.0 111.259 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -124.23 -29.35 3.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt 28.98 66.64 0.68 Allowed Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 126.482 1.913 . . . . 0.0 113.251 -171.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.08 173.28 2.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.558 2.172 . . . . 0.0 111.381 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -84.98 124.45 31.71 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 112' ' ' SER . 3.1 mm? -122.35 14.59 10.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.069 1.348 . . . . 0.0 110.657 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -69.07 -3.88 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 119.82 -1.8 . . . . 0.0 112.81 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.25 4.59 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.034 1.334 . . . . 0.0 110.789 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.78 157.36 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.886 0.874 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -113.38 149.43 34.09 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -128.01 164.82 21.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.546 0.689 . . . . 0.0 109.507 174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.1 153.73 21.96 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.62 136.66 53.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.24 135.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -169.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.82 -27.35 1.64 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.081 1.324 . . . . 0.0 112.709 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 mt -48.35 130.04 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.048 2.139 . . . . 0.0 109.273 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -95.03 7.26 69.69 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.027 1.299 . . . . 0.0 111.759 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 125.602 1.561 . . . . 0.0 113.161 -179.28 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.22 -54.74 40.42 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.253 0.933 . . . . 0.0 109.894 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -40.12 95.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.9 88.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.334 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.28 -34.32 77.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.222 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.14 -43.87 85.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.724 1.147 . . . . 0.0 110.5 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -65.03 -37.43 87.57 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 109.911 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -35.12 79.09 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.562 . . . . 0.0 111.282 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.587 ' HB3' HD23 ' A' ' 80' ' ' LEU . 17.9 m -72.4 -27.29 62.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.562 0.345 . . . . 0.0 110.229 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.28 -23.46 2.86 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.541 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 135.57 54.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.2 1.5 . . . . 0.0 108.554 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -80.78 132.62 35.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -77.87 100.0 6.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 m -73.91 153.21 39.92 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.04 -122.06 24.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.8 pt-20 -157.47 174.78 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.981 1.712 . . . . 0.0 107.831 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -54.34 127.84 28.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.809 0.844 . . . . 0.0 109.537 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 tt -99.24 155.27 17.58 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.641 1.576 . . . . 0.0 108.834 -171.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.65 147.85 44.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.329 -0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.318 -176.707 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.527 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.88 -44.88 91.7 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.135 0.879 . . . . 0.0 109.214 174.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.24 -51.63 68.16 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.11 -42.12 98.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.403 0.525 . . . . 0.0 112.111 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 m -58.54 -61.58 2.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 0.0 109.821 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -55.2 -46.06 75.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.7 0.8 . . . . 0.0 112.277 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.03 -54.62 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.556 0.742 . . . . 0.0 109.387 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -16.8 61.94 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.004 0.82 . . . . 0.0 112.471 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 mp -80.74 -44.18 19.06 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.329 0.652 . . . . 0.0 111.034 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -37.05 75.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.923 0.783 . . . . 0.0 110.976 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.7 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.938 1.295 . . . . 0.0 109.93 174.198 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.18 170.07 22.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.934 1.294 . . . . 0.0 109.29 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.64 -23.32 17.66 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.591 1.157 . . . . 0.0 110.895 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.92 127.74 55.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 108.946 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -92.33 129.3 38.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.99 98.63 8.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.83 89.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -92.12 49.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.598 2.359 . . . . 0.0 111.079 -168.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.85 174.26 46.7 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 121.45 -0.781 . . . . 0.0 112.558 175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.8 p -129.34 -48.21 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.621 1.168 . . . . 0.0 110.299 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 p -86.44 -72.21 0.51 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.4 tp -157.14 23.36 0.31 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 110.379 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.94 169.29 42.19 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.37 46.5 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.047 1.784 . . . . 0.0 108.809 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 102.61 0.45 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.303 1.041 . . . . 0.0 111.533 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.97 -38.64 89.3 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.515 0.726 . . . . 0.0 110.637 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.35 -42.59 91.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.283 0.633 . . . . 0.0 110.705 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.14 -49.33 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.96 93.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.104 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.91 -41.35 91.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.008 0.523 . . . . 0.0 110.819 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -61.99 -47.77 83.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.65 0.659 . . . . 0.0 110.066 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.42 -53.43 57.54 Favored 'General case' 0 N--CA 1.46 0.039 0 C-N-CA 124.057 0.943 . . . . 0.0 110.173 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.35 59.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.256 1.022 . . . . 0.0 110.712 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.17 -54.51 46.12 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -58.3 -37.3 74.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -70.81 -28.07 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.859 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.71 -39.65 73.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.632 1.56 . . . . 0.0 109.804 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.57 -28.17 69.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.463 0.705 . . . . 0.0 111.332 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.34 -10.82 60.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 112.348 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 16.92 8.7 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.912 -0.938 . . . . 0.0 113.424 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -117.73 -167.9 1.41 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.485 1.142 . . . . 0.0 108.84 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -130.82 150.29 52.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 p -140.84 156.99 46.01 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.911 -0.493 . . . . 0.0 110.446 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -133.15 105.47 7.05 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.09 122.79 21.55 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.386 1.074 . . . . 0.0 108.533 175.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -149.75 138.59 21.0 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 122.79 0.436 . . . . 0.0 111.014 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -85.48 43.86 1.06 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.667 -1.27 . . . . 0.0 108.393 168.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.31 56.21 1.2 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 127.358 2.408 . . . . 0.0 115.757 -169.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.62 -24.78 46.97 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.343 2.572 . . . . 0.0 115.367 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.4 mt -118.45 15.58 13.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.977 1.711 . . . . 0.0 109.363 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp 66.06 -30.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.506 2.722 . . . . 0.0 113.106 -169.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -168.13 94.45 0.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.334 1.854 . . . . 0.0 106.342 -169.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.29 -44.35 83.73 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.95 153.02 69.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.812 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.65 -171.51 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.443 3.428 . . . . 0.0 112.231 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.35 27.61 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.852 1.661 . . . . 0.0 113.42 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -156.49 138.0 14.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.99 2.116 . . . . 0.0 106.81 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.41 -140.4 11.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mm -128.46 133.83 65.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.524 ' CD1' HG21 ' A' ' 83' ' ' VAL . 8.3 m0 -117.71 135.31 54.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.9 mt -128.95 142.37 50.96 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.93 133.08 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.29 104.58 6.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 123.791 0.836 . . . . 0.0 108.856 -169.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -171.56 131.1 0.71 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.574 1.949 . . . . 0.0 107.409 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.7 m -72.36 102.41 3.14 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 119.113 0.869 . . . . 0.0 108.686 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 115.349 -169.785 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 117.92 -1.038 . . . . 0.0 113.777 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.34 147.74 51.85 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.286 1.434 . . . . 0.0 107.263 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 -61.28 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.527 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -87.91 -40.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.449 2.1 . . . . 0.0 112.418 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -59.58 -52.65 64.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -62.99 -43.92 97.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.923 0.329 . . . . 0.0 110.458 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -63.54 -46.91 83.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.068 0.394 . . . . 0.0 109.969 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.75 71.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.522 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.3 -58.0 10.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.374 0.988 . . . . 0.0 109.079 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -62.64 -26.41 68.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.95 -30.77 71.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.072 0.549 . . . . 0.0 111.658 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -124.91 -23.8 4.2 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 30.78 66.4 0.87 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.65 1.98 . . . . 0.0 112.056 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -57.89 160.5 15.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.404 2.736 . . . . 0.0 113.123 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -79.9 61.12 3.71 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 122.37 1.081 . . . . 0.0 110.779 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.2 mt -71.63 10.47 0.65 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.772 1.629 . . . . 0.0 112.792 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -62.46 -7.42 4.51 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 129.665 3.186 . . . . 0.0 113.042 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.83 11.31 17.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.577 1.551 . . . . 0.0 110.791 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -130.28 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.966 0.889 . . . . 0.0 111.154 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -95.01 151.02 19.53 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.88 145.47 45.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.47 115.23 1.33 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 140.0 47.33 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.6 mt -137.32 128.34 40.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.99 -10.92 2.15 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.314 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mt -48.52 129.93 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.791 2.036 . . . . 0.0 109.465 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.67 -20.35 66.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.243 0.925 . . . . 0.0 112.163 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 127.953 2.501 . . . . 0.0 114.95 -177.574 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.56 -54.18 46.48 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.71 -41.81 95.97 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.84 76.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -67.78 -30.88 70.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.168 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.84 -44.07 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.755 1.161 . . . . 0.0 110.769 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.06 -35.06 73.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.432 0.693 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -32.21 71.4 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 125.954 1.702 . . . . 0.0 111.902 174.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.8 m -64.76 -48.35 74.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.6 -15.74 0.38 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.059 -1.412 . . . . 0.0 115.393 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.05 138.46 58.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.588 1.694 . . . . 0.0 110.61 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -84.03 111.53 19.37 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.64 111.76 2.89 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 42.5 m -84.17 152.51 24.23 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.96 -121.31 26.24 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.562 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 3.0 pt-20 -150.3 -176.35 5.44 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.909 2.083 . . . . 0.0 106.049 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -41.36 111.46 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.622 1.569 . . . . 0.0 111.376 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 161.54 28.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -133.79 149.37 51.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -170.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.562 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.63 -42.24 98.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.292 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 tp -57.99 -53.32 59.59 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.77 -42.68 98.13 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 m -59.0 -62.19 2.07 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 125.146 1.378 . . . . 0.0 110.149 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -57.15 -44.36 83.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.75 0.82 . . . . 0.0 112.016 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.48 -53.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.439 0.696 . . . . 0.0 109.475 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.23 -17.42 62.5 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.31 0.959 . . . . 0.0 112.407 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -79.18 -42.87 25.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.564 0.62 . . . . 0.0 111.227 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -37.56 75.12 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.947 0.794 . . . . 0.0 111.079 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.9 mttm . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.39 1.476 . . . . 0.0 109.937 174.068 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.24 159.59 44.13 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.509 1.124 . . . . 0.0 108.853 173.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -111.85 -23.13 10.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.444 1.898 . . . . 0.0 110.872 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.03 122.85 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -85.06 128.58 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.34 95.33 6.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -82.74 83.21 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -83.72 31.97 0.47 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 128.804 2.841 . . . . 0.0 112.682 -168.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.42 155.62 26.61 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 121.599 -0.688 . . . . 0.0 112.173 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.33 -37.8 1.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 110.387 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.5 p -130.6 49.56 2.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.8 tp 52.22 42.41 30.75 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.126 1.771 . . . . 0.0 111.101 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.18 159.18 16.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 128.042 2.734 . . . . 0.0 106.798 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.36 -160.4 32.52 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.357 1.078 . . . . 0.0 111.301 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.43 46.26 0.33 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.475 1.91 . . . . 0.0 113.525 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -53.52 -35.22 60.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.192 0.997 . . . . 0.0 112.828 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.01 -45.75 93.56 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.772 . . . . 0.0 110.736 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.05 -40.9 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.534 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.11 -41.52 94.83 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.177 0.899 . . . . 0.0 110.984 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -64.8 -45.5 85.99 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.745 -0.597 . . . . 0.0 109.904 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.24 -51.24 68.82 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.225 1.01 . . . . 0.0 110.271 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.36 -49.83 60.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 110.897 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.16 -53.48 57.8 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.193 0.997 . . . . 0.0 110.244 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.71 -37.95 77.23 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mp -69.71 -26.51 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.86 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -70.04 -43.82 70.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.854 1.661 . . . . 0.0 109.316 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.0 -26.33 67.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.48 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.34 -16.26 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.713 0.805 . . . . 0.0 112.219 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.07 15.66 2.05 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.523 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -131.66 -165.25 1.55 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.304 1.552 . . . . 0.0 110.041 -169.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 p -131.18 151.68 51.22 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.9 p -144.11 159.78 42.04 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.038 0.535 . . . . 0.0 109.796 -169.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.1 107.23 7.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 m -78.17 120.15 22.56 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -147.07 137.47 23.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.194 0.598 . . . . 0.0 110.057 -169.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -82.39 41.49 0.7 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.608 -1.307 . . . . 0.0 109.677 169.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 38.7 55.12 2.22 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.636 2.065 . . . . 0.0 115.022 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.39 -20.3 54.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.808 2.339 . . . . 0.0 113.499 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.4 mt -118.07 15.18 14.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.293 1.837 . . . . 0.0 109.068 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tp 63.84 -28.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.088 2.955 . . . . 0.0 113.97 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -164.98 93.45 0.62 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.408 1.483 . . . . 0.0 107.111 -168.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.08 -43.78 77.77 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.467 -0.771 . . . . 0.0 110.007 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.35 154.5 74.34 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 47' ' ' SER . 41.8 Cg_endo -66.52 -173.68 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.934 3.089 . . . . 0.0 112.554 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 29.94 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.178 1.391 . . . . 0.0 112.661 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 45' ' ' PRO . 18.0 m -152.33 136.91 16.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.967 2.507 . . . . 0.0 106.41 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.13 -141.59 12.74 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mm -123.76 139.83 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CD1' HG21 ' A' ' 83' ' ' VAL . 10.3 m0 -122.04 135.12 54.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.8 mt -128.79 140.7 51.59 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.58 134.43 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -137.68 113.78 11.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -170.93 -156.51 0.12 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.935 2.494 . . . . 0.0 105.668 174.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m -147.6 138.78 23.62 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 121.06 1.755 . . . . 0.0 109.305 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.0 p . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.619 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.448 HD12 ' H ' ' A' ' 66' ' ' LEU . 5.9 mp -65.34 146.16 55.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.721 1.208 . . . . 0.0 108.69 174.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.454 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 29.8 m -122.22 -63.67 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 117.248 -1.358 . . . . 0.0 111.172 176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 67' ' ' SER . 43.9 Cg_endo -66.75 -39.31 15.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.92 1.722 . . . . 0.0 110.993 -175.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -60.28 -50.35 73.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.35 0.66 . . . . 0.0 110.091 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.28 -48.97 78.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.67 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -60.94 -45.81 93.23 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.772 0.714 . . . . 0.0 110.462 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.4 72.61 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.43 -58.02 8.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 119.202 0.91 . . . . 0.0 109.233 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -63.6 -24.64 67.88 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.56 -33.69 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.022 0.529 . . . . 0.0 111.38 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -123.47 -23.76 4.73 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 29.91 66.53 0.78 Allowed Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 126.885 2.074 . . . . 0.0 112.086 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.75 163.88 17.58 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.037 2.492 . . . . 0.0 113.529 -169.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.99 59.86 2.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.285 1.834 . . . . 0.0 112.009 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 7.16 2.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.036 1.334 . . . . 0.0 113.163 -171.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -63.52 -4.06 2.57 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.259 -1.526 . . . . 0.0 112.614 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.9 6.56 25.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.3 1.44 . . . . 0.0 111.459 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.1 p -130.71 162.07 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.914 0.885 . . . . 0.0 109.966 175.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -118.0 152.74 34.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -119.92 151.56 38.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.922 1.689 . . . . 0.0 108.134 -169.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.39 150.85 23.16 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.9 138.95 53.82 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.7 mt -137.08 124.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -169.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.23 -30.27 1.39 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.801 1.191 . . . . 0.0 111.803 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.43 143.45 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.452 1.901 . . . . 0.0 108.005 169.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 15.54 0.11 Allowed Glycine 0 CA--C 1.523 0.563 0 CA-C-O 119.055 -0.858 . . . . 0.0 113.8 -174.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 125.037 1.335 . . . . 0.0 112.878 178.629 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.2 mttm . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.21 -58.82 5.92 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.788 1.177 . . . . 0.0 109.842 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.57 -37.68 84.73 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -175.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.2 -51.75 67.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.009 0.923 . . . . 0.0 109.953 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.69 -35.22 80.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.428 1.013 . . . . 0.0 111.158 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.62 -50.1 72.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.174 0.897 . . . . 0.0 110.942 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.322 11.7 ptmt -71.78 -28.1 63.4 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.938 -0.476 . . . . 0.0 112.204 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -36.19 82.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.333 1.053 . . . . 0.0 111.009 169.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.6 m -68.52 -33.7 74.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.948 0.34 . . . . 0.0 110.561 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.69 -28.9 0.37 Allowed Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.668 169.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.47 141.2 57.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.654 1.227 . . . . 0.0 110.11 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -80.69 129.16 34.36 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -75.6 100.95 4.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 170.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 99.6 m -73.32 149.87 42.31 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.34 -124.43 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.474 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.0 pt-20 -152.1 166.05 32.84 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.337 1.055 . . . . 0.0 108.301 169.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.5 m -51.03 130.89 26.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.842 1.257 . . . . 0.0 111.222 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -92.64 160.47 14.99 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.928 2.091 . . . . 0.0 108.429 -176.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.414 ' H ' HD23 ' A' ' 121' ' ' LEU . 47.3 mtmt -131.36 144.05 50.95 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--N 1.324 -0.535 0 C-N-CA 127.747 2.419 . . . . 0.0 106.448 -179.583 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 . . . . . 0 CA--C 1.538 0.513 0 CA-C-O 119.395 -0.336 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.474 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.87 -48.47 78.05 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.335 0.654 . . . . 0.0 109.711 171.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.62 -49.14 77.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.074 0.95 . . . . 0.0 109.217 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.0 -52.51 46.3 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.932 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -63.24 -44.74 94.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.286 0.543 . . . . 0.0 110.524 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.39 -41.84 94.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.274 1.43 . . . . 0.0 110.804 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.77 -48.03 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.084 0.953 . . . . 0.0 109.547 172.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.35 -29.74 70.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.257 0.935 . . . . 0.0 111.612 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.21 -46.99 25.65 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.363 1.065 . . . . 0.0 110.505 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.01 -29.91 62.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.353 0.524 . . . . 0.0 112.054 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.3 mttt . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.374 1.07 . . . . 0.0 109.86 171.815 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.81 158.8 35.73 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.1 -22.25 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.1 1.76 . . . . 0.0 110.712 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.5 mt -134.81 128.94 51.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.547 1.139 . . . . 0.0 108.065 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -89.01 131.88 34.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 95.1 5.39 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.1 mt -89.94 110.39 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.35 143.67 44.06 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 122.813 0.445 . . . . 0.0 111.622 -169.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.5 168.29 12.22 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 124.598 1.094 . . . . 0.0 112.002 169.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 p -117.88 -8.8 10.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 0.0 112.516 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t -141.79 -54.44 0.45 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -149.4 17.12 0.93 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.485 1.039 . . . . 0.0 111.661 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.93 172.1 28.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 127.432 2.444 . . . . 0.0 107.68 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.71 10.07 4.12 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.015 -1.436 . . . . 0.0 115.053 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 2.86 1.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.077 1.938 . . . . 0.0 113.405 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.8 -31.55 62.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.486 1.114 . . . . 0.0 112.125 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -58.1 -53.5 57.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.458 0.703 . . . . 0.0 111.525 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.09 -30.54 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.03 77.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.001 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.35 -41.22 89.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.015 0.825 . . . . 0.0 111.083 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -63.07 -46.9 85.28 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.1 mt -57.12 -51.17 70.35 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.044 0.937 . . . . 0.0 110.461 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.72 -48.53 63.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.761 1.224 . . . . 0.0 110.685 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.71 -53.89 52.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.484 0.714 . . . . 0.0 110.345 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -57.92 -38.12 75.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.92 -33.13 75.02 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.254 0.621 . . . . 0.0 111.183 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -70.04 -38.21 75.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 119.921 1.237 . . . . 0.0 110.325 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.51 -28.96 70.3 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.165 0.893 . . . . 0.0 111.42 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.34 63.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.393 0.677 . . . . 0.0 111.597 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.26 -6.49 5.34 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.493 -1.171 . . . . 0.0 113.706 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.9 -165.44 1.34 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.341 1.57 . . . . 0.0 109.395 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.5 p -144.88 160.08 41.87 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.701 -0.624 . . . . 0.0 110.618 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.07 115.61 15.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 m -78.93 123.82 27.64 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 mt -140.5 156.79 46.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.112 0.565 . . . . 0.0 110.396 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -105.03 35.8 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.432 1.093 . . . . 0.0 108.77 169.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.57 48.05 28.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.727 1.632 . . . . 0.0 115.048 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.38 -20.57 61.47 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 121.046 2.423 . . . . 0.0 113.808 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -122.31 14.92 10.49 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.022 1.729 . . . . 0.0 109.094 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.6 tp 64.9 -30.09 0.12 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.979 2.512 . . . . 0.0 113.543 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -165.31 86.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.223 1.409 . . . . 0.0 107.452 -168.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.7 -41.74 99.28 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.956 -0.465 . . . . 0.0 110.185 176.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.47 150.11 36.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.58 -178.92 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.88 3.053 . . . . 0.0 113.239 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 32.55 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.994 1.718 . . . . 0.0 112.549 171.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 m -157.36 125.34 5.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 106.044 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.86 -143.36 14.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 mm -124.38 130.97 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -118.89 144.62 46.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.2 mt -137.14 135.77 37.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -132.6 137.55 53.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -173.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -128.07 96.71 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.169 1.388 . . . . 0.0 107.258 -170.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.5 p -145.52 -6.29 0.63 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -173.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m 37.98 60.95 1.14 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.468 0.431 0 C-N-CA 124.122 0.969 . . . . 0.0 112.384 169.932 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.0 mt 37.66 58.81 1.33 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.078 1.418 . . . . 0.0 108.395 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.402 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 50.5 m -63.61 -48.01 81.45 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.488 1.915 . . . . 0.0 114.174 -168.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 67' ' ' SER . 37.2 Cg_endo -63.14 -34.07 70.42 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 121.176 1.456 . . . . 0.0 110.647 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -72.33 -42.84 64.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.403 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -53.52 -51.56 62.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.99 1.316 . . . . 0.0 110.261 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -61.8 -42.52 99.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.822 0.737 . . . . 0.0 110.87 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.6 86.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.219 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.49 -56.34 23.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.241 0.928 . . . . 0.0 109.106 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -20.18 65.06 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.84 -31.06 63.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.876 0.762 . . . . 0.0 111.635 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -121.11 -28.56 4.72 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 23.75 70.91 0.33 Allowed Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 127.722 2.409 . . . . 0.0 113.7 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -58.84 175.38 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.605 2.204 . . . . 0.0 111.729 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -89.96 79.16 6.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.995 0.918 . . . . 0.0 110.022 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.557 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.1 mm? -75.39 3.17 9.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.264 0.626 . . . . 0.0 112.174 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -63.8 -6.74 6.23 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.026 2.13 . . . . 0.0 112.926 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.13 6.21 38.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.774 1.629 . . . . 0.0 110.792 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.31 145.66 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 122.147 0.975 . . . . 0.0 111.732 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.407 HH11 ' HG3' ' A' ' 84' ' ' ARG . 1.6 ptm180 -94.67 144.55 25.52 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -113.07 146.5 39.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.09 121.81 3.67 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.09 132.16 43.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.24 108.28 18.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -30.03 0.43 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.227 0.918 . . . . 0.0 113.049 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.76 123.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.0 45.74 0.29 Allowed Glycine 0 CA--C 1.502 -0.722 0 CA-C-O 121.722 0.623 . . . . 0.0 111.75 -169.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 118.82 -0.61 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.83 -56.49 19.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.721 0.808 . . . . 0.0 110.138 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.14 -38.87 92.0 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.63 72.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -63.24 -42.12 99.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.775 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -57.28 -47.59 81.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.304 0.956 . . . . 0.0 110.714 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -73.51 -36.0 65.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.852 0.861 . . . . 0.0 109.688 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -34.38 78.23 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.377 1.471 . . . . 0.0 111.629 173.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.557 ' HB3' HD23 ' A' ' 80' ' ' LEU . 14.8 m -73.65 -17.72 61.12 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.251 0.22 . . . . 0.0 110.636 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.25 -17.64 5.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 117.921 -1.488 . . . . 0.0 114.085 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 130.75 44.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.649 1.725 . . . . 0.0 109.258 -170.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -86.37 111.08 20.15 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.04 117.51 5.18 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 94.7 m -129.38 143.13 50.72 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.244 0.618 . . . . 0.0 110.737 -169.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.38 -103.34 2.99 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -165.03 -175.88 3.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.357 1.863 . . . . 0.0 107.448 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.4 m -63.01 113.64 3.22 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 122' ' ' LYS . 1.3 tt -71.37 153.62 42.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.511 ' H ' HD23 ' A' ' 121' ' ' LEU . 37.6 mttp -130.8 143.0 50.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 125.722 1.609 . . . . 0.0 107.213 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.533 0.305 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.451 ' CE3' HD12 ' A' ' 121' ' ' LEU . 13.8 t90 -59.08 -54.92 41.57 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.307 0.643 . . . . 0.0 109.538 173.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -55.91 20.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.631 1.573 . . . . 0.0 109.09 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.1 -42.59 98.02 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.737 -0.48 . . . . 0.0 112.133 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -60.17 -60.35 3.96 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.82 0.81 . . . . 0.0 109.03 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -56.85 -46.54 81.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.386 1.074 . . . . 0.0 111.485 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.01 -55.78 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.702 0.801 . . . . 0.0 109.683 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -15.96 62.49 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.059 0.845 . . . . 0.0 112.421 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.61 -48.47 13.71 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.467 0.707 . . . . 0.0 110.769 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.73 -32.58 65.8 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.766 0.712 . . . . 0.0 111.958 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.1 mttt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.228 1.011 . . . . 0.0 109.74 174.006 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.62 152.59 45.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.273 0.942 . . . . 0.0 111.628 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.43 -22.51 16.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.193 1.797 . . . . 0.0 110.865 170.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.21 129.49 53.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.781 1.233 . . . . 0.0 108.144 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -90.42 127.96 36.35 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.91 95.62 5.66 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.64 131.54 33.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.83 -174.35 3.7 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.058 1.743 . . . . 0.0 109.038 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.27 42.44 90.58 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.547 -0.721 . . . . 0.0 112.476 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -44.91 -44.56 9.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.396 2.278 . . . . 0.0 114.329 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -82.23 22.78 0.79 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.188 1.795 . . . . 0.0 112.188 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt 59.04 54.17 5.13 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.74 1.257 . . . . 0.0 107.654 -168.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.32 -135.98 3.33 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.096 1.808 . . . . 0.0 108.739 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.46 149.32 21.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.18 16.27 0.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.321 1.849 . . . . 0.0 111.108 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.24 -16.91 37.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 0.0 113.683 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.64 -48.08 66.63 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.283 1.402 . . . . 0.0 112.14 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.07 -31.72 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.967 -0.458 . . . . 0.0 110.177 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.53 78.07 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.074 0.55 . . . . 0.0 111.114 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.31 -37.45 80.61 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.055 0.942 . . . . 0.0 110.371 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -65.25 -42.44 93.31 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.72 -0.612 . . . . 0.0 110.008 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 mt -61.49 -51.73 67.43 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.93 64.96 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.451 1.501 . . . . 0.0 111.312 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 -54.74 40.16 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.517 0.675 . . . . 0.0 109.954 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.56 -38.74 91.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -60.93 -40.17 92.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.478 0.711 . . . . 0.0 110.897 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.55 -36.52 68.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.16 -0.962 . . . . 0.0 110.469 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.8 -31.3 71.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.481 0.712 . . . . 0.0 111.262 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.5 -21.49 62.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.375 0.67 . . . . 0.0 111.736 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.99 -7.82 3.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.178 -1.345 . . . . 0.0 114.295 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -94.99 -168.86 1.88 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.802 1.801 . . . . 0.0 110.205 -171.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -128.89 149.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.7 p -142.71 155.64 44.91 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.823 -0.548 . . . . 0.0 111.065 -170.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -121.73 90.67 3.36 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.906 1.283 . . . . 0.0 108.331 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -67.53 120.66 14.33 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.1 mt -146.86 168.37 21.59 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.834 0.854 . . . . 0.0 111.534 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -109.52 31.88 5.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.884 1.273 . . . . 0.0 109.584 169.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.86 49.73 46.93 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.602 1.572 . . . . 0.0 114.537 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 -21.01 64.96 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.061 2.507 . . . . 0.0 113.99 -172.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.11 12.76 11.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.674 1.59 . . . . 0.0 109.577 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 tp 63.91 -25.8 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.939 2.496 . . . . 0.0 113.455 -169.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -166.75 82.67 0.25 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -169.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.98 -43.89 97.54 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.879 -0.513 . . . . 0.0 109.841 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.48 151.28 44.07 Favored Pre-proline 0 C--N 1.345 0.409 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 169.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 47' ' ' SER . 37.5 Cg_endo -67.07 -175.12 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 124.151 3.234 . . . . 0.0 113.005 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.04 29.77 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.645 1.578 . . . . 0.0 113.193 171.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' PRO . 20.3 m -152.56 127.17 9.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.964 2.506 . . . . 0.0 106.157 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.08 -140.92 12.19 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.3 mm -127.97 135.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CD1' HG21 ' A' ' 83' ' ' VAL . 18.2 m0 -119.52 130.02 54.98 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.3 mt -126.97 133.58 50.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.37 103.5 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -169.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.0 mp -78.72 126.04 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.9 m -159.57 176.95 11.43 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.128 1.771 . . . . 0.0 107.05 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 m -149.92 65.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 p . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 126.749 2.019 . . . . 0.0 113.399 -169.835 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 119.968 3.322 . . . . 0.0 119.968 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.29 72.57 10.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.8 m -67.21 -51.3 35.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.746 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 -38.73 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.453 1.435 . . . . 0.0 110.18 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.31 -52.33 54.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.592 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -59.38 -46.26 89.16 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.286 0.948 . . . . 0.0 110.845 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -63.5 -49.54 73.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.512 0.596 . . . . 0.0 110.274 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.26 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -60.52 -56.29 23.21 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.836 0.855 . . . . 0.0 109.577 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.41 -23.57 66.99 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.49 -33.7 73.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.746 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -124.59 -21.83 4.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 30.26 64.53 0.89 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 127.068 2.147 . . . . 0.0 112.911 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.7 165.24 18.84 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.938 2.425 . . . . 0.0 113.375 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.34 63.96 4.99 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.731 1.212 . . . . 0.0 111.232 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 9.95 0.33 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.45 1.5 . . . . 0.0 113.281 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 m -64.04 -2.43 1.98 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.756 2.823 . . . . 0.0 113.171 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.85 9.1 11.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.741 1.616 . . . . 0.0 110.981 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -128.5 154.13 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.689 0.677 . . . . 0.0 110.75 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.36 143.26 32.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -103.01 154.61 19.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.98 115.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.1 133.92 47.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.32 116.67 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.46 -11.37 18.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.625 1.107 . . . . 0.0 114.36 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.64 130.5 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.012 1.725 . . . . 0.0 108.609 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.96 -38.88 3.71 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 -170.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 125.705 1.602 . . . . 0.0 111.565 170.363 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.404 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.9 tm? -59.37 -59.04 6.08 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.292 0.951 . . . . 0.0 109.442 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.06 -38.61 79.78 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.318 0.508 . . . . 0.0 110.852 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.91 88.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.879 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -64.84 -36.59 84.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.967 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.67 -47.25 86.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.255 0.934 . . . . 0.0 110.814 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -69.46 -35.47 75.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.993 0.517 . . . . 0.0 110.217 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -36.48 84.18 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.293 1.437 . . . . 0.0 111.037 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.8 m -67.16 -36.14 81.18 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.607 0.363 . . . . 0.0 110.097 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.66 -25.66 0.25 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.29 -1.284 . . . . 0.0 115.396 169.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.35 139.98 55.87 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.344 1.572 . . . . 0.0 110.524 -170.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -83.73 146.14 28.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -92.58 98.37 11.4 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.8 m -75.3 151.72 38.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.82 -116.89 8.63 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 7.3 pt-20 -146.8 178.99 7.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.334 1.053 . . . . 0.0 108.561 170.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -54.43 119.53 5.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.5 1.12 . . . . 0.0 108.8 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.7 OUTLIER -76.09 151.35 37.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.463 ' H ' HD23 ' A' ' 121' ' ' LEU . 28.0 mtmm -138.87 141.84 38.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.324 -0.533 0 C-N-CA 127.501 2.321 . . . . 0.0 108.657 -171.613 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 119.601 -0.237 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.438 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 8.3 m-90 -63.22 -51.29 66.84 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.007 0.523 . . . . 0.0 109.833 177.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.8 mt -58.62 -55.7 31.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.693 0.621 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.51 -49.16 75.61 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.383 -0.676 . . . . 0.0 111.414 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -48.03 77.71 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.155 0.977 . . . . 0.0 110.176 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -60.16 -42.96 96.07 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.569 -0.707 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.8 t -57.39 -50.33 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.555 1.142 . . . . 0.0 109.727 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.74 -26.96 68.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.129 0.877 . . . . 0.0 111.986 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.8 -45.98 16.1 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.671 0.789 . . . . 0.0 110.401 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.05 -34.69 68.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.375 0.534 . . . . 0.0 111.754 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.2 mttt . . . . . 0 C--O 1.248 0.98 0 C-N-CA 124.155 0.982 . . . . 0.0 110.026 176.14 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 tpp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.71 163.22 40.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.369 1.068 . . . . 0.0 109.924 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.14 -24.3 16.91 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.752 1.221 . . . . 0.0 110.891 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.7 mt -132.48 124.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 127.8 35.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.16 103.4 14.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mt -89.92 74.45 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -78.83 138.88 38.38 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.783 -0.573 . . . . 0.0 109.988 -170.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.63 136.11 3.15 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 124.563 1.078 . . . . 0.0 111.082 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -87.21 -7.22 58.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.931 0.892 . . . . 0.0 110.509 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -143.74 -144.35 0.15 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.992 3.317 . . . . 0.0 102.954 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.62 8.12 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.44 -176.52 48.08 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 128.931 3.158 . . . . 0.0 107.413 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 7.87 5.29 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.232 -1.316 . . . . 0.0 114.709 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.82 -2.48 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.638 1.719 . . . . 0.0 113.732 -175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.01 -33.39 64.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.425 1.09 . . . . 0.0 112.432 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.59 -42.65 88.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.515 0.726 . . . . 0.0 111.469 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.77 -28.18 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.01 77.59 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.145 0.884 . . . . 0.0 111.338 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.08 -42.05 93.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.918 0.781 . . . . 0.0 111.278 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -68.59 -43.2 77.01 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.698 -0.627 . . . . 0.0 110.663 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.73 -50.5 73.01 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.001 0.92 . . . . 0.0 110.432 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.97 67.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.732 1.213 . . . . 0.0 110.995 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.98 -52.99 61.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.683 0.674 . . . . 0.0 110.18 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -60.35 -40.55 91.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.91 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.518 175.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.53 -39.98 80.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.388 0.995 . . . . 0.0 109.737 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.94 -29.1 70.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.389 0.995 . . . . 0.0 111.6 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.3 -17.73 63.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.716 0.806 . . . . 0.0 111.622 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.35 14.03 4.6 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.323 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.72 -172.38 2.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.442 1.621 . . . . 0.0 110.419 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -122.86 153.58 39.44 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p -141.61 154.56 45.48 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.875 -0.516 . . . . 0.0 111.615 -169.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -117.94 91.92 3.7 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.634 1.574 . . . . 0.0 106.923 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -69.21 118.44 12.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 172.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.09 166.0 27.43 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.747 1.219 . . . . 0.0 108.738 -173.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -101.44 31.18 3.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.493 0.717 . . . . 0.0 110.653 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.62 50.79 47.39 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 118.143 -1.365 . . . . 0.0 113.935 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.2 -21.36 67.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.082 2.521 . . . . 0.0 113.638 -171.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.2 mt -125.74 15.87 8.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.739 1.616 . . . . 0.0 109.54 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.6 tp 63.0 -26.69 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.328 2.651 . . . . 0.0 114.31 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -161.17 82.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.536 1.134 . . . . 0.0 108.22 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.36 -43.96 84.52 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.777 -0.577 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.3 mt -85.65 151.36 55.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.24 -178.29 1.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.968 3.112 . . . . 0.0 113.292 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 31.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.758 2.023 . . . . 0.0 112.941 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -159.87 116.87 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.928 2.091 . . . . 0.0 106.312 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.0 -146.01 15.4 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -173.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mm -123.64 136.18 60.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -118.36 148.78 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.5 mt -134.54 142.91 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.75 130.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.41 110.4 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -168.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 m -149.51 -174.67 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.23 1.012 . . . . 0.0 109.361 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -154.48 134.73 13.24 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.622 1.169 . . . . 0.0 108.313 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 CA--C 1.531 0.218 0 C-N-CA 122.903 0.481 . . . . 0.0 111.237 -170.562 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 t30 . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.36 61.27 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.012 1.725 . . . . 0.0 108.66 170.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.5 m -65.94 -48.02 62.38 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 125.957 1.703 . . . . 0.0 110.838 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -72.71 -39.95 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 120.414 1.184 . . . . 0.0 110.251 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -60.21 3.53 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -169.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -59.79 -43.21 94.55 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.984 0.913 . . . . 0.0 110.336 -169.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -69.31 -46.87 66.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.001 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -26.91 68.59 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.651 1.114 . . . . 0.0 112.886 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.9 mt -61.98 -61.34 2.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -57.48 -25.8 60.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.096 1.758 . . . . 0.0 113.719 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -30.81 70.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -126.88 -29.95 2.78 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HD2' HD21 ' A' ' 111' ' ' ASN . 36.6 mtmt 23.81 67.85 0.38 Allowed Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 127.153 2.181 . . . . 0.0 113.401 -169.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.6 175.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.833 1.689 . . . . 0.0 110.672 171.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -87.87 125.93 34.75 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.9 mm? -120.27 11.79 11.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.619 1.168 . . . . 0.0 111.145 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.7 m -67.0 -4.87 10.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 119.662 -1.899 . . . . 0.0 113.033 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.1 5.06 42.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.308 1.443 . . . . 0.0 110.734 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.06 157.17 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.961 0.886 . . . . 0.0 110.896 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -110.46 151.99 26.86 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -121.44 157.22 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.85 118.84 2.4 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.17 140.6 31.63 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.79 125.89 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -170.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.58 52.78 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.381 0.991 . . . . 0.0 113.796 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.55 80.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 108.151 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.54 -11.39 2.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 127.174 2.321 . . . . 0.0 117.806 -168.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 CA--C 1.541 0.603 0 CA-C-N 120.525 2.162 . . . . 0.0 109.692 172.397 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt . . . . . 0 C--O 1.233 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.35 -55.4 35.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.471 1.108 . . . . 0.0 109.545 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.56 -39.85 92.16 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.837 -171.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.38 78.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.224 1.01 . . . . 0.0 109.889 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -63.72 -35.74 81.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.422 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.8 -42.5 94.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.206 1.366 . . . . 0.0 111.289 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -65.55 -38.85 90.81 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.111 0.565 . . . . 0.0 109.764 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.471 HD21 ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.65 -31.32 71.23 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.986 1.314 . . . . 0.0 111.684 176.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.627 ' HB3' HD23 ' A' ' 80' ' ' LEU . 15.5 m -73.52 -29.91 62.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.855 0.462 . . . . 0.0 109.847 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.71 -17.35 4.44 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-O 118.457 -1.19 . . . . 0.0 113.599 169.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 136.23 56.67 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.892 1.346 . . . . 0.0 108.287 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -84.56 126.81 33.65 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -77.27 98.65 5.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.8 m -73.45 151.33 41.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.59 -117.35 10.83 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.571 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 10.3 pt-20 -157.0 170.08 23.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.123 1.769 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -55.3 126.44 24.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.603 0.761 . . . . 0.0 109.739 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -84.25 161.42 20.5 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.065 1.746 . . . . 0.0 107.674 176.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.437 ' H ' HD23 ' A' ' 121' ' ' LEU . 60.6 mtpt -136.52 150.87 48.87 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.327 0 C-N-CA 123.394 0.678 . . . . 0.0 110.387 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.571 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -61.93 -40.54 95.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.836 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -55.73 27.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.64 -49.0 67.61 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.266 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.7 m -60.61 -55.53 32.24 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 111.83 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -55.99 -42.7 76.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.65 1.18 . . . . 0.0 111.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 t -58.23 -49.35 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.145 0.578 . . . . 0.0 109.83 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.59 -30.12 70.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.372 0.987 . . . . 0.0 111.397 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.9 -46.12 25.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.014 0.925 . . . . 0.0 110.452 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.69 -33.66 66.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.058 0.543 . . . . 0.0 111.586 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 83.7 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.484 1.114 . . . . 0.0 110.09 173.227 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.76 168.7 24.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.359 1.064 . . . . 0.0 109.988 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.37 -23.77 14.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 111.224 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.13 121.94 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -85.12 133.89 34.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.69 96.52 6.13 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 174.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.3 mt -92.9 107.38 19.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -92.12 95.27 9.66 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.24 0.22 23.82 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 118.291 -1.283 . . . . 0.0 114.803 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.89 106.12 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.451 1.625 . . . . 0.0 109.648 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m 46.83 44.45 14.31 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.068 1.347 . . . . 0.0 110.357 -170.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.89 47.9 21.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.649 1.58 . . . . 0.0 111.985 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.19 -173.19 40.76 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.538 1.542 . . . . 0.0 110.723 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.97 -165.82 39.0 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.68 55.56 0.67 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 111.221 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -54.24 -31.44 53.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.085 1.354 . . . . 0.0 112.105 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -55.7 -40.77 72.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.861 0.864 . . . . 0.0 111.721 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.58 -29.94 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.18 74.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.09 0.859 . . . . 0.0 110.638 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.13 -38.91 93.06 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.557 0.617 . . . . 0.0 110.907 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -67.11 -42.62 84.22 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.697 -0.627 . . . . 0.0 110.29 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -59.35 -52.54 65.2 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.697 0.799 . . . . 0.0 109.919 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.99 -49.55 63.06 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.162 1.385 . . . . 0.0 110.931 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.19 -54.35 47.92 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 110.426 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.16 -25.03 65.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.34 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.64 -43.38 80.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 120.738 1.608 . . . . 0.0 109.319 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.85 -26.21 68.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.749 -0.594 . . . . 0.0 111.597 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -13.02 62.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.943 0.897 . . . . 0.0 112.549 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.33 19.04 2.95 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.087 169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -132.0 -165.48 1.59 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.63 1.215 . . . . 0.0 109.837 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 p -132.36 151.75 51.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -141.77 154.91 45.56 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.971 -0.456 . . . . 0.0 111.468 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -125.72 95.66 4.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.518 1.127 . . . . 0.0 108.647 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.7 m -70.2 121.46 17.6 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.47 165.01 29.82 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.395 0.617 . . . . 0.0 111.469 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -107.46 31.1 5.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.728 1.211 . . . . 0.0 110.165 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.88 45.41 70.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.854 -1.526 . . . . 0.0 115.113 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.43 -21.41 66.39 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.049 2.499 . . . . 0.0 114.118 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.9 mt -116.45 11.72 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.529 1.532 . . . . 0.0 109.887 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 tp 64.21 -23.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.787 2.435 . . . . 0.0 113.467 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -169.82 82.63 0.12 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.963 1.705 . . . . 0.0 106.65 -169.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.45 -43.82 96.3 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.876 -0.515 . . . . 0.0 109.666 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.8 mt -96.06 150.8 37.72 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 169.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.31 -177.6 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.742 2.962 . . . . 0.0 113.154 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.17 35.75 0.05 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.73 1.612 . . . . 0.0 112.037 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 m -160.51 130.24 5.11 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.186 2.195 . . . . 0.0 106.008 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.28 -143.45 14.54 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -172.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mm -127.39 141.07 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CD1' HG21 ' A' ' 83' ' ' VAL . 5.1 m0 -128.92 146.86 50.84 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.8 mt -132.55 140.12 48.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.22 121.98 58.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.95 60.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -120.77 41.31 3.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.256 -169.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -26.53 107.76 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 128.584 2.754 . . . . 0.0 113.914 -172.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.224 -0.287 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.723 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.3 t30 . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.29 72.52 1.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.4 -51.92 57.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.513 0.725 . . . . 0.0 112.454 -168.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.8 -39.58 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.612 1.541 . . . . 0.0 110.516 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.36 -51.43 60.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.699 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -60.09 -49.85 76.03 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.519 0.6 . . . . 0.0 110.261 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.44 -44.7 95.79 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.541 0.609 . . . . 0.0 110.387 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.06 91.78 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.198 0.453 . . . . 0.0 111.919 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.5 mt -58.71 -55.68 31.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.952 0.796 . . . . 0.0 109.739 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -65.59 -20.01 66.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.25 -34.11 65.66 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.37 0.532 . . . . 0.0 111.598 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -122.85 -21.36 5.58 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 29.24 65.95 0.73 Allowed Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 127.07 2.148 . . . . 0.0 113.034 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.87 165.29 14.41 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.533 2.155 . . . . 0.0 112.738 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -80.74 63.93 5.33 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.05 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -68.37 4.53 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.139 0.976 . . . . 0.0 112.789 -177.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -62.09 -8.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.812 2.845 . . . . 0.0 113.104 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.55 10.4 19.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.713 1.605 . . . . 0.0 110.752 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 50' ' ' TRP . 1.5 p -132.27 153.08 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 110.813 175.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -107.34 152.42 24.18 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -120.05 156.41 30.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.07 126.59 3.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 106.524 -2.63 . . . . 0.0 106.524 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.22 138.92 31.68 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 mt -139.31 124.45 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.72 -12.05 3.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.066 0.841 . . . . 0.0 114.352 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.7 mm -55.14 133.81 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.229 1.412 . . . . 0.0 107.857 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.88 -21.72 17.72 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -169.702 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.85 -57.38 12.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.677 0.671 . . . . 0.0 109.788 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.39 -36.08 81.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.498 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.8 -50.42 73.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.421 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.81 -42.34 93.26 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.604 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 mt -60.18 -48.15 82.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.844 0.747 . . . . 0.0 111.167 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -67.99 -36.2 79.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.198 0.599 . . . . 0.0 109.867 -177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -31.89 72.8 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.7 1.2 . . . . 0.0 111.798 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.0 m -69.54 -33.49 72.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.803 0.441 . . . . 0.0 110.508 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.65 -38.39 0.3 Allowed Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 169.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . . . -70.92 174.12 6.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.442 1.121 . . . . 0.0 111.664 -174.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -132.12 145.93 51.71 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -74.25 126.06 29.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.0 m -88.8 157.95 18.31 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.42 -133.02 30.3 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.33 161.68 38.36 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.427 1.091 . . . . 0.0 108.378 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 m -57.45 123.97 17.32 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.85 0.86 . . . . 0.0 111.632 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.21 171.14 15.5 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.161 1.784 . . . . 0.0 108.285 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -137.95 156.81 47.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 121.149 -0.97 . . . . 0.0 109.093 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 119.042 -0.504 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -50.79 72.48 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.839 0.745 . . . . 0.0 110.657 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.54 -52.09 62.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.26 -47.39 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.5 t -61.76 -57.51 11.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -57.24 -43.31 82.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.605 0.762 . . . . 0.0 111.916 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.6 t -59.25 -55.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.726 1.21 . . . . 0.0 109.98 175.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -13.78 62.64 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.591 1.087 . . . . 0.0 112.213 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.95 -48.12 13.91 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.058 0.943 . . . . 0.0 110.825 170.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -71.56 -33.46 69.13 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.892 0.769 . . . . 0.0 112.176 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.3 mttt . . . . . 0 C--O 1.248 1.021 0 C-N-CA 125.022 1.329 . . . . 0.0 109.49 173.614 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.09 37.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.15 0.98 . . . . 0.0 110.117 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.89 -23.76 17.3 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.4 1.48 . . . . 0.0 110.753 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.78 130.38 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.543 1.137 . . . . 0.0 108.327 -174.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 t -89.88 129.07 36.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -111.2 93.68 4.6 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.7 mm -72.16 98.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -86.49 13.85 7.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.541 1.937 . . . . 0.0 114.305 -168.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.98 158.81 31.77 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 118.929 0.786 . . . . 0.0 112.623 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -93.76 -30.72 14.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.446 1.498 . . . . 0.0 111.547 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -124.37 48.51 1.92 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.461 1.124 . . . . 0.0 108.948 -169.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.5 tp 56.01 27.87 11.93 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.4 1.48 . . . . 0.0 111.334 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.7 165.05 26.44 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 128.328 2.87 . . . . 0.0 106.869 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.69 -146.6 11.76 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 118.211 1.006 . . . . 0.0 110.862 -173.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.68 50.77 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.499 1.919 . . . . 0.0 112.076 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.62 -29.23 66.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.683 1.193 . . . . 0.0 112.144 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -60.08 -51.31 70.17 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.7 0.682 . . . . 0.0 111.078 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.55 -28.52 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.84 -0.537 . . . . 0.0 109.667 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.9 98.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.646 0.657 . . . . 0.0 110.736 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.55 -40.55 92.98 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.178 0.591 . . . . 0.0 110.566 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.26 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.714 -0.616 . . . . 0.0 110.622 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -60.46 -51.02 71.23 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.563 1.145 . . . . 0.0 109.719 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.19 66.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 111.073 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.89 -52.19 66.11 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.131 0.973 . . . . 0.0 110.653 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -57.33 -37.76 73.04 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.68 -29.72 69.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.833 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -70.64 -44.23 67.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.542 1.519 . . . . 0.0 109.847 171.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.04 -26.53 67.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 0.0 111.406 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.69 -21.12 64.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.809 0.843 . . . . 0.0 111.963 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.28 12.05 1.48 Allowed Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.516 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -127.36 -165.97 1.54 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.603 1.701 . . . . 0.0 109.626 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -131.44 149.94 52.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 p -140.38 153.27 46.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.095 0.474 . . . . 0.0 110.461 -170.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -117.57 89.95 3.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -173.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 m -67.69 120.33 13.89 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -146.0 136.95 24.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.528 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -80.83 35.42 0.37 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.923 -1.111 . . . . 0.0 111.344 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.48 41.79 49.61 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.989 1.757 . . . . 0.0 115.605 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.98 -21.12 50.19 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.718 2.759 . . . . 0.0 114.137 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.2 mt -121.4 13.13 10.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.743 1.617 . . . . 0.0 108.936 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.4 tp 64.16 -29.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.269 2.627 . . . . 0.0 113.734 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -168.13 91.22 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.004 1.322 . . . . 0.0 107.677 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.77 -43.35 79.99 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.62 152.94 67.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 -173.42 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.99 3.127 . . . . 0.0 112.953 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.8 34.14 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.785 1.634 . . . . 0.0 112.29 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 m -158.08 133.7 8.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.668 1.987 . . . . 0.0 106.893 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.55 -143.17 14.13 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.4 mm -123.49 140.1 48.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -117.76 149.88 40.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -138.63 142.87 39.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.68 123.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.77 117.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -160.44 -175.7 5.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.178 1.791 . . . . 0.0 108.008 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -152.47 72.9 1.0 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.313 -1.492 . . . . 0.0 110.897 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 65' ' ' ASN . 3.1 p . . . . . 0 CA--C 1.547 0.841 0 C-N-CA 126.348 1.859 . . . . 0.0 114.873 175.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' A' ' 56' ' ' THR . 26.6 t-20 . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.8 140.56 36.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.37 -57.88 0.11 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.911 -171.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.81 -37.17 0.94 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.04 1.407 . . . . 0.0 111.715 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -59.58 5.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.801 0.84 . . . . 0.0 111.133 -169.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.12 -48.26 79.07 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 124.055 0.847 . . . . 0.0 110.69 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.02 -45.94 83.38 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.852 0.296 . . . . 0.0 110.712 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.133 -0.46 . . . . 0.0 111.73 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -56.77 -55.67 31.27 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.812 0.733 . . . . 0.0 109.511 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -68.18 -18.66 64.65 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.53 -32.1 64.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.449 0.568 . . . . 0.0 111.693 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -122.45 -25.18 4.82 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 32.26 62.78 1.3 Allowed Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 127.139 2.175 . . . . 0.0 112.375 -176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.87 164.52 21.49 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -79.75 65.32 4.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 -174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.39 16.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.914 1.686 . . . . 0.0 113.039 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.7 p -66.03 -2.34 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 119.746 -1.846 . . . . 0.0 112.87 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.6 12.78 9.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.186 1.794 . . . . 0.0 110.777 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.6 158.83 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.654 0.74 . . . . 0.0 110.989 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -128.58 154.56 46.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.152 1.381 . . . . 0.0 107.469 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -113.77 167.83 10.3 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.34 120.04 2.12 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.47 34.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.8 mt -133.45 126.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.68 -18.55 2.96 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.953 1.263 . . . . 0.0 113.507 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -46.53 142.37 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.71 2.404 . . . . 0.0 110.539 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.35 15.02 8.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.042 1.782 . . . . 0.0 111.373 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 CA--C 1.536 0.406 0 C-N-CA 124.954 1.302 . . . . 0.0 112.359 175.068 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 C--O 1.227 -0.085 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.48 -55.79 30.45 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.324 0.965 . . . . 0.0 109.54 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -71.14 -34.27 70.86 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.341 0.656 . . . . 0.0 109.684 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.94 87.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.003 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.66 -38.26 88.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.572 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.04 -50.27 74.72 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.298 0.954 . . . . 0.0 111.018 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.335 4.8 ptmm? -73.49 -27.98 61.68 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.897 -0.502 . . . . 0.0 112.321 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -37.74 87.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.453 1.101 . . . . 0.0 110.574 169.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -69.18 -36.24 77.12 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.543 0.337 . . . . 0.0 110.136 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.03 -20.69 0.36 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.52 -1.156 . . . . 0.0 114.99 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.31 -177.51 3.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.738 1.269 . . . . 0.0 111.139 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -141.59 152.87 44.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.104 1.362 . . . . 0.0 107.342 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -76.23 128.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -81.54 141.68 33.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.61 0.61 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.338 0.97 . . . . 0.0 111.871 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.14 178.11 10.66 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.266 2.226 . . . . 0.0 107.051 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.2 m -70.87 131.18 43.39 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.012 -1.055 . . . . 0.0 108.576 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.539 HD12 ' CE3' ' A' ' 138' ' ' TRP . 2.6 tt -83.01 147.83 27.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.411 ' N ' HD23 ' A' ' 121' ' ' LEU . 6.0 mptt -131.9 136.58 47.51 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 C-N-CA 123.924 0.89 . . . . 0.0 109.284 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.539 ' CE3' HD12 ' A' ' 121' ' ' LEU . 8.2 t90 -56.08 -57.92 10.12 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 109.244 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tp -53.07 -53.05 55.97 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.635 1.209 . . . . 0.0 110.062 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.97 -53.09 48.02 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -64.67 -45.26 87.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.471 0.635 . . . . 0.0 110.357 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -61.6 -41.37 97.36 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.214 1.006 . . . . 0.0 110.864 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.35 -48.53 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.135 0.574 . . . . 0.0 109.569 172.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.44 -28.86 70.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.193 0.906 . . . . 0.0 111.785 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mp -78.8 -45.78 20.2 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.263 1.025 . . . . 0.0 110.504 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.5 65.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.348 0.522 . . . . 0.0 111.702 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.302 1.041 . . . . 0.0 110.049 171.863 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.59 156.97 43.34 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 0.0 108.431 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.86 -24.12 12.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 110.817 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.2 mt -130.0 122.86 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 t -88.37 132.76 34.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.85 97.24 7.87 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 mm -83.92 70.55 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.57 165.56 23.57 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.298 0.57 . . . . 0.0 110.704 -177.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.08 -174.34 50.95 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 p -144.66 -53.95 0.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.8 p -87.1 40.09 0.9 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.177 1.791 . . . . 0.0 109.631 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp 62.88 24.86 14.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.821 1.648 . . . . 0.0 112.003 -169.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.14 164.44 33.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.76 170.72 20.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.069 1.319 . . . . 0.0 111.198 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 55.63 -1.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.238 2.615 . . . . 0.0 117.449 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.58 -32.95 69.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.43 1.468 . . . . 0.0 112.262 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -58.64 -43.58 89.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.979 0.512 . . . . 0.0 111.163 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.31 -37.86 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.93 83.89 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.089 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.53 -45.12 95.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.917 0.781 . . . . 0.0 110.421 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -64.97 -46.51 81.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.973 0.352 . . . . 0.0 110.093 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.16 -54.17 48.38 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.023 0.929 . . . . 0.0 110.301 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.22 -43.59 74.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.341 1.056 . . . . 0.0 111.17 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -61.31 -54.11 48.15 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.813 0.733 . . . . 0.0 110.596 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -57.94 -36.23 72.22 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.4 mt -71.95 -26.23 62.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.092 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.38 -41.23 73.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 120.241 1.382 . . . . 0.0 108.911 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.18 -26.31 68.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.534 0.734 . . . . 0.0 111.458 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.54 -14.0 62.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.966 0.907 . . . . 0.0 111.745 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.92 17.23 6.95 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.845 -0.975 . . . . 0.0 113.594 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -122.73 -168.99 1.84 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.684 1.242 . . . . 0.0 109.853 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -126.15 153.2 44.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.7 p -143.33 159.31 42.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.827 -0.546 . . . . 0.0 110.06 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.31 97.81 4.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -69.91 122.56 19.53 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -147.07 175.72 10.49 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.982 1.313 . . . . 0.0 108.663 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -120.21 39.97 3.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 108.482 169.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.99 46.41 32.68 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 117.599 -1.667 . . . . 0.0 115.108 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -64.37 -22.09 66.27 Favored 'Trans proline' 0 C--N 1.35 0.651 0 CA-C-N 121.205 2.502 . . . . 0.0 113.616 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.71 8.78 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.028 1.731 . . . . 0.0 109.832 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 58.33 -14.79 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.502 2.721 . . . . 0.0 115.197 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -159.26 76.32 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 120.004 1.274 . . . . 0.0 109.438 -169.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.32 -47.85 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.593 -0.692 . . . . 0.0 109.529 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.65 153.43 58.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.32 -176.5 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.14 3.227 . . . . 0.0 113.301 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.43 33.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.874 1.67 . . . . 0.0 112.567 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -159.76 133.42 7.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.238 2.215 . . . . 0.0 106.792 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.7 -144.96 16.4 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -121.35 146.99 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.409 ' CD1' HG21 ' A' ' 83' ' ' VAL . 4.9 m95 -133.34 153.81 51.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.5 mt -136.61 143.35 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -123.24 131.85 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.7 91.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -142.57 -170.78 3.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.264 1.825 . . . . 0.0 107.908 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m -144.61 133.27 22.23 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -171.508 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.2 55.63 3.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -54.7 52.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.433 -0.792 . . . . 0.0 112.445 -168.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -77.84 -41.36 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.568 2.178 . . . . 0.0 110.514 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.12 -51.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.347 0.659 . . . . 0.0 110.937 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.23 -43.55 91.06 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.99 0.814 . . . . 0.0 110.476 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -62.54 -47.27 84.64 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.832 0.742 . . . . 0.0 110.256 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.13 -32.09 72.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.89 -59.69 4.97 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.178 0.899 . . . . 0.0 109.437 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.28 -17.2 62.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.01 -35.06 79.08 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.242 0.617 . . . . 0.0 111.129 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.0 -22.03 4.21 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 33.7 63.22 1.66 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.81 164.23 16.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.027 2.485 . . . . 0.0 113.634 -169.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -80.42 64.97 5.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.54 1.136 . . . . 0.0 111.234 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.12 17.05 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 113.063 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 p -66.78 -2.87 5.56 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 119.922 -1.736 . . . . 0.0 112.789 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.1 11.97 9.56 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.1 1.76 . . . . 0.0 110.946 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -130.29 156.11 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.73 0.776 . . . . 0.0 111.439 176.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -121.33 152.47 38.92 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 108.323 169.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.401 ' CZ ' ' CE3' ' A' ' 50' ' ' TRP . 5.8 m-85 -123.69 166.96 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.599 -169.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.91 144.48 12.96 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.969 -2.852 . . . . 0.0 105.969 168.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.36 125.54 50.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 90' ' ' ILE . 34.3 mt -129.59 133.12 65.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -169.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.64 -28.42 1.54 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.799 1.19 . . . . 0.0 112.091 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' H ' ' C ' ' A' ' 88' ' ' ILE . 62.2 mt -48.83 138.77 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.509 2.724 . . . . 0.0 108.404 173.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.2 -0.0 35.39 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.344 1.45 . . . . 0.0 111.468 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 127.995 2.518 . . . . 0.0 115.81 -172.061 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.68 -57.28 13.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.653 0.661 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -34.66 78.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.846 0.458 . . . . 0.0 110.245 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.54 94.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.03 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.53 -38.49 90.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.995 0.816 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.48 -44.36 87.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.835 0.743 . . . . 0.0 111.408 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -67.33 -36.05 80.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.537 0.735 . . . . 0.0 109.816 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -36.26 82.44 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.207 1.403 . . . . 0.0 111.332 172.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.6 m -67.56 -35.4 78.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.861 0.464 . . . . 0.0 110.521 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.86 -24.6 0.3 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.686 -1.063 . . . . 0.0 115.061 169.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.94 170.96 11.61 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.617 1.208 . . . . 0.0 111.384 -173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -121.62 133.18 54.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -78.78 102.27 8.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 169.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 m -70.77 150.79 45.52 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.86 -129.24 26.96 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.3 pt-20 -153.99 174.93 14.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.908 1.283 . . . . 0.0 108.592 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -59.52 129.79 43.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.108 0.963 . . . . 0.0 110.604 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.4 148.51 22.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.21 2.204 . . . . 0.0 107.946 -173.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -125.99 146.51 49.85 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--N 1.33 -0.271 0 C-N-CA 125.265 1.426 . . . . 0.0 109.374 -169.979 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.428 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.34 -42.3 77.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.018 172.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.98 -48.84 77.1 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.92 -47.42 59.52 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.074 0.858 . . . . 0.0 111.437 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -62.57 -55.0 31.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.529 0.665 . . . . 0.0 110.166 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -55.04 -39.78 69.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.49 1.916 . . . . 0.0 111.34 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.31 -58.83 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 109.733 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -16.01 63.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.274 0.943 . . . . 0.0 112.303 -172.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.12 -38.46 61.1 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.023 0.929 . . . . 0.0 111.236 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -34.8 44.87 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.647 0.779 . . . . 0.0 111.878 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttm . . . . . 0 C--O 1.248 1.015 0 C-N-CA 125.233 1.413 . . . . 0.0 109.867 171.193 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.3 161.06 43.18 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.004 0.922 . . . . 0.0 110.179 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.88 -23.9 16.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.769 1.627 . . . . 0.0 110.479 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.5 mt -135.18 127.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.532 1.133 . . . . 0.0 108.023 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 t -88.2 126.66 35.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.68 95.58 6.14 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.856 1.262 . . . . 0.0 108.885 -169.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -76.36 159.38 30.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.52 9.17 0.03 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.02 123.81 17.15 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.227 2.014 . . . . 0.0 109.587 175.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p 38.21 57.57 1.62 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.57 1.948 . . . . 0.0 113.573 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.1 tp 51.26 63.18 2.35 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 111.372 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.16 -149.77 17.28 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.3 -179.69 38.98 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 117.736 0.768 . . . . 0.0 111.929 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.06 56.16 0.76 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.008 1.323 . . . . 0.0 109.642 171.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.44 -28.91 67.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.363 -0.836 . . . . 0.0 112.228 -172.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -62.14 -40.9 97.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.971 0.805 . . . . 0.0 110.854 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.16 -37.73 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.72 87.6 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.885 0.766 . . . . 0.0 110.952 174.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.21 -40.05 82.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.298 0.639 . . . . 0.0 110.931 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.11 -46.22 88.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.457 -0.777 . . . . 0.0 110.396 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.1 mt -55.99 -52.69 63.28 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.599 1.159 . . . . 0.0 109.894 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.12 -49.97 59.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.533 1.133 . . . . 0.0 110.924 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.29 -53.93 49.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 110.576 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -60.61 -39.39 87.99 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.51 -33.68 76.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.166 0.587 . . . . 0.0 111.52 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.73 -37.14 67.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.846 -1.159 . . . . 0.0 110.265 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.03 -30.15 70.77 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.668 0.667 . . . . 0.0 111.113 170.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.65 62.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 111.797 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.27 -2.53 6.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.247 -1.307 . . . . 0.0 114.257 169.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -101.25 -168.23 1.53 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.564 1.682 . . . . 0.0 110.104 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -128.36 150.92 49.89 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.3 p -142.9 154.59 44.26 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.9 -0.5 . . . . 0.0 111.836 -169.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -119.81 99.37 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.463 1.505 . . . . 0.0 107.966 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -73.97 122.58 22.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.61 169.95 17.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.849 0.859 . . . . 0.0 111.06 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -119.6 39.57 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.197 1.799 . . . . 0.0 108.789 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 51.62 11.58 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.858 -1.523 . . . . 0.0 114.801 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -21.94 64.67 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 120.662 2.231 . . . . 0.0 113.389 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.87 16.75 6.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.552 1.941 . . . . 0.0 108.741 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 tp 59.9 -25.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.354 3.062 . . . . 0.0 115.076 -169.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.42 85.68 0.86 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -168.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.91 -44.8 88.37 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.536 -0.727 . . . . 0.0 109.847 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.22 151.29 59.59 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.52 -176.79 1.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 124.128 3.219 . . . . 0.0 113.087 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.26 31.88 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.989 1.716 . . . . 0.0 112.933 172.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.4 m -158.93 121.79 3.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.699 2.0 . . . . 0.0 106.445 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.16 -142.88 11.49 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -122.29 136.26 59.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.464 ' CD1' HG21 ' A' ' 83' ' ' VAL . 12.1 m0 -119.41 137.31 53.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 172.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 mt -131.81 137.69 48.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 173.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.82 137.72 53.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.07 113.01 23.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -161.73 -178.18 6.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.117 1.367 . . . . 0.0 108.457 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 m -133.18 124.85 28.2 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 124.024 0.93 . . . . 0.0 113.301 -169.261 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -129.68 90.28 2.96 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -53.74 31.51 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 124.857 1.263 . . . . 0.0 113.209 -168.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.47 -38.59 8.21 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.175 1.25 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -57.83 8.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.774 -170.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.58 -47.16 86.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.704 -171.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -64.5 -48.64 74.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.626 0.648 . . . . 0.0 110.539 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.41 -26.24 67.89 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.8 mt -62.34 -62.4 1.78 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.238 0.926 . . . . 0.0 108.868 170.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -67.18 -19.57 65.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.45 -34.49 78.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.601 0.76 . . . . 0.0 111.462 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.39 -23.19 2.4 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.84 63.13 1.01 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 127.13 2.172 . . . . 0.0 113.077 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 166.85 17.89 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.968 2.445 . . . . 0.0 113.164 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.66 63.8 5.21 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.954 1.302 . . . . 0.0 111.343 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.91 9.87 0.48 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.273 1.429 . . . . 0.0 113.074 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -63.93 -2.48 1.93 Allowed 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.105 2.962 . . . . 0.0 113.235 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.06 9.71 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.991 1.716 . . . . 0.0 110.919 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -124.65 146.44 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.916 0.865 . . . . 0.0 111.401 172.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -97.67 141.26 30.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.63 153.04 32.0 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.581 1.952 . . . . 0.0 107.537 -174.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.67 149.55 21.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.96 134.95 54.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -175.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.8 mt -134.8 128.79 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.17 -29.08 1.65 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.389 0.995 . . . . 0.0 112.461 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.1 mt -47.97 117.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.784 2.434 . . . . 0.0 107.849 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.01 -41.01 28.62 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.888 1.708 . . . . 0.0 111.079 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.535 0.379 0 C-N-CA 126.085 1.754 . . . . 0.0 110.208 178.22 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.57 -54.32 48.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.41 1.004 . . . . 0.0 109.678 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -67.66 -37.66 82.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.761 1.224 . . . . 0.0 108.673 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.9 79.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.527 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.82 -34.95 79.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.136 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.55 -49.99 75.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.745 1.157 . . . . 0.0 111.201 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -69.28 -34.28 74.48 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.727 0.811 . . . . 0.0 109.938 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -37.78 84.16 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.763 1.625 . . . . 0.0 111.231 172.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -65.86 -40.49 91.72 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.35 -20.61 0.4 Allowed Glycine 0 C--N 1.341 0.827 0 CA-C-O 117.811 -1.55 . . . . 0.0 115.135 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 132.82 49.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.699 1.749 . . . . 0.0 109.453 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -83.84 114.67 21.81 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -64.02 114.67 4.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 170.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.4 m -126.65 115.08 18.9 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.32 103.78 2.37 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -169.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -52.95 137.26 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.149 -1.526 . . . . 0.0 107.379 169.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.2 m -47.87 116.42 1.49 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.722 1.609 . . . . 0.0 111.347 -169.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.69 153.8 26.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.188 1.795 . . . . 0.0 107.718 -169.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -129.09 146.5 51.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.328 -0.365 0 C-N-CA 124.549 1.139 . . . . 0.0 111.252 -169.841 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -45.26 77.92 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.437 0.695 . . . . 0.0 109.871 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.69 -52.6 65.02 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.48 95.01 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.047 0.84 . . . . 0.0 112.051 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -59.29 -62.94 1.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.074 1.35 . . . . 0.0 110.239 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -56.09 -44.78 79.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.612 1.165 . . . . 0.0 111.978 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.4 -55.92 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.848 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -16.29 63.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.81 1.186 . . . . 0.0 112.053 -174.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.1 mp -78.2 -47.22 18.52 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.535 0.734 . . . . 0.0 111.029 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.18 -32.54 64.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.0 0.818 . . . . 0.0 112.329 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.7 mttt . . . . . 0 C--O 1.249 1.028 0 C-N-CA 124.752 1.221 . . . . 0.0 109.611 173.34 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 tpp . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.02 160.16 43.14 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.575 1.15 . . . . 0.0 108.917 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.61 -25.13 13.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.43 1.492 . . . . 0.0 111.059 175.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.56 121.77 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -83.88 130.55 34.91 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.56 109.6 21.33 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.5 mt -103.66 94.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.22 14.82 27.07 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.06 0.944 . . . . 0.0 112.075 -171.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.64 58.87 4.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.128 -171.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -54.6 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.741 1.27 . . . . 0.0 110.25 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m 57.7 42.3 23.95 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.78 0.832 . . . . 0.0 110.804 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.1 39.56 29.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.236 1.815 . . . . 0.0 111.398 -169.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.94 -145.3 7.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.493 1.996 . . . . 0.0 109.7 173.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.72 62.12 0.29 Allowed Glycine 0 C--N 1.334 0.447 0 CA-C-N 117.556 0.678 . . . . 0.0 111.902 -172.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.53 19.96 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.5 1.12 . . . . 0.0 112.476 172.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.9 -20.19 64.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 112.482 -170.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.93 -40.4 76.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.237 0.926 . . . . 0.0 111.326 176.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.96 -41.42 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.776 -176.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.23 -43.55 94.61 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 110.43 175.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -66.35 -44.41 83.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.044 -0.41 . . . . 0.0 110.039 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.46 -52.45 65.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.159 0.584 . . . . 0.0 110.733 177.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.27 -45.37 65.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.287 1.035 . . . . 0.0 110.76 176.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.33 -54.2 48.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.158 0.89 . . . . 0.0 110.484 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -57.66 -43.75 85.19 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 123.646 0.778 . . . . 0.0 112.275 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -69.15 -34.49 75.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.919 0.887 . . . . 0.0 111.356 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.9 -44.05 73.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.316 -0.865 . . . . 0.0 109.642 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -71.65 -18.52 62.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.174 0.897 . . . . 0.0 111.954 174.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -18.95 63.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.83 0.741 . . . . 0.0 111.083 169.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.09 12.54 5.78 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.267 -1.296 . . . . 0.0 114.442 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -117.8 -172.08 2.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.411 1.606 . . . . 0.0 109.93 -174.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -124.13 153.99 40.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 170.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -142.54 158.91 43.18 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.838 -0.539 . . . . 0.0 109.93 -169.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.2 99.24 5.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 m -72.18 118.88 15.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.0 mt -149.48 164.95 33.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.625 0.726 . . . . 0.0 111.585 -169.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -106.12 35.68 2.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.393 1.477 . . . . 0.0 108.506 168.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.74 14.26 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.963 -175.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.5 -20.31 65.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 120.871 2.335 . . . . 0.0 113.864 -173.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.25 9.89 14.69 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.654 . . . . 0.0 109.766 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt 60.38 -18.19 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.406 2.682 . . . . 0.0 114.627 -169.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -166.3 75.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.498 1.519 . . . . 0.0 107.232 -169.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.38 -44.61 96.04 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.773 -0.579 . . . . 0.0 109.818 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.6 mt -89.24 150.39 44.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.42 -177.45 1.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.674 2.916 . . . . 0.0 113.106 -175.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.08 35.51 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.65 1.58 . . . . 0.0 111.898 169.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -157.69 125.15 5.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.973 2.109 . . . . 0.0 106.272 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.96 -145.23 17.19 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -174.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.4 mm -126.48 144.34 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -127.1 158.12 37.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -143.28 143.79 31.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.15 135.35 62.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.17 124.59 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -170.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.0 m -163.98 -167.48 1.37 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.216 2.206 . . . . 0.0 107.1 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.1 m -148.88 62.57 1.06 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.435 -1.415 . . . . 0.0 108.0 172.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 125.569 1.548 . . . . 0.0 114.128 -169.506 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 31.2 t30 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.1 mt 52.75 46.23 27.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 108.575 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 m -75.88 -49.5 3.43 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 124.549 1.14 . . . . 0.0 111.833 -170.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 -34.45 41.59 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.97 1.382 . . . . 0.0 110.584 176.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -59.69 -51.3 70.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.976 0.911 . . . . 0.0 110.125 173.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 104' ' ' LYS . 39.0 t80 -55.46 -48.29 74.73 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.48 1.112 . . . . 0.0 110.846 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -65.65 -41.65 92.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.523 0.601 . . . . 0.0 111.453 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.6 84.83 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.666 0.666 . . . . 0.0 111.326 -178.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.63 -57.35 12.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.777 0.717 . . . . 0.0 109.816 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -69.2 -15.57 63.42 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.65 -32.09 63.83 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.85 0.75 . . . . 0.0 111.295 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.78 -30.1 4.52 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -173.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 26.64 70.37 0.43 Allowed Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.06 2.144 . . . . 0.0 113.331 -172.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -58.15 176.65 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.791 2.327 . . . . 0.0 112.004 174.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -90.02 76.16 7.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.73 0.812 . . . . 0.0 110.342 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.588 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.1 mm? -74.74 5.63 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.617 0.767 . . . . 0.0 112.557 -175.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 m -65.14 -5.51 6.9 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 127.839 2.456 . . . . 0.0 113.268 -176.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.93 8.74 26.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.469 1.508 . . . . 0.0 110.702 176.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.94 160.54 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 122.146 0.974 . . . . 0.0 110.945 176.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -129.11 154.11 47.02 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.08 1.752 . . . . 0.0 106.929 172.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -127.38 173.9 9.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.534 0.683 . . . . 0.0 109.428 178.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.13 157.87 26.17 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.64 125.13 41.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.0 mt -129.31 134.08 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -168.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.71 -31.78 1.69 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.537 1.541 . . . . 0.0 112.009 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.3 mt -47.88 154.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 129.583 3.153 . . . . 0.0 110.857 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.63 -15.1 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.051 -0.86 . . . . 0.0 114.73 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 N--CA 1.45 -0.447 0 CA-C-N 118.304 1.052 . . . . 0.0 109.805 177.349 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 51.5 mtmt . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.55 -53.15 58.98 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 47.9 mp0 -61.24 -41.18 96.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.595 1.158 . . . . 0.0 110.455 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.77 76.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.49 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.246 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 mt -58.65 -46.64 86.7 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.427 1.012 . . . . 0.0 110.867 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -67.34 -41.26 85.48 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.462 0.705 . . . . 0.0 109.723 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -30.85 71.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.043 1.337 . . . . 0.0 111.331 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.588 ' HB3' HD23 ' A' ' 80' ' ' LEU . 16.2 m -74.16 -13.88 60.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.25 0.22 . . . . 0.0 111.496 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.48 -24.33 3.73 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 121.174 -0.954 . . . . 0.0 113.033 169.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.25 167.8 15.54 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.053 0.927 . . . . 0.0 110.631 -177.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -120.54 144.3 48.13 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -83.68 104.73 14.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 83.2 m -70.38 153.46 42.97 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 -131.29 21.43 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 178.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.4 pt-20 -150.43 178.56 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.192 1.397 . . . . 0.0 107.862 169.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.49 123.08 9.03 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.927 1.291 . . . . 0.0 109.824 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.55 155.75 17.13 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.61 1.564 . . . . 0.0 107.712 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -139.33 151.4 46.36 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 C-N-CA 126.125 1.77 . . . . 0.0 106.718 -169.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . 0.451 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -61.11 -42.04 97.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.599 0.76 . . . . 0.0 110.281 172.257 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.93 -49.68 73.82 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.96 -46.62 68.61 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 123.823 0.702 . . . . 0.0 111.721 177.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.1 m -62.47 -59.17 5.34 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.345 1.458 . . . . 0.0 110.818 177.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -49.8 -41.72 45.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.969 2.108 . . . . 0.0 111.872 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.0 t -63.96 -58.41 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 125.182 1.393 . . . . 0.0 109.813 173.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -15.74 63.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.311 0.959 . . . . 0.0 112.324 -173.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.87 -41.55 59.57 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.022 0.929 . . . . 0.0 111.168 170.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.5 -31.27 42.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -176.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.1 1.36 . . . . 0.0 109.721 169.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 tpp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.012 -0.736 . . . . 10.0 109.012 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.23 161.9 41.89 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.887 0.875 . . . . 10.0 110.287 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -94.11 -18.62 21.6 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.751 1.22 . . . . 10.0 110.984 167.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 mt -137.22 129.15 42.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 C-N-CA 124.399 1.08 . . . . 10.0 108.429 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 t -91.41 137.62 32.22 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 107.645 -1.242 . . . . 10.0 107.645 168.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -112.4 91.75 3.77 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 104.614 -2.365 . . . . 10.0 104.614 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.5 mt -87.4 104.08 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.4 1.48 . . . . 10.0 107.195 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 m -128.69 46.09 2.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.469 0.708 . . . . 10.0 111.868 -154.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.39 56.33 0.44 Allowed Glycine 0 C--N 1.338 0.671 0 CA-C-O 117.968 -1.462 . . . . 10.0 114.103 -161.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 m -33.39 -52.86 0.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.124 1.77 . . . . 10.0 113.646 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.35 42.33 2.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.514 1.125 . . . . 10.0 108.491 -170.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.9 tp 56.9 28.8 15.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.658 1.583 . . . . 10.0 111.075 -164.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.33 155.22 17.34 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 127.965 2.698 . . . . 10.0 106.485 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.05 -164.78 35.55 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 117.932 0.866 . . . . 10.0 111.669 -166.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.47 52.23 0.62 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.578 1.951 . . . . 10.0 112.882 -170.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -55.8 -31.63 62.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.241 1.016 . . . . 10.0 112.212 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -60.92 -50.07 74.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.981 0.81 . . . . 10.0 110.768 175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.45 -39.97 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.29 84.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.897 -0.573 . . . . 10.0 111.813 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.37 -39.48 85.7 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.974 0.807 . . . . 10.0 110.331 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -63.65 -46.82 83.88 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.93 -0.482 . . . . 10.0 110.279 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.4 mt -57.96 -47.28 83.38 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.811 0.844 . . . . 10.0 110.15 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.18 83.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.209 1.004 . . . . 10.0 110.028 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.54 -47.06 87.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.371 0.532 . . . . 10.0 110.687 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -61.58 -34.7 76.07 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 121.673 -0.642 . . . . 10.0 111.33 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.17 -32.89 67.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.516 0.598 . . . . 10.0 111.185 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -70.79 -38.94 73.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.708 1.14 . . . . 10.0 109.865 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.68 -32.45 71.66 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.244 0.618 . . . . 10.0 111.087 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.19 -17.07 64.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.733 0.813 . . . . 10.0 112.799 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.38 18.96 4.35 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.836 -0.98 . . . . 10.0 113.555 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -120.82 -170.88 2.08 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.808 1.304 . . . . 10.0 109.797 -174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 p -131.66 145.26 51.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.146 -1.427 . . . . 10.0 107.146 172.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 36.7 p -136.65 158.86 43.45 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.125 -0.359 . . . . 10.0 110.912 -167.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.01 92.59 3.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -65.17 119.84 11.59 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.307 1.043 . . . . 10.0 108.42 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -148.39 149.01 31.0 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 123.584 0.754 . . . . 10.0 108.988 -171.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -90.49 35.43 0.88 Allowed 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.292 -0.88 . . . . 10.0 110.184 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.22 51.02 21.48 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.983 1.754 . . . . 10.0 114.572 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.04 -15.68 49.56 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.858 2.372 . . . . 10.0 113.435 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.2 mt -121.11 13.6 11.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.404 1.482 . . . . 10.0 110.704 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 tp 62.42 -43.89 0.18 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.557 2.743 . . . . 10.0 113.316 -166.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -148.8 78.11 1.39 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.873 1.669 . . . . 10.0 108.121 -167.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.473 -0.767 . . . . 10.0 111.357 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.2 mt -84.48 147.42 49.62 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.947 -1.131 . . . . 10.0 107.947 164.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.64 -175.4 1.12 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.08 2.52 . . . . 10.0 111.873 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.61 21.94 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.896 1.678 . . . . 10.0 113.694 173.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.9 m -142.39 136.08 29.21 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.321 1.848 . . . . 10.0 106.797 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.01 -136.88 10.11 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.92 -1.272 . . . . 10.0 109.92 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mm -130.35 136.34 58.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.159 -1.793 . . . . 10.0 106.159 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 38.8 m0 -117.87 157.5 26.53 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 169.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -141.72 145.87 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.021 -1.844 . . . . 10.0 106.021 168.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.3 t -130.88 124.34 56.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 106.787 -1.56 . . . . 10.0 106.787 -173.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.37 97.36 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 106.669 -1.604 . . . . 10.0 106.669 -164.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -148.7 174.12 12.5 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.672 1.589 . . . . 10.0 108.372 -170.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 m -137.52 70.47 1.4 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.597 1.09 . . . . 10.0 110.312 -174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.2 p -69.62 -15.71 63.25 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.137 1.532 . . . . 10.0 115.137 -169.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -79.35 -106.56 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.873 1.215 . . . . 10.0 109.765 -172.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.72 3.89 47.28 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 120.183 -1.573 . . . . 10.0 114.056 -167.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.19 14.21 4.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.124 1.77 . . . . 10.0 110.31 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.01 112.22 4.44 Favored Glycine 0 C--N 1.341 0.814 0 N-CA-C 109.027 -1.629 . . . . 10.0 109.027 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -64.11 156.61 27.85 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.019 0.41 . . . . 10.0 111.387 -177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -26.72 -60.3 0.18 Allowed Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 129.426 3.09 . . . . 10.0 115.375 -170.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.73 -33.02 6.91 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 121.939 1.728 . . . . 10.0 113.392 -166.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.9 t70 176.73 -47.52 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.08 1.352 . . . . 10.0 108.481 -161.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 t30 126.28 -34.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 1 C-N-CA 132.096 4.159 . . . . 10.0 110.298 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.19 58.48 1.31 Allowed 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.486 0.714 . . . . 10.0 110.038 -170.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.5 m -45.95 -56.17 11.09 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 117.228 -1.368 . . . . 10.0 114.566 -167.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.57 -44.34 0.3 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 122.034 1.762 . . . . 10.0 111.633 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -65.41 -43.35 90.82 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 10.0 111.264 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -65.36 -45.49 83.9 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 118.921 0.782 . . . . 10.0 110.158 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.18 -42.79 99.42 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.65 -40.12 96.03 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.03 0.377 . . . . 10.0 111.461 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -59.69 -51.56 69.26 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.703 0.683 . . . . 10.0 109.47 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.19 -31.27 72.4 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.667 0.667 . . . . 10.0 111.81 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.87 -30.95 71.63 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.724 0.81 . . . . 10.0 112.251 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -124.21 -27.3 3.84 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.491 1.293 . . . . 10.0 114.491 -173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 32.45 61.78 1.38 Allowed Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.286 1.834 . . . . 10.0 112.572 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.47 160.26 40.33 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.12 2.546 . . . . 10.0 110.955 -172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -73.23 76.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.071 0.949 . . . . 10.0 111.187 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 9.22 1.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.93 1.292 . . . . 10.0 112.269 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.0 m -60.84 -17.5 50.34 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.219 -1.551 . . . . 10.0 113.344 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.44 10.83 39.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.78 1.232 . . . . 10.0 112.594 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 p -132.95 160.79 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 124.229 1.012 . . . . 10.0 108.997 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -123.81 150.81 44.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.296 -1.742 . . . . 10.0 106.296 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.63 163.53 25.86 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.606 0.717 . . . . 10.0 110.476 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.04 116.66 1.69 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.394 -2.682 . . . . 10.0 106.394 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.04 144.32 56.22 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 165.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 mt -141.38 131.23 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.521 -1.659 . . . . 10.0 106.521 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.09 -27.54 1.71 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.757 1.17 . . . . 10.0 113.012 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.24 139.29 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 127.15 2.18 . . . . 10.0 107.606 171.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.58 0.72 8.67 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 119.269 -0.739 . . . . 10.0 112.387 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -53.2 56.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.518 1.127 . . . . 10.0 109.834 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 19.97 -97.3 0.0 OUTLIER 'General case' 0 C--N 1.346 0.45 0 C-N-CA 128.787 2.835 . . . . 10.0 114.197 171.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -148.42 5.1 0.71 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.22 1.808 . . . . 10.0 108.858 -159.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -149.09 -27.67 0.28 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.613 0.365 . . . . 10.0 110.751 -143.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -119.77 34.91 5.03 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 122.471 1.129 . . . . 10.0 109.95 159.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.2 p -70.22 35.81 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.822 1.649 . . . . 10.0 110.591 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -105.12 -37.22 7.0 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.741 -1.225 . . . . 10.0 112.949 -144.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 62.9 m -115.71 8.14 14.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.234 1.014 . . . . 10.0 110.773 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.88 -163.53 35.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 108.601 -1.8 . . . . 10.0 108.601 -172.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -133.02 58.84 1.75 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.475 1.11 . . . . 10.0 109.782 -174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 pt -60.53 -4.16 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.492 1.117 . . . . 10.0 113.083 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -48.25 -17.86 0.17 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.391 1.876 . . . . 10.0 112.844 158.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -34.61 -43.44 0.17 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.636 1.575 . . . . 10.0 113.491 164.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.84 -52.8 62.69 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.23 0.923 . . . . 10.0 110.813 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -61.52 -43.77 98.26 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.1 93.94 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.046 0.938 . . . . 10.0 111.437 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -67.97 -36.79 80.65 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.416 1.007 . . . . 10.0 111.222 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.05 -45.14 94.85 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.278 0.944 . . . . 10.0 110.06 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -65.87 -39.21 90.49 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.22 0.608 . . . . 10.0 110.524 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -41.58 97.2 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.364 1.066 . . . . 10.0 110.975 173.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 m -72.45 -29.08 63.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.727 0.411 . . . . 10.0 110.651 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 146.89 -13.15 1.49 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.426 -1.208 . . . . 10.0 114.327 160.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.08 116.55 9.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.241 1.521 . . . . 10.0 108.131 -174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -61.73 139.02 58.36 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 167.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -80.84 128.78 34.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.154 -2.165 . . . . 10.0 105.154 158.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 m -105.06 148.45 26.78 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.8 -133.93 46.84 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.09 -1.604 . . . . 10.0 109.09 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.93 163.65 33.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.535 -1.654 . . . . 10.0 106.535 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.6 m -48.59 123.32 6.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.293 1.037 . . . . 10.0 112.082 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.33 147.36 48.14 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.793 1.237 . . . . 10.0 107.92 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -118.6 136.75 53.7 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.838 -1.171 . . . . 10.0 107.838 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.77 140.71 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 158.33 30.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.516 -0.55 . . . . 10.0 109.516 174.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.3 pt -146.24 -168.54 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 126.36 1.864 . . . . 10.0 107.379 -172.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.8 tp 7.09 -69.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 130.173 3.389 . . . . 10.0 116.575 164.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -119.08 139.05 52.39 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.435 1.094 . . . . 10.0 108.891 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -53.62 150.46 7.0 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.858 0.863 . . . . 10.0 110.037 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -142.67 -88.25 0.14 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 118.366 -0.825 . . . . 10.0 110.515 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.0 mm -130.72 -58.08 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 117.426 -1.273 . . . . 10.0 110.542 -170.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -82.06 -6.28 12.15 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.318 2.012 . . . . 10.0 113.355 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 76.41 -35.9 0.26 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.421 2.688 . . . . 10.0 114.407 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -139.88 132.1 14.84 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 119.356 0.98 . . . . 10.0 111.181 -158.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.63 159.5 47.9 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.116 2.544 . . . . 10.0 112.055 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.75 52.56 1.4 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.456 1.103 . . . . 10.0 110.119 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.22 -23.65 62.49 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.879 -1.138 . . . . 10.0 111.013 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.21 -36.16 81.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.588 -0.72 . . . . 10.0 111.223 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.81 -44.92 93.75 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.483 1.038 . . . . 10.0 108.934 171.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.47 -46.03 91.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.42 97.3 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.409 0.528 . . . . 10.0 112.672 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.6 m -61.57 -56.79 16.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.341 1.071 . . . . 10.0 110.75 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -59.51 -40.69 87.94 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.942 1.297 . . . . 10.0 110.699 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.27 -56.18 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.849 -0.596 . . . . 10.0 110.042 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -69.68 -21.86 63.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 10.0 112.136 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.45 -45.25 76.56 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.708 0.685 . . . . 10.0 110.631 168.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -22.43 57.69 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.973 0.806 . . . . 10.0 112.61 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.9 mttt . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.252 1.021 . . . . 10.0 108.406 169.521 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 tpp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.55 167.21 31.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.126 1.371 . . . . 0.0 108.921 -178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -86.36 -25.07 25.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.697 0.799 . . . . 0.0 110.893 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 55.6 mt -138.27 127.63 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.749 1.22 . . . . 0.0 107.943 -171.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.18 135.21 33.39 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 169.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -110.4 104.64 13.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.7 mt -96.46 100.57 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -102.64 20.12 17.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.241 1.016 . . . . 0.0 110.735 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.2 36.51 2.17 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.072 1.32 . . . . 0.0 115.163 -169.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -47.65 -50.84 23.51 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.215 1.406 . . . . 0.0 112.268 -172.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -127.33 50.77 1.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 171.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.7 tp 63.29 20.05 12.03 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.813 2.045 . . . . 0.0 111.283 -169.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.14 178.1 36.64 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 129.248 3.308 . . . . 0.0 106.661 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.86 -3.19 1.51 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.009 -1.439 . . . . 0.0 115.026 169.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.14 2.14 0.76 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.877 1.839 . . . . 0.0 113.966 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -53.29 -36.39 61.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.297 1.039 . . . . 0.0 112.07 -172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -54.97 -30.75 59.82 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.779 1.232 . . . . 0.0 112.825 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.99 -26.33 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.776 0.83 . . . . 0.0 109.522 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.36 72.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.228 0.922 . . . . 0.0 111.346 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -64.88 -39.3 93.32 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.238 0.926 . . . . 0.0 111.243 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -67.97 -45.4 74.27 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.804 -0.56 . . . . 0.0 109.617 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.2 mt -54.13 -50.82 66.04 Favored 'General case' 0 C--N 1.337 0.035 0 C-N-CA 124.359 1.064 . . . . 0.0 110.323 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.8 -48.69 72.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.895 0.878 . . . . 0.0 110.88 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -57.81 -53.56 56.81 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.69 0.677 . . . . 0.0 110.675 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -54.91 -42.51 72.26 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 123.838 0.855 . . . . 0.0 111.816 176.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -32.2 67.92 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.88 -46.67 74.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.472 1.033 . . . . 0.0 109.842 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -67.38 -14.13 62.64 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.658 0.663 . . . . 0.0 112.312 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.16 -19.12 63.22 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.128 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.56 17.64 0.74 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.274 -1.292 . . . . 0.0 115.887 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -139.18 -171.44 3.11 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.602 1.701 . . . . 0.0 111.236 -169.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.6 p -124.71 147.61 48.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.6 p -140.66 157.86 44.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -130.12 98.98 4.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.76 123.43 19.72 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.3 mt -142.26 153.99 44.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 123.558 0.743 . . . . 0.0 109.298 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -89.76 31.68 0.94 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.675 0.79 . . . . 0.0 110.968 172.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.13 48.77 38.78 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.587 1.565 . . . . 0.0 114.533 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.49 -21.45 66.07 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.683 2.255 . . . . 0.0 113.503 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.7 mt -124.31 10.15 8.61 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.967 1.707 . . . . 0.0 109.89 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.2 tp 60.86 -19.15 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.85 2.46 . . . . 0.0 114.31 -169.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -166.47 87.06 0.32 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.68 -44.81 76.9 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.723 -0.611 . . . . 0.0 109.989 174.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.8 mt -80.23 151.58 72.7 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 169.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.38 -175.31 0.65 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.056 3.171 . . . . 0.0 112.621 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.74 34.42 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.147 1.379 . . . . 0.0 112.377 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.1 m -158.62 132.12 7.49 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 127.01 2.124 . . . . 0.0 106.311 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.79 -142.97 14.44 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.1 mm -126.53 140.32 49.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -121.76 152.52 39.37 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.7 mt -138.76 142.8 38.81 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 169.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.6 t -128.5 125.52 63.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -127.2 103.21 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -148.85 -177.3 5.72 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.876 1.271 . . . . 0.0 108.795 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 71.2 m -150.65 65.56 0.93 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 120.749 -1.219 . . . . 0.0 108.366 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.1 p -47.92 -32.53 6.46 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.99 2.116 . . . . 0.0 112.916 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -130.94 128.32 40.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 102.85 -3.018 . . . . 0.0 102.85 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.72 -39.95 2.41 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.344 0.973 . . . . 0.0 111.016 -170.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.73 36.85 2.64 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.425 1.49 . . . . 0.0 108.67 170.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.78 -148.37 5.97 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 126.495 1.997 . . . . 0.0 109.021 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -148.7 -46.95 0.15 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.793 1.237 . . . . 0.0 110.35 -174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.7 pt -149.74 171.19 6.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 128.23 2.612 . . . . 0.0 106.743 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -47.18 -34.41 17.7 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.648 2.899 . . . . 0.0 115.549 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.78 -11.44 7.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.182 0.993 . . . . 0.0 113.42 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -52.12 -40.02 60.73 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.024 0.93 . . . . 0.0 110.589 169.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.41 120.73 24.24 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.63 -58.52 0.43 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.55 -169.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.31 -42.34 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.873 1.715 . . . . 0.0 111.369 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.65 -64.0 1.09 Allowed 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.218 1.007 . . . . 0.0 111.624 -168.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -60.56 -41.8 95.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.128 -169.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -71.17 -45.98 62.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 119.305 -0.378 . . . . 0.0 110.958 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.06 -35.58 79.06 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.714 0.688 . . . . 0.0 111.271 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.1 mt -55.12 -57.29 12.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 118.411 0.551 . . . . 0.0 110.002 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -74.11 -15.7 61.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -73.42 -38.21 65.65 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.692 0.678 . . . . 0.0 111.231 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -114.42 -26.49 7.94 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 32.88 60.43 1.51 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 126.683 1.993 . . . . 0.0 113.133 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -65.16 165.41 22.0 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.587 2.191 . . . . 0.0 112.538 -170.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.53 63.38 2.66 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.405 1.482 . . . . 0.0 111.561 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.41 9.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.15 1.38 . . . . 0.0 112.391 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.4 m -61.1 -7.09 2.33 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.299 2.64 . . . . 0.0 112.871 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.24 10.02 17.15 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.795 1.638 . . . . 0.0 111.217 177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.81 163.68 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 122.192 0.996 . . . . 0.0 110.283 174.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -122.09 149.83 43.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 171.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -123.61 166.84 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 123.721 0.638 . . . . 0.0 110.036 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.08 115.43 1.02 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 106.831 -2.507 . . . . 0.0 106.831 169.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.81 143.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.2 mt -139.42 131.34 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -174.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.98 -23.57 1.35 Allowed Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.293 0.949 . . . . 0.0 114.082 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -50.19 128.46 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 126.137 1.775 . . . . 0.0 108.415 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -103.06 -27.69 6.48 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m -61.33 107.23 0.73 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.441 1.096 . . . . 0.0 108.77 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -147.03 159.0 44.1 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.275 1.43 . . . . 0.0 107.885 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -59.06 -22.66 61.11 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.492 1.517 . . . . 0.0 112.874 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -117.69 14.33 14.38 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.194 1.798 . . . . 0.0 111.467 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -134.31 22.76 3.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.423 1.089 . . . . 0.0 110.739 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -73.8 14.32 0.4 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.395 1.878 . . . . 0.0 114.264 -171.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -60.46 -23.78 64.72 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.299 1.44 . . . . 0.0 113.946 -169.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 65.6 m -115.35 24.2 11.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.538 1.135 . . . . 0.0 111.101 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.42 20.96 79.98 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.669 0.652 . . . . 0.0 111.785 -172.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.12 54.74 1.09 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.038 1.735 . . . . 0.0 111.135 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.0 mm -58.59 143.5 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -66.92 26.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.678 2.391 . . . . 0.0 115.403 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . 45.2 mtpt -57.84 -26.84 62.58 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.637 -1.29 . . . . 0.0 113.948 -169.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -63.32 -56.04 19.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.514 1.052 . . . . 0.0 109.394 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -60.59 -39.49 88.25 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.294 0.638 . . . . 0.0 109.568 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . . . -61.3 -46.6 89.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 118.469 -0.776 . . . . 0.0 109.967 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -62.43 -37.75 87.06 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.158 0.89 . . . . 0.0 111.029 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -64.07 -48.25 76.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.05 0.841 . . . . 0.0 111.057 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.331 6.9 ptmt -71.8 -28.35 63.55 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -37.72 86.33 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.961 0.904 . . . . 0.0 110.852 169.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -66.99 -40.96 87.5 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 155.92 -22.97 0.53 Allowed Glycine 0 C--N 1.34 0.75 0 CA-C-O 118.243 -1.31 . . . . 0.0 114.987 169.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.9 137.92 56.92 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.216 1.508 . . . . 0.0 108.869 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.95 134.04 35.63 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 174.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -80.6 99.47 8.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 97.4 m -73.54 145.59 45.43 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.32 -123.58 29.87 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.482 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.4 pt-20 -153.11 176.11 12.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.42 1.488 . . . . 0.0 108.598 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.4 m -49.8 121.73 5.63 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.085 1.354 . . . . 0.0 109.922 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.1 153.33 26.14 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -127.65 144.23 51.09 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -172.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.29 162.01 7.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.802 1.241 . . . . 0.0 108.965 175.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.03 175.49 7.54 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.514 1.926 . . . . 0.0 108.306 169.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.4 tt -154.62 145.62 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.0 tp 63.22 -21.84 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 128.534 2.734 . . . . 0.0 115.073 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -151.64 -169.35 3.34 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.917 2.487 . . . . 0.0 106.584 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -125.81 155.87 40.42 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.388 1.475 . . . . 0.0 107.142 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.41 -176.69 5.91 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.139 0.976 . . . . 0.0 109.598 -174.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.1 mm -31.26 -53.4 0.44 Allowed Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 127.539 2.335 . . . . 0.0 116.488 -170.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -59.88 -53.35 3.28 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 122.482 1.922 . . . . 0.0 110.117 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . 0.26 38.6 tt0 146.37 -103.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 1 C-N-CA 133.097 4.559 . . . . 0.0 105.6 169.557 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -167.65 -43.92 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 116.412 -1.756 . . . . 0.0 114.335 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.89 131.36 45.53 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.808 2.338 . . . . 0.0 112.833 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.5 -43.54 0.69 Allowed 'General case' 0 C--N 1.34 0.172 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.45 -35.09 79.79 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.697 0.68 . . . . 0.0 110.921 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.9 mp0 -64.46 -43.87 92.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.988 0.915 . . . . 0.0 110.034 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.482 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.7 m-90 -65.6 -50.65 64.32 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.195 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.1 mt -55.08 -51.29 66.84 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.13 -51.96 54.25 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.2 t -64.16 -46.24 84.92 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.495 1.148 . . . . 0.0 110.774 -177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.0 t90 -61.56 -39.04 89.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.398 1.079 . . . . 0.0 110.783 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.9 t -64.85 -47.58 87.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 124.835 1.254 . . . . 0.0 110.381 171.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -60.38 -24.4 65.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.551 1.069 . . . . 0.0 111.288 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.06 -28.63 43.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.409 0.684 . . . . 0.0 111.794 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -36.49 19.28 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.04 0.936 . . . . 0.0 111.531 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 125.448 1.499 . . . . 0.0 109.824 172.036 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.07 161.01 43.54 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.238 1.015 . . . . 0.0 109.854 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -95.52 -24.12 16.78 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.674 1.59 . . . . 0.0 110.492 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.7 mt -136.22 128.94 46.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 124.33 1.052 . . . . 0.0 108.223 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -85.92 126.98 34.49 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 169.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.91 97.53 7.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 104.442 -2.429 . . . . 0.0 104.442 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -96.38 89.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 108.694 -169.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -75.9 141.07 42.43 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 168.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.99 1.1 0.07 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 117.913 -1.493 . . . . 0.0 116.774 -175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 115.28 2.35 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.984 1.892 . . . . 0.0 109.714 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.0 m 46.06 40.86 7.63 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.217 1.807 . . . . 0.0 111.811 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.2 tp 47.84 69.64 0.51 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 126.003 1.721 . . . . 0.0 111.16 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 163.14 25.59 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.534 1.54 . . . . 0.0 109.423 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.38 -29.92 2.82 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.415 -1.214 . . . . 0.0 114.244 -169.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 41.47 43.96 2.36 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.955 1.302 . . . . 0.0 111.412 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.4 mp0 -50.7 -33.29 22.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.966 1.306 . . . . 0.0 113.592 -169.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -59.37 -52.22 66.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.735 1.152 . . . . 0.0 111.431 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.09 -29.05 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.646 -0.659 . . . . 0.0 110.279 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.46 91.12 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.575 0.625 . . . . 0.0 110.87 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.47 -38.19 71.26 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.686 -0.633 . . . . 0.0 110.242 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -58.73 -44.18 90.37 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.57 0.623 . . . . 0.0 110.368 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -59.02 -55.82 30.2 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.393 0.677 . . . . 0.0 109.989 172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.4 -40.42 65.05 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.727 0.811 . . . . 0.0 111.781 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -53.77 -54.03 43.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 123.358 0.663 . . . . 0.0 110.083 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -62.44 -41.76 98.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -58.22 -45.3 87.92 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.446 0.566 . . . . 0.0 109.799 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.21 -35.97 71.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.391 -0.818 . . . . 0.0 110.833 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -63.16 -29.65 70.96 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.665 0.786 . . . . 0.0 111.586 172.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.45 -18.1 63.69 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.861 0.755 . . . . 0.0 111.795 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.1 -4.8 4.98 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.499 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -100.41 -170.31 1.85 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.568 1.684 . . . . 0.0 109.82 -169.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.8 p -128.88 148.58 50.92 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 168.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -139.89 149.95 44.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.174 0.511 . . . . 0.0 111.826 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -111.26 92.13 3.92 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 m -69.29 118.02 11.65 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.9 mt -149.35 153.76 37.92 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.281 0.562 . . . . 0.0 112.186 -169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -93.7 39.22 1.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.386 1.074 . . . . 0.0 108.432 168.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 39.14 54.66 2.5 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.724 2.107 . . . . 0.0 115.42 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.48 -20.69 54.09 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.792 2.328 . . . . 0.0 113.731 -173.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.0 mt -112.94 8.3 18.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.661 1.584 . . . . 0.0 109.772 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tt 60.29 -17.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.557 2.743 . . . . 0.0 114.563 -169.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -169.46 76.82 0.1 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.94 -45.38 93.94 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.744 -0.598 . . . . 0.0 109.566 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.2 mt -88.63 149.43 44.09 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.28 -175.46 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.793 2.995 . . . . 0.0 112.798 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.88 36.63 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.61 1.564 . . . . 0.0 111.334 169.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.7 m -158.3 128.69 6.13 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.31 2.244 . . . . 0.0 106.321 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.55 -145.98 17.54 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.2 mm -124.55 142.0 42.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -122.12 151.21 41.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 49.8 mt -137.44 138.9 40.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.07 134.25 66.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.12 111.91 30.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.7 m -156.53 -176.4 5.95 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.433 1.093 . . . . 0.0 108.638 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 p -153.07 62.82 0.77 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.4 1.095 . . . . 0.0 110.344 -169.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.1 p -64.5 -14.85 59.35 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.301 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -59.27 167.62 1.74 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.769 1.227 . . . . 0.0 112.261 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.54 -65.81 3.07 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.036 1.303 . . . . 0.0 111.507 173.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.78 -8.42 0.22 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.281 1.032 . . . . 0.0 113.71 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.96 -146.65 38.84 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 119.787 1.176 . . . . 0.0 110.735 -170.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -143.78 169.49 17.66 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.098 1.359 . . . . 0.0 108.147 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 90.9 mt -46.35 -52.72 27.39 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.534 1.533 . . . . 0.0 112.836 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.87 -44.28 1.38 Allowed 'Trans proline' 0 C--N 1.354 0.84 0 CA-C-N 121.86 1.7 . . . . 0.0 111.465 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -172.2 -61.81 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.767 1.627 . . . . 0.0 108.608 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 178.78 -53.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.84 2.456 . . . . 0.0 106.403 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.402 HD12 ' H ' ' A' ' 66' ' ' LEU . 4.5 mp -75.48 131.16 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 169.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.44 -58.87 0.33 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 119.045 0.839 . . . . 0.0 110.228 -170.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -81.18 -38.56 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.325 2.016 . . . . 0.0 111.989 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -59.29 -49.9 76.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.432 0.693 . . . . 0.0 111.511 -169.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -60.26 -44.28 95.44 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.348 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -65.37 -47.56 75.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.31 0.504 . . . . 0.0 110.467 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.21 89.28 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.01 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 mt -53.72 -55.62 24.65 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.914 0.779 . . . . 0.0 109.463 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -72.14 -17.27 61.97 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.87 -32.25 65.28 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.732 0.413 . . . . 0.0 111.337 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -117.9 -29.97 5.51 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 mttt 27.45 66.28 0.57 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.804 2.042 . . . . 0.0 113.273 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.94 176.81 1.66 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.824 2.349 . . . . 0.0 112.715 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -82.13 68.67 8.63 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.383 1.073 . . . . 0.0 111.125 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.22 3.11 1.8 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.875 0.87 . . . . 0.0 112.886 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -64.67 -6.25 7.41 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.365 2.666 . . . . 0.0 113.336 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.78 9.04 24.82 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.85 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 p -134.62 157.22 41.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.573 0.749 . . . . 0.0 110.529 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -121.01 152.02 39.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 168.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -118.1 173.87 6.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -146.03 160.11 28.08 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 106.68 -2.568 . . . . 0.0 106.68 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.81 145.87 50.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.45 121.1 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.09 -14.4 6.32 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.818 1.199 . . . . 0.0 114.593 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.9 141.34 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.981 1.313 . . . . 0.0 108.799 -176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.47 -15.01 60.84 Favored Glycine 0 N--CA 1.468 0.768 0 O-C-N 121.083 -1.01 . . . . 0.0 112.919 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.4 m -54.75 -14.87 1.54 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.553 2.341 . . . . 0.0 115.195 -174.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -125.01 2.3 8.0 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.651 1.114 . . . . 0.0 113.095 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -142.95 -24.1 0.62 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -170.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -116.69 -33.9 4.68 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.321 1.048 . . . . 0.0 111.419 -172.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -106.44 10.87 31.31 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 122.753 1.263 . . . . 0.0 112.952 -172.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.0 p -69.58 20.05 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.732 2.413 . . . . 0.0 113.696 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -136.24 -14.53 1.76 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.297 1.839 . . . . 0.0 111.595 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 57.0 m -132.92 -5.07 3.14 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 41.59 31.22 0.66 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 127.292 2.377 . . . . 0.0 115.445 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.82 -30.97 66.06 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.037 1.418 . . . . 0.0 112.018 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.6 -0.01 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.549 1.54 . . . . 0.0 112.027 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -51.75 -28.73 16.13 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.317 1.447 . . . . 0.0 110.618 168.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -46.34 -37.48 7.53 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 128.648 2.779 . . . . 0.0 113.149 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.41 -57.25 13.79 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.581 0.628 . . . . 0.0 109.433 -175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.38 -31.17 65.34 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.093 0.557 . . . . 0.0 109.725 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.89 94.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.431 -0.795 . . . . 0.0 110.002 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -67.53 -37.98 83.56 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.503 1.047 . . . . 0.0 110.449 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.6 mt -62.43 -40.48 96.72 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.536 0.734 . . . . 0.0 111.626 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.297 7.6 ptmm? -79.92 -29.54 39.81 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.544 -0.722 . . . . 0.0 112.509 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.42 86.46 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.162 0.985 . . . . 0.0 110.995 172.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 p -77.49 -20.48 54.28 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.07 -37.48 0.46 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.715 0.689 . . . . 0.0 113.597 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.91 -177.99 2.6 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.97 0.891 . . . . 0.0 111.435 -175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -135.14 150.14 50.12 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -77.11 126.98 31.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.6 m -77.58 140.93 39.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.45 -121.31 19.73 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -153.81 162.33 41.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.877 1.271 . . . . 0.0 108.927 175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.9 m -53.41 124.18 14.07 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.437 1.495 . . . . 0.0 113.811 -169.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.51 164.66 26.13 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.864 1.666 . . . . 0.0 108.283 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -135.99 144.4 45.32 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.014 -1.053 . . . . 0.0 109.318 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 pp -144.92 155.28 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 127.003 2.121 . . . . 0.0 108.697 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -162.5 154.09 18.17 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.59 24.39 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.244 1.417 . . . . 0.0 111.009 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.0 mt -125.43 -178.12 4.12 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.611 1.564 . . . . 0.0 107.965 173.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.85 -42.87 98.68 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.812 0.445 . . . . 0.0 111.337 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -164.34 164.26 22.3 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.034 1.334 . . . . 0.0 109.893 173.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -162.96 -162.41 0.77 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.887 2.875 . . . . 0.0 104.015 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 46.8 mm -67.01 -50.35 42.44 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 117.407 -1.283 . . . . 0.0 111.735 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.58 -40.1 10.91 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.05 1.833 . . . . 0.0 111.019 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 68.78 -28.51 0.16 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.113 2.565 . . . . 0.0 116.016 169.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -150.01 141.26 14.73 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 120.059 1.3 . . . . 0.0 111.911 -169.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.58 99.24 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.014 3.143 . . . . 0.0 110.759 169.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.24 67.53 1.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.723 1.609 . . . . 0.0 110.182 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -55.44 -34.49 64.52 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.523 1.129 . . . . 0.0 111.036 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.64 -30.65 71.68 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.345 0.658 . . . . 0.0 111.603 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -66.14 -44.85 83.01 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.599 0.759 . . . . 0.0 109.579 175.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.3 tp -61.59 -52.05 66.0 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -50.9 -49.74 40.76 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 124.518 1.136 . . . . 0.0 111.475 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.1 m -61.47 -54.55 41.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 125.111 1.364 . . . . 0.0 111.54 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -55.7 -41.18 73.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.151 0.98 . . . . 0.0 111.365 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.4 t -60.56 -49.54 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.358 1.063 . . . . 0.0 109.83 173.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.81 -27.65 68.2 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.474 1.033 . . . . 0.0 111.651 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.79 -45.01 19.59 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.932 0.893 . . . . 0.0 110.513 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 pp -71.15 -36.01 71.88 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.607 0.64 . . . . 0.0 111.592 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.6 mttm . . . . . 0 C--O 1.248 0.991 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 175.799 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 119.244 -0.408 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.92 164.05 36.47 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.777 1.231 . . . . 0.0 109.147 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -103.46 -23.34 13.54 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.354 1.462 . . . . 0.0 110.64 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.1 mt -133.11 126.19 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.813 1.245 . . . . 0.0 108.078 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -88.09 126.81 35.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -102.37 91.19 4.16 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.4 mt -86.09 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.4 t -111.54 -162.2 0.79 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.311 1.044 . . . . 0.0 108.319 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.36 51.32 57.29 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 123.646 0.641 . . . . 0.0 111.858 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -44.37 121.77 2.73 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.108 1.363 . . . . 0.0 111.095 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.272 39.1 m 67.31 53.15 0.78 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.884 1.273 . . . . 0.0 110.478 -171.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 52.92 37.85 25.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.954 2.101 . . . . 0.0 114.494 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.83 156.52 10.15 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.246 0.926 . . . . 0.0 111.478 172.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.16 -171.06 41.11 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.39 68.38 2.07 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.217 1.407 . . . . 0.0 110.893 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -51.85 -24.46 6.2 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.075 1.35 . . . . 0.0 112.763 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -51.95 -34.78 43.53 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.148 0.979 . . . . 0.0 112.906 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 p -71.69 -34.2 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 119.641 1.109 . . . . 0.0 109.853 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.98 -31.47 61.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.378 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.73 -40.45 84.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.031 0.832 . . . . 0.0 110.361 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -57.88 -51.16 70.75 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.509 0.724 . . . . 0.0 109.347 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.8 mt -56.32 -49.89 73.03 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.096 0.558 . . . . 0.0 110.487 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.25 -40.8 64.87 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.671 1.188 . . . . 0.0 111.796 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.98 -58.5 7.87 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.336 0.971 . . . . 0.0 109.998 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -53.89 -43.4 69.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.657 1.183 . . . . 0.0 112.188 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.1 -36.83 82.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.733 0.813 . . . . 0.0 111.967 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -70.67 -36.99 73.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.703 1.138 . . . . 0.0 109.732 176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -64.83 -23.2 67.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.287 0.635 . . . . 0.0 111.801 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.97 -10.92 60.32 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.853 0.861 . . . . 0.0 112.108 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.79 21.61 5.98 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 118.918 -0.934 . . . . 0.0 114.319 169.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -125.87 -171.81 2.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.465 1.132 . . . . 0.0 109.584 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.5 p -125.16 151.02 46.34 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p -142.29 159.8 41.51 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.861 -0.524 . . . . 0.0 110.336 -170.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.31 110.96 11.92 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.5 m -76.01 124.6 27.65 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.9 mt -141.88 159.45 42.21 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.268 0.627 . . . . 0.0 110.718 -169.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -110.74 39.39 2.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.165 1.386 . . . . 0.0 109.022 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.78 46.67 39.48 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-O 117.914 -1.492 . . . . 0.0 114.906 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.62 -21.16 70.22 Favored 'Trans proline' 0 C--N 1.35 0.636 0 CA-C-N 121.398 2.599 . . . . 0.0 113.736 -172.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -126.32 14.2 7.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.43 1.892 . . . . 0.0 109.309 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 66.12 -31.72 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 128.366 2.667 . . . . 0.0 112.436 -169.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.12 89.8 1.02 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.132 1.773 . . . . 0.0 107.075 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.54 -42.49 91.86 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.667 -0.645 . . . . 0.0 110.409 175.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.59 154.5 59.1 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.35 -175.27 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.055 3.17 . . . . 0.0 113.173 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.57 28.84 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.63 1.572 . . . . 0.0 113.067 171.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.7 m -153.56 137.33 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.817 2.447 . . . . 0.0 106.342 -174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.23 -140.58 12.42 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.2 mm -121.55 137.3 55.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 173.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -122.34 137.23 54.92 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 mt -129.83 134.18 47.39 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.09 128.09 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -107.23 59.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 126.335 1.854 . . . . 0.0 106.689 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -67.92 -32.36 72.77 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.661 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.1 m 28.54 55.31 0.09 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 127.905 2.482 . . . . 0.0 113.505 -173.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.7 p -42.37 -40.0 2.36 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 127.63 2.372 . . . . 0.0 114.715 -169.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -140.59 17.37 2.36 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.825 0.739 . . . . 0.0 111.397 168.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.5 -25.95 29.08 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.42 1.009 . . . . 0.0 111.182 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.34 54.7 0.86 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.868 2.467 . . . . 0.0 105.107 169.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.41 -146.62 4.91 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.424 1.011 . . . . 0.0 111.479 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -151.91 -34.4 0.13 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.614 1.165 . . . . 0.0 112.829 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 pt -156.37 167.04 15.19 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.789 2.036 . . . . 0.0 108.547 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.25 -28.71 8.36 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.819 3.013 . . . . 0.0 115.131 172.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -77.76 9.03 3.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.104 1.362 . . . . 0.0 113.48 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -54.03 -27.23 30.83 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.222 1.409 . . . . 0.0 113.785 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.704 ' H ' HD23 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -107.36 84.45 1.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.274 -2.862 . . . . 0.0 103.274 169.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.5 m -70.51 -56.49 6.43 Favored Pre-proline 0 N--CA 1.452 -0.353 0 CA-C-O 118.242 -0.885 . . . . 0.0 112.644 -167.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.12 -37.91 39.48 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 120.428 1.189 . . . . 0.0 110.006 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.0 m-30 -68.19 -50.43 54.35 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.58 -46.36 83.04 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.883 0.765 . . . . 0.0 110.844 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.46 -40.44 94.5 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.841 1.2 . . . . 0.0 110.922 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.86 -39.29 90.61 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.737 -0.649 . . . . 0.0 111.314 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.2 mt -54.65 -52.72 61.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.512 1.051 . . . . 0.0 109.78 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -67.03 -22.59 65.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -75.42 -43.64 48.8 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.486 0.585 . . . . 0.0 111.083 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -98.88 -29.16 13.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.54 62.68 0.98 Allowed Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 127.014 2.126 . . . . 0.0 112.609 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.75 164.63 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.259 2.639 . . . . 0.0 113.278 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -77.13 64.41 2.57 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.372 1.469 . . . . 0.0 111.613 -174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.19 9.53 0.97 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 112.737 -178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.4 m -60.55 -6.87 1.81 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 127.858 2.463 . . . . 0.0 112.717 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -111.62 8.75 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.758 1.623 . . . . 0.0 111.183 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.69 152.84 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.93 0.871 . . . . 0.0 111.808 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -105.0 152.69 22.4 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 169.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -122.8 147.89 46.01 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.911 1.285 . . . . 0.0 107.561 -172.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.05 116.98 1.65 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 106.116 -2.793 . . . . 0.0 106.116 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.23 145.19 35.65 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 mt -139.37 124.11 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.61 -2.82 20.75 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.714 1.626 . . . . 0.0 113.996 173.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 mt -60.3 117.51 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.532 . . . . 0.0 107.955 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.13 -29.96 63.77 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.5 m -64.59 54.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 129.719 3.208 . . . . 0.0 111.768 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.05 -44.86 0.79 Allowed 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 126.968 2.107 . . . . 0.0 109.723 174.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -151.71 -36.12 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.099 0.959 . . . . 0.0 111.113 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -71.82 -20.97 61.76 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.47 1.108 . . . . 0.0 112.374 -172.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -83.34 33.14 0.45 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.25 1.42 . . . . 0.0 113.216 -169.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 p -72.0 9.75 0.87 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.315 1.446 . . . . 0.0 113.409 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -62.58 -38.62 90.83 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.774 1.23 . . . . 0.0 110.059 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.9 p -142.21 20.26 2.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.785 1.234 . . . . 0.0 111.395 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.53 27.2 70.53 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.376 0.989 . . . . 0.0 112.586 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.89 21.74 1.85 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.276 1.038 . . . . 0.0 112.485 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.4 pt -60.62 16.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 129.215 3.006 . . . . 0.0 116.655 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -160.65 2.62 0.07 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.175 0.99 . . . . 0.0 112.727 169.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -57.64 -41.3 81.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -168.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.6 -57.31 7.49 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.586 1.084 . . . . 0.0 108.461 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -58.46 -37.78 76.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.083 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.63 -46.56 67.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 126.157 1.783 . . . . 0.0 109.873 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -63.93 -34.17 77.37 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.132 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.1 -40.65 74.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 119.903 1.229 . . . . 0.0 110.402 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -63.97 -41.54 97.52 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.966 1.306 . . . . 0.0 109.586 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -34.11 73.38 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.057 1.743 . . . . 0.0 111.742 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -67.56 -42.16 83.06 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.81 -17.32 0.56 Allowed Glycine 0 CA--C 1.528 0.898 0 CA-C-O 117.956 -1.469 . . . . 0.0 115.391 169.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.35 140.16 57.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.809 1.804 . . . . 0.0 109.43 -170.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -89.12 112.91 24.0 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -64.16 128.67 36.83 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 169.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 88.7 m -106.39 149.97 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.86 -122.4 29.86 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 108.554 -1.818 . . . . 0.0 108.554 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -157.83 168.67 26.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.19 1.396 . . . . 0.0 108.315 170.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.1 m -43.91 116.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.09 169.51 15.87 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.879 1.672 . . . . 0.0 108.095 172.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 138.96 42.79 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 120.948 -1.095 . . . . 0.0 111.123 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.66 159.36 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 127.247 2.219 . . . . 0.0 105.372 169.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -147.02 122.36 10.28 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 118.319 0.509 . . . . 0.0 110.337 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.6 tp -158.7 162.12 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.574 1.55 . . . . 0.0 107.418 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.5 tp 64.2 -9.39 0.16 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.297 2.239 . . . . 0.0 115.411 169.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -151.84 170.69 19.19 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.81 1.644 . . . . 0.0 108.82 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -59.3 160.52 6.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.211 1.405 . . . . 0.0 110.983 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.25 140.54 45.07 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.84 0.829 . . . . 0.0 111.283 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.474 ' H ' ' HD2' ' A' ' 131' ' ' PRO . 7.1 mm -146.05 -55.66 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 128.276 2.63 . . . . 0.0 106.02 175.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.474 ' HD2' ' H ' ' A' ' 130' ' ' ILE . 26.0 Cg_endo -78.54 -131.58 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 122.52 2.147 . . . . 0.0 110.11 171.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.5 -177.3 5.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.281 2.632 . . . . 0.0 105.606 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.601 ' H ' ' HD2' ' A' ' 134' ' ' PRO . 21.7 t70 -142.02 -34.56 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 117.226 2.306 . . . . 0.0 117.226 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.601 ' HD2' ' H ' ' A' ' 133' ' ' ASP . 69.0 Cg_endo -79.6 36.7 0.63 Allowed 'Trans proline' 0 CA--C 1.547 1.171 0 C-N-CA 122.684 2.256 . . . . 0.0 112.522 -177.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.07 26.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.836 2.055 . . . . 0.0 113.772 -171.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -61.96 -33.27 73.98 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.735 -1.228 . . . . 0.0 110.678 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.18 -33.68 76.31 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.55 -0.719 . . . . 0.0 111.111 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.65 -44.63 93.27 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 173.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.4 tp -59.12 -52.64 64.85 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.265 1.026 . . . . 0.0 108.807 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.53 -44.91 85.72 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.252 0.93 . . . . 0.0 111.844 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 11.5 t -61.71 -55.01 34.92 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.567 0.683 . . . . 0.0 109.548 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -57.69 -40.52 79.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.525 0.73 . . . . 0.0 111.666 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -58.41 -55.28 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 124.924 1.29 . . . . 0.0 109.699 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -15.05 63.34 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.442 1.019 . . . . 0.0 112.197 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.69 -45.85 20.4 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 124.024 0.929 . . . . 0.0 110.796 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.7 -36.87 76.32 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.57 0.623 . . . . 0.0 111.639 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.032 0 C-N-CA 125.435 1.494 . . . . 0.0 109.658 175.264 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 ttm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.41 165.61 33.6 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.05 0.94 . . . . 0.0 110.37 -173.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -99.15 -23.07 15.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.721 1.608 . . . . 0.0 110.808 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.1 mt -133.69 126.69 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.411 1.084 . . . . 0.0 108.328 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -85.73 128.91 34.92 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -108.7 88.33 2.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.8 mt -77.74 91.41 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -93.02 17.1 11.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.812 2.045 . . . . 0.0 112.98 -168.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.89 77.78 0.11 Allowed Glycine 0 N--CA 1.446 -0.657 0 O-C-N 121.707 -0.621 . . . . 0.0 112.086 -169.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 56.7 m -56.44 -14.4 3.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.247 1.019 . . . . 0.0 113.344 169.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 p -122.08 33.42 5.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.722 2.009 . . . . 0.0 109.92 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 80.8 mt 58.11 23.97 10.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.699 1.999 . . . . 0.0 112.854 -171.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.0 161.96 16.25 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 128.585 2.993 . . . . 0.0 106.223 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.35 -36.33 0.29 Allowed Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.917 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.82 16.42 0.98 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.034 1.417 . . . . 0.0 113.826 -169.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.26 -36.49 63.66 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.535 1.061 . . . . 0.0 113.288 -170.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -60.65 -50.56 73.0 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.559 0.618 . . . . 0.0 111.313 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.8 -32.24 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 122.029 -0.419 . . . . 0.0 110.094 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.95 -37.61 87.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.476 -0.773 . . . . 0.0 110.919 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -62.17 -40.06 94.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.323 0.965 . . . . 0.0 111.147 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -64.98 -47.6 76.96 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.639 -0.663 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.41 -49.54 72.12 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.984 0.914 . . . . 0.0 110.606 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.58 -48.23 72.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.999 1.319 . . . . 0.0 110.774 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.59 -50.75 72.27 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 123.962 0.905 . . . . 0.0 110.524 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -71.1 -22.64 62.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.567 175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -72.79 -41.5 64.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 121.156 1.798 . . . . 0.0 109.024 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -62.9 -25.08 68.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.779 0.832 . . . . 0.0 111.462 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.13 -11.99 60.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.149 0.98 . . . . 0.0 112.546 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 19.85 7.03 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.241 172.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -124.21 -166.78 1.55 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.354 1.061 . . . . 0.0 108.642 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.3 p -132.1 150.73 52.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.9 p -141.71 153.88 44.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 110.806 -169.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -123.13 90.48 3.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.231 1.012 . . . . 0.0 108.524 -172.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -66.61 118.9 10.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.2 mt -145.59 138.07 25.76 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.815 0.846 . . . . 0.0 109.167 -170.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -83.66 40.88 0.76 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.035 -1.041 . . . . 0.0 110.601 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.16 44.98 34.2 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 117.892 -1.504 . . . . 0.0 115.863 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.69 -20.99 39.64 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.175 2.487 . . . . 0.0 114.005 -170.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.37 13.41 12.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.53 1.532 . . . . 0.0 109.391 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.0 tp 64.52 -27.2 0.09 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.886 2.474 . . . . 0.0 113.568 -170.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -174.1 87.77 0.05 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.507 1.523 . . . . 0.0 107.378 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.37 -43.29 91.23 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.816 -0.553 . . . . 0.0 110.298 175.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.81 151.1 49.42 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 47' ' ' SER . 40.1 Cg_endo -67.69 -174.33 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.139 3.226 . . . . 0.0 112.962 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.44 29.02 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.527 1.531 . . . . 0.0 113.115 171.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' PRO . 18.7 m -152.23 131.93 13.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.949 2.5 . . . . 0.0 106.287 -175.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.39 -139.73 11.19 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.1 mm -126.89 137.07 58.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.473 ' CD1' HG21 ' A' ' 83' ' ' VAL . 11.1 m0 -121.76 133.95 54.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 175.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 55.0 mt -127.62 138.12 52.76 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.0 t -123.22 133.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -132.93 107.58 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 -171.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.3 m -163.53 -160.52 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.08 2.152 . . . . 0.0 105.598 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 m -148.02 155.12 41.15 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 120.199 -1.563 . . . . 0.0 109.045 170.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.7 p -128.65 -26.65 2.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.207 0.603 . . . . 0.0 111.872 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -66.58 -26.48 67.13 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.52 -0.738 . . . . 0.0 111.271 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.39 -177.3 36.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 45.74 44.88 11.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.904 1.282 . . . . 0.0 110.683 -170.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.3 -148.64 5.5 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.064 1.316 . . . . 0.0 109.923 -169.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.5 t70 47.75 -45.22 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.49 1 C-N-CA 131.858 4.063 . . . . 0.0 118.536 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.2 mt -56.9 -52.47 73.75 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 120.298 1.408 . . . . 0.0 111.048 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -80.92 40.08 0.95 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.406 2.737 . . . . 0.0 111.133 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t70 52.28 30.23 7.69 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.995 1.718 . . . . 0.0 111.589 -169.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.72 -18.6 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.521 3.129 . . . . 0.0 115.742 -170.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -148.25 120.94 8.62 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -54.89 0.56 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.3 -172.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -99.3 -34.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.18 2.587 . . . . 0.0 113.554 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.93 -54.68 44.44 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.722 0.809 . . . . 0.0 112.063 -168.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -65.42 -40.3 93.17 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.659 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.47 -49.62 76.07 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.246 0.475 . . . . 0.0 110.038 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.13 93.22 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 mt -57.01 -53.75 54.58 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 118.773 0.715 . . . . 0.0 110.305 -177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -72.92 -19.0 61.34 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -68.6 -49.82 56.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 119.493 -0.289 . . . . 0.0 110.368 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -100.8 -26.53 13.74 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -172.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt 29.36 64.66 0.78 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 127.19 2.196 . . . . 0.0 113.011 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -63.65 164.81 19.91 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.605 2.203 . . . . 0.0 112.443 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -82.39 66.19 7.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.661 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.43 7.52 0.6 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.306 1.042 . . . . 0.0 113.041 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 m -62.82 -6.12 3.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 128.517 2.727 . . . . 0.0 113.041 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.21 8.77 19.95 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.271 1.428 . . . . 0.0 110.983 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.6 p -132.46 147.22 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 118.709 0.686 . . . . 0.0 110.911 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -97.75 154.05 17.85 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -119.52 152.11 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 -174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.6 146.78 17.55 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 169.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -123.8 135.71 53.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.5 mt -136.55 127.88 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.48 -19.99 3.62 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 124.352 0.977 . . . . 0.0 113.662 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 mm -52.67 144.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.3 1.84 . . . . 0.0 108.677 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.09 -19.61 1.1 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.783 1.182 . . . . 0.0 113.308 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 p -52.99 -25.4 11.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.396 1.878 . . . . 0.0 113.34 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -74.66 -26.63 59.98 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -146.75 -22.54 0.42 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 -168.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -126.65 -35.41 2.34 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -168.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.69 11.36 9.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 122.164 0.983 . . . . 0.0 112.239 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 p -67.78 7.13 0.55 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.952 2.501 . . . . 0.0 115.051 -169.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -77.69 -39.27 45.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.539 1.136 . . . . 0.0 110.354 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 20.2 p -153.52 19.51 0.54 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.851 0.86 . . . . 0.0 112.563 -174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.07 58.73 4.32 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 125.553 1.549 . . . . 0.0 113.096 -169.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.53 -22.58 34.03 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.124 0.97 . . . . 0.0 113.053 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -11.79 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 118.641 -0.695 . . . . 0.0 112.694 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.08 -28.23 0.69 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.159 2.184 . . . . 0.0 112.907 169.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -56.75 -23.12 40.54 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.101 0.96 . . . . 0.0 112.73 176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.45 -59.12 5.73 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 120.013 1.279 . . . . 0.0 109.185 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.88 -39.52 81.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.109 0.413 . . . . 0.0 110.597 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.21 81.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.015 -0.517 . . . . 0.0 110.269 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -64.56 -38.18 90.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.048 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.97 -46.91 88.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.29 0.95 . . . . 0.0 110.592 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -65.69 -38.34 88.97 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.798 0.839 . . . . 0.0 110.074 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -34.24 77.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.688 1.195 . . . . 0.0 111.324 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.1 m -71.67 -31.25 66.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 119.388 -0.339 . . . . 0.0 111.336 -176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.97 -33.15 0.56 Allowed Glycine 0 C--N 1.341 0.844 0 CA-C-O 118.994 -0.892 . . . . 0.0 114.781 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.6 171.97 6.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.433 1.116 . . . . 0.0 110.465 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -132.72 141.93 48.8 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -75.78 111.13 10.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 172.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 91.0 m -74.58 152.69 39.24 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.08 -104.13 1.68 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.79 -177.34 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.812 2.445 . . . . 0.0 106.541 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 124.99 31.51 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD12 ' CE3' ' A' ' 138' ' ' TRP . 2.3 tt -79.65 151.02 30.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -129.85 146.67 51.57 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.814 1.188 . . . . 0.0 108.798 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.69 170.17 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.712 1.205 . . . . 0.0 110.9 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 108.83 141.97 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.655 1 C-N-CA 132.042 4.137 . . . . 0.0 110.879 169.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.05 5.76 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.936 1.694 . . . . 0.0 110.906 169.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.5 -47.32 86.18 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.015 0.926 . . . . 0.0 109.852 -171.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -141.32 18.84 2.24 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.535 1.134 . . . . 0.0 110.329 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 47.48 55.47 8.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.691 1.596 . . . . 0.0 110.572 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -65.88 -178.85 0.63 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.857 1.263 . . . . 0.0 110.28 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.274 98.0 mt 6.37 -78.86 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.878 1 C-N-CA 132.475 4.31 . . . . 0.0 115.358 -172.086 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -69.9 -31.0 20.74 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.489 2.126 . . . . 0.0 112.359 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 86.59 -16.07 0.43 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.12 2.968 . . . . 0.0 111.625 170.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -145.77 122.33 5.94 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.645 1.178 . . . . 0.0 108.484 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -72.91 165.9 31.51 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.755 2.304 . . . . 0.0 111.272 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -136.74 49.51 2.06 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.996 1.318 . . . . 0.0 109.382 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.71 -21.75 55.68 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.85 -24.87 67.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.256 1.023 . . . . 0.0 112.042 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.427 ' CE3' HD12 ' A' ' 121' ' ' LEU . 9.2 t90 -51.85 -50.34 61.13 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 110.653 173.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.82 -55.96 24.53 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.483 1.114 . . . . 0.0 109.359 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.28 -42.38 99.76 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 123.319 0.387 . . . . 0.0 112.179 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -60.28 -63.35 1.33 Allowed 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 125.194 1.397 . . . . 0.0 110.171 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -53.95 -46.72 71.66 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.846 1.658 . . . . 0.0 111.849 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.5 t -59.77 -55.89 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.497 0.719 . . . . 0.0 109.779 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -18.17 63.4 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.461 1.028 . . . . 0.0 112.201 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.6 mp -77.24 -47.1 21.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.545 0.611 . . . . 0.0 111.0 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.17 -30.69 62.36 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.92 0.782 . . . . 0.0 112.261 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.9 mttm . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.804 1.242 . . . . 0.0 109.781 171.491 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.2 167.63 29.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.842 1.257 . . . . 0.0 109.309 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.07 -27.59 18.49 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.882 0.873 . . . . 0.0 110.025 170.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.9 mt -132.71 132.09 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 123.941 0.896 . . . . 0.0 109.319 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -89.46 129.86 35.89 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.57 95.11 5.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.2 mt -88.27 77.51 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -74.27 153.75 39.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.31 -0.869 . . . . 0.0 109.54 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.93 -175.64 32.63 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-O 122.576 1.098 . . . . 0.0 114.973 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.4 p -150.51 -50.07 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 113.05 -1.575 . . . . 0.0 109.508 -169.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 48.0 m -121.48 58.64 0.98 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.0 tp 48.89 48.08 20.82 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.067 2.147 . . . . 0.0 112.549 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.72 153.34 10.98 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.154 -2.378 . . . . 0.0 107.154 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.21 -174.51 41.09 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 118.31 1.055 . . . . 0.0 113.745 -169.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.06 59.5 1.32 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.296 1.838 . . . . 0.0 110.52 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -56.67 -27.38 58.58 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.148 -0.97 . . . . 0.0 112.05 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -58.91 -44.81 91.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.932 0.787 . . . . 0.0 111.324 172.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -68.71 -43.14 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.33 91.38 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.549 -0.262 . . . . 0.0 111.212 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -69.66 -41.45 75.51 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.363 0.665 . . . . 0.0 110.886 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -61.27 -45.55 94.04 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.736 -0.602 . . . . 0.0 110.147 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.13 -52.57 65.0 Favored 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.093 0.957 . . . . 0.0 110.469 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.55 -46.25 57.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.224 1.009 . . . . 0.0 110.886 177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -56.69 -54.23 48.53 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.549 0.613 . . . . 0.0 110.575 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -61.65 -39.45 91.38 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -66.87 -37.59 84.72 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.396 0.678 . . . . 0.0 110.779 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.36 -39.41 89.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.592 0.633 . . . . 0.0 110.369 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -63.14 -30.01 71.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.867 0.758 . . . . 0.0 111.388 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.33 -20.62 60.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.623 0.769 . . . . 0.0 111.676 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 16.92 6.73 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 118.514 -1.159 . . . . 0.0 114.228 169.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -128.03 142.58 51.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.066 1.433 . . . . 0.0 108.49 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 p -83.15 151.84 25.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -138.32 158.62 43.93 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.03 104.46 7.8 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 m -68.82 123.21 20.33 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.271 1.028 . . . . 0.0 108.344 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.7 mt -145.43 166.35 25.88 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.163 0.985 . . . . 0.0 110.042 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -110.36 39.33 2.21 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.622 1.169 . . . . 0.0 109.141 169.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.85 50.9 14.1 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.718 1.627 . . . . 0.0 114.867 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.1 -21.75 62.61 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.846 2.364 . . . . 0.0 113.775 -173.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.0 mt -124.1 13.93 9.07 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.18 1.792 . . . . 0.0 108.93 177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.7 tp 61.59 -25.57 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 128.654 2.782 . . . . 0.0 114.464 -169.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -161.3 86.44 0.68 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -168.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.57 -45.25 87.82 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.685 -0.634 . . . . 0.0 110.081 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.7 mt -84.13 151.34 59.93 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.48 -178.9 1.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.584 2.856 . . . . 0.0 112.996 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.54 35.92 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.882 1.673 . . . . 0.0 111.807 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.8 m -158.49 123.99 4.42 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.293 2.237 . . . . 0.0 105.773 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.48 -147.9 19.38 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -174.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 25.6 mm -123.5 128.91 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -119.79 152.25 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.4 mt -140.43 138.16 34.51 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.76 132.29 44.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -125.11 68.44 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.931 1.292 . . . . 0.0 108.292 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -103.09 16.24 27.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.524 1.13 . . . . 0.0 112.241 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.8 m 2.22 83.49 0.0 OUTLIER 'General case' 0 C--N 1.344 0.357 0 C-N-CA 129.999 3.319 . . . . 0.0 114.516 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.6 p -64.79 -48.31 74.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.148 0.979 . . . . 0.0 109.609 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -83.1 61.88 6.29 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.288 1.035 . . . . 0.0 108.306 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.98 60.74 0.23 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 52.57 40.38 29.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.326 1.45 . . . . 0.0 111.654 -169.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.14 -138.2 5.44 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 125.563 1.554 . . . . 0.0 109.822 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.2 t70 47.59 -51.81 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 1 C-N-CA 131.886 4.074 . . . . 0.0 117.945 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.9 mt -54.92 -53.12 64.64 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 120.172 1.351 . . . . 0.0 112.302 -170.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -82.24 49.14 3.03 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.212 2.608 . . . . 0.0 110.485 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.0 t0 47.43 41.48 12.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.225 1.41 . . . . 0.0 109.641 -169.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 t30 61.35 -47.52 0.13 Allowed 'General case' 0 C--N 1.338 0.08 0 C-N-CA 130.473 3.509 . . . . 0.0 114.533 -168.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -150.09 108.07 3.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.1 m -82.65 -63.04 0.28 Allowed Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.948 -169.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.86 -40.57 16.34 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.695 1.596 . . . . 0.0 110.625 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -63.46 -49.87 71.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.976 0.51 . . . . 0.0 110.718 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.53 -45.83 88.81 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.247 -0.406 . . . . 0.0 110.801 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -61.07 -46.43 90.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.746 0.703 . . . . 0.0 110.231 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -24.02 67.09 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.6 mt -67.71 -61.24 1.98 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.469 1.031 . . . . 0.0 108.657 169.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -73.62 -13.14 60.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -169.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.19 -36.11 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.202 1.001 . . . . 0.0 110.356 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -120.72 -30.11 4.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.798 -172.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.3 mttt 25.62 68.69 0.43 Allowed Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.043 1.737 . . . . 0.0 112.872 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -59.45 173.95 1.29 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.309 2.006 . . . . 0.0 111.883 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -81.15 95.6 6.94 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 121.37 -0.832 . . . . 0.0 108.992 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.487 HD23 ' HB3' ' A' ' 112' ' ' SER . 3.0 mm? -88.45 6.25 38.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.992 0.517 . . . . 0.0 111.561 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.6 p -68.06 -5.26 16.61 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 119.694 -1.879 . . . . 0.0 112.583 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.56 43.41 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.461 1.504 . . . . 0.0 110.939 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.61 155.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 122.246 1.022 . . . . 0.0 111.095 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -114.91 147.48 39.91 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -125.61 156.92 38.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 109.791 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.45 116.42 2.15 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 107.548 -2.221 . . . . 0.0 107.548 169.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.6 146.36 44.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 169.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.1 mt -139.99 129.45 28.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.92 -9.36 2.01 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.442 1.02 . . . . 0.0 113.775 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.85 136.17 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.35 14.22 7.35 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.799 1.19 . . . . 0.0 112.052 -173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -68.85 -9.98 54.44 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.308 1.443 . . . . 0.0 113.392 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -157.58 175.19 14.27 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.996 2.119 . . . . 0.0 107.854 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 77.33 -25.95 0.19 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 129.287 3.035 . . . . 0.0 112.475 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -136.67 -26.49 1.07 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.632 1.173 . . . . 0.0 112.76 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -149.27 87.44 1.52 Allowed 'General case' 0 C--O 1.231 0.092 0 CA-C-N 119.283 0.947 . . . . 0.0 108.655 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.8 p -75.7 4.3 8.07 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -87.96 -17.95 30.15 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.295 0.638 . . . . 0.0 109.713 169.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 87.4 m -76.14 19.68 0.23 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.122 0.969 . . . . 0.0 112.3 169.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -55.17 -29.92 53.48 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.102 0.858 . . . . 0.0 111.829 171.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.57 -16.6 16.42 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.401 1.08 . . . . 0.0 113.662 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.3 pt -125.45 19.24 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 124.916 1.286 . . . . 0.0 110.726 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.38 -0.05 24.28 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.666 -1.271 . . . . 0.0 112.348 169.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -51.07 -40.89 59.39 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.977 1.711 . . . . 0.0 112.874 -170.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.5 -57.81 11.36 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.13 -40.31 95.49 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.8 68.12 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -70.22 -32.51 70.43 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 117.329 -1.32 . . . . 0.0 111.603 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.98 -45.0 94.5 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.736 1.607 . . . . 0.0 110.805 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -65.84 -39.47 90.83 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -30.71 70.92 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.161 1.384 . . . . 0.0 111.948 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.487 ' HB3' HD23 ' A' ' 80' ' ' LEU . 13.9 m -80.58 -18.65 47.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.953 0.501 . . . . 0.0 111.098 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.5 -19.58 4.5 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 118.039 -1.423 . . . . 0.0 114.694 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.49 136.89 55.31 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.674 1.737 . . . . 0.0 108.829 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -86.23 132.77 33.92 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -85.63 103.23 14.26 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.5 m -77.09 150.26 35.68 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.322 -0.236 . . . . 0.0 110.487 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.65 -95.45 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.413 1.006 . . . . 0.0 111.195 169.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.34 176.99 6.31 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 128.439 2.696 . . . . 0.0 106.511 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.3 m -63.72 131.03 46.62 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.48 HD12 ' CE3' ' A' ' 138' ' ' TRP . 3.5 tt -73.78 139.93 45.54 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.51 139.77 51.45 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.06 169.18 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.924 1.29 . . . . 0.0 108.702 -174.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.37 157.97 44.49 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 46.7 pt -134.51 165.37 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.4 tp -60.03 -35.18 74.54 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.955 0.502 . . . . 0.0 111.104 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -64.93 -44.91 87.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.08 0.552 . . . . 0.0 112.168 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -168.18 157.76 9.64 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.23 1.012 . . . . 0.0 109.823 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -72.83 152.33 41.58 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.322 40.2 mm -108.38 -91.1 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 116.12 -1.895 . . . . 0.0 108.459 -174.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.44 -53.99 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 CA-C-N 123.967 2.452 . . . . 0.0 110.583 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -168.44 -49.95 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.807 1.643 . . . . 0.0 108.795 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.84 142.76 15.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.429 1.092 . . . . 0.0 109.01 -169.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.2 162.45 40.56 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.764 2.309 . . . . 0.0 112.353 -175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.05 46.87 1.0 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.363 1.465 . . . . 0.0 109.167 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.46 -19.02 13.27 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -55.37 -23.41 24.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.35 1.46 . . . . 0.0 112.394 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.48 ' CE3' HD12 ' A' ' 121' ' ' LEU . 10.7 t90 -44.14 -56.66 3.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 125.359 1.464 . . . . 0.0 110.943 171.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.11 -59.17 4.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.809 1.644 . . . . 0.0 109.002 -174.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.07 60.32 Favored Glycine 0 CA--C 1.526 0.728 0 O-C-N 123.874 0.734 . . . . 0.0 111.349 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 t -65.27 -47.86 75.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.671 0.735 . . . . 0.0 110.566 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 73.4 t90 -60.67 -41.66 95.5 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.655 1.182 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 t -59.4 -49.94 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.557 0.743 . . . . 0.0 109.675 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -61.26 -30.33 70.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.241 0.928 . . . . 0.0 111.247 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.3 mp -76.23 -46.83 26.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.96 0.904 . . . . 0.0 110.442 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -74.16 -32.01 62.94 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.188 0.449 . . . . 0.0 112.129 -177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.1 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.443 1.097 . . . . 0.0 109.825 173.376 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.43 164.62 37.17 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.184 0.994 . . . . 0.0 109.96 -172.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.92 -24.0 15.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.672 1.589 . . . . 0.0 110.577 169.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.15 126.6 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.291 1.036 . . . . 0.0 108.413 -175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -87.48 127.2 35.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 169.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -103.44 95.55 6.15 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.1 mt -91.26 117.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.29 168.65 17.18 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.315 0.646 . . . . 0.0 110.525 -169.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.64 38.77 93.49 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.918 -0.379 . . . . 0.0 112.34 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 m -61.64 0.31 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.521 2.329 . . . . 0.0 116.343 -169.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -123.31 31.53 5.94 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.118 1.767 . . . . 0.0 108.183 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.2 tp 53.66 63.92 2.03 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 126.223 1.809 . . . . 0.0 109.952 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -145.56 -144.7 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.07 1.795 . . . . 0.0 109.189 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.97 163.37 34.77 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -148.75 37.22 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.128 1.771 . . . . 0.0 108.125 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.56 -36.4 61.82 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.031 1.332 . . . . 0.0 113.244 -169.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -58.62 -47.02 85.77 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.099 0.863 . . . . 0.0 110.819 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.0 t -72.82 -47.09 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.85 99.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -70.99 -38.59 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.904 0.482 . . . . 0.0 110.49 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -61.81 -48.0 82.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.764 0.711 . . . . 0.0 110.031 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.91 -54.06 49.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 123.856 0.863 . . . . 0.0 109.878 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.06 63.9 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.408 1.083 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -59.61 -54.92 40.85 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.567 0.747 . . . . 0.0 110.476 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -59.52 -37.12 77.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.2 mt -66.08 -34.31 77.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.213 0.605 . . . . 0.0 111.42 175.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -70.66 -38.3 73.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 120.046 1.294 . . . . 0.0 110.263 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.05 -29.76 70.51 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.37 0.668 . . . . 0.0 111.134 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.46 -14.77 62.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.819 0.848 . . . . 0.0 112.112 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.04 7.32 6.61 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.197 -1.335 . . . . 0.0 114.522 169.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -112.1 -167.94 1.25 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.668 1.734 . . . . 0.0 110.131 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.4 p -128.7 150.22 50.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.1 p -142.0 154.46 45.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.264 0.554 . . . . 0.0 112.061 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -121.26 98.03 5.79 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.579 1.552 . . . . 0.0 108.013 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -72.42 121.0 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.1 mt -146.16 149.0 33.15 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 122.996 0.518 . . . . 0.0 111.456 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -90.87 34.9 0.9 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.112 0.965 . . . . 0.0 110.319 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 49.94 27.74 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.735 1.636 . . . . 0.0 114.791 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.64 -21.89 65.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.82 2.347 . . . . 0.0 114.007 -171.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.16 10.54 4.54 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.78 2.032 . . . . 0.0 107.099 -175.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 62.99 -26.66 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.628 2.771 . . . . 0.0 114.03 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -157.59 80.43 0.88 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.857 0.863 . . . . 0.0 109.271 -168.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.97 -44.73 96.14 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.586 -0.696 . . . . 0.0 110.523 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.11 151.25 69.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 47' ' ' SER . 43.4 Cg_endo -67.92 -173.93 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.261 3.307 . . . . 0.0 113.021 -176.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.45 27.56 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.422 1.489 . . . . 0.0 113.262 170.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 45' ' ' PRO . 15.5 m -150.76 133.28 15.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.768 2.427 . . . . 0.0 106.403 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.88 -142.07 13.28 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.9 mm -124.29 142.77 39.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.407 ' CD1' HG21 ' A' ' 83' ' ' VAL . 17.2 m0 -121.41 150.45 41.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.9 mt -141.07 141.2 34.29 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -133.71 121.19 39.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.72 103.09 14.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.324 1.85 . . . . 0.0 107.138 -169.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -146.09 -161.0 1.22 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.334 1.054 . . . . 0.0 108.685 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.0 m -150.43 150.61 31.58 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.663 -1.273 . . . . 0.0 108.414 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p -146.85 -39.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.658 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.1 t60 51.89 21.82 1.57 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.116 1.366 . . . . 0.0 113.718 178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.76 -28.67 5.62 Favored Glycine 0 C--N 1.339 0.726 0 O-C-N 120.868 -1.145 . . . . 0.0 112.864 -177.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.68 -68.17 0.09 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.526 1.13 . . . . 0.0 108.267 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 147.95 -160.83 28.44 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.62 -28.42 69.11 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 169.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.6 pt -139.47 160.72 60.56 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.654 2.382 . . . . 0.0 107.076 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -55.69 -26.58 56.74 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.38 2.72 . . . . 0.0 114.39 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.23 43.12 1.21 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.781 1.632 . . . . 0.0 109.285 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -56.75 -19.77 18.6 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -169.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.68 77.8 1.76 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -66.64 -55.12 19.29 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 127.706 2.402 . . . . 0.0 112.411 -168.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.39 -34.53 54.2 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 121.117 1.211 . . . . 0.0 110.071 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -58.77 -59.42 5.45 Favored 'General case' 0 CA--C 1.521 -0.149 0 O-C-N 123.783 0.677 . . . . 0.0 109.689 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -59.55 -46.81 87.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.957 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -62.12 -46.13 90.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.274 0.943 . . . . 0.0 110.775 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.27 -23.53 65.69 Favored 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.1 mt -67.06 -62.35 1.47 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 169.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.61 -20.11 65.92 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -171.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.98 -34.49 77.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.545 0.738 . . . . 0.0 111.11 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -128.86 -24.41 2.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.3 mttt 28.58 65.1 0.69 Allowed Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 127.108 2.163 . . . . 0.0 112.763 -170.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.28 163.29 20.72 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.679 2.253 . . . . 0.0 113.195 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -80.79 66.76 6.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.734 1.214 . . . . 0.0 110.731 -174.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.91 17.42 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.578 1.551 . . . . 0.0 112.886 -177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 p -65.99 -4.29 6.85 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 119.955 -1.715 . . . . 0.0 112.6 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.82 11.14 13.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.877 1.671 . . . . 0.0 111.081 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.407 HG21 ' CD1' ' A' ' 50' ' ' TRP . 3.1 p -134.99 157.16 40.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 121.815 0.817 . . . . 0.0 110.926 176.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.403 HH22 HD22 ' A' ' 146' ' ' LEU . 3.9 ptt-85 -120.02 148.56 43.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -115.46 169.25 9.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.06 120.19 1.58 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 107.183 -2.367 . . . . 0.0 107.183 169.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.31 139.93 41.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.5 mt -138.59 130.86 38.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.55 -26.69 1.08 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.09 0.852 . . . . 0.0 112.77 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.3 mt -52.68 155.49 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 128.096 2.558 . . . . 0.0 108.453 169.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.47 20.7 0.82 Allowed Glycine 0 CA--C 1.526 0.754 0 O-C-N 121.664 -0.647 . . . . 0.0 112.58 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.46 -13.31 60.12 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.62 1.168 . . . . 0.0 111.804 174.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.15 145.67 36.17 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -54.29 -25.38 23.31 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.0 1.32 . . . . 0.0 113.753 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -72.2 -17.62 61.91 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -131.88 19.53 4.59 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.519 1.054 . . . . 0.0 113.353 -169.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.6 p -70.09 95.35 0.96 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.133 1.373 . . . . 0.0 110.302 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -133.3 -16.36 2.43 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 76.1 m -120.65 20.78 11.7 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.124 1.37 . . . . 0.0 110.987 173.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.76 -177.38 37.19 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.13 1.824 . . . . 0.0 108.987 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.41 40.48 1.21 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.454 1.101 . . . . 0.0 110.324 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.8 pt -126.97 158.25 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.751 1.22 . . . . 0.0 109.384 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -148.55 25.24 0.97 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.848 0.859 . . . . 0.0 112.195 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -52.43 -34.46 48.65 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.422 1.089 . . . . 0.0 112.794 -173.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.31 -57.5 12.07 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.173 0.589 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.51 -38.24 89.16 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.278 0.631 . . . . 0.0 109.359 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.13 83.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.206 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.82 -35.71 81.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.716 -1.135 . . . . 0.0 111.192 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.84 -47.93 84.12 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.896 1.226 . . . . 0.0 110.876 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -66.21 -37.02 84.55 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.142 0.977 . . . . 0.0 110.092 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -36.8 79.48 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.262 1.425 . . . . 0.0 111.518 174.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.5 m -68.96 -38.5 79.45 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.45 -25.46 0.52 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.97 169.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.67 135.6 48.45 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.305 1.553 . . . . 0.0 108.986 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -84.23 141.62 30.86 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -82.05 113.38 19.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 m -72.28 146.26 47.33 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 56.8 -119.77 17.1 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 170.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.22 159.51 44.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.64 1.576 . . . . 0.0 107.388 171.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.5 m -48.8 125.11 9.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.976 1.31 . . . . 0.0 111.358 -175.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.51 147.78 35.64 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.647 1.579 . . . . 0.0 107.817 -173.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -116.13 142.82 46.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 169.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.59 161.32 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -169.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 58.96 157.25 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 131.037 3.735 . . . . 0.0 116.045 172.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.7 pp -142.27 16.28 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 125.55 1.54 . . . . 0.0 110.821 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.0 tp -63.82 -35.69 81.45 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 121.393 -0.817 . . . . 0.0 110.692 -174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -153.51 176.97 11.43 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.309 1.844 . . . . 0.0 106.889 173.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -57.77 140.65 51.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.385 1.474 . . . . 0.0 109.224 170.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -154.08 -166.31 2.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.37 1.468 . . . . 0.0 108.253 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.0 mt -74.24 -58.17 2.02 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-O 117.672 -1.156 . . . . 0.0 109.36 171.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.04 -51.38 0.14 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.586 1.524 . . . . 0.0 112.35 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 37.57 58.48 1.33 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.98 2.512 . . . . 0.0 114.397 174.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.6 139.46 13.58 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 124.031 0.933 . . . . 0.0 109.081 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.28 132.34 23.89 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.208 1.939 . . . . 0.0 111.258 -175.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.92 -25.85 65.69 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -170.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.03 -34.33 68.08 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -169.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.45 -41.04 69.95 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.964 0.802 . . . . 0.0 110.152 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -46.94 81.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.106 172.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.4 tp -57.16 -47.2 81.79 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 123.191 0.596 . . . . 0.0 109.827 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.66 -49.32 79.79 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.5 t -62.94 -43.97 97.35 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.177 0.988 . . . . 0.0 110.822 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 85.4 t90 -63.56 -38.37 90.88 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.621 1.568 . . . . 0.0 110.677 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.3 t -63.31 -46.63 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.962 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -61.79 -28.41 69.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.761 -1.212 . . . . 0.0 111.456 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.77 -47.18 40.86 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.077 0.951 . . . . 0.0 110.686 177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.403 HD22 HH22 ' A' ' 84' ' ' ARG . 1.6 pp -71.45 -33.39 69.31 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.569 0.622 . . . . 0.0 112.04 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 49.1 mttm . . . . . 0 C--O 1.249 1.044 0 C-N-CA 125.292 1.437 . . . . 0.0 110.004 173.468 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.8 mtt . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.816 0.341 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.95 173.12 0.65 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.009 1.324 . . . . 0.0 112.24 169.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.39 -24.86 27.35 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.982 0.913 . . . . 0.0 110.872 169.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.0 mt -138.47 125.81 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.066 0.947 . . . . 0.0 109.28 -171.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 t -85.63 133.03 34.06 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 168.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 mp -111.58 100.33 8.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 mt -71.82 96.75 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 170.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -88.48 21.5 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.099 2.16 . . . . 0.0 112.201 -168.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -167.36 179.26 41.03 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.4 p -138.33 -27.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.643 0.777 . . . . 0.0 112.383 -174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.5 p -121.66 42.84 3.0 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.8 tp 56.12 37.33 28.73 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.449 1.5 . . . . 0.0 111.045 -169.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.06 163.24 27.15 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 126.265 1.888 . . . . 0.0 108.983 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -161.75 34.8 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 123.996 0.808 . . . . 0.0 111.336 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 60.05 0.9 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.346 1.859 . . . . 0.0 112.209 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -55.85 -31.45 62.76 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.629 0.771 . . . . 0.0 112.642 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -61.19 -42.05 97.89 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.236 0.926 . . . . 0.0 111.008 175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.44 -39.39 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.24 90.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.568 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.55 -39.75 92.07 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.028 0.831 . . . . 0.0 110.752 175.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -65.18 -38.54 90.81 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.383 -0.823 . . . . 0.0 110.699 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.94 -49.8 71.18 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 123.89 0.876 . . . . 0.0 110.185 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.42 -42.63 54.17 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.535 1.134 . . . . 0.0 111.117 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -54.9 -54.34 43.89 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.051 0.841 . . . . 0.0 110.157 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -60.94 -42.31 97.94 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.2 -39.94 95.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.441 0.696 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.89 -33.17 62.01 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 121.177 -0.952 . . . . 0.0 110.323 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -62.41 -32.16 72.96 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.972 0.805 . . . . 0.0 111.026 169.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.62 -20.53 63.61 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.561 0.618 . . . . 0.0 111.518 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.95 -4.64 6.92 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.57 -1.128 . . . . 0.0 113.588 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -89.36 -170.79 2.99 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.211 1.505 . . . . 0.0 109.925 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -129.16 148.01 51.06 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 p -139.69 150.72 45.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.144 0.497 . . . . 0.0 111.939 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -113.57 90.7 3.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.891 1.677 . . . . 0.0 107.219 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 m -70.61 120.08 15.7 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -148.05 137.89 22.52 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.783 0.833 . . . . 0.0 110.725 -169.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -80.04 36.91 0.36 Allowed 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.551 -1.343 . . . . 0.0 111.404 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 49.64 49.47 33.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.922 1.725 . . . . 0.0 114.86 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.77 -22.13 69.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.004 2.47 . . . . 0.0 113.888 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.1 mt -128.74 12.03 6.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.03 1.732 . . . . 0.0 109.418 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.8 tp 62.11 -25.01 0.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 127.994 2.518 . . . . 0.0 114.161 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -160.37 78.46 0.64 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.407 1.083 . . . . 0.0 108.924 -168.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -64.2 -46.07 85.54 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.656 -0.653 . . . . 0.0 110.032 172.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 mt -81.48 154.26 71.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 169.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -64.29 179.3 1.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.846 3.03 . . . . 0.0 113.584 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.84 32.25 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.116 1.766 . . . . 0.0 112.591 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.1 m -153.89 133.78 13.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.782 2.433 . . . . 0.0 106.536 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 123.86 -138.95 11.7 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 mm -121.24 135.54 61.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.455 ' CD1' HG21 ' A' ' 83' ' ' VAL . 6.0 m0 -125.65 138.9 53.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.5 mt -128.36 146.7 50.7 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.23 133.76 55.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -125.94 108.53 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -170.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 m -156.72 -163.1 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.506 1.122 . . . . 0.0 108.611 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.96 144.04 25.6 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 169.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.6 p -128.84 -81.64 0.57 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.289 0.95 . . . . 0.0 110.714 -171.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -58.56 122.01 12.35 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.19 -7.28 81.24 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.226 0.917 . . . . 0.0 114.498 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.0 30.84 1.28 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.765 1.626 . . . . 0.0 110.32 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.66 -172.98 47.92 Favored Glycine 0 CA--C 1.525 0.676 0 O-C-N 121.433 -0.792 . . . . 0.0 113.546 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -137.78 177.63 7.73 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.573 1.949 . . . . 0.0 107.635 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -52.56 -52.44 63.73 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.113 1.365 . . . . 0.0 111.541 -173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -68.49 -53.29 0.37 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 121.674 1.633 . . . . 0.0 110.992 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -167.08 -60.59 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.989 1.316 . . . . 0.0 108.841 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -171.26 -51.8 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.914 2.486 . . . . 0.0 105.351 170.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.62 135.9 57.82 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -122.55 -64.4 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 117.266 -1.349 . . . . 0.0 111.375 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.6 -39.34 9.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 122.073 1.776 . . . . 0.0 110.103 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -61.22 -46.44 90.41 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.864 1.266 . . . . 0.0 110.088 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.6 -51.24 69.39 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.303 1.041 . . . . 0.0 110.399 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -63.55 -45.34 90.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.833 0.742 . . . . 0.0 110.98 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.76 82.98 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.65 -55.57 33.19 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 123.264 0.626 . . . . 0.0 110.123 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -68.35 -18.98 64.61 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.49 -32.92 66.59 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.211 -0.423 . . . . 0.0 111.4 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.55 -25.3 5.58 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 32.42 63.04 1.33 Allowed Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 126.631 1.972 . . . . 0.0 112.954 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -63.93 167.54 13.81 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.02 2.48 . . . . 0.0 113.39 -169.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -78.97 63.74 3.73 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.181 1.392 . . . . 0.0 111.454 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.07 8.85 0.66 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.757 1.223 . . . . 0.0 112.738 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.1 m -62.3 -6.83 3.51 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.637 2.775 . . . . 0.0 112.911 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.59 9.33 19.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.265 1.426 . . . . 0.0 111.12 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.1 p -131.31 154.63 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 118.824 0.738 . . . . 0.0 112.403 178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -109.21 149.35 29.51 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.507 1.123 . . . . 0.0 108.745 171.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.89 153.87 23.87 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.997 1.319 . . . . 0.0 108.059 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.16 106.65 0.46 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 106.026 -2.829 . . . . 0.0 106.026 169.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.06 142.08 29.81 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 mt -140.07 132.73 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -169.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -28.44 1.61 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.619 1.104 . . . . 0.0 113.01 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.4 mt -48.99 142.05 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.297 2.239 . . . . 0.0 108.778 170.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.3 -36.65 8.05 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.6 m -51.35 140.73 16.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.194 1.798 . . . . 0.0 111.0 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -158.74 172.06 18.95 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -57.84 -25.62 60.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.92 0.488 . . . . 0.0 112.051 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -144.91 105.1 4.06 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.331 1.052 . . . . 0.0 109.097 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -148.68 19.58 1.03 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.103 1.361 . . . . 0.0 109.715 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.7 t -161.31 167.68 25.41 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.956 -1.09 . . . . 0.0 109.199 -169.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -156.82 -42.36 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.093 1.357 . . . . 0.0 109.303 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.8 m -137.57 43.26 2.3 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.754 1.621 . . . . 0.0 109.437 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.94 -161.32 8.67 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.738 1.161 . . . . 0.0 110.814 -175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.67 158.25 6.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.33 0.652 . . . . 0.0 110.149 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.9 pt -134.19 167.27 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.754 0.821 . . . . 0.0 109.56 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.71 39.04 0.13 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.271 2.229 . . . . 0.0 113.719 -173.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -47.1 -44.43 21.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.515 1.126 . . . . 0.0 113.035 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.33 -53.06 62.56 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.781 0.832 . . . . 0.0 109.575 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.35 -39.69 92.66 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.9 75.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.562 1.145 . . . . 0.0 110.238 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -63.26 -39.37 94.41 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.979 0.809 . . . . 0.0 110.981 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -70.14 -41.89 73.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.887 0.767 . . . . 0.0 111.54 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -61.69 -37.7 85.09 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.466 1.507 . . . . 0.0 109.223 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.82 -37.11 73.2 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.078 1.351 . . . . 0.0 111.92 174.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -67.24 -35.92 80.57 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.108 0.563 . . . . 0.0 110.59 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.87 -28.43 0.36 Allowed Glycine 0 C--N 1.341 0.81 0 CA-C-O 118.672 -1.071 . . . . 0.0 115.015 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.14 170.41 8.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.765 1.283 . . . . 0.0 110.663 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -130.36 137.28 49.82 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.1 tt0 -72.04 124.61 25.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.8 m -86.82 154.43 20.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.78 -117.27 10.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 173.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.25 175.9 12.15 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.9 1.68 . . . . 0.0 107.002 169.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.5 m -60.04 128.21 35.7 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.52 -0.738 . . . . 0.0 110.115 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 122' ' ' LYS . 1.8 tt -79.88 156.49 27.3 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.991 1.316 . . . . 0.0 107.822 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.618 ' H ' HD23 ' A' ' 121' ' ' LEU . 7.8 mptt -126.91 140.11 52.57 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.625 1.17 . . . . 0.0 108.083 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.6 pp -138.36 153.65 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.993 1.317 . . . . 0.0 109.011 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.14 17.63 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 175.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.18 24.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 125.188 1.395 . . . . 0.0 113.517 -172.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -143.26 -57.89 0.41 Allowed 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.796 1.239 . . . . 0.0 109.515 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -161.94 164.41 28.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.962 1.305 . . . . 0.0 108.342 -175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -60.09 160.53 7.99 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.385 1.074 . . . . 0.0 110.895 171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.71 -69.76 0.12 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.558 ' H ' ' HD2' ' A' ' 131' ' ' PRO . 24.1 mm -142.3 -56.5 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.906 1.683 . . . . 0.0 110.659 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.558 ' HD2' ' H ' ' A' ' 130' ' ' ILE . 70.5 Cg_endo -71.98 -38.97 3.51 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 121.904 1.716 . . . . 0.0 111.454 -175.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 65.2 17.67 11.12 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.697 1.599 . . . . 0.0 112.081 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -154.68 114.98 2.43 Favored Pre-proline 0 CA--C 1.538 0.491 0 C-N-CA 124.634 1.174 . . . . 0.0 109.082 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.76 154.56 48.64 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.841 2.361 . . . . 0.0 112.062 172.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.63 46.9 1.68 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.367 1.067 . . . . 0.0 110.135 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -62.26 -14.69 41.27 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.155 -0.966 . . . . 0.0 113.273 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -59.92 -27.17 66.53 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.193 -0.942 . . . . 0.0 111.366 169.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.405 ' CG ' ' HG ' ' A' ' 121' ' ' LEU . 6.8 t90 -57.5 -52.35 65.73 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 124.618 1.167 . . . . 0.0 110.12 171.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.36 -56.21 12.31 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.691 1.596 . . . . 0.0 108.509 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.42 -45.37 94.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.433 0.54 . . . . 0.0 112.656 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.4 m -62.19 -60.44 3.59 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 125.237 1.415 . . . . 0.0 110.457 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -52.93 -41.65 64.66 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.115 1.766 . . . . 0.0 111.567 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.12 -57.65 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.783 0.833 . . . . 0.0 109.946 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -14.43 62.48 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.47 -0.769 . . . . 0.0 112.398 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.0 mp -80.78 -49.15 11.49 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.388 1.075 . . . . 0.0 110.782 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.19 -33.62 70.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 111.596 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.6 mttt . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.519 1.127 . . . . 0.0 109.647 173.917 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.93 164.31 38.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.117 0.967 . . . . 0.0 110.157 -172.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -98.51 -22.83 15.8 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.778 1.231 . . . . 0.0 110.887 169.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 mt -131.95 126.22 56.37 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 t -90.98 128.28 36.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -95.76 103.93 15.84 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -96.43 86.84 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 159.16 16.27 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 111.646 -169.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.73 79.56 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 169.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.15 -45.02 8.08 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.228 2.211 . . . . 0.0 115.531 -169.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.7 m -127.89 54.72 1.69 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt 52.91 37.0 23.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.545 1.938 . . . . 0.0 111.929 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.78 4.5 69.4 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.645 1.117 . . . . 0.0 113.235 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.55 -79.39 1.84 Allowed Glycine 0 C--N 1.338 0.644 0 C-N-CA 124.817 1.199 . . . . 0.0 111.118 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.7 18.08 0.45 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.354 1.862 . . . . 0.0 113.889 -169.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.31 -26.03 67.12 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.354 -0.841 . . . . 0.0 111.834 -169.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.97 -47.65 84.96 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.73 0.695 . . . . 0.0 110.584 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.1 t -72.65 -38.77 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.3 80.32 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.963 -0.541 . . . . 0.0 111.838 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.58 -40.46 76.71 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.868 0.758 . . . . 0.0 110.357 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -62.48 -47.69 82.87 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.949 -0.47 . . . . 0.0 110.238 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.18 -51.66 67.23 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 124.402 1.081 . . . . 0.0 110.868 174.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.58 -41.05 66.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.748 0.819 . . . . 0.0 111.393 176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -58.09 -47.78 82.17 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.421 1.009 . . . . 0.0 111.079 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -58.04 -44.32 87.34 Favored 'General case' 0 C--N 1.337 0.034 0 C-N-CA 122.671 0.389 . . . . 0.0 111.308 175.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 26' ' ' LEU . 3.3 mm? -66.29 -33.02 74.79 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.56 -45.55 78.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.018 0.826 . . . . 0.0 109.581 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -71.2 -17.3 62.53 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.813 0.733 . . . . 0.0 112.157 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.04 -15.5 62.03 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.919 0.781 . . . . 0.0 111.442 171.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.98 22.41 5.96 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-O 118.83 -0.983 . . . . 0.0 114.491 169.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -129.08 171.87 11.97 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.59 1.195 . . . . 0.0 110.28 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 p -105.71 154.47 20.42 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -141.53 155.23 45.81 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.771 -0.581 . . . . 0.0 111.449 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -118.71 93.51 4.13 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -70.53 120.95 16.92 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.7 mt -148.51 170.16 18.68 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 124.37 1.068 . . . . 0.0 109.477 -173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -110.23 37.81 2.61 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.133 1.773 . . . . 0.0 108.603 169.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.53 48.77 22.01 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.842 1.686 . . . . 0.0 115.086 -177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.56 -20.5 69.59 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 CA-C-N 121.083 2.442 . . . . 0.0 114.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -122.99 13.25 9.77 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.063 1.745 . . . . 0.0 109.701 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.84 -28.6 0.12 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 128.278 2.631 . . . . 0.0 112.649 -169.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -160.37 88.24 0.79 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.371 1.469 . . . . 0.0 107.674 -168.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.36 -43.21 82.02 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.303 -0.873 . . . . 0.0 110.136 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.64 154.08 68.18 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.56 -175.53 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.176 3.25 . . . . 0.0 113.186 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.76 33.59 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.799 1.64 . . . . 0.0 112.574 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -158.14 135.92 10.53 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.605 1.962 . . . . 0.0 106.801 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.48 -140.27 11.9 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.88 134.24 66.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -118.96 133.25 55.94 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.8 mt -122.95 137.91 54.82 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 170.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.1 t -122.11 126.23 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -175.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.02 67.08 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -169.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -135.31 48.48 2.25 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.726 -169.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.1 m -30.79 98.19 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 128.977 2.911 . . . . 0.0 115.652 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -57.35 -42.31 81.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.795 1.638 . . . . 0.0 111.92 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 48.44 176.33 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.247 3.019 . . . . 0.0 115.425 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.96 38.1 1.09 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.3 1.429 . . . . 0.0 114.702 -169.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.52 -34.26 0.12 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.068 1.347 . . . . 0.0 111.259 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.54 -156.2 17.1 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 118.378 0.535 . . . . 0.0 111.975 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -146.49 171.36 15.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.314 1.446 . . . . 0.0 107.749 169.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 91.9 mt -45.85 -52.54 24.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.69 1.596 . . . . 0.0 112.82 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.59 -43.6 1.89 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 CA-C-N 121.907 1.717 . . . . 0.0 111.527 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -174.42 -60.62 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.216 1.807 . . . . 0.0 107.691 -176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 168.02 -54.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 130.249 3.42 . . . . 0.0 104.282 -177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.46 146.12 52.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.331 -2.099 . . . . 0.0 105.331 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.431 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 1.5 m -122.3 -65.6 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 117.279 -1.344 . . . . 0.0 110.578 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.431 ' HD2' ' H ' ' A' ' 67' ' ' SER . 58.8 Cg_endo -68.25 -41.37 7.07 Favored 'Trans proline' 0 C--N 1.35 0.623 0 CA-C-N 121.862 1.701 . . . . 0.0 110.171 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -61.09 -48.5 81.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.453 1.101 . . . . 0.0 109.436 177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -62.03 -49.55 75.56 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.298 0.499 . . . . 0.0 110.694 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.18 -43.79 98.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.591 0.632 . . . . 0.0 110.512 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -29.49 69.28 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.351 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -61.87 -57.45 11.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 119.559 1.072 . . . . 0.0 108.96 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -62.99 -26.01 68.65 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.1 -31.56 72.49 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.966 0.506 . . . . 0.0 111.424 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -122.99 -26.76 4.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 117.943 -1.027 . . . . 0.0 113.768 -175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 31.48 62.99 1.14 Allowed Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 126.291 1.837 . . . . 0.0 112.148 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.21 162.31 23.69 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.875 2.383 . . . . 0.0 113.466 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -78.74 67.43 4.47 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.73 1.212 . . . . 0.0 111.131 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.63 15.17 0.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.607 1.563 . . . . 0.0 112.811 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 64.0 p -64.13 -5.37 4.7 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.147 -1.596 . . . . 0.0 112.426 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.58 10.55 14.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.282 1.833 . . . . 0.0 111.004 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -130.51 149.66 33.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 121.831 0.825 . . . . 0.0 111.131 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.1 ptm85 -100.57 151.26 21.8 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -123.51 142.02 51.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -173.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.55 110.25 0.81 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.46 136.61 44.23 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.0 mt -138.1 129.7 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.12 -25.59 2.63 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.837 0.732 . . . . 0.0 111.962 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.3 mm -48.57 134.78 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 127.5 2.32 . . . . 0.0 106.752 168.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.72 -21.87 4.51 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.957 0.789 . . . . 0.0 111.993 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -48.39 -29.1 3.67 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 128.46 2.704 . . . . 0.0 114.331 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.58 -45.11 73.5 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 123.547 0.739 . . . . 0.0 111.672 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 178.12 -46.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.305 1.442 . . . . 0.0 110.768 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -56.78 -30.15 63.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -168.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -148.74 50.39 0.99 Allowed 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.1 t -76.47 176.94 7.79 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.944 0.878 . . . . 0.0 110.782 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -132.18 76.57 1.71 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.466 -2.049 . . . . 0.0 105.466 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.4 m 50.42 27.81 2.98 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.204 1.802 . . . . 0.0 113.855 -175.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.22 -1.04 28.46 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.97 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.12 -1.52 7.94 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.629 1.715 . . . . 0.0 113.086 -177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.7 pt -126.27 9.25 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 126.885 2.074 . . . . 0.0 110.862 -172.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.83 -9.4 14.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.594 1.158 . . . . 0.0 112.206 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -53.21 -44.59 68.12 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 126.493 1.917 . . . . 0.0 112.056 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.53 -57.39 12.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 118.749 0.704 . . . . 0.0 110.43 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -63.9 -39.14 93.49 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.34 -50.31 74.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.053 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -63.61 -36.46 83.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 119.271 0.941 . . . . 0.0 111.183 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 66.7 mt -65.23 -45.0 86.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.06 0.845 . . . . 0.0 110.738 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -68.57 -36.03 78.18 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 123.796 0.838 . . . . 0.0 110.021 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -37.81 87.33 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.193 1.397 . . . . 0.0 111.058 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -39.85 83.82 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.23 -17.54 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-O 117.96 -1.467 . . . . 0.0 115.195 169.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.19 137.12 53.0 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 119.656 1.728 . . . . 0.0 109.777 -169.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -82.35 110.19 17.29 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -65.74 111.99 3.48 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 37.7 m -88.4 152.51 21.86 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.66 -124.27 35.52 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.06 157.59 43.29 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 62.4 m -46.17 127.78 8.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.31 1.844 . . . . 0.0 112.541 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.09 160.88 19.88 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.242 1.417 . . . . 0.0 108.512 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -134.59 146.85 49.99 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.02 170.15 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 126.824 2.05 . . . . 0.0 109.116 -172.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -135.55 170.1 16.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.506 1.923 . . . . 0.0 106.504 169.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.5 tt -108.32 4.89 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.522 0.729 . . . . 0.0 110.66 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.7 mt 70.39 -42.01 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 129.441 3.097 . . . . 0.0 112.132 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.04 -24.36 65.99 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.968 0.907 . . . . 0.0 110.667 169.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -154.66 172.16 18.34 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.0 1.72 . . . . 0.0 108.478 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -140.81 153.12 45.67 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.908 2.083 . . . . 0.0 108.204 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.9 mm -130.07 -70.17 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 116.706 -1.616 . . . . 0.0 109.831 -171.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.16 -56.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 CA-C-N 122.379 1.885 . . . . 0.0 111.449 -174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -174.39 -176.44 1.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.708 2.803 . . . . 0.0 106.499 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.85 117.95 56.26 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.118 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.14 174.98 11.93 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.779 2.986 . . . . 0.0 112.082 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.93 139.73 29.3 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.369 1.068 . . . . 0.0 108.766 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.29 -16.1 63.76 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.081 0.953 . . . . 0.0 112.172 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.9 -30.19 65.69 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.868 0.867 . . . . 0.0 111.487 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.83 -42.94 97.53 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.035 0.834 . . . . 0.0 111.23 175.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -51.94 66.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.227 1.411 . . . . 0.0 107.803 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.26 -43.24 95.61 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 123.816 0.722 . . . . 0.0 112.422 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.9 m -59.57 -60.64 3.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.068 1.347 . . . . 0.0 109.996 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.4 ' CZ3' HD11 ' A' ' 26' ' ' LEU . 49.2 t90 -57.37 -43.87 83.91 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.207 0.603 . . . . 0.0 112.097 -177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.6 t -61.49 -52.89 55.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 C-N-CA 123.201 0.6 . . . . 0.0 109.955 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -16.15 63.02 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.628 1.104 . . . . 0.0 112.129 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.08 -44.85 21.29 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.482 0.713 . . . . 0.0 111.252 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.35 73.67 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.965 0.802 . . . . 0.0 111.462 -178.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 53.7 mttm . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.317 1.447 . . . . 0.0 109.72 174.436 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.85 164.08 37.84 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.342 1.057 . . . . 0.0 110.079 -171.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -93.43 -24.36 18.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.445 1.498 . . . . 0.0 110.924 170.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.8 mt -134.41 124.23 44.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.666 1.186 . . . . 0.0 108.3 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -85.74 132.91 34.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mp -109.68 92.01 3.88 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -77.81 111.56 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -127.83 -162.7 1.2 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.258 1.823 . . . . 0.0 107.168 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 28.89 58.59 Favored Glycine 0 CA--C 1.526 0.77 0 O-C-N 120.785 -1.197 . . . . 0.0 112.266 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -32.92 -48.97 0.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.975 2.91 . . . . 0.0 115.136 -170.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p -125.83 51.72 1.73 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.118 1.367 . . . . 0.0 108.05 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.3 tp 58.69 31.27 20.97 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.976 1.71 . . . . 0.0 110.188 -169.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.81 154.54 8.21 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 128.027 2.727 . . . . 0.0 107.586 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.08 -160.03 22.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 118.049 0.924 . . . . 0.0 110.914 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.14 41.35 0.29 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.612 1.565 . . . . 0.0 112.541 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.9 -32.16 65.62 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.17 -0.956 . . . . 0.0 112.542 -172.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.93 -42.54 98.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.845 0.748 . . . . 0.0 110.833 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.0 t -72.75 -39.58 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.16 -39.88 83.83 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.24 0.473 . . . . 0.0 110.875 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.56 -40.49 92.87 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.893 0.77 . . . . 0.0 110.94 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -64.15 -44.73 91.23 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.675 -0.641 . . . . 0.0 110.295 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.92 -50.03 75.59 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 124.635 1.174 . . . . 0.0 110.498 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.58 -47.8 63.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.274 1.03 . . . . 0.0 110.807 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -57.31 -52.75 64.08 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.558 0.743 . . . . 0.0 110.595 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm -56.16 -39.0 71.66 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 122.886 0.474 . . . . 0.0 112.029 177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.7 mt -73.49 -26.39 60.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 118.634 -0.698 . . . . 0.0 112.429 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -71.05 -38.73 72.52 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 120.566 1.53 . . . . 0.0 109.55 169.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -62.32 -26.19 68.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.555 0.742 . . . . 0.0 111.409 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.65 55.1 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.549 174.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.21 23.93 6.76 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.163 0.892 . . . . 0.0 113.334 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.73 -169.44 2.05 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.404 1.082 . . . . 0.0 109.277 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.7 p -128.35 149.14 50.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 79.0 p -141.63 154.86 45.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.89 0.376 . . . . 0.0 111.223 -169.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.82 94.95 4.43 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.196 0.999 . . . . 0.0 108.413 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 m -68.65 120.87 15.34 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.8 mt -145.63 143.56 29.92 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 122.551 0.341 . . . . 0.0 111.158 -170.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -88.28 33.25 0.74 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 169.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.91 55.85 7.1 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.577 2.036 . . . . 0.0 114.38 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.84 -20.46 68.44 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.032 2.488 . . . . 0.0 113.695 -174.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.0 mt -123.56 17.99 9.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.07 1.748 . . . . 0.0 109.066 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.9 tp 64.48 -30.77 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.399 2.68 . . . . 0.0 113.79 -169.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -165.4 87.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.412 1.885 . . . . 0.0 106.539 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.18 -41.52 97.08 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.9 -0.5 . . . . 0.0 110.446 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt -89.11 150.04 44.34 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.25 -175.83 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.162 3.241 . . . . 0.0 113.116 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.58 33.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.501 1.52 . . . . 0.0 112.43 171.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.0 m -158.68 134.55 8.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.86 2.064 . . . . 0.0 106.351 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.15 -142.86 13.86 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.41 140.05 50.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -123.39 151.79 42.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.8 mt -137.74 142.67 40.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.47 126.99 61.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.37 108.21 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -169.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m -145.76 -166.89 2.56 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.828 0.851 . . . . 0.0 109.281 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.3 p -156.28 66.06 0.57 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 122.2 1.0 . . . . 0.0 112.194 -168.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p -62.98 -36.78 84.65 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.307 0.643 . . . . 0.0 111.763 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -65.86 -43.9 87.02 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.306 0.642 . . . . 0.0 111.759 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.03 -33.65 26.07 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.579 -0.567 . . . . 0.0 113.531 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.14 33.84 0.82 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.345 1.058 . . . . 0.0 111.047 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -50.22 147.38 7.62 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -146.3 170.09 17.48 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 117.303 0.551 . . . . 0.0 110.925 -169.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 47.9 mm -50.59 -49.73 76.66 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.911 1.684 . . . . 0.0 112.732 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.31 -55.89 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 122.049 1.768 . . . . 0.0 110.339 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -168.74 -51.21 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.835 1.254 . . . . 0.0 109.195 169.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -171.43 -55.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.372 1.469 . . . . 0.0 109.012 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.549 HD12 ' H ' ' A' ' 66' ' ' LEU . 3.3 mp -70.5 137.01 49.86 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 170.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.74 -62.87 0.21 Allowed Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.142 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.35 -39.83 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 121.733 1.622 . . . . 0.0 111.745 -175.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -63.48 -46.1 87.72 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 122.86 0.464 . . . . 0.0 110.537 -171.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -60.81 -48.54 81.32 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.927 0.331 . . . . 0.0 110.207 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -62.34 -45.79 91.59 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.137 0.426 . . . . 0.0 110.259 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.42 -36.07 79.31 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.378 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.89 -55.65 31.49 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.241 0.928 . . . . 0.0 108.937 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -61.32 -27.67 68.66 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.21 -31.25 69.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.707 0.403 . . . . 0.0 111.648 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -122.4 -25.26 4.83 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt 29.54 63.41 0.82 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 126.996 2.118 . . . . 0.0 112.307 -173.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.67 164.45 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.898 2.399 . . . . 0.0 113.063 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -77.57 64.91 2.98 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.266 1.426 . . . . 0.0 111.239 -174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.46 9.03 1.15 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.037 1.335 . . . . 0.0 112.601 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.3 m -61.45 -6.39 2.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.213 2.605 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.62 10.38 18.02 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.99 1.716 . . . . 0.0 111.03 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.14 153.62 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 118.783 0.719 . . . . 0.0 111.292 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -103.56 150.41 23.97 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 169.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -122.58 159.01 28.68 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 169.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.96 140.37 11.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 169.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.46 141.65 43.28 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mt -139.09 138.85 40.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -169.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.53 -30.43 2.22 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.721 1.153 . . . . 0.0 111.766 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.2 mt -50.64 127.34 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.867 2.067 . . . . 0.0 106.974 169.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.55 -13.77 40.09 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.603 0.621 . . . . 0.0 112.877 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 m -48.82 -27.37 2.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 128.636 2.774 . . . . 0.0 116.602 -169.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -72.89 -20.71 61.04 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.992 0.814 . . . . 0.0 112.004 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -140.98 -23.23 0.77 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -128.53 155.23 45.19 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.908 1.283 . . . . 0.0 111.609 -169.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.7 t0 49.61 35.62 8.97 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.079 2.152 . . . . 0.0 114.139 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.0 p -119.97 18.79 12.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.557 1.543 . . . . 0.0 110.561 173.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -71.07 -25.95 62.85 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.532 1.133 . . . . 0.0 111.929 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 12.6 p -148.48 23.73 1.01 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.121 1.368 . . . . 0.0 111.572 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.27 -172.69 42.95 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.6 143.7 41.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.389 1.076 . . . . 0.0 109.183 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.7 pt -144.75 24.2 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 125.995 1.718 . . . . 0.0 109.798 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -106.4 9.85 31.67 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.835 1.254 . . . . 0.0 111.757 -171.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -65.94 -29.39 69.78 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.516 -169.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.9 tm? -53.84 -57.31 11.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.331 0.968 . . . . 0.0 109.622 172.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -63.51 -40.63 97.56 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -48.59 81.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.859 0.464 . . . . 0.0 110.202 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.78 -31.86 72.77 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 117.687 -1.149 . . . . 0.0 111.739 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 73.9 mt -66.68 -44.27 82.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 120.101 1.318 . . . . 0.0 110.78 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -63.15 -40.47 97.67 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.578 0.751 . . . . 0.0 109.656 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -36.81 83.63 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 125.157 1.383 . . . . 0.0 111.303 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.9 m -70.86 -39.79 72.7 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.84 -20.45 0.68 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-O 118.101 -1.388 . . . . 0.0 114.881 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 136.65 54.89 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.568 1.684 . . . . 0.0 108.834 -172.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -79.25 126.97 31.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -74.51 112.73 10.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.5 m -85.46 154.94 21.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.29 -125.38 37.49 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.455 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.6 pt-20 -154.41 169.0 24.79 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.269 1.428 . . . . 0.0 107.592 169.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.9 m -51.98 129.92 28.31 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.07 146.15 23.96 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.505 1.922 . . . . 0.0 107.405 -174.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -121.56 145.88 47.52 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.7 154.82 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 125.303 1.441 . . . . 0.0 107.782 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -164.03 176.45 9.33 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.603 -0.685 . . . . 0.0 111.576 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 40.4 pt -129.24 -22.88 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.054 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.3 tt -158.27 -66.73 0.09 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.939 1.245 . . . . 0.0 108.753 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -148.16 -13.58 0.36 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.25 1.02 . . . . 0.0 112.338 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -148.95 156.14 41.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 169.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -159.57 -63.95 0.07 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 22.7 mm -133.87 -62.11 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 111.318 -2.674 . . . . 0.0 105.607 169.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -90.54 -137.46 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.882 0 N-CA-C 105.906 -2.382 . . . . 0.0 105.906 168.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.33 -1.8 0.91 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -169.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -152.43 122.1 3.41 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 118.228 -0.892 . . . . 0.0 108.846 -172.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.58 152.39 38.07 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.234 1.956 . . . . 0.0 110.167 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -138.71 39.62 2.19 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.517 1.127 . . . . 0.0 109.852 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -52.41 -28.58 20.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.58 1.552 . . . . 0.0 113.235 -173.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.21 -28.63 42.2 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.382 1.073 . . . . 0.0 112.331 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.455 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -55.95 -41.76 75.18 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.487 0.715 . . . . 0.0 110.849 173.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.7 tp -61.63 -50.11 73.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -56.14 -48.69 72.42 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.99 0.806 . . . . 0.0 111.822 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.0 m -60.01 -57.05 14.54 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.727 1.211 . . . . 0.0 110.69 175.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -53.11 -44.67 67.82 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.505 1.522 . . . . 0.0 111.691 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 t -56.5 -58.07 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 110.077 173.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -16.73 63.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.307 0.958 . . . . 0.0 112.176 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.03 -50.32 15.12 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.099 0.959 . . . . 0.0 110.432 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.35 -27.21 59.11 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttm . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.494 1.118 . . . . 0.0 109.634 171.102 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 tpp . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.29 148.23 32.2 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.221 1.008 . . . . 0.0 108.365 170.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -99.64 -22.97 15.2 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.607 1.563 . . . . 0.0 110.438 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.35 130.42 43.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.358 1.063 . . . . 0.0 109.214 -172.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 t -86.2 130.25 34.58 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 169.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.9 94.21 4.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -87.2 98.15 7.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 -169.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -88.65 51.93 2.3 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.82 8.55 59.43 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-O 117.306 -1.83 . . . . 0.0 115.098 -169.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.0 -42.71 2.92 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.032 1.733 . . . . 0.0 113.983 -169.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 t -149.17 53.09 0.96 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 169.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 tp 56.33 38.99 30.27 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.468 1.507 . . . . 0.0 110.699 -169.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.43 154.38 7.43 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.202 2.81 . . . . 0.0 107.073 -171.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.95 -151.16 6.9 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 117.928 0.864 . . . . 0.0 110.951 -170.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 65.76 1.21 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.323 1.449 . . . . 0.0 111.0 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -53.74 -37.37 63.3 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.64 0.776 . . . . 0.0 112.63 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -59.81 -45.13 93.3 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.441 0.564 . . . . 0.0 110.255 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -32.69 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.61 97.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.658 0.663 . . . . 0.0 110.853 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.42 -39.55 89.02 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.994 0.518 . . . . 0.0 110.681 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -62.86 -46.51 87.55 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.469 -0.77 . . . . 0.0 110.501 176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.8 mt -55.77 -52.68 63.12 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 124.486 1.114 . . . . 0.0 109.92 176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -50.82 -52.09 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.165 0.986 . . . . 0.0 110.532 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -55.34 -54.26 45.84 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.358 0.663 . . . . 0.0 110.775 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -59.88 -38.87 83.45 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -68.96 -32.7 72.48 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.157 0.583 . . . . 0.0 111.691 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.58 -37.35 71.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 119.757 1.162 . . . . 0.0 110.152 173.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -63.6 -29.77 70.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 111.217 171.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.77 -21.74 62.47 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.562 0.745 . . . . 0.0 111.259 175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.02 -5.01 5.37 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.062 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -95.52 -167.07 1.55 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.686 1.743 . . . . 0.0 109.602 -174.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 p -130.19 151.09 51.09 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 168.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 58.9 p -143.74 160.28 41.0 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.283 -170.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 106.31 8.93 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -71.94 121.09 18.48 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 mt -139.11 157.98 44.99 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.401 0.68 . . . . 0.0 110.71 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -95.23 21.88 7.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.421 1.088 . . . . 0.0 110.766 170.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.11 42.89 73.01 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 117.912 -1.493 . . . . 0.0 113.139 -168.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.12 -22.29 61.83 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.201 2.601 . . . . 0.0 114.825 -169.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.5 mt -115.24 13.53 16.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.523 1.529 . . . . 0.0 109.666 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.4 tp 65.57 -25.69 0.1 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.016 2.527 . . . . 0.0 112.916 -169.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -169.13 85.81 0.15 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.034 1.734 . . . . 0.0 107.331 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.44 -42.9 98.66 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.594 -0.691 . . . . 0.0 110.249 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -90.81 149.32 40.16 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 169.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.38 -179.33 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.919 3.079 . . . . 0.0 113.449 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.83 30.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.671 1.988 . . . . 0.0 113.102 173.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.7 p -161.72 107.83 1.33 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.367 1.867 . . . . 0.0 106.393 -177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.38 -147.48 16.75 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.0 mm -127.53 131.72 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m0 -119.69 152.75 36.64 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.3 mt -143.59 141.16 30.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.16 136.24 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -126.66 123.33 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -172.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.0 m -162.43 -172.86 3.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.243 1.817 . . . . 0.0 108.158 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -149.98 69.77 1.03 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.535 -1.353 . . . . 0.0 108.088 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.9 p -50.97 -27.04 6.81 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.591 1.957 . . . . 0.0 115.657 -169.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -127.3 25.44 6.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.879 0.872 . . . . 0.0 111.525 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -136.58 -30.92 0.28 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.146 0.879 . . . . 0.0 112.307 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.79 34.37 2.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.736 1.615 . . . . 0.0 108.913 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.33 -175.69 40.46 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.38 0.99 . . . . 0.0 112.817 -174.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -145.47 153.36 41.07 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.6 pt -53.31 -35.61 28.75 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.72 -31.01 8.95 Favored 'Trans proline' 0 C--N 1.356 0.953 0 CA-C-N 123.894 2.426 . . . . 0.0 111.768 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -176.06 -57.62 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.391 1.876 . . . . 0.0 107.579 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.3 t30 136.48 -55.77 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 130.389 3.476 . . . . 0.0 107.335 -175.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -68.42 84.43 0.27 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 126.629 1.972 . . . . 0.0 106.701 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -54.4 25.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 124.54 1.136 . . . . 0.0 111.091 -168.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.18 -41.85 0.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.118 1.879 . . . . 0.0 110.776 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -65.62 -50.96 63.11 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 118.582 -0.723 . . . . 0.0 112.209 -169.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.95 -44.9 95.8 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.954 0.797 . . . . 0.0 110.023 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -64.44 -47.16 80.1 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.254 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.03 -35.91 74.09 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.204 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -58.77 -59.59 5.18 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.603 1.092 . . . . 0.0 109.266 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -16.82 63.73 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -175.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.25 -32.55 70.43 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.415 0.552 . . . . 0.0 111.259 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -124.23 -29.35 3.57 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt 28.98 66.64 0.68 Allowed Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 126.482 1.913 . . . . 0.0 113.251 -171.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.08 173.28 2.49 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.558 2.172 . . . . 0.0 111.381 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -84.98 124.45 31.71 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 112' ' ' SER . 3.1 mm? -122.35 14.59 10.42 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.069 1.348 . . . . 0.0 110.657 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.0 p -69.07 -3.88 14.92 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 119.82 -1.8 . . . . 0.0 112.81 -175.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.25 4.59 41.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.034 1.334 . . . . 0.0 110.789 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.78 157.36 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.886 0.874 . . . . 0.0 110.475 177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -113.38 149.43 34.09 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -128.01 164.82 21.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.546 0.689 . . . . 0.0 109.507 174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.1 153.73 21.96 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.62 136.66 53.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mt -136.24 135.51 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -169.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.82 -27.35 1.64 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.081 1.324 . . . . 0.0 112.709 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 mt -48.35 130.04 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.048 2.139 . . . . 0.0 109.273 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -95.03 7.26 69.69 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.027 1.299 . . . . 0.0 111.759 -174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 25.0 m -82.15 6.42 16.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.602 1.561 . . . . 0.0 113.161 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -51.73 -46.05 63.85 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.953 1.301 . . . . 0.0 114.138 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -140.94 -79.92 0.26 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.338 0.655 . . . . 0.0 110.778 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -141.69 11.72 2.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.247 1.019 . . . . 0.0 112.786 -169.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -79.18 37.84 0.33 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.135 0.974 . . . . 0.0 110.645 175.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.2 p -69.15 160.08 31.75 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.984 1.714 . . . . 0.0 112.309 -171.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -154.55 -174.79 5.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.157 2.183 . . . . 0.0 106.401 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 61.9 m -66.22 79.32 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.645 1.178 . . . . 0.0 109.265 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -161.05 -150.1 5.8 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.244 1.402 . . . . 0.0 110.329 -171.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.63 -30.65 71.73 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -169.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . 0.267 47.1 pt 42.0 48.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 125.375 1.47 . . . . 0.0 112.332 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.7 t70 81.2 -16.82 0.61 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 128.337 2.655 . . . . 0.0 113.904 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.25 -35.24 76.72 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.993 -1.067 . . . . 0.0 113.039 -171.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.22 -54.74 40.42 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.253 0.933 . . . . 0.0 109.894 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -62.24 -40.12 95.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.9 88.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.334 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.28 -34.32 77.86 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.222 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.14 -43.87 85.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.724 1.147 . . . . 0.0 110.5 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -65.03 -37.43 87.57 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 109.911 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -35.12 79.09 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.562 . . . . 0.0 111.282 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.587 ' HB3' HD23 ' A' ' 80' ' ' LEU . 17.9 m -72.4 -27.29 62.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.562 0.345 . . . . 0.0 110.229 178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 139.28 -23.46 2.86 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.541 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 135.57 54.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.2 1.5 . . . . 0.0 108.554 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -80.78 132.62 35.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -77.87 100.0 6.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 35.5 m -73.91 153.21 39.92 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.04 -122.06 24.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 12.8 pt-20 -157.47 174.78 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.981 1.712 . . . . 0.0 107.831 172.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m -54.34 127.84 28.99 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.809 0.844 . . . . 0.0 109.537 175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 tt -99.24 155.27 17.58 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.641 1.576 . . . . 0.0 108.834 -171.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.65 147.85 44.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp -139.65 167.46 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 124.894 1.278 . . . . 0.0 109.318 -176.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.84 143.48 24.43 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 169.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 26.8 pt -76.73 -171.04 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 123.815 0.846 . . . . 0.0 110.464 176.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.25 1.07 0.53 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.62 1.568 . . . . 0.0 114.915 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -147.81 160.23 42.97 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.219 2.208 . . . . 0.0 106.523 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -56.59 138.67 51.84 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.78 0.832 . . . . 0.0 111.281 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -152.76 167.97 27.24 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.207 1.403 . . . . 0.0 110.074 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . 0.28 49.6 mm -5.98 -77.2 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 130.529 3.532 . . . . 0.0 116.877 -169.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.28 -30.4 8.54 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.489 2.126 . . . . 0.0 111.971 -172.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 62.88 40.59 9.46 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.045 2.138 . . . . 0.0 109.991 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -147.66 101.14 3.72 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.726 1.211 . . . . 0.0 109.33 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.03 -15.55 34.15 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.845 3.03 . . . . 0.0 115.522 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 36.73 50.18 0.81 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.793 2.437 . . . . 0.0 114.603 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.79 -28.59 64.15 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.472 -0.768 . . . . 0.0 111.182 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.18 -36.91 82.79 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.634 0.774 . . . . 0.0 111.327 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.527 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.88 -44.88 91.7 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.135 0.879 . . . . 0.0 109.214 174.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 tp -61.24 -51.63 68.16 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.11 -42.12 98.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 123.403 0.525 . . . . 0.0 112.111 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.5 m -58.54 -61.58 2.49 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.569 1.148 . . . . 0.0 109.821 174.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -55.2 -46.06 75.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.7 0.8 . . . . 0.0 112.277 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.03 -54.62 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 123.556 0.742 . . . . 0.0 109.387 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -16.8 61.94 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.004 0.82 . . . . 0.0 112.471 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.2 mp -80.74 -44.18 19.06 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.329 0.652 . . . . 0.0 111.034 173.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -37.05 75.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.923 0.783 . . . . 0.0 110.976 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.7 mttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 124.938 1.295 . . . . 0.0 109.93 174.198 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.18 170.07 22.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.934 1.294 . . . . 0.0 109.29 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.64 -23.32 17.66 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.591 1.157 . . . . 0.0 110.895 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 mt -132.92 127.74 55.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.407 1.083 . . . . 0.0 108.946 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -92.33 129.3 38.31 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.99 98.63 8.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.83 89.33 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 m -92.12 49.05 1.47 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.598 2.359 . . . . 0.0 111.079 -168.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.85 174.26 46.7 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 121.45 -0.781 . . . . 0.0 112.558 175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.8 p -129.34 -48.21 1.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 124.621 1.168 . . . . 0.0 110.299 -173.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 p -86.44 -72.21 0.51 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 14.4 tp -157.14 23.36 0.31 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 110.379 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.94 169.29 42.19 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -174.51 174.37 46.5 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.047 1.784 . . . . 0.0 108.809 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.6 102.61 0.45 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.303 1.041 . . . . 0.0 111.533 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -61.97 -38.64 89.3 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.515 0.726 . . . . 0.0 110.637 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -59.35 -42.59 91.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.283 0.633 . . . . 0.0 110.705 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -69.14 -49.33 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.42 -40.96 93.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.104 -172.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -65.91 -41.35 91.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.008 0.523 . . . . 0.0 110.819 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -61.99 -47.77 83.34 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.65 0.659 . . . . 0.0 110.066 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.0 mt -56.42 -53.43 57.54 Favored 'General case' 0 N--CA 1.46 0.039 0 C-N-CA 124.057 0.943 . . . . 0.0 110.173 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.37 -50.35 59.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.256 1.022 . . . . 0.0 110.712 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.17 -54.51 46.12 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.887 0.875 . . . . 0.0 110.639 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -58.3 -37.3 74.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -70.81 -28.07 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.859 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -70.71 -39.65 73.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.632 1.56 . . . . 0.0 109.804 170.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -62.57 -28.17 69.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.463 0.705 . . . . 0.0 111.332 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.34 -10.82 60.1 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.111 0.964 . . . . 0.0 112.348 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.05 16.92 8.7 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 118.912 -0.938 . . . . 0.0 113.424 170.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -117.73 -167.9 1.41 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.485 1.142 . . . . 0.0 108.84 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -130.82 150.29 52.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 p -140.84 156.99 46.01 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.911 -0.493 . . . . 0.0 110.446 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -133.15 105.47 7.05 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.09 122.79 21.55 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.386 1.074 . . . . 0.0 108.533 175.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.1 mt -149.75 138.59 21.0 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 122.79 0.436 . . . . 0.0 111.014 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -85.48 43.86 1.06 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.667 -1.27 . . . . 0.0 108.393 168.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 36.31 56.21 1.2 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 127.358 2.408 . . . . 0.0 115.757 -169.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.62 -24.78 46.97 Favored 'Trans proline' 0 C--N 1.353 0.791 0 CA-C-N 121.343 2.572 . . . . 0.0 115.367 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.4 mt -118.45 15.58 13.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.977 1.711 . . . . 0.0 109.363 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp 66.06 -30.24 0.14 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 128.506 2.722 . . . . 0.0 113.106 -169.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -168.13 94.45 0.39 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.334 1.854 . . . . 0.0 106.342 -169.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -66.29 -44.35 83.73 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.673 -0.642 . . . . 0.0 109.918 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.6 mt -81.95 153.02 69.55 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.812 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.65 -171.51 0.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.443 3.428 . . . . 0.0 112.231 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.35 27.61 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.852 1.661 . . . . 0.0 113.42 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -156.49 138.0 14.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.99 2.116 . . . . 0.0 106.81 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.41 -140.4 11.73 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.8 mm -128.46 133.83 65.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.524 ' CD1' HG21 ' A' ' 83' ' ' VAL . 8.3 m0 -117.71 135.31 54.11 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.9 mt -128.95 142.37 50.96 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.93 133.08 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.29 104.58 6.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 C-N-CA 123.791 0.836 . . . . 0.0 108.856 -169.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.2 m -171.56 131.1 0.71 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.574 1.949 . . . . 0.0 107.409 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.7 m -72.36 102.41 3.14 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 119.113 0.869 . . . . 0.0 108.686 170.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 p -56.25 -16.77 5.92 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 115.349 -169.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -116.42 -54.14 2.48 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.714 1.143 . . . . 0.0 110.235 169.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.87 61.11 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.059 0.838 . . . . 0.0 114.417 -174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.53 39.01 2.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.7 2.0 . . . . 0.0 108.357 174.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.29 -141.97 3.28 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.654 1.121 . . . . 0.0 110.868 -169.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 t70 44.22 -53.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 1 C-N-CA 132.231 4.212 . . . . 0.0 117.962 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.7 mm -51.57 -49.95 79.78 Favored Pre-proline 0 CA--C 1.548 0.869 0 CA-C-N 120.16 1.346 . . . . 0.0 112.601 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.94 43.06 1.4 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.292 2.662 . . . . 0.0 110.969 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.5 t0 52.42 32.03 10.63 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.93 1.692 . . . . 0.0 110.686 -168.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.97 -51.38 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 129.673 3.189 . . . . 0.0 113.777 -169.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mp -133.34 147.74 51.85 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.286 1.434 . . . . 0.0 107.263 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 -61.28 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 117.845 -1.074 . . . . 0.0 109.527 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -87.91 -40.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.449 2.1 . . . . 0.0 112.418 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -59.58 -52.65 64.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.166 0.986 . . . . 0.0 112.025 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -62.99 -43.92 97.47 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.923 0.329 . . . . 0.0 110.458 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -63.54 -46.91 83.81 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.068 0.394 . . . . 0.0 109.969 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.75 71.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.522 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.3 -58.0 10.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.374 0.988 . . . . 0.0 109.079 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -62.64 -26.41 68.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.95 -30.77 71.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.072 0.549 . . . . 0.0 111.658 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -124.91 -23.8 4.2 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 30.78 66.4 0.87 Allowed Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.65 1.98 . . . . 0.0 112.056 -172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -57.89 160.5 15.03 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.404 2.736 . . . . 0.0 113.123 -169.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -79.9 61.12 3.71 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 122.37 1.081 . . . . 0.0 110.779 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.2 mt -71.63 10.47 0.65 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.772 1.629 . . . . 0.0 112.792 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 m -62.46 -7.42 4.51 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 129.665 3.186 . . . . 0.0 113.042 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.83 11.31 17.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.577 1.551 . . . . 0.0 110.791 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -130.28 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 121.966 0.889 . . . . 0.0 111.154 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -95.01 151.02 19.53 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 170.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.88 145.47 45.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.47 115.23 1.33 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.84 140.0 47.33 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.6 mt -137.32 128.34 40.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.99 -10.92 2.15 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.368 -1.24 . . . . 0.0 114.314 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.0 mt -48.52 129.93 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.791 2.036 . . . . 0.0 109.465 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.67 -20.35 66.22 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.243 0.925 . . . . 0.0 112.163 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -56.08 -6.17 0.23 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.953 2.501 . . . . 0.0 114.95 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -63.2 -15.64 57.6 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.244 -0.91 . . . . 0.0 110.65 168.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 101.87 -23.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 131.176 3.791 . . . . 0.0 110.109 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -64.21 -14.75 57.44 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.611 1.565 . . . . 0.0 112.871 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.06 86.51 1.98 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 124.387 1.075 . . . . 0.0 108.849 171.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.5 t -159.76 168.5 25.76 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.498 1.119 . . . . 0.0 108.092 169.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -146.02 11.58 1.21 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.033 1.733 . . . . 0.0 109.342 169.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 60.1 m -135.59 26.19 3.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.514 1.126 . . . . 0.0 112.084 -169.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.27 -173.33 35.77 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.73 -27.34 67.85 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -171.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.2 pt 43.74 33.98 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.629 1.971 . . . . 0.0 113.59 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -83.7 2.29 38.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.62 1.168 . . . . 0.0 113.071 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -54.85 -37.8 66.67 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.185 0.994 . . . . 0.0 112.785 -171.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.56 -54.18 46.48 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -60.71 -41.81 95.97 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.06 -49.84 76.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -67.78 -30.88 70.43 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.168 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 65.3 mt -64.84 -44.07 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.755 1.161 . . . . 0.0 110.769 173.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.06 -35.06 73.97 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.432 0.693 . . . . 0.0 110.198 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -32.21 71.4 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 125.954 1.702 . . . . 0.0 111.902 174.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.8 m -64.76 -48.35 74.86 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 169.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.6 -15.74 0.38 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.059 -1.412 . . . . 0.0 115.393 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.05 138.46 58.35 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.588 1.694 . . . . 0.0 110.61 -169.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -84.03 111.53 19.37 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.64 111.76 2.89 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 42.5 m -84.17 152.51 24.23 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.96 -121.31 26.24 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.562 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 3.0 pt-20 -150.3 -176.35 5.44 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 126.909 2.083 . . . . 0.0 106.049 169.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.2 m -41.36 111.46 0.22 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.622 1.569 . . . . 0.0 111.376 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.09 161.54 28.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 173.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -133.79 149.37 51.42 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -170.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.44 155.92 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 169.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.74 52.05 0.28 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -172.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.9 tt -132.31 147.91 32.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 123.954 0.902 . . . . 0.0 109.806 -169.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.2 tp 60.65 -62.72 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 129.304 3.042 . . . . 0.0 113.615 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -153.98 -5.65 0.17 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.713 1.605 . . . . 0.0 111.668 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -87.98 45.66 1.3 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.201 1.4 . . . . 0.0 110.535 -169.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -70.84 -16.97 62.75 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.296 1.438 . . . . 0.0 113.143 -172.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.0 mt -15.63 -65.85 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 128.975 2.91 . . . . 0.0 114.276 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.65 -82.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.959 1.735 . . . . 0.0 113.065 -174.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -174.63 155.24 2.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.947 1.699 . . . . 0.0 108.88 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.94 -35.73 37.23 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 117.89 2.552 . . . . 0.0 117.89 -173.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -59.84 23.47 0.04 OUTLIER 'Trans proline' 0 CA--C 1.547 1.153 1 C-N-CA 125.928 4.418 . . . . 0.0 119.434 -173.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.75 -49.43 38.45 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.517 1.527 . . . . 0.0 112.732 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.75 -36.93 81.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.887 0.475 . . . . 0.0 110.787 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -65.44 -41.06 93.88 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.935 0.494 . . . . 0.0 109.738 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.562 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 1.2 m-90 -63.63 -42.24 98.17 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.9 -0.571 . . . . 0.0 111.292 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 tp -57.99 -53.32 59.59 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.77 -42.68 98.13 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.0 m -59.0 -62.19 2.07 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 125.146 1.378 . . . . 0.0 110.149 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -57.15 -44.36 83.38 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.75 0.82 . . . . 0.0 112.016 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.48 -53.94 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.439 0.696 . . . . 0.0 109.475 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.23 -17.42 62.5 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.31 0.959 . . . . 0.0 112.407 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.0 mp -79.18 -42.87 25.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.564 0.62 . . . . 0.0 111.227 172.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -37.56 75.12 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.947 0.794 . . . . 0.0 111.079 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.9 mttm . . . . . 0 C--O 1.249 1.071 0 C-N-CA 125.39 1.476 . . . . 0.0 109.937 174.068 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.24 159.59 44.13 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.509 1.124 . . . . 0.0 108.853 173.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -111.85 -23.13 10.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.444 1.898 . . . . 0.0 110.872 176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 mt -134.03 122.85 42.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -85.06 128.58 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 169.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.34 95.33 6.02 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -82.74 83.21 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 m -83.72 31.97 0.47 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 128.804 2.841 . . . . 0.0 112.682 -168.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.42 155.62 26.61 Favored Glycine 0 C--N 1.335 0.51 0 O-C-N 121.599 -0.688 . . . . 0.0 112.173 -171.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.33 -37.8 1.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 110.387 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.5 p -130.6 49.56 2.29 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.8 tp 52.22 42.41 30.75 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.126 1.771 . . . . 0.0 111.101 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.18 159.18 16.65 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 128.042 2.734 . . . . 0.0 106.798 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.36 -160.4 32.52 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 118.357 1.078 . . . . 0.0 111.301 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.43 46.26 0.33 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.475 1.91 . . . . 0.0 113.525 -169.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -53.52 -35.22 60.44 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.192 0.997 . . . . 0.0 112.828 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.01 -45.75 93.56 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.897 0.772 . . . . 0.0 110.736 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -73.05 -40.9 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -36.45 80.22 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.534 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.11 -41.52 94.83 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.177 0.899 . . . . 0.0 110.984 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -64.8 -45.5 85.99 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.745 -0.597 . . . . 0.0 109.904 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.24 -51.24 68.82 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.225 1.01 . . . . 0.0 110.271 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.36 -49.83 60.71 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 110.897 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -58.16 -53.48 57.8 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.193 0.997 . . . . 0.0 110.244 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -58.71 -37.95 77.23 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mp -69.71 -26.51 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.86 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -70.04 -43.82 70.5 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.854 1.661 . . . . 0.0 109.316 169.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -61.0 -26.33 67.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.48 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.34 -16.26 63.5 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.713 0.805 . . . . 0.0 112.219 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.07 15.66 2.05 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.523 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -131.66 -165.25 1.55 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.304 1.552 . . . . 0.0 110.041 -169.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.7 p -131.18 151.68 51.22 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.9 p -144.11 159.78 42.04 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.038 0.535 . . . . 0.0 109.796 -169.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.1 107.23 7.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 m -78.17 120.15 22.56 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt -147.07 137.47 23.49 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.194 0.598 . . . . 0.0 110.057 -169.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -82.39 41.49 0.7 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.608 -1.307 . . . . 0.0 109.677 169.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 38.7 55.12 2.22 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.636 2.065 . . . . 0.0 115.022 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.39 -20.3 54.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.808 2.339 . . . . 0.0 113.499 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.4 mt -118.07 15.18 14.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.293 1.837 . . . . 0.0 109.068 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 tp 63.84 -28.12 0.09 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 129.088 2.955 . . . . 0.0 113.97 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -164.98 93.45 0.62 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.408 1.483 . . . . 0.0 107.111 -168.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.08 -43.78 77.77 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.467 -0.771 . . . . 0.0 110.007 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.35 154.5 74.34 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 47' ' ' SER . 41.8 Cg_endo -66.52 -173.68 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.934 3.089 . . . . 0.0 112.554 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.99 29.94 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.178 1.391 . . . . 0.0 112.661 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 45' ' ' PRO . 18.0 m -152.33 136.91 16.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.967 2.507 . . . . 0.0 106.41 -175.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.13 -141.59 12.74 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mm -123.76 139.83 49.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 169.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CD1' HG21 ' A' ' 83' ' ' VAL . 10.3 m0 -122.04 135.12 54.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.8 mt -128.79 140.7 51.59 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 171.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.58 134.43 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mp -137.68 113.78 11.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -169.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 m -170.93 -156.51 0.12 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.935 2.494 . . . . 0.0 105.668 174.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.6 m -147.6 138.78 23.62 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 121.06 1.755 . . . . 0.0 109.305 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.0 p -138.1 -6.49 1.62 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -56.29 145.39 27.03 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.03 -157.62 16.43 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.88 -32.24 69.31 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.877 -0.582 . . . . 0.0 112.263 -177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 52.98 -140.87 30.39 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -144.18 166.98 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 169.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.0 mm -48.83 -46.12 73.1 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-O 117.407 -1.282 . . . . 0.0 112.984 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.02 -5.06 16.13 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.318 2.012 . . . . 0.0 114.837 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.5 t70 133.95 -54.51 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.978 1 C-N-CA 131.791 4.036 . . . . 0.0 106.809 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 165.58 -45.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 129.105 2.962 . . . . 0.0 107.001 -175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.448 HD12 ' H ' ' A' ' 66' ' ' LEU . 5.9 mp -65.34 146.16 55.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.721 1.208 . . . . 0.0 108.69 174.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.454 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 29.8 m -122.22 -63.67 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 117.248 -1.358 . . . . 0.0 111.172 176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HD2' ' H ' ' A' ' 67' ' ' SER . 43.9 Cg_endo -66.75 -39.31 15.45 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 121.92 1.722 . . . . 0.0 110.993 -175.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -60.28 -50.35 73.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.35 0.66 . . . . 0.0 110.091 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -61.28 -48.97 78.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.67 -175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -60.94 -45.81 93.23 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.772 0.714 . . . . 0.0 110.462 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.7 -31.4 72.61 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -63.43 -58.02 8.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 119.202 0.91 . . . . 0.0 109.233 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -63.6 -24.64 67.88 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.56 -33.69 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.022 0.529 . . . . 0.0 111.38 -177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -123.47 -23.76 4.73 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 29.91 66.53 0.78 Allowed Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 126.885 2.074 . . . . 0.0 112.086 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -61.75 163.88 17.58 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.037 2.492 . . . . 0.0 113.529 -169.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.99 59.86 2.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.285 1.834 . . . . 0.0 112.009 -169.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.9 7.16 2.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.036 1.334 . . . . 0.0 113.163 -171.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.8 p -63.52 -4.06 2.57 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.259 -1.526 . . . . 0.0 112.614 176.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.9 6.56 25.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.3 1.44 . . . . 0.0 111.459 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.1 p -130.71 162.07 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.914 0.885 . . . . 0.0 109.966 175.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -118.0 152.74 34.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -119.92 151.56 38.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.922 1.689 . . . . 0.0 108.134 -169.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -147.39 150.85 23.16 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -125.9 138.95 53.82 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.7 mt -137.08 124.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -169.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.23 -30.27 1.39 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.801 1.191 . . . . 0.0 111.803 -175.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 48.3 mm -47.43 143.45 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 126.452 1.901 . . . . 0.0 108.005 169.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -163.26 15.54 0.11 Allowed Glycine 0 CA--C 1.523 0.563 0 CA-C-O 119.055 -0.858 . . . . 0.0 113.8 -174.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 p -60.61 -15.05 24.26 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.037 1.335 . . . . 0.0 112.878 178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -62.18 -27.06 68.7 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.826 -1.171 . . . . 0.0 112.668 169.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 66.73 -12.89 0.2 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.746 2.819 . . . . 0.0 114.559 169.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -52.65 -12.65 0.31 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.487 2.715 . . . . 0.0 113.747 175.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.98 -2.8 8.25 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.72 1.208 . . . . 0.0 113.739 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.4 t -152.26 -172.7 4.31 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 129.291 3.037 . . . . 0.0 107.602 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -75.12 -17.55 60.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.495 1.118 . . . . 0.0 113.009 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 65.3 m -63.11 153.59 33.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.272 1.029 . . . . 0.0 112.058 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.62 153.86 30.48 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 123.884 0.754 . . . . 0.0 111.72 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.81 153.12 42.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.852 0.861 . . . . 0.0 112.938 -171.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 pt -138.6 25.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 128.456 2.703 . . . . 0.0 108.808 169.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.38 31.16 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 129.063 2.945 . . . . 0.0 115.876 -169.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -55.51 -30.28 60.38 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.0 -1.063 . . . . 0.0 112.054 -173.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.21 -58.82 5.92 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.788 1.177 . . . . 0.0 109.842 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -61.57 -37.68 84.73 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -175.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.2 -51.75 67.7 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.009 0.923 . . . . 0.0 109.953 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -65.69 -35.22 80.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.428 1.013 . . . . 0.0 111.158 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.62 -50.1 72.59 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.174 0.897 . . . . 0.0 110.942 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.322 11.7 ptmt -71.78 -28.1 63.4 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.938 -0.476 . . . . 0.0 112.204 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -36.19 82.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.333 1.053 . . . . 0.0 111.009 169.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.6 m -68.52 -33.7 74.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.948 0.34 . . . . 0.0 110.561 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.69 -28.9 0.37 Allowed Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.668 169.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.47 141.2 57.04 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 118.654 1.227 . . . . 0.0 110.11 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -80.69 129.16 34.36 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 170.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -75.6 100.95 4.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 170.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 99.6 m -73.32 149.87 42.31 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 58.34 -124.43 36.38 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.474 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.0 pt-20 -152.1 166.05 32.84 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.337 1.055 . . . . 0.0 108.301 169.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.5 m -51.03 130.89 26.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.842 1.257 . . . . 0.0 111.222 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -92.64 160.47 14.99 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.928 2.091 . . . . 0.0 108.429 -176.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.414 ' H ' HD23 ' A' ' 121' ' ' LEU . 47.3 mtmt -131.36 144.05 50.95 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.17 162.72 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.747 2.419 . . . . 0.0 106.448 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -157.24 155.84 31.51 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 121.716 -0.615 . . . . 0.0 111.233 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.9 pt -141.61 168.83 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.721 2.008 . . . . 0.0 107.404 174.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.2 mt 56.56 -167.3 0.12 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.001 1.32 . . . . 0.0 110.594 -172.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.65 -38.38 90.79 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.547 -0.721 . . . . 0.0 111.368 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -164.97 174.33 10.62 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.106 1.762 . . . . 0.0 108.876 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.09 -71.66 0.15 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.41 ' H ' ' HD2' ' A' ' 131' ' ' PRO . 23.4 mt -139.37 -63.67 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.644 1.578 . . . . 0.0 110.22 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 130' ' ' ILE . 74.0 Cg_endo -74.29 -42.52 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 CA-C-N 121.589 1.603 . . . . 0.0 111.337 -172.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 58.56 23.6 11.03 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.502 1.521 . . . . 0.0 111.909 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -151.71 77.16 7.23 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 121.2 -0.938 . . . . 0.0 110.402 -172.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.48 148.34 20.37 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.158 2.572 . . . . 0.0 112.706 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.64 38.72 1.51 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.48 1.512 . . . . 0.0 109.513 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -59.77 -16.25 26.44 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.28 1.432 . . . . 0.0 113.785 -172.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -57.15 -27.79 62.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.594 0.757 . . . . 0.0 111.423 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.474 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.87 -48.47 78.05 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.335 0.654 . . . . 0.0 109.711 171.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.8 tp -61.62 -49.14 77.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.074 0.95 . . . . 0.0 109.217 -175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.0 -52.51 46.3 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.932 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.7 t -63.24 -44.74 94.33 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 117.286 0.543 . . . . 0.0 110.524 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.39 -41.84 94.63 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.274 1.43 . . . . 0.0 110.804 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.77 -48.03 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.084 0.953 . . . . 0.0 109.547 172.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.35 -29.74 70.68 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.257 0.935 . . . . 0.0 111.612 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 mp -76.21 -46.99 25.65 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.363 1.065 . . . . 0.0 110.505 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -74.01 -29.91 62.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.353 0.524 . . . . 0.0 112.054 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.3 mttt . . . . . 0 C--O 1.248 1.007 0 C-N-CA 124.374 1.07 . . . . 0.0 109.86 171.815 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.81 158.8 35.73 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.174 0.512 . . . . 0.0 110.324 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.1 -22.25 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.1 1.76 . . . . 0.0 110.712 174.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.5 mt -134.81 128.94 51.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.547 1.139 . . . . 0.0 108.065 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -89.01 131.88 34.99 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 169.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.65 95.1 5.39 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.1 mt -89.94 110.39 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -113.35 143.67 44.06 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 122.813 0.445 . . . . 0.0 111.622 -169.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.5 168.29 12.22 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 124.598 1.094 . . . . 0.0 112.002 169.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.9 p -117.88 -8.8 10.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.302 0.641 . . . . 0.0 112.516 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 t -141.79 -54.44 0.45 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 169.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.2 tp -149.4 17.12 0.93 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.485 1.039 . . . . 0.0 111.661 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.93 172.1 28.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 127.432 2.444 . . . . 0.0 107.68 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.71 10.07 4.12 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 118.015 -1.436 . . . . 0.0 115.053 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.75 2.86 1.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.077 1.938 . . . . 0.0 113.405 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.8 -31.55 62.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.486 1.114 . . . . 0.0 112.125 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -58.1 -53.5 57.57 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.458 0.703 . . . . 0.0 111.525 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -79.09 -30.54 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.966 -0.459 . . . . 0.0 109.904 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.03 77.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.001 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.35 -41.22 89.82 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.015 0.825 . . . . 0.0 111.083 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -63.07 -46.9 85.28 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.1 mt -57.12 -51.17 70.35 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.044 0.937 . . . . 0.0 110.461 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.72 -48.53 63.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.761 1.224 . . . . 0.0 110.685 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.71 -53.89 52.74 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 123.484 0.714 . . . . 0.0 110.345 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -57.92 -38.12 75.31 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.92 -33.13 75.02 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.254 0.621 . . . . 0.0 111.183 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -70.04 -38.21 75.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 119.921 1.237 . . . . 0.0 110.325 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -63.51 -28.96 70.3 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.165 0.893 . . . . 0.0 111.42 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.34 63.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.393 0.677 . . . . 0.0 111.597 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.26 -6.49 5.34 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.493 -1.171 . . . . 0.0 113.706 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.9 -165.44 1.34 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.341 1.57 . . . . 0.0 109.395 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -132.38 150.89 52.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.5 p -144.88 160.08 41.87 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.701 -0.624 . . . . 0.0 110.618 -169.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.07 115.61 15.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 m -78.93 123.82 27.64 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.0 mt -140.5 156.79 46.22 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.112 0.565 . . . . 0.0 110.396 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.9 p-80 -105.03 35.8 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.432 1.093 . . . . 0.0 108.77 169.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.57 48.05 28.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.727 1.632 . . . . 0.0 115.048 -170.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.38 -20.57 61.47 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 121.046 2.423 . . . . 0.0 113.808 -171.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.5 mt -122.31 14.92 10.49 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.022 1.729 . . . . 0.0 109.094 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.6 tp 64.9 -30.09 0.12 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 127.979 2.512 . . . . 0.0 113.543 -169.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -165.31 86.57 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.223 1.409 . . . . 0.0 107.452 -168.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.7 -41.74 99.28 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.956 -0.465 . . . . 0.0 110.185 176.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.7 mt -96.47 150.11 36.67 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.58 -178.92 1.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.88 3.053 . . . . 0.0 113.239 -175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 32.55 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.994 1.718 . . . . 0.0 112.549 171.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.7 m -157.36 125.34 5.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.729 2.011 . . . . 0.0 106.044 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.86 -143.36 14.85 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -172.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 mm -124.38 130.97 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -118.89 144.62 46.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.2 mt -137.14 135.77 37.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 172.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 t -132.6 137.55 53.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -173.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -128.07 96.71 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.169 1.388 . . . . 0.0 107.258 -170.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.5 p -145.52 -6.29 0.63 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.949 1.833 . . . . 0.0 115.949 -173.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.6 m 37.98 60.95 1.14 Allowed 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p -49.73 -36.8 26.82 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.122 0.969 . . . . 0.0 112.384 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -44.09 -29.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.052 2.141 . . . . 0.0 114.13 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.08 16.56 0.18 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-N 120.449 1.477 . . . . 0.0 115.617 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.74 46.38 0.94 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.506 1.922 . . . . 0.0 109.232 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.54 -179.15 10.09 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.137 -0.977 . . . . 0.0 111.735 170.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -134.1 164.52 27.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.061 1.345 . . . . 0.0 107.719 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.3 mm -61.28 -47.85 93.08 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-O 117.345 -1.312 . . . . 0.0 111.371 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.64 -49.83 3.91 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.009 1.806 . . . . 0.0 112.152 171.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -162.87 -60.31 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.329 0.652 . . . . 0.0 111.958 170.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 155.96 139.55 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 130.426 3.49 . . . . 0.0 104.402 -169.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.0 mt 37.66 58.81 1.33 Allowed 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.078 1.418 . . . . 0.0 108.395 -169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.402 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 50.5 m -63.61 -48.01 81.45 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.488 1.915 . . . . 0.0 114.174 -168.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 67' ' ' SER . 37.2 Cg_endo -63.14 -34.07 70.42 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 121.176 1.456 . . . . 0.0 110.647 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -72.33 -42.84 64.92 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.403 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -53.52 -51.56 62.44 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.99 1.316 . . . . 0.0 110.261 171.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -61.8 -42.52 99.12 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.822 0.737 . . . . 0.0 110.87 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.6 86.32 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 118.863 -0.589 . . . . 0.0 112.219 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.49 -56.34 23.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.241 0.928 . . . . 0.0 109.106 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -20.18 65.06 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.84 -31.06 63.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.876 0.762 . . . . 0.0 111.635 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -121.11 -28.56 4.72 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt 23.75 70.91 0.33 Allowed Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 127.722 2.409 . . . . 0.0 113.7 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -58.84 175.38 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.605 2.204 . . . . 0.0 111.729 172.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -89.96 79.16 6.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.995 0.918 . . . . 0.0 110.022 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.557 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.1 mm? -75.39 3.17 9.63 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.264 0.626 . . . . 0.0 112.174 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -63.8 -6.74 6.23 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.026 2.13 . . . . 0.0 112.926 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.13 6.21 38.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.774 1.629 . . . . 0.0 110.792 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.31 145.66 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 122.147 0.975 . . . . 0.0 111.732 174.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.407 HH11 ' HG3' ' A' ' 84' ' ' ARG . 1.6 ptm180 -94.67 144.55 25.52 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 169.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -113.07 146.5 39.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.09 121.81 3.67 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.09 132.16 43.83 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.8 mt -127.24 108.28 18.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.17 -30.03 0.43 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.227 0.918 . . . . 0.0 113.049 -171.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.76 123.03 2.83 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.0 45.74 0.29 Allowed Glycine 0 CA--C 1.502 -0.722 0 CA-C-O 121.722 0.623 . . . . 0.0 111.75 -169.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -37.85 68.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 26.09 -70.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 1 C-N-CA 133.186 4.594 . . . . 0.0 117.132 169.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -57.47 -26.78 61.77 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.864 0.865 . . . . 0.0 111.643 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -120.81 10.35 10.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.621 2.769 . . . . 0.0 110.595 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -80.24 62.61 4.45 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 171.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.2 t -154.31 177.4 11.18 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.747 1.619 . . . . 0.0 109.603 -173.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -57.96 -19.18 28.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.284 1.834 . . . . 0.0 114.836 -169.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 18.4 p -116.92 17.63 14.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.767 1.227 . . . . 0.0 112.718 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.42 166.43 54.61 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.607 0.623 . . . . 0.0 112.027 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.44 14.01 1.24 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.689 1.195 . . . . 0.0 112.187 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.1 tt -149.12 23.76 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 125.315 1.446 . . . . 0.0 108.885 -177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -135.2 -3.01 2.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.265 2.226 . . . . 0.0 112.038 -169.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -63.29 -25.39 68.29 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.661 -0.649 . . . . 0.0 111.552 -169.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.83 -56.49 19.92 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.721 0.808 . . . . 0.0 110.138 169.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -65.14 -38.87 92.0 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.63 72.65 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -63.24 -42.12 99.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.775 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.7 mt -57.28 -47.59 81.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.304 0.956 . . . . 0.0 110.714 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -73.51 -36.0 65.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.852 0.861 . . . . 0.0 109.688 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -34.38 78.23 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.377 1.471 . . . . 0.0 111.629 173.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.557 ' HB3' HD23 ' A' ' 80' ' ' LEU . 14.8 m -73.65 -17.72 61.12 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.251 0.22 . . . . 0.0 110.636 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.25 -17.64 5.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 117.921 -1.488 . . . . 0.0 114.085 169.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 130.75 44.49 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.649 1.725 . . . . 0.0 109.258 -170.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -86.37 111.08 20.15 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.04 117.51 5.18 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 170.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 94.7 m -129.38 143.13 50.72 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.244 0.618 . . . . 0.0 110.737 -169.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.38 -103.34 2.99 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 105.685 -2.966 . . . . 0.0 105.685 -173.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -165.03 -175.88 3.9 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.357 1.863 . . . . 0.0 107.448 169.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.4 m -63.01 113.64 3.22 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 169.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 122' ' ' LYS . 1.3 tt -71.37 153.62 42.18 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.511 ' H ' HD23 ' A' ' 121' ' ' LEU . 37.6 mttp -130.8 143.0 50.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.12 156.25 33.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.722 1.609 . . . . 0.0 107.213 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.66 28.29 0.79 Allowed 'General case' 0 C--O 1.232 0.171 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.1 157.37 4.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 168.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 tp -51.95 -37.03 51.38 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.946 0.898 . . . . 0.0 113.327 -169.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.96 -22.56 62.19 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -140.35 60.65 1.54 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.751 1.62 . . . . 0.0 109.416 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -65.57 -18.88 65.65 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.241 -0.912 . . . . 0.0 111.563 169.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 83.9 mt -2.37 -72.37 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 130.398 3.479 . . . . 0.0 114.755 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -79.09 -78.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.682 1.994 . . . . 0.0 112.859 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -177.79 158.55 1.32 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.441 2.296 . . . . 0.0 107.512 -169.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -55.0 -45.74 99.78 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -169.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.36 160.82 41.39 Favored 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 122.577 1.956 . . . . 0.0 113.069 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.29 -47.76 0.13 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.329 1.052 . . . . 0.0 111.036 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -64.94 -24.22 67.46 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -170.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.28 -34.21 77.59 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.708 0.403 . . . . 0.0 110.636 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.451 ' CE3' HD12 ' A' ' 121' ' ' LEU . 13.8 t90 -59.08 -54.92 41.57 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 123.307 0.643 . . . . 0.0 109.538 173.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.02 -55.91 20.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.631 1.573 . . . . 0.0 109.09 -176.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.1 -42.59 98.02 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.737 -0.48 . . . . 0.0 112.133 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -60.17 -60.35 3.96 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.82 0.81 . . . . 0.0 109.03 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.5 t90 -56.85 -46.54 81.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.386 1.074 . . . . 0.0 111.485 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.01 -55.78 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.702 0.801 . . . . 0.0 109.683 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -15.96 62.49 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.059 0.845 . . . . 0.0 112.421 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.61 -48.47 13.71 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.467 0.707 . . . . 0.0 110.769 173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.8 pp -72.73 -32.58 65.8 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.766 0.712 . . . . 0.0 111.958 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.1 mttt . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.228 1.011 . . . . 0.0 109.74 174.006 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.62 152.59 45.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 119.273 0.942 . . . . 0.0 111.628 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -98.43 -22.51 16.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.193 1.797 . . . . 0.0 110.865 170.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.21 129.49 53.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.781 1.233 . . . . 0.0 108.144 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -90.42 127.96 36.35 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.91 95.62 5.66 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.8 mm -84.64 131.54 33.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.83 -174.35 3.7 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.058 1.743 . . . . 0.0 109.038 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 67.27 42.44 90.58 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.547 -0.721 . . . . 0.0 112.476 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -44.91 -44.56 9.79 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.396 2.278 . . . . 0.0 114.329 -169.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 p -82.23 22.78 0.79 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.188 1.795 . . . . 0.0 112.188 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt 59.04 54.17 5.13 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 122.74 1.257 . . . . 0.0 107.654 -168.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.32 -135.98 3.33 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.096 1.808 . . . . 0.0 108.739 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.46 149.32 21.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 174.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.18 16.27 0.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.321 1.849 . . . . 0.0 111.108 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.24 -16.91 37.91 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.548 1.139 . . . . 0.0 113.683 -169.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -52.64 -48.08 66.63 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 120.283 1.402 . . . . 0.0 112.14 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.07 -31.72 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 O-C-N 121.967 -0.458 . . . . 0.0 110.177 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.53 78.07 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.074 0.55 . . . . 0.0 111.114 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.31 -37.45 80.61 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.055 0.942 . . . . 0.0 110.371 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -65.25 -42.44 93.31 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.72 -0.612 . . . . 0.0 110.008 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 mt -61.49 -51.73 67.43 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.377 0.671 . . . . 0.0 110.032 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.93 64.96 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.451 1.501 . . . . 0.0 111.312 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 -54.74 40.16 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.517 0.675 . . . . 0.0 109.954 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -62.56 -38.74 91.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -60.93 -40.17 92.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.478 0.711 . . . . 0.0 110.897 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.55 -36.52 68.26 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 121.16 -0.962 . . . . 0.0 110.469 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -61.8 -31.3 71.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.481 0.712 . . . . 0.0 111.262 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.5 -21.49 62.75 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.375 0.67 . . . . 0.0 111.736 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.99 -7.82 3.82 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.178 -1.345 . . . . 0.0 114.295 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -94.99 -168.86 1.88 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.802 1.801 . . . . 0.0 110.205 -171.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -128.89 149.67 50.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 169.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.7 p -142.71 155.64 44.91 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.823 -0.548 . . . . 0.0 111.065 -170.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -121.73 90.67 3.36 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.906 1.283 . . . . 0.0 108.331 -177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -67.53 120.66 14.33 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 173.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.1 mt -146.86 168.37 21.59 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 123.834 0.854 . . . . 0.0 111.534 -169.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -109.52 31.88 5.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.884 1.273 . . . . 0.0 109.584 169.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.86 49.73 46.93 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.602 1.572 . . . . 0.0 114.537 -174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.81 -21.01 64.96 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.061 2.507 . . . . 0.0 113.99 -172.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.11 12.76 11.96 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.674 1.59 . . . . 0.0 109.577 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.7 tp 63.91 -25.8 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.939 2.496 . . . . 0.0 113.455 -169.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -166.75 82.67 0.25 Allowed 'General case' 0 C--O 1.232 0.184 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -169.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.98 -43.89 97.54 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.879 -0.513 . . . . 0.0 109.841 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 77.1 mt -90.48 151.28 44.07 Favored Pre-proline 0 C--N 1.345 0.409 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 169.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 47' ' ' SER . 37.5 Cg_endo -67.07 -175.12 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 124.151 3.234 . . . . 0.0 113.005 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.04 29.77 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.645 1.578 . . . . 0.0 113.193 171.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' PRO . 20.3 m -152.56 127.17 9.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.964 2.506 . . . . 0.0 106.157 -176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.08 -140.92 12.19 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.3 mm -127.97 135.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' CD1' HG21 ' A' ' 83' ' ' VAL . 18.2 m0 -119.52 130.02 54.98 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 56.3 mt -126.97 133.58 50.56 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -127.37 103.5 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -169.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.0 mp -78.72 126.04 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.9 m -159.57 176.95 11.43 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.128 1.771 . . . . 0.0 107.05 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 m -149.92 65.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 p -51.73 -26.27 9.08 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.749 2.019 . . . . 0.0 113.399 -169.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -133.13 44.35 2.84 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.146 1.378 . . . . 0.0 109.637 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.98 -36.89 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 O-C-N 121.439 -0.788 . . . . 0.0 113.428 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.38 58.45 0.64 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.967 1.307 . . . . 0.0 107.802 178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.72 168.39 35.5 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 123.827 0.727 . . . . 0.0 111.313 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.15 85.44 5.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.341 8.0 pt -38.97 -38.84 0.73 Allowed Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 119.654 3.205 . . . . 0.0 119.654 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.19 -8.16 12.94 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 CA-C-N 123.827 2.402 . . . . 0.0 114.017 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -149.92 -41.09 0.14 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.293 1.406 . . . . 0.0 114.629 -169.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.5 t30 31.46 -56.28 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 1 C-N-CA 132.694 4.398 . . . . 0.0 119.968 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.29 72.57 10.55 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.8 m -67.21 -51.3 35.83 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.746 -169.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 -38.73 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.453 1.435 . . . . 0.0 110.18 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -65.31 -52.33 54.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.592 -171.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -59.38 -46.26 89.16 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 119.286 0.948 . . . . 0.0 110.845 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -63.5 -49.54 73.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.512 0.596 . . . . 0.0 110.274 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.26 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -60.52 -56.29 23.21 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.836 0.855 . . . . 0.0 109.577 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -65.41 -23.57 66.99 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.49 -33.7 73.24 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 119.244 -0.408 . . . . 0.0 111.746 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -124.59 -21.83 4.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt 30.26 64.53 0.89 Allowed Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 127.068 2.147 . . . . 0.0 112.911 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.7 165.24 18.84 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.938 2.425 . . . . 0.0 113.375 -169.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -80.34 63.96 4.99 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.731 1.212 . . . . 0.0 111.232 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.85 9.95 0.33 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.45 1.5 . . . . 0.0 113.281 -177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.1 m -64.04 -2.43 1.98 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.756 2.823 . . . . 0.0 113.171 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.85 9.1 11.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.741 1.616 . . . . 0.0 110.981 177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -128.5 154.13 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.689 0.677 . . . . 0.0 110.75 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.36 143.26 32.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -103.01 154.61 19.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.98 115.42 0.85 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 169.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.1 133.92 47.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.7 mt -130.32 116.67 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.46 -11.37 18.52 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.625 1.107 . . . . 0.0 114.36 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mt -55.64 130.5 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.012 1.725 . . . . 0.0 108.609 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.96 -38.88 3.71 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.899 -0.481 . . . . 0.0 111.899 -170.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -53.08 -33.49 52.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.705 1.602 . . . . 0.0 111.565 170.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -66.88 -25.23 66.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.943 0.897 . . . . 0.0 112.464 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -105.61 -73.62 0.68 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.856 0.753 . . . . 0.0 112.624 -168.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -155.51 -25.74 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -169.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -87.92 33.87 0.72 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.638 1.108 . . . . 0.0 111.377 -169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.4 p -50.55 119.86 4.15 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.133 1.773 . . . . 0.0 110.838 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -62.7 165.92 5.98 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.395 0.678 . . . . 0.0 109.521 170.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 56.6 m -71.21 39.0 0.06 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.185 1.794 . . . . 0.0 111.727 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 162.84 42.76 0.02 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.488 1.994 . . . . 0.0 108.164 -169.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.46 158.84 11.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.014 0.926 . . . . 0.0 111.523 -170.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.4 tp -112.28 22.09 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.278 1.031 . . . . 0.0 110.204 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.03 -15.92 10.9 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.419 1.088 . . . . 0.0 113.049 176.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -56.37 -25.69 50.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.94 0.896 . . . . 0.0 111.769 170.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.404 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.9 tm? -59.37 -59.04 6.08 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.292 0.951 . . . . 0.0 109.442 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.06 -38.61 79.78 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.318 0.508 . . . . 0.0 110.852 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.91 88.04 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.879 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -64.84 -36.59 84.83 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.967 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 13.0 mt -61.67 -47.25 86.17 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.255 0.934 . . . . 0.0 110.814 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -69.46 -35.47 75.64 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.993 0.517 . . . . 0.0 110.217 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -36.48 84.18 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.293 1.437 . . . . 0.0 111.037 172.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.8 m -67.16 -36.14 81.18 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.607 0.363 . . . . 0.0 110.097 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 161.66 -25.66 0.25 Allowed Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.29 -1.284 . . . . 0.0 115.396 169.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.35 139.98 55.87 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.344 1.572 . . . . 0.0 110.524 -170.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -83.73 146.14 28.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -92.58 98.37 11.4 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 171.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.8 m -75.3 151.72 38.28 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.82 -116.89 8.63 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.438 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 7.3 pt-20 -146.8 178.99 7.89 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.334 1.053 . . . . 0.0 108.561 170.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 m -54.43 119.53 5.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.5 1.12 . . . . 0.0 108.8 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.7 OUTLIER -76.09 151.35 37.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.463 ' H ' HD23 ' A' ' 121' ' ' LEU . 28.0 mtmm -138.87 141.84 38.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp -149.76 160.1 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 127.501 2.321 . . . . 0.0 108.657 -171.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -159.93 -179.49 7.85 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.233 0.613 . . . . 0.0 109.497 169.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 47.0 pt -124.72 2.78 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 125.315 1.446 . . . . 0.0 111.105 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -142.71 144.2 32.6 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.96 131.31 44.36 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.761 0.824 . . . . 0.0 112.299 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.3 t60 32.78 95.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.816 3.246 . . . . 0.0 115.719 175.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -127.72 -160.66 1.03 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.386 1.474 . . . . 0.0 108.001 169.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.8 mm -44.73 -52.22 19.09 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.314 1.846 . . . . 0.0 113.6 -169.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.77 -98.41 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.577 2.184 . . . . 0.0 109.864 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.03 158.5 10.48 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.345 1.858 . . . . 0.0 106.411 170.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -77.64 -54.12 1.44 Allowed Pre-proline 0 CA--C 1.542 0.667 0 CA-C-O 117.34 -1.314 . . . . 0.0 113.577 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.6 152.36 48.18 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.023 1.815 . . . . 0.0 111.276 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.29 -20.96 0.62 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.285 1.034 . . . . 0.0 113.034 -177.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.38 -25.03 67.71 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.501 0.591 . . . . 0.0 111.927 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -64.31 -42.83 96.16 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.362 0.665 . . . . 0.0 110.412 176.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.438 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 8.3 m-90 -63.22 -51.29 66.84 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 123.007 0.523 . . . . 0.0 109.833 177.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 35.8 mt -58.62 -55.7 31.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 123.693 0.621 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -57.51 -49.16 75.61 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.383 -0.676 . . . . 0.0 111.414 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -48.03 77.71 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.155 0.977 . . . . 0.0 110.176 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 52.3 t90 -60.16 -42.96 96.07 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.569 -0.707 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.8 t -57.39 -50.33 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.555 1.142 . . . . 0.0 109.727 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -61.74 -26.96 68.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.129 0.877 . . . . 0.0 111.986 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.8 -45.98 16.1 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.671 0.789 . . . . 0.0 110.401 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -72.05 -34.69 68.96 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.375 0.534 . . . . 0.0 111.754 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.2 mttt . . . . . 0 C--O 1.248 0.98 0 C-N-CA 124.155 0.982 . . . . 0.0 110.026 176.14 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 tpp . . . . . 0 N--CA 1.479 1.006 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.71 163.22 40.37 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.369 1.068 . . . . 0.0 109.924 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -95.14 -24.3 16.91 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.752 1.221 . . . . 0.0 110.891 169.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.7 mt -132.48 124.54 51.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -86.78 127.8 35.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.16 103.4 14.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 171.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mt -89.92 74.45 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -78.83 138.88 38.38 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.783 -0.573 . . . . 0.0 109.988 -170.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.63 136.11 3.15 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 124.563 1.078 . . . . 0.0 111.082 169.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 m -87.21 -7.22 58.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.931 0.892 . . . . 0.0 110.509 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.4 t -143.74 -144.35 0.15 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 129.992 3.317 . . . . 0.0 102.954 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -65.62 8.12 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.44 -176.52 48.08 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 128.931 3.158 . . . . 0.0 107.413 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.1 7.87 5.29 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.232 -1.316 . . . . 0.0 114.709 169.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.82 -2.48 1.04 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.638 1.719 . . . . 0.0 113.732 -175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -56.01 -33.39 64.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.425 1.09 . . . . 0.0 112.432 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.59 -42.65 88.55 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.515 0.726 . . . . 0.0 111.469 -179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.77 -28.18 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.01 77.59 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.145 0.884 . . . . 0.0 111.338 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.08 -42.05 93.75 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.918 0.781 . . . . 0.0 111.278 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -68.59 -43.2 77.01 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.698 -0.627 . . . . 0.0 110.663 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.73 -50.5 73.01 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 124.001 0.92 . . . . 0.0 110.432 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.85 -47.97 67.39 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.732 1.213 . . . . 0.0 110.995 174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -54.98 -52.99 61.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.683 0.674 . . . . 0.0 110.18 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -60.35 -40.55 91.12 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.91 -32.9 74.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.742 0.701 . . . . 0.0 111.518 175.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.53 -39.98 80.92 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 119.388 0.995 . . . . 0.0 109.737 173.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.94 -29.1 70.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.389 0.995 . . . . 0.0 111.6 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.3 -17.73 63.09 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.716 0.806 . . . . 0.0 111.622 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.35 14.03 4.6 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-O 118.292 -1.282 . . . . 0.0 114.323 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -121.72 -172.38 2.42 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.442 1.621 . . . . 0.0 110.419 -174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 p -122.86 153.58 39.44 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p -141.61 154.56 45.48 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.875 -0.516 . . . . 0.0 111.615 -169.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -117.94 91.92 3.7 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.634 1.574 . . . . 0.0 106.923 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 m -69.21 118.44 12.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 172.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.5 mt -146.09 166.0 27.43 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.747 1.219 . . . . 0.0 108.738 -173.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -101.44 31.18 3.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.493 0.717 . . . . 0.0 110.653 170.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.62 50.79 47.39 Favored Glycine 0 CA--C 1.535 1.322 0 CA-C-O 118.143 -1.365 . . . . 0.0 113.935 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.2 -21.36 67.5 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.082 2.521 . . . . 0.0 113.638 -171.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 75.2 mt -125.74 15.87 8.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.739 1.616 . . . . 0.0 109.54 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.6 tp 63.0 -26.69 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 128.328 2.651 . . . . 0.0 114.31 -169.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -161.17 82.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.536 1.134 . . . . 0.0 108.22 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -66.36 -43.96 84.52 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.777 -0.577 . . . . 0.0 110.255 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.3 mt -85.65 151.36 55.46 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.24 -178.29 1.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.968 3.112 . . . . 0.0 113.292 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.89 31.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.758 2.023 . . . . 0.0 112.941 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -159.87 116.87 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.928 2.091 . . . . 0.0 106.312 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.0 -146.01 15.4 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -173.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.3 mm -123.64 136.18 60.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 172.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -118.36 148.78 42.15 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.5 mt -134.54 142.91 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.75 130.65 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.41 110.4 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -168.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 m -149.51 -174.67 4.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.23 1.012 . . . . 0.0 109.361 -169.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.7 m -154.48 134.73 13.24 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.622 1.169 . . . . 0.0 108.313 170.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.7 p -140.76 -64.94 0.45 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.903 0.481 . . . . 0.0 111.237 -170.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.0 t60 52.12 28.98 5.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.163 1.385 . . . . 0.0 112.112 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 53.53 21.93 15.29 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.615 1.102 . . . . 0.0 113.976 -172.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.6 41.54 0.61 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.343 1.857 . . . . 0.0 109.277 -169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.21 -172.74 7.11 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 123.777 0.703 . . . . 0.0 111.412 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -57.52 -27.74 62.86 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.194 -0.592 . . . . 0.0 111.695 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 tp -148.97 153.44 38.4 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.718 2.407 . . . . 0.0 104.963 169.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -59.45 16.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.937 3.758 . . . . 0.0 116.297 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -145.08 37.5 1.15 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.655 2.382 . . . . 0.0 107.552 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -51.89 -42.48 62.73 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.213 1.405 . . . . 0.0 112.299 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.36 61.27 0.89 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.012 1.725 . . . . 0.0 108.66 170.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 66.5 m -65.94 -48.02 62.38 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 125.957 1.703 . . . . 0.0 110.838 -169.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -72.71 -39.95 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 120.414 1.184 . . . . 0.0 110.251 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -60.21 3.53 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -169.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -59.79 -43.21 94.55 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.984 0.913 . . . . 0.0 110.336 -169.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -69.31 -46.87 66.07 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.001 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -26.91 68.59 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.651 1.114 . . . . 0.0 112.886 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.9 mt -61.98 -61.34 2.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -57.48 -25.8 60.29 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.096 1.758 . . . . 0.0 113.719 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -30.81 70.4 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.61 0.764 . . . . 0.0 111.289 -177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -126.88 -29.95 2.78 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.471 ' HD2' HD21 ' A' ' 111' ' ' ASN . 36.6 mtmt 23.81 67.85 0.38 Allowed Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 127.153 2.181 . . . . 0.0 113.401 -169.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.6 175.98 1.94 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.833 1.689 . . . . 0.0 110.672 171.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -87.87 125.93 34.75 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.627 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.9 mm? -120.27 11.79 11.62 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.619 1.168 . . . . 0.0 111.145 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.7 m -67.0 -4.87 10.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 119.662 -1.899 . . . . 0.0 113.033 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.1 5.06 42.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.308 1.443 . . . . 0.0 110.734 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 p -132.06 157.17 43.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.961 0.886 . . . . 0.0 110.896 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -110.46 151.99 26.86 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 170.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -121.44 157.22 31.05 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.85 118.84 2.4 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.17 140.6 31.63 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.7 mt -138.79 125.89 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -170.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.92 -5.58 52.78 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.381 0.991 . . . . 0.0 113.796 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.0 mt -77.55 80.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 108.151 -170.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.54 -11.39 2.64 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 127.174 2.321 . . . . 0.0 117.806 -168.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -67.18 -41.98 84.98 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.525 2.162 . . . . 0.0 109.692 172.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 36.2 ttt85 55.55 -76.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.139 2.575 . . . . 0.0 114.038 173.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -159.83 -42.56 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.65 1.98 . . . . 0.0 108.473 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -146.18 1.08 0.84 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.414 1.486 . . . . 0.0 112.031 -171.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -87.73 34.48 0.71 Allowed 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.205 -0.934 . . . . 0.0 111.133 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.1 t -154.63 169.36 24.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.083 2.153 . . . . 0.0 107.448 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -117.89 7.22 12.32 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.423 1.489 . . . . 0.0 110.258 171.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 62.9 m -132.73 22.21 4.25 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.413 1.485 . . . . 0.0 111.149 -172.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.2 -169.35 38.26 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.253 0.93 . . . . 0.0 111.167 -175.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.72 -135.45 0.08 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.329 1.852 . . . . 0.0 106.101 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.8 140.5 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 168.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 106' ' ' GLU . 2.0 t70 -63.55 150.12 44.69 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -169.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -56.3 -41.14 75.48 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 169.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -57.35 -55.4 35.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.471 1.108 . . . . 0.0 109.545 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.447 ' H ' ' HB3' ' A' ' 103' ' ' ASP . 48.6 mt-10 -65.56 -39.85 92.16 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.837 -171.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.38 78.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.224 1.01 . . . . 0.0 109.889 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -63.72 -35.74 81.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.438 -0.792 . . . . 0.0 111.422 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.8 -42.5 94.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 120.206 1.366 . . . . 0.0 111.289 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -65.55 -38.85 90.81 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.111 0.565 . . . . 0.0 109.764 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.471 HD21 ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -67.65 -31.32 71.23 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.986 1.314 . . . . 0.0 111.684 176.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.627 ' HB3' HD23 ' A' ' 80' ' ' LEU . 15.5 m -73.52 -29.91 62.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 122.855 0.462 . . . . 0.0 109.847 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.71 -17.35 4.44 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-O 118.457 -1.19 . . . . 0.0 113.599 169.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 136.23 56.67 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.892 1.346 . . . . 0.0 108.287 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -84.56 126.81 33.65 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -77.27 98.65 5.23 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 169.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 48.8 m -73.45 151.33 41.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.59 -117.35 10.83 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.571 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 10.3 pt-20 -157.0 170.08 23.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.123 1.769 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.3 m -55.3 126.44 24.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.603 0.761 . . . . 0.0 109.739 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 122' ' ' LYS . 0.5 OUTLIER -84.25 161.42 20.5 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.065 1.746 . . . . 0.0 107.674 176.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.437 ' H ' HD23 ' A' ' 121' ' ' LEU . 60.6 mtpt -136.52 150.87 48.87 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.45 157.38 24.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 123.394 0.678 . . . . 0.0 110.387 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.32 170.28 14.85 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.881 0.872 . . . . 0.0 109.788 169.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 37.6 mm -126.31 -62.7 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.1 tp -160.04 -57.26 0.06 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.717 0.807 . . . . 0.0 109.574 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -68.87 126.84 31.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -67.16 162.37 22.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.062 0.945 . . . . 0.0 111.227 -172.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -147.94 -166.23 2.47 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.075 1.75 . . . . 0.0 107.692 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.67 -54.15 56.89 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.916 1.286 . . . . 0.0 111.025 173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.5 -47.15 0.75 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.13 1.887 . . . . 0.0 112.29 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . 0.261 16.7 pt-20 45.68 37.71 3.54 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.683 1.993 . . . . 0.0 114.698 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -146.98 112.6 4.16 Favored Pre-proline 0 N--CA 1.467 0.384 0 CA-C-O 118.104 -0.95 . . . . 0.0 108.674 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.21 -29.49 46.77 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 124.006 3.137 . . . . 0.0 115.658 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 35.87 40.23 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.961 2.504 . . . . 0.0 115.333 177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.39 -23.95 64.73 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -169.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -59.78 -29.96 68.56 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.287 1.035 . . . . 0.0 111.208 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.571 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.9 OUTLIER -61.93 -40.54 95.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.836 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -55.73 27.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -55.64 -49.0 67.61 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.266 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.7 m -60.61 -55.53 32.24 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 124.585 1.154 . . . . 0.0 111.83 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 49.1 t90 -55.99 -42.7 76.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.65 1.18 . . . . 0.0 111.288 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 t -58.23 -49.35 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.145 0.578 . . . . 0.0 109.83 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.59 -30.12 70.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.372 0.987 . . . . 0.0 111.397 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.1 mp -76.9 -46.12 25.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.014 0.925 . . . . 0.0 110.452 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.69 -33.66 66.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.058 0.543 . . . . 0.0 111.586 -178.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 83.7 mttt . . . . . 0 C--O 1.248 1.004 0 C-N-CA 124.484 1.114 . . . . 0.0 110.09 173.227 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.76 168.7 24.23 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.359 1.064 . . . . 0.0 109.988 -171.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -101.37 -23.77 14.31 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 111.224 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.13 121.94 52.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -85.12 133.89 34.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.69 96.52 6.13 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 174.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.3 mt -92.9 107.38 19.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -171.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -92.12 95.27 9.66 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.24 0.22 23.82 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 118.291 -1.283 . . . . 0.0 114.803 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.89 106.12 0.33 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.451 1.625 . . . . 0.0 109.648 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m 46.83 44.45 14.31 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.068 1.347 . . . . 0.0 110.357 -170.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.5 tp 54.89 47.9 21.23 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.649 1.58 . . . . 0.0 111.985 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.19 -173.19 40.76 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.538 1.542 . . . . 0.0 110.723 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 167.97 -165.82 39.0 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.68 55.56 0.67 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 111.221 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -54.24 -31.44 53.39 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.085 1.354 . . . . 0.0 112.105 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -55.7 -40.77 72.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.861 0.864 . . . . 0.0 111.721 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 t -91.58 -29.94 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.16 -37.18 74.19 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.09 0.859 . . . . 0.0 110.638 173.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.13 -38.91 93.06 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.557 0.617 . . . . 0.0 110.907 176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -67.11 -42.62 84.22 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.697 -0.627 . . . . 0.0 110.29 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -59.35 -52.54 65.2 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.697 0.799 . . . . 0.0 109.919 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.99 -49.55 63.06 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.162 1.385 . . . . 0.0 110.931 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -58.19 -54.35 47.92 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 110.426 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -56.53 -39.14 72.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.16 -25.03 65.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.34 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.64 -43.38 80.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 120.738 1.608 . . . . 0.0 109.319 170.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.85 -26.21 68.65 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.749 -0.594 . . . . 0.0 111.597 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -13.02 62.03 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.943 0.897 . . . . 0.0 112.549 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.33 19.04 2.95 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.835 -0.98 . . . . 0.0 114.087 169.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -132.0 -165.48 1.59 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.63 1.215 . . . . 0.0 109.837 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 p -132.36 151.75 51.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -141.77 154.91 45.56 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.971 -0.456 . . . . 0.0 111.468 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -125.72 95.66 4.51 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.518 1.127 . . . . 0.0 108.647 -173.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.7 m -70.2 121.46 17.6 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.6 mt -145.47 165.01 29.82 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.395 0.617 . . . . 0.0 111.469 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -107.46 31.1 5.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.728 1.211 . . . . 0.0 110.165 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 53.88 45.41 70.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.854 -1.526 . . . . 0.0 115.113 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.43 -21.41 66.39 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.049 2.499 . . . . 0.0 114.118 -170.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.9 mt -116.45 11.72 14.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.529 1.532 . . . . 0.0 109.887 -176.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 tp 64.21 -23.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.787 2.435 . . . . 0.0 113.467 -169.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -169.82 82.63 0.12 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.963 1.705 . . . . 0.0 106.65 -169.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.45 -43.82 96.3 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 121.876 -0.515 . . . . 0.0 109.666 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.8 mt -96.06 150.8 37.72 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 169.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.31 -177.6 1.16 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.742 2.962 . . . . 0.0 113.154 -175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.17 35.75 0.05 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.73 1.612 . . . . 0.0 112.037 170.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.3 m -160.51 130.24 5.11 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.186 2.195 . . . . 0.0 106.008 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.28 -143.45 14.54 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -172.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 22.2 mm -127.39 141.07 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CD1' HG21 ' A' ' 83' ' ' VAL . 5.1 m0 -128.92 146.86 50.84 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.8 mt -132.55 140.12 48.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.22 121.98 58.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.95 60.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 -169.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m -120.77 41.31 3.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.256 -169.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -26.53 107.76 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 128.584 2.754 . . . . 0.0 113.914 -172.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.6 p -80.12 -20.03 45.94 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.723 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.3 m80 51.03 22.73 1.29 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.607 1.094 . . . . 0.0 112.86 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.45 -64.95 3.16 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.841 1.21 . . . . 0.0 111.871 -173.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.28 -7.1 54.27 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -170.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.36 146.14 6.59 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.624 1.583 . . . . 0.0 110.451 -169.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.64 -27.36 65.94 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 169.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.0 pt -136.51 159.61 69.88 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 128.05 2.54 . . . . 0.0 106.135 169.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.37 -17.73 22.24 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.711 2.94 . . . . 0.0 115.794 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -133.47 61.24 1.68 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.599 1.56 . . . . 0.0 107.727 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -52.44 -23.37 5.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.269 2.228 . . . . 0.0 116.182 -169.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.29 72.52 1.38 Allowed 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.4 -51.92 57.05 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.513 0.725 . . . . 0.0 112.454 -168.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.8 -39.58 0.93 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.612 1.541 . . . . 0.0 110.516 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.36 -51.43 60.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.699 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -60.09 -49.85 76.03 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.519 0.6 . . . . 0.0 110.261 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -62.44 -44.7 95.79 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.541 0.609 . . . . 0.0 110.387 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.06 91.78 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.198 0.453 . . . . 0.0 111.919 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.5 mt -58.71 -55.68 31.92 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.952 0.796 . . . . 0.0 109.739 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -65.59 -20.01 66.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.25 -34.11 65.66 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.37 0.532 . . . . 0.0 111.598 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -122.85 -21.36 5.58 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 29.24 65.95 0.73 Allowed Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 127.07 2.148 . . . . 0.0 113.034 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.87 165.29 14.41 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.533 2.155 . . . . 0.0 112.738 -169.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -80.74 63.93 5.33 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.05 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -68.37 4.53 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.139 0.976 . . . . 0.0 112.789 -177.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -62.09 -8.07 4.9 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 128.812 2.845 . . . . 0.0 113.104 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.55 10.4 19.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.713 1.605 . . . . 0.0 110.752 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.406 HG21 ' CD1' ' A' ' 50' ' ' TRP . 1.5 p -132.27 153.08 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 110.813 175.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -107.34 152.42 24.18 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 171.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -120.05 156.41 30.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.07 126.59 3.74 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 106.524 -2.63 . . . . 0.0 106.524 169.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.22 138.92 31.68 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.3 mt -139.31 124.45 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -170.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.72 -12.05 3.03 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.066 0.841 . . . . 0.0 114.352 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.7 mm -55.14 133.81 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.229 1.412 . . . . 0.0 107.857 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.88 -21.72 17.72 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.9 m -58.77 -28.85 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -169.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -71.09 -22.12 62.14 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.288 0.635 . . . . 0.0 111.844 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -146.21 -62.3 0.31 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -168.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -53.34 -39.35 64.04 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.778 1.631 . . . . 0.0 113.327 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -133.76 15.54 3.97 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.276 0.56 . . . . 0.0 112.316 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.6 p 60.69 160.55 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.757 2.823 . . . . 0.0 115.959 172.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -59.16 -21.24 59.07 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.768 1.227 . . . . 0.0 112.779 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.9 p -115.68 23.6 12.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.632 1.573 . . . . 0.0 111.676 -172.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.5 -42.08 0.04 OUTLIER Glycine 0 CA--C 1.527 0.831 0 C-N-CA 123.949 0.785 . . . . 0.0 111.234 176.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.74 171.4 5.26 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.822 0.849 . . . . 0.0 112.462 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.5 pt -73.03 36.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 125.891 1.676 . . . . 0.0 111.482 169.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -59.18 -16.62 21.39 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.655 1.982 . . . . 0.0 113.6 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -53.09 -27.42 20.23 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.969 0.908 . . . . 0.0 112.639 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.85 -57.38 12.89 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.677 0.671 . . . . 0.0 109.788 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.39 -36.08 81.2 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.498 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.8 -50.42 73.9 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.421 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.81 -42.34 93.26 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 118.779 -0.629 . . . . 0.0 110.604 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.0 mt -60.18 -48.15 82.93 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.844 0.747 . . . . 0.0 111.167 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -67.99 -36.2 79.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.198 0.599 . . . . 0.0 109.867 -177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -31.89 72.8 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.7 1.2 . . . . 0.0 111.798 174.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.0 m -69.54 -33.49 72.86 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.803 0.441 . . . . 0.0 110.508 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 164.65 -38.39 0.3 Allowed Glycine 0 C--N 1.344 0.993 0 N-CA-C 115.56 0.984 . . . . 0.0 115.56 169.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . . . -70.92 174.12 6.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.442 1.121 . . . . 0.0 111.664 -174.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -132.12 145.93 51.71 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 169.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -74.25 126.06 29.79 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 40.0 m -88.8 157.95 18.31 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 171.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.42 -133.02 30.3 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.33 161.68 38.36 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.427 1.091 . . . . 0.0 108.378 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 m -57.45 123.97 17.32 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.85 0.86 . . . . 0.0 111.632 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.21 171.14 15.5 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.161 1.784 . . . . 0.0 108.285 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -137.95 156.81 47.48 Favored 'General case' 0 CA--C 1.516 -0.336 0 O-C-N 121.149 -0.97 . . . . 0.0 109.093 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.63 138.93 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 169.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.01 173.33 4.42 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.907 1.283 . . . . 0.0 108.958 169.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.0 pt -142.87 159.36 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.804 1.241 . . . . 0.0 109.011 175.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.2 tp 65.29 -45.89 0.36 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 129.228 3.011 . . . . 0.0 116.359 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -156.09 171.32 20.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 120.064 1.302 . . . . 0.0 110.96 -169.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -58.67 159.8 6.28 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.128 1.371 . . . . 0.0 110.066 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 130' ' ' ILE . 40.9 t0 -150.92 -92.84 0.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 122.41 1.1 . . . . 0.0 109.289 -171.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' H ' ' HB3' ' A' ' 129' ' ' ASP . 29.4 mm -130.95 -48.35 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 128.823 2.849 . . . . 0.0 105.616 169.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -179.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 124.653 3.569 . . . . 0.0 117.846 167.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -124.33 164.84 18.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 109.664 -3.426 . . . . 0.0 107.735 169.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -56.87 116.65 13.88 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 124.626 1.171 . . . . 0.0 111.561 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.76 160.39 12.14 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.517 2.811 . . . . 0.0 112.541 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.26 144.23 25.44 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.8 0.84 . . . . 0.0 109.277 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.11 -25.83 68.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.208 1.003 . . . . 0.0 110.988 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.45 -32.18 62.55 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.305 1.042 . . . . 0.0 112.049 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -50.79 72.48 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.839 0.745 . . . . 0.0 110.657 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 31.4 mt -63.54 -52.09 62.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.26 -47.39 61.72 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.5 t -61.76 -57.51 11.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -57.24 -43.31 82.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.605 0.762 . . . . 0.0 111.916 -175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.6 t -59.25 -55.94 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.726 1.21 . . . . 0.0 109.98 175.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -13.78 62.64 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.591 1.087 . . . . 0.0 112.213 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.95 -48.12 13.91 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.058 0.943 . . . . 0.0 110.825 170.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.6 pp -71.56 -33.46 69.13 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.892 0.769 . . . . 0.0 112.176 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 86.3 mttt . . . . . 0 C--O 1.248 1.021 0 C-N-CA 125.022 1.329 . . . . 0.0 109.49 173.614 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.02 164.09 37.93 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.15 0.98 . . . . 0.0 110.117 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.89 -23.76 17.3 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.4 1.48 . . . . 0.0 110.753 170.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.3 mt -135.78 130.38 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.543 1.137 . . . . 0.0 108.327 -174.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 t -89.88 129.07 36.3 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 169.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -111.2 93.68 4.6 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.7 mm -72.16 98.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.0 m -86.49 13.85 7.72 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.541 1.937 . . . . 0.0 114.305 -168.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.98 158.81 31.77 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 118.929 0.786 . . . . 0.0 112.623 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -93.76 -30.72 14.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.446 1.498 . . . . 0.0 111.547 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 t -124.37 48.51 1.92 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.461 1.124 . . . . 0.0 108.948 -169.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.5 tp 56.01 27.87 11.93 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.4 1.48 . . . . 0.0 111.334 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 169.7 165.05 26.44 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 128.328 2.87 . . . . 0.0 106.869 -172.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.69 -146.6 11.76 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 118.211 1.006 . . . . 0.0 110.862 -173.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.68 50.77 0.25 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.499 1.919 . . . . 0.0 112.076 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.62 -29.23 66.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.683 1.193 . . . . 0.0 112.144 -173.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -60.08 -51.31 70.17 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.7 0.682 . . . . 0.0 111.078 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.55 -28.52 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.84 -0.537 . . . . 0.0 109.667 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.9 98.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.646 0.657 . . . . 0.0 110.736 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -65.55 -40.55 92.98 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.178 0.591 . . . . 0.0 110.566 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -62.26 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.714 -0.616 . . . . 0.0 110.622 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.4 mt -60.46 -51.02 71.23 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.563 1.145 . . . . 0.0 109.719 176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.19 66.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 111.073 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.89 -52.19 66.11 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.131 0.973 . . . . 0.0 110.653 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -57.33 -37.76 73.04 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.68 -29.72 69.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.833 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -70.64 -44.23 67.57 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.542 1.519 . . . . 0.0 109.847 171.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.04 -26.53 67.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 0.0 111.406 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.69 -21.12 64.44 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.809 0.843 . . . . 0.0 111.963 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.28 12.05 1.48 Allowed Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.319 -1.267 . . . . 0.0 114.516 171.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -127.36 -165.97 1.54 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.603 1.701 . . . . 0.0 109.626 -170.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -131.44 149.94 52.34 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 170.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 p -140.38 153.27 46.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.095 0.474 . . . . 0.0 110.461 -170.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -117.57 89.95 3.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -173.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 m -67.69 120.33 13.89 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.5 mt -146.0 136.95 24.5 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 123.904 0.882 . . . . 0.0 109.528 -170.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -80.83 35.42 0.37 Allowed 'General case' 0 CA--C 1.547 0.848 0 O-C-N 120.923 -1.111 . . . . 0.0 111.344 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.48 41.79 49.61 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.989 1.757 . . . . 0.0 115.605 -171.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.98 -21.12 50.19 Favored 'Trans proline' 0 C--N 1.35 0.639 0 CA-C-N 121.718 2.759 . . . . 0.0 114.137 -169.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.2 mt -121.4 13.13 10.98 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.743 1.617 . . . . 0.0 108.936 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.4 tp 64.16 -29.57 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 128.269 2.627 . . . . 0.0 113.734 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -168.13 91.22 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.004 1.322 . . . . 0.0 107.677 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.77 -43.35 79.99 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.574 -0.704 . . . . 0.0 110.229 174.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 mt -82.62 152.94 67.54 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 169.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 -173.42 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.99 3.127 . . . . 0.0 112.953 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.8 34.14 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.785 1.634 . . . . 0.0 112.29 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 m -158.08 133.7 8.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.668 1.987 . . . . 0.0 106.893 -177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.55 -143.17 14.13 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.4 mm -123.49 140.1 48.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -117.76 149.88 40.05 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 58.7 mt -138.63 142.87 39.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.68 123.95 22.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.77 117.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -160.44 -175.7 5.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.178 1.791 . . . . 0.0 108.008 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -152.47 72.9 1.0 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.313 -1.492 . . . . 0.0 110.897 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 65' ' ' ASN . 3.1 p -64.52 9.92 0.07 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.348 1.859 . . . . 0.0 114.873 175.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -48.77 158.94 0.27 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.181 1.393 . . . . 0.0 113.08 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.47 -149.09 43.54 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.54 4.48 6.01 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.95 -146.79 40.39 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -171.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -140.27 168.67 19.27 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.541 1.136 . . . . 0.0 108.654 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.267 20.1 tt -49.93 -38.73 37.85 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -170.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.94 -21.5 15.93 Favored 'Trans proline' 0 C--N 1.356 0.97 0 CA-C-N 123.63 2.332 . . . . 0.0 112.772 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 150.64 -58.89 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 130.896 3.678 . . . . 0.0 106.438 -169.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' A' ' 56' ' ' THR . 26.6 t-20 158.65 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 130.661 3.584 . . . . 0.0 105.239 -175.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.8 140.56 36.81 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.37 -57.88 0.11 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.911 -171.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -77.81 -37.17 0.94 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.04 1.407 . . . . 0.0 111.715 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -59.58 5.23 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.801 0.84 . . . . 0.0 111.133 -169.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.12 -48.26 79.07 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 124.055 0.847 . . . . 0.0 110.69 -174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -65.02 -45.94 83.38 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 117.852 0.296 . . . . 0.0 110.712 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.133 -0.46 . . . . 0.0 111.73 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -56.77 -55.67 31.27 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.812 0.733 . . . . 0.0 109.511 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -68.18 -18.66 64.65 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -177.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -73.53 -32.1 64.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.449 0.568 . . . . 0.0 111.693 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -122.45 -25.18 4.82 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -173.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt 32.26 62.78 1.3 Allowed Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 127.139 2.175 . . . . 0.0 112.375 -176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.87 164.52 21.49 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.907 2.405 . . . . 0.0 113.078 -169.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -79.75 65.32 4.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.609 1.164 . . . . 0.0 111.016 -174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.39 16.25 0.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.914 1.686 . . . . 0.0 113.039 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.7 p -66.03 -2.34 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 119.746 -1.846 . . . . 0.0 112.87 -174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.6 12.78 9.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.186 1.794 . . . . 0.0 110.777 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.6 158.83 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.654 0.74 . . . . 0.0 110.989 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 -128.58 154.56 46.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.152 1.381 . . . . 0.0 107.469 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -113.77 167.83 10.3 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -136.34 120.04 2.12 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 106.144 -2.782 . . . . 0.0 106.144 169.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.47 34.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.8 mt -133.45 126.7 52.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.68 -18.55 2.96 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.953 1.263 . . . . 0.0 113.507 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -46.53 142.37 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.71 2.404 . . . . 0.0 110.539 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.35 15.02 8.18 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.042 1.782 . . . . 0.0 111.373 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.5 m -64.33 -18.79 64.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.954 1.302 . . . . 0.0 112.359 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -158.1 167.12 30.74 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.719 1.607 . . . . 0.0 108.786 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 73.7 -27.26 0.19 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 129.978 3.311 . . . . 0.0 113.287 169.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -154.98 138.48 15.95 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.054 0.942 . . . . 0.0 111.027 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.9 t0 38.36 45.73 0.85 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.289 2.636 . . . . 0.0 114.475 174.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.82 169.11 8.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.215 1.406 . . . . 0.0 111.919 174.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -146.45 157.97 43.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.023 1.729 . . . . 0.0 106.895 169.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.8 m -76.05 67.97 2.45 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.555 1.142 . . . . 0.0 109.706 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.28 -178.04 21.39 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 123.961 0.791 . . . . 0.0 112.015 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.58 -1.01 4.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.267 1.427 . . . . 0.0 114.495 -171.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.1 pt -54.18 -30.53 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.296 1.438 . . . . 0.0 113.279 -175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.2 -29.39 69.04 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.801 0.84 . . . . 0.0 112.41 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.42 -23.84 67.05 Favored 'General case' 0 C--O 1.227 -0.085 0 CA-C-O 118.356 -0.83 . . . . 0.0 112.705 -169.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -58.48 -55.79 30.45 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.324 0.965 . . . . 0.0 109.54 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -71.14 -34.27 70.86 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.341 0.656 . . . . 0.0 109.684 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.94 87.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.003 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.66 -38.26 88.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.572 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.04 -50.27 74.72 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.298 0.954 . . . . 0.0 111.018 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.335 4.8 ptmm? -73.49 -27.98 61.68 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.897 -0.502 . . . . 0.0 112.321 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -37.74 87.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.453 1.101 . . . . 0.0 110.574 169.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.8 m -69.18 -36.24 77.12 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.543 0.337 . . . . 0.0 110.136 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.03 -20.69 0.36 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.52 -1.156 . . . . 0.0 114.99 169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.31 -177.51 3.06 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.738 1.269 . . . . 0.0 111.139 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -141.59 152.87 44.42 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.104 1.362 . . . . 0.0 107.342 169.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -76.23 128.47 34.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -81.54 141.68 33.56 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.61 0.61 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 124.338 0.97 . . . . 0.0 111.871 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -156.14 178.11 10.66 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.266 2.226 . . . . 0.0 107.051 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.2 m -70.87 131.18 43.39 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.012 -1.055 . . . . 0.0 108.576 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.539 HD12 ' CE3' ' A' ' 138' ' ' TRP . 2.6 tt -83.01 147.83 27.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.411 ' N ' HD23 ' A' ' 121' ' ' LEU . 6.0 mptt -131.9 136.58 47.51 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.04 136.07 45.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 123.924 0.89 . . . . 0.0 109.284 -174.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.02 171.57 12.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.229 1.811 . . . . 0.0 107.59 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 39.9 pt -136.5 -173.38 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.103 1.761 . . . . 0.0 107.611 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.9 tp -53.99 -38.03 64.64 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.388 0.675 . . . . 0.0 111.16 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -76.21 64.59 2.04 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.878 1.271 . . . . 0.0 108.789 169.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -66.44 165.72 13.8 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.907 2.083 . . . . 0.0 112.001 -173.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.89 -63.1 0.26 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.065 0.946 . . . . 0.0 112.254 -170.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.5 mt -133.65 -66.64 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 117.095 -1.431 . . . . 0.0 111.251 -169.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.43 -33.24 2.55 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.338 2.025 . . . . 0.0 112.36 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 68.29 19.54 8.98 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.086 1.754 . . . . 0.0 112.402 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -144.95 139.94 15.72 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.482 1.113 . . . . 0.0 109.835 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -83.99 -13.01 8.09 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.627 2.885 . . . . 0.0 115.149 -175.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 33.61 45.34 0.09 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.123 2.569 . . . . 0.0 114.807 -174.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -62.76 -22.56 66.67 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.308 -0.87 . . . . 0.0 112.692 -174.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -61.85 -28.23 69.35 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.926 0.89 . . . . 0.0 111.614 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.539 ' CE3' HD12 ' A' ' 121' ' ' LEU . 8.2 t90 -56.08 -57.92 10.12 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 123.724 0.81 . . . . 0.0 109.244 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.9 tp -53.07 -53.05 55.97 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.635 1.209 . . . . 0.0 110.062 -176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -60.97 -53.09 48.02 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.3 t -64.67 -45.26 87.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.471 0.635 . . . . 0.0 110.357 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 78.7 t90 -61.6 -41.37 97.36 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.214 1.006 . . . . 0.0 110.864 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 15.7 t -59.35 -48.53 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.135 0.574 . . . . 0.0 109.569 172.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.44 -28.86 70.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.193 0.906 . . . . 0.0 111.785 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.4 mp -78.8 -45.78 20.2 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.263 1.025 . . . . 0.0 110.504 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.5 65.18 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.348 0.522 . . . . 0.0 111.702 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 C--O 1.249 1.058 0 C-N-CA 124.302 1.041 . . . . 0.0 110.049 171.863 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.59 156.97 43.34 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.473 1.109 . . . . 0.0 108.431 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -106.86 -24.12 12.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.882 1.673 . . . . 0.0 110.817 176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 23.2 mt -130.0 122.86 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 t -88.37 132.76 34.31 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -100.85 97.24 7.87 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.0 mm -83.92 70.55 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.57 165.56 23.57 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.298 0.57 . . . . 0.0 110.704 -177.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.08 -174.34 50.95 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 p -144.66 -53.95 0.32 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.8 p -87.1 40.09 0.9 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.177 1.791 . . . . 0.0 109.631 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 13.2 tp 62.88 24.86 14.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.821 1.648 . . . . 0.0 112.003 -169.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.14 164.44 33.79 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.76 170.72 20.23 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.069 1.319 . . . . 0.0 111.198 -176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 55.63 -1.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.238 2.615 . . . . 0.0 117.449 174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -58.58 -32.95 69.42 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 120.43 1.468 . . . . 0.0 112.262 -173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -58.64 -43.58 89.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.979 0.512 . . . . 0.0 111.163 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.31 -37.86 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.93 83.89 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.089 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -60.53 -45.12 95.04 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.917 0.781 . . . . 0.0 110.421 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -64.97 -46.51 81.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.973 0.352 . . . . 0.0 110.093 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.16 -54.17 48.38 Favored 'General case' 0 N--CA 1.461 0.076 0 C-N-CA 124.023 0.929 . . . . 0.0 110.301 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.22 -43.59 74.63 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.341 1.056 . . . . 0.0 111.17 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -61.31 -54.11 48.15 Favored 'General case' 0 C--N 1.338 0.09 0 CA-C-N 118.813 0.733 . . . . 0.0 110.596 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -57.94 -36.23 72.22 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.4 mt -71.95 -26.23 62.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 118.845 -0.598 . . . . 0.0 112.092 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -70.38 -41.23 73.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 120.241 1.382 . . . . 0.0 108.911 169.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.18 -26.31 68.75 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.534 0.734 . . . . 0.0 111.458 173.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.54 -14.0 62.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.966 0.907 . . . . 0.0 111.745 174.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.92 17.23 6.95 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.845 -0.975 . . . . 0.0 113.594 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -122.73 -168.99 1.84 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.684 1.242 . . . . 0.0 109.853 -175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.4 p -126.15 153.2 44.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.7 p -143.33 159.31 42.6 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.827 -0.546 . . . . 0.0 110.06 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.31 97.81 4.69 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 m -69.91 122.56 19.53 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.1 mt -147.07 175.72 10.49 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.982 1.313 . . . . 0.0 108.663 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -120.21 39.97 3.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.432 1.493 . . . . 0.0 108.482 169.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.99 46.41 32.68 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 117.599 -1.667 . . . . 0.0 115.108 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -64.37 -22.09 66.27 Favored 'Trans proline' 0 C--N 1.35 0.651 0 CA-C-N 121.205 2.502 . . . . 0.0 113.616 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.6 mt -124.71 8.78 8.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.028 1.731 . . . . 0.0 109.832 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp 58.33 -14.79 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 128.502 2.721 . . . . 0.0 115.197 -169.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -159.26 76.32 0.69 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 120.004 1.274 . . . . 0.0 109.438 -169.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.32 -47.85 72.19 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 121.593 -0.692 . . . . 0.0 109.529 170.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.65 153.43 58.26 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 169.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.32 -176.5 0.86 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.14 3.227 . . . . 0.0 113.301 -178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.43 33.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.874 1.67 . . . . 0.0 112.567 172.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -159.76 133.42 7.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.238 2.215 . . . . 0.0 106.792 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 130.7 -144.96 16.4 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -176.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.1 mm -121.35 146.99 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 170.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.409 ' CD1' HG21 ' A' ' 83' ' ' VAL . 4.9 m95 -133.34 153.81 51.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.5 mt -136.61 143.35 43.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.2 t -123.24 131.85 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.7 91.6 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -142.57 -170.78 3.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.264 1.825 . . . . 0.0 107.908 -170.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m -144.61 133.27 22.23 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p -133.81 1.17 3.3 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -171.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -58.78 135.19 57.4 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.747 1.158 . . . . 0.0 108.287 169.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.96 32.42 75.26 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -173.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 61.65 6.77 1.65 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.874 2.47 . . . . 0.0 114.544 -169.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.26 -164.97 12.4 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.932 1.254 . . . . 0.0 111.286 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.44 -24.22 66.39 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.689 0.796 . . . . 0.0 112.86 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 46.8 pt -138.4 163.34 47.92 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.719 2.007 . . . . 0.0 107.629 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -56.01 -16.04 15.37 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.154 3.236 . . . . 0.0 116.74 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -142.96 63.74 1.37 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.751 1.22 . . . . 0.0 107.926 175.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -60.95 -34.16 74.3 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.379 1.072 . . . . 0.0 113.839 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.2 55.63 3.41 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.72 -54.7 52.06 Favored Pre-proline 0 CA--C 1.534 0.332 0 O-C-N 121.433 -0.792 . . . . 0.0 112.445 -168.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -77.84 -41.36 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.568 2.178 . . . . 0.0 110.514 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.12 -51.26 64.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.347 0.659 . . . . 0.0 110.937 -169.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -65.23 -43.55 91.06 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.99 0.814 . . . . 0.0 110.476 -174.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -62.54 -47.27 84.64 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.832 0.742 . . . . 0.0 110.256 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.13 -32.09 72.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.89 -59.69 4.97 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.178 0.899 . . . . 0.0 109.437 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.28 -17.2 62.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -67.01 -35.06 79.08 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.242 0.617 . . . . 0.0 111.129 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -126.0 -22.03 4.21 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 33.7 63.22 1.66 Allowed Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.81 164.23 16.84 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.027 2.485 . . . . 0.0 113.634 -169.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -80.42 64.97 5.41 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.54 1.136 . . . . 0.0 111.234 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.12 17.05 0.06 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 113.063 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.7 p -66.78 -2.87 5.56 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 119.922 -1.736 . . . . 0.0 112.789 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.1 11.97 9.56 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.1 1.76 . . . . 0.0 110.946 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -130.29 156.11 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.73 0.776 . . . . 0.0 111.439 176.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -121.33 152.47 38.92 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.878 1.271 . . . . 0.0 108.323 169.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.401 ' CZ ' ' CE3' ' A' ' 50' ' ' TRP . 5.8 m-85 -123.69 166.96 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.103 1.361 . . . . 0.0 108.599 -169.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -145.91 144.48 12.96 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.969 -2.852 . . . . 0.0 105.969 168.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -118.36 125.54 50.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 90' ' ' ILE . 34.3 mt -129.59 133.12 65.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -169.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.64 -28.42 1.54 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.799 1.19 . . . . 0.0 112.091 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' H ' ' C ' ' A' ' 88' ' ' ILE . 62.2 mt -48.83 138.77 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 128.509 2.724 . . . . 0.0 108.404 173.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.2 -0.0 35.39 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.344 1.45 . . . . 0.0 111.468 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 m -58.17 -0.11 0.08 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.995 2.518 . . . . 0.0 115.81 -172.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 93' ' ' ARG . 4.6 mmp_? -144.56 146.56 32.41 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 168.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 70.87 -21.07 0.2 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 128.675 2.79 . . . . 0.0 113.252 176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -132.54 -0.17 3.59 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.1 1.36 . . . . 0.0 111.862 -169.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -94.42 3.54 55.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.636 1.574 . . . . 0.0 113.569 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.5 p -76.32 -3.6 37.61 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.41 1.484 . . . . 0.0 113.334 177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -76.58 -19.45 57.86 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.52 1.928 . . . . 0.0 110.987 170.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.3 31.52 3.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.991 1.716 . . . . 0.0 109.701 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.28 -80.84 1.24 Allowed Glycine 0 C--N 1.338 0.667 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -161.16 148.16 15.0 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.1 1.36 . . . . 0.0 108.582 169.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.0 mm -127.27 2.71 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 126.732 2.013 . . . . 0.0 108.728 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -43.22 -29.14 0.36 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.68 1.992 . . . . 0.0 113.965 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -45.51 -35.71 4.04 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.64 1.576 . . . . 0.0 113.099 176.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.68 -57.28 13.37 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.653 0.661 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -66.83 -34.66 78.29 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.846 0.458 . . . . 0.0 110.245 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.54 94.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.03 -177.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.53 -38.49 90.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 118.995 0.816 . . . . 0.0 110.619 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.48 -44.36 87.36 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.835 0.743 . . . . 0.0 111.408 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -67.33 -36.05 80.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.537 0.735 . . . . 0.0 109.816 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -36.26 82.44 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.207 1.403 . . . . 0.0 111.332 172.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.6 m -67.56 -35.4 78.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.861 0.464 . . . . 0.0 110.521 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.86 -24.6 0.3 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.686 -1.063 . . . . 0.0 115.061 169.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.94 170.96 11.61 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.617 1.208 . . . . 0.0 111.384 -173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -121.62 133.18 54.98 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 168.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -78.78 102.27 8.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 169.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 m -70.77 150.79 45.52 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.86 -129.24 26.96 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.3 pt-20 -153.99 174.93 14.01 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.908 1.283 . . . . 0.0 108.592 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.1 m -59.52 129.79 43.68 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.108 0.963 . . . . 0.0 110.604 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.4 148.51 22.38 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.21 2.204 . . . . 0.0 107.946 -173.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -125.99 146.51 49.85 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.61 157.16 26.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 125.265 1.426 . . . . 0.0 109.374 -169.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -164.07 29.6 0.08 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.317 0.647 . . . . 0.0 111.359 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.6 tp -64.81 100.04 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.274 1.03 . . . . 0.0 110.254 -173.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.0 tp 47.96 32.0 2.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.687 1.995 . . . . 0.0 112.447 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -160.72 155.01 23.2 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.57 1.548 . . . . 0.0 108.067 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.07 153.62 51.69 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.115 1.366 . . . . 0.0 108.834 -177.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -151.76 -70.88 0.16 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.76 0.791 . . . . 0.0 110.944 -169.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.591 ' H ' ' HD2' ' A' ' 131' ' ' PRO . 8.3 mm -145.83 -52.6 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 126.454 1.901 . . . . 0.0 113.038 -169.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.591 ' HD2' ' H ' ' A' ' 130' ' ' ILE . 63.8 Cg_endo -75.51 -46.4 0.22 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 121.876 1.706 . . . . 0.0 112.47 -171.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 49.99 34.85 8.66 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.162 1.785 . . . . 0.0 111.991 -174.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -153.71 81.43 4.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.364 1.466 . . . . 0.0 108.504 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.68 153.53 75.77 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.637 2.224 . . . . 0.0 111.533 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -144.87 41.84 1.31 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.026 1.33 . . . . 0.0 109.967 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -58.16 -19.73 35.3 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.319 1.448 . . . . 0.0 114.304 -169.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -57.64 -25.86 60.77 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.09 0.956 . . . . 0.0 111.731 173.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.428 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.2 OUTLIER -56.34 -42.3 77.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.505 -0.759 . . . . 0.0 111.018 172.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.4 tp -62.98 -48.84 77.1 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -52.92 -47.42 59.52 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.074 0.858 . . . . 0.0 111.437 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.4 t -62.57 -55.0 31.29 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.529 0.665 . . . . 0.0 110.166 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -55.04 -39.78 69.54 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.49 1.916 . . . . 0.0 111.34 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.31 -58.83 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.477 1.511 . . . . 0.0 109.733 172.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -16.01 63.99 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.274 0.943 . . . . 0.0 112.303 -172.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.12 -38.46 61.1 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.023 0.929 . . . . 0.0 111.236 171.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -34.8 44.87 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.647 0.779 . . . . 0.0 111.878 -177.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.6 mttm . . . . . 0 C--O 1.248 1.015 0 C-N-CA 125.233 1.413 . . . . 0.0 109.867 171.193 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.3 161.06 43.18 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.004 0.922 . . . . 0.0 110.179 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.88 -23.9 16.13 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.769 1.627 . . . . 0.0 110.479 169.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.5 mt -135.18 127.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.532 1.133 . . . . 0.0 108.023 -174.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 t -88.2 126.66 35.26 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.68 95.58 6.14 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mt -95.81 95.46 4.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.856 1.262 . . . . 0.0 108.885 -169.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -76.36 159.38 30.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.52 9.17 0.03 OUTLIER Glycine 0 C--N 1.34 0.761 0 N-CA-C 116.913 1.525 . . . . 0.0 116.913 174.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.02 123.81 17.15 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.227 2.014 . . . . 0.0 109.587 175.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.2 p 38.21 57.57 1.62 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.57 1.948 . . . . 0.0 113.573 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.1 tp 51.26 63.18 2.35 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 111.372 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 164.16 -149.77 17.28 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -171.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.3 -179.69 38.98 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 117.736 0.768 . . . . 0.0 111.929 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.06 56.16 0.76 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.008 1.323 . . . . 0.0 109.642 171.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.44 -28.91 67.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.363 -0.836 . . . . 0.0 112.228 -172.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -62.14 -40.9 97.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.971 0.805 . . . . 0.0 110.854 173.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -73.16 -37.73 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.72 87.6 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.885 0.766 . . . . 0.0 110.952 174.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -68.21 -40.05 82.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.298 0.639 . . . . 0.0 110.931 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -63.11 -46.22 88.36 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.457 -0.777 . . . . 0.0 110.396 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.1 mt -55.99 -52.69 63.28 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.599 1.159 . . . . 0.0 109.894 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -51.12 -49.97 59.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.533 1.133 . . . . 0.0 110.924 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -55.29 -53.93 49.88 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.764 0.711 . . . . 0.0 110.576 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -60.61 -39.39 87.99 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 65.5 mt -66.51 -33.68 76.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.166 0.587 . . . . 0.0 111.52 177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.73 -37.14 67.84 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 120.846 -1.159 . . . . 0.0 110.265 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -62.03 -30.15 70.77 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.668 0.667 . . . . 0.0 111.113 170.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -18.65 62.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.777 0.831 . . . . 0.0 111.797 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.27 -2.53 6.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.247 -1.307 . . . . 0.0 114.257 169.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -101.25 -168.23 1.53 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.564 1.682 . . . . 0.0 110.104 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 p -128.36 150.92 49.89 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 169.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.3 p -142.9 154.59 44.26 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.9 -0.5 . . . . 0.0 111.836 -169.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -119.81 99.37 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.463 1.505 . . . . 0.0 107.966 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.4 m -73.97 122.58 22.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 71.7 mt -146.61 169.95 17.93 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.849 0.859 . . . . 0.0 111.06 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -119.6 39.57 3.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.197 1.799 . . . . 0.0 108.789 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.31 51.62 11.58 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 117.858 -1.523 . . . . 0.0 114.801 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -21.94 64.67 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 120.662 2.231 . . . . 0.0 113.389 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.87 16.75 6.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.552 1.941 . . . . 0.0 108.741 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 tp 59.9 -25.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 129.354 3.062 . . . . 0.0 115.076 -169.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.42 85.68 0.86 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -168.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.91 -44.8 88.37 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.536 -0.727 . . . . 0.0 109.847 172.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.0 mt -84.22 151.29 59.59 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.52 -176.79 1.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 124.128 3.219 . . . . 0.0 113.087 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.26 31.88 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.989 1.716 . . . . 0.0 112.933 172.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.4 m -158.93 121.79 3.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.699 2.0 . . . . 0.0 106.445 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.16 -142.88 11.49 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.4 mm -122.29 136.26 59.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 170.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.464 ' CD1' HG21 ' A' ' 83' ' ' VAL . 12.1 m0 -119.41 137.31 53.83 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 172.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 61.7 mt -131.81 137.69 48.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 173.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.82 137.72 53.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.07 113.01 23.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -161.73 -178.18 6.36 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.117 1.367 . . . . 0.0 108.457 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 m -133.18 124.85 28.2 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.1 p -122.05 2.41 9.87 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.024 0.93 . . . . 0.0 113.301 -169.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -142.94 148.43 36.88 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 170.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.76 -33.45 0.72 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.014 1.292 . . . . 0.0 114.875 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -144.34 44.74 1.42 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.602 1.561 . . . . 0.0 110.42 -170.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.42 -158.78 7.82 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -149.45 77.52 1.35 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.794 1.638 . . . . 0.0 106.76 -172.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.1 pt -46.96 -29.99 1.12 Allowed Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 -169.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -57.84 -31.93 93.68 Favored 'Trans proline' 0 C--N 1.353 0.788 0 CA-C-N 123.833 2.405 . . . . 0.0 113.982 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -160.11 45.21 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 122.368 1.08 . . . . 0.0 109.799 -171.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.03 -31.69 65.41 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.237 1.815 . . . . 0.0 114.662 -169.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mp -129.68 90.28 2.96 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 174.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.05 -53.74 31.51 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 124.857 1.263 . . . . 0.0 113.209 -168.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.47 -38.59 8.21 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.175 1.25 . . . . 0.0 109.909 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -64.47 -57.83 8.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.774 -170.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -59.58 -47.16 86.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.704 -171.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -64.5 -48.64 74.39 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.626 0.648 . . . . 0.0 110.539 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.41 -26.24 67.89 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.8 mt -62.34 -62.4 1.78 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.238 0.926 . . . . 0.0 108.868 170.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -67.18 -19.57 65.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.45 -34.49 78.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.601 0.76 . . . . 0.0 111.462 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.39 -23.19 2.4 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt 30.84 63.13 1.01 Allowed Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 127.13 2.172 . . . . 0.0 113.077 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -65.26 166.85 17.89 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.968 2.445 . . . . 0.0 113.164 -169.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.66 63.8 5.21 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.954 1.302 . . . . 0.0 111.343 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.91 9.87 0.48 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.273 1.429 . . . . 0.0 113.074 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -63.93 -2.48 1.93 Allowed 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.105 2.962 . . . . 0.0 113.235 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -120.06 9.71 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.991 1.716 . . . . 0.0 110.919 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 50' ' ' TRP . 2.3 p -124.65 146.44 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-O 121.916 0.865 . . . . 0.0 111.401 172.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -97.67 141.26 30.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 169.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -115.63 153.04 32.0 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.581 1.952 . . . . 0.0 107.537 -174.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.67 149.55 21.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 169.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.96 134.95 54.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -175.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.8 mt -134.8 128.79 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.17 -29.08 1.65 Allowed Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.389 0.995 . . . . 0.0 112.461 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 51.1 mt -47.97 117.93 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 127.784 2.434 . . . . 0.0 107.849 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.01 -41.01 28.62 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 125.888 1.708 . . . . 0.0 111.079 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.1 p -51.37 106.56 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.085 1.754 . . . . 0.0 110.208 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -150.55 -172.29 4.15 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.232 1.813 . . . . 0.0 107.19 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -60.85 -20.75 62.33 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.8 1.24 . . . . 0.0 111.537 169.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -139.31 -173.49 3.61 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 128.498 2.719 . . . . 0.0 108.413 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t0 48.01 43.63 18.11 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 122.793 1.282 . . . . 0.0 111.122 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.7 m -151.82 66.55 0.86 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -169.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -126.7 -16.16 5.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -168.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 31.9 p -134.05 16.66 3.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.294 0.952 . . . . 0.0 112.219 175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 171.71 166.54 30.6 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.221 1.391 . . . . 0.0 110.11 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -156.69 150.2 24.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.115 1.366 . . . . 0.0 108.131 171.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 40.64 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.69 -22.88 25.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.148 1.379 . . . . 0.0 112.068 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -52.71 -29.83 28.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.594 1.157 . . . . 0.0 112.748 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.57 -54.32 48.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.41 1.004 . . . . 0.0 109.678 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -67.66 -37.66 82.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.761 1.224 . . . . 0.0 108.673 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.9 79.69 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.527 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.82 -34.95 79.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.797 -1.097 . . . . 0.0 111.136 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.55 -49.99 75.63 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.745 1.157 . . . . 0.0 111.201 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -69.28 -34.28 74.48 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.727 0.811 . . . . 0.0 109.938 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -37.78 84.16 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.763 1.625 . . . . 0.0 111.231 172.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.3 m -65.86 -40.49 91.72 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.35 -20.61 0.4 Allowed Glycine 0 C--N 1.341 0.827 0 CA-C-O 117.811 -1.55 . . . . 0.0 115.135 169.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.06 132.82 49.43 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.699 1.749 . . . . 0.0 109.453 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -83.84 114.67 21.81 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -64.02 114.67 4.28 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 170.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.4 m -126.65 115.08 18.9 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 169.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.32 103.78 2.37 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 106.34 -2.704 . . . . 0.0 106.34 -169.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -52.95 137.26 33.04 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.149 -1.526 . . . . 0.0 107.379 169.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.2 m -47.87 116.42 1.49 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.722 1.609 . . . . 0.0 111.347 -169.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.69 153.8 26.4 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.188 1.795 . . . . 0.0 107.718 -169.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -129.09 146.5 51.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.5 pp -135.39 163.0 36.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 124.549 1.139 . . . . 0.0 111.252 -169.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 57.89 141.59 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 130.262 3.425 . . . . 0.0 115.31 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 7.7 tp -150.01 9.8 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 124.402 1.081 . . . . 0.0 110.936 -174.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.29 -29.42 70.42 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.155 -0.966 . . . . 0.0 111.436 -176.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -149.18 167.92 24.64 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.555 1.942 . . . . 0.0 106.704 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -56.72 148.06 21.27 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.1 0.56 . . . . 0.0 109.668 170.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -154.93 -126.38 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.473 0.709 . . . . 0.0 110.184 -173.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.5 mm -135.6 -61.92 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 127.394 2.278 . . . . 0.0 109.037 -176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.92 -48.91 2.46 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.271 1.981 . . . . 0.0 110.039 171.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 44.53 68.0 0.61 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.878 2.071 . . . . 0.0 113.107 169.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -150.64 140.59 13.99 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 121.407 -0.808 . . . . 0.0 111.293 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.1 -19.15 19.53 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.337 3.358 . . . . 0.0 116.731 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 68.68 -36.92 0.34 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 128.661 2.784 . . . . 0.0 115.153 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.16 -33.04 70.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.545 0.738 . . . . 0.0 112.702 -169.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.08 -37.39 72.45 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.027 -0.421 . . . . 0.0 110.443 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -67.05 -45.26 77.92 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.437 0.695 . . . . 0.0 109.871 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.69 -52.6 65.02 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.48 95.01 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.047 0.84 . . . . 0.0 112.051 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 58.5 m -59.29 -62.94 1.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.074 1.35 . . . . 0.0 110.239 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -56.09 -44.78 79.32 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.612 1.165 . . . . 0.0 111.978 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.4 -55.92 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.361 1.064 . . . . 0.0 109.848 178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -16.29 63.6 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.81 1.186 . . . . 0.0 112.053 -174.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.1 mp -78.2 -47.22 18.52 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.535 0.734 . . . . 0.0 111.029 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.18 -32.54 64.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.0 0.818 . . . . 0.0 112.329 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 82.7 mttt . . . . . 0 C--O 1.249 1.028 0 C-N-CA 124.752 1.221 . . . . 0.0 109.611 173.34 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 tpp . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.02 160.16 43.14 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.575 1.15 . . . . 0.0 108.917 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -103.61 -25.13 13.3 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.43 1.492 . . . . 0.0 111.059 175.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.56 121.77 48.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -83.88 130.55 34.91 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.56 109.6 21.33 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.5 mt -103.66 94.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.22 14.82 27.07 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.06 0.944 . . . . 0.0 112.075 -171.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.64 58.87 4.37 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.128 -171.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -54.6 100.36 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.741 1.27 . . . . 0.0 110.25 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m 57.7 42.3 23.95 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.78 0.832 . . . . 0.0 110.804 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.1 39.56 29.78 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.236 1.815 . . . . 0.0 111.398 -169.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.94 -145.3 7.38 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.493 1.996 . . . . 0.0 109.7 173.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -160.72 62.12 0.29 Allowed Glycine 0 C--N 1.334 0.447 0 CA-C-N 117.556 0.678 . . . . 0.0 111.902 -172.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.53 19.96 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.5 1.12 . . . . 0.0 112.476 172.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.9 -20.19 64.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.011 1.324 . . . . 0.0 112.482 -170.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.93 -40.4 76.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.237 0.926 . . . . 0.0 111.326 176.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.4 t -71.96 -41.42 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.72 -30.87 71.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.259 -0.877 . . . . 0.0 112.776 -176.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.23 -43.55 94.61 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.67 1.123 . . . . 0.0 110.43 175.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -66.35 -44.41 83.32 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.044 -0.41 . . . . 0.0 110.039 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.46 -52.45 65.35 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.159 0.584 . . . . 0.0 110.733 177.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.27 -45.37 65.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.287 1.035 . . . . 0.0 110.76 176.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -56.33 -54.2 48.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.158 0.89 . . . . 0.0 110.484 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -57.66 -43.75 85.19 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 123.646 0.778 . . . . 0.0 112.275 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -69.15 -34.49 75.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.919 0.887 . . . . 0.0 111.356 -179.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.9 -44.05 73.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.316 -0.865 . . . . 0.0 109.642 177.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -71.65 -18.52 62.19 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.174 0.897 . . . . 0.0 111.954 174.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.35 -18.95 63.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.83 0.741 . . . . 0.0 111.083 169.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.09 12.54 5.78 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.267 -1.296 . . . . 0.0 114.442 169.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -117.8 -172.08 2.18 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.411 1.606 . . . . 0.0 109.93 -174.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -124.13 153.99 40.69 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 170.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.8 p -142.54 158.91 43.18 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.838 -0.539 . . . . 0.0 109.93 -169.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.2 99.24 5.8 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 m -72.18 118.88 15.61 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.0 mt -149.48 164.95 33.59 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.625 0.726 . . . . 0.0 111.585 -169.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -106.12 35.68 2.84 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.393 1.477 . . . . 0.0 108.506 168.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.8 50.74 14.26 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.963 -175.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.5 -20.31 65.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 120.871 2.335 . . . . 0.0 113.864 -173.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.3 mt -116.25 9.89 14.69 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.834 1.654 . . . . 0.0 109.766 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt 60.38 -18.19 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.406 2.682 . . . . 0.0 114.627 -169.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -166.3 75.36 0.19 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.498 1.519 . . . . 0.0 107.232 -169.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.38 -44.61 96.04 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.773 -0.579 . . . . 0.0 109.818 176.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.6 mt -89.24 150.39 44.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.42 -177.45 1.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.674 2.916 . . . . 0.0 113.106 -175.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.08 35.51 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.65 1.58 . . . . 0.0 111.898 169.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.9 m -157.69 125.15 5.19 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.973 2.109 . . . . 0.0 106.272 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.96 -145.23 17.19 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -174.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.4 mm -126.48 144.34 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 173.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -127.1 158.12 37.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -143.28 143.79 31.86 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.15 135.35 62.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -176.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.17 124.59 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -170.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.0 m -163.98 -167.48 1.37 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.216 2.206 . . . . 0.0 107.1 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.1 m -148.88 62.57 1.06 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.435 -1.415 . . . . 0.0 108.0 172.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -55.51 -26.75 44.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.569 1.548 . . . . 0.0 114.128 -169.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -61.08 -22.82 64.97 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 176.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 171.31 16.15 0.02 OUTLIER Glycine 0 C--N 1.341 0.857 0 N-CA-C 117.436 1.735 . . . . 0.0 117.436 176.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.58 24.12 2.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.384 1.073 . . . . 0.0 111.095 176.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.7 163.58 51.74 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 169.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.67 -24.18 61.79 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.981 -0.717 . . . . 0.0 112.188 -175.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 65' ' ' ASN . 10.7 tp -143.94 152.22 54.69 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 171.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -52.81 -34.08 63.72 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.526 2.151 . . . . 0.0 115.532 -176.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.54 -47.09 70.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.866 0.757 . . . . 0.0 110.84 174.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' H ' HG23 ' A' ' 62' ' ' ILE . 31.2 t30 58.32 143.4 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 130.701 3.601 . . . . 0.0 115.269 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 33.1 mt 52.75 46.23 27.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.568 1.147 . . . . 0.0 108.575 -175.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.1 m -75.88 -49.5 3.43 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 124.549 1.14 . . . . 0.0 111.833 -170.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.63 -34.45 41.59 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.97 1.382 . . . . 0.0 110.584 176.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -59.69 -51.3 70.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.976 0.911 . . . . 0.0 110.125 173.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 104' ' ' LYS . 39.0 t80 -55.46 -48.29 74.73 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.48 1.112 . . . . 0.0 110.846 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -65.65 -41.65 92.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.523 0.601 . . . . 0.0 111.453 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.6 84.83 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.666 0.666 . . . . 0.0 111.326 -178.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.8 mt -55.63 -57.35 12.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 118.777 0.717 . . . . 0.0 109.816 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -69.2 -15.57 63.42 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -73.65 -32.09 63.83 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.85 0.75 . . . . 0.0 111.295 177.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.78 -30.1 4.52 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -173.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt 26.64 70.37 0.43 Allowed Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 127.06 2.144 . . . . 0.0 113.331 -172.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -58.15 176.65 0.34 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.791 2.327 . . . . 0.0 112.004 174.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -90.02 76.16 7.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.73 0.812 . . . . 0.0 110.342 -179.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.588 HD23 ' HB3' ' A' ' 112' ' ' SER . 2.1 mm? -74.74 5.63 4.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.617 0.767 . . . . 0.0 112.557 -175.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.8 m -65.14 -5.51 6.9 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 127.839 2.456 . . . . 0.0 113.268 -176.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.93 8.74 26.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.469 1.508 . . . . 0.0 110.702 176.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.94 160.54 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 122.146 0.974 . . . . 0.0 110.945 176.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -129.11 154.11 47.02 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.08 1.752 . . . . 0.0 106.929 172.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -127.38 173.9 9.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.534 0.683 . . . . 0.0 109.428 178.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.13 157.87 26.17 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 107.465 -2.254 . . . . 0.0 107.465 169.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.64 125.13 41.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -173.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.0 mt -129.31 134.08 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -168.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.71 -31.78 1.69 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.537 1.541 . . . . 0.0 112.009 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.3 mt -47.88 154.07 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 129.583 3.153 . . . . 0.0 110.857 176.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -138.63 -15.1 0.66 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.051 -0.86 . . . . 0.0 114.73 -179.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.9 m -61.57 132.32 52.95 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.304 1.052 . . . . 0.0 109.805 177.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -148.73 170.64 17.73 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 126.807 2.043 . . . . 0.0 106.939 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -55.4 -21.52 16.0 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.518 1.527 . . . . 0.0 113.363 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -117.74 4.77 12.26 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.541 1.537 . . . . 0.0 112.37 -177.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -102.01 17.2 23.81 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.101 0.953 . . . . 0.0 110.731 175.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.4 p -70.2 17.53 0.06 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.39 2.676 . . . . 0.0 115.157 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -128.45 -9.55 5.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.546 1.538 . . . . 0.0 111.026 174.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.44 24.46 2.93 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.903 1.281 . . . . 0.0 111.04 -173.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.22 -167.27 16.6 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -176.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.52 18.8 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.087 2.155 . . . . 0.0 113.163 179.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.3 mt 49.3 32.43 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 126.539 1.936 . . . . 0.0 110.452 -169.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 57.04 11.12 0.91 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.571 1.948 . . . . 0.0 114.022 -177.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 51.5 mtmt -64.91 -42.17 94.96 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.541 -1.349 . . . . 0.0 113.33 -169.483 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.55 -53.15 58.98 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 47.9 mp0 -61.24 -41.18 96.44 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.595 1.158 . . . . 0.0 110.455 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.48 -49.77 76.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.386 -0.816 . . . . 0.0 109.49 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.246 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 mt -58.65 -46.64 86.7 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.427 1.012 . . . . 0.0 110.867 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -67.34 -41.26 85.48 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 123.462 0.705 . . . . 0.0 109.723 -178.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -30.85 71.87 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.043 1.337 . . . . 0.0 111.331 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.588 ' HB3' HD23 ' A' ' 80' ' ' LEU . 16.2 m -74.16 -13.88 60.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.25 0.22 . . . . 0.0 111.496 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.48 -24.33 3.73 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 121.174 -0.954 . . . . 0.0 113.033 169.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.25 167.8 15.54 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.053 0.927 . . . . 0.0 110.631 -177.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -120.54 144.3 48.13 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 169.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -83.68 104.73 14.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 83.2 m -70.38 153.46 42.97 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.63 -131.29 21.43 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 178.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.451 ' HG3' ' HE1' ' A' ' 138' ' ' TRP . 11.4 pt-20 -150.43 178.56 8.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.192 1.397 . . . . 0.0 107.862 169.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.49 123.08 9.03 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.927 1.291 . . . . 0.0 109.824 177.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.55 155.75 17.13 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.61 1.564 . . . . 0.0 107.712 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -139.33 151.4 46.36 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -144.05 124.77 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 126.125 1.77 . . . . 0.0 106.718 -169.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -164.06 -177.8 5.23 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.332 -0.855 . . . . 0.0 112.23 176.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.6 tt -151.39 174.66 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.058 1.743 . . . . 0.0 107.773 -171.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.5 tt -53.42 -35.64 60.64 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.986 1.315 . . . . 0.0 112.225 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -75.03 77.09 2.22 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -56.75 156.15 6.84 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -169.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -140.46 -170.21 2.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.995 2.518 . . . . 0.0 107.873 171.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.99 -50.3 75.77 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 126.352 1.861 . . . . 0.0 113.384 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -63.9 -38.93 35.67 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.405 2.07 . . . . 0.0 111.502 178.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 72.34 -26.35 0.18 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.812 2.445 . . . . 0.0 114.532 169.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -144.73 124.49 7.18 Favored Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 123.995 0.918 . . . . 0.0 109.826 -171.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -71.22 157.38 57.37 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.682 2.255 . . . . 0.0 111.64 177.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -139.82 41.08 2.0 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.194 1.398 . . . . 0.0 109.707 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -57.15 -19.01 17.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.254 1.422 . . . . 0.0 114.804 -169.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.62 -26.32 65.37 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.416 -0.803 . . . . 0.0 111.458 173.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . 0.451 ' HE1' ' HG3' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -61.11 -42.04 97.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.599 0.76 . . . . 0.0 110.281 172.257 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.0 tp -62.93 -49.68 73.82 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.96 -46.62 68.61 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 123.823 0.702 . . . . 0.0 111.721 177.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.1 m -62.47 -59.17 5.34 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.345 1.458 . . . . 0.0 110.818 177.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -49.8 -41.72 45.25 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.969 2.108 . . . . 0.0 111.872 178.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.0 t -63.96 -58.41 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 125.182 1.393 . . . . 0.0 109.813 173.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -15.74 63.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.311 0.959 . . . . 0.0 112.324 -173.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.87 -41.55 59.57 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.022 0.929 . . . . 0.0 111.168 170.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.5 -31.27 42.22 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -176.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 56.6 mttm . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.1 1.36 . . . . 0.0 109.721 169.972 . . . . . . . . 0 0 . 1 stop_ save_